Citrus Sinensis ID: 004986
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | yes | no | 0.937 | 0.723 | 0.598 | 0.0 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.375 | 0.328 | 0.647 | 1e-101 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.381 | 0.213 | 0.431 | 6e-66 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.35 | 0.392 | 0.468 | 3e-64 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.362 | 0.378 | 0.441 | 3e-62 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.356 | 0.343 | 0.447 | 5e-61 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.375 | 0.294 | 0.431 | 8e-61 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.365 | 0.158 | 0.357 | 2e-57 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.419 | 0.185 | 0.354 | 2e-56 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.362 | 0.158 | 0.383 | 6e-54 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 783 bits (2022), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/713 (59%), Positives = 516/713 (72%), Gaps = 38/713 (5%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
W E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGSHYTG EDDA
Sbjct: 244 WTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGSHYTGNEDDA 303
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P + SND
Sbjct: 304 VNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQFSNDV----- 358
Query: 122 KPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPNQS 181
PK EGSS +S + S L+ + +E+ +S S+P S SS + Q
Sbjct: 359 -PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSPSSVTSSTQL 415
Query: 182 DYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGAGK 241
+ SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLNPFQ KGA K
Sbjct: 416 ENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLNPFQNKGADK 469
Query: 242 TSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKINR 301
+ + V++F + NP+ GR P PMM KN + NE P++KE SY+E +LPK++R
Sbjct: 470 LYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYIENLLPKLHR 528
Query: 302 EPN-NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQLNG 360
+P N +S +TSS++ + +N+ +D+ + + S S+ +Q
Sbjct: 529 DPRYGNTQSSYATSSSNGAIS---------SNVHGRDNVTFVSPVAVPSSFTSTENQFR- 578
Query: 361 PPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRF-MGTNLKLRDLESP 410
P +VED++ N+ +E P ++ E HD RK T D G + +L+D ES
Sbjct: 579 PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCDPRLKDHEST 638
Query: 411 SSSVDSSTSKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF 468
SSS+DS++ + D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+GTEVAVKKF
Sbjct: 639 SSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKF 698
Query: 469 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 528
LDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRGSL+RILHRP
Sbjct: 699 LDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP 758
Query: 529 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588
+DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV DFGLSRLKH
Sbjct: 759 KSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKH 818
Query: 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 648
NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGA
Sbjct: 819 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGA 878
Query: 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701
VGFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV+P+
Sbjct: 879 VGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPT 931
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (946), Expect = e-101, Method: Compositional matrix adjust.
Identities = 176/272 (64%), Positives = 215/272 (79%), Gaps = 2/272 (0%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGM 548
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700
II CW +P RPSFA + L+PL + +P
Sbjct: 783 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 122/283 (43%), Positives = 181/283 (63%), Gaps = 8/283 (2%)
Query: 405 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 464
+D + P ++ + +V++ F E E+P ++ +G RIG G YG+V+ W GTEVA
Sbjct: 822 KDHQFPVPTIPAKIIEVEKPF-----EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVA 876
Query: 465 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 524
VK + + + + + ++EV ++ +LRHPN+VLFMGA T P + I+TE+L RGSL I
Sbjct: 877 VKMLFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936
Query: 525 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584
L ++D R+++ D ARGM LH+ P I+HRDLK+ NLLVD +W VKV+DFGL+
Sbjct: 937 LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLA 996
Query: 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 644
+K +TF +K+ GT W+APEVL E EK DVYS+ ++LWEL T +P+ G N MQ
Sbjct: 997 TVKSHTF--AKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ 1054
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
VV ++ + RL +P P A ++ CW+TDP+ RPSF ++
Sbjct: 1055 VVRSID-RGERLPMPAWCPPKYAALMNRCWETDPTHRPSFPEI 1096
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (629), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 119/254 (46%), Positives = 167/254 (65%), Gaps = 2/254 (0%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
+I + +G RIG G+YGEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HPNV+ F+G+ PP++ I TE++PRGSL+ ILH Q+ IKM +D A+G+ LH
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLH 487
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 488 NSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 545
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R +P+ P +++ +
Sbjct: 546 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLID 605
Query: 673 CWQTDPSLRPSFAQ 686
C +PS RP+ Q
Sbjct: 606 CLNENPSHRPTMEQ 619
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 116/263 (44%), Positives = 169/263 (64%), Gaps = 2/263 (0%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
+I + + +G RIG G++GEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HPNV+ F+G+ P++ I TE++PRGSL+ ILH ++ +M +D A+G+ LH
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLH 504
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 505 GSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 562
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R PK P +++ +
Sbjct: 563 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKD 622
Query: 673 CWQTDPSLRPSFAQLTVALKPLQ 695
C +PS RP+ Q L+ ++
Sbjct: 623 CLNENPSQRPTMEQCLEILESIE 645
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 120/268 (44%), Positives = 164/268 (61%), Gaps = 11/268 (4%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL-----DQDFSGAALLEFKREVKIM 488
I ++V+ RIG GS EV+ W G VA+KK D+DF L E +E IM
Sbjct: 486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDF----LNELAQEATIM 541
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
+LRHPN+ F+G PP + I+ E++P GSL+RILH P +D R MALD+A+GM
Sbjct: 542 SQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGM 601
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAP 606
N LH P ++HRDLKS NLLVD+++ VK+SDFGLS KH ++ + GTP W AP
Sbjct: 602 NYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAP 661
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
EVLRN+P EK DV+SF ++LWE+ T + P+ GM Q+V +VG R +P ++
Sbjct: 662 EVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPF 721
Query: 667 ARIIWECWQTDPSLRPSFAQLTVALKPL 694
R+I ECW DP RPSF ++ L+ +
Sbjct: 722 TRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (600), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 120/278 (43%), Positives = 178/278 (64%), Gaps = 8/278 (2%)
Query: 411 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF-L 469
S SV S+ Q F D EI + +L + ++G G++G VY W G+ VA+K+ +
Sbjct: 638 SGSVVEPPSQQQQYFSD----IEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 470 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 529
++D + L EF++E+ I+ RLRHPN+VL M A T PPNL ITE+LP GSL+ LH
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 530 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589
+++ + K+A+ +A+GMN LH S ++HRD+KS NLL+D++ NVK+ DFGLS+LK
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLS--GVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSK 811
Query: 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 649
+ +KS G+P WM+PE+L E EK DVY+FG+ILWEL T +LP+ G++ +Q+ AV
Sbjct: 812 STEMTKSI-GSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAV 870
Query: 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
++ R IP ++ +I CW DP RPSF ++
Sbjct: 871 TTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEI 908
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 224 bits (571), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 95/266 (35%), Positives = 172/266 (64%), Gaps = 3/266 (1%)
Query: 429 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 488
+C I ++++ +GE+IGLGSYG VY W +VA+KKF+ Q LL + E+ +
Sbjct: 1389 LCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFL 1448
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
++L HPN++ +GA + PN+ I+TE++ +G+L + +++ ++IK+ +++A+G+
Sbjct: 1449 KKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGI 1508
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
+ LH+ P I+HRD+K N+L+D+NWNVK++DFG +R+K + ++ GTP W APE+
Sbjct: 1509 SYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPEI 1566
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
+RN+ +EK DV+SFG+++WE+ T K P+IG N M++ + ++ R +IP++ A+
Sbjct: 1567 IRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAK 1625
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPL 694
++ +CW + RP+ + + L
Sbjct: 1626 LMRKCWHAKSTKRPTMDDVIIVLAKF 1651
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 115/324 (35%), Positives = 185/324 (57%), Gaps = 22/324 (6%)
Query: 386 YHDRRKCTHDRFMG--TNLKLRDLESPSSSVDSSTSKVDQIFDDD--------------- 428
Y + + +RF G T + D ++ S + D S +I D D
Sbjct: 1294 YEIKFEILKNRFFGGITYVNYND-DTDSGTADDSNYDSGKIIDIDYMADIDKEDSFLTSA 1352
Query: 429 -VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 487
+C I ++++ +G++IGLGSYG V++ W G +VAVKKF+ Q S LLEF+ E+
Sbjct: 1353 NMCRWIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAF 1412
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
+ L+H N+V F+GA + PN+ I+TE++ G+L +L P ++ ++K+ A G
Sbjct: 1413 LSELKHSNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMG 1472
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 607
++ LH+S P IVHRD+K N+LVD+++NVK++DFG +R+K + ++ + GTP W APE
Sbjct: 1473 IDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPE 1530
Query: 608 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667
V+R E EK DV+SFGV++WE+ T K P+ N M+V + + R IP + A
Sbjct: 1531 VIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEFA 1589
Query: 668 RIIWECWQTDPSLRPSFAQLTVAL 691
++I +CW RP+ ++ L
Sbjct: 1590 KLIKKCWHAKAHKRPTMTEVVQQL 1613
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 102/266 (38%), Positives = 159/266 (59%), Gaps = 5/266 (1%)
Query: 429 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 488
+C I ++D+ +G++IG+GSYG V W VAVKKF+ Q +LEF+ E+ +
Sbjct: 1384 LCRWIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFL 1443
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
+LRHP+++L +GA + PN+ I+TEF+ GSL ++ + + K +IKM A G+
Sbjct: 1444 SQLRHPHIILMIGACLKRPNICIVTEFMGNGSLRNVIKTT--KPEWKLKIKMLYQTALGI 1501
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
LH S P I+HRD+K N+LVD + NVK++DFG +R+K S + GTP W APE+
Sbjct: 1502 GYLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEEN--SVMTRCGTPCWTAPEI 1559
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
+R E EK DV+SFG+++WE+ T K P+ G N M+V + + R +IP + +
Sbjct: 1560 IRGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDI-LEGARPQIPSDCPIDFTK 1618
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPL 694
++ +CW P RPS + + L +
Sbjct: 1619 LMKQCWHAKPDKRPSMEDVIMGLNDM 1644
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| 224125544 | 967 | predicted protein [Populus trichocarpa] | 0.984 | 0.733 | 0.716 | 0.0 | |
| 255542402 | 958 | map3k delta-1 protein kinase, putative [ | 0.990 | 0.744 | 0.712 | 0.0 | |
| 224130772 | 955 | predicted protein [Populus trichocarpa] | 0.959 | 0.723 | 0.716 | 0.0 | |
| 359487849 | 955 | PREDICTED: serine/threonine-protein kina | 0.994 | 0.749 | 0.700 | 0.0 | |
| 356535135 | 930 | PREDICTED: serine/threonine-protein kina | 0.931 | 0.721 | 0.686 | 0.0 | |
| 229335619 | 913 | EDR1 [Glycine max] | 0.931 | 0.734 | 0.686 | 0.0 | |
| 262213688 | 871 | EDR1 [Glycine max] | 0.918 | 0.758 | 0.681 | 0.0 | |
| 356576743 | 932 | PREDICTED: serine/threonine-protein kina | 0.929 | 0.717 | 0.682 | 0.0 | |
| 449435758 | 935 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.969 | 0.746 | 0.646 | 0.0 | |
| 350536633 | 982 | TCTR2 protein [Solanum lycopersicum] gi| | 0.977 | 0.716 | 0.644 | 0.0 |
| >gi|224125544|ref|XP_002319612.1| predicted protein [Populus trichocarpa] gi|222857988|gb|EEE95535.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1049 bits (2713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 526/734 (71%), Positives = 602/734 (82%), Gaps = 25/734 (3%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
W+ERS+ELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLVKGSHYTG+EDDA
Sbjct: 244 WIERSSELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLVKGSHYTGIEDDA 303
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNIIKL++EREFLVDLMAAPGTLIPAD+ SAKD+ FK IP LR++ND+G V++
Sbjct: 304 VNIIKLKDEREFLVDLMAAPGTLIPADVPSAKDSTFK--------IPSLRSTNDTGVVFT 355
Query: 122 KPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTP-NQ 180
+P PL EG+SQ+S+VDG P N SE AESLP F S + G SSG++++ P NQ
Sbjct: 356 RPNPLPGEGTSQSSSVDGISPFNSRLNSENAESLPFFSGSSSDAGVGSSGVANKAAPTNQ 415
Query: 181 SDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGAG 240
+SS+ IGTS+YKG RG +AVGDG RMNVNVVPYG EDSK+LF+DLNPFQIKG G
Sbjct: 416 FGNISSTAIGTSVYKGSRGGHAVGDGVRMNVNVVPYGPNSPEDSKNLFSDLNPFQIKGTG 475
Query: 241 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 300
K+ +H P E+K+ EF + NPV G PP P++ KN++ YNEVPR+KE +EG+ P+IN
Sbjct: 476 KSFMHHKPVENKINEFPGRKNNPVPG-PPAPLVWKNRYAYNEVPRRKENELVEGLYPRIN 534
Query: 301 REPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQLNG 360
REPNN + ASTSS SE P FK S++ N S+K+S++R+ S +L+S SQ
Sbjct: 535 REPNNYNQSLASTSS-SEKVYPQGFKSSSNFNPSNKESDTRNYASSVSSALSSDPSQCYS 593
Query: 361 PPLVEDLSSNSKDE---NPKNV-----------EDHEIGYHDRRKCTHDRFMGTNLKLRD 406
P VE+ +SN K+ + KN+ ED+EI +HDRRKCT+DRFMGTNLKL+D
Sbjct: 594 FPSVEEANSNFKENKLWDAKNLQNDSEAMAKEHEDNEIDFHDRRKCTYDRFMGTNLKLKD 653
Query: 407 LESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK 466
ESPS+SVD + +VDQI DD EI WEDL++GERIGLGSYGEVYHADWNGTEVAVK
Sbjct: 654 PESPSASVDPISHRVDQIMDDVDVGDEICWEDLIIGERIGLGSYGEVYHADWNGTEVAVK 713
Query: 467 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 526
KFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL+RILH
Sbjct: 714 KFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLYRILH 773
Query: 527 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586
RP CQ+DEKRRI+MALDVARGMNCLH S PTIVHRDLKSPNLLVDKNW VKV DFGLSRL
Sbjct: 774 RPQCQIDEKRRIRMALDVARGMNCLHASIPTIVHRDLKSPNLLVDKNWTVKVCDFGLSRL 833
Query: 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 646
KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELAT++LPW GMNPMQVV
Sbjct: 834 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATIRLPWSGMNPMQVV 893
Query: 647 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 706
GAVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRLVIPSH DQP
Sbjct: 894 GAVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRLVIPSHLDQP 953
Query: 707 SSALPQEISVNSTP 720
S L QEI+VNSTP
Sbjct: 954 SPPLQQEIAVNSTP 967
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542402|ref|XP_002512264.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223548225|gb|EEF49716.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1034 bits (2674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/737 (71%), Positives = 603/737 (81%), Gaps = 24/737 (3%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
WMERST+LR+SL TS LPIGSI+IGLSRHRALLFKVLAD+IR PCRLVKGSHYTG+EDDA
Sbjct: 228 WMERSTDLRKSLHTSALPIGSIDIGLSRHRALLFKVLADNIRFPCRLVKGSHYTGIEDDA 287
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
+NIIKLE+EREFLVDLMA PGTLIPAD+LSAKDT FK YNP I+ I L++ N+S +Y+
Sbjct: 288 INIIKLEDEREFLVDLMADPGTLIPADVLSAKDTTFKSYNPNINIIAGLQSPNESEIIYT 347
Query: 122 KPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRV-TPNQ 180
+ P EGSSQNS++DGSLPL+ S++E AESL SF S G SSG S+V + NQ
Sbjct: 348 RSSPSFGEGSSQNSSMDGSLPLDRRSSNETAESLASFSGASSNVGVGSSGGPSKVASSNQ 407
Query: 181 SDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGAG 240
+SS IG YKGGRG +AV D RMNVNV+PYGQ EDS++LF+DLNPFQIKG G
Sbjct: 408 HGNISSLAIG---YKGGRGTHAVADAVRMNVNVIPYGQNSLEDSRNLFSDLNPFQIKGTG 464
Query: 241 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 300
K+ +H P E+KVE+F + N + GRPP P+ KN++ YNEVPRKKEY Y+EG+ P I+
Sbjct: 465 KSFMHNKPAENKVEDFHGQKDNLLPGRPPAPLKWKNRYAYNEVPRKKEYDYIEGLFPGIS 524
Query: 301 REPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQL 358
REPN N S ++S+S+ SE P S+ +N SS+D ++ ++ SG+ +LAS +Q
Sbjct: 525 REPNGYNQSSLASSSSTMSEKVYPQGLNSSSSSNTSSRDGDAWNSSSGTNSALASGMNQC 584
Query: 359 NGPPLVEDLSSNSKDENPKNV--------------EDHEIGYHDRRKCTHDRFMGTNLKL 404
LVE+ +S+ K E+P++ E++EIG+ DRRKCTHDRFMG NLKL
Sbjct: 585 YKSSLVEEANSDFK-ESPRDAKNFQNDAEVTIRDDENNEIGFQDRRKCTHDRFMGINLKL 643
Query: 405 RDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEV 463
+ ES SSS+DS +KVDQIFDD DV ECEIPWEDL LGERIGLGSYGEVYHADWNGTEV
Sbjct: 644 K--ESSSSSIDSGKNKVDQIFDDVDVGECEIPWEDLDLGERIGLGSYGEVYHADWNGTEV 701
Query: 464 AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFR 523
AVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSII+EFLPRGSL+R
Sbjct: 702 AVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIISEFLPRGSLYR 761
Query: 524 ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583
ILHRPHCQ+DEKRRIKMALDVARGMNCLH+S PTIVHRDLKSPNLLVDKNWNVKV DFGL
Sbjct: 762 ILHRPHCQIDEKRRIKMALDVARGMNCLHSSIPTIVHRDLKSPNLLVDKNWNVKVCDFGL 821
Query: 584 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 643
SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPM
Sbjct: 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPM 881
Query: 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703
QVVGAVGFQNRRLEIPK++DP VA IIW+CWQ+DP+ RPSFA+LT ALKPLQRLVIPSH
Sbjct: 882 QVVGAVGFQNRRLEIPKDIDPKVAMIIWQCWQSDPNARPSFAELTTALKPLQRLVIPSHL 941
Query: 704 DQPSSALPQEISVNSTP 720
DQPSS L QEISVNSTP
Sbjct: 942 DQPSSPLQQEISVNSTP 958
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130772|ref|XP_002328373.1| predicted protein [Populus trichocarpa] gi|222838088|gb|EEE76453.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/715 (71%), Positives = 586/715 (81%), Gaps = 24/715 (3%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
WM+RSTELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLVKGSHYTG+EDDA
Sbjct: 247 WMDRSTELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLVKGSHYTGIEDDA 306
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNIIKLE+EREFLVDLMAAPGTLIPAD+ SAKDT FK IP R SN++G V++
Sbjct: 307 VNIIKLEDEREFLVDLMAAPGTLIPADVPSAKDTTFK--------IPAPR-SNETGVVFA 357
Query: 122 KPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTP-NQ 180
+ KPL EG+SQNS+VDG PL+ SE AESLPSF S G SSG+S++ P NQ
Sbjct: 358 RSKPLTGEGTSQNSSVDGISPLDRILCSENAESLPSFSGSSNNAGVGSSGVSNKTAPTNQ 417
Query: 181 SDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGAG 240
++S+ GTS+YKG RG +A+GDG RMNVNVVPY EDSK+LFADLNPFQIKG G
Sbjct: 418 LGNIASTAFGTSVYKGSRGVHAIGDGLRMNVNVVPYVPNTSEDSKNLFADLNPFQIKGTG 477
Query: 241 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 300
K+ +H P E+K+ EFQ + NPV PP P+M KN+ YNEVPR+K+ +EG+ P+IN
Sbjct: 478 KSFMHNKPAENKINEFQGRKNNPVPS-PPAPLMWKNRFAYNEVPRRKDNDNVEGLYPRIN 536
Query: 301 REPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQLNG 360
REPNN +S +++S SE P FK S++ N S+++S++R++ S + L+S T+Q
Sbjct: 537 REPNNYNHSSLASTSLSEKVYPQGFKSSSNLNTSNRESDTRNSASSASSELSSYTNQGYS 596
Query: 361 PPLVEDLSSNSKDE--NPKNV-----------EDHEIGYHDRRKCTHDRFMGTNLKLRDL 407
P VE+++SN +++ + KN+ ED+EIG+HDRRKC HDRFMGTNLKL+
Sbjct: 597 LPSVEEVNSNFEEKLWDAKNLQNDMEASVKESEDNEIGFHDRRKCIHDRFMGTNLKLKGP 656
Query: 408 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 467
ESPS+SVDSST +VD+I DD EI WEDLV GERIGLGSYGEVYHADWNGTEVAVKK
Sbjct: 657 ESPSTSVDSSTHRVDRILDDVDVGDEICWEDLVFGERIGLGSYGEVYHADWNGTEVAVKK 716
Query: 468 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 527
FLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL+RILHR
Sbjct: 717 FLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLYRILHR 776
Query: 528 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
P CQ+DEKRRIKMALDVARGMNCLH STPTIVHRDLKSPNLLVD+NW VKV DFGLSRLK
Sbjct: 777 PQCQIDEKRRIKMALDVARGMNCLHASTPTIVHRDLKSPNLLVDENWTVKVCDFGLSRLK 836
Query: 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 647
HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK PW GMNPMQVVG
Sbjct: 837 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKSPWSGMNPMQVVG 896
Query: 648 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702
AVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFA+L VAL PLQRLV+PSH
Sbjct: 897 AVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAELAVALMPLQRLVVPSH 951
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487849|ref|XP_002271755.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1017 bits (2629), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/738 (70%), Positives = 592/738 (80%), Gaps = 22/738 (2%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVKGSHYTGVEDDA
Sbjct: 221 WMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVKGSHYTGVEDDA 280
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNIIKL+ EREFLVDLM APGTLIPADILSAKD++ K YNP +SKIP L+ S D G VYS
Sbjct: 281 VNIIKLDNEREFLVDLMGAPGTLIPADILSAKDSSLKSYNPKLSKIPTLQASKDPGGVYS 340
Query: 122 KPKPLHA--EGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTP- 178
+PKPL EGSSQ ST++ SLP + ++SEK ESL SF S S + G +S IS RVTP
Sbjct: 341 RPKPLLGDYEGSSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTSRISKRVTPV 400
Query: 179 NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKG 238
NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFADLNPFQ+ G
Sbjct: 401 NQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFADLNPFQMIG 460
Query: 239 AGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPK 298
+ K S P E+KV+EFQ + + GRPP+P+M KN++ NEVPRKKE ++EG+ PK
Sbjct: 461 SSKASAQSKPMENKVDEFQREKNSAAPGRPPLPLMWKNRYANNEVPRKKENDFVEGLFPK 520
Query: 299 INREPNN-NL-STSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTS 356
INRE N+ NL S +++ ++TSE FK S +A +++K ++ +++ + LA STS
Sbjct: 521 INRETNDYNLPSLTSNNATTSEKVYSGVFKLSGNAYMNNKVNDDQNSSCNTTSMLAPSTS 580
Query: 357 QLNGPPLVEDLSSNSKDENPKN-----------VEDH---EIGYHDRRKCTHDRFMGTNL 402
Q N L ED+++N ++ K+ ++H E G HD RK HD FM NL
Sbjct: 581 QFNRLSLDEDVNANYNEKYHKDGKVFQSDMVDAAKEHDKNETGLHDHRKFRHDSFMENNL 640
Query: 403 KLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTE 462
R+ ESP SSVDS KVDQ+F+D V ECEIPWEDLVLGERIGLGSYGEVYH DWNGTE
Sbjct: 641 --REAESPCSSVDSDAGKVDQMFED-VGECEIPWEDLVLGERIGLGSYGEVYHGDWNGTE 697
Query: 463 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522
VAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL+
Sbjct: 698 VAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLY 757
Query: 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
RILHRP CQ+DEKRRIKMALDVA+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVKV DFG
Sbjct: 758 RILHRPSCQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVKVCDFG 817
Query: 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 642
LSRLKHNTFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW GMNP
Sbjct: 818 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPWSGMNP 877
Query: 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702
MQVVGAVGFQNRRL+IPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRLVIP H
Sbjct: 878 MQVVGAVGFQNRRLDIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRLVIPQH 937
Query: 703 PDQPSSALPQEISVNSTP 720
DQ S L QEISVNSTP
Sbjct: 938 LDQQSLTLQQEISVNSTP 955
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535135|ref|XP_003536104.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2473), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/722 (68%), Positives = 561/722 (77%), Gaps = 51/722 (7%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
W E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSHYTGVEDDA
Sbjct: 257 WTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSHYTGVEDDA 316
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++ D+ YS
Sbjct: 317 VNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPSTKDNEFSYS 374
Query: 122 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 179
+P +P H EGSSQNS V D SLP NG EK+E PS S + G S I ++ TPN
Sbjct: 375 RPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSKIPNKGTPN 432
Query: 180 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 239
Q + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 433 QLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADLNPFQIKGM 491
Query: 240 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 299
GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK ++ E P
Sbjct: 492 GKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRKTNHNPNEYNPPLF 551
Query: 300 NREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQLN 359
++ SS SE + S KP ++NI++ + +LA T ++
Sbjct: 552 ----------VSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQTLAQVTGSVS 592
Query: 360 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 419
P HD+R CT+DRFMG+NLKL+D ESPSSS+DS T+
Sbjct: 593 PP------------------------NHDQRNCTYDRFMGSNLKLKDPESPSSSIDSITN 628
Query: 420 KVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 478
+VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKFLDQDFSGAAL
Sbjct: 629 RVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 688
Query: 479 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 538
EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP+CQ+DEKRRI
Sbjct: 689 SEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRPNCQIDEKRRI 748
Query: 539 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598
KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSKSTA
Sbjct: 749 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSKSTA 808
Query: 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 658
GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAVGFQNRRL+I
Sbjct: 809 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGAVGFQNRRLDI 868
Query: 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNS 718
PKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ + +PQEISVNS
Sbjct: 869 PKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLAPPMPQEISVNS 928
Query: 719 TP 720
TP
Sbjct: 929 TP 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|229335619|gb|ACQ57002.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/722 (68%), Positives = 560/722 (77%), Gaps = 51/722 (7%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
W E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSHYTGVEDDA
Sbjct: 240 WTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSHYTGVEDDA 299
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++ D+ YS
Sbjct: 300 VNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPSTKDNEFSYS 357
Query: 122 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 179
+P +P H EGSSQNS V D SLP NG EK+E PS S + G S I ++ TPN
Sbjct: 358 RPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSKIPNKGTPN 415
Query: 180 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 239
Q + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 416 QLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADLNPFQIKGM 474
Query: 240 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 299
GK +H P E+K E +S + VSGRPP+P+M KN+H YNE PRK ++ E P
Sbjct: 475 GKAPVHNKPVENKPPELKSTKNYAVSGRPPVPLMWKNRHAYNEDPRKTNHNPNEYNPPLF 534
Query: 300 NREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQLN 359
++ SS SE + S KP ++NI++ + +LA T ++
Sbjct: 535 ----------VSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQTLAQVTGSVS 575
Query: 360 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 419
P HD+R CT+DRFMG+NLKL+D ESPSSS+DS T+
Sbjct: 576 PP------------------------NHDQRNCTYDRFMGSNLKLKDPESPSSSIDSITN 611
Query: 420 KVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 478
+VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKFLDQDFSGAAL
Sbjct: 612 RVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 671
Query: 479 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 538
EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP+CQ+DEKRRI
Sbjct: 672 SEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRPNCQIDEKRRI 731
Query: 539 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598
KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSKSTA
Sbjct: 732 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSKSTA 791
Query: 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 658
GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAVGFQNRRL+I
Sbjct: 792 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGAVGFQNRRLDI 851
Query: 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNS 718
PKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ + +PQEISVNS
Sbjct: 852 PKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQVAPPMPQEISVNS 911
Query: 719 TP 720
TP
Sbjct: 912 TP 913
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|262213688|gb|ACY36006.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 950 bits (2455), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/722 (68%), Positives = 556/722 (77%), Gaps = 61/722 (8%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
W E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSHYTGVEDDA
Sbjct: 208 WTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSHYTGVEDDA 267
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++ D+ YS
Sbjct: 268 VNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPSTKDNEFSYS 325
Query: 122 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 179
+P +P H EGSSQNS V D SLP NG EK + G S I ++ TPN
Sbjct: 326 RPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEK------------DSGVGPSKIPNKGTPN 373
Query: 180 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 239
Q + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 374 QLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADLNPFQIKGM 432
Query: 240 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 299
GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK ++ E P
Sbjct: 433 GKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRKTNHNPNEYNPPLF 492
Query: 300 NREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQLN 359
++ SS SE + S KP ++NI++ + +LA T ++
Sbjct: 493 ----------VSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQTLAQVTGSVS 533
Query: 360 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 419
P HD+R CT+DRFMG+NLKL+D ESPSSS+DS T+
Sbjct: 534 PP------------------------NHDQRNCTYDRFMGSNLKLKDPESPSSSIDSITN 569
Query: 420 KVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 478
+VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKFLDQDFSGAAL
Sbjct: 570 RVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKFLDQDFSGAAL 629
Query: 479 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 538
EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP+CQ+DEKRRI
Sbjct: 630 SEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRPNCQIDEKRRI 689
Query: 539 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598
KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSKSTA
Sbjct: 690 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSKSTA 749
Query: 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 658
GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAVGFQNRRL+I
Sbjct: 750 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGAVGFQNRRLDI 809
Query: 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNS 718
PKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ + +PQEISVNS
Sbjct: 810 PKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLAPPMPQEISVNS 869
Query: 719 TP 720
TP
Sbjct: 870 TP 871
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576743|ref|XP_003556489.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/724 (68%), Positives = 556/724 (76%), Gaps = 55/724 (7%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
W E ELR SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRL+KGSHYTGVEDDA
Sbjct: 259 WTETRAELRTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLLKGSHYTGVEDDA 318
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNIIKLE EREFLVDLMAAPGTLIPADILS KD+AFK YNP I +P L ++ D+ YS
Sbjct: 319 VNIIKLEGEREFLVDLMAAPGTLIPADILSTKDSAFKSYNPKI--LPSLPSTKDNEFSYS 376
Query: 122 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 179
+P +P H EGSSQNS + D SLP NG EK+E PS S E G S I ++ TPN
Sbjct: 377 RPIQPFHGEGSSQNSVIKDYSLPWNGKPYFEKSE--PSNLGLSRESGTGPSKIPNKGTPN 434
Query: 180 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 239
Q D L + + G SLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 435 QLDNLPALS-GASLYKGTLGMNTVGDGTRLNVNVVPYTNISPNDSRNLFADLNPFQIKGM 493
Query: 240 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 299
GK +H P E+K E +S + N VSGRPP+P+M KN+ YNE PRK
Sbjct: 494 GKAPVHNKPVENKPPELKSTKNNTVSGRPPVPLMWKNRPAYNEDPRK------------T 541
Query: 300 NREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ 357
N PN N ++ SSTSEN + S KP ++NI++ + +LA T
Sbjct: 542 NHNPNDYNPPLFVSNGSSTSENIDLSSSKPLYNSNINN---------DVNAQTLAQVTGS 592
Query: 358 LNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSS 417
++ P HD+RKCT+DRFMG+NLKL+D ESPSSS+DS
Sbjct: 593 VSPP------------------------NHDQRKCTYDRFMGSNLKLKDPESPSSSIDSI 628
Query: 418 TSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA 476
T+++D I DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKFLDQDFSGA
Sbjct: 629 TNRIDPILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKFLDQDFSGA 688
Query: 477 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR 536
AL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHR + Q+DEKR
Sbjct: 689 ALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRSNYQIDEKR 748
Query: 537 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596
RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSKS
Sbjct: 749 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSKS 808
Query: 597 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 656
TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW MN MQVVGAVGFQNRRL
Sbjct: 809 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSEMNTMQVVGAVGFQNRRL 868
Query: 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 716
+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ + +PQEISV
Sbjct: 869 DIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQVAPPMPQEISV 928
Query: 717 NSTP 720
NSTP
Sbjct: 929 NSTP 932
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435758|ref|XP_004135661.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/735 (64%), Positives = 560/735 (76%), Gaps = 37/735 (5%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
WMERSTELR SL TSVLPIGSINIGLSRHRALLFKVLADSI++PCRLVKGSHYTGVE+DA
Sbjct: 222 WMERSTELRTSLHTSVLPIGSINIGLSRHRALLFKVLADSIKMPCRLVKGSHYTGVEEDA 281
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTA-FKPYNPLISKIPILRTSNDSGAVY 120
VNIIKLE+EREFLVDLMAAPGTL+PADI +AKDT FKPYNP +S+IP L SND G
Sbjct: 282 VNIIKLEDEREFLVDLMAAPGTLLPADIFNAKDTTNFKPYNPKVSRIPSLHHSNDVGISS 341
Query: 121 SKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPNQ 180
+KP EGSSQN + ++G + ES+PS SSG++ +
Sbjct: 342 AKPTSGLEEGSSQNFGAEAISLMDGKLGYGRTESVPS-----------SSGVTCXINSRL 390
Query: 181 SDYLSSSTIGTSLYKGGRGPNAVGDG-ARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 239
+ LS GTS YKG GDG R+NVNVVP+GQ+ EDSK+LFADLNPF I+G
Sbjct: 391 MENLSLLGTGTSRYKGAH----FGDGNVRLNVNVVPFGQS-SEDSKNLFADLNPFLIRGT 445
Query: 240 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 299
GK+ + +++K EE Q P G PP+P+ KN+ +N VP K EY YMEG P+I
Sbjct: 446 GKSFIPNKFSDNKSEELQK----PTIGHPPVPLW-KNRFAFNAVPNKNEYDYMEGRFPRI 500
Query: 300 NREPNN-NLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQL 358
+R PN+ N++ S+S S+ SE+ P SND + S + +E S+ S A +
Sbjct: 501 SRGPNDQNMALSSSNSTGSESVKPGGSGTSNDLSASVRSAEVGSSSSNMYAQPAFGMMEP 560
Query: 359 NGPPLVEDLSSNSKDENPKNVE------------DHEIGYHDRRKCTHDRFMGTNLKLRD 406
N P +++ + S E+ N + D+ I + +RRK T++R +GTNL L+D
Sbjct: 561 NILPFIDEQNRKSNGEHSGNTDMEDEKVDAVDGRDNLIRFDNRRKFTYERSVGTNLILKD 620
Query: 407 LESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAV 465
+P V+ S+++ +Q++DD DV +CEI WEDLV+GERIGLGSYGEVYHADWN TEVAV
Sbjct: 621 SGNPGLLVNPSSNRFEQVYDDVDVGQCEIQWEDLVIGERIGLGSYGEVYHADWNDTEVAV 680
Query: 466 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 525
KKFLDQDFSGAAL EFKREV IMR+LRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+RI+
Sbjct: 681 KKFLDQDFSGAALAEFKREVLIMRQLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRII 740
Query: 526 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585
HRP+CQ+DEKRRIKMALDVARGMNCLHTS PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR
Sbjct: 741 HRPNCQIDEKRRIKMALDVARGMNCLHTSNPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 800
Query: 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 645
LKHNTFLSSKST GTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELATL+LPW GMNPMQV
Sbjct: 801 LKHNTFLSSKSTGGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATLRLPWSGMNPMQV 860
Query: 646 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 705
VGAVGF+N+RLEIPKE+DP VARIIWECWQTDP+LRPSF+QL LKPLQRLV+P H DQ
Sbjct: 861 VGAVGFRNQRLEIPKEVDPTVARIIWECWQTDPNLRPSFSQLANILKPLQRLVLPPHSDQ 920
Query: 706 PSSALPQEISVNSTP 720
PSS++ QEISVNSTP
Sbjct: 921 PSSSVLQEISVNSTP 935
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350536633|ref|NP_001234768.1| TCTR2 protein [Solanum lycopersicum] gi|3201541|emb|CAA06334.1| TCTR2 protein [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2307), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/738 (64%), Positives = 550/738 (74%), Gaps = 34/738 (4%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
WME STELR SL TSVLPIGS+ IGLSRHRALLFKVLAD + +PCRLVKGSHYTGVEDDA
Sbjct: 260 WMEISTELRTSLHTSVLPIGSLKIGLSRHRALLFKVLADHVGIPCRLVKGSHYTGVEDDA 319
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VNI+KL + EFLVDLM APGTLIPAD+LSAKD +F +P ++KIP L +++ SG Y
Sbjct: 320 VNIVKLPNDSEFLVDLMGAPGTLIPADVLSAKDASFN--SPKLNKIPSLPSNSHSGVSYP 377
Query: 122 KPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPNQS 181
+ L S QNS + +G S EK ES+ S A SSGI+ R + NQ
Sbjct: 378 RRNLL----SGQNSVLGDDF--SGRSKPEKIESVHSISDAGGSSTAGSSGINKRPSSNQV 431
Query: 182 DYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGAGK 241
D+ S IGTSLYKGGRGPNA GDG R+NVNVVPY Q ED K+LFADLNPFQIKG+G
Sbjct: 432 DWTSPLAIGTSLYKGGRGPNAAGDGLRLNVNVVPYDQNNPEDPKNLFADLNPFQIKGSGN 491
Query: 242 TSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKINR 301
T L KNP +KV E Q + GRPP PMM KN++ NEVPRK E S EG+ PK N
Sbjct: 492 TLLQKNPARNKVSELQQPINTLIPGRPPAPMMWKNRYAPNEVPRKNE-SDSEGLFPKKNG 550
Query: 302 EPNN-NLSTSASTSST------------------SENFNPHSFKPSNDANISSKDSESRS 342
+ N+S+ ASTSS + N N+++I S + E R
Sbjct: 551 GSSGYNISSIASTSSNIPQKSSTDTSRLHGNSRPAYRGNDEVASTRNNSSILSAELEFRR 610
Query: 343 ALSGSGPSLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNL 402
+ + TSQ G L D + ++ D I D + + +GTN+
Sbjct: 611 LSVQNSQNNNRETSQWEGHSLQSDDLNRTQAYG-----DDIIVESDHTRNLQAQSIGTNI 665
Query: 403 KLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTE 462
KL++ E+P+SS + S+VD +FDD V +CEIPWEDLV+GERIGLGSYGEVYHADWNGTE
Sbjct: 666 KLKEPENPTSSGNLGPSQVDPVFDD-VGDCEIPWEDLVIGERIGLGSYGEVYHADWNGTE 724
Query: 463 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522
VAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVV FMGA+TRPP+LSIITEFLPRGSL+
Sbjct: 725 VAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVRFMGAITRPPHLSIITEFLPRGSLY 784
Query: 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
RI+HRPH Q+DE+++IKMALDVA+GM+CLHTS PTIVHRDLKSPNLLVD +WNVKV DFG
Sbjct: 785 RIIHRPHFQIDERQKIKMALDVAKGMDCLHTSNPTIVHRDLKSPNLLVDTDWNVKVCDFG 844
Query: 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 642
LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD+YSFGVILWELATL+LPW GMNP
Sbjct: 845 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDIYSFGVILWELATLRLPWSGMNP 904
Query: 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702
MQVVGAVGFQN+RLEIPKELDP+VARIIWECWQTDP+LRPSFAQLTVAL PLQRLVIP++
Sbjct: 905 MQVVGAVGFQNKRLEIPKELDPIVARIIWECWQTDPNLRPSFAQLTVALTPLQRLVIPAY 964
Query: 703 PDQPSSALPQEISVNSTP 720
DQ +S LPQEISVNSTP
Sbjct: 965 VDQLNSRLPQEISVNSTP 982
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.938 | 0.724 | 0.582 | 8.6e-207 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.393 | 0.321 | 0.759 | 5.2e-149 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.398 | 0.278 | 0.717 | 2.1e-145 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.381 | 0.277 | 0.720 | 1.7e-137 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.375 | 0.328 | 0.647 | 1.9e-92 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.381 | 0.355 | 0.602 | 1.7e-89 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.368 | 0.360 | 0.615 | 1.2e-88 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.380 | 0.358 | 0.595 | 4.1e-88 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.351 | 0.377 | 0.623 | 1.4e-85 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.211 | 0.182 | 0.638 | 5.8e-80 |
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2000 (709.1 bits), Expect = 8.6e-207, P = 8.6e-207
Identities = 415/712 (58%), Positives = 494/712 (69%)
Query: 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 61
W E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGSHYTG EDDA
Sbjct: 244 WTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGSHYTGNEDDA 303
Query: 62 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 121
VN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P + SND
Sbjct: 304 VNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQFSNDV----- 358
Query: 122 KPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPNQS 181
PK EGSS +S + S L+ + +E+ +S S+P S SS + Q
Sbjct: 359 -PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSPSSVTSSTQL 415
Query: 182 DYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGAGK 241
+ SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLNPFQ KGA K
Sbjct: 416 ENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLNPFQNKGADK 469
Query: 242 TSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKINR 301
+ + V++F + NP+ GR P PMM KN + NE P++KE SY+E +LPK++R
Sbjct: 470 LYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYIENLLPKLHR 528
Query: 302 EPNNNLXXXXXXXXXXENFNPHSFKPSNDANISSKDXXXXXXXXXXXXXXXXXXXQLNGP 361
+P ++ S + +N+ +D Q P
Sbjct: 529 DPRYG--------NTQSSYATSSSNGAISSNVHGRDNVTFVSPVAVPSSFTSTENQFR-P 579
Query: 362 PLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRFM-GTNLKLRDLEXXX 411
+VED++ N+ +E P ++ E HD RK T D G + +L+D E
Sbjct: 580 SIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCDPRLKDHESTS 639
Query: 412 XXXXXXXXKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL 469
+ D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+GTEVAVKKFL
Sbjct: 640 SSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFL 699
Query: 470 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 529
DQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRGSL+RILHRP
Sbjct: 700 DQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPK 759
Query: 530 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589
+DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV DFGLSRLKHN
Sbjct: 760 SHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHN 819
Query: 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 649
TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAV
Sbjct: 820 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAV 879
Query: 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701
GFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV+P+
Sbjct: 880 GFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPT 931
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 5.2e-149, Sum P(2) = 5.2e-149
Identities = 215/283 (75%), Positives = 247/283 (87%)
Query: 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 487
+ + EI WEDL +GERIG+GSYGEVY A+WNGTEVAVKKFLDQDFSG AL +FK E++I
Sbjct: 598 EAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEI 657
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
M RLRHPNVVLFMGAVTRPPN SI+TEFLPRGSL+R+LHRP+ Q+DEKRR++MALDVA+G
Sbjct: 658 MLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKG 717
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 607
MN LHTS PT+VHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGTPEWMAPE
Sbjct: 718 MNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPE 777
Query: 608 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667
VLRNEP+NEKCDVYSFGVILWELAT ++PW G+NPMQVVGAVGFQNRRLEIP ++D VA
Sbjct: 778 VLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVA 837
Query: 668 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 710
+II ECWQT+P LRPSF QL +LK LQ L I + + S +
Sbjct: 838 QIIRECWQTEPHLRPSFTQLMQSLKRLQGLNISNRANTSESLM 880
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 2.1e-145, Sum P(3) = 2.1e-145
Identities = 208/290 (71%), Positives = 249/290 (85%)
Query: 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 486
DDV +CEI WE++ +GERIGLGSYGEVY DW+GTEVAVKKFLDQD +G AL EF+ EV+
Sbjct: 736 DDVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVR 795
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 546
IM++LRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE+RR++MALD AR
Sbjct: 796 IMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAAR 855
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGT EWMAP
Sbjct: 856 GMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAP 915
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP +DP +
Sbjct: 916 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAI 975
Query: 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP---SSALPQE 713
A +I +CWQTD LRPSFA++ +LK LQ+ V S+ +P SS+LP E
Sbjct: 976 ADLISKCWQTDSKLRPSFAEIMASLKRLQKPVTGSNIPRPVPSSSSLPTE 1025
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 1.7e-137, Sum P(2) = 1.7e-137
Identities = 201/279 (72%), Positives = 240/279 (86%)
Query: 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 486
DDV ECEI WE++ + ERIGLGSYGEVY DW+GT VAVKKF+DQD +G AL EF+ EV+
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVR 762
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 546
+MRRLRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE++R++MALD AR
Sbjct: 763 MMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAAR 822
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+K +T+LSSKSTAGT EWMAP
Sbjct: 823 GMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAP 882
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP+ +DP +
Sbjct: 883 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGI 942
Query: 667 ARIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPS 701
A II +CWQTDP LRPSF ++ +LK P+QR +PS
Sbjct: 943 ADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAAVPS 981
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 1.9e-92, P = 1.9e-92
Identities = 176/272 (64%), Positives = 215/272 (79%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGM 548
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700
II CW +P RPSFA + L+PL + +P
Sbjct: 783 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
Identities = 167/277 (60%), Positives = 213/277 (76%)
Query: 420 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 479
KVD D + E EI W+DL +GE++G GS G VYH W G++VAVK F Q++S +
Sbjct: 477 KVDT--DSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIE 534
Query: 480 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 539
FK+EV +M+RLRHPNV+LFMGAVT P L I++EFLPRGSLFR+L + ++D +RRI
Sbjct: 535 SFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIH 594
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 599
MALD+ARGMN LH +P I+HRDLKS NLLVDKNW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 595 MALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKG 654
Query: 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF ++RLEIP
Sbjct: 655 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIP 714
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
K++DP ++ CW +D LRP+F +L L+ LQR
Sbjct: 715 KDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDLQR 751
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
Identities = 163/265 (61%), Positives = 205/265 (77%)
Query: 432 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
CEI WEDL LGE +G GS+ V+ WNG++VA+K + D D++ L E K+E+ IM++L
Sbjct: 461 CEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKL 520
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
RHPNV+LFMGAV +II E++PRGSLF+ILH + +D+KRR++MALDVARGMN L
Sbjct: 521 RHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMNYL 580
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
H P IVHRDLKS NLLVDKNWNVKV DFGLS+ K+ TFLS+KS GTP+WMAPEVLR+
Sbjct: 581 HRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRS 640
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671
EPSNEKCDV+SFGVILWEL T +PW +N +QVVG VGF +RRL++P+ L+P +A II
Sbjct: 641 EPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASIIQ 700
Query: 672 ECWQTDPSLRPSFAQLTVALKPLQR 696
+CWQTDP+ RPSF +L + L R
Sbjct: 701 DCWQTDPAKRPSFEELISQMMSLFR 725
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 165/277 (59%), Positives = 208/277 (75%)
Query: 420 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 479
KVD D D + EI WEDL +GE+IG GS G VYH W G++VAVK F Q++S +
Sbjct: 470 KVDM--DSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIIT 527
Query: 480 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 539
FK+EV +M+RLRHPNV+LFMGAV P L I+TEFLPRGSLFR+L R ++D +RRI
Sbjct: 528 SFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIH 587
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 599
MA D+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L++ G
Sbjct: 588 MASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR-G 646
Query: 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
TP+WMAPEVLRNE ++EK DVYSFGV+LWEL T K+PW +N MQV+GAVGF N+RLE+P
Sbjct: 647 TPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVP 706
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
K++DP ++ CW ++P RPSF +L L+ LQR
Sbjct: 707 KDVDPQWIALMESCWHSEPQCRPSFQELMDKLRELQR 743
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 159/255 (62%), Positives = 199/255 (78%)
Query: 420 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 479
KVD D D E EI W+DL +GE+IG GS G VYH W G++VAVK F Q++S + +
Sbjct: 417 KVD--IDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIK 474
Query: 480 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 539
F++EV +M+RLRHPNV+LFMGAVT P L I++EF+PRGSLFR+L R ++D +RRI
Sbjct: 475 SFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKLDWRRRIN 534
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 599
MALD+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 535 MALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKG 594
Query: 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF N+RLEIP
Sbjct: 595 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIP 654
Query: 660 KELDPLVARIIWECW 674
K+ DP +I CW
Sbjct: 655 KDTDPDWISLIESCW 669
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
Identities = 97/152 (63%), Positives = 120/152 (78%)
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 604
ARGMN LH TP I+HRDLKS NLLVDKNW VKV+DFGLSR+KH T+L++K+ GTP+WM
Sbjct: 658 ARGMNYLHHCTPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTTKTGRGTPQWM 717
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
APEVLRNE ++EK DVYSFGVILWEL T K+PW +N MQV+GAVGF N+RLE+PK +DP
Sbjct: 718 APEVLRNEAADEKSDVYSFGVILWELVTEKIPWESLNAMQVIGAVGFMNQRLEVPKNVDP 777
Query: 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
++ CW ++P RPSF ++ L+ LQR
Sbjct: 778 QWISLMESCWHSEPQDRPSFQEIMEKLRELQR 809
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FPR3 | EDR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5988 | 0.9375 | 0.7234 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00130329 | SubName- Full=Putative uncharacterized protein; (967 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 720 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-74 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-72 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-71 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-65 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-64 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-61 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-57 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-51 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-48 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-47 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 3e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-46 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-45 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-44 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-44 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-43 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-41 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-40 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-40 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-39 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-39 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-39 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-39 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-39 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-37 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-37 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-37 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-36 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-36 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-35 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-35 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-35 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-35 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-34 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-34 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-34 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-33 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-33 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-33 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-33 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-32 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-31 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-31 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-31 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-31 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-31 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-30 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-30 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-30 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-29 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-29 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-29 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-29 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-29 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-28 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-27 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-27 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-26 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-25 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-24 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-23 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-20 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-17 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-14 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 240 bits (616), Expect = 2e-74
Identities = 99/258 (38%), Positives = 146/258 (56%), Gaps = 13/258 (5%)
Query: 439 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
L LG+++G G++GEVY G T+VAVK L + S EF E IM++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HPN+V +G T+ L I+TE++P G L L + ++ K ++MAL +A+GM L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 610
+ VHRDL + N LV +N VK+SDFGLSR + K G P +WMAPE L+
Sbjct: 120 SK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P+ + +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 670 IWECWQTDPSLRPSFAQL 687
+ +CW DP RP+F++L
Sbjct: 237 MLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 3e-72
Identities = 100/263 (38%), Positives = 141/263 (53%), Gaps = 16/263 (6%)
Query: 439 LVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HPNVV +G T L I+ E++ G L L + ++ + AL +ARGM L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAPEVL 609
S +HRDL + N LV +N VK+SDFGLSR ++ G WMAPE L
Sbjct: 120 -SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRWMAPESL 175
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P P +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYD 234
Query: 669 IIWECWQTDPSLRPSFAQLTVAL 691
++ +CW DP RP+F++L L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 8e-71
Identities = 99/258 (38%), Positives = 143/258 (55%), Gaps = 13/258 (5%)
Query: 439 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCL 551
HPN+V +G T L I+ E++P G L L + + + + AL +ARGM L
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 610
S +HRDL + N LV +N VK+SDFGLSR ++ P WMAPE L+
Sbjct: 120 E-SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
K DV+SFGV+LWE+ TL + P+ GM+ +V+ + + RL P P + ++
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKL 236
Query: 670 IWECWQTDPSLRPSFAQL 687
+ +CW DP RP+F++L
Sbjct: 237 MLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 2e-65
Identities = 76/255 (29%), Positives = 124/255 (48%), Gaps = 17/255 (6%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ E++G GS+G+VY A T VA+K + + RE+KI+++L+HPN+V
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
L ++ E+ G LF +L + ++ E + + LH+ I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG--I 118
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
VHRDLK N+L+D++ +VK++DFGL+R + GTPE+MAPEVL + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 619 DVYSFGVILWELATLKLPWIGMNPMQVV------GAVGFQNRRLEIPKELDPLVARIIWE 672
D++S GVIL+EL T K P+ G + + + F +I E L+ +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK---- 233
Query: 673 CWQTDPSLRPSFAQL 687
DP R + +
Sbjct: 234 LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 8e-64
Identities = 92/267 (34%), Positives = 140/267 (52%), Gaps = 22/267 (8%)
Query: 443 ERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+++G G++GEVY G TEVAVK L +D S +F +E ++M++L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ------VDEKRRIKMALDVARGMN 549
+G T L ++ E++ G L L RP + K + A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAP 606
L + VHRDL + N LV ++ VK+SDFGLSR + G WMAP
Sbjct: 120 YLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
E L++ K DV+SFGV+LWE+ TL P+ G++ +V+ + + RL P+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDE 235
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALK 692
+ ++ CWQ DP RP+F++L L+
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 2e-62
Identities = 89/259 (34%), Positives = 136/259 (52%), Gaps = 15/259 (5%)
Query: 439 LVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 496
L ++G GS+G VY A GT VAVK + +RE++I+RRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
V + A +L ++ E+ G LF L R + E K+AL + RG+ LH++
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSN 615
I+HRDLK N+L+D+N VK++DFGL++ + S + GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 616 EKCDVYSFGVILWELATLKLPW---IGMNPMQVVGAVGFQNRRLEIPKELDPLVAR---- 668
K DV+S GVIL+EL T K P+ ++ +Q++ + LE + +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL--GPPLEFDEPKWSSGSEEAKD 235
Query: 669 IIWECWQTDPSLRPSFAQL 687
+I +C DPS RP+ ++
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 4e-61
Identities = 81/247 (32%), Positives = 124/247 (50%), Gaps = 40/247 (16%)
Query: 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502
+G G +G VY A G +VA+K ++ S + L E RE++I+++L HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 503 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 562
+L ++ E+ GSL +L ++ E +++ L + G+ LH S I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-SNG-IIHRD 117
Query: 563 LKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDV 620
LK N+L+D N VK++DFGLS+L + K+ GTP +MAPEVL + +EK D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 621 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 680
+S GVIL+EL LK +I + Q DP
Sbjct: 178 WSLGVILYELPELK---------------------------------DLIRKMLQKDPEK 204
Query: 681 RPSFAQL 687
RPS ++
Sbjct: 205 RPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 4e-57
Identities = 87/257 (33%), Positives = 133/257 (51%), Gaps = 10/257 (3%)
Query: 438 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
+ GE +G GS+G VY A G +AVK S L +RE++I+ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 496 VVLFMGA-VTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
+V + G+ N L+I E++ GSL +L + ++ E K + G+ LH+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRN 611
+ IVHRD+K N+LVD + VK++DFG ++ + + S GTP WMAPEV+R
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARII 670
E D++S G + E+AT K PW + NPM + +G EIP+ L +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237
Query: 671 WECWQTDPSLRPSFAQL 687
+C + DP RP+ +L
Sbjct: 238 RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 6e-51
Identities = 96/262 (36%), Positives = 142/262 (54%), Gaps = 13/262 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
I ++L LG IG G +G+V D+ G +VAVK D A F E +M LR
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTLR 58
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCL 551
HPN+V +G V + L I+TE++ +GSL L R + +++ ALDV GM L
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 610
VHRDL + N+LV ++ KVSDFGL++ S K P +W APE LR
Sbjct: 119 EEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPEALR 172
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ + K DV+SFG++LWE+ + ++P+ + VV V + R+E P+ P V ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKV 231
Query: 670 IWECWQTDPSLRPSFAQLTVAL 691
+ +CW+ DP+ RP+F QL L
Sbjct: 232 MKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 89/265 (33%), Positives = 135/265 (50%), Gaps = 22/265 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EIP E L L ++G G +GEV+ WNG T+VAVK S A L+ E +IM++L
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDV 544
RH +V + + I+TE++ +GSL L VD MA +
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQI 112
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EW 603
A GM L + +HRDL + N+LV +N K++DFGL+RL + +++ A P +W
Sbjct: 113 AEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
APE K DV+SFG++L E+ T ++P+ GM +V+ V + R+ P
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNC 229
Query: 663 DPLVARIIWECWQTDPSLRPSFAQL 687
+ ++ +CW DP RP+F L
Sbjct: 230 PEELYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 98/267 (36%), Positives = 147/267 (55%), Gaps = 11/267 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
E+ D+ + ++G G YGEVY W VAVK L +D + EF +E +M+
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKED--TMEVEEFLKEAAVMKE 58
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMN 549
++HPN+V +G TR P IITEF+ G+L L + Q V+ + MA ++ M
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 608
L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W APE
Sbjct: 119 YLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667
L + K DV++FGV+LWE+AT + P+ G++ QV + + R+E P+ P V
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235
Query: 668 RIIWECWQTDPSLRPSFAQLTVALKPL 694
++ CWQ +PS RPSFA++ A + +
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 5e-47
Identities = 79/250 (31%), Positives = 136/250 (54%), Gaps = 8/250 (3%)
Query: 441 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
LG+ IG G++G VY + G VA+K+ + AL +E+ +++ L+HPN+V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
++G++ +L II E+ GSL +I+ + E V +G+ LH +
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLHEQ--GV 120
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 617
+HRD+K+ N+L K+ VK++DFG++ +L + S GTP WMAPEV+ ++
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 677
D++S G + EL T P+ +NPM + + Q+ +P+ + P + + +C+Q D
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD 238
Query: 678 PSLRPSFAQL 687
P+LRP+ QL
Sbjct: 239 PNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 55/86 (63%), Positives = 66/86 (76%), Gaps = 2/86 (2%)
Query: 1 MWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDD 60
W E S EL+ + V+P+GS+ IGL RHRALLFKVLADSI LPCRLVKG Y G +DD
Sbjct: 120 RWKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYCGSDDD 177
Query: 61 AVNIIKLEEEREFLVDLMAAPGTLIP 86
A N++K ++ RE+LVDLM APGTLIP
Sbjct: 178 ASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 7e-46
Identities = 74/252 (29%), Positives = 130/252 (51%), Gaps = 16/252 (6%)
Query: 445 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
IG GS+G+VY +G +K+ + + AL EVKI+++L HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL----NEVKILKKLNHPNIIK 63
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHTST 555
+ + L I+ E+ G L +I + E++ + + + + LH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
I+HRD+K N+ + N VK+ DFG+S++ +T +K+ GTP +++PE+ +N+P N
Sbjct: 124 --ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181
Query: 616 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675
K D++S G +L+EL TLK P+ G N +++ + IP + + ++ Q
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQ 240
Query: 676 TDPSLRPSFAQL 687
DP RPS AQ+
Sbjct: 241 KDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-45
Identities = 86/268 (32%), Positives = 134/268 (50%), Gaps = 28/268 (10%)
Query: 445 IGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G G +G+V ++ G +VAVK L+ +F+RE++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 499 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+ G +P +L +I E+LP GSL L R Q++ KR + + + +GM+ L +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEP 613
+HRDL + N+LV+ VK+SDFGL+++ + + K +P W APE LR
Sbjct: 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 614 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 659
+ DV+SFGV L+EL T L++ I M V + + RL P
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQL 687
V ++ CW+ +P RPSFA L
Sbjct: 249 PSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 88/262 (33%), Positives = 133/262 (50%), Gaps = 8/262 (3%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
E P E+ L ++G G +GEV+ W VA+K L D +F++EV+ ++RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSD-DLLKQQDFQKEVQALKRL 59
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNC 550
RH +++ + + IITE + +GSL L P QV I MA VA GM
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
L +HRDL + N+LV ++ KV+DFGL+RL S +W APE
Sbjct: 120 LEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ + K DV+SFG++L+E+ T ++P+ GMN +V + R+ P + + +I
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236
Query: 670 IWECWQTDPSLRPSFAQLTVAL 691
+ ECW +P RPSF L L
Sbjct: 237 MLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-44
Identities = 84/261 (32%), Positives = 138/261 (52%), Gaps = 23/261 (8%)
Query: 436 WEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 493
+E L E+IG G +GEVY A G EVA+K + S + E++I+++ +H
Sbjct: 2 FEIL---EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKH 56
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCLH 552
PN+V + G+ + L I+ EF GSL +L + Q + +I + ++ +G+ LH
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
++ I+HRD+K+ N+L+ + VK+ DFGLS +T + + GTP WMAPEV+ +
Sbjct: 116 SNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVINGK 172
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPKELDPLV 666
P + K D++S G+ ELA K P+ + PM+ G G +N P++
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-----PEKWSDEF 227
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
+ +C Q +P RP+ QL
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-44
Identities = 85/261 (32%), Positives = 130/261 (49%), Gaps = 14/261 (5%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EI + L ++G G +GEV+ WN T VAVK +F E +IM++L
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGM 548
RHP ++ T + I+TE + GSL L ++ + I MA VA GM
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL--IDMAAQVASGM 116
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 607
L +HRDL + N+LV +N KV+DFGL+R +K + + + + +W APE
Sbjct: 117 AYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 608 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
+ K DV+SFG++L E+ T ++P+ GM +V+ V Q R+ P +
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
I+ +CW+ DP RP+F L
Sbjct: 234 YDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 88/280 (31%), Positives = 144/280 (51%), Gaps = 23/280 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E+P E + L +G GS+G VY G T VA+K ++++ S +EF E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT-VNENASMRERIEFLNEA 60
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP---HCQV----DEKR 536
+M+ +VV +G V+ ++ E + +G L L RP + ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 537 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596
I+MA ++A GM L VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 FIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 597 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
G P WMAPE L++ K DV+SFGV+LWE+ATL + P+ G++ +V+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693
L++P+ + ++ CWQ +P +RP+F ++ +LK
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 88/254 (34%), Positives = 130/254 (51%), Gaps = 14/254 (5%)
Query: 442 GERIGLGSYGEVYHADWN---GTEVAVK--KFLDQDFSG-AALLEFKREVKIMRRLRHPN 495
GE +G GS+G VY N G AVK D +G A+ + ++E+ ++ +L+HPN
Sbjct: 5 GELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V ++G NL I E +P GSL ++L + + E + G+ LH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDR- 121
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE-P 613
VHRD+K N+LVD N VK++DFG++ K S +KS G+P WMAPEV+ +
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
D++S G + E+AT K PW + + V +G IP L I +C
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238
Query: 674 WQTDPSLRPSFAQL 687
Q DPSLRP+ A+L
Sbjct: 239 LQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 89/258 (34%), Positives = 142/258 (55%), Gaps = 13/258 (5%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+ L LGE IG G +G V ++ G +VAVK + D + A LE E +M +L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQAFLE---ETAVMTKLHHKNL 61
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTST 555
V +G + L I+ E + +G+L L R V + ++ +LDVA GM + +
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME--YLES 118
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
+VHRDL + N+LV ++ KVSDFGL+R+ +SK +W APE L+++ +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKFS 175
Query: 616 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674
K DV+S+GV+LWE+ + + P+ M+ +V V + R+E P+ V ++ CW
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCW 234
Query: 675 QTDPSLRPSFAQLTVALK 692
+T+P RPSF +L L+
Sbjct: 235 ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 24/272 (8%)
Query: 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKRE 484
D+ P E E+IG G+ GEVY A T EVA+KK E
Sbjct: 9 KDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINE 65
Query: 485 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544
+ IM+ +HPN+V + + L ++ E++ GSL I+ + +++E + + +V
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREV 125
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG----LSRLKHNTFLSSKSTAGT 600
+G+ LH+ ++HRD+KS N+L+ K+ +VK++DFG L++ K S GT
Sbjct: 126 LQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGT 179
Query: 601 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----R 655
P WMAPEV++ + K D++S G++ E+A + P++ P++ + F
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPP 235
Query: 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
L+ P++ P + +C DP RPS +L
Sbjct: 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 14/256 (5%)
Query: 443 ERIGLGSYGEVYHADW---NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+++G GS+G V +W G VAVK L D + +F +E IM L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCLHTSTP 556
G V P L ++TE P GSL L + + A+ +A GM L +
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+HRDL + N+L+ + VK+ DFGL R + ++ + W APE LR
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 614 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
+ DV+ FGV LWE+ T + PW G++ Q++ + + RLE P+ + ++ +
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236
Query: 673 CWQTDPSLRPSFAQLT 688
CW +P+ RP+FA L
Sbjct: 237 CWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 85/259 (32%), Positives = 134/259 (51%), Gaps = 13/259 (5%)
Query: 438 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+L + +G G +G V+ W G +VA+K + S +F E K+M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
V G T+ + I+TE++ G L L ++ + + M DV M L ++
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-- 119
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
+HRDL + N LV ++ VKVSDFGL+R + + + SS+ T +W PEV +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 616 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWE 672
K DV+SFGV++WE+ + K+P+ + +VV +V G+ RL PK V I++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVYTIMYS 236
Query: 673 CWQTDPSLRPSFAQLTVAL 691
CW P RP+F +L L
Sbjct: 237 CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 75/256 (29%), Positives = 130/256 (50%), Gaps = 9/256 (3%)
Query: 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
P E + E++G GSYG VY A G VA+K L E +E+ I+++
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCD 56
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
P +V + G+ + +L I+ E+ GS+ I+ + + E+ + +G+ LH
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
++ +HRD+K+ N+L+++ K++DFG+S +T + GTP WMAPEV++
Sbjct: 117 SNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIW 671
N K D++S G+ E+A K P+ ++PM+ + + + L P++ P +
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234
Query: 672 ECWQTDPSLRPSFAQL 687
+C DP RPS QL
Sbjct: 235 KCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 82/254 (32%), Positives = 134/254 (52%), Gaps = 8/254 (3%)
Query: 443 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
E+IG G++G+VY TEVAVK +F +E +I+++ HPN+V +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIG 59
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ + I+ E +P GSL L + ++ K+ ++M+LD A GM L + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIHR 117
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKSTAGTP-EWMAPEVLRNEPSNEKCD 619
DL + N LV +N +K+SDFG+SR + + S P +W APE L + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 620 VYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678
V+S+G++LWE +L P+ GM+ Q + R+ P+ + R++ +CW DP
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 679 SLRPSFAQLTVALK 692
RPSF+++ L+
Sbjct: 237 ENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 20/261 (7%)
Query: 441 LGERIGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
G +IG G++G+VY A D G +AVK+ QD + E E+K++ L+HPN+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-ALDVARGMNCLHTSTP 556
+ G + I E+ G+L +L H ++ ++ I++ L + G+ LH+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNT---FLSSKSTAGTPEWMAPEVLRNE 612
IVHRD+K N+ +D N +K+ DFG + +LK+NT +S AGTP +MAPEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 613 PSNEK---CDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPK--ELDPLV 666
D++S G ++ E+AT K PW + N Q++ VG ++ IP +L P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPEG 237
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
+ C ++DP RP+ ++L
Sbjct: 238 KDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-40
Identities = 86/254 (33%), Positives = 126/254 (49%), Gaps = 9/254 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
+DL + +G G +G V + W G +VA+K + S EF E K+M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V G T+ + I+TE++ G L L + + ++M DV GM L +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK- 119
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
+HRDL + N LVD VKVSDFGLSR + + + SS + W PEVL
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 615 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
+ K DV++FGV++WE+ +L K+P+ N + V V Q RL P V I++ C
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC 237
Query: 674 WQTDPSLRPSFAQL 687
W RP+F QL
Sbjct: 238 WHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 80/262 (30%), Positives = 131/262 (50%), Gaps = 25/262 (9%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
E L E IG GS+GEVY A T VA+K +D + + + + ++E++ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+ + G+ + L II E+ GS +L +P ++DE + +V G+ LH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KP-GKLDETYIAFILREVLLGLEYLHEE 117
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
+HRD+K+ N+L+ + +VK++DFG+S +T + GTP WMAPEV++
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE-- 672
+EK D++S G+ ELA + P ++PM+V+ IPK P + +
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEGNKFSKP 226
Query: 673 -------CWQTDPSLRPSFAQL 687
C DP RPS +L
Sbjct: 227 FKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 94/264 (35%), Positives = 143/264 (54%), Gaps = 21/264 (7%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EIP E L L +++G G +GEV+ WNG T+VAVK S + LE E +IM++L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK------MALDVA 545
RH +V V+ P + I+TE++ +GSL L + E R +K MA VA
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-----KDGEGRALKLPNLVDMAAQVA 112
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 604
GM + +HRDL+S N+LV K++DFGL+RL + +++ A P +W
Sbjct: 113 AGM--AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
APE K DV+SFG++L EL T ++P+ GMN +V+ V + R+ P++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 229
Query: 664 PLVARIIWECWQTDPSLRPSFAQL 687
+ ++ +CW+ DP RP+F L
Sbjct: 230 ISLHELMLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 90/285 (31%), Positives = 151/285 (52%), Gaps = 30/285 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 485
E+P + L LG+ +G G++G+V A+ G + VAVK L D + L + E+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLVSEM 66
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP-------------H 529
++M+ + +H N++ +G T+ L ++ E+ G+L L RP
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 530 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589
+ +K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R H+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 590 TFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVV 646
K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++ +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 243
Query: 647 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691
+ + R+E P+ + ++ +CW PS RP+F QL L
Sbjct: 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 89/255 (34%), Positives = 139/255 (54%), Gaps = 15/255 (5%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 496
++L L + IG G +G+V D+ G +VAVK + D + A F E +M +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQA---FLAEASVMTQLRHSNL 61
Query: 497 VLFMGA-VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTS 554
V +G V L I+TE++ +GSL L R + +K +LDV M L +
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEP 613
VHRDL + N+LV ++ KVSDFGL++ S++ T P +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKK 175
Query: 614 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
+ K DV+SFG++LWE+ + ++P+ + VV V + +++ P P+V ++ +
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQ 234
Query: 673 CWQTDPSLRPSFAQL 687
CW D + RPSF QL
Sbjct: 235 CWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 16/264 (6%)
Query: 435 PWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK--KFLDQDFSGAALLEFKREVKIMRR 490
P ED L +RIG G+YG+VY A G VA+K K D ++E+ +++
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKE 56
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
RHPN+V + G+ R L I+ E+ GSL I + E + + + +G+
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 609
LH + +HRD+K N+L+ ++ +VK++DFG+S T KS GTP WMAPEV
Sbjct: 117 LHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 610 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV---GAVGFQNRRLEIPKELDP 664
R + KCD+++ G+ ELA L+ P ++PM+ + F +L+ ++ P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234
Query: 665 LVARIIWECWQTDPSLRPSFAQLT 688
+ I +C DP RP+ +L
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 18/265 (6%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHADWNGT-----EVAVKKFLDQDFSGAALLEFKREVKIM 488
I + + + IG G +GEV +VA+K S L+F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIM 59
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
+ HPN++ G VT+ + IITE++ GSL + L + + + M +A GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TP-EWMA 605
L S VHRDL + N+LV+ N KVSDFGLSR ++ ++ +T G P W A
Sbjct: 120 KYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-EATYTTKGGKIPIRWTA 176
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKEL 662
PE + DV+SFG+++WE+ + + P+ M+ V+ AV G+ RL P +
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDC 233
Query: 663 DPLVARIIWECWQTDPSLRPSFAQL 687
+ +++ +CWQ D + RP+F+Q+
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 89/288 (30%), Positives = 145/288 (50%), Gaps = 31/288 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
EIP + E +G G++G+VY + G T VA+K L ++ EF++E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 540
++M L+HPN+V +G T+ ++ E+L G L F + + PH V +K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 541 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590
+LD +A GM L S+ VHRDL + N LV + VK+SDFGLSR ++
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 591 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 647
+ +S + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 648 AVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ ++R+ L P++ V ++ ECW P+ RP F + L+
Sbjct: 238 MI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 85/257 (33%), Positives = 131/257 (50%), Gaps = 9/257 (3%)
Query: 438 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+L + +G G +G V+ W +VA+K + S +F E K+M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
V G T+ L I+TEF+ G L L + ++ + + M DV GM L +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSN 615
+ +HRDL + N LV VKVSDFG++R + +S S A P +W PEV +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 616 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674
K DV+SFGV++WE+ T K+P+ + +VV + + RL PK V +++ CW
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCW 238
Query: 675 QTDPSLRPSFAQLTVAL 691
P RP+FA+L A+
Sbjct: 239 HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 17/258 (6%)
Query: 441 LGERIGLGSYGEVY---HADWNGTEVAVKKF-LDQDFSGAA--LLEFKREVKIMRRLRHP 494
G+ +G G++G VY D G E+AVK+ D D + + E+++++ L+H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+V + G + LSI E++P GS+ L + R K + G+ LH++
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN 123
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLK----HNTFLSSKSTAGTPEWMAPEVL 609
IVHRD+K N+L D NVK+ DFG S RL+ T + KS GTP WM+PEV+
Sbjct: 124 M--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGTPYWMSPEVI 179
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
E K DV+S G + E+ T K PW M + + Q ++P + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 670 IWECWQTDPSLRPSFAQL 687
+ + + RPS +L
Sbjct: 240 LRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 485
+ + +VL +G G++G+V+ + + VAVK L + S A +F+RE
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREA 59
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR-------------PHCQV 532
+++ +H N+V F G T ++ E++ G L + L P ++
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 533 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-F 591
+ +++A+ +A GM L ++ VHRDL + N LV + VK+ DFG+SR + T +
Sbjct: 120 TLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 592 LSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 649
P WM PE + + DV+SFGV+LWE+ T K PW G++ +V+ +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 684
Q R L+ P+ V I+ CW+ DP R +
Sbjct: 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 6e-37
Identities = 90/264 (34%), Positives = 142/264 (53%), Gaps = 11/264 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EIP E L L ++G G +GEV+ WNGT VA+K S A L+ E ++M++L
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNC 550
RH +V V+ P + I+TE++ +GSL L + + + + MA +A GM
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM-- 115
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 609
+ VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W APE
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 234
Query: 669 IIWECWQTDPSLRPSFAQLTVALK 692
++ +CW+ +P RP+F L L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 80/248 (32%), Positives = 132/248 (53%), Gaps = 7/248 (2%)
Query: 443 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
E +G G++GEV+ + T VAVK +D ++F E +I+++ HPN+V +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
T+ + I+ E +P G L + ++ K+ +K ALD A GM + + +HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGM--AYLESKNCIHR 117
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDV 620
DL + N LV +N +K+SDFG+SR + + SS P +W APE L + + DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 621 YSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 679
+S+G++LWE +L + P+ GM Q V + R+ P++ V +++ CW P
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236
Query: 680 LRPSFAQL 687
RP F++L
Sbjct: 237 NRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 86/264 (32%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
E+P E L L +++G G +GEV+ +NG T+VA+K S A L E +M++L
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA---EANLMKQL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNC 550
+HP +V VT+ P + IITE++ GSL L P ++ + I MA +A GM
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 609
+ +HRDL++ N+LV + K++DFGL+RL + +++ A P +W APE +
Sbjct: 118 IERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P +
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYE 234
Query: 669 IIWECWQTDPSLRPSFAQLTVALK 692
++ CW+ P RP+F L L+
Sbjct: 235 LMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 80/259 (30%), Positives = 129/259 (49%), Gaps = 15/259 (5%)
Query: 443 ERIGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ +G G++G V + +G EV V K L Q+ A EF RE +M +L HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+G V + L ++ E P G L + L + ++ ++A VA GM L +
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH--F 116
Query: 559 VHRDLKSPN-LLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPS 614
VHRDL + N LLV+++ K+SDFG+SR + + + + P +W APE +
Sbjct: 117 VHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 615 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
+ K DV+S+GV LWE + P+ M +V+ + RL P+E + I+ C
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234
Query: 674 WQTDPSLRPSFAQLTVALK 692
W+ P RP+F++L +
Sbjct: 235 WKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 29/264 (10%)
Query: 443 ERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRH 493
E IG GS+G V D G + K+ D+ + E ++ EV I+R L+H
Sbjct: 6 ETIGKGSFGTVRKVRRKSD--GKILVWKEI---DYGN--MTEKEKQQLVSEVNILRELKH 58
Query: 494 PNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMALDVAR 546
PN+V + + N L I+ E+ G L +++ + C+ ++E+ ++ +
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIEEEFIWRILTQLLL 116
Query: 547 GMNCLHT---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 603
+ H T++HRDLK N+ +D N NVK+ DFGL+++ + +K+ GTP +
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
M+PE L + +EK D++S G +++EL L P+ N +Q+ + + + IP
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYS 235
Query: 664 PLVARIIWECWQTDPSLRPSFAQL 687
+ +I DP RPS +L
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 89/267 (33%), Positives = 141/267 (52%), Gaps = 17/267 (6%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EIP E L L +++G G +GEV+ A +N T+VAVK S A L E +M+ L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNC 550
+H +V VT+ P + IITEF+ +GSL L + + I + +A GM
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM-- 115
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 609
+HRDL++ N+LV + K++DFGL+R+ + +++ A P +W APE +
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDPL 665
K DV+SFG++L E+ T ++P+ GM+ +V+ A+ G++ R E P+EL
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL--- 232
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALK 692
I+ CW+ P RP+F + L
Sbjct: 233 -YNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 87/256 (33%), Positives = 137/256 (53%), Gaps = 11/256 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EIP E L L ++G G +GEV+ WNGT +VA+K A L+ E +IM++L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKKL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNC 550
RH +V V+ P + I+TEF+ +GSL L + + + + MA +A GM
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 609
+ +HRDL++ N+LV N K++DFGL+RL + +++ A P +W APE
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P+ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234
Query: 669 IIWECWQTDPSLRPSF 684
++ CW+ DP RP+F
Sbjct: 235 LMKLCWKKDPDERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 84/256 (32%), Positives = 130/256 (50%), Gaps = 13/256 (5%)
Query: 437 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
+L L + IG G +G V+ W +VA+K + S +F E ++M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V G T + ++ EF+ G L L + ++ + M LDV GM L +S
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS- 119
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK-HNTFLSSKSTAGTPEWMAPEVLRNEPS 614
++HRDL + N LV +N VKVSDFG++R + + SS T +W +PEV
Sbjct: 120 -NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 615 NEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIW 671
+ K DV+SFGV++WE+ + K P+ + +VV + GF RL P+ V ++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELMQ 235
Query: 672 ECWQTDPSLRPSFAQL 687
CW+ P RPSF+ L
Sbjct: 236 HCWKERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 83/261 (31%), Positives = 124/261 (47%), Gaps = 10/261 (3%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHA---DWNGTEVAVK-KFLDQDFSGAALLEFKREVKIM 488
EI ED+ LG IG G +G+VY ++AV K S + +F +E IM
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
R+ HP++V +G +T P + I+ E P G L L +D I + ++ +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPE 607
L + VHRD+ + N+LV VK+ DFGLSR + S P +WMAPE
Sbjct: 121 AYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 608 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
+ DV+ FGV +WE+ L P+ G+ V+G + RL +P P +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTL 237
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
++ +CW DPS RP F +L
Sbjct: 238 YSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 2e-34
Identities = 88/266 (33%), Positives = 142/266 (53%), Gaps = 16/266 (6%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EIP E + L +++G G +GEV+ + N T+VAVK S A LE E +M+ L
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTL 58
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNC 550
+H +V VT+ + IITE++ +GSL L +V + I + +A GM
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM-- 116
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 609
+ +HRDL++ N+LV ++ K++DFGL+R+ + +++ A P +W APE +
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDPL 665
K DV+SFG++L+E+ T K+P+ GM+ V+ A+ G++ R+E P EL
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL--- 233
Query: 666 VARIIWECWQTDPSLRPSFAQLTVAL 691
I+ CW+ RP+F L L
Sbjct: 234 -YDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 19/276 (6%)
Query: 439 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
L + +G G++G VY W VA+K + + S A E E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HP+VV +G + + +IT+ +P G L + + + + + +A+GM+ L
Sbjct: 68 HPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL- 125
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 610
+VHRDL + N+LV +VK++DFGL++L + G P +WMA E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ K DV+S+GV +WEL T P+ G+ +++ + + RL P V +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMV 243
Query: 670 IWECWQTDPSLRPSFAQLT-----VALKPLQRLVIP 700
+ +CW D RP+F +L +A P + LVI
Sbjct: 244 LVKCWMIDAESRPTFKELINEFSKMARDPQRYLVIQ 279
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 5e-34
Identities = 87/285 (30%), Positives = 146/285 (51%), Gaps = 29/285 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVY--HADWNGTE----VAVKKFLDQDFSGAALLEFKREVK 486
E+P + E +G ++G++Y H G + VA+K D + + EF++E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEAS 59
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPH----CQVDEKRRIKM 540
+M L HPN+V +G VT+ + ++ E+L +G L F I+ PH C DE +K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 541 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590
+LD +A GM L S+ VH+DL + N+L+ + +VK+SD GLSR ++
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 591 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 647
+ + + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 648 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
V + + L ++ P + ++ ECWQ PS RP F + L+
Sbjct: 238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 6e-34
Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 445 IGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G G +GEV+ A G E V VK EF+RE+ + R+L H NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE--------KRRIKMALDVARGMN 549
+G +I E+ G L + L + ++ K+++ + +A GM+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 608
H S VHRDL + N LV VKVS LS+ +N+ A P W+APE
Sbjct: 132 --HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 609 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667
++ + + K DV+SFGV++WE+ T +LP+ G++ +V+ + L +P+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 668 RIIWECWQTDPSLRPSFAQLTVAL 691
+++ CW +P RPSF++L AL
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 84/263 (31%), Positives = 128/263 (48%), Gaps = 15/263 (5%)
Query: 443 ERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
E IG G +GEV VA+K L ++ +F E IM + HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
G VT+ + IITEF+ G+L L + Q + + M +A GM L S
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SEMN 126
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRNE 612
VHRDL + N+LV+ N KVSDFGLSR + T+ SS W APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 613 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671
DV+S+G+++WE+ + + P+ M+ V+ A+ Q+ RL P + + +++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLML 245
Query: 672 ECWQTDPSLRPSFAQLTVALKPL 694
+CWQ D + RP F Q+ L +
Sbjct: 246 DCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 93/299 (31%), Positives = 144/299 (48%), Gaps = 53/299 (17%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 474
E P + L E++G G +GEV+ + +G + VAVK L D S
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDAS 59
Query: 475 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 534
A +F +EVKI+ RL PN+ +G T P L +I E++ G L + L + H
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK-HVAETS 118
Query: 535 KRR-----------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583
+ MA +A GM + + VHRDL + N LV KN+ +K++DFG+
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMR--YLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 584 SR-LKHNTFLSSKSTAGTP-EWMAPE-VLRNEPSNEKCDVYSFGVILWELATL--KLPWI 638
SR L + + + A P WMA E VL + + K DV++FGV LWE+ TL + P+
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYE 235
Query: 639 GMNPMQVVGAVG--FQNRRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ QV+ G F++ +I PK+ + ++ ECW+ D RP+F ++
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 78/270 (28%), Positives = 135/270 (50%), Gaps = 27/270 (10%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVKKF------LDQDFSG-----AALLEFKREVK 486
V GE IG G+YG VY A G +AVK+ + S AL + E++
Sbjct: 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL---RSEIE 60
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 546
++ L H N+V ++G T LSI E++P GS+ L R + + +E+ V
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLE 119
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 604
G+ LH+ I+HRDLK+ NLLVD + K+SDFG+S+ + + + ++ + G+ WM
Sbjct: 120 GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 605 APEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
APEV+ + + K D++S G ++ E+ + PW + + +G + IP ++
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237
Query: 663 DPLVARI----IWECWQTDPSLRPSFAQLT 688
++ + + C+ +P RP+ +L
Sbjct: 238 SMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 91/283 (32%), Positives = 139/283 (49%), Gaps = 30/283 (10%)
Query: 436 WEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
WED+ + IG G++G+V A D A+K L + S +F E++++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDFAGELEVLCKL 59
Query: 492 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEK 535
HPN++ +GA L I E+ P G+L L H + +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 536 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595
+ ++ A DVA GM L S +HRDL + N+LV +N K++DFGLSR + + K
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE---VYVK 174
Query: 596 STAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQ 652
T G WMA E L K DV+SFGV+LWE+ +L P+ GM ++ + Q
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 233
Query: 653 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695
R+E P+ D V ++ +CW+ P RP FAQ++V L +
Sbjct: 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 88/279 (31%), Positives = 145/279 (51%), Gaps = 23/279 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 60
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 536
+M+ +VV +G V++ +I E + RG L L RP + + K+
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 537 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596
I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 121 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 597 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
G WM+PE L++ DV+SFGV+LWE+ATL + P+ GM+ QV+ V +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 71/261 (27%), Positives = 127/261 (48%), Gaps = 19/261 (7%)
Query: 442 GERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA----ALLEFKREVKIMRRLRHPN 495
G+++G G++ Y A GT +AVK+ + + + ++E+++M RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
++ +GA + ++ E++ GS+ +L + + E I + RG++ LH +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 556 PTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKST-----AGTPEWMAPEVL 609
I+HRD+K NLL+D ++++DFG + + + GT +MAPEVL
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRLEIPKELDPLV 666
R E CDV+S G ++ E+AT K PW N + ++ + IP+ L P +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
+ C + P RP +L
Sbjct: 241 RDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 90/288 (31%), Positives = 143/288 (49%), Gaps = 44/288 (15%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLD-------QDFSGAALLEFK 482
+ W D+ + IG G++G+V A D + A+K+ + +DF+G
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG------- 56
Query: 483 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILH 526
E++++ +L HPN++ +GA L + E+ P G+L F I +
Sbjct: 57 -ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115
Query: 527 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586
+ ++ + A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 173
Query: 587 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 643
+ + K T G WMA E L DV+S+GV+LWE+ +L P+ GM
Sbjct: 174 QE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230
Query: 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691
++ + Q RLE P D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 231 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 91/283 (32%), Positives = 151/283 (53%), Gaps = 32/283 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 483
E+P + LVLG+ +G G +G+V A+ G T+VAVK L D + L +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEKDLSDLIS 72
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-----------HRPHCQ 531
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L + P
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 532 VDEKRRIK----MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
+E+ K A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 588 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
H+ K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE 249
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ + + R++ P + ++ +CW PS RP+F QL
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 30/279 (10%)
Query: 439 LVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 493
L LG+ +G G +G V + + VAVK + + + EF E M+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 494 PNVVLFMG------AVTRPPNLSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMAL 542
PNV+ +G ++ + P +I F+ G L L + + +K +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP 601
D+A GM L S +HRDL + N ++ ++ V V+DFGLS+ ++ + A P
Sbjct: 121 DIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 602 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG-----AVGFQNRR 655
+W+A E L + K DV++FGV +WE+AT G P V R
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-----GQTPYPGVENHEIYDYLRHGNR 233
Query: 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
L+ P++ + +++ CW+ DP RP+F +L L+ +
Sbjct: 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 24/264 (9%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLR 492
DL + +G GS G VY G A+KK + LL RE+K +R
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
P VV GA + +SI+ E++ GSL L + ++ E +A + +G++ LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAP 606
T I+HRD+K NLL++ VK++DFG+S++ + NTF+ GT +M+P
Sbjct: 117 T-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSP 169
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWI---GMNPMQVVGAVGFQNRRLEIPKELD 663
E ++ E + D++S G+ L E A K P++ + +++ A+ +E
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS 229
Query: 664 PLVARIIWECWQTDPSLRPSFAQL 687
P I C Q DP RPS A+L
Sbjct: 230 PEFRDFISACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 83/253 (32%), Positives = 131/253 (51%), Gaps = 19/253 (7%)
Query: 443 ERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
ERIG G++GEV+ + T VAVK + L D +F +E +I+++ HPN+V
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA----KFLQEARILKQYSHPNIV 56
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+G T+ + I+ E + G L ++ K I+M + A GM L +
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK--H 114
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WMAPEVLRNEP 613
+HRDL + N LV + +K+SDFG+SR + + + ST G + W APE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGGMKQIPVKWTAPEALNYGR 172
Query: 614 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
+ + DV+SFG++LWE +L +P+ ++ Q A+ Q RL P+ V R++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMER 231
Query: 673 CWQTDPSLRPSFA 685
CW+ DP RPSF+
Sbjct: 232 CWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 71/248 (28%), Positives = 120/248 (48%), Gaps = 10/248 (4%)
Query: 445 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502
+G GSYG VY A+K+ S + E++I+ + HPN++ + A
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 503 VTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTPTIV 559
L I+ E+ P G L + + + + + E+ ++ + + RG+ LH I+
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--IL 125
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 619
HRDLKS N+L+ N VK+ D G+S++ K+ GTP +MAPEV + P + K D
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 620 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 679
++S G +L+E+AT P+ + MQ + + + IP + I Q P
Sbjct: 184 IWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPK 242
Query: 680 LRPSFAQL 687
LRP+ ++
Sbjct: 243 LRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 86/277 (31%), Positives = 139/277 (50%), Gaps = 30/277 (10%)
Query: 445 IGLGSYGEV----YH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G G++G V Y D G VAVKK Q + L +F+RE++I++ L+H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 499 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+ G NL ++ E+LP GSL L + ++D ++ + A + +GM L +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--GSK 127
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPE-WMAPEVLRNEP 613
VHRDL + N+LV+ VK+ DFGL+++ + + + +P W APE L
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 614 SNEKCDVYSFGVILWELAT----------LKLPWIGMN---PMQVVGAVGF--QNRRLEI 658
+ DV+SFGV+L+EL T + +G + M V + N RL
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA 247
Query: 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695
P + I+ ECW DPS RPSF++L + ++ ++
Sbjct: 248 PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 41/294 (13%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E P ++ IG G++G V+ A G T VAVK L ++ S +F+RE
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREA 59
Query: 486 KIMRRLRHPNVVLFMG--AVTRPPNLSIITEFLPRGSLFRILHR---------------- 527
+M HPN+V +G AV +P + ++ E++ G L L
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 528 -----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
+ ++ +A VA GM + S VHRDL + N LV +N VK++DFG
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGM--AYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 583 LSRLKHNT--FLSSKSTAGTPEWMAPE-VLRNEPSNEKCDVYSFGVILWELATLKL-PWI 638
LSR ++ + +S++ A WM PE + N + E DV+++GV+LWE+ + + P+
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYY 234
Query: 639 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
GM +V+ V N L P + ++ CW PS RPSFA + L+
Sbjct: 235 GMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 64/253 (25%), Positives = 124/253 (49%), Gaps = 6/253 (2%)
Query: 438 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
D + +IG GS+G V+ + A+K+ + E E +++ +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTS 554
++ + + L+I+ E+ G L ++L + + E + + + + G+ LH+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
I+HRD+KS NL +D NVK+ D G+++L + + + GTP +++PE+ ++P
Sbjct: 121 K--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674
NEK DV++ GV+L+E T K P+ N ++ + + + + +A++I +C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 675 QTDPSLRPSFAQL 687
D RP QL
Sbjct: 238 TKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 82/255 (32%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 445 IGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG G +G VYH D AVK L++ + +F +E IM+ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 500 MGAVTRPPNLS-IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+G ++ ++ G L + K I L VA+GM L ++
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL--ASKKF 119
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTP-EWMAPEVLRNEPS 614
VHRDL + N ++D+++ VKV+DFGL+R K + + + A P +WMA E L+ +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 615 NEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKEL-DPLVARIIWE 672
K DV+SFGV+LWEL T P+ ++ + + Q RRL P+ DPL ++
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLY-EVMLS 237
Query: 673 CWQTDPSLRPSFAQL 687
CW P +RP+F++L
Sbjct: 238 CWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 78/262 (29%), Positives = 136/262 (51%), Gaps = 21/262 (8%)
Query: 442 GERIGLGSYGEVY---HADWNGTEVAVKKF------LDQDFSGAALLE-FKREVKIMRRL 491
G IG GS+G VY +A +G +AVK+ ++L+ RE+ +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
+H N+V ++G+ +L+I E++P GS+ +L+ + +E + +G+N L
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYL 122
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK------STAGTPEWMA 605
H I+HRD+K N+LVD +K+SDFG+S+ LS+K S G+ WMA
Sbjct: 123 HNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
PEV++ K D++S G ++ E+ T K P+ +Q + +G +N EIP +
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSE 239
Query: 666 VARIIWECWQTDPSLRPSFAQL 687
+ + ++ D + RP+ A+L
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 88/290 (30%), Positives = 150/290 (51%), Gaps = 32/290 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 483
E P + LVLG+ +G G +G+V A+ G + VAVK L + + L +
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLIS 66
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 527
E+++M+ + +H N++ +G T+ L +I E+ +G+L F I
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 528 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 588 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
H+ K++ G +WMAPE L + + DV+SFG+++WE+ TL P+ G+ P++
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ + + R++ P + ++ ECW P+ RP+F QL AL +
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 86/262 (32%), Positives = 130/262 (49%), Gaps = 23/262 (8%)
Query: 442 GERIGLGSYGEVYHADWN-GTEVAVKKF-LDQDFSGAALLEFKR---EVKIMRRLRHPNV 496
GE +G G+YG VY N G +AVK+ LD AA E+++ EV +++ L+H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTS 554
V ++G +SI EF+P GS+ IL+R P + + K LD G+ LH +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNN 121
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--------LKHNTFLSSKSTAGTPEWMAP 606
+VHRD+K N+++ N +K+ DFG +R H+ L KS GTP WMAP
Sbjct: 122 C--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAP 177
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPL 665
EV+ K D++S G ++E+AT K P M+ + + +G + +P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237
Query: 666 VARIIWECWQTDPSLRPSFAQL 687
+ C D RPS QL
Sbjct: 238 AIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 29/269 (10%)
Query: 437 EDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 489
D+VL +G G++G+V+ A + + VAVK ++ S +A +F+RE +++
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR---------- 537
L+H ++V F G T L ++ E++ G L R L H P ++
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 538 --IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLS 593
+ +A +A GM ++ ++ VHRDL + N LV + VK+ DFG+SR ++T +
Sbjct: 123 QMLAIASQIASGM--VYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 652
T WM PE + + D++SFGV+LWE+ T K PW ++ + + + Q
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 653 NRRLEIPKELDPLVARIIWECWQTDPSLR 681
R LE P+ P V I+ CWQ +P R
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 81/258 (31%), Positives = 128/258 (49%), Gaps = 11/258 (4%)
Query: 445 IGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
IG G +GEV E+ V K L ++ +F E IM + HPN++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
G VT+ + I+TE++ GSL L + Q + + M +A GM L S VH
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDMGYVH 129
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 617
RDL + N+LV+ N KVSDFGLSR+ + ++ +T G W APE +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 618 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
DV+S+G+++WE+ + + P+ M+ V+ A+ + RL P + + +++ +CWQ
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQK 248
Query: 677 DPSLRPSFAQLTVALKPL 694
D + RP F Q+ L L
Sbjct: 249 DRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 84/274 (30%), Positives = 137/274 (50%), Gaps = 43/274 (15%)
Query: 436 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
WE ++GE +G G++G+VY A T + A K + + S L +F E+ I+ +HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHP 62
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
N+V A L I+ EF G+L I+ + E + + + +N LH+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEV 608
++HRDLK+ N+L+ + +VK++DFG+S K +TF+ GTP WMAPEV
Sbjct: 123 K--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEV 174
Query: 609 L-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
+ ++ P + K D++S G+ L ELA ++ P +NPM+V+ L+I K
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEP 225
Query: 664 PLVAR----------IIWECWQTDPSLRPSFAQL 687
P + + + C DP RP+ A+L
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 24/276 (8%)
Query: 439 LVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 493
LG +G G +G V A D + +VAVK FS + + EF RE M+ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 494 PNVVLFMG------AVTRPPNLSIITEFLPRGSLF------RILHRPHCQVDEKRRIKMA 541
PNV+ +G A R P +I F+ G L RI P + + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTLVRFM 119
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 600
+D+A GM L S+ +HRDL + N ++++N V V+DFGLS+ + + +
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 601 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 658
P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ + + RL+
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQ 236
Query: 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
P + V ++ +CW +P RPSF L L+ +
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 77/261 (29%), Positives = 126/261 (48%), Gaps = 38/261 (14%)
Query: 444 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFM 500
+IG G + VY A +G VA+KK + A A + +E+ ++++L HPNV+ ++
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTPT 557
+ L+I+ E G L R++ Q + E+ K + + + +H+
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-- 126
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRNE 612
I+HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQN-RRLEIP--------KE 661
N K D++S G +L+E+A L+ P+ G MN + + + + P +E
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEKCDYPPLPADHYSEE 236
Query: 662 LDPLVARIIWECWQTDPSLRP 682
L LV+R C DP RP
Sbjct: 237 LRDLVSR----CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 90/296 (30%), Positives = 143/296 (48%), Gaps = 40/296 (13%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE----------------VAVKKFLDQDFSGA 476
E P + L L E++G G +GEV+ + G VAVK L D +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTKT 59
Query: 477 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----- 531
A +F +E+KIM RL++PN++ +G L +ITE++ G L + L + +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 532 ------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585
V + MA+ +A GM L ++ VHRDL + N LV ++ +K++DFG+SR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 586 -LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGMN 641
L + + A P WMA E + DV++FGV LWE+ TL + P+ ++
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237
Query: 642 PMQVVGAVG--FQNRRLEIPKELDPL----VARIIWECWQTDPSLRPSFAQLTVAL 691
QV+ G F+N+ +I PL V +++ CW D RP+F ++ L
Sbjct: 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 86/271 (31%), Positives = 138/271 (50%), Gaps = 30/271 (11%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
+D L E IG+G+ VY A N +VA+K+ +D + ++ E ++EV+ M + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLH 552
NVV + + L ++ +L GSL I+ P +DE + +V +G+ LH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----------RLKHNTFLSSKSTAGTPE 602
++ +HRD+K+ N+L+ ++ +VK++DFG+S R TF GTP
Sbjct: 120 SNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------VGTPC 171
Query: 603 WMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIP 659
WMAPEV+ + K D++SFG+ ELAT P+ PM+V+ + QN LE
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLETG 230
Query: 660 KELDP---LVARIIWECWQTDPSLRPSFAQL 687
+ ++I C Q DPS RP+ +L
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 32/283 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 483
E + L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVS 69
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 527
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + I
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 528 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
P Q+ K + VARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 588 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
+N K+T G +WMAPE L + + DV+SFGV++WE+ TL P+ G+ P++
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 246
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ + + R++ P + ++ +CW PS RP+F QL
Sbjct: 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 84/260 (32%), Positives = 129/260 (49%), Gaps = 15/260 (5%)
Query: 445 IGLGSYGEVYHADWN---GTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
IG G +GEV+ EVAV K L ++ +F E IM + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
G VT+ IITE++ G+L + L + + + M +A GM L S VH
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYVH 130
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 617
RDL + N+LV+ N KVSDFGLSR+ + + +T+G W APE +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 618 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECW 674
DV+SFG+++WE+ + + P+ M+ +V+ A+ GF RL P + V +++ +CW
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSAVYQLMLQCW 247
Query: 675 QTDPSLRPSFAQLTVALKPL 694
Q D + RP F + L L
Sbjct: 248 QQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 92/283 (32%), Positives = 149/283 (52%), Gaps = 32/283 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 483
E+ L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLVS 66
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RP--------HCQV 532
E+++M+ + +H N++ +GA T+ L ++ E+ +G+L L RP C++
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 533 DE-----KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
E K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 588 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
HN K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 243
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ + + R++ P + I+ ECW PS RP+F QL
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 81/280 (28%), Positives = 134/280 (47%), Gaps = 17/280 (6%)
Query: 443 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVL 498
E IG G+YG VY T V K ++ D + + +REV ++ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+ G+ + P L II E+ GS+ R L + + EK + +V + +H +
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGP-IAEKYISVIIREVLVALKYIHKVG--V 122
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 617
+HRD+K+ N+LV NVK+ DFG++ L + + GTP WMAPEV+ + K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEIPKELDPLVARIIWECWQT 676
D++S G+ ++E+AT P+ ++ + + + + RLE L+ + C
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREFVAACLDE 241
Query: 677 DPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 716
+P R S +L L+ I +H P S L + IS
Sbjct: 242 EPKERLSAEEL------LKSKWIKAHSKTPVSILKELISR 275
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 87/274 (31%), Positives = 132/274 (48%), Gaps = 23/274 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVY-----HADWNGTEVAVK-KFLDQDFSGAALLEFKREVK 486
E+P + + L +G G++GEVY D + E+ V K L + S +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 487 IMRRLRHPNVVLFMG-AVTRPPNLSIITEFLPRGSLFRILH--RPH----CQVDEKRRIK 539
IM + H N+V +G + R P I+ E + G L L RP + K +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPN-LLVDKNWN--VKVSDFGLSR-LKHNTFLSSK 595
A DVA+G L + +HRD+ + N LL K K++DFG++R + ++
Sbjct: 121 CARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 596 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
A P +WM PE + K DV+SFGV+LWE+ +L +P+ G +V+ V
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGG 237
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
RL+ PK V RI+ +CWQ P RP+FA +
Sbjct: 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 94/297 (31%), Positives = 144/297 (48%), Gaps = 41/297 (13%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 474
E P + L E++G G +GEV+ + G E VAVK L +D +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDAN 59
Query: 475 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ- 531
A +F +E+KIM RL+ PN++ + L +ITE++ G L + L H P
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 532 VDEKRR-------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584
I MA +A GM L S+ VHRDL + N LV KN+ +K++DFG+S
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 585 R-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGM 640
R L + + A P WM+ E + DV++FGV LWE+ TL + P+ +
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237
Query: 641 NPMQVVGAVG-F---QNRRLEIPKE-LDP-LVARIIWECWQTDPSLRPSFAQLTVAL 691
+ QV+ G F Q R++ +PK L P + +++ CW+ + RPSF ++ L
Sbjct: 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 86/278 (30%), Positives = 136/278 (48%), Gaps = 35/278 (12%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSG--AALLEFKR 483
E P +L G+ +G G++G+V A G +VAVK S AL+
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMA 541
E+KIM L H N+V +GA T + +ITE+ G L L R + + + +
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 600
VA+GM L ++ +HRDL + N+L+ VK+ DFGL+R + +++ K A
Sbjct: 148 YQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 601 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM-------NPMQVVGAVGF 651
P +WMAPE + N + DV+S+G++LWE+ +L P+ GM ++ G+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGY 261
Query: 652 QNRRLE-IPKELDPLVARIIWECWQTDPSLRPSFAQLT 688
+ + E P E + I+ CW DP RP+F Q+
Sbjct: 262 RMAQPEHAPAE----IYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 82/266 (30%), Positives = 126/266 (47%), Gaps = 34/266 (12%)
Query: 445 IGLGSYGEVYHA-----DWNGTE---VAVKKF----LDQDFSGAALLEFKREVKIMRRLR 492
+G G++GEVY G+ VAVK DQ+ EF +E +M
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-----EFLKEAHLMSNFN 57
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------VDEKRRIKMALDVAR 546
HPN+V +G II E + G L L + + K + + LDVA+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 600
G C++ +HRDL + N LV D + VK+ DFGL+R + + + +
Sbjct: 118 G--CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 601 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 658
P WMAPE L + + DV+SFGV++WE+ TL + P+ +N +V+ V RL+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234
Query: 659 PKELDPLVARIIWECWQTDPSLRPSF 684
P+ + +++ CW DPS RP+F
Sbjct: 235 PENCPDKIYQLMTNCWAQDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 23/279 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E+ E + L +G GS+G VY + T VAVK +++ S +EF E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEA 60
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 536
+M+ +VV +G V++ ++ E + G L L RP + + +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 537 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596
I+MA ++A GM L+ VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 597 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
G WMAPE L++ D++SFGV+LWE+ +L + P+ G++ QV+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 237
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
L+ P V ++ CWQ +P +RP+F ++ LK
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 88/273 (32%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHAD-WNGTE------VAVKKFLDQDFSGAALLEFKREVK 486
I D+VL +G G++G+V+ A+ +N + VAVK D AA +F+RE +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAE 59
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ--VDEKRR----- 537
++ L+H ++V F G L ++ E++ G L + L H P VD + R
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 538 ------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 590
+ +A +A GM ++ ++ VHRDL + N LV N VK+ DFG+SR ++T
Sbjct: 120 LGLSQMLHIASQIASGM--VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 591 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGA 648
+ T WM PE + + DV+SFGVILWE+ T K PW ++ +V+
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 681
+ Q R LE P+ V I+ CWQ +P R
Sbjct: 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 90/293 (30%), Positives = 138/293 (47%), Gaps = 45/293 (15%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 485
EI + E +G +G+VY GT VA+K D+ G EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 540
+ RL+HPN+V +G VT+ LS+I + L F ++ PH V D+ + +K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 541 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR----- 585
L+ +A GM L S+ +VH+DL + N+LV NVK+SD GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 586 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM 640
L N+ L + WM+PE + + D++S+GV+LWE+ + L P+ G
Sbjct: 178 DYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 641 NPMQVVGAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
+ V+ + +NR+ L P + V ++ ECW PS RP F + L+
Sbjct: 231 SNQDVIEMI--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 37/290 (12%)
Query: 438 DLVLGERIGLGSYGEVYHA---DWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
+LVLG+ +G G +G+V A G T VAVK L ++ S + L + E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQ 59
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSL---FRILHRPHCQ---------------- 531
+ HP+V+ GA ++ L +I E+ GSL R +
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 532 ----VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-- 585
+ I A ++RGM L + +VHRDL + N+LV + +K+SDFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQ 644
+ ++++ +WMA E L + + DV+SFGV+LWE+ TL P+ G+ P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ + R+E P+ + ++ CW+ +P RP+FA ++ L+ +
Sbjct: 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 75/216 (34%), Positives = 117/216 (54%), Gaps = 8/216 (3%)
Query: 435 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 493
P ED L +RIG G+YG+VY A + N E+A K + + G ++E+ +M+ +H
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKH 65
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
N+V + G+ R L I EF GSL I H + E + ++ + +G+ LH+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS 124
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL---R 610
+HRD+K N+L+ N +VK++DFG+S T KS GTP WMAPEV R
Sbjct: 125 KGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 646
N+ CD+++ G+ ELA L+ P ++PM+ +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 86/269 (31%), Positives = 135/269 (50%), Gaps = 28/269 (10%)
Query: 445 IGLGSYGEVYHA--DWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 500
IG G++G+V A +G + A K + + S +F E++++ +L HPN++ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 501 GAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEKRRIKMALDVA 545
GA L + E+ P G+L L + + ++ + A DVA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TPEW 603
RGM+ L S +HRDL + N+LV +N+ K++DFGLSR + + K T G W
Sbjct: 123 RGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRW 177
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
MA E L DV+S+GV+LWE+ +L P+ GM ++ + Q RLE P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236
Query: 663 DPLVARIIWECWQTDPSLRPSFAQLTVAL 691
D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 71/244 (29%), Positives = 119/244 (48%), Gaps = 16/244 (6%)
Query: 445 IGLGSYGEVY---HADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVV-L 498
+G GS+G+V D G A+K L + + E I+ R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKD-TGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTPT 557
T L ++ E+ P G LF L + E+R R A ++ + LH+
Sbjct: 59 HYAFQT-EEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAA-EIVLALEYLHSLG-- 113
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 617
I++RDLK N+L+D + ++K++DFGL++ + + + GTPE++APEVL + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 677
D +S GV+L+E+ T K P+ + ++ + L P+ L P +I Q D
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQKD 231
Query: 678 PSLR 681
P+ R
Sbjct: 232 PTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 74/251 (29%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 443 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 498
++IG GS+G++Y A + +E V K + D + + E K+EV ++ +++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIK--EIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPT 557
F + L I+ E+ G L + ++R E + + + ++ G+ +H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK-- 121
Query: 558 IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 616
I+HRD+KS N+ + KN V K+ DFG++R +++ + + GTP +++PE+ +N P N
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 617 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
K D++S G +L+EL TLK P+ G N Q+V + Q I + +I + ++
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLFKV 240
Query: 677 DPSLRPSFAQL 687
P RPS +
Sbjct: 241 SPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 79/285 (27%), Positives = 140/285 (49%), Gaps = 27/285 (9%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVK 486
I ++VL +G G++G+V+ A+ + VAVK +D S A +F RE +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAE 59
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH------------RPHCQVDE 534
++ L+H ++V F G L ++ E++ G L + L ++ +
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 535 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FL 592
+ + +A +A GM ++ ++ VHRDL + N LV +N VK+ DFG+SR ++T +
Sbjct: 120 SQMLHIAQQIAAGM--VYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 651
T WM PE + + DV+S GV+LWE+ T K PW ++ +V+ +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236
Query: 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
Q R L+ P+ V ++ CWQ +P +R + ++ L+ L +
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 59/252 (23%), Positives = 122/252 (48%), Gaps = 6/252 (2%)
Query: 445 IGLGSYGE--VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502
+G G++GE +Y + + V K+ S + E+ I+ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 503 VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
L I E+ G+L+ +I+ + +E+ + + ++ +H + I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 621
D+K+ N+ + K +K+ DFG+S++ + + +++ GTP +M+PE+ + N K D++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 622 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 681
+ G +L+EL TLK + NP+ +V + Q + + ++ Q DP R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 682 PSFAQLTVALKP 693
P+ ++
Sbjct: 245 PTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 77/254 (30%), Positives = 130/254 (51%), Gaps = 22/254 (8%)
Query: 443 ERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
ERIG GS+GEV+ N T+ V K +D + + + + ++E+ ++ + P V + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ + L II E+L GS +L DE + M ++ +G++ LH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK--IHR 125
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 621
D+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 622 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA--------RIIWEC 673
S G+ ELA + P M+PM+V+ IPK P + I C
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 674 WQTDPSLRPSFAQL 687
DPS RP+ +L
Sbjct: 237 LNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 21/272 (7%)
Query: 439 LVLGERIGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
L LG+ +G G +G V N + VAVK + + + +F E M+ HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 495 NVVLFMGAVTRP------PNLSIITEFLPRGSL--FRILHRPHCQ---VDEKRRIKMALD 543
NV+ +G + P+ +I F+ G L F + R + + +K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP- 601
+A GM L S+ + +HRDL + N ++++N NV V+DFGLS+ +N + A P
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 660
+W+A E L + K DV+SFGV +WE+AT + P+ G+ ++ + NR + P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238
Query: 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
LD L + ++ CW +P RPSF L L+
Sbjct: 239 CLDGLYS-LMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 74/254 (29%), Positives = 131/254 (51%), Gaps = 22/254 (8%)
Query: 443 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
ERIG GS+GEVY N T EV K +D + + + + ++E+ ++ + P + + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ + L II E+L GS +L +P ++E + ++ +G++ LH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPG-PLEETYIATILREILKGLDYLHSERK--IHR 125
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 621
D+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 622 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV--------ARIIWEC 673
S G+ ELA + P ++PM+V+ IPK P + + C
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKPFKEFVEAC 236
Query: 674 WQTDPSLRPSFAQL 687
DP RP+ +L
Sbjct: 237 LNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 75/230 (32%), Positives = 119/230 (51%), Gaps = 15/230 (6%)
Query: 441 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 494
LG+ +G G++GEVY AD G E+AVK+ D + + + E+++++ LRH
Sbjct: 6 LGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 495 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
+V + G + P LSI E++P GS+ L + + + E + + +G++ LH
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVL 609
++ IVHRD+K N+L D NVK+ DFG S+ +S KS GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
E K DV+S + E+ T K PW M + + Q + +P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 65/305 (21%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFK-----REV 485
+D G+ IG GS+ V A E A+K + L + E K E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--------EKKVKYVKIEK 52
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RRI 538
+++ RL HP ++ NL + E+ P G L + + + + +DEK I
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEI 111
Query: 539 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---- 594
+AL+ I+HRDLK N+L+DK+ ++K++DFG +++
Sbjct: 112 LLALEYLHSKG--------IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 595 ----------------KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 638
S GT E+++PE+L +P+ + D+++ G I++++ T K P+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
Query: 639 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698
G N + P P +I + DP R + LK
Sbjct: 224 GSNEYLTFQKI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK------ 275
Query: 699 IPSHP 703
+HP
Sbjct: 276 --AHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 86/285 (30%), Positives = 138/285 (48%), Gaps = 35/285 (12%)
Query: 436 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
WE ++GE +G G++G+VY A T A K ++ S L ++ E++I+ HP
Sbjct: 14 WE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHP 69
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGS-------LFRILHRPHCQVDEKRRIKMALDVARG 547
+V +GA L I+ EF P G+ L R L P QV ++ ++
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE-------A 122
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 607
+ LH+ I+HRDLK+ N+L+ + ++K++DFG+S T S GTP WMAPE
Sbjct: 123 LQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 608 V-----LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKE 661
V +++ P + K D++S G+ L E+A ++ P +NPM+V+ + L P +
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQL--------TVALKPLQRLV 698
+ P RPS AQL + +PL+ LV
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 443 ERIGLGSYGEVYHADWN---GTEVAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPN 495
E++G G+YG VY A + G VA+KK LD + AL RE+ +++ L+HPN
Sbjct: 5 EKLGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELKHPN 59
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHTS 554
+V + + L ++ E+ L + L + + IK + + RG+ H+
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP-NLIKSIMYQLLRGLAYCHSH 117
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 609
I+HRDLK N+L++++ +K++DFGL+R T E W APE+L
Sbjct: 118 R--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 610 RNEPS-NEKCDVYSFGVILWELATLK 634
+ D++S G I E+ T K
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 75/260 (28%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 445 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
+G G++G VY W G V + K L++ A +EF E IM + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
+G V P + ++T+ +P G L +H + + + + +A+GM ++ +V
Sbjct: 75 LG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM--MYLEERRLV 131
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--EWMAPEVLRNEPSNEK 617
HRDL + N+LV +VK++DFGL+RL + G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 618 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
DV+S+GV +WEL T P+ G+ P + + + + RL P V ++ +CW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 677 DPSLRPSFAQLTVALKPLQR 696
D RP F +L + R
Sbjct: 251 DADSRPKFKELAAEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 28/268 (10%)
Query: 445 IGLGSYGEVY------HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G G +G+V D G +VAVK L + G + + K+E++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 499 FMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+ G T I I EFLP GSL L R +++ K+++K A+ + +GM+ L +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNT-FLSSKSTAGTPE-WMAPEVLRNEP 613
VHRDL + N+LV+ VK+ DFGL++ ++ + + + K +P W APE L
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 614 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 659
DV+SFGV L+EL T LK+ M V V + +RL P
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQL 687
V +++ +CW+ PS R +F L
Sbjct: 249 PNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 86/303 (28%), Positives = 138/303 (45%), Gaps = 53/303 (17%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 474
+ P L+ E++G G +GEV+ + + VAVK L D +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDAN 59
Query: 475 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 534
A +F +EVKI+ RL+ PN++ +G L +ITE++ G L + L +D+
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDD 117
Query: 535 KRR--------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 574
K + +AL +A GM L S+ VHRDL + N LV +N
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENL 175
Query: 575 NVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
+K++DFG+SR L + + A P WMA E + DV++FGV LWE+
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 633 L--KLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE----CWQTDPSLRPSF 684
L + P+ + QV+ G F+++ ++ P + ++E CW D RPSF
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 685 AQL 687
+ +
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 19/263 (7%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK---REVKIMRR 490
+DL +G G+ G V G +AVK L+ + K RE+ I+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-----EAIQKQILRELDILHK 55
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
P +V F GA ++SI E++ GSL +IL ++ E+ K+A+ V +G+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
LH I+HRD+K N+LV+ +K+ DFG+S N+ +K+ GT +MAPE ++
Sbjct: 116 LH-EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQ 172
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIG-----MNPMQVVGAVGFQNRRLEIPKELDPL 665
+ K D++S G+ L ELAT + P+ +++ + + + P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232
Query: 666 VARIIWECWQTDPSLRPSFAQLT 688
+ C DP RPS+ +L
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 21/271 (7%)
Query: 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHP-NVVL 498
+ ++G GS+GEVY A + VA+K + S + +E F RE++I+ L HP N+V
Sbjct: 4 ILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTP 556
+L ++ E++ GSL +L + + E + + + + LH+
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 557 TIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVL 609
I+HRD+K N+L+D++ VK+ DFGL++L + +S A GTP +MAPEVL
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 610 R---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
++ D++S G+ L+EL T P+ G L P PL
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697
+ +A P RL
Sbjct: 241 PSNPE----LISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 72/251 (28%), Positives = 130/251 (51%), Gaps = 16/251 (6%)
Query: 445 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502
+G G++G V+ + V +K+ + + L + E ++++ L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 503 VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
L I+ E+ P G+L + R + +DE + + + ++ +HT I+HR
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHR 125
Query: 562 DLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTA----GTPEWMAPEVLRNEPSNE 616
DLK+ N+L+DK+ V K+ DFG+S++ LSSKS A GTP +++PE+ +P N+
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 617 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
K D+++ G +L+ELA+LK + N +V + I P + ++I
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 677 DPSLRPSFAQL 687
DPS RP +Q+
Sbjct: 240 DPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 82/262 (31%), Positives = 126/262 (48%), Gaps = 24/262 (9%)
Query: 441 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 494
LG+ +G G++G VY AD G E+AVK+ + + + + E+++++ L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 495 NVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
+V + G + P LSI E +P GS+ L + + + E K + G++ LH
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVL 609
++ IVHRD+K N+L D NVK+ DFG S+ LS KS GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD----PL 665
E K D++S G + E+ T K PW M + + Q +P +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 666 VARIIWECWQTDPSLRPSFAQL 687
+ RI E LRPS +L
Sbjct: 242 LKRIFVEA-----KLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 71/254 (27%), Positives = 133/254 (52%), Gaps = 6/254 (2%)
Query: 435 PWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 493
P E E+IG GS+GEV+ N T+ V K +D + + + + ++E+ ++ +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
P V + G+ + L II E+L GS +L +DE + + ++ +G++ LH+
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+HRD+K+ N+L+ ++ VK++DFG++ +T + + GTP WMAPEV++
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
+ K D++S G+ ELA + P ++PM+V+ + +N + + + C
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 236
Query: 674 WQTDPSLRPSFAQL 687
+PS RP+ +L
Sbjct: 237 LNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 81/242 (33%), Positives = 127/242 (52%), Gaps = 27/242 (11%)
Query: 436 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
WE ++GE +G G++G+VY A T V A K +D S L ++ E+ I+ HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHP 62
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNCL 551
N+V + A NL I+ EF G++ + L RP + + K L+ +N L
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYL 119
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-- 609
H + I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 610 ---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
++ P + K DV+S G+ L E+A ++ P +NPM+V+ L+I K P +
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPTL 228
Query: 667 AR 668
A+
Sbjct: 229 AQ 230
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 10/233 (4%)
Query: 463 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522
VA+ L S F E + + H N+V G +TR + I+TE++ G+L
Sbjct: 36 VAIHT-LRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
L + Q+ + + M +A GM L S VH+ L + +LV+ + K+S F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 583 -LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 640
L K ++ S W APE ++ + DV+SFG+++WE+ + + P+ M
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
Query: 641 NPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691
+ V+ AV GF RL P+ L+ +++ +CWQ + RP F+Q+ L
Sbjct: 213 SGQDVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 27/268 (10%)
Query: 435 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLD----QDFSGAALLEFKREVKIMR 489
P D L +R+G G+YG+VY A + + E+A K + DFS ++E+ +++
Sbjct: 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMVK 61
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDVA 545
+H N+V + G+ L I E+ GSL I H Q+ + +
Sbjct: 62 ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQI-----AYVCRETL 116
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605
+G+ LH+ +HRD+K N+L+ N +VK++DFG++ T KS GTP WMA
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 606 PEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIP 659
PEV +N N+ CD+++ G+ ELA L+ P ++PM+ ++ FQ +L+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQL 687
+ + +P RP+ +L
Sbjct: 235 TKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 21/282 (7%)
Query: 445 IGLGSYGEVYHADWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
+G G++G VY W VK K L + S A E E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
+G + + +IT+ +P G L + + + + + +A+GMN L +V
Sbjct: 75 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 617
HRDL + N+LV +VK++DFGL++L + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 618 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
DV+S+GV +WEL T P+ G+ P + ++ + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 677 DPSLRPSFAQLT-----VALKPLQRLVI----PSHPDQPSSA 709
D RP F +L +A P + LVI H P+ +
Sbjct: 251 DADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 292
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 22/234 (9%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 501
I G+YG V+ A T A+K D ++ E I+ + + P VV
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ NL ++ E+LP G L +L ++ RI +A ++ + LH++ I+HR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSNG--IIHR 117
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRL--------KHNTFLSSKSTAGTPEWMAPEVLRNEP 613
DLK N+L+D N ++K++DFGLS++ ++ K GTP+++APEV+ +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDP 664
++ D +S G IL+E P+ G P ++ FQN ++E P++++
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 54/196 (27%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 443 ERIGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
++IG GS+G+ V + +G + +K+ S E ++EV ++ ++HPN+V +
Sbjct: 6 KKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 500 MGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+ NL I+ ++ G L+ +I + E + + + + + +H I
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--I 122
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
+HRD+KS N+ + K+ +K+ DFG++R+ ++T +++ GTP +++PE+ N P N K
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 619 DVYSFGVILWELATLK 634
D+++ G +L+E+ TLK
Sbjct: 183 DIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 69/263 (26%), Positives = 125/263 (47%), Gaps = 41/263 (15%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFK------REVKIM 488
+D + +G GS+G V G+ A+K S A +++ K E +I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLNEKRIL 55
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQVDEKRRIKMAL 542
+ +RHP +V G+ NL ++ E++P G LF L + P + A
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF-------YAA 108
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTP 601
V + LH+ IV+RDLK NLL+D + +K++DFG + R+K T+ + GTP
Sbjct: 109 QVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTP 162
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEI 658
E++APE++ ++ + D ++ G++++E+ P+ NP+Q+ ++ ++
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKILEGKVRF 217
Query: 659 PKELDPLVARIIWECWQTDPSLR 681
P P +I Q D + R
Sbjct: 218 PSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 440 VLGERIGLGSYGEV--YHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 493
VLGE G +G+V Y D G VAVK L ++ +K+E+ I++ L H
Sbjct: 11 VLGE----GHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYH 65
Query: 494 PNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
N+V + G + L +I E++P GSL L P +++ + + A + GM L
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEV 608
H+ +HRDL + N+L+D + VK+ DFGL++ H + + W A E
Sbjct: 124 HSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 609 LRNEPSNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGFQNRRL 656
L+ + DV+SFGV L+EL T ++ M VV + R +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 657 EIPKELD-PLVARIIWE-CWQTDPSLRPSFAQLTVALK 692
+P + P I+ + CW+T+ RP+F L LK
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 13/256 (5%)
Query: 445 IGLGSYGEV----YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
+G G++G V Y + VAVK + + A E RE +M++L +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
G + + ++ E G L + L + V EK ++ V+ GM L + VH
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETN--FVH 118
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEK 617
RDL + N+L+ K+SDFGLS+ + +K+ P +W APE + + K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 618 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
DV+SFGV++WE + P+ GM +V + R+E P+ P + ++ CW
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTY 237
Query: 677 DPSLRPSFAQLTVALK 692
RP FA + + L+
Sbjct: 238 GVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 49/277 (17%)
Query: 443 ERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR-----------EVKIM 488
E +G G++G VY + +A+K+ + A + KR EV I+
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEI---NVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 489 R-RLRHPNVVLFMGAVTRPPNLSIITEFL---PRGSLFRILHRPHCQVDEKRRIKMALDV 544
+ +LRHPN+V + L I+ + + P G F L + E+R + + +
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH-NTFLSSKSTAGTPEW 603
+ LH IVHRDL N+++ ++ V ++DFGL++ K + L+S GT +
Sbjct: 123 VLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGTILY 179
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIP 659
PE+++NEP EK DV++FG IL+++ TL+ P+ N ++V AV
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV---------- 229
Query: 660 KELDPL--------VARIIWECWQTDPSLRPSFAQLT 688
+PL V +I C D RP Q++
Sbjct: 230 --YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 77/256 (30%), Positives = 126/256 (49%), Gaps = 9/256 (3%)
Query: 435 PWEDLVLGERIGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
P L +IG GS G V G +VAVKK +D L F EV IMR +
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKK-MDLRKQQRRELLFN-EVVIMRDYQ 74
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HPN+V + L ++ EFL G+L I+ H +++E++ + L V + ++ LH
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLH 132
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
++HRD+KS ++L+ + VK+SDFG KS GTP WMAPEV+
Sbjct: 133 AQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRLEIPKELDPLVARIIW 671
P + D++S G+++ E+ + P+ P+Q + + +L+ ++ P + +
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250
Query: 672 ECWQTDPSLRPSFAQL 687
DP+ R + A+L
Sbjct: 251 RMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 24/265 (9%)
Query: 442 GERIGLGSYGEV---YHADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHPN 495
G+ +G G++G V Y D G E+A K+ + + + + E+++++ L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 496 VVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
+V + G + L+I E++P GS+ L + + + E K + GM+ LH+
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVLR 610
+ IVHRD+K N+L D NVK+ DFG S+ +S +S GTP WM+PEV+
Sbjct: 125 NM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----LV 666
E K DV+S G + E+ T K PW M + + Q ++P + +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 667 ARIIWECWQTDPS----LRPSFAQL 687
I E PS LR FAQL
Sbjct: 243 GCIFVEARHR-PSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 72/249 (28%), Positives = 129/249 (51%), Gaps = 11/249 (4%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR +HPN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNYL 82
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
+ L ++ E+L GSL ++ +DE + + + + + LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--VIH 138
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSNEKCD 619
RD+KS N+L+ + +VK++DFG + S +ST GTP WMAPEV+ + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 620 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDP 678
++S G++ E+ + P++ NP++ + + L+ P++L + + C + D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257
Query: 679 SLRPSFAQL 687
R S +L
Sbjct: 258 EKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 49/275 (17%)
Query: 448 GSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 498
G++G +++ EV VK D A+ ++ +E ++ L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 499 FMGAVTR---PP-------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
+ PP N + FL + L + ++ + MA+ +A GM
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL--GEANNPQALSTQQLVHMAIQIACGM 130
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE-----W 603
+ LH ++H+D+ + N ++D+ VK++D LSR + F G E W
Sbjct: 131 SYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENRPVKW 185
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE--- 657
MA E L N+ + DV+SFGV+LWEL TL + P++ ++P ++ + G+ RL
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLAQPI 242
Query: 658 -IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691
P EL ++A CW DP RPSF+QL L
Sbjct: 243 NCPDELFAVMAC----CWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 81/256 (31%), Positives = 125/256 (48%), Gaps = 14/256 (5%)
Query: 442 GERI--GLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
GER+ G G+YG VY A T+V A+K+ ++D L E+ + L+H N+V
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV 68
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTST 555
++G+ + I E +P GSL +L + +E+ I + G+ LH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 556 PTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
IVHRD+K N+LV+ V K+SDFG S+ +++ GT ++MAPEV+ P
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 615 --NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671
D++S G + E+AT K P+I + P + VG EIP+ L I
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246
Query: 672 ECWQTDPSLRPSFAQL 687
C++ DP R S L
Sbjct: 247 RCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 83/257 (32%), Positives = 122/257 (47%), Gaps = 29/257 (11%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 498
IG GS+G VY A T VA+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+ G R ++ E+ GS IL H+ Q E I +G+ LH+
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAI--CHGALQGLAYLHSHE- 135
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVL--RNE 612
+HRD+K+ N+L+ + VK++DFG + L N+F+ GTP WMAPEV+ +E
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDE 188
Query: 613 PS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARII 670
+ K DV+S G+ ELA K P MN M + + QN + + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWSDYFRNFV 247
Query: 671 WECWQTDPSLRPSFAQL 687
C Q P RPS +L
Sbjct: 248 DSCLQKIPQDRPSSEEL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+IG G+YG VY A G VA+KK F + AL RE+K+++ L HPN+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNI 60
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+ + +L ++ EF+ L++++ + E + +G+ H+
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRN 611
I+HRDLK NLL++ +K++DFGL+R S T W APE+L
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 612 EPS-NEKCDVYSFGVILWELATLKLPWIGMN 641
+ + D++S G I EL + + + G +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 67/247 (27%), Positives = 124/247 (50%), Gaps = 7/247 (2%)
Query: 445 IGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502
+G GSYGEV +G + +KK ++ S ++E +++ +L+HPN+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 503 VTRPPN-LSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIVH 560
L I+ F G L+ L ++ E + ++ + +A + LH I+H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILH 125
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 620
RDLK+ N+ + + +KV D G++R+ N + + GTP +M+PE+ N+P N K DV
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 621 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 680
++ G ++E+ATLK + + +V + + + +PK+ P + +I P
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSKRPEK 244
Query: 681 RPSFAQL 687
RPS +
Sbjct: 245 RPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 84/278 (30%), Positives = 124/278 (44%), Gaps = 49/278 (17%)
Query: 441 LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 496
L E IG G+YG+VY H G VA+K D E K E I+R+ HPN+
Sbjct: 10 LVEVIGEGTYGKVYKARHKK-TGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 497 VLFMGAVT--RPPN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------DV 544
F GA PP L ++ E GS+ ++ + +R+K +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRET 122
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 604
RG+ LH + ++HRD+K N+L+ KN VK+ DFG+S +T + GTP WM
Sbjct: 123 LRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 605 APEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
APEV+ + + + DV+S G+ ELA K P M+PM+ + F+ IP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK-----IP 231
Query: 660 KELDPLVAR----------IIWECWQTDPSLRPSFAQL 687
+ P + I EC + RP +L
Sbjct: 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 18/208 (8%)
Query: 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLF 499
++IG G + EVY A +G VA+KK D A A + +E+ ++++L HPNV+ +
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTP 556
+ L+I+ E G L R++ Q + EK K + + + +H+
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRN 611
++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIG 639
N K D++S G +L+E+A L+ P+ G
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 70/248 (28%), Positives = 127/248 (51%), Gaps = 9/248 (3%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
E+IG G+ G V+ A G EVA+K+ Q L+ E+ +M+ L++PN+V F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNFL 82
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
+ L ++ E+L GSL ++ C +DE + + + + + LH + ++H
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTET-C-MDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 620
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 621 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 679
+S G++ E+ + P++ NP++ + + L+ P++L P+ + C + D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 680 LRPSFAQL 687
R S +L
Sbjct: 259 KRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 7e-23
Identities = 69/260 (26%), Positives = 131/260 (50%), Gaps = 20/260 (7%)
Query: 440 VLGERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
+L +R+G GS+G VY A +K+ + + ++ +E +++ +L HP
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQ--VDEKRRIKMALDVARGMNCL 551
+V F + IITE+ L ++ H + E + + + + G++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
H I+HRDLK+ N+ + N +K+ DFG+SRL + + + GTP +M+PE L++
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----KELDPLVA 667
+ + K D++S G IL+E+ L + G N + VV + + +P ++L+ ++
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQ 238
Query: 668 RIIWECWQTDPSLRPSFAQL 687
++ DPSLRPS A++
Sbjct: 239 SML----NKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 58/238 (24%), Positives = 115/238 (48%), Gaps = 12/238 (5%)
Query: 453 VYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV----LFMGAVTRPP 507
+Y +N EV ++ F L++ + E+K +RR+ N++ + V P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 567
LS+I E+ RG L +L + + K ++ MA+D +G+ L+ T +++L S +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTSVS 153
Query: 568 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGV 625
LV +N+ +K+ GL ++ + K+ + + ++L + K D+YS GV
Sbjct: 154 FLVTENYKLKIICHGLEKILSSP--PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 626 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 683
+LWE+ T K+P+ + ++ + +N L++P + + I+ C D RP+
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 69/266 (25%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
LGE G GS + N + K + D + + RE++I + + P +V +
Sbjct: 9 LGEGAG-GSVTKCRLK--NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 501 GAVTRPP--NLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTST 555
GA ++ I E+ GSL I + + + EK K+A V +G++ LH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
I+HRD+K N+L+ + VK+ DFG+S N+ + + GT +MAPE ++ +P +
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYS 181
Query: 616 EKCDVYSFGVILWELATLKLPWI-----GMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670
DV+S G+ L E+A + P+ + P++++ + + P+ D I
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDEPGNGIK 237
Query: 671 W---------ECWQTDPSLRPSFAQL 687
W +C + DP+ RP+ +
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDM 263
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 76/280 (27%), Positives = 136/280 (48%), Gaps = 11/280 (3%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR ++PN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 82
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
+ L ++ E+L GSL ++ C +DE + + + + ++ LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALDFLHSNQ--VIH 138
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 620
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 621 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 679
+S G++ E+ + P++ NP++ + + L+ P+ L + + C + D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 680 LRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 719
R S +L P +L P P +E NS+
Sbjct: 259 RRGSAKELL--QHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 4e-22
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPNV 496
+IG G+YG+VY A T VA+KK ++ + F A+ RE+K++++LRHPN+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI----REIKLLQKLRHPNI 60
Query: 497 VLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHT 553
V VT SI + E++ L +L P + E + IK + G+ LH+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ-IKCYMKQLLEGLQYLHS 118
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 608
+ I+HRD+K N+L++ + +K++DFGL+R + S T W PE+
Sbjct: 119 NG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRPPEL 172
Query: 609 LRNEPS-NEKCDVYSFGVILWELAT 632
L + D++S G IL EL
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 8/205 (3%)
Query: 444 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+IG GS G V A G +VAVKK +D L F EV IMR H NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFN-EVVIMRDYHHENVVDMYN 86
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ L ++ EFL G+L I+ H +++E++ + L V R ++ LH ++HR
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQG--VIHR 142
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 621
D+KS ++L+ + +K+SDFG KS GTP WMAPEV+ P + D++
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 622 SFGVILWELATLKLPWIGMNPMQVV 646
S G+++ E+ + P+ P+Q +
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAM 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 76/279 (27%), Positives = 134/279 (48%), Gaps = 25/279 (8%)
Query: 438 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR 492
+L + +G G +G V+ W + ++ V QD SG E + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
H +V +G + +L ++T+ P GSL + + +D +R + + +A+GM L
Sbjct: 68 HAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTP-EWMAP 606
+VHR+L + N+L+ + V+++DFG++ L K + S TP +WMA
Sbjct: 127 EHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKTPIKWMAL 180
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
E + + DV+S+GV +WE+ + P+ GM P +V + + RL P+
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239
Query: 666 VARIIWECWQTDPSLRPSFAQLT-----VALKPLQRLVI 699
V ++ +CW D ++RP+F +L +A P + LVI
Sbjct: 240 VYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYLVI 278
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 12/260 (4%)
Query: 445 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
+G G++G VY W +G V + K L ++ S A E E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
+G + + ++T+ +P G L + ++ + + + +A+GM+ L +V
Sbjct: 75 LG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 617
HRDL + N+LV +VK++DFGL+RL + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 618 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
DV+S+GV +WEL T P+ G+ P + + + + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 677 DPSLRPSFAQLTVALKPLQR 696
D RP F +L + R
Sbjct: 251 DSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 69/251 (27%), Positives = 123/251 (49%), Gaps = 13/251 (5%)
Query: 445 IGLGSYG----EVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
+G G++G VY +VA+K L + + E RE +IM +L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
G V L ++ E G L + L ++ +++ V+ GM L VH
Sbjct: 62 G-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVH 118
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEK 617
RDL + N+L+ K+SDFGLS+ +++ ++S P +W APE + + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 618 CDVYSFGVILWE-LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
DV+S+G+ +WE + + P+ M +V+ + Q +RL+ P E P + ++ +CW
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIY 237
Query: 677 DPSLRPSFAQL 687
RP+FA++
Sbjct: 238 KWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 9/247 (3%)
Query: 444 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+IG GS G V A +G VAVKK +D L F EV IMR +H NVV
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFN-EVVIMRDYQHENVVEMYN 84
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ L ++ EFL G+L I+ H +++E++ + L V + ++ LH ++HR
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQG--VIHR 140
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 621
D+KS ++L+ + VK+SDFG KS GTP WMAPE++ P + D++
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 622 SFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQTDPSL 680
S G+++ E+ + P+ P++ + + +L+ ++ P + + DP+
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 681 RPSFAQL 687
R + A+L
Sbjct: 261 RATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 483 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
RE++IM R P +V F GA N+ + EF+ GSL RI + + + K+A+
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILGKIAV 110
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 602
V G+ L+ + I+HRD+K N+LV+ +K+ DFG+S N+ + + GT
Sbjct: 111 AVVEGLTYLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTST 167
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-----------F 651
+M+PE ++ K DV+S G+ + ELA K P+ + + G
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF-AFSNIDDDGQDDPMGILDLLQQIV 226
Query: 652 QNRRLEIPKELDPLVAR-IIWECWQTDPSLRPSFAQLT 688
Q +P P R + C DP+ RP+ QL
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 68/248 (27%), Positives = 125/248 (50%), Gaps = 9/248 (3%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
E+IG G+ G VY A G EVA+++ Q L+ E+ +MR ++PN+V ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 83
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
+ L ++ E+L GSL ++ C +DE + + + + + LH++ ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALEFLHSNQ--VIH 139
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 620
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 621 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 679
+S G++ E+ + P++ NP++ + + L+ P++L + + C D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 680 LRPSFAQL 687
R S +L
Sbjct: 260 KRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 71/259 (27%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 438 DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 494
+ + ++IG G + EVY A + VA+KK + + A + +E+ ++++L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCL 551
NV+ ++ + L+I+ E G L +++ Q + E+ K + + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAP 606
H+ ++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+P
Sbjct: 123 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSP 175
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-LD 663
E + N K D++S G +L+E+A L+ P+ G MN + + Q +P E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHYS 234
Query: 664 PLVARIIWECWQTDPSLRP 682
+ ++ C DP RP
Sbjct: 235 EKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 445 IGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+G GS+G V H N + K + S +A+ + ++E ++ +++HPN+V F
Sbjct: 8 VGEGSFGRALLVQHV--NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIVH 560
+ +L I+ E+ G L + + ++ E ++ + + G+ +H ++H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLH 123
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 620
RD+KS N+ + +N VK+ DFG +RL + + + GTP ++ PE+ N P N K D+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183
Query: 621 YSFGVILWELATLKLPW 637
+S G IL+EL TLK P+
Sbjct: 184 WSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 79/266 (29%), Positives = 122/266 (45%), Gaps = 23/266 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVK 486
+ P E V IG GS+G VY A + T VAVKK +SG E +EVK
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVK 73
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRILHRPHCQVDEKRRIKMALDV 544
+++L+HPN + + G + ++ E+ L + +P +V+ AL
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL-- 131
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 604
+G+ LH+ ++HRD+K+ N+L+ + VK++DFG + + S GTP WM
Sbjct: 132 -QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWM 184
Query: 605 APEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
APEV+ + K DV+S G+ ELA K P MN M + + + E
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQL 687
+ C Q P RP+ A+L
Sbjct: 245 WTDSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 90/340 (26%), Positives = 148/340 (43%), Gaps = 81/340 (23%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 485
E P + L LG+ +G G++G+V AD G + VAVK L + + + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSEL 61
Query: 486 KIMRRL-RHPNVVLFMGAVTRP--PNLSII----------------TEFLP---RGSLFR 523
KI+ + H NVV +GA T+P P + I+ EF+P + + FR
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFR 121
Query: 524 -------------------------------ILHRPHCQVDEKRR--------------- 537
+ + V+E+
Sbjct: 122 QGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDL 181
Query: 538 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 596
I + VA+GM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 182 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 597 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNR 654
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 300 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 26/263 (9%)
Query: 443 ERIGLGSYGEVYHADWN-GTEVA--VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
+ IG G +G+V + + G A V K L + L F +EV+ R L HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRI--KMALDVARGMNCLHTST 555
+G ++ EF P G L L R ++ + +MA +VA G+ LH +
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+H DL N + + +VK+ D+GL + + +++ A W+APE++
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 614 SN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK-ELD- 663
+ +K +++S GV +WEL T P+ ++ QV+ V + + +++PK +LD
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLDL 237
Query: 664 PLVAR---IIWECWQTDPSLRPS 683
R ++ CW DP RP+
Sbjct: 238 KYSDRWYEVMQFCW-LDPETRPT 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 83/285 (29%), Positives = 129/285 (45%), Gaps = 26/285 (9%)
Query: 417 STSKVDQIFDDDVCEC---EIPWEDLVLGERIGLGSYGEVYHA-DWNGTEV-AVKKFLDQ 471
STS+ + D ++ E E P + IG GS+G VY A D EV A+KK
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM--- 58
Query: 472 DFSGAALLE----FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRIL 525
+SG E +EVK ++R++HPN + + G R ++ E+ L +
Sbjct: 59 SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH 118
Query: 526 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585
+P +V+ AL +G+ LH+ ++HRD+K+ N+L+ + VK++DFG +
Sbjct: 119 KKPLQEVEIAAITHGAL---QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSAS 173
Query: 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNP 642
+ + S GTP WMAPEV+ + K DV+S G+ ELA K P MN
Sbjct: 174 IAS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
Query: 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
M + + E + C Q P RP+ +L
Sbjct: 230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 61/288 (21%)
Query: 445 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+G GSYG V H + G VA+KKFL+ + RE++++++LRH N+V +
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
R L ++ EF+ L + P+ +DE R K + RG+ H+ I+HR
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN--IIHR 124
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT----PEWM-APEVLRNEPSNE 616
D+K N+LV ++ VK+ DFG +R L++ T W APE+L +
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 617 K-CDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVG-------------- 650
+ D+++ G ++ E+ T P+ ++ +G
Sbjct: 180 RAVDIWAVGCLVTEMLT-------GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 651 -FQNRRLEIPKELDPL----------VARIIWECWQTDPSLRPSFAQL 687
F RL KE++PL V + +C + DP RPS +QL
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 440 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGA-------ALLEFKREVKIMRR 490
G+++G G+Y VY A D G VA+KK + A AL RE+K+++
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLLQE 58
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALDVARG 547
L+HPN++ + N++++ EF+ L +++ D K + M L RG
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RG 114
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK----STAGTPEW 603
+ LH++ I+HRDLK NLL+ + +K++DFGL+R +F S T +
Sbjct: 115 LEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNRKMTHQVVTRWY 168
Query: 604 MAPEVLRNEPS-NEKCDVYSFGVILWEL 630
APE+L D++S G I EL
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 39/261 (14%)
Query: 438 DLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMR 489
D +GE +G GS+G V A GT A+K ++ +L+ K+ E I+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-----ILKMKQVQHVAQEKSILM 73
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--- 546
L HP +V M + + + EF+ G LF L ++ + DVA+
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKFYH 124
Query: 547 -----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGT 600
LH+ I++RDLK NLL+D +VKV+DFG + ++ TF + GT
Sbjct: 125 AELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGT 178
Query: 601 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 660
PE++APEV++++ + D ++ GV+L+E P+ P ++ + RL+ P
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPN 236
Query: 661 ELDPLVARIIWECWQTDPSLR 681
D ++ QTD + R
Sbjct: 237 WFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 5e-20
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 41/214 (19%)
Query: 445 IGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV- 497
IG G+YG V A G +VA+KK F D + L RE+K++R LRH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENIIG 63
Query: 498 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
L + RPP+ I+TE + L +++ P D+ + + + RG+ L
Sbjct: 64 LL--DILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYL 119
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM------- 604
H++ ++HRDLK N+LV+ N ++K+ DFGL+R ++
Sbjct: 120 HSAN--VIHRDLKPSNILVNSNCDLKICDFGLAR-------GVDPDEDEKGFLTEYVVTR 170
Query: 605 ---APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
APE+L + + D++S G I EL T K
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 5e-20
Identities = 54/158 (34%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 538 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 596
I + VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 597 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 654
A P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + F R
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRR 288
Query: 655 -----RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
R+ P+ P + I+ +CW +P RP+F++L
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 50/138 (36%), Positives = 80/138 (57%), Gaps = 3/138 (2%)
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVL 609
H + ++HRD+KS N+L+ N VK+ DFG S++ T ++ GTP ++APE+
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
R +P ++K D++S GV+L+EL TLK P+ G N M+ V R +P + P + I
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPSISPEMQEI 276
Query: 670 IWECWQTDPSLRPSFAQL 687
+ +DP RPS ++L
Sbjct: 277 VTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 55/235 (23%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKF-----LDQDFSGAALLEFKREVKIMR 489
+D + + IG G++GEV+ T A+K + ++ + E I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILA 56
Query: 490 RLRHPNVV-LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALD 543
P +V L+ + +L ++ E++P G L +L R +E R + +ALD
Sbjct: 57 DADSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------------------- 584
+ +HRD+K N+L+D + ++K++DFGL
Sbjct: 116 SVHKLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 585 ----------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 629
R + + ST GTP+++APEVLR P +CD +S GVIL+E
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-20
Identities = 84/306 (27%), Positives = 123/306 (40%), Gaps = 52/306 (16%)
Query: 407 LESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAV 465
L PSSS SS+S +L RIG G+ G VY T +
Sbjct: 47 LPPPSSSSSSSSSSSAS---GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 466 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 525
K + + + RE++I+R + HPNVV + ++ EF+ GSL
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL---- 159
Query: 526 HRPHCQVDEKRRIKMAL---DVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578
E I DVAR G+ LH IVHRD+K NLL++ NVK+
Sbjct: 160 --------EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKI 209
Query: 579 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC-----DVYSFGVILWELATL 633
+DFG+SR+ T S+ GT +M+PE + + ++ D++S GV + E
Sbjct: 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 634 KLPWIGMNPMQVVGAVGFQ------------NRRLEIPKELDPLVARIIWECWQTDPSLR 681
+ P+ VG Q ++ E P I C Q +P+ R
Sbjct: 270 RFPF----------GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKR 319
Query: 682 PSFAQL 687
S QL
Sbjct: 320 WSAMQL 325
|
Length = 353 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 445 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFM 500
I G++G VY A G A+K D + + K E IM P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 501 GAVTRPPNLSIITEFLPRG---SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ L ++ E+L G SL + L + E + +V G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG-- 117
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 617
I+HRD+K NLL+D+ ++K++DFGLSR L +K GTP+++APE + ++
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKE 661
D +S G +++E P+ P V F N RR+ P+E
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 84/268 (31%), Positives = 120/268 (44%), Gaps = 34/268 (12%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL-RHPNVV 497
E IG G+YG+VY +G+ AVK LD D E + E I++ L HPNVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDE----EIEAEYNILQSLPNHPNVV 82
Query: 498 LFMGAVTRPPNLS-----IITEFLPRGS---LFRILHRPHCQVDEKRRIKMALDVARGMN 549
F G + L ++ E GS L + L ++DE + G+
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 609
LH + I+HRD+K N+L+ VK+ DFG+S +T L ++ GTP WMAPEV+
Sbjct: 143 HLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 610 RNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
E + +CDV+S G+ EL P M+P++ + F+ R P L P
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPRNPPPTLLHP 256
Query: 665 L-----VARIIWECWQTDPSLRPSFAQL 687
I +C D RPS L
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 27/268 (10%)
Query: 437 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRR 490
+DL + E +G G+YG V H GT +AVK+ S E KR ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQ----EQKRLLMDLDISMR 55
Query: 491 LRH-PNVVLFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVARG 547
P V F GA+ R ++ I E + ++ ++ + E K+A+ + +
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 607
+ LH S +++HRD+K N+L+++N VK+ DFG+S ++ ++ AG +MAPE
Sbjct: 116 LEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPE 173
Query: 608 VLRNEPS----NEKCDVYSFGVILWELATLKLP---WIGMNPMQVVGAVGFQNRRLEIPK 660
+ E + + K DV+S G+ + ELAT + P W P Q + V + ++P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW--KTPFQQLKQV-VEEPSPQLPA 230
Query: 661 E-LDPLVARIIWECWQTDPSLRPSFAQL 687
E P + +C + + RP++ +L
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
+G G+YG V T VA+KKF + + REVK++R+LRH N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
A R L ++ E++ R +L +L + + + + H+ I+H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIH 123
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVLRNEPS 614
RD+K N+LV ++ +K+ DFG +R L ++ + T + APE+L + +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 615 NEK-CDVYSFGVILWELAT 632
K DV++ G I+ EL
Sbjct: 179 YGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 36/270 (13%)
Query: 441 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 498
L E +G G+YG+VY T ++A K +D +G E K+E+ ++++ H N+
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 499 FMGAVTR--PPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCL 551
+ GA + PP + ++ EF GS+ ++ ++ I + ++ RG++ L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 128 HQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 612 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
+ + + K D++S G+ E+A P M+PM+ + IP+ P +
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRL 236
Query: 667 ARIIW---------ECWQTDPSLRPSFAQL 687
W C + S RP+ QL
Sbjct: 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 5/157 (3%)
Query: 541 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG 599
+ VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K +A
Sbjct: 180 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 600 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLE 657
P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
P+ P + RI+ CWQ DP RP+F+ L L L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 80/269 (29%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 437 EDLV-LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRL 491
EDL LGE IG G++G V H +GT +AVK+ + ++ +MR
Sbjct: 4 EDLKDLGE-IGRGAFGTVNKMLHKP-SGTIMAVKR-IRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDVA 545
P +V F GA+ R + I E L SL + + K I K+A+
Sbjct: 61 DCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEV--LKSVIPEEILGKIAVATV 117
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605
+ +N L I+HRD+K N+L+D+N N+K+ DFG+S ++ ++ AG +MA
Sbjct: 118 KALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMA 175
Query: 606 PEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRL--EI 658
PE + + + + DV+S G+ L+E+AT K P+ N + Q+ V L
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235
Query: 659 PKELDPLVARIIWECWQTDPSLRPSFAQL 687
+E P I C D S RP + +L
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 440 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLR-- 492
IG G+YG VY A D N G VA+KK L ++ + L RE+ ++++L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL---REIALLKQLESF 58
Query: 493 -HPNVVLFMG-----AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVA 545
HPN+V + R L+++ E + + L L + IK + +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 604
RG++ LH+ IVHRDLK N+LV + VK++DFGL+R+ +F + ++ W
Sbjct: 118 RGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYR 173
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATLK 634
APEVL D++S G I EL +
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 444 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+IG GS G V A +G +VAVK +D L F EV IMR +H NVV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYK 85
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ L ++ EFL G+L I+ + +++E++ + V + + LH+ ++HR
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHR 141
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 621
D+KS ++L+ + VK+SDFG KS GTP WMAPEV+ P + D++
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 622 SFGVILWELATLKLPWIGMNPMQVV 646
S G+++ E+ + P+ +P+Q +
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 53/158 (33%), Positives = 88/158 (55%), Gaps = 3/158 (1%)
Query: 482 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 541
K E I+ + HP +V A L +I +FL G LF L + +E + +A
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 601
++A ++ LH+ I++RDLK N+L+D+ ++K++DFGLS+ + + S GT
Sbjct: 106 -ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 639
E+MAPEV+ + D +SFGV+++E+ T LP+ G
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 445 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 495
IG GS+G+V A +G+ AVK + +L+ K + IM + L+HP
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKK-----TILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V + L + +++ G LF L R C ++ + R A +VA + LH+
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN 116
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
I++RDLK N+L+D +V ++DFGL + ++ + GTPE++APEVLR EP +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 616 EKCDVYSFGVILWEL 630
D + G +L+E+
Sbjct: 175 RTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 445 IGLGSYGEVY--HADWNGTEVAVKKFL-DQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+G+G +G V A+K E +I+ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GMNCLHT 553
+ ++ E+ G L+ IL R AR LH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---------RGLFDEYTARFYIACVVLAFEYLHN 111
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGL-----SRLKHNTFLSSKSTAGTPEWMAPEV 608
I++RDLK NLL+D N VK+ DFG S K TF GTPE++APE+
Sbjct: 112 RG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEYVAPEI 163
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKELDP 664
+ N+ + D +S G++L+EL T + P+ +PM++ + N +LE P +D
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDK 221
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 61/249 (24%), Positives = 122/249 (48%), Gaps = 13/249 (5%)
Query: 437 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 493
+DL + +G G++G V+ + A+K + + E ++++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
P ++ L ++ E++P G LF L R + + A ++ + LH+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 612
IV+RDLK N+L+DK ++K++DFG ++ L+ T+ + GTPE++APEV++++
Sbjct: 120 KE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPEVIQSK 173
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
N+ D ++ G++++E+ P+ NP + + +LE P+ LD +I +
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLDLYAKDLIKK 231
Query: 673 CWQTDPSLR 681
D + R
Sbjct: 232 LLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 56/164 (34%), Positives = 87/164 (53%), Gaps = 23/164 (14%)
Query: 437 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
D + ++G G++GEVY A G VA+KK L + + RE+KI+++L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 495 NVV-LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRPHCQVDEKRRIK-MA 541
NVV L AV RP RGS++ + L P ++ E + IK
Sbjct: 68 NVVPLIDMAVERPDKSKRK-----RGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKCYM 121
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585
L + G+N LH + I+HRD+K+ N+L+D +K++DFGL+R
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVK-------IMRRLRH 493
++G G YG+V+ A T VA+K+ LL EV+ I+ +
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKS------LLFKLNEVRHVLTERDILTTTKS 60
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
+V + A L + E++P G +L+ ++ R MA ++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+HRDLK N L+D + ++K++DFGLS+ + S G+P++MAPEVLR +
Sbjct: 120 LG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQV 645
+ D +S G +L+E P+ G P +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 73/249 (29%), Positives = 112/249 (44%), Gaps = 21/249 (8%)
Query: 445 IGLGSYGEVYHA-DWNGTEV-AVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 498
IG GS+G VY A D +EV A+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 499 FMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ G R ++ E+ L S +H+ Q E + +G+ LH+
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG--ALQGLAYLHSH--N 135
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 616
++HRD+K+ N+L+ + VK+ DFG + + + GTP WMAPEV+ +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 617 --KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674
K DV+S G+ ELA K P MN M + + + C
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 675 QTDPSLRPS 683
Q P RP+
Sbjct: 252 QKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 43/278 (15%)
Query: 436 WEDLVLGERIGLGSYGEVY--HADWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL 491
WE + E IG G+YG+V+ NG++ AVK LD D E + E I++ L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDE----EIEAEYNILKAL 71
Query: 492 R-HPNVVLFMGA-----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
HPNVV F G V L ++ E GS+ ++ + + +A +
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 546 RG-MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 604
M H +HRD+K N+L+ VK+ DFG+S +T L ++ GTP WM
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 605 APEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
APEV+ E + +CDV+S G+ EL P ++PM+ + +IP
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIP 242
Query: 660 KELDPLVAR----------IIWECWQTDPSLRPSFAQL 687
+ P + + I +C D RP+ + L
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 483 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKR----R 537
E +I++ L HP +V + N+ ++ + L G L + + + ++ +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE 108
Query: 538 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 597
I +AL+ I+HRD+K N+L+D+ +V ++DF ++ L++ ST
Sbjct: 109 IVLALEYLHSKG--------IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-ST 159
Query: 598 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637
+GTP +MAPEVL + + D +S GV +E K P+
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 69/233 (29%), Positives = 118/233 (50%), Gaps = 40/233 (17%)
Query: 445 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM----------RRL--- 491
+G GS+G+V+ A+ GT +Q F+ AL K++V +M +R+
Sbjct: 3 LGKGSFGKVFLAELKGT--------NQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSL 51
Query: 492 --RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGM 548
HP + NL + E+L G L + H C + D R A ++ G+
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAP 606
LH+ IV+RDLK N+L+D + ++K++DFG+ K N +K+ GTP+++AP
Sbjct: 110 QFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAP 165
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
E+L + N D +SFGV+L+E+ + P+ G + ++ FQ+ R++ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 445 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G GS+G+V A+ GT A+KK L+ D ++E R V + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVE--RRVLALA-WEHPFLT 59
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+L + E+L G L + + DE R A ++ G+ LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG-- 116
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 617
I++RDLK N+L+DK+ ++K++DFG+ + N + + GTP+++APE+L+ + NE
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
D +SFGV+L+E+ + P+ G + ++ F + + P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 21/197 (10%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 495
IG GS+G+V A E AVK + A+L+ K E IM + ++HP
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKK-----AILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V + L + +++ G LF L R C ++ + R A ++A + LH+
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN 116
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
IV+RDLK N+L+D ++ ++DFGL + ++HN ++ + GTPE++APEVL +P
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQP 172
Query: 614 SNEKCDVYSFGVILWEL 630
+ D + G +L+E+
Sbjct: 173 YDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 496
E+IG G+YG VY A G VA+KK L+ + G A+ RE+ +++ L HPN+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI----REISLLKELNHPNI 60
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMAL-DVARGMNCLHTS 554
V + V L ++ EFL L + + P +D IK L + +G+ H+
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCHSH 118
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPE----WM-AP 606
++HRDLK NLL+D+ +K++DFGL+R + T+ T E W AP
Sbjct: 119 R--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--------THEVVTLWYRAP 168
Query: 607 EVLRNEPS-NEKCDVYSFGVILWELATLK 634
E+L + D++S G I E+ +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 4/198 (2%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
E ++++ RHP + + L + E+ G LF L R +++ R A +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-E 103
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 603
+ ++ LH S +V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLS 220
Query: 664 PLVARIIWECWQTDPSLR 681
P ++ + DP R
Sbjct: 221 PEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 46/154 (29%), Positives = 84/154 (54%), Gaps = 3/154 (1%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
E ++++ RHP + + L + E++ G LF L R +++ R A +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-E 103
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 603
+ ++ LH+ IV+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637
+APEVL + D + GV+++E+ +LP+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 5/198 (2%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
E ++++ RHP + A L + E+ G LF L R +E+ R A +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-E 103
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 603
+ + LH+ +V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE+
Sbjct: 104 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLS 219
Query: 664 PLVARIIWECWQTDPSLR 681
P ++ + DP R
Sbjct: 220 PEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ RIG G++G V+ A G VA+KK + G + RE+K ++ +HP VV
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTST 555
+ ++ E++P L +L RP + K ++M L G+ +H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHANG 119
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----W-MAPEVLR 610
I+HRDLK NLL+ + +K++DFGL+RL F + + + W APE+L
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 611 NEPS-NEKCDVYSFGVILWEL 630
+ D+++ G I EL
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 52/268 (19%)
Query: 445 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-------FKREVKIMRRLRH-PNV 496
+G G+YG+V+ G A K + + A +++ + E +++ +R P +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKR----RIKMALDVARGMNCL 551
V A L +I +++ G LF L R H E R I +ALD L
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HL 121
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAP 606
H I++RD+K N+L+D +V ++DFGLS+ FL+ + S GT E+MAP
Sbjct: 122 HQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERAYSFCGTIEYMAP 175
Query: 607 EVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------ 658
EV+R ++ D +S GV+ +EL T G +P V G QN + EI
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLT------GASPFTVDGE---QNSQSEISRRILK 226
Query: 659 -----PKELDPLVARIIWECWQTDPSLR 681
PK + I + + DP R
Sbjct: 227 SKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 445 IGLGSYGEVYHADWNGT-EV----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G GS+G+V A+ GT E+ +KK L D + E KR + + + HP +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE-KRVLALAGK--HPFLT 59
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
L + E++ G L + R + DE R A ++ G+ LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERG-- 116
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRN 611
I++RDLK N+L+D ++K++DFG+ + +TF GTP+++APE+L
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDYIAPEILSY 170
Query: 612 EPSNEKCDVYSFGVILWEL 630
+P D ++ GV+L+E+
Sbjct: 171 QPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPN 495
E VL E +G G+YG VY T V + K + + + + E+ I+ + P
Sbjct: 2 EIEVLDE-LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHT 553
+V F GA + + E++ GSL ++ + E ++ V +G+ L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE 612
I+HRD+K N+LV+ N VK+ DFG+S N S +K+ G +MAPE +++
Sbjct: 121 EH-NIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 613 PSNE------KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------EIPK 660
N+ + DV+S G+ + E+A + P+ P + + Q + +P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLPS 232
Query: 661 ELDPLVARIIWECWQTDPSLRPSFAQLT 688
+ +C P+ RP++AQL
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 9/156 (5%)
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 601
VA GM L ++ VHRDL + N+L+ + VK+ DFGL+R ++ + ++S ST
Sbjct: 248 VANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---KLPWIGMNPMQVVGAVGFQNRRLEI 658
+WMAPE + N DV+SFG++LWE+ TL P + MN Q A+ + R+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFYNAIK-RGYRMAK 363
Query: 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
P + I+ +CW+ +RP F+QL + L
Sbjct: 364 PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 444 RIGLGSYGEVYHAD--WNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPNVV 497
+IG G++GEV+ A VA+KK L + F AL RE+KI++ L+H NVV
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL----REIKILQLLKHENVV 74
Query: 498 LFMGAVTRPPN--------LSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVAR 546
+ ++ EF L +L + + K+ +KM L+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN--- 130
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG------- 599
G+ +H + I+HRD+K+ N+L+ K+ +K++DFGL+R F SK++
Sbjct: 131 GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRYTNRV 184
Query: 600 -TPEWMAPEVLRNEPS-NEKCDVYSFGVILWELAT 632
T + PE+L E D++ G I+ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 29/261 (11%)
Query: 437 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
+D+ E +G G+ G VY A + K + D + + E++I+ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDVARGMN 549
++ F GA +SI TEF+ GSL D R+I ++A+ V +G+
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLT 109
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 609
L + I+HRD+K N+LV+ VK+ DFG+S N+ +K+ GT +MAPE +
Sbjct: 110 YLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERI 165
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWI-------GMNPMQVVGAVGFQNRRLEIPKEL 662
E DV+S G+ ELA + P+ + P+Q++ + ++ + +
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225
Query: 663 DPLVARIIWECWQTDPSLRPS 683
I +C + P RP+
Sbjct: 226 SEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
E+IG G+YG VY T VA+KK L+ + G RE+ +++ L+HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCL 64
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMAL-DVARGMNCLHTSTPT 557
+ + L +I EFL L + L P Q + +K L + +G+ H+
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 616
++HRDLK NLL+D +K++DFGL+R T + APEVL P +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 617 KCDVYSFGVILWELATLK 634
D++S G I E+AT K
Sbjct: 182 PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 7e-17
Identities = 55/159 (34%), Positives = 88/159 (55%), Gaps = 15/159 (9%)
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 601
VARGM L ++ VHRDL + N+L+ + VK+ DFGL+R + + ++S ST
Sbjct: 246 VARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR-----R 655
+WMAPE + + DV+S+G++LWE+ +L P+ GM +V + F N+ R
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM----IVDST-FYNKIKSGYR 358
Query: 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ P V I+ +CW ++P RPSF L+ ++ L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 495
IG GS+G+V A AVK A+L+ K + IM + ++HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V + L + +++ G LF L R + + R A ++A + LH+
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSLN 116
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEP 613
I++RDLK N+L+D +V ++DFGL K S ++ GTPE++APEVLR +P
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 614 SNEKCDVYSFGVILWEL 630
+ D + G +L+E+
Sbjct: 173 YDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 39/208 (18%)
Query: 445 IGLGSYGEVYHADWN--GTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG G+YG V A G +VA+KK F Q F L RE+KI+RR +H N++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENIIGI 68
Query: 500 MGAVTRPPNLS------IITEFLPRGSLFRI-----LHRPHCQVDEKRRIKMALDVARGM 548
+ + RPP+ I+ E + L+++ L H Q + RG+
Sbjct: 69 L-DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQY-------FLYQILRGL 119
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPEW 603
+H++ ++HRDLK NLL++ N ++K+ DFGL+R+ H FL+ T +
Sbjct: 120 KYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT--EYVATRWY 175
Query: 604 MAPEVLRNEPSNEKC-DVYSFGVILWEL 630
APE++ N K D++S G IL E+
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 30/273 (10%)
Query: 443 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ IG G +G+V ++ + +V VK+ L S ++F E + R L+H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE-LRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV------DEKRRIKMALDVARGMNCLH 552
+G T ++ EF P G L L C+ D +MA ++A G+ LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRS--CRKAELMTPDPTTLQRMACEIALGL--LH 115
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLR 610
+H DL N L+ + VK+ D+GLS K+ + +++ W+APE++
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 611 NEPSN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVG-AVGFQNRRLEIPKE 661
N ++ +V+S GV +WEL L P+ ++ QV+ V Q +L P+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 662 LDPLVAR---IIWECWQTDPSLRPSFAQLTVAL 691
PL R ++ CW P RPS ++ + L
Sbjct: 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 441 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 498
L E +G G+YG+VY T ++A K +D + E K E+ ++++ H N+
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 499 FMGAVTR--PP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCL 551
+ GA + PP L ++ EF GS+ ++ ++ I + ++ RG+ L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 138 HAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 612 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVV 646
+ + + + D++S G+ E+A P M+PM+ +
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 440 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 496
+ +++G G++G VY A G VA+KK + +S + REVK +R+L HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNI 60
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
V L + E++ G+L++ + R E + + +G+ +H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWM-APEV-LRN 611
HRDLK NLLV VK++DFGL+R + + ST W APE+ LR+
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST----RWYRAPEILLRS 173
Query: 612 EPSNEKCDVYSFGVILWELATLK 634
+ D+++ G I+ EL TL+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 61/193 (31%), Positives = 105/193 (54%), Gaps = 18/193 (9%)
Query: 445 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVVLFMG 501
+G+G++G V A G VA+KK + + FS L + RE+K+++ LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM-KPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 502 AVTRP-PNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIK-MALDVARGMNCLHTSTPTI 558
P ++ +TE L L R+L RP EK+ I+ + RG+ +H++ +
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPL----EKQFIQYFLYQILRGLKYVHSAG--V 129
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEK 617
VHRDLK N+L+++N ++K+ DFGL+R++ ST + APE+ L + + +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR---YYRAPEIMLTWQKYDVE 186
Query: 618 CDVYSFGVILWEL 630
D++S G I E+
Sbjct: 187 VDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 445 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA--ALLEFKREVKIMRRLRHPNVVLFMG 501
+G G +GEV T ++ K + + A + F+ E I+ P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTPTIVH 560
A NL ++ E+ P G L +L+R Q DE + +A ++ ++ +H VH
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG--YVH 125
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK-- 617
RD+K N+L+D+ ++K++DFG + RL N ++SK GTP+++APEVL + K
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 618 ----CDVYSFGVILWEL 630
CD +S GVI +E+
Sbjct: 186 YGVECDWWSLGVIAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 61/194 (31%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 445 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVL 498
+G G +G+V A++ T E+ K L + A +L+ KR + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
++ + E+ G L +H E R + A V G+ LH + I
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK--I 122
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKST-AGTPEWMAPEVLRNEPSNE 616
V+RDLK NLL+D VK++DFGL K F ST GTPE++APEVL
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 617 KCDVYSFGVILWEL 630
D + GV+++E+
Sbjct: 181 AVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-- 492
DL IG G+ G+VY + G +AVK+ E KR I+ L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKR---ILMDLDVV 67
Query: 493 ---H--PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
H P +V G ++ I E L L ++L R + E KM + + +
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKS---TAGTPEW 603
++ L ++HRD+K N+L+D + NVK+ DFG+S RL + SK+ +AG +
Sbjct: 127 LHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-----VDSKAKTRSAGCAAY 180
Query: 604 MAPEVLRNEPSNEK----CDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNR-RLE 657
MAPE + N K DV+S G+ L ELAT + P+ +V+ + + L
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240
Query: 658 IPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ P + C D RP + +L
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 7e-16
Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 5/179 (2%)
Query: 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571
++ + IL +D + + + VA+GM+ L ++ +HRDL + N+L+
Sbjct: 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLT 248
Query: 572 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWE 629
K+ DFGL+R +++++ K A P +WMAPE + N + DV+S+G++LWE
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 630 LATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ +L P+ GM + + R+ P+ + I+ CW DP RP+F Q+
Sbjct: 309 IFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-16
Identities = 58/187 (31%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 460 GTEVAVKKFLDQDFSGAALL-EFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 517
G EVA+K F+RE + RL HPN+V L P L + E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 518 RGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DK 572
+L +L + R + LD + C H IVHRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAHNQG--IVHRDLKPQNIMVSQTGV 117
Query: 573 NWNVKVSDFGLSRLKHNTFLSSKSTA-------GTPEWMAPEVLRNEPSNEKCDVYSFGV 625
+ KV DFG+ L + +T GTP + APE LR EP D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 626 ILWELAT 632
I E T
Sbjct: 178 IFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 50/239 (20%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKF----------LDQDFSGAA 477
+ ++ +ED +G GS+G V A + + VA+K+F +D FS
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS--- 80
Query: 478 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR- 536
E KI+ + HP V G+ L ++ EF+ G F L R KR
Sbjct: 81 ------ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------NKRF 128
Query: 537 ----------RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586
+I + + + +N IV+RDLK NLL+DK+ +K++DFG +++
Sbjct: 129 PNDVGCFYAAQIVLIFEYLQSLN--------IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
Query: 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 645
+ + GTPE++APE+L N + D ++ G+ ++E+ P+ P+ +
Sbjct: 181 VDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 445 IGLGSYGEVY--HADWNGTEVAVKKFLD-------QDFSGAALLEFKREVKIMRRLRHPN 495
+G G +GEV G A KK LD + A E KI+ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALN-----EKKILEKVSSRF 54
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+V A +L ++ + G L + I + E R I A + G+ LH
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
IV+RDLK N+L+D + NV++SD GL+ LK K AGTP +MAPEVL+ E
Sbjct: 115 R--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEV 170
Query: 614 SNEKCDVYSFGVILWEL 630
+ D ++ G L+E+
Sbjct: 171 YDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 445 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK----REVKIMRRLRHPNVVL 498
+G G+YG+V A T +VA+KK L + F A RE+++++ + H NV+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKK-LSRPFQSA---IHAKRTYRELRLLKHMDHENVIG 78
Query: 499 FMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNC 550
+ T +L ++T + L I+ CQ D+ + + + RG+
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK---CQKLSDDHIQF-LVYQILRGLKY 133
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEV 608
+H++ I+HRDLK N+ V+++ +K+ DFGL+R + T T + APE+
Sbjct: 134 IHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEI 186
Query: 609 LRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGA 648
+ N N+ D++S G I+ EL T K + G + M +VG
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 39/239 (16%)
Query: 441 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFK------------REVK 486
G +G G+YG+V A D G VA+KK + S + + RE+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 487 IMRRLRHPNVVLFMGAV---TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
IM ++H N+ MG V ++++ + + L +++ R + + + + L
Sbjct: 73 IMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQ 127
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG---- 599
+ G+N LH +HRDL N+ ++ K++DFGL+R S +
Sbjct: 128 ILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 600 -----TPE----WM-APEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 647
T + W APE+L E + D++S G I EL T K + G N + +G
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
|
Length = 335 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 5/155 (3%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMAL 542
E ++++ RHP + + L + E+ G LF H +V E R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA 102
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 602
++ + LH+ +V+RDLK NL++DK+ ++K++DFGL + + + K+ GTPE
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637
++APEVL + D + GV+++E+ +LP+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 444 RIGLGSYGEVYHA-DWNGTE-VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
RIG G+YG VY A D E VA+KK +D + G + RE+ ++ LRHPN+V
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 501 GAVT--RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
V ++ ++ E+ + L +L E + + L + RG+ LH + I
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--I 129
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEK 617
+HRDLK NLL+ +K++DFGL+R T + APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189
Query: 618 CDVYSFGVILWEL 630
D+++ G IL EL
Sbjct: 190 IDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 31/245 (12%)
Query: 445 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFK-----REVK--------IMRRL 491
IG GS+G+V A K+ LD +L+ K +E K +++ +
Sbjct: 3 IGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
+HP +V + L + +F+ G LF L R + + R A ++A + L
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYL 112
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
H+ IV+RDLK N+L+D +V ++DFGL + ++ + GTPE++APEV+R
Sbjct: 113 HSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671
+P + D + G +L+E+ G+ P + L P L P + W
Sbjct: 171 QPYDNTVDWWCLGAVLYEML------YGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
Query: 672 ECWQT 676
+
Sbjct: 225 SILEE 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 65/253 (25%), Positives = 126/253 (49%), Gaps = 21/253 (8%)
Query: 399 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 454
G N + DL+ P+ ++D+ ++ ++I + + ++ ED + + IG G++GEV
Sbjct: 2 GLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRK-IRKLQMKAEDYDVVKVIGRGAFGEVQ 60
Query: 455 HADWNGTE-VAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509
++ V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFCAFQDDKYL 118
Query: 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 569
++ E++P G L ++ + V EK +V ++ +H+ ++HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNML 174
Query: 570 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 624
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 625 VILWELATLKLPW 637
V L+E+ P+
Sbjct: 235 VFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 465 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 524
V K L D L F +M +L H ++V G R N+ ++ E++ G L
Sbjct: 34 VLKVLGSD--HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVF 90
Query: 525 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VK 577
LHR V ++ +A +A ++ L +VH ++ N+LV + +K
Sbjct: 91 LHREKNNVSLHWKLDVAKQLASALHYLEDK--KLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 578 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN--EKCDVYSFGVILWELAT-LK 634
+SD G+ T LS + W+APE +RN ++ D +SFG L E+ + +
Sbjct: 149 LSDPGIPI----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 635 LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
P ++ + F + +P +A +I +CW DP+ RPSF +
Sbjct: 205 EP---LSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 443 ERIGLGSYGEVY---HADWNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPN 495
+IG GSYG V+ + + G VA+KKF+ D AL RE++++++L+HPN
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPN 61
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V + R L ++ E+ L + P V E K+ + +N H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 614
+HRD+K N+L+ K +K+ DFG +R+ T + APE+L +
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 615 NEKCDVYSFGVILWELATLKLPWIG 639
DV++ G + EL T + W G
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502
+G G+YG V T+ VA+KKF D + + RE+K++R L+ N+V A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 503 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 562
R L ++ E++ + L + P+ EK R + + ++ H + IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKND--IVHRD 125
Query: 563 LKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA------PEVLRNEPSNE 616
+K NLL+ N +K+ DFG +R LS S A E++A PE+L P +
Sbjct: 126 IKPENLLISHNDVLKLCDFGFAR-----NLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 617 KCDVYSFGVILWELA 631
D++S G IL EL+
Sbjct: 181 AVDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 69/260 (26%), Positives = 111/260 (42%), Gaps = 46/260 (17%)
Query: 445 IGLGSYGEV---YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFM 500
IG G++GEV D G A+KK + + + E I+ +P VV
Sbjct: 9 IGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
+ L +I E+LP G + +L + +E+ R +A + ++ +H +H
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIH 124
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLS-------------RLKHN----------TFLSSK-- 595
RD+K NLL+D ++K+SDFGL L H +SSK
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 596 -------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 642
ST GTP+++APEV N++CD +S GVI++E+ P+ NP
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 643 MQVVGAVGFQNRRLEIPKEL 662
+ + L+ P E+
Sbjct: 245 QETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 445 IGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVL 498
IG G+YG+V+ A G VA+K+ Q L REV ++R L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 499 FMGAVT-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
T R L+++ E + + + P V + M + RG++ LH+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+VHRDLK N+LV + +K++DFGL+R+ + S T + APEVL
Sbjct: 129 HR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQSS 185
Query: 614 SNEKCDVYSFGVILWEL 630
D++S G I E+
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-14
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 59/237 (24%)
Query: 445 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNVVLFM 500
IG G GEVY + VA+KK + +D S LL+ F RE KI L HP +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIV--- 65
Query: 501 GAVTRPPNLSIITEFLP--------RG----SLFR------ILHRPHCQVDEKRRIKMAL 542
P SI ++ P G SL + L + EK + L
Sbjct: 66 ------PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL---AEKTSVGAFL 116
Query: 543 ----DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH---------- 588
+ + +H+ ++HRDLK N+L+ V + D+G + K
Sbjct: 117 SIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 589 ---NTFLSSKST-----AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637
S T GTP++MAPE L P++E D+Y+ GVIL+++ TL P+
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 39/222 (17%)
Query: 445 IGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
IG G++G V W +G VA+KK + + + RE+K++ +H NV
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-- 61
Query: 499 FMGA--VTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 549
+ A + +PP++ ++TE + + L +I+ P + +K+ L + RG+
Sbjct: 62 -LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSD--HVKVFLYQILRGLK 117
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEW 603
LH++ I+HRD+K NLLV+ N +K+ DFGL+R+ KH T T +
Sbjct: 118 YLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT-----QEVVTQYY 170
Query: 604 MAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 644
APE+L D++S G I EL ++ + +P+Q
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 60/242 (24%), Positives = 118/242 (48%), Gaps = 25/242 (10%)
Query: 405 RDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY---HAD 457
D + P+ ++D+ S+ ++ + + + + ED + + IG G++GEV H
Sbjct: 8 YDCDIPALRKNKNIDNFLSRYEKAAEK-ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS 66
Query: 458 WNGTEVAVKKFLDQD----FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513
+V K L + S +A F E IM +V A L ++
Sbjct: 67 SK--QVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122
Query: 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573
E++P G L ++ + + EK +V ++ +H+ +HRD+K N+L+DK+
Sbjct: 123 EYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS 178
Query: 574 WNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFGVILW 628
++K++DFG ++ N + + GTP++++PEVL+++ + +CD +S GV L+
Sbjct: 179 GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 629 EL 630
E+
Sbjct: 239 EM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 45/214 (21%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVV 497
E IG G+YG V A +G +VA+KK + KR E+KI+R +H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPH---AFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRP-HCQVD-EKRRIKMAL-D 543
+I P G+ F+ LH H + I+ L
Sbjct: 68 ------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKST 597
+ RG+ +H++ ++HRDLK NLLV+++ +++ DFG++R +H F++
Sbjct: 116 LLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 598 AGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 630
T + APE+L + P D++S G I E+
Sbjct: 174 --TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 57/228 (25%), Positives = 113/228 (49%), Gaps = 21/228 (9%)
Query: 445 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G GS+G+V A+ GT+ + K + QD + KR + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLTQ 65
Query: 499 FMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQV---DEKRRIKMALDVARGMNCLHTS 554
L + E++ G L + I QV E + A ++A G+ LH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
I++RDLK N+++D ++K++DFG+ + ++++ GTP+++APE++ +P
Sbjct: 121 G--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
+ D ++FGV+L+E+ + P+ G + ++ ++ N + PK L
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 16/219 (7%)
Query: 438 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
++G+ + T VAVKK S L ++E+ R+L+HPN++
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL---DVARGMNCLHTS 554
++ + L +++ + GS L + H + + +A DV ++ +H+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK 120
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDF--GLSRLKHN-----TFLSSKSTAGTPEWMAPE 607
+HR +K+ ++L+ + V +S +S +KH KS+ W++PE
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 608 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQ 644
VL+ NEK D+YS G+ ELA +P+ M Q
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 48/157 (30%), Positives = 89/157 (56%), Gaps = 11/157 (7%)
Query: 538 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 596
++ + VA+GM+ L ++ +HRD+ + N+L+ K+ DFGL+R + +++ K
Sbjct: 215 LRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 597 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM---NPMQVVGAVGF 651
A P +WMAPE + + + DV+S+G++LWE+ +L K P+ G+ + + G+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY 332
Query: 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 688
Q R P P + I+ CW +P+ RP+F+Q++
Sbjct: 333 QMSR---PDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 4/154 (2%)
Query: 483 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
RE+K++ P +V F GA +SI E + GSL ++L + ++ E K+++
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISI 106
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 602
V RG+ L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT
Sbjct: 107 AVLRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRS 163
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 636
+M+PE L+ + D++S G+ L E+A + P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 533 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592
E R + G+ LH I++RDLK N+L+D + NV++SD GL+ +
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152
Query: 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637
+K AGTP +MAPE+L+ E + D ++ GV L+E+ + P+
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 38/190 (20%)
Query: 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 567
NL +I EFLP G + +L + +E+ + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDN 131
Query: 568 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 595
LL+D +VK+SDFGL L H+ TF ++SK
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 596 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 652
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251
Query: 653 NRRLEIPKEL 662
L P E+
Sbjct: 252 KETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 445 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL-------EFKREVKIMRRLRHPNVV 497
+G G YG+V+ K F + A ++ K E I+ ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-----RRIKMALDVARGMNCLH 552
+ A L +I E+L G LF L R +++ I +AL+ H
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE--------H 115
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 610
I++RDLK N+L+D +VK++DFGL K + + + GT E+MAPE+L
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMN 641
+ D +S G +++++ T P+ N
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 3/149 (2%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
E ++ ++ P +V + P L ++ F+ G LF L R D R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAE 101
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 603
+ + LH +++RDLK N+L+D ++ + DFGL +L + + GTPE+
Sbjct: 102 LLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELAT 632
+APE+L + D ++ GV+L+E+ T
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
E+IG G+YG VY A G VA+KK LD + G RE+ +++ L HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKL 64
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------DVARGMNCLHT 553
+ + L ++ EFL + + I + L + +G+ H+
Sbjct: 65 LDVIHTENKLYLVFEFLHQDL------KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 119 H--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 174
Query: 614 SNEKCDVYSFGVILWEL 630
C YS V +W L
Sbjct: 175 ----CKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 66/249 (26%), Positives = 114/249 (45%), Gaps = 16/249 (6%)
Query: 445 IGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG GSY +V TE VKK L D ++ ++ V + HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGL 61
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
L + E++ G L + R +E R A +++ +N LH I+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--II 118
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 619
+RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 620 VYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 672
++ GV+++E+ + P+ +G NP Q FQ +++ IP+ L A ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 238
Query: 673 CWQTDPSLR 681
DP R
Sbjct: 239 FLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 444 RIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVV--- 497
RI G+YG VY A T VA+KK ++++ G + RE+ I+ +L+HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVK 70
Query: 498 -LFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+ +G + + ++ E++ SL + +P Q + K + L G+ LH +
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---SGVAHLHDN 125
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTPEWMAPEVL 609
I+HRDLK+ NLL++ +K+ DFGL+R LK T T + APE+L
Sbjct: 126 W--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-----QLVVTLWYRAPELL 178
Query: 610 RNEPS-NEKCDVYSFGVILWELATLK 634
+ D++S G I EL T K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 38/190 (20%)
Query: 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 567
NL +I EFLP G + +L + +E + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPDN 131
Query: 568 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 595
LL+D +VK+SDFGL L HN +F ++SK
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 596 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 652
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251
Query: 653 NRRLEIPKEL 662
L P E+
Sbjct: 252 KETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 443 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
E++G GSY VY + NG VA+K Q+ G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLH 69
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-------RIKMAL-DVARGMNCLH 552
+ L+++ E++ H CQ +K +K+ L + RG++ +H
Sbjct: 70 DIIHTKETLTLVFEYV---------HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
I+HRDLK NLL+ +K++DFGL+R K + + T + P+VL
Sbjct: 121 QRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 613 PSNEKC-DVYSFGVILWELATLKLPWIGMNPMQ 644
C D++ G I E+ + GM +Q
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 51/201 (25%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 445 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G GS+G+V A+ GT+ + K + QD + KR + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK--PPFLTQ 65
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
L + E++ G L + + + E + A ++A G+ LH+ I
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKG--I 122
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
++RDLK N+++D ++K++DFG+ + +++K+ GTP+++APE++ +P +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 619 DVYSFGVILWELATLKLPWIG 639
D ++FGV+L+E+ + P+ G
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 42/219 (19%)
Query: 445 IGLGSYGEVYHADW----NGTEVAVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPN 495
IG G+YG VY A +G E A+KKF S +A RE+ ++R L+H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALLRELKHEN 63
Query: 496 VVLFMGAVTRPPNLSI-----ITEFLPRGSLFRIL--HRPH--CQVDE---KRRIKMALD 543
VV + + S+ E L++I+ HR + K + L+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHN---TFLSSKS 596
G++ LH++ ++HRDLK N+LV + VK+ D GL+RL +
Sbjct: 120 ---GVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 597 TAGTPEWMAPEVLRNEPSNEKC-DVYSFGVILWELATLK 634
T + APE+L K D+++ G I EL TL+
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 445 IGLGSYGEVYHADWN--GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
IG G+ G V A G VA+KK F + + A RE+ +M+ + H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY----RELVLMKLVNHKNIIG 79
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR----------GM 548
+ T +L EF + ++ CQV I+M LD R G+
Sbjct: 80 LLNVFTPQKSLE---EFQDVYLVMELMDANLCQV-----IQMDLDHERMSYLLYQMLCGI 131
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV
Sbjct: 132 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEV 188
Query: 609 LRNEPSNEKCDVYSFGVILWEL 630
+ E D++S G I+ E+
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 64/253 (25%), Positives = 122/253 (48%), Gaps = 21/253 (8%)
Query: 399 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 454
G + + DL+ P+ ++D+ ++ + + + + ED + + IG G++GEV
Sbjct: 2 GLDALVYDLDFPALRKNKNIDNFLNRYKDTINK-IRDLRMKAEDYEVVKVIGRGAFGEVQ 60
Query: 455 HADWNGT-EVAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509
T +V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYL 118
Query: 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 569
++ E++P G L ++ + V EK +V ++ +H+ +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNML 174
Query: 570 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 624
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 625 VILWELATLKLPW 637
V L+E+ P+
Sbjct: 235 VFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 61/225 (27%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 445 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRR------LRHPNVV 497
+G GS+G+V A+ G E K L +D L++ E ++ + +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKD---VVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 498 LFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+L + EFL G L F I + + D R A ++ G+ LH+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPS 614
I++RDLK N+++D++ ++K++DFG+ K N F ++++ GTP+++APE+L+
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
D +SFGV+L+E+ + P+ G + ++ F++ R++ P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 542
E +I+ ++ VV A L ++ + G L F I H +E R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 602
++ G+ LH IV+RDLK N+L+D + ++++SD GL+ + + K GT
Sbjct: 110 EICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVG 166
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-E 661
+MAPEV++NE D ++ G +L+E+ + G FQ R+ +I + E
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEM--------------IAGQSPFQQRKKKIKREE 212
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697
++ LV + E + S ++ + P +RL
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 444 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFM 500
+IG G++ EV A G A+K + + F + RE++ +RRL HPN++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKC-MKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 501 GAVTRPPN--LSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ L+++ E L +L+ I R + EKR + + ++ +H +
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--------EWM-APEV 608
I HRD+K N+L+ + +K++DFG S + P W APE
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG----------SCRGIYSKPPYTEYISTRWYRAPEC 169
Query: 609 LRNEPS-NEKCDVYSFGVILWELATLK 634
L + K D+++ G + +E+ +L
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 445 IGLGSYGEVYHADWNGT--EVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG G+YG V A + T +VA+KK D L RE+K++R L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---REIKLLRHLDHENVIA- 68
Query: 500 MGAVTRPPN------LSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVARG 547
+ + PP+ + I+ E L L +I+ HCQ + RG
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQY-------FLYQLLRG 120
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 607
+ +H++ ++HRDLK NLL++ N ++K+ DFGL+R T + APE
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 608 VLRNEPSNE---KCDVYSFGVILWELATLK 634
+L N +E DV+S G I EL K
Sbjct: 179 LLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 445 IGLGSYGEVYHADWN--GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501
IG G+YG+VY A G VA+KK LD + G + RE+KI+R+L H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNHRNIVNLKE 73
Query: 502 AVT----------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
VT ++ E++ L +L E + G+N
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC 132
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE--VL 609
H +HRD+K N+L++ +K++DFGL+RL ++ + W P +L
Sbjct: 133 HKK--NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190
Query: 610 RNEPSNEKCDVYSFGVILWELATLK 634
E DV+S G IL EL T K
Sbjct: 191 GEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 11/192 (5%)
Query: 445 IGLGSYGEVYHADWNGT-EVAVKKFLD-----QDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G GS+G+V A+ GT EV K L QD + KR + + + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
L + E++ G L + R + DE R A +V + LH +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHG--V 117
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
++RDLK N+L+D + K++DFG+ + +++ + GTP+++APE+L+
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 619 DVYSFGVILWEL 630
D ++ GV+++E+
Sbjct: 178 DWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 50/174 (28%), Positives = 90/174 (51%), Gaps = 4/174 (2%)
Query: 463 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522
+ +K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
++L ++ E+ K+++ V RG+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 92 QVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 636
+S ++ + S GT +M+PE L+ + + D++S G+ L ELA + P
Sbjct: 150 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 445 IGLGSYGEV--YHADWNGTEVAVKKFLDQDF----SGA--ALLEFKREVKIMRRLRHPNV 496
+G G +GEV G A KK LD+ SG ALLE +I+ ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLE----KEILEKVNSPFI 55
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
V A +L ++ + G L + I + ++ +R I + + G+ LH +
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI--LHLHS 113
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
IV+RD+K N+L+D N ++SD GL+ LK ++ + AGT +MAPE+L+ EP
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYMAPEILKEEPY 171
Query: 615 NEKCDVYSFGVILWELATLKLPW 637
+ D ++ G ++E+ + P+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 445 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLF 499
IG+G+YG VY A +G VA+K Q L REV +++RL HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 500 MGAVT-----RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCL 551
M R ++++ E + + L L + P + + + RG++ L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDFL 124
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
H + IVHRDLK N+LV VK++DFGL+R+ ++ ++ T + APEVL
Sbjct: 125 HANC--IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 612 EPSNEKCDVYSFGVILWEL 630
D++S G I E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 43/271 (15%)
Query: 443 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ IG G +G+V + D V VK+ L + S EF ++ R L+HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKE-LKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-------IKMALDVARGMNCL 551
+G ++ E+ G L L Q RR +MA ++A G+ +
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVL 609
H +H DL N + + VKV D+G+ SR K + + W+APE++
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 610 -----------RNEPSNEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAVGFQNRRLE 657
+ +PSN V++ GV LWEL P+ ++ +V+ V ++++++
Sbjct: 174 GEFHGGLITAEQTKPSN----VWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVK 228
Query: 658 IPK-ELD-PLVAR---IIWECWQTDPSLRPS 683
+ K +L+ P R ++ CW + P R +
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWLS-PEKRAT 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 16/249 (6%)
Query: 445 IGLGSYGEVYHADWNGTEVA-----VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG GSY +V + T +KK L D ++ ++ V HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLVGL 61
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
L + EF+ G L + R +E R A +++ +N LH I+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERG--II 118
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 619
+RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 620 VYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 672
++ GV+++E+ + P+ +GM NP Q FQ +++ IP+ L + ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG 238
Query: 673 CWQTDPSLR 681
DP R
Sbjct: 239 FLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 445 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G G+YG V A G +VA+KK F + F+ A RE+++++ ++H NV+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMKHENVIG 78
Query: 499 FMGAVTRPPNLSIITEF---LP-----RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
+ T +L +F +P G L + H ++ E R + + +G+
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKY 133
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
+H + I+HRDLK NL V+++ +K+ DFGL+R T T + APEV+
Sbjct: 134 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVIL 188
Query: 611 N-EPSNEKCDVYSFGVILWELATLK 634
N + D++S G I+ E+ T K
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL---------------KHNTFLSSKSTAGTPE 602
IVHRDLK NLL+ ++K++DFGLS++ K K GTPE
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
++APEV+ + + D ++ G+IL+E +P+ G P ++ G V + +E P+
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDDIEWPEGD 239
Query: 663 DPLVAR---IIWECWQTDPSLR 681
+ L A +I + +P R
Sbjct: 240 EALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 45/264 (17%)
Query: 445 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--------PNV 496
+G G+YG+V+ K + + AAL++ + V+ R R+ P +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR----RIKMALDVARGMNCL 551
V A L +I +++ G +F L+ R + DE R I +AL+
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE-------- 119
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAP 606
H IV+RD+K N+L+D +V ++DFGLS+ FLS + S GT E+MAP
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYMAP 175
Query: 607 EVLRNEPSNEKC-DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRL-----E 657
E++R + + K D +S G++++EL T G +P + G Q +RR+
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLT------GASPFTLEGERNTQSEVSRRILKCDPP 229
Query: 658 IPKELDPLVARIIWECWQTDPSLR 681
P + P ++ + + DP R
Sbjct: 230 FPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 496
E+IG G+YG V+ A VA+K+ LD D G +AL RE+ +++ L+H N+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 61
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
V + L+++ E+ + L + + +D + + +G+ H+
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN- 119
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SN 615
++HRDLK NLL++KN +K++DFGL+R + T + P+VL +
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178
Query: 616 EKCDVYSFGVILWELA 631
D++S G I ELA
Sbjct: 179 TSIDMWSAGCIFAELA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 445 IGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 503
+G G+ G V+ + + +K + + A + RE++++ P +V F GA
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 504 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 563
+SI E + GSL ++L + ++ E+ K+++ V +G+ L I+HRD+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH-KIMHRDV 130
Query: 564 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 623
K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+ + + D++S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 624 GVILWELATLKLP 636
G+ L E+A + P
Sbjct: 189 GLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREV-------KIMRR---LR 492
IG G++G+VY T A+K + K+EV I+ R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
P +V + +L ++T+++ G LF L + + E R ++ + LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH 113
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
IV+RDLK N+L+D ++ + DFGLS+ ++ + GT E++APEVL +E
Sbjct: 114 KYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 613 PSNEK-CDVYSFGVILWEL 630
K D +S GV+++E+
Sbjct: 172 KGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 13/193 (6%)
Query: 445 IGLGSYGEVYHA------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G GS+G+V A +V K + QD + KR + + R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPT 557
P L + EF+ G L + H + DE R A ++ + LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 617
I++RDLK N+L+D + K++DFG+ + ++ + GTP+++APE+L+
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 618 CDVYSFGVILWEL 630
D ++ GV+L+E+
Sbjct: 177 VDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
E++G G+Y VY G VA+K+ LD + G RE+ +M+ L+H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAI-REISLMKELKHENIVRL 63
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ L ++ E++ L + + H +D + +G+ H +
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNEP 613
++HRDLK NLL++K +K++DFGL+R + NTF + T W AP+VL
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL----WYRAPDVLLGSR 176
Query: 614 S-NEKCDVYSFGVILWELAT 632
+ + D++S G I+ E+ T
Sbjct: 177 TYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 48/201 (23%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 445 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G GS+G+V A+ GT+ + K + QD + KR + + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL--QDKPPFLTQ 65
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
L + E++ G L + + + E + + A +++ G+ LH I
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRG--I 122
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
++RDLK N+++D ++K++DFG+ + +++++ GTP+++APE++ +P +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 619 DVYSFGVILWELATLKLPWIG 639
D +++GV+L+E+ + P+ G
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 14/247 (5%)
Query: 445 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG GSY +V + VKK L D ++ ++ V + +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHV-FEQASSNPFLVGL 61
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
L ++ E++ G L + R +E R A ++ +N LH I+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHERG--II 118
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 619
+RDLK N+L+D + ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 620 VYSFGVILWELATLKLPW--IGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECW 674
++ GV+++E+ + P+ I NP FQ + + IP+ L + ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFL 238
Query: 675 QTDPSLR 681
DP R
Sbjct: 239 NKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 482 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKR--- 536
+ E +++ +R P +V A L +I +++ G LF + R + E +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 537 -RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-S 594
I +AL+ H I++RD+K N+L+D N +V ++DFGLS+ H + +
Sbjct: 112 GEIVLALE--------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 595 KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 652
S GT E+MAP+++R ++ D +S GV+++EL T G +P V G Q
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT------GASPFTVDGEKNSQ 217
Query: 653 ---NRRL-----EIPKELDPLVARIIWECWQTDPSLR 681
+RR+ P+E+ L II DP R
Sbjct: 218 AEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 79/303 (26%), Positives = 120/303 (39%), Gaps = 81/303 (26%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRHPNVVL 498
E IG GSYG V A G +VA+KK D + S A RE+K++R LRHP++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT--RILREIKLLRLLRHPDIVE 63
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA------------R 546
+ + PP+ EF +F ++ QV IK D+ R
Sbjct: 64 -IKHIMLPPSRR---EFKDIYVVFELMESDLHQV-----IKANDDLTPEHHQFFLYQLLR 114
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 604
+ +HT+ + HRDLK N+L + + +K+ DFGL+R+ N T W
Sbjct: 115 ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFN------DTPTAIFWTDY 166
Query: 605 -------APEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMN----------- 641
APE+ + P+ D++S G I E+ T K + G N
Sbjct: 167 VATRWYRAPELCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223
Query: 642 ----PMQVVGAVG-------FQNRRLEIPKEL-------DPLVARIIWECWQTDPSLRPS 683
+ + V + R + P DPL R++ DP RP+
Sbjct: 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 684 FAQ 686
+
Sbjct: 284 AEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
E+IG G+YG VY A T +A+KK L+Q+ G RE+ +++ ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVRL 66
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHTSTPTI 558
V L ++ E+L + P + R IK L + RG+ H+ +
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP-RLIKTYLYQILRGIAYCHSHR--V 123
Query: 559 VHRDLKSPNLLVDKNWN-VKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNEP 613
+HRDLK NLL+D+ N +K++DFGL+R + TF T W APE+L
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----WYRAPEILLGSR 179
Query: 614 S-NEKCDVYSFGVILWELATLK 634
+ D++S G I E+ K
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 44/140 (31%), Positives = 78/140 (55%), Gaps = 19/140 (13%)
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKSTAGTPEWMAPEVLRNEPS 614
++HRDLKS N+ + +K+ DFG S+ +++ +S + S GTP ++APE+ +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------RLEIPKELDPLVA 667
++K D++S GVIL+EL TL P+ G + +++ V + + LDPL++
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308
Query: 668 RIIWECWQTDPSLRPSFAQL 687
+ +P+LRP+ QL
Sbjct: 309 K--------NPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 53/235 (22%), Positives = 110/235 (46%), Gaps = 11/235 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRH 493
ED + + IG G++GEV N +V K L+ + A F+ E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
+ A NL ++ ++ G L +L + ++ E ++ ++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L+
Sbjct: 121 LH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 613 PSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
+ +CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 445 IGLGSYGEVYHADWN--GTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVV---- 497
+G GS G V+ A + VAVKK L S L RE+KI+RRL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL---REIKIIRRLDHDNIVKVYE 69
Query: 498 -LFMGAVTRPPNLSIITEF--------LPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
L ++ +TE L +L + E+ + RG+
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGL 127
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRL-----KHNTFLSSKSTAGTPE 602
+H++ ++HRDLK N+ ++ V K+ DFGL+R+ H +LS T
Sbjct: 128 KYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKW 183
Query: 603 WMAPEVLRNEPSN--EKCDVYSFGVILWELATLKLPWIGMNPMQ 644
+ +P +L + P+N + D+++ G I E+ T K + G + ++
Sbjct: 184 YRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 445 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKR------------EVKIMRR 490
+G G +GEV G A KK LE KR E +I+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKK-----------LEKKRIKKRKGEAMALNEKQILEK 56
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMN 549
+ VV A L ++ + G L F I + + DE+R + A ++ G+
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEV 608
LH IV+RDLK N+L+D ++++SD GL+ + + + GT +MAPEV
Sbjct: 117 DLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRVGTVGYMAPEV 172
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKE 661
++NE Y+F W L L I G +P F+ R+ ++ +E
Sbjct: 173 VKNER-------YTFSPDWWGLGCLIYEMIEGKSP--------FRQRKEKVKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 18/187 (9%)
Query: 448 GSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507
GS G V+ A G V + Q G L+E +++ + HP+V+ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQ--KGTTLIE----AMLLQNVNHPSVIRMKDTLVSGA 130
Query: 508 NLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565
++ LP L+ L + + + + + + G+ LH I+HRD+K+
Sbjct: 131 ITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKT 185
Query: 566 PNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 623
N+ ++ V + D G ++ FL AGT E APEVL + N K D++S
Sbjct: 186 ENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 624 GVILWEL 630
G++L+E+
Sbjct: 243 GIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 49/246 (19%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 501
IG+G++GEV T A+K D K E I+ + VV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ NL + +++P G + +L R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMG--FIHR 125
Query: 562 DLKSPNLLVDKNWNVKVSDFGLS---RLKHN----------------------------- 589
D+K N+L+D++ ++K++DFGL R H+
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 590 -----------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 638
+ S GTP ++APEVL + CD +S GVIL+E+ + P++
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
Query: 639 GMNPMQ 644
P +
Sbjct: 246 ADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 5e-11
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 49/212 (23%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGA--ALLEFKREVKIMRRLR-HPNVV 497
+++G G+YG V+ A VA+KK D F A A F RE+ ++ L HPN+V
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 498 LFMGAVTRPPN---LSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVARG 547
+ V + N + ++ E++ R ++ +H KR I L A
Sbjct: 71 KLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--------KRYIMYQLLKA-- 119
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP------ 601
+ +H+ ++HRDLK N+L++ + VK++DFGL+R + + P
Sbjct: 120 LKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTDYV 173
Query: 602 --EWM-APEVLRNEPSNEKCDVYSFGVILWEL 630
W APE+L Y+ GV +W +
Sbjct: 174 ATRWYRAPEILLGSTR------YTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-- 541
E I+R + HP+++ G T +I LPR ++ +C + KR I +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPR---YKT--DLYCYLAAKRNIAICDI 184
Query: 542 ----LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----RLKHNTFLS 593
V R + LH + I+HRD+K+ N+ ++ +V + DFG + + N +
Sbjct: 185 LAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
AGT APE+L +P D++S G++L+E+AT
Sbjct: 243 ---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
+++G G+Y VY T+ VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMAL-DVARGMNCLHTSTPTI 558
+ +L+++ E+L + L + L C +K+ L + RG+N H +
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 617
+HRDLK NLL+++ +K++DFGL+R K + + T + P++L + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 618 CDVYSFGVILWELAT 632
D++ G I +E++T
Sbjct: 186 IDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 53/235 (22%)
Query: 445 IGLGSYGEV--YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 501
IG G++GEV G A+K L + F L K E ++ P VV
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ L +I EFLP G L +L + ++ R MA + + +H +HR
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVHKLG--FIHR 125
Query: 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------------------------ 591
D+K N+L+D+ ++K+SDFGLS H
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 592 --LSSK---------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 629
+SSK ST GTP+++APE+ + ++CD +S G I++E
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKK-FLDQDFSG---AALLEFKREVKIMRRLRHPNV 496
E+IG G+YG+VY A G VA+KK L+ D G AL RE+ +++ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIY 62
Query: 497 VLFMGAVTR------PPNLSIITEFLPRG-SLFRILHR--PHCQVDEKRRIKMALDVARG 547
++ + V P+L ++ E+L F + P + K + +G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
+ H ++HRDLK NLLVDK + K++D GL R S T + AP
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 607 EVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 644
EVL + D++S G I E++ + + G + +Q
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 460 GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515
G VAVKK F +Q + A RE+ +++ + H N++ + T +L EF
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAY----RELVLLKCVNHKNIISLLNVFTPQKSLE---EF 98
Query: 516 LPRGSLFRILHRPHCQV-----DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 570
+ ++ CQV D +R + + G+ LH++ I+HRDLK N++V
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV 156
Query: 571 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 630
+ +K+ DFGL+R F+ + T + APEV+ E D++S G I+ EL
Sbjct: 157 KSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
E++G G+Y V+ TE VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 501 GAVTRPPNLSIITEFLPR---------GSLFRILHRPHCQVDEKRRIKMAL-DVARGMNC 550
V +L+++ E+L + G++ + +K+ L + RG+
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-----------HNVKIFLYQILRGLAY 119
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
H ++HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 120 CHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 611 NEPS-NEKCDVYSFGVILWELAT 632
+ + D++ G I +E+A+
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 23/200 (11%)
Query: 445 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 499
+G G+YG V A G VAVKK L + F +++ KR E+++++ ++H NV+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 500 MGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHT 553
+ T +L + L L I+ CQ ++ + + RG+ +H+
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-E 612
+ I+HRDLK NL V+++ +K+ DFGL+R +T T + APE++ N
Sbjct: 139 AD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 613 PSNEKCDVYSFGVILWELAT 632
N+ D++S G I+ EL T
Sbjct: 194 HYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 7/199 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
E V +++G G+Y V+ TE VA+K+ + GA REV +++ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHA 63
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
N+V + L+++ E+L + + + +I M + RG++ H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM-FQLLRGLSYCHKR 122
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
I+HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 123 K--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 615 -NEKCDVYSFGVILWELAT 632
+ D++ G IL+E+AT
Sbjct: 181 YSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 445 IGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFK-REVKIMRRLR-HPNVV- 497
+G G+YG V A T VA+KK + FS L + RE+K++R R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK-ITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 498 LF-MGAVTRPP-NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHTS 554
L+ M V N + E L L +I+ Q + + + G+ +H++
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS----KSTAGTPEWMAPEV-L 609
++HRDLK NLLV+ + +K+ DFGL+R + T + APE+ L
Sbjct: 125 N--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182
Query: 610 RNEPSNEKCDVYSFGVILWELATLK 634
+ + DV+S G IL EL K
Sbjct: 183 SFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 33/239 (13%)
Query: 463 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 45 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKSLE---EFQDV 97
Query: 519 GSLFRILHRPHCQV-----DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573
+ ++ CQV D +R + + G+ LH++ I+HRDLK N++V +
Sbjct: 98 YLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 155
Query: 574 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL 633
+K+ DFGL+R +F+ + T + APEV+ E D++S G I+ E+
Sbjct: 156 CTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 634 KLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 688
K+ + G + + +V+ +G E K+L P V + RP +A LT
Sbjct: 215 KILFPGRDYIDQWNKVIEQLGTPCP--EFMKKLQPTVRNYVEN--------RPKYAGLT 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 445 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G G+YG V A G +VA+KK F + F+ A RE+ +++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----RELTLLKHMQHENVIG 78
Query: 499 FMGAVTRPPNLSIITEF---LP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
+ T + +F +P + L +I+ P + E + + + G+ +H+
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGLKYIHS 135
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN- 611
+ I+HRDLK NL V+++ +K+ DFGL+R T W APEV+ N
Sbjct: 136 AG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT----RWYRAPEVILNW 189
Query: 612 EPSNEKCDVYSFGVILWELATLK 634
N+ D++S G I+ E+ T K
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 29/193 (15%)
Query: 463 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 52 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLE---EFQDV 104
Query: 519 GSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKSPNL 568
+ ++ CQV I+M LD R G+ LH++ I+HRDLK N+
Sbjct: 105 YIVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 157
Query: 569 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 628
+V + +K+ DFGL+R +F+ + T + APEV+ E D++S G I+
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 629 ELATLKLPWIGMN 641
E+ + + G +
Sbjct: 217 EMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 445 IGLGSYGEVY---HADWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRH----P 494
IG G +GEVY AD G A+K LD+ L +IM L P
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMK-CLDKKRIKMKQGETLALNE--RIMLSLVSTGDCP 57
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+V A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVL-RN 611
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL +
Sbjct: 117 F--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 612 EPSNEKCDVYSFGVILWEL 630
+ D +S G +L++L
Sbjct: 171 VAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-09
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 44/232 (18%)
Query: 443 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRHPNVV 497
++IG G +GEV+ T+ + F + S L E ++ EV +MR L+H N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 498 LFMGAVTRPPN--LSIITEFLPRGSLFRILHR---------PHCQVDEKRRIKMALDVAR 546
++ N L I+ EF G L R + + H VD R++ AL
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVD-------------KNWN----VKVSDFGLSRLKHN 589
+ + ++HRDLK N+ + N N K+ DFGLS+ N
Sbjct: 136 NLKD-GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---N 191
Query: 590 TFLSS--KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPW 637
+ S S GTP + +PE+L +E ++K D+++ G I++EL + K P+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 57/279 (20%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+G+G++GEV A T+ A+K +D + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ NL + +++P G + +L R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG--FIHR 125
Query: 562 DLKSPNLLVDKNWNVKVSDFGL-------------------------------------- 583
D+K N+L+D++ ++K++DFGL
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 584 -SRLK---------HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL 633
RLK H L+ S GTP ++APEVL + CD +S GVIL+E+
Sbjct: 186 GDRLKPLERRAARQHQRCLA-HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 634 KLPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 670
+ P++ P++ V L IP + L P + +I
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 4/157 (2%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 542
E +I+ ++ VV A L ++ + G L F I + + +E+R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 602
++ G+ LH V+RDLK N+L+D ++++SD GL+ +K S + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 639
+MAPEVL N+ D + G +++E+ + P+ G
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 55/278 (19%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 501
+G+G++GEV A T A+K +D + + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561
+ NL + +++P G + +L R + R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG--FIHR 125
Query: 562 DLKSPNLLVDKNWNVKVSDFGLS---RLKHNTFLSSK----------------------- 595
D+K N+L+D + ++K++DFGL R HN+ K
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185
Query: 596 ---------------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 634
S GTP ++APEVL + + CD +S GVIL+E+ +
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
Query: 635 LPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 670
P++ P + V L IP + L P +I
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 33/111 (29%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPS-- 614
VHRD+K N+L+D N +++++DFG S LK N + S GTP++++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 615 ---NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
+CD +S GV ++E+ + P+ + ++ G + R + P +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 448 GSYGEVY---HADWNGTEVAVKKFLD-QDFSGAALLEFKREV-KIMRRLRHPNVVLFMGA 502
G +G+V H ++ V+K + ++F+ +E V ++M+ +PN + +
Sbjct: 27 GKFGKVSVLKHKPTQ--KLFVQKIIKAKNFNA---IEPM--VHQLMKD--NPNFIKLYYS 77
Query: 503 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 562
VT +I +++ G LF +L + + E K+ + +N LH I+H D
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHN--IIHND 134
Query: 563 LKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEKCDV 620
+K N+L D + + D+GL ++ + S GT ++ +PE ++ + D
Sbjct: 135 IKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEKIKGHNYDVSFDW 189
Query: 621 YSFGVILWELATLKLP 636
++ GV+ +EL T K P
Sbjct: 190 WAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
+G G G V+ GT A+K K + + ++E I+ L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILATLDHPFLPTL 66
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ L ++ ++ P G LFR+L R C +E R A +V + LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG-- 123
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLS------------------------RLKHNTFLS 593
IV+RDLK N+L+ ++ ++ +SDF LS + TF
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 594 -----SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 630
S S GT E++APEV+ + D ++ G++L+E+
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 63/256 (24%), Positives = 116/256 (45%), Gaps = 32/256 (12%)
Query: 442 GERIGLGSYGEVYHADWNGTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVL 498
G R +G YGE++ TEV + K LD +++S + F +M +L H ++VL
Sbjct: 14 GIRREVGDYGELHK-----TEV-LLKVLDKSHRNYSES----FFEAASMMSQLSHKHLVL 63
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
G ++ E++ GSL L + ++ ++++A +A ++ L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--GL 121
Query: 559 VHRDLKSPNLLV-----DKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
H ++ + N+L+ K N +K+SD G+S T L + W+ PE +
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPECIE 177
Query: 611 NEPS-NEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
N + + D +SFG LWE+ + P ++ + + F R ++P +A
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLPAPKWTELAN 234
Query: 669 IIWECWQTDPSLRPSF 684
+I +C +P RPSF
Sbjct: 235 LINQCMDYEPDFRPSF 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 460 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519
GT V V+ ++ + L + EV + RHPN++ T L +I+ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 520 SLFRILHRPHCQVDEKRRIKMALDVA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578
S +L + + I L A RG+N LH + +HR++K+ ++L+ + V +
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSL 142
Query: 579 SDFGLSRL--------KHNTF--LSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVI 626
S GLS L K ST+ P W++PE+LR + N K D+YS G+
Sbjct: 143 S--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYNVKSDIYSVGIT 199
Query: 627 LWELATLKLPWIGMNPMQVV 646
ELAT ++P+ M Q++
Sbjct: 200 ACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 25/199 (12%)
Query: 445 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 499
+G G+YG V A +VAVKK L + F +L+ +R E+++++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKK-LSRPFQ--SLIHARRTYRELRLLKHMKHENVIGL 79
Query: 500 MGAVTRPPNLSIITEF-----LPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHT 553
+ T ++ E L L I+ CQ ++ + + RG+ +H+
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN- 611
+ I+HRDLK N+ V+++ +++ DFGL+R + +T W APE++ N
Sbjct: 137 AG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT----RWYRAPEIMLNW 190
Query: 612 EPSNEKCDVYSFGVILWEL 630
N+ D++S G I+ EL
Sbjct: 191 MHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 31/109 (28%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 616
VHRD+K N+L+DKN +++++DFG RL + + S GTP++++PE+L+ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 617 ----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
+CD +S GV ++E+ + P+ + ++ G + + P +
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 4/155 (2%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 542
E +I+ ++ VV A L ++ + G L F I + + DE+R I A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 602
++ G+ L IV+RDLK N+L+D ++++SD GL+ ++ + + GT
Sbjct: 110 ELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVG 166
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637
+MAPEV+ NE D + G +++E+ + P+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 445 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----PNVV 497
IG G +GEVY AD G A+K + +IM L P +V
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
A P L I + + G L L + H EK A ++ G+ +H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRNEPS- 614
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL+ +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAY 173
Query: 615 NEKCDVYSFGVILWEL 630
+ D +S G +L++L
Sbjct: 174 DSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 7/191 (3%)
Query: 443 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
E++G GSY VY + NG VA+K + G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLH 69
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560
+ L+ + E++ ++ P R+ M + RG+ +H I+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHGQH--ILH 126
Query: 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCD 619
RDLK NLL+ +K++DFGL+R K + S T + P+VL + D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 620 VYSFGVILWEL 630
++ G I E+
Sbjct: 187 IWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
+++G GSY VY G VA+K+ + GA RE +++ L+H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLH 69
Query: 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-------RRIKMAL-DVARGMNCLH 552
+ L+++ E+L Q + +++ L + RG+ H
Sbjct: 70 DIIHTKKTLTLVFEYL---------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
++HRDLK NLL+ + +K++DFGL+R K
Sbjct: 121 QRR--VLHRDLKPQNLLISERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 442 GERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
G ++G G+YG VY A + E A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 498 LFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 548
+ + F L+ I+ K+ +++ + + G+
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 549 NCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPE 602
+ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 603 WM-APEVLRNEPSNEKC-DVYSFGVILWELAT 632
W APE+L K D+++ G I EL T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 442 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 498 LFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 548
+ + F L+ I+ K+ +++ + + G+
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 549 NCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPE 602
+ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 603 WM-APEVLRNEPSNEKC-DVYSFGVILWELAT 632
W APE+L K D+++ G I EL T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
E+ M +L+HPN+V +G +I E++ +L +L + +RR K+A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIG 788
Query: 544 VARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTFLSSKSTAGT 600
+A+ + LH +P +V +L +++D ++++S GL F+SS
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 601 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 636
++APE + EK D+Y FG+IL EL T K P
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 20/236 (8%)
Query: 459 NGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517
NG E+ V K LD AL F +M ++ H ++ G R ++ EF+
Sbjct: 41 NGRELRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVE 99
Query: 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 574
G L L + +V +I +A +A ++ L +VH ++ + N+L+ +
Sbjct: 100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157
Query: 575 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWE 629
+K+SD G+S T LS + W+APE + S + D +SFG L E
Sbjct: 158 GTSPFIKLSDPGVSF----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 630 LA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 684
+ ++P P + F ++ +P+ +A +I +C +P+ RPSF
Sbjct: 214 ICFDGEVPLKERTPSE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF 266
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 39/105 (37%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVK--KFLDQDFSGAALLEFKR 483
E+P ++LVLG +G G++G V A +G +VAVK K + AL+
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMS--- 89
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 527
E+KIM L H N+V +GA T+ + IITE+ G L LHR
Sbjct: 90 ELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 47/279 (16%)
Query: 377 KNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPW 436
+++ +E H K +F + KL + E ++ +++ D+D+ P
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS--PN 65
Query: 437 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK-REVKIMRRLRH 493
+ LG IG GS+G VY A T +VA+KK L QD ++K RE+ IM+ L H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QD------PQYKNRELLIMKNLNH 118
Query: 494 PNVVL-----FMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL--- 542
N++ + + L+++ EF+P+ H + R AL
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV--------HKYMKHYARNNHALPLF 170
Query: 543 -------DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLKHNTFLSS 594
+ R + +H+ I HRDLK NLL+D N + +K+ DFG ++ N
Sbjct: 171 LVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQ 225
Query: 595 KSTA--GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 630
+S + + + APE++ + D++S G I+ E+
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 479 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 538
L F +MR++ H ++VL G R ++ EF+ G L +HR + +
Sbjct: 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF 108
Query: 539 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGLSRLKHNTF 591
K+A +A ++ L +VH ++ + N+L+ + +K+SD G+ T
Sbjct: 109 KVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TV 162
Query: 592 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 630
LS + W+APE + + + + D +SFG LWE+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 484 EVKIMRRLRHPNVVLFM-----GAVT---RPPNLSIITEFLPRGSLFRILHRPHCQVDE- 534
E +++RRL HP V+ + G +T P S + +L G+ R L QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL--GARLRPLGLA--QVTAV 265
Query: 535 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594
R++ A+D G I+HRD+K+ N+LV+ ++ + DFG + ++ +
Sbjct: 266 ARQLLSAIDYIHGEG--------IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 595 --KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 631
AGT + APEVL +P D++S G++++E A
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 448 GSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 503
GS GEV+ H D +V VK +G RE+ I++ + H ++ + A
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAV-----TGGKTPG--REIDILKTISHRAIINLIHAY 155
Query: 504 TRPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGM----NCLHTSTPT 557
S + +P + LF + R ++ A+ + R + LH
Sbjct: 156 R---WKSTVCMVMPKYKCDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG-- 205
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
I+HRD+K+ N+ +D+ N + DFG + +L H +GT E +PE+L +P
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 616 EKCDVYSFGVILWELATLKLPWIG 639
K D++S G++L+E++ + G
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 6/173 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 493
E+ V+ + I G++G+VY N AVK D ++ + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
P +V ++ N+ ++ E+L G + +LH + DE+ +K +VA ++ LH
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR 122
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
I+HRDLK N+L+ ++K++DFGLS++ N L+ TP P
Sbjct: 123 HG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
+HR KS N+L+ W+ + G F + + + P +MAPEV++ + EK
Sbjct: 33 LHRQAKSGNILL--TWDGLLKLDGSV-----AFKTPEQSRPDPYFMAPEVIQGQSYTEKA 85
Query: 619 DVYSFGVILWELATLKLPWIGMNPM 643
D+YS G+ L+E +LP+ +
Sbjct: 86 DIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 35/157 (22%), Positives = 70/157 (44%), Gaps = 22/157 (14%)
Query: 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPN 495
+ I G+ E+Y D+ G + +K + + + L E +RE +IM R R
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60
Query: 496 V----VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
V V F+ P N I+ E++ L +++ ++++ ++ R + L
Sbjct: 61 VNVPAVYFVD----PENFIIVMEYIEGEPLKDLINSN-----GMEELELSREIGRLVGKL 111
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588
H++ I+H DL + N+++ + + DFGL+
Sbjct: 112 HSA--GIIHGDLTTSNMILSGG-KIYLIDFGLAEFSK 145
|
Length = 211 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 44/137 (32%), Positives = 62/137 (45%), Gaps = 12/137 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E P + LVLG +G G++G+V G +VAVK L + E+
Sbjct: 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVK-MLKPTARSSEKQALMSEL 91
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMAL 542
KIM L H N+V +GA T+ + IITE+ G L LH R + + K L
Sbjct: 92 KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDL 151
Query: 543 DVARGMNCLHTSTPTIV 559
D+ G+N ST + V
Sbjct: 152 DIF-GINPADESTRSYV 167
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 16/101 (15%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFK--- 482
E P + L LG+ +G G++G+V A G E VAVK + GA E+K
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE----GATASEYKALM 58
Query: 483 REVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSL 521
E+KI+ + H NVV +GA T+P L +I E+ G+L
Sbjct: 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 459 NGTEVAVKKFLDQDFSGAALLEF-KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517
G V V++ ++ + ++ F + E+ + + HPN+V + L ++T F+
Sbjct: 24 TGEYVTVRR-INLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 518 RGSLFRILHRPHCQ--VDEKRRIKMA---LDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 572
GS ++ C +D + +A V + ++ +H VHR +K+ ++L+
Sbjct: 83 YGSAKDLI----CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISV 136
Query: 573 NWNVKVSDF--GLSRLKHNTFLS-----SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSF 623
+ V +S LS + H L K + W++PEVL+ + + K D+YS
Sbjct: 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 624 GVILWELATLKLPWIGMNPMQV 645
G+ ELA +P+ M Q+
Sbjct: 197 GITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGA--ALLEFKR 483
E P ++L G+ +G G++G+V A + N VAVK + AL+
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS--- 90
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 527
E+KI+ L +H N+V +GA T + +ITE+ G L L +
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 38/198 (19%), Positives = 56/198 (28%), Gaps = 58/198 (29%)
Query: 443 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-----PNVV 497
+ G+ Y +K A E +RE+ ++R L P V+
Sbjct: 3 RPLSGGASNRTYLVGTGDGRYVLKLAP----PAEAAEELRRELALLRHLAAAGIPVPRVL 58
Query: 498 LF------------------MGAVTRPPNLSIITEFLPR-GSLFRILHR-PHCQVDEKRR 537
+TRP + + L L LH P + RR
Sbjct: 59 AGGTDGGGLGLPFLLMEGLPGEVLTRPLDPAERGALLEALARLLARLHSVPPEALPLARR 118
Query: 538 IKMALDVARG----------------------------MNCLHTSTPTIVHRDLKSPNLL 569
++ L + R + L +VH DL NLL
Sbjct: 119 LRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLL 178
Query: 570 VDKNWNVK-VSDFGLSRL 586
VD V V DF + L
Sbjct: 179 VDPGGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 37/154 (24%), Positives = 59/154 (38%), Gaps = 31/154 (20%)
Query: 445 IGLGSYGEVYHADWNGTEVAVK---------KFLDQDFSGAALLEFKREVKIMRRLRHPN 495
I G+ +Y D+ G VK LD+ +RE +I+ + R
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREARILAKAREAG 60
Query: 496 V----VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
V V P N I+ E++ G L + E+ R + +V R + L
Sbjct: 61 VPVPIVYD----VDPDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKL 108
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585
H + IVH DL + N+++ + DFGL
Sbjct: 109 HKA--GIVHGDLTTSNIILSGG-RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 37/105 (35%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFK--- 482
E P + L LG+ +G G++G+V A G + VAVK + GA E K
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKE----GATASEHKALM 58
Query: 483 REVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRIL 525
E+KI+ + H NVV +GA T+P L +I EF G+L L
Sbjct: 59 SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.91 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.9 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.9 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.83 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.73 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.55 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.26 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.26 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.86 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.85 | |
| PLN02236 | 344 | choline kinase | 96.8 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 96.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.66 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.45 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 96.27 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.9 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.81 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.2 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.15 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.13 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.02 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 94.78 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.33 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.26 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=427.08 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=227.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.+..++|+++++||+|+||+||+++. +++.||+|++.+....+. ....+..|..||.+++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999976 789999999988765443 577789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|||+||+.||+|+.+|++.+ .+++..+..++.+|+.||.|||++| ||||||||+|||||.+|+++|+||||++....
T Consensus 101 ylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999998754 6888888888999999999999999 99999999999999999999999999997666
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
......++|||+.|||||++.+..|+..+|||||||++|||++|.+||.+.+..++.+.|.... ....|..++.+.++|
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHH
Confidence 6566777999999999999999999999999999999999999999999999999999986432 245566699999999
Q ss_pred HHHhhhcCCCCCC----CHHHHHH
Q 004986 670 IWECWQTDPSLRP----SFAQLTV 689 (720)
Q Consensus 670 I~~cL~~DP~kRP----S~~ELL~ 689 (720)
|.++|.+||++|. ++.+|.+
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhc
Confidence 9999999999996 4555544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=419.87 Aligned_cols=251 Identities=32% Similarity=0.473 Sum_probs=228.8
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-e
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-L 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~-l 509 (720)
.+..++++.++.||+|..|+||++.+ +++.+|+|.+ .-..+.....++.+|++++++.+|||||.+|++|..+.. +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 46678889999999999999999988 6899999998 445667778899999999999999999999999999995 9
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||++|+|++++.+. ++++|....+++.++++||.|||. ++ ||||||||+||||+..|+|||||||.++.+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 9999999999999999765 469999999999999999999996 66 9999999999999999999999999999887
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHhhhhccccccCCCCC-C
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGFQNRRLEIPKE-L 662 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~-----~~~~i~~~i~~~~~~~~ip~~-l 662 (720)
+. ...+++||..|||||.+.+..|+.++||||||+.++||..|++||... +..+++..|. .+.++.+|.. +
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~f 307 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEF 307 (364)
T ss_pred hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccC
Confidence 76 457899999999999999999999999999999999999999999874 6677778886 3456678886 9
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++++++||..||++||.+||+++|+++|
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=426.64 Aligned_cols=274 Identities=47% Similarity=0.793 Sum_probs=249.8
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEECCcE-EEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~-VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
...+.+.++++.+.+.||+|+||+||++.+.|+. ||||++...........+|.+|+.+|.+++|||||+|+|++.+..
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3456677888888999999999999999999998 999999887777666889999999999999999999999999988
Q ss_pred -ceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecccc
Q 004986 508 -NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLS 584 (720)
Q Consensus 508 -~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlA 584 (720)
.+++||||+++|+|.+++++ .+..++...++.|+.||+.||+|||++++ ||||||||+||||+.++ ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence 79999999999999999987 46789999999999999999999999985 99999999999999998 9999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~--g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
+.........+...||+.|||||+++ ...|+.|+|||||||++|||++|..||.+....+....+.....++.+|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 97765433444478999999999999 5689999999999999999999999999999988888888888899999999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
++.+..|+.+||+.||.+||++.+++..|+.+...+....+
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~ 312 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP 312 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence 99999999999999999999999999999999887765444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=434.57 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=233.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.+|+.++.||+|||++||.++. +|..||+|++.+.... ......+.+||+|.++|+|||||+|+++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999987 7999999999886543 344667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+|..++|..++++ ...++|.+++++++||+.||.|||+++ |||||||..|+||+++.+|||+|||||..+......
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999985 458999999999999999999999999 999999999999999999999999999998877777
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
..+.|||+.|+|||++....++..+||||+||+||.|++|++||+..+-.+++..|+. ....+|..++.++++||.++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--NEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh--cCcccccccCHHHHHHHHHH
Confidence 8899999999999999999999999999999999999999999999999999999853 45667889999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~L~ 692 (720)
|+.+|.+||++++|+.+=-
T Consensus 253 L~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred hcCCcccCCCHHHHhcCHh
Confidence 9999999999999998743
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=396.23 Aligned_cols=240 Identities=25% Similarity=0.457 Sum_probs=221.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
...++|++++.||.|+||+|.+++. ++..||+|++.+...-. ...+...+|..+|+.+.||+++++++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 5568999999999999999999976 78899999998765433 34556789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
|||||++||.|+.++++.+ ++++..++.++.||+.||+|||.++ |++|||||+|||||.+|++||+|||+|+.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998764 7999999999999999999999999 999999999999999999999999999977543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
+.+.|||+.|+|||++..++|++++|||+|||++|||+.|.+||.+.++.+++++|. .....+|..++.++++||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHHH
Confidence 557899999999999999999999999999999999999999999999999999995 456778999999999999
Q ss_pred HHhhhcCCCCC
Q 004986 671 WECWQTDPSLR 681 (720)
Q Consensus 671 ~~cL~~DP~kR 681 (720)
..+|+.|-++|
T Consensus 273 ~~LL~vD~t~R 283 (355)
T KOG0616|consen 273 KKLLQVDLTKR 283 (355)
T ss_pred HHHHhhhhHhh
Confidence 99999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=410.45 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=215.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH-----HHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-----~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
..+.|.+.+.||+|+||.|-+|.. +++.||||++.++..... ....+.+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 347799999999999999999965 799999999987654332 2334679999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEecccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLS 584 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~IKL~DFGlA 584 (720)
..||||||++||+|++.+-.++ .+.+.....+++||+.|+.|||++| |+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999986654 5778888889999999999999999 9999999999999765 78999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhcccccc--CC
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRL--EI 658 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~---s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~~~~~~~--~i 658 (720)
+..+.. ....++|||+.|.|||++.++.+ ..++|+|||||+||-+++|.+||.+..... ..+.|....... ..
T Consensus 327 K~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 988744 45677999999999999987653 448899999999999999999998755444 555554332222 34
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+..++.+.++||.+||..||++||++.|+++|
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 56789999999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=403.92 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=224.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.+|.+.+.||.|+|++||+|++ ++..||||.+.+..+....++-+..|+.||+.++|||||+|++++.+++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 6899999999999999999987 68999999999988777777888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC------CcEEEEecccccccc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLKH 588 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~------g~IKL~DFGlAk~~~ 588 (720)
||.||+|.+|+++.+ .+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999999998754 7999999999999999999999999 9999999999999864 569999999999887
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-CCCCCCcHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLVA 667 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~-~ip~~ls~~l~ 667 (720)
.. ....+.||++-|||||+++.+.|+-|+|+||+|+++|+|++|..||...++.+++..+....... .++..++..+.
T Consensus 167 ~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred ch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 54 34567899999999999999999999999999999999999999999999999998877555444 45556777888
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+|+...|+.++.+|-++.+...+
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhh
Confidence 99999999999999887766544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=412.41 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=227.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~L 511 (720)
..||.+++.||.|+|++|++|+. +++.||||++.+..+.. .....+..|..+|.+| .||.||+|+..|+|+..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 47899999999999999999976 78999999987765433 3455677899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+||+++|+|.++|.+. +.+++..++.++.||+.||+|||++| ||||||||+|||||.+|++||+|||.|+.+....
T Consensus 152 vLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999886 47999999999999999999999999 9999999999999999999999999999764321
Q ss_pred -----------c--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC
Q 004986 592 -----------L--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 658 (720)
Q Consensus 592 -----------~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~i 658 (720)
. ...+++||..|.+||++.....++.+|+|+|||+||+|+.|.+||.+.++.-+++.| ......+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QALDYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHhcccC
Confidence 1 125689999999999999999999999999999999999999999999999999888 4556788
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
|..+++.+++||+++|..||.+|++..||.+|-
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 999999999999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=392.82 Aligned_cols=257 Identities=28% Similarity=0.487 Sum_probs=228.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeee-eecCCc-e
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA-VTRPPN-L 509 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~-~~~~~~-l 509 (720)
....+|+|+++||+|.||.||++.+ ++..+|.|.+.....+.........|+.+|++|+|||||+++++ |.+++. +
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3457899999999999999999976 89999999999877787788889999999999999999999994 555555 9
Q ss_pred EEEEeecCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 510 SIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTP--TIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~---~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~--~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
+||||||.+|+|..+++ +.++.+++..+|+++.|++.||.++|.+=+ .|+||||||.||+|+.+|.+||+||||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999885 356679999999999999999999999422 4999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC-CCCc
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KELD 663 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip-~~ls 663 (720)
+.+........+.+|||.||+||++.+.+|+.++|||||||++|||+.-+.||++.+-.++..+|... ..+.+| ..++
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhh
Confidence 99887777777889999999999999999999999999999999999999999999988888888643 334466 6789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
.++..||..|+..||++||+...++..+
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred hHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 9999999999999999999854444433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=406.02 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=223.1
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++++.||+|+||.||+|+. +|..||+|++++... .......++.|..||...++|+||+||..|++.+.
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 356789999999999999999999965 799999999988754 34456788999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+||||||++||++..+|.+.+ .+++..+..++.+++.||+-||+.| +|||||||+|+|||..||+||+||||+.-+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999999997654 7999999999999999999999999 9999999999999999999999999986321
Q ss_pred C-----------------------Ccc------------------------cCCCCCCCCCccCcccccCCCCCchhhHH
Q 004986 589 N-----------------------TFL------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVY 621 (720)
Q Consensus 589 ~-----------------------~~~------------------------~~~s~~GT~~Y~APEvi~g~~~s~ksDVW 621 (720)
. ... ...+.+|||.|||||++.+..|+..+|||
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 01145799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 004986 622 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRP---SFAQLTVA 690 (720)
Q Consensus 622 SLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~--~ls~~l~dLI~~cL~~DP~kRP---S~~ELL~~ 690 (720)
|||||+||||.|.+||...++.++...|......+.+|. .++++++|||.+||. ||.+|. .++||.+|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 999999999999999999999999998875554455554 567999999999999 999996 47777654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=397.25 Aligned_cols=256 Identities=32% Similarity=0.483 Sum_probs=226.4
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCc
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~---~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~ 508 (720)
....|.+++.||+|+||+|++|.+ ++..||||++.+.... ......+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 347899999999999999999976 7899999977664221 123456678999999998 9999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~DFGlAk~~ 587 (720)
+|+||||+.||+|++++.+ ..++.+..+.++++||+.|++|||++| |+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999988 568999999999999999999999999 9999999999999999 99999999999987
Q ss_pred cCCcccCCCCCCCCCccCcccccCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCC-cH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEP-SN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL-DP 664 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~-~s-~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~l-s~ 664 (720)
........+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...++..| ......+|..+ ++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S~ 249 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLSP 249 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCCH
Confidence 43334567789999999999999977 74 7999999999999999999999998888888876 45567788888 99
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
++++||.+||..||.+|+++.+++ .-.-++.
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 999999999999999999999999 4444443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=410.90 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=223.9
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 507 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~ 507 (720)
..+..++|.++++||+|.||+|+++.. +++.||||++++..+ .....+....|..|+... +||++++++..|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 356779999999999999999999987 678999999988754 455677788899999887 6999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
++|+||||+.||++..+.+. ..+++..+..|+.+|+.||.|||++| |||||||.+|||||.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999995544443 46999999999999999999999999 999999999999999999999999999976
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
......+.++|||+.|||||++.+..|+..+|||+|||+|||||.|+.||.+.+.+++++.|. .....+|..++.++.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAI 596 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHH
Confidence 655567788999999999999999999999999999999999999999999999999999995 446778899999999
Q ss_pred HHHHHhhhcCCCCCCCH
Q 004986 668 RIIWECWQTDPSLRPSF 684 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~ 684 (720)
++++++|.++|++|..+
T Consensus 597 ~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhccCcccccCC
Confidence 99999999999999755
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.12 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=214.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++.|+.+.++|+|+||+||+|++ +|+.||||++....-++...+-..+|+++|++|+|+|+|.|+++|.....++||+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46788999999999999999976 7999999999887766666677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|||+..-|.+ |.+....++...+.++++|++.|+.|+|+++ +|||||||+||||..+|.+||||||+|+.+..+...
T Consensus 81 E~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 9997755544 5555567899999999999999999999999 999999999999999999999999999988755555
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-------------c------c
Q 004986 594 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------Q------N 653 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-------------~------~ 653 (720)
-+.++.|.+|+|||.+.| ..|+..+|||++||++.||++|.+.|.+..+-+.+..|.. . .
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 566789999999999998 6799999999999999999999999999776554433321 0 0
Q ss_pred cccCCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 RRLEIP----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ~~~~ip----------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+..+ +.++..+.||++.||+.||++|++.+|++.|
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 011111 2456679999999999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=401.88 Aligned_cols=249 Identities=30% Similarity=0.473 Sum_probs=228.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecC-CCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~-~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.-|++++.||+|+.|.|.+|++ +|+.+|||++.+. .........+++|+.||+-+.||||+++|++|.+..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3478899999999999999988 8999999999876 555556778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||++||.|++++.+.+ ++.+.+++++++||+.|+.|||..+ |+||||||+|+|||..++|||+|||+|.+.... ..
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 9999999999997654 7888999999999999999999999 999999999999999999999999999875443 45
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
..+.||++.|.|||++.|.+| +.++||||.||+||.|++|..||.+.+...++.++ +...+++|.+++.++++||.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHH
Confidence 567899999999999999998 67899999999999999999999999999998887 556788999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~L 691 (720)
||..||.+|.|++||++|-
T Consensus 246 ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HhccCccccccHHHHhhCc
Confidence 9999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=398.78 Aligned_cols=250 Identities=29% Similarity=0.464 Sum_probs=229.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|.+.+.||+|.||.||||++ +.+.||+|.+.+....+..+..+.+|++|+++++|||||.++++|+...++|+|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 46889999999999999999976 6788999999998888888889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+.| +|+.+|... ..++++.+..++.+++.||.|||+++ |+|||+||.|||++..|.+||||||+|+........
T Consensus 81 e~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 99977 999999765 47999999999999999999999998 999999999999999999999999999987665555
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.+...||+.|||||++.++.|+..+|+|||||++|||+.|++||......++...|... +...|...+..+..|++.+
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--PVKPPSTASSSFVNFLQGL 234 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--CCCCcccccHHHHHHHHHH
Confidence 56678999999999999999999999999999999999999999999988888888543 4555678999999999999
Q ss_pred hhcCCCCCCCHHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~L 691 (720)
|.+||.+|.+..+++.|=
T Consensus 235 L~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred hhcChhhcccHHHHhcCh
Confidence 999999999999998763
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=391.63 Aligned_cols=264 Identities=39% Similarity=0.655 Sum_probs=230.4
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+++|..+++.++..||+|.||+||+|+|.| .||||++.......+.++.|++|+.+|++.+|.||+-|.|||..+..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 35678888999999999999999999999987 58999999998888899999999999999999999999999998776
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.||+.+|+|-+|+.+++..+.+++....+.||+||++||.|||.++ |||||||..||++.+++.|||+||||+....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999988888999999999999999999999999 9999999999999999999999999987532
Q ss_pred CC--cccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc---cccCCCC
Q 004986 589 NT--FLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPK 660 (720)
Q Consensus 589 ~~--~~~~~s~~GT~~Y~APEvi~g---~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~---~~~~ip~ 660 (720)
.- ........|...|||||+++. .+|+..+|||||||++|||++|..||...+.++++-.+..+. .......
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 21 112223457889999999974 458999999999999999999999999777776664443331 1223445
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+++.++++|+..||.+++++||.+.+|+..|+.+.+
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 778899999999999999999999999998888866
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=376.38 Aligned_cols=263 Identities=33% Similarity=0.528 Sum_probs=216.0
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 503 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~ 503 (720)
+++..++|++.+.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+|+.+ +|||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 356778999999999999999999964 24679999886443 333456788999999999 899999999988
Q ss_pred ecCC-ceEEEEeecCCCCHHHHHcCCC-----------------------------------------------------
Q 004986 504 TRPP-NLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 529 (720)
Q Consensus 504 ~~~~-~l~LVmEy~~ggsL~d~L~~~~----------------------------------------------------- 529 (720)
...+ .+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 5899999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCC
Q 004986 530 --------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAG 599 (720)
Q Consensus 530 --------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~G 599 (720)
..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 24777888999999999999999998 9999999999999999999999999998653221 11223456
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 600 T~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............+..+++.+.+||.+||+.||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 788999999999999999999999999999996 9999987654333322222333445667889999999999999999
Q ss_pred CCCCCHHHHHHHHHhhhHh
Q 004986 679 SLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 679 ~kRPS~~ELL~~L~~i~~~ 697 (720)
.+||++.+|++.|+.+...
T Consensus 319 ~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 319 KERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=396.47 Aligned_cols=250 Identities=28% Similarity=0.483 Sum_probs=226.4
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
....|....+||+|+.|.||.++. +++.||||++....... ..-+.+|+.+|+..+|+|||++++.|...+.+|+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 346788889999999999999976 78889999997765433 44568999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
||||+||+|.|++... .++|.++..|+++++.||+|||.+| |||||||.+|||++.+|.+||+|||++..+.....
T Consensus 349 MEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999999764 5999999999999999999999998 99999999999999999999999999998877766
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~ip~~ls~~l~dLI~ 671 (720)
...+.+||+.|||||++....|+.++|||||||+++||+.|++||...++.+.+..|.... ..+..+..+++.+++|+.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 7788999999999999999999999999999999999999999999999888877776333 233567889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
+||+.|+.+|+++.|||+|
T Consensus 505 ~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcchhcCCCHHHHhcC
Confidence 9999999999999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=382.09 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=224.1
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEEC--CcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++++.||+|.-|+||+|+.. +..+|+|++.+.... ...+.+++.|..||+.++||+++.||..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 3466788999999999999999999885 478999999887554 4456778889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.|+|||||+||+|..++++ .+..+++..+..++.+++.||+|||..| ||+|||||+||||.++|+|.|+||.|+...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999976 4456999999999999999999999999 999999999999999999999999986421
Q ss_pred cC-----------------------------------C---------------------cccCCCCCCCCCccCcccccC
Q 004986 588 HN-----------------------------------T---------------------FLSSKSTAGTPEWMAPEVLRN 611 (720)
Q Consensus 588 ~~-----------------------------------~---------------------~~~~~s~~GT~~Y~APEvi~g 611 (720)
.. . .....+++||-+|+|||+|.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 011235689999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHH
Q 004986 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS----FAQL 687 (720)
Q Consensus 612 ~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS----~~EL 687 (720)
...+.++|||+|||++|||++|..||.+.+..+.+..|..+.....-...++..++|||+++|.+||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999999887665554444577899999999999999999988 6777
Q ss_pred HHH
Q 004986 688 TVA 690 (720)
Q Consensus 688 L~~ 690 (720)
.+|
T Consensus 390 K~H 392 (459)
T KOG0610|consen 390 KRH 392 (459)
T ss_pred hcC
Confidence 665
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=369.56 Aligned_cols=246 Identities=24% Similarity=0.413 Sum_probs=217.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.++++++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999999987 5889999998764332 233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999999764 36899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....++..++..+++||.+|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--GKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCcCCCccCCHHHHHHHHHH
Confidence 2345799999999999999999999999999999999999999999888777766643 34567778899999999999
Q ss_pred hhcCCCCCCC-----HHHHHHH
Q 004986 674 WQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS-----~~ELL~~ 690 (720)
|+.||.+|++ +.++++|
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcC
Confidence 9999999995 9998887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=379.75 Aligned_cols=258 Identities=31% Similarity=0.517 Sum_probs=220.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC--ceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~--~l~LV 512 (720)
.+|..++.||+|+||+||++.. +++..|||.+...... ....+.+|+.+|++++|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4577788999999999999987 4799999988766322 2667889999999999999999999855544 59999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEeccccccccC--
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN-- 589 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~~~~-- 589 (720)
|||+++|+|.+++.+.+..+++..+..++.||++||+|||++| ||||||||+||||+. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999886657999999999999999999999998 999999999999999 79999999999987653
Q ss_pred -CcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 -TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 -~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.........||+.|||||++..+ ....++|||||||++.||++|..||.. .......-.+......+.+|..++.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 12224457899999999999953 344599999999999999999999988 455555555655555568999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
++||.+||.++|.+|||+.+++.|.--.....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999986655444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=390.34 Aligned_cols=263 Identities=36% Similarity=0.619 Sum_probs=233.9
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEECCc-EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~-~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+++..+.+..++.||+|-||.|++|.+++. .||+|.++..... ...|.+|+++|++|+|+|||+|+++|..++.
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 34567778888999999999999999999776 8999998876444 3577899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+|||||||+.|+|.++|+. .+..+...+.+.++.||++||+||++++ +|||||-+.||||+++..+||+|||||+..
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999999986 5667999999999999999999999999 999999999999999999999999999966
Q ss_pred cCCcccC-CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 588 HNTFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 588 ~~~~~~~-~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.+..... ....-...|.|||.+...+++.|+|||||||+||||++ |+.||.++...+++..+. ...+..-|..++++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDE 432 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHH
Confidence 5544322 22233568999999999999999999999999999987 899999999999998886 45577788999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
+.+++..||+.+|++||||+.+...|+.+...-
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 999999999999999999999999998886543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=374.04 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=219.6
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 4568999999999999999999987 578999999876532 2234566889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+.+++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999999764 36888999999999999999999998 999999999999999999999999999865432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..++..+++||
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLV 246 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHH
Confidence 234679999999999999999999999999999999999999999988877776664 335567788999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 004986 671 WECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
.+||+.||.+|++ +++++.|
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999986 7888866
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=372.80 Aligned_cols=243 Identities=24% Similarity=0.417 Sum_probs=213.1
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 688999999876532 2334566788999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 599 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~G 599 (720)
+|.+++.+. ..+++.++..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999998764 36899999999999999999999998 999999999999999999999999999754333333445689
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 004986 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 679 (720)
Q Consensus 600 T~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~ 679 (720)
|+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.. ....++..++.++++||.+||++||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999999999999999999998887777666643 34567788999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 004986 680 LRP-----SFAQLTVA 690 (720)
Q Consensus 680 kRP-----S~~ELL~~ 690 (720)
+|| ++.++++|
T Consensus 236 ~R~~~~~~~~~~ll~h 251 (323)
T cd05571 236 QRLGGGPEDAKEIMEH 251 (323)
T ss_pred HcCCCCCCCHHHHHcC
Confidence 999 79999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=361.15 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=216.9
Q ss_pred EEeeecCcEEEEEEEECCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCceEEEEeecC
Q 004986 443 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLP 517 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~----~~~l~LVmEy~~ 517 (720)
..||+|++|.||+|+++++.||||.+....... .....+.+|+.+|++++|||||++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999999999999999987654333 234678899999999999999999999876 346899999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCC
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s 596 (720)
+|+|.+++.+. ..+++...+.++.|++.||.|||.. + ++||||||+|||+++++.+||+|||+++..... ...
T Consensus 106 ~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~ 179 (283)
T PHA02988 106 RGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFK 179 (283)
T ss_pred CCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhccc---ccc
Confidence 99999999764 3688999999999999999999985 6 889999999999999999999999999865432 123
Q ss_pred CCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 597 TAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 597 ~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
..|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..++...+.....++.++..++..+++|+.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 578999999999976 678999999999999999999999999988877777665455566677788999999999999
Q ss_pred hcCCCCCCCHHHHHHHHHhhhH
Q 004986 675 QTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+.||.+||++.+++..|+.++.
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999998764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=370.20 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=231.3
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
.-.+.+++|..+++||+|.||+|.+|+. +++.||||+++++.. ..........|-++|+..+||++..|...|+..+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 3457889999999999999999999976 799999999988754 4455667788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+|+||||..||.|+.+|.+. ..+++.....+..+|+.||.|||+.+ ||+||||.+|+|+|++|+|||+|||+++..
T Consensus 242 rlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred eEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999999999999875 46888888899999999999999998 999999999999999999999999999977
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
........++|||+.|+|||++....|+.++|||.+|+++|||+||+.||+..+...++..|.. ....+|..++++++
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr~ls~eAk 396 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--EDLKFPRTLSPEAK 396 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh--hhccCCccCCHHHH
Confidence 6666777889999999999999999999999999999999999999999999999999988854 36678999999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHH
Q 004986 668 RIIWECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
.|+..+|.+||.+|. ++.||.+|
T Consensus 397 tLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 999999999999995 46666654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=384.04 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=215.8
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCC-c
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP-N 508 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~-~ 508 (720)
.+.+++|.++++||.|+||.||+|+. ++..||||++++....-+ ...-.+|++.|++|. |||||+|.+++.+.+ .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 34568899999999999999999976 788999999987765532 233468999999997 999999999999988 8
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||||+. +|+++++.++..+++..++.|+.||++||+|+|++| +.||||||||||+.....|||+|||+|+.+.
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccc
Confidence 9999999965 899999888889999999999999999999999999 9999999999999988899999999999775
Q ss_pred CCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 655 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~------------ 655 (720)
.. ..-+.++.|++|+|||++. ...|+.++|||++||+++|+.+-++.|.+.+..+.+.+|....+.
T Consensus 162 Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred cC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 43 2345578999999999874 667899999999999999999999999998776554333210000
Q ss_pred -----cC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 656 -----LE-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 656 -----~~-----------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
+. +-...+.++.+||.+||.+||.+|||+.|.+++-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00 1134788999999999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.72 Aligned_cols=270 Identities=23% Similarity=0.311 Sum_probs=227.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|...++||+|.||.||+|++ +|+.||||+++..+..+.......+|+++|+.++|+||+.++++|-+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999987 79999999999887766666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|++ .+|...++.....++..++..|+.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+|+.+.......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 995 5999999988889999999999999999999999999 9999999999999999999999999999988776665
Q ss_pred CCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc------cc---C-------
Q 004986 595 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------RL---E------- 657 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------~~---~------- 657 (720)
...+-|.+|+|||.+.|.+ |+..+||||.||++.||+-|.+-|.+.++-+.+..|-..-. ++ .
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 6568899999999999854 89999999999999999999998988776655433310000 00 0
Q ss_pred ----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCCCCCCC
Q 004986 658 ----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 710 (720)
Q Consensus 658 ----------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~~~~~~ 710 (720)
+-...+.++.||+.+||..||.+|.++.|++++= -+.....|+.|...|.+.
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCcCCc
Confidence 1123466789999999999999999999998762 223355555554444433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=356.96 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=208.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|++.++||+|+||+||+|.+ +++.||+|++...... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 57899999999999999999977 6789999998654322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++ +|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 899988766556889999999999999999999998 999999999999999999999999999865433333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-----------------c
Q 004986 594 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------R 655 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-----------------~ 655 (720)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 344578999999999875 5689999999999999999999999988776554433211000 0
Q ss_pred c-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 L-----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ~-----------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. .....++.++++||.+||+.||.+|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0113467899999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=366.04 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=214.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4699999999999999999987 5789999998765332 233556889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 999999999999754 36889999999999999999999998 99999999999999999999999999986543 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC------CCCcHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP------KELDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip------~~ls~~l~ 667 (720)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........+ ..++.++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345679999999999999999999999999999999999999999888777665554222222222 25689999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||..+|.+||++.+++++
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=380.32 Aligned_cols=252 Identities=26% Similarity=0.354 Sum_probs=218.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSI 511 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~L 511 (720)
.+.|+.++.||+|+||.||+|++ +|+.||+|+++.....+.......+||.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 46789999999999999999987 789999999998887777777888999999999999999999998776 67999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+|||+. +|.-++....-.|++.++..|+.||+.||+|||.+| |+|||||..|||||.+|.+||+|||||+++....
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9999965 899999888888999999999999999999999999 9999999999999999999999999999765443
Q ss_pred c-cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------ccCCC--
Q 004986 592 L-SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------RLEIP-- 659 (720)
Q Consensus 592 ~-~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~--------~~~ip-- 659 (720)
. ..+..+-|++|.|||.+.|. .|+.++|+||.||||.||+.|++.|.+.+..+.+..|-.... ...+|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 2 34556789999999999986 499999999999999999999999999887766655421000 00111
Q ss_pred -----------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 -----------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 -----------------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++....+|+..||..||.+|.|+.+++..
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 3567889999999999999999999998764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.63 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=211.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|++ +++.||||++..... .......+.+|+.++.+++|+||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999987 678999999976433 2233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-- 591 (720)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999764 36899999999999999999999998 9999999999999999999999999987543210
Q ss_pred ---------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004986 592 ---------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 638 (720)
Q Consensus 592 ---------------------------------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~ 638 (720)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00124579999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 004986 639 GMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPS---LRPSFAQLTVA 690 (720)
Q Consensus 639 ~~~~~~i~~~i~~~~~~~~ip~--~ls~~l~dLI~~cL~~DP~---kRPS~~ELL~~ 690 (720)
+.+..+....+........+|. .+++++++||.+|+. +|. .||+++||++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9888777766653333334443 468899999999765 444 46899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=365.06 Aligned_cols=243 Identities=24% Similarity=0.420 Sum_probs=211.5
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
+.||+|+||.||+++. +++.||+|++..... .......+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999986 688999999876532 2334566778999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 599 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~G 599 (720)
+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 9999886643 6899999999999999999999998 999999999999999999999999998754333233345679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 004986 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 679 (720)
Q Consensus 600 T~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~ 679 (720)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. ....+|..+++++++||.+||++||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 9999999999999999999999999999999999999998887776666532 24456788999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 004986 680 LRP-----SFAQLTVA 690 (720)
Q Consensus 680 kRP-----S~~ELL~~ 690 (720)
+|+ ++.++++|
T Consensus 236 ~R~~~~~~~~~~~l~h 251 (323)
T cd05595 236 QRLGGGPSDAKEVMEH 251 (323)
T ss_pred HhCCCCCCCHHHHHcC
Confidence 998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.11 Aligned_cols=241 Identities=24% Similarity=0.382 Sum_probs=210.2
Q ss_pred eeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 445 LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
||+|+||.||+|++ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999987 578899999876432 333456778899999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCC
Q 004986 522 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 601 (720)
Q Consensus 522 ~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~ 601 (720)
.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 9999764 36899999999999999999999998 99999999999999999999999999986443333344567999
Q ss_pred CccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 004986 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 681 (720)
Q Consensus 602 ~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kR 681 (720)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....++..+++++++||.+||..||.+|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999999999999999999999999999999888777766653 33556778899999999999999999999
Q ss_pred CC---HHHHHHH
Q 004986 682 PS---FAQLTVA 690 (720)
Q Consensus 682 PS---~~ELL~~ 690 (720)
|+ +.+++.|
T Consensus 236 ~~~~~~~e~l~h 247 (312)
T cd05585 236 LGYNGAQEIKNH 247 (312)
T ss_pred CCCCCHHHHHcC
Confidence 75 6676654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=371.02 Aligned_cols=248 Identities=25% Similarity=0.457 Sum_probs=224.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.+|++.+.||+|.||+|-+++. .|+.||||.|++..+. ++.+..+.+||+||..|+||||+++|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5799999999999999999965 7999999999887664 456788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||..+|+|+||+.+++ .+++.++..|++||+.|+.|+|+++ ++|||||.+|||+|.++++||+||||+.++.+. ..
T Consensus 133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 9999999999998764 7999999999999999999999998 999999999999999999999999999988665 44
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
..++||++-|.+||++.|.+| +..+|-|||||+||.|+.|..||.+.+...++..|..+..+. +.-+..+.-||.+
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRw 285 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIRW 285 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHHH
Confidence 577999999999999999998 678999999999999999999999999998888885433222 3345678999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~L 691 (720)
||..+|++|.|+++|..|.
T Consensus 286 mLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHhcCcccchhHHHHhhhh
Confidence 9999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.70 Aligned_cols=257 Identities=25% Similarity=0.439 Sum_probs=219.5
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
+..++|++.+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.++++++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4567899999999999999999975 35679999887543 33445678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.++||||+++++|.+++.+....+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999775567899999999999999999999998 9999999999999999999999999876542
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 589 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+... .....+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHH
Confidence 221 11122345678999999999999999999999999999775 99999988877776665422 3445677889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+++.+||+.+|.+||++++|++.|.++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=367.96 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=216.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|++ +++.||||++....... .....+.+|+.++..++|+||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4799999999999999999987 48999999987654322 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-- 591 (720)
||+++++|.+++.+. ..+++..++.++.||+.||+|||.+| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999765 47899999999999999999999998 9999999999999999999999999998654432
Q ss_pred ---------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 004986 592 ---------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 644 (720)
Q Consensus 592 ---------------------------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~ 644 (720)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12334579999999999999999999999999999999999999999888776
Q ss_pred HHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 004986 645 VVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS-FAQLTVA 690 (720)
Q Consensus 645 i~~~i~~~~~~~~ip~--~ls~~l~dLI~~cL~~DP~kRPS-~~ELL~~ 690 (720)
....+........+|. .+++++.+||.+||. ||.+||+ +.+++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 6666543223333333 359999999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=353.90 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=228.6
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++++.||+|-||.||+|+. ++-.||+|++.+..+.. ....++.+|++|-..|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 346779999999999999999999976 57789999987765432 334578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.||++||..+|+|+..|.. ...++++...+.++.|++.||.|+|.++ ||||||||+|+|++.+|.+||+|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999999974 3346999999999999999999999998 999999999999999999999999999764
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
. .....+.|||..|++||+..+..++..+|+|++|++.||++.|.+||......+.+..|. ..+..+|..++.+++
T Consensus 175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGGAA 250 (281)
T ss_pred C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChhHH
Confidence 3 455678899999999999999999999999999999999999999999999888888885 446778899999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
|||.+||.++|.+|....|++.|
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHhccCccccccHHHHhhh
Confidence 99999999999999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.32 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=209.8
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
|++.+.||+|+||.||+|.+ +++.||||.+....... .....+.+|+.++++++|+||+++++++.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77899999999999999976 68999999987654332 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...... ...
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Cee
Confidence 999999988754 2346899999999999999999999998 999999999999999999999999999865432 222
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--ccccccCCCCCCcHHHHHHHHH
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~--~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
....||..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .......++..++.++.+||.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 34579999999999999999999999999999999999999998755432221111 1223345667889999999999
Q ss_pred hhhcCCCCCCC-----HHHHHHH
Q 004986 673 CWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS-----~~ELL~~ 690 (720)
||+.||.+||+ +++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999997 8899885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=365.71 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=212.5
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
+.||+|+||.||+++. +++.||||++..... .......+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 688999999976532 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 599 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~G 599 (720)
+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 999988664 36899999999999999999999998 999999999999999999999999999754333233345679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 004986 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 679 (720)
Q Consensus 600 T~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~ 679 (720)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....+|..++.++.+||.+||.+||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 999999999999999999999999999999999999999888777666553 234567788999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 004986 680 LRP-----SFAQLTVA 690 (720)
Q Consensus 680 kRP-----S~~ELL~~ 690 (720)
+|+ ++.|+++|
T Consensus 236 ~R~~~~~~~~~~il~h 251 (328)
T cd05593 236 KRLGGGPDDAKEIMRH 251 (328)
T ss_pred HcCCCCCCCHHHHhcC
Confidence 997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=368.40 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=219.2
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEEC---CcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~---g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
..+..++|++.+.||+|+||.||+|.+. +..||+|++..... .......+.+|+.+++.++|||||++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3456789999999999999999999762 35799999875432 2334567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999997643 6899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.. ....+|..++..++
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~ 256 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYFPKFLDNNCK 256 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHH
Confidence 432 2346799999999999999899999999999999999999999998887776666642 34456788999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHH
Q 004986 668 RIIWECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
+||.+||+.||.+|+ +++++++|
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999999999995 89999876
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.21 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=207.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999987 57889999997665444455677899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-c
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-~ 593 (720)
|++++.+..+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9998777665543 346899999999999999999999998 99999999999999999999999999987543221 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------------------c
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------R 654 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------------------~ 654 (720)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 234578999999999999889999999999999999999999998765543322111000 0
Q ss_pred cc-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 RL-----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ~~-----------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. .....++.++.+||.+||+.||++||+++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0112367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=374.40 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=217.8
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH------------HHHHHHHHHHHHHHcCCCceeEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVLF 499 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~------------~~~e~~~Ei~iL~~L~HpNIVkL 499 (720)
...++|++++.||+|.||.|.+|+. +++.||||++.+...... ..+.+.+||.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4568999999999999999999987 789999999876433211 13478899999999999999999
Q ss_pred eeeeecC--CceEEEEeecCCCCHHHHHcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcE
Q 004986 500 MGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 576 (720)
Q Consensus 500 ~g~~~~~--~~l~LVmEy~~ggsL~d~L~~~~~~-lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~I 576 (720)
+++..+. +.+|||+|||..|.+...-.. .. +++.++++|+++++.||+|||.+| ||||||||.|+||+.+|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcE
Confidence 9999875 469999999999887765332 23 899999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccC-----CcccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHh
Q 004986 577 KVSDFGLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 647 (720)
Q Consensus 577 KL~DFGlAk~~~~-----~~~~~~s~~GT~~Y~APEvi~g~~----~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~ 647 (720)
||+|||.+..... ........+||+.|+|||...++. .+.+.|||||||+||.|+.|+.||.+....++++
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 9999999886522 112223468999999999987733 3678999999999999999999999999999999
Q ss_pred hhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 648 AVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 648 ~i~~~~~~~~ip~--~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+|.. .++.+|. .+.+++++||.+||.+||++|.++.+|..|.-....
T Consensus 330 KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhc--CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9954 4555554 479999999999999999999999999988755543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=367.88 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=213.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|++ +++.||||++..... .......+.+|+.+|+.++|+||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 688999999976532 2234556788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999987643 6899999999999999999999998 99999999999999999999999999875422110
Q ss_pred -------------------------------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004986 593 -------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 635 (720)
Q Consensus 593 -------------------------------------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~ 635 (720)
.....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 1113469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 004986 636 PWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 690 (720)
Q Consensus 636 PF~~~~~~~i~~~i~~~~~~~~ip~--~ls~~l~dLI~~cL~~DP~kRPS---~~ELL~~ 690 (720)
||...+..+....+........++. .+++++++||.+||. +|.+|++ +.|++.|
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999887776665543333333333 468999999999996 9999997 9998885
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.33 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=211.0
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHH---HHcCCCceeEEeeeeecCCceEEE
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIM---RRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL---~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999987 688999999976532 222345566676665 456899999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|..++.+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999998865 35899999999999999999999998 99999999999999999999999999875433333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. ....++..++..+.+||.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRFLSREAISIMRR 234 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHH
Confidence 34456899999999999999999999999999999999999999998888777766643 2445677899999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHH
Q 004986 673 CWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRP-----S~~ELL~~ 690 (720)
||+.||.+|| ++.+++++
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhC
Confidence 9999999999 57777775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=378.82 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=224.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
..|...++||+|.||.||+|.+ +++.||+|++..+... ....++.+|+.+|.+++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4577779999999999999987 7889999999776543 356788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
||.||++.+.+.... .+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.......
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999997643 4588888889999999999999998 9999999999999999999999999999888777777
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
.+++||+.|||||++.+..|+.|+|||||||+.+||.+|.+||.+..+...+..|. ...++.+...+++.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHh
Confidence 88999999999999999999999999999999999999999999999977766664 33455566689999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
++||+.||++.++++|
T Consensus 248 ~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKH 263 (467)
T ss_pred hcCcccCcCHHHHhhh
Confidence 9999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.40 Aligned_cols=257 Identities=30% Similarity=0.436 Sum_probs=221.3
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
..+.++.++|++.++||.|..++||+|+. ++..||||++..+..... +..+.+|++.|+.++|||||+++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34566778999999999999999999987 789999999988776654 788999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 508 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
.+|+||.||.+|++.+++.. ....++|..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999999964 3345999999999999999999999999 99999999999999999999999998765
Q ss_pred ccCCcccC----CCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc----
Q 004986 587 KHNTFLSS----KSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---- 656 (720)
Q Consensus 587 ~~~~~~~~----~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~---- 656 (720)
+.+..... .+++||+.|||||++.. ..|+.|+|||||||+.+||.+|..||....+.+++-... ++.++
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccc
Confidence 44332211 56799999999999653 468999999999999999999999999999888764332 22222
Q ss_pred -C----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 -E----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 -~----ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ....++..++.+|..||.+||++||++.+++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1 113467789999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=352.26 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=210.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC------------------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~------------------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN 495 (720)
+..++|++.++||+|+||.||+|.+. +..||+|.+.... ......++.+|+.+|.+++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 45578999999999999999999742 3369999886543 3445667899999999999999
Q ss_pred eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 004986 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH------------------CQVDEKRRIKMALDVARGMNCLHTSTPT 557 (720)
Q Consensus 496 IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~ 557 (720)
|+++++++.+.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999985421 23677888999999999999999998
Q ss_pred EEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--C
Q 004986 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--L 633 (720)
Q Consensus 558 IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt--G 633 (720)
|+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999998653321 11223456789999999999899999999999999999986 6
Q ss_pred CCCCCCCChHHHHhhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 634 KLPWIGMNPMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 634 ~~PF~~~~~~~i~~~i~~------~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
..||...+..+....+.. .......+..++..+.+||.+||..||.+||++.+|.+.|+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 688887766655443321 01112345567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.95 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=213.2
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCC-CceeEEeeeeecCCceEEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~H-pNIVkL~g~~~~~~~l~LVm 513 (720)
+|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|+.++..+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999987 567899999876532 23345667889999999965 56889999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999998654 36889999999999999999999998 999999999999999999999999998754332233
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....++..++.++.+||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999888877776664 334567788999999999999
Q ss_pred hhcCCCCCCCH-----HHHHHH
Q 004986 674 WQTDPSLRPSF-----AQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~-----~ELL~~ 690 (720)
|++||.+|++. +++++|
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999976 676655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=357.30 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=212.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+..++|++.+.||+|+||.||++++ ++..||+|.+.... .......+.+|+++|++++||||+++++++.+.+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4568999999999999999999987 57889999886542 34455678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999999997643 6889999999999999999999853 3999999999999999999999999999765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------------
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------- 651 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-------------------- 651 (720)
......||..|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 22345799999999999999999999999999999999999999976655443221110
Q ss_pred -------------------------cccccCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 652 -------------------------QNRRLEI-PKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 652 -------------------------~~~~~~i-p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
....... ...++.++++||.+||++||++||++.+++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0001111 124678999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=363.99 Aligned_cols=243 Identities=24% Similarity=0.414 Sum_probs=211.4
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
+.||+|+||.||++++ +++.||+|++..... .......+..|+++++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 688999999976533 2234556778999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
+|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999988664 368999999999999999999997 67 99999999999999999999999999875433323334567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..+++++.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999888777766653 33455778899999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 004986 679 SLRP-----SFAQLTVA 690 (720)
Q Consensus 679 ~kRP-----S~~ELL~~ 690 (720)
.+|+ ++.++++|
T Consensus 236 ~~R~~~~~~~~~~il~h 252 (325)
T cd05594 236 KQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhCCCCCCCHHHHhcC
Confidence 9996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=367.38 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=211.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++++.||+|+||+||++.+ +++.||||++..... .......+.+|+.++++++|||||+++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999977 788999999876432 3334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999754 46889999999999999999999998 99999999999999999999999999863211000
Q ss_pred ----------------------------------------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHH
Q 004986 593 ----------------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVI 626 (720)
Q Consensus 593 ----------------------------------------------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGil 626 (720)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0013579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 004986 627 LWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLR---PSFAQLTVA 690 (720)
Q Consensus 627 LyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~--~ls~~l~dLI~~cL~~DP~kR---PS~~ELL~~ 690 (720)
+|||++|..||...+..+....+........+|. .++.++++||.+||. +|.+| +++.+++.|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999998877666655543333344443 578999999999997 77765 599999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.57 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=210.6
Q ss_pred EEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 443 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+.||+|+||.||+++. .++.||||++...... ......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 5788999998764321 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|.+++.+.+ .+.+..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999997643 6788888899999999999999998 99999999999999999999999999975433333334
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~ 675 (720)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....++..+++.+.+||.+||+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--GKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHcc
Confidence 56799999999999998899999999999999999999999998887776666642 3456778899999999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 004986 676 TDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 676 ~DP~kRP-----S~~ELL~~ 690 (720)
++|.+|| ++.+++.+
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcC
Confidence 9999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=368.00 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=210.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.+++.++|+|||++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999987 678999999976543 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc---
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--- 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--- 591 (720)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||..+ |+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999997643 6889999999999999999999998 9999999999999999999999999975321000
Q ss_pred --------------------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHH
Q 004986 592 --------------------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 627 (720)
Q Consensus 592 --------------------------------------------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilL 627 (720)
....+.+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 004986 628 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQ--TDPSLRPSFAQLTVA 690 (720)
Q Consensus 628 yELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~--~ls~~l~dLI~~cL~--~DP~kRPS~~ELL~~ 690 (720)
|||++|..||...+..+....+........++. .+++++++||.+|+. .++..|+++.+++.|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999998777665555543233333333 579999999999554 555569999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.94 Aligned_cols=248 Identities=21% Similarity=0.360 Sum_probs=213.2
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|..++..+ +|++|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999987 567899999876532 222344567788888877 6899999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998654 36899999999999999999999998 999999999999999999999999999754333333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ....+|..++.++.+|+.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHH
Confidence 4456899999999999999999999999999999999999999999888777776643 34567788999999999999
Q ss_pred hhcCCCCCCCH-----HHHHHH
Q 004986 674 WQTDPSLRPSF-----AQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~-----~ELL~~ 690 (720)
|+++|.+|++. .+++.+
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhcC
Confidence 99999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=347.16 Aligned_cols=257 Identities=31% Similarity=0.574 Sum_probs=219.4
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECC-------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g-------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+..++|++.+.||+|+||.||+|...+ ..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 445789999999999999999997632 569999876443 334456789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd 571 (720)
...+++|||+++++|.+++.... ..+++..++.++.||+.||.|||..+ |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 99999999999999999986431 35788899999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 004986 572 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 648 (720)
Q Consensus 572 ~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~ 648 (720)
+++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653322 11233457889999999998889999999999999999997 9999999888777766
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+... .....+..++.++.+|+.+||+.||.+||++.||+++|+.+
T Consensus 239 i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 6532 23456778999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=381.12 Aligned_cols=257 Identities=36% Similarity=0.635 Sum_probs=229.7
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
...++|.++...-++.||.|+.|.||+|+..++.||||+++.-. +.+|+-|++|+|+||+.|.|+|...-+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 34577888888889999999999999999999999999863211 357888999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|||||||..|-|..+|+.. +.+.......|..+|+.||.|||.+. |||||||.-||||..+..|||+|||.++...
T Consensus 187 yCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999999999764 47888999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
+. ....+++||..|||||+|+.++.++|+|||||||+||||+||..||.+.+...++-.+......+..|..+++.++=
T Consensus 264 ~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 264 DK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence 54 45567999999999999999999999999999999999999999999988776665555555667788999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
||++||+..|..||+|+|++.||+-....+
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 999999999999999999999998654433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.70 Aligned_cols=251 Identities=33% Similarity=0.555 Sum_probs=215.6
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+.++|++.+.||+|+||.||++++ .+..+|+|.+...... ...+.+|+.+|++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 447899999999999999999988 4558999987654433 356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999999765456899999999999999999999998 999999999999999999999999999865432221
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 594 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 594 -~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+... .....+...+..+.+|+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHH
Confidence 122345678999999998889999999999999999999 89999988877777666532 234456667889999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L 691 (720)
+||+.+|.+||++.++++.|
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHccCCcccCcCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=366.81 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=216.4
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~ 502 (720)
.+.+..++|++.+.||+|+||.||+|.+ ++..||||++..... ......+.+|+.+++.+ +|+|||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 3456678999999999999999999975 234799999875543 23456788999999999 89999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCC-----------------------------------------------------
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 529 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~----------------------------------------------------- 529 (720)
|.....+++||||+++|+|.+++.+..
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999985321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 530 ----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 530 ----------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
..+++.++++++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24678889999999999999999998 99999999999999999999999999976543211
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 593 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 593 -~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
......++..|+|||++.+..++.++|||||||++|||++ |..||.....................+..+++++++||
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1112345678999999999899999999999999999997 99999876554433333223334445667789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 671 WECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.+||+.||.+||++.+|++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=361.72 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=211.2
Q ss_pred EEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 443 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
+.||+|+||.||+++. +++.||+|++............+..|+.+|++++||||+++++++.+.+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 57899999998655444445567789999999999999999999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCC
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 597 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~ 597 (720)
+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999664 36899999999999999999999998 9999999999999999999999999998654443334456
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcC
Q 004986 598 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 677 (720)
Q Consensus 598 ~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~D 677 (720)
+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....++..+++.+.+||.+||+.|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 89999999999999889999999999999999999999999888777766653 2345677889999999999999999
Q ss_pred CCCCCC-----HHHHHHH
Q 004986 678 PSLRPS-----FAQLTVA 690 (720)
Q Consensus 678 P~kRPS-----~~ELL~~ 690 (720)
|.+||+ +.+++.+
T Consensus 237 P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 237 PANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HhHcCCCCCCCHHHHhCC
Confidence 999999 5555543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=351.34 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=202.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||+||+|+. +++.||||++....... ....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 7899999999999999999987 68899999987543221 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+. ++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 995 5788887665567899999999999999999999998 9999999999999999999999999997554333333
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcc-cc-----------------
Q 004986 595 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQ-NR----------------- 654 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~-~~----------------- 654 (720)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... +.+..+... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 44678999999999875 45889999999999999999999999875432 222111100 00
Q ss_pred -cc--CCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 -RL--EIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 -~~--~ip---------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ..+ ..++..+++||.+||+.||.+|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 000 1234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.93 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=214.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||++++ +++.||||++..... .......+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999987 688999999986543 2334566788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+++++|.+++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999876567999999999999999999999998 99999999999999999999999999986543221
Q ss_pred cCCCCCCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcH
Q 004986 593 SSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDP 664 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~------g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~~ls~ 664 (720)
......||+.|+|||++. +..++.++|||||||++|||++|..||...+.......+........++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223357999999999987 4567889999999999999999999999887776666554333233333 35789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+++||.+||+ +|.+||++.+++.|
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 99999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.90 Aligned_cols=243 Identities=24% Similarity=0.364 Sum_probs=209.6
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|++ +++.||||++.+... .......+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 578999999876432 223455667888888877 799999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999998764 36899999999999999999999998 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+. .....++..++.++++||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999988887777664 33455677899999999999999999
Q ss_pred CCCCCH------HHHHHH
Q 004986 679 SLRPSF------AQLTVA 690 (720)
Q Consensus 679 ~kRPS~------~ELL~~ 690 (720)
.+||++ ++++.|
T Consensus 236 ~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 236 TMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHCCCCCCCCCHHHHHcC
Confidence 999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=366.95 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=210.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|++++|+||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3799999999999999999987 688999999865432 2223456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC---
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--- 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~--- 590 (720)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999764 36888999999999999999999998 999999999999999999999999997532100
Q ss_pred ----------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHH
Q 004986 591 ----------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 630 (720)
Q Consensus 591 ----------------------------------------~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyEL 630 (720)
.......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 004986 631 ATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRP---SFAQLTVA 690 (720)
Q Consensus 631 ltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~~ls~~l~dLI~~cL~~DP~kRP---S~~ELL~~ 690 (720)
++|..||...+..+....+........++ ..+++++.+||.+|+ .+|.+|+ ++.+++.|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999888766655543222222232 367899999999977 5999999 89999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=366.17 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=217.9
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
...+..++|++.+.||+|+||.||++++ +++.||+|++...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4456778999999999999999999987 6889999998754322 223445778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999999998653 4788899999999999999999998 999999999999999999999999999865
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--
Q 004986 588 HNTF-LSSKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-- 660 (720)
Q Consensus 588 ~~~~-~~~~s~~GT~~Y~APEvi~g~----~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~-- 660 (720)
.... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+........++.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 4322 223456799999999998754 378899999999999999999999999887777666654333344444
Q ss_pred CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 004986 661 ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 690 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~k--RPS~~ELL~~ 690 (720)
.++.++++||.+||+.+|.+ |+++.+++.|
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57999999999999999988 9999999877
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=364.57 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=213.1
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 503 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~ 503 (720)
..+..++|++.+.||+|+||+||+|++ ++..||||++..... ......+.+|+.+|..+ +|||||+++++|
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 455667899999999999999999964 355799998865432 23345688999999999 899999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcCCC------------------------------------------------------
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHRPH------------------------------------------------------ 529 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~~~------------------------------------------------------ 529 (720)
.+.+..++||||+++|+|.+++.+..
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999985421
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 530 --------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 530 --------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 24678889999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 TFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 ~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....................+...+.++
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 346 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM 346 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence 221 1122345678999999999999999999999999999997 8999987654332222222222344556678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
++||.+||+.||.+||++.||++.|++
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=358.25 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=210.3
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3599999999999987 577899999876532 233445667888898876 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999988654 36889999999999999999999998 99999999999999999999999999976443333344567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. ....+|..++.++.+||.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhccCH
Confidence 99999999999999999999999999999999999999999888877776643 3345667789999999999999999
Q ss_pred CCCC-------CHHHHHHH
Q 004986 679 SLRP-------SFAQLTVA 690 (720)
Q Consensus 679 ~kRP-------S~~ELL~~ 690 (720)
.+|+ ++.+++++
T Consensus 236 ~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 236 NKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHcCCCCCCCCCHHHHhcC
Confidence 9999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=357.17 Aligned_cols=242 Identities=25% Similarity=0.423 Sum_probs=206.8
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 577899999876532 222344556677777655 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999998664 36899999999999999999999998 99999999999999999999999999986543333344568
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+. .....++..++.++.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988877776663 33556778899999999999999999
Q ss_pred CCCCCHH-HHHH
Q 004986 679 SLRPSFA-QLTV 689 (720)
Q Consensus 679 ~kRPS~~-ELL~ 689 (720)
.+||++. ++++
T Consensus 236 ~~R~~~~~~l~~ 247 (316)
T cd05592 236 TKRLGVDGDIRQ 247 (316)
T ss_pred HHcCCChHHHHc
Confidence 9999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.67 Aligned_cols=252 Identities=19% Similarity=0.326 Sum_probs=211.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||++++ +++.||+|++.+... .......+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999987 678899999875322 2233455788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999875557899999999999999999999998 99999999999999999999999999976543322
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC---CCcH
Q 004986 593 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK---ELDP 664 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g-----~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~---~ls~ 664 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....+..++. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2233579999999999876 4578899999999999999999999998887777666654333333443 4689
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSL--RPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~k--RPS~~ELL~~ 690 (720)
++++||.+||..++.+ |++++++++|
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999999866554 4689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=365.40 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=209.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.++++++|+|||++++.|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999987 678899999876432 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC----
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT---- 590 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~---- 590 (720)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999998764 36889999999999999999999998 999999999999999999999999997532100
Q ss_pred -------------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHH
Q 004986 591 -------------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 627 (720)
Q Consensus 591 -------------------------------------------~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilL 627 (720)
.......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 004986 628 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPS---FAQLTVA 690 (720)
Q Consensus 628 yELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~~ls~~l~dLI~~cL~~DP~kRPS---~~ELL~~ 690 (720)
|||++|+.||...++.+....+........+| ..+++++.+||.+|+ .+|.+|++ +.+++.|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999888776665554322233333 467899999999986 59999987 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=335.24 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=219.8
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||+|++ +++.|++|.+............+.+|+.++++++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 578899999999999999987 688999999887666666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999998763 457899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. .....++..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHc
Confidence 445789999999999999999999999999999999999999988877666655542 2233455578899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
+.+|++||++.+++++
T Consensus 238 ~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 238 TKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.01 Aligned_cols=256 Identities=30% Similarity=0.542 Sum_probs=218.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
.+..++|++.++||+|+||.||+|.. .+..||+|.+..... ....+.+|+.++++++|+||+++++.+.+.+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 46778999999999999999999987 567799998765332 24678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.+ ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999865 3346888999999999999999999998 999999999999999999999999999876443
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~-~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+... ........++.++.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYD 235 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 211 122346778999999998889999999999999999998 99999887776666655422 233444578899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
|+.+||+.+|++||+++++.+.|+++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=338.15 Aligned_cols=257 Identities=24% Similarity=0.449 Sum_probs=216.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||+|++ +++.||||.+.... ........+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6799999999999999999986 78999999886543 33444567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988742 3345889999999999999999999998 999999999999999999999999998866543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~--~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
........|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+.....+...+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3333345788999999999988899999999999999999999999976432 33444433222222223467789999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
|+.+||+.+|.+||++.++++.|++++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.38 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=228.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
-|.+.+.||+|.|..|-++++ +|..||||++.+..++......+.+|+++|+-++|||||+||++......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 477788999999999999987 999999999999998888888899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
-++|+|+||+-+....+.+..+.+|+.||+.|+.|+|+.. +|||||||+||++. +-|-|||+|||++..+... ...
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL 175 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL 175 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence 9999999999887778999999999999999999999998 99999999999886 5789999999999877544 556
Q ss_pred CCCCCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s-~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.+.||+..|-|||++.|..|+ +++||||||++||.|+||++||...++.+.+-.| ......+|..++.++++||..|
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHHHHH
Confidence 779999999999999998885 6899999999999999999999999998888777 5667889999999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|..||.+|.+.++|...
T Consensus 254 LvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVST 270 (864)
T ss_pred HhcCchhhccHHHHhcc
Confidence 99999999999998753
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=338.45 Aligned_cols=256 Identities=32% Similarity=0.531 Sum_probs=219.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
..++|++.+.||+|+||.||+|.+. ...||||.+.... ......++.+|+.++++++|+||+++++.+...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3478999999999999999999873 3478999876543 344466788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999999776567899999999999999999999998 99999999999999999999999999987642
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 TFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 ~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHH
Confidence 211 1222345678999999999899999999999999999997 9999988777776666642 22334556789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+|+.+||+.+|++||++.+|+++|.++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.51 Aligned_cols=271 Identities=22% Similarity=0.294 Sum_probs=219.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.|++.+.||+|+||+||++.+ +++.||||++........ ....+.+|+.++++++|+||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 378899999999999999987 688999999876543322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 515 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999888543 346899999999999999999999998 9999999999999999999999999998654322 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--ccccccCCCCCCcHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~--~~~~~~~ip~~ls~~l~dLI~ 671 (720)
.....|+..|+|||++.+..++.++|||||||++|||++|..||.+.+.......+. .......++..++..+++||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 234579999999999999899999999999999999999999998765533222221 122234456678999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHH--HHhh-hHhcCCCCCCCCCCCCC
Q 004986 672 ECWQTDPSLRP-----SFAQLTVA--LKPL-QRLVIPSHPDQPSSALP 711 (720)
Q Consensus 672 ~cL~~DP~kRP-----S~~ELL~~--L~~i-~~~~~p~~p~~~~~~~~ 711 (720)
+||+.||.+|| ++++++.+ +... .+.....+.++|-.+.|
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCCC
Confidence 99999999999 89999886 3321 22333455555555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.46 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=201.3
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----ceE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 510 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~-----~l~ 510 (720)
+|++.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999986 6889999998754333334557889999999999999999999875432 489
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+. ++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68999886543 6899999999999999999999998 999999999999999999999999999854322
Q ss_pred c---ccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------
Q 004986 591 F---LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 651 (720)
Q Consensus 591 ~---~~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-------------- 651 (720)
. .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234579999999999876 6789999999999999999999999987654332211100
Q ss_pred ------------cccccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 652 ------------QNRRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 652 ------------~~~~~~---ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...... ....+++.+.+||.+||+.||++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 112467889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=361.67 Aligned_cols=247 Identities=29% Similarity=0.408 Sum_probs=205.9
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
..++|++++.||+|+||+||+|++ +++.||||++.... .......+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 446788899999999999999987 58899999986543 334456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|.... ...+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 151 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999986532 3567788889999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHhhhhccccccCCCCCCcH
Q 004986 593 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g-----~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~---i~~~i~~~~~~~~ip~~ls~ 664 (720)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ....+. .......+..++.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 302 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASR 302 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCH
Confidence 3445689999999998843 334568999999999999999999997433222 222221 2234456678899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++++||.+||+.||.+||++.|+++|
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999987
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=357.09 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=207.4
Q ss_pred CeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 438 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
+|++.+.||+|+||+||+++. +++.||+|++.+.... ......+..|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999975 5788999998754321 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999998654 36899999999999999999999998 99999999999999999999999999986433
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCCc
Q 004986 590 TF-LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 590 ~~-~~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~~~~~ip~~ls 663 (720)
.. ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ..+...+ ......++..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 22 2233467999999999998754 78899999999999999999999965322 2222222 223455677899
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 004986 664 PLVARIIWECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
..+++||.+||+.||.+|| +++++++|
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=366.48 Aligned_cols=259 Identities=36% Similarity=0.552 Sum_probs=209.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEEC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-eEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~-l~LVmE 514 (720)
+.|.-...||+|+||.||+|... ++.||||++....... ..+|.+|+.+|.+++|||+|+|+|||.+.+. .+||||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 56777788999999999999884 5899999876654432 4569999999999999999999999999994 999999
Q ss_pred ecCCCCHHHHHcCCCC-CCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 515 FLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~-~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|+++|+|.++|+.... .++|.++++||.++|.||+|||.. .++|||||||+.|||||++++.||+|||+|+.......
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999987665 899999999999999999999995 44799999999999999999999999999976543111
Q ss_pred cCCCC-CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhh--ccc------cccCCC-
Q 004986 593 SSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVG--FQN------RRLEIP- 659 (720)
Q Consensus 593 ~~~s~-~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~---~~~i~~~i~--~~~------~~~~ip- 659 (720)
...+. .||.+|+|||.+..+..+.|+||||||++|.||++|+.+..... ...+..|.. ... ..+.+.
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE 312 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence 11222 89999999999999889999999999999999999998876432 112333221 111 111222
Q ss_pred CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 660 KELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 660 ~~ls-----~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
...+ ..+..+..+|++.+|.+||+|.||++.|+.+...
T Consensus 313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 2222 2367888899999999999999999999766554
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=355.51 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=206.7
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||.||+|++ +++.||+|++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3699999999999987 678999999876432 122344566788888765 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999998664 36889999999999999999999998 99999999999999999999999999875332223334568
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....++..++.++++||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccCCH
Confidence 99999999999999999999999999999999999999998888777766642 3455677899999999999999999
Q ss_pred CCCCCHH-HHHH
Q 004986 679 SLRPSFA-QLTV 689 (720)
Q Consensus 679 ~kRPS~~-ELL~ 689 (720)
.+|+++. +++.
T Consensus 236 ~~R~~~~~~~~~ 247 (316)
T cd05620 236 TRRLGVVGNIRG 247 (316)
T ss_pred HHcCCChHHHHc
Confidence 9999984 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=361.59 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=211.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|.+ +++.||||++..... .......+..|+.++..++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999987 688999999875432 2334567788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-- 591 (720)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999764 36899999999999999999999998 9999999999999999999999999987542210
Q ss_pred ---------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004986 592 ---------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 638 (720)
Q Consensus 592 ---------------------------------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~ 638 (720)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00124579999999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 004986 639 GMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 690 (720)
Q Consensus 639 ~~~~~~i~~~i~~~~~~~~ip~--~ls~~l~dLI~~cL~~DP~kRPS---~~ELL~~ 690 (720)
..+.......+........+|. .++.++++||.+|+ .+|.+|++ +.+++.|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9888777666643333333443 37899999999987 59999984 7777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=356.20 Aligned_cols=242 Identities=25% Similarity=0.405 Sum_probs=205.5
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~-iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|++ +++.||||++...... .....++..|.. +++.++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999987 6889999998764322 222344555554 45778999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999998764 36889999999999999999999998 99999999999999999999999999976433333344567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..++..+.+||.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999988777766664 23455667889999999999999999
Q ss_pred CCCCCHH----HHHH
Q 004986 679 SLRPSFA----QLTV 689 (720)
Q Consensus 679 ~kRPS~~----ELL~ 689 (720)
.+||++. +++.
T Consensus 236 ~~R~~~~~~~~~il~ 250 (323)
T cd05575 236 TKRLGAKDDFLEIKN 250 (323)
T ss_pred HhCCCCCCCHHHHHc
Confidence 9999874 5554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=372.70 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=221.5
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP- 507 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~- 507 (720)
..+...++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.++..++|+||+++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3445557999999999999999999976 7899999999887766667778899999999999999999988775432
Q ss_pred -------ceEEEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEE
Q 004986 508 -------NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 577 (720)
Q Consensus 508 -------~l~LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IK 577 (720)
.+++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEE
Confidence 26899999999999999854 2346899999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc
Q 004986 578 VSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 655 (720)
Q Consensus 578 L~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~ 655 (720)
|+|||+++.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+... ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~-~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG-RY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CC
Confidence 99999998654321 2234567999999999999999999999999999999999999999988877776665432 23
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++..+++++.+|+.+||+.||.+||++.+++.+
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 35678899999999999999999999999999875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.52 Aligned_cols=252 Identities=20% Similarity=0.342 Sum_probs=211.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||++++ +++.||+|++.+... .......+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999987 577899999865322 2223445788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc-c
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-L 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-~ 592 (720)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999875567899999999999999999999998 9999999999999999999999999987543322 2
Q ss_pred cCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC---CCCcH
Q 004986 593 SSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 664 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip---~~ls~ 664 (720)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3457889999999999999999999999988877776665433333333 35789
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSL--RPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~k--RPS~~ELL~~ 690 (720)
++++||.+||..++.+ |+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999765544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.88 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=212.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVm 513 (720)
+|++.+.||+|+||+||+|++ +++.||||++..... .......+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999987 688999999876432 2233456778888998885 678889999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++|+|.+++.+. ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999998664 36899999999999999999999998 999999999999999999999999999754333333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. ....+|..++.++.+|+.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHH
Confidence 4456799999999999999999999999999999999999999999888777766643 34566788999999999999
Q ss_pred hhcCCCCCCCH-----HHHHHH
Q 004986 674 WQTDPSLRPSF-----AQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~-----~ELL~~ 690 (720)
|+++|.+|++. +++++|
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcC
Confidence 99999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=340.27 Aligned_cols=256 Identities=29% Similarity=0.546 Sum_probs=217.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+.+++|++.+.||+|+||+||+|.+ .+..||+|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4568899999999999999999974 45689999887543 3344567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 004986 508 NLSIITEFLPRGSLFRILHRP----------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~----------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd 571 (720)
..|+||||+++++|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 999999999999999998532 124788889999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 004986 572 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 648 (720)
Q Consensus 572 ~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~ 648 (720)
.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653321 11233456778999999998889999999999999999998 9999988777666655
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
+.. ......+..++..+.+++.+||+.||.+||++.+|+++|+.
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 542 22345667889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=336.38 Aligned_cols=256 Identities=36% Similarity=0.623 Sum_probs=219.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++...+|.+.+.||+|+||.||+|.+ .++.||+|++.... ....++.+|+.++++++|+||+++++++.....++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45667899999999999999999976 58889999876543 23567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999998653 345889999999999999999999998 99999999999999999999999999986544
Q ss_pred CcccC-CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 590 TFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 590 ~~~~~-~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
..... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.. ......+..++.++.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHH
Confidence 32211 12234668999999999999999999999999999998 9999988777766655542 234456778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+||.+||+.+|++||++.++++.|+.+
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.65 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=202.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeee-----c
Q 004986 437 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 505 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L---~HpNIVkL~g~~~-----~ 505 (720)
++|++.+.||+|+||+||+|++ .++.||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4689999999999999999976 367899998876543333334556777777766 6999999999875 3
Q ss_pred CCceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 5899888653 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---------
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------- 655 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--------- 655 (720)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+......
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 865433 2234457999999999999989999999999999999999999999987765554443211000
Q ss_pred ----------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ----------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ----------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+...++..+++||.+||+.||++||++.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00123567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.12 Aligned_cols=243 Identities=23% Similarity=0.387 Sum_probs=210.2
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|++ +++.||||++.+... .......+..|+.+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 578899999976532 223355667888999888 799999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++.+. ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999998764 36899999999999999999999998 99999999999999999999999999875333323334467
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..++..+.+||.+||+.||
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888777766653 23455677899999999999999999
Q ss_pred CCCCCH-----HHHHHH
Q 004986 679 SLRPSF-----AQLTVA 690 (720)
Q Consensus 679 ~kRPS~-----~ELL~~ 690 (720)
.+||++ .+++.+
T Consensus 236 ~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 236 EKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.05 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=215.6
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++.+.||+|+||.||++++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 455668899999999999999999987 578899999875432 22334567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||+++|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999999653 5789999999999999999999998 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC--C
Q 004986 589 NTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--E 661 (720)
Q Consensus 589 ~~~-~~~~s~~GT~~Y~APEvi~g~~----~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~--~ 661 (720)
... ....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+........+|. .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 322 2234568999999999997643 78899999999999999999999998887777766654433444444 5
Q ss_pred CcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSL--RPSFAQLTVA 690 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~k--RPS~~ELL~~ 690 (720)
++..+++||.+||..++.+ |+++.|+++|
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 6899999999999855544 8899999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.89 Aligned_cols=255 Identities=33% Similarity=0.597 Sum_probs=220.8
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
...+|++.+.||.|+||.||+|.+ .+..+|+|.+..... .....+..|+.+++.++|+||+++++++.+...+++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 346799999999999999999987 568899998866543 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 514 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
||+++++|.+++.+. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999999753 346899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.. ..+...+..++..+.++|.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHH
Confidence 3334456778999999998889999999999999999998 8999988887777766652 2344566788999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhh
Q 004986 672 ECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+||+.||.+||++.++++.|+.+
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=356.49 Aligned_cols=239 Identities=25% Similarity=0.385 Sum_probs=202.4
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~-iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|++ +++.||+|++...... ......+..|.. +++.++|+||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 5778999998764322 122334444444 56778999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++.+. ..+.+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999999764 35788888899999999999999998 99999999999999999999999999976443333344568
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..++..+.+||.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999888877766663 23445667899999999999999999
Q ss_pred CCCCCHHH
Q 004986 679 SLRPSFAQ 686 (720)
Q Consensus 679 ~kRPS~~E 686 (720)
.+|+++.+
T Consensus 236 ~~R~~~~~ 243 (325)
T cd05602 236 TKRLGAKD 243 (325)
T ss_pred HHCCCCCC
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=352.27 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=208.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+..++|++.+.||+|+||.||++++ ++..+|+|++.... .......+.+|++++++++|+|||+++++|.+.+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4568899999999999999999987 57889999876543 34455678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999997643 588999999999999999999975 5 999999999999999999999999999765332
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--------------------
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------------------- 650 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~-------------------- 650 (720)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2234579999999999999889999999999999999999999997654433321110
Q ss_pred -----------------------ccccccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 651 -----------------------FQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 651 -----------------------~~~~~~~ip-~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.......++ ..++.++++||.+||++||.+||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000111111 1357889999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=341.32 Aligned_cols=259 Identities=30% Similarity=0.532 Sum_probs=220.5
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
|++++|.+.+.||+|+||+||++.. ++..+|+|.+.... ......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 5678999999999999999999974 23568889875432 33456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 574 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 574 (720)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999986422 24899999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhc
Q 004986 575 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 651 (720)
Q Consensus 575 ~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~ 651 (720)
.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999998553321 11223346788999999999999999999999999999998 9999988877776666643
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 652 ~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
. .....+..++..+.+|+.+||+.+|.+||++.+++..|+.+.+.
T Consensus 238 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 G-RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred C-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2 23345667889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=346.33 Aligned_cols=258 Identities=28% Similarity=0.494 Sum_probs=216.8
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
...+|++.+.||+|+||+||+|++ ++. .||||++.... ......++.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 447899999999999999999976 333 48999886432 334456788999999999999999999998764 5
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.++|+||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccccc
Confidence 78999999999999999876667889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 589 NTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~--~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....++...+. .......+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHH
Confidence 33221 122334678999999999999999999999999999997 999998877666554443 23344456678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+.+++.+||..+|.+||++.+++..|..+.+.
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 99999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=333.76 Aligned_cols=251 Identities=30% Similarity=0.489 Sum_probs=216.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH---HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~---~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+.|++.+.||+|+||.||+|.. +++.||+|.+....... .....+.+|+.++++++||||+++++++.+.+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999976 68999999887554322 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999998754 35889999999999999999999998 9999999999999999999999999997653321
Q ss_pred ccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 592 LSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 592 ~~~---~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+........++..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23568889999999999999999999999999999999999998876665555554444455677889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||.+||.++|.+||++.+++.+
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.05 Aligned_cols=256 Identities=33% Similarity=0.548 Sum_probs=218.4
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++..++|++.+.||+|+||.||+|.+ .++.||||.+...... ..++.+|+.++++++|+||+++++++...+.+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 45668899999999999999999987 5677999988655432 4568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999996543 46899999999999999999999998 999999999999999999999999999876532
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~-~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+.. ......+..++..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHH
Confidence 211 111223457999999999999999999999999999998 9999988877766665532 2234456678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
++.+||+.+|.+||++.+++..|+.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.50 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=206.5
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 577899999876532 122344566778888765 999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
|+|.+++.+. ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999754 36889999999999999999999998 99999999999999999999999999875433223334567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||..|+|||++.+..++.++|||||||++|||++|..||...+..+....+... ...++..++.++++||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCH
Confidence 999999999999999999999999999999999999999998887777666432 345667789999999999999999
Q ss_pred CCCCCHH-HHHH
Q 004986 679 SLRPSFA-QLTV 689 (720)
Q Consensus 679 ~kRPS~~-ELL~ 689 (720)
.+||++. +++.
T Consensus 236 ~~R~~~~~~l~~ 247 (316)
T cd05619 236 ERRLGVKGDIRQ 247 (316)
T ss_pred hhcCCChHHHHc
Confidence 9999997 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=370.91 Aligned_cols=252 Identities=24% Similarity=0.427 Sum_probs=231.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-eEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~-l~LV 512 (720)
+++|++++++|+|+||.++++++ .++.|++|++......+.......+|+.++++++|||||.+++.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 47899999999999999999976 67889999998887777667788999999999999999999999999998 9999
Q ss_pred EeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+||+||+|.+.+.+.+ ..++++.+..|+.||+.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999987644 67999999999999999999999888 9999999999999999999999999999987765
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
....+.+||+.||+||++.+.+|+.|+|||||||++|||++-+++|...+...+...|.... -..+|...+.+++.||.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence 56677899999999999999999999999999999999999999999999988887775333 45678899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
.||.++|..||++.+++.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999986
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.47 Aligned_cols=252 Identities=33% Similarity=0.550 Sum_probs=215.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEECC-cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+.++|++.+.||+|+||+||++++.+ ..+|||.+...... ..++.+|+.++++++||||+++++++.....+++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45789999999999999999998744 46999988755433 356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+.+++|.+++......+++.+++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999999765557899999999999999999999998 99999999999999999999999999886543221
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.. ..+...+...+..+++++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHH
Confidence 1112345678999999998889999999999999999998 9999988777666666543 2334455667899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L~ 692 (720)
+||+.+|.+||++.+|+..|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=351.18 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=210.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||+++. +++.||||++.+.. ........+.+|+.++..++|+||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 58899999987532 22334556788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999765567899999999999999999999998 99999999999999999999999999875543222
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC---CCCcH
Q 004986 593 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 664 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g-----~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip---~~ls~ 664 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+........++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223469999999999873 457889999999999999999999999887776666554333233333 34789
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSL--RPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~k--RPS~~ELL~~ 690 (720)
.+++||.+||..++.+ |+++.+++.|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999998754443 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.89 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=205.2
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||.||+|++ +++.||||++...... ......+..|+.++..+ +||||++++++|.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 6789999999865432 23455678899999998 799999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999988654 46999999999999999999999998 99999999999999999999999999975333223344568
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---------MQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~---------~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+ ......+|..++..+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999999999999999999963211 1122222 233456778899999999
Q ss_pred HHHhhhcCCCCCCC------HHHHHHH
Q 004986 670 IWECWQTDPSLRPS------FAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS------~~ELL~~ 690 (720)
|.+||+.||.+|++ +.+++.|
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999987 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.29 Aligned_cols=238 Identities=27% Similarity=0.402 Sum_probs=202.9
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~-iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||.||+|++ +++.||+|++.+.... ......+..|+. +++.++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 6789999998765332 223344555554 57888999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|..++.+. ..+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9999988654 36888999999999999999999998 99999999999999999999999999875433333344567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....++...+..+.++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999988777766663 33556777889999999999999999
Q ss_pred CCCCCHH
Q 004986 679 SLRPSFA 685 (720)
Q Consensus 679 ~kRPS~~ 685 (720)
.+|++..
T Consensus 236 ~~R~~~~ 242 (321)
T cd05603 236 RRRLGAK 242 (321)
T ss_pred hhcCCCC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.71 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=204.0
Q ss_pred eeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 445 LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
||+|+||+||++.+ +++.||+|++....... .....+..|+.+++.++|+||+++++++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999976 68899999987654322 2345677899999999999999999999999999999999999999
Q ss_pred HHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 522 FRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 522 ~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 988743 2346899999999999999999999998 99999999999999999999999999986554433344567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ......++..++..+.+|+.+||
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999764332 222222 22234566778999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 004986 675 QTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRP-----S~~ELL~~ 690 (720)
+.||.+|| ++++++.|
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.97 Aligned_cols=248 Identities=36% Similarity=0.634 Sum_probs=209.5
Q ss_pred eEeEEeeecCcEEEEEEEEC------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 440 VLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 440 ~i~k~LGkG~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++.+.||.|.||.||+|++. +..|+||.+.. ........++.+|++++++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999886 67899999854 334445788999999999999999999999999888899999
Q ss_pred eecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC--
Q 004986 514 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~-- 590 (720)
||+++|+|.+++... ...+++.+++.|+.||+.||.|||+++ |+|+||+++|||++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999775 567999999999999999999999998 999999999999999999999999999876221
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+. ...+...+..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-QGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-TTEETTSBTTSBHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccceeccchhHHHHHH
Confidence 112233456779999999999989999999999999999999 789999988888777774 444556777899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L 691 (720)
|.+||..+|.+||++.++++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=336.75 Aligned_cols=256 Identities=32% Similarity=0.547 Sum_probs=219.0
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
++..++|++.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 466789999999999999999999763 2679999876443 23345678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 576 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~---------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~I 576 (720)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 999999999999999999986421 24678889999999999999999998 9999999999999999999
Q ss_pred EEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc
Q 004986 577 KVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 577 KL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~ 653 (720)
||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cC
Confidence 999999998654322 12233457889999999998889999999999999999998 999999888777776665 33
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 654 ~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
....++..++..+.+||.+||+.+|.+||++.+++..|+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 445667788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=334.13 Aligned_cols=255 Identities=31% Similarity=0.559 Sum_probs=217.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++..++|++.++||+|+||.||+|.. +++.||+|.+...... ...+.+|+.++++++|+||+++++++. .+.+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 46678999999999999999999987 6788999998765543 356889999999999999999999874 467899
Q ss_pred EEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||+.+++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999999864 3346889999999999999999999998 999999999999999999999999999865522
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+.. ......+..++.++.+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELYE 234 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 2 12223356778999999998889999999999999999998 9999988877766655532 2234566778899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
||.+||+.+|++||++++++..|+.+
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHhhcC
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=362.32 Aligned_cols=265 Identities=32% Similarity=0.477 Sum_probs=218.6
Q ss_pred CccccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEE
Q 004986 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLF 499 (720)
Q Consensus 428 ~~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL 499 (720)
....++++.++|+++++||+|+||.||+|++. ...||||++.... .......+.+|+.+|+++. |||||++
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 33456777889999999999999999999762 2469999986543 3334567889999999995 9999999
Q ss_pred eeeeecCCceEEEEeecCCCCHHHHHcCCC--------------------------------------------------
Q 004986 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPH-------------------------------------------------- 529 (720)
Q Consensus 500 ~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~-------------------------------------------------- 529 (720)
++++.+...+|||||||++|+|.+++.+..
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 999999999999999999999999885421
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 004986 530 ---------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 564 (720)
Q Consensus 530 ---------------------------------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLK 564 (720)
..+++..++.++.||+.||+|||..+ |+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dik 264 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLA 264 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCC
Confidence 23677888899999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 004986 565 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 641 (720)
Q Consensus 565 PeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~ 641 (720)
|+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999999999998654321 12223457788999999999999999999999999999996 999998754
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 642 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 642 ~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.................+..++.++.+|+.+||+.+|++||++.+|.+.|+++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 433322222223344566788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=360.03 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=215.7
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
...+..++|++.+.||+|+||.||+|++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3456678999999999999999999987 678899999875432 2233455778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999999999753 4788899999999999999999998 999999999999999999999999999865
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--C
Q 004986 588 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 660 (720)
Q Consensus 588 ~~~~-~~~~s~~GT~~Y~APEvi~g~~----~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~ 660 (720)
.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+........++ .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 4322 2234567999999999997643 7889999999999999999999999988877777665433333333 4
Q ss_pred CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 004986 661 ELDPLVARIIWECWQTDPSL--RPSFAQLTVAL 691 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~k--RPS~~ELL~~L 691 (720)
.++..+++||.+||...+.+ |+++.++++|.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 68999999999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.17 Aligned_cols=263 Identities=32% Similarity=0.536 Sum_probs=221.4
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 500 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~ 500 (720)
.+++..++|.+.+.||+|+||.||++++. ...+|+|.+.... ......++.+|+.+++.+ +|+||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 45667789999999999999999999752 2469999887543 334456788899999999 899999999
Q ss_pred eeeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 501 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 501 g~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
+++...+.+++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+++ ++||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 99999999999999999999999996532 24788899999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~~--~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||...+.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999999765432111 112234578999999999989999999999999999998 8899988777
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.+....+.. ......+..++.++.+||.+||..+|.+||++.++++.|+++...
T Consensus 249 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 666655542 234456778899999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=338.34 Aligned_cols=256 Identities=30% Similarity=0.521 Sum_probs=217.3
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+..++|.+.+.||+|+||.||+|++. +..||||.+..... ......+.+|+++|+.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34577899999999999999999752 46799998865432 33457889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH-------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~-------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 573 (720)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 99999999999999999996432 34788899999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhh
Q 004986 574 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 650 (720)
Q Consensus 574 g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~ 650 (720)
+.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999997543221 11223356788999999999999999999999999999998 999998888777776665
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 651 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 651 ~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
. ......+..++..+++|+.+||..||.+||++.|+++.|++
T Consensus 239 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 Q-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 2 22334556789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=337.67 Aligned_cols=256 Identities=32% Similarity=0.539 Sum_probs=214.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+..++|++.+.||+|+||.||+|.+. +..||||++.... ......++.+|+.+++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45578999999999999999999753 3579999875433 223456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEE
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 577 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~---------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IK 577 (720)
...++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEE
Confidence 99999999999999999986422 23567788899999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccc
Q 004986 578 VSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 654 (720)
Q Consensus 578 L~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~ 654 (720)
|+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.. ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME-GG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CC
Confidence 999999875433221 1122345788999999999999999999999999999998 7899988877766655542 23
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 655 ~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
....+..++..+++||.+||+.+|.+||++.|+++.|++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 345667788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=334.40 Aligned_cols=251 Identities=33% Similarity=0.560 Sum_probs=214.1
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
...+|++.+.||+|+||.||++.+ .+..+|+|++...... ...+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 346788999999999999999987 4567999988654433 345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999999999765557899999999999999999999998 999999999999999999999999999865432211
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 594 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 594 -~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..++..+.+|+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHH
Confidence 111234568999999999999999999999999999998 8999988777766665542 2344566778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L 691 (720)
+||+.+|.+||++.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.50 Aligned_cols=251 Identities=33% Similarity=0.592 Sum_probs=215.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee-ecCCceEEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSII 512 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~-~~~~~l~LV 512 (720)
+.+++|++.+.||+|+||.||++...+..||+|.+.... ....+.+|+.++++++|+||+++++++ ......++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 566889999999999999999999999999999875432 245688999999999999999999975 455678999
Q ss_pred EeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|||+++++|.+++.+.. ..+++..++.++.||+.||+|||.++ |+||||||+||++++++.+||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999999987543 34788999999999999999999998 9999999999999999999999999987543321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.. ......+..+++.+.+||
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDVM 232 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence 23345678999999999889999999999999999997 9999988877776665542 234455677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 671 WECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+||+.+|.+||++.++++.|+.+
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 233 KQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.90 Aligned_cols=252 Identities=37% Similarity=0.629 Sum_probs=219.4
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+..++|++.+.||.|+||.||+|...++.||+|.+..... ...++.+|+.++++++|+||+++++++.+....++||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4567899999999999999999999999999999875532 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 514 EFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
||+++++|.+++.... ..+++..+..++.|++.||.|||.++ |+||||||+||+++.++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999999996543 36899999999999999999999998 9999999999999999999999999998663221
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..+++.+.+||.
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHHH
Confidence 12345678999999998889999999999999999997 9999988877766655532 2244556778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhh
Q 004986 672 ECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+||..+|.+||++.+++..|+.+
T Consensus 234 ~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 234 DCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHhccChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=353.29 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=204.1
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|++ +++.||+|++.+.... ......+.+|+.++.++ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 6788999999865332 33455677899998887 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|..++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999988654 36899999999999999999999998 99999999999999999999999999975433333344568
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------PMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~---------~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
||..|+|||++.+..++.++|||||||++|+|++|..||.... .......+ ......+|..++..+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999999999995311 11122222 233556788899999999
Q ss_pred HHHhhhcCCCCCCC------HHHHHHH
Q 004986 670 IWECWQTDPSLRPS------FAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS------~~ELL~~ 690 (720)
|.+||+.||.+||+ +.+++.|
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999998 5677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.55 Aligned_cols=253 Identities=28% Similarity=0.503 Sum_probs=214.7
Q ss_pred eeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-----
Q 004986 439 LVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 508 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~----- 508 (720)
|.+.+.||+|+||.||+|.+. +..||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999762 3679999988765555567788999999999999999999998766554
Q ss_pred -eEEEEeecCCCCHHHHHcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 509 -LSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 509 -l~LVmEy~~ggsL~d~L~~-----~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
.++||||+++++|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 7999999999999998843 2236889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCC
Q 004986 583 LSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 583 lAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip 659 (720)
+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-GNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 9986543221 1112345678999999998889999999999999999999 8999988887777766643 2345567
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 78999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.68 Aligned_cols=246 Identities=28% Similarity=0.475 Sum_probs=211.5
Q ss_pred EeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 444 RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
+||+|+||.||+|.+ ++..+|+|++...........++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 5678999998766555556678899999999999999999999875 45678999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc---CCC
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKS 596 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~---~~s 596 (720)
+|.+++.+. ..+++..++.++.|++.||+|||+++ |+||||||.|||++.++.+||+|||+++........ ...
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999654 36899999999999999999999998 999999999999999999999999999865433211 122
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 004986 597 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675 (720)
Q Consensus 597 ~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~ 675 (720)
..++..|+|||.+....++.++|||||||++|||++ |..||...+..+....+... .....+..++.++.+||.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHhc
Confidence 345679999999988889999999999999999997 99999988877777666533 3456778899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 004986 676 TDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 676 ~DP~kRPS~~ELL~~L~~i 694 (720)
.||.+||++.+|...|+++
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 237 YGVDERPGFAVVELRLRNY 255 (257)
T ss_pred cCchhCcCHHHHHHHHhcc
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.34 Aligned_cols=249 Identities=25% Similarity=0.418 Sum_probs=215.4
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||++++ ++..||+|.+..... ......+.+|+.+++.++|+||+++++.+.+.+.+++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999987 688999999865432 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||+++++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999998864 3345789999999999999999999998 9999999999999999999999999998665443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. .....++..++..+++||.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-GSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHH
Confidence 446789999999999999899999999999999999999999998777666555532 2233456778899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
+.||.+||++.+++..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=345.20 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=207.5
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.+++|++.+.||+|+||.||+|++ +++.||+|.+...... .....+.+|+.++++++|+||+++++++..++.+++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 357899999999999999999976 6788999998754322 2234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 999975 888888766566899999999999999999999998 99999999999999999999999999976544333
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------------c
Q 004986 593 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------R 654 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-----------------~ 654 (720)
......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3334578999999999875 458899999999999999999999998876544432221000 0
Q ss_pred cc-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 RL-----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ~~-----------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. .....++.++++||.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 0113468899999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.95 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=214.8
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-~~~l~LVmE 514 (720)
.|++.+.||+|+||.||++.+ +++.||+|++............+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999976 57889999987765555556678899999999999999999998764 445899999
Q ss_pred ecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 515 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+++++|.+++... ...+++.+++.++.|++.||++||+++ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999998653 345899999999999999999999998 999999999999999999999999999876543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+. .......+..+++.+.+||.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHH
Confidence 445678999999999999999999999999999999999999998877665554443 2223345677899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|+.+|.+||++.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 238 LSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hccCcccCCCHHHHhcC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=367.72 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=214.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--C-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
..|.+.+.||+|+||.||+|.. + +..||+|++.... ......+.+|+.+|+.++|||||+++++|...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4599999999999999999976 3 5678888764432 333456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999998753 2346889999999999999999999998 999999999999999999999999999876433
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.... ...++..++.++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCccCCHHHHH
Confidence 21 2345679999999999999999999999999999999999999999888777776665332 23456678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||.+||.+||.+||++.+++.+
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999998754
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.99 Aligned_cols=261 Identities=31% Similarity=0.555 Sum_probs=221.2
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~ 502 (720)
.+++..++|++.+.||+|+||.||++.+. ...+|+|.+.... ......++.+|+.+++++ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 35677789999999999999999999763 2578999887543 333456788999999999 89999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 567 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~---------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeN 567 (720)
+.....+++||||+++++|..++... ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999998532 346889999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 004986 568 LLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 644 (720)
Q Consensus 568 ILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~ 644 (720)
||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999986543221 1122335678999999999999999999999999999997 999999888777
Q ss_pred HHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 645 i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
....+... .....+..++..+.+|+.+||..+|.+||++.++++.|+.+.
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 66655432 344566778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=352.92 Aligned_cols=262 Identities=31% Similarity=0.506 Sum_probs=214.5
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 503 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~ 503 (720)
+++..++|++.+.||+|+||.||+|.+ +++.||+|++.... .......+..|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 456678999999999999999999964 24679999886543 233456678899999999 899999999987
Q ss_pred ec-CCceEEEEeecCCCCHHHHHcCCC-----------------------------------------------------
Q 004986 504 TR-PPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 529 (720)
Q Consensus 504 ~~-~~~l~LVmEy~~ggsL~d~L~~~~----------------------------------------------------- 529 (720)
.. +..++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 456889999999999999885321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCC
Q 004986 530 -------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGT 600 (720)
Q Consensus 530 -------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT 600 (720)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999998 9999999999999999999999999998653321 112234567
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 004986 601 PEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 679 (720)
Q Consensus 601 ~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~ 679 (720)
..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............+...++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999997 99999875543333222222234445667889999999999999999
Q ss_pred CCCCHHHHHHHHHhhhH
Q 004986 680 LRPSFAQLTVALKPLQR 696 (720)
Q Consensus 680 kRPS~~ELL~~L~~i~~ 696 (720)
+||++.|++++|+++..
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.64 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=203.6
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHH-HHHHcCCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~-iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|++ +++.||||++..... .......+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3599999999999987 688999999876432 2233445556655 46778999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9999988654 46899999999999999999999998 99999999999999999999999999975433333344567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+.. ....++...+..+.++|.+||+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccCH
Confidence 99999999999999999999999999999999999999999887777766643 2445566789999999999999999
Q ss_pred CCCCCHHH
Q 004986 679 SLRPSFAQ 686 (720)
Q Consensus 679 ~kRPS~~E 686 (720)
.+||++.+
T Consensus 236 ~~R~~~~~ 243 (325)
T cd05604 236 QRRLGAKE 243 (325)
T ss_pred HhcCCCCC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.20 Aligned_cols=258 Identities=32% Similarity=0.571 Sum_probs=215.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCc--EEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~--~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~ 510 (720)
|++|++.+.||+|+||.||+|.. ++. .+++|.++.. ........+.+|+.+++++ +||||+++++++.....++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57899999999999999999976 333 4688876532 2333456788999999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 004986 511 IITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 575 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 575 (720)
+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996432 24788999999999999999999998 999999999999999999
Q ss_pred EEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccc
Q 004986 576 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 654 (720)
Q Consensus 576 IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~ 654 (720)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||......+....+.. ..
T Consensus 158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 235 (297)
T ss_pred EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CC
Confidence 9999999986432211 1122233567999999999999999999999999999997 9999998887776665542 22
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 655 ~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
....+..++..+++||.+||+.+|.+||++.++++.|+.+....
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 34456778999999999999999999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=360.27 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=195.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC------CceeEEeeeee
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAVT 504 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H------pNIVkL~g~~~ 504 (720)
++..++|++.++||+|+||+||+|.+ +++.||||++.... ....++..|+.+++.++| .+|++++++|.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34567899999999999999999977 67889999986432 223445667777777754 45899999887
Q ss_pred cC-CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC--------
Q 004986 505 RP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW-------- 574 (720)
Q Consensus 505 ~~-~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g-------- 574 (720)
.. ..+|+|||++ +++|.+++.+. ..+++..+..|+.||+.||.|||. .+ ||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 65 4688999988 77888888654 468999999999999999999997 47 99999999999998765
Q ss_pred --------cEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 004986 575 --------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 646 (720)
Q Consensus 575 --------~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~ 646 (720)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998864322 234568999999999999999999999999999999999999999887654433
Q ss_pred hhhhccccc-------------------------cCC-C--------------CCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 004986 647 GAVGFQNRR-------------------------LEI-P--------------KELDPLVARIIWECWQTDPSLRPSFAQ 686 (720)
Q Consensus 647 ~~i~~~~~~-------------------------~~i-p--------------~~ls~~l~dLI~~cL~~DP~kRPS~~E 686 (720)
..+...... ... + ...++.+.+||.+||++||.+||+++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 222110000 000 0 012456789999999999999999999
Q ss_pred HHHH
Q 004986 687 LTVA 690 (720)
Q Consensus 687 LL~~ 690 (720)
+++|
T Consensus 435 ~L~H 438 (467)
T PTZ00284 435 MTTH 438 (467)
T ss_pred HhcC
Confidence 9985
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=329.62 Aligned_cols=256 Identities=25% Similarity=0.474 Sum_probs=216.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||+|.. +++.||+|.++.... .......+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6799999999999999999987 689999998875433 3334667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||+++++|..++.. ....+++.+++.++.+|+.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998853 3346899999999999999999999998 999999999999999999999999998865443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhhccccccCCCC-CCcHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPK-ELDPLVA 667 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~--~~~i~~~i~~~~~~~~ip~-~ls~~l~ 667 (720)
........|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....+.... ....+. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-YPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-CCCCChhhcCHHHH
Confidence 333344578999999999999889999999999999999999999996543 223333332221 223333 6788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
++|.+||..+|.+||++.+|++.|+.++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=359.77 Aligned_cols=249 Identities=30% Similarity=0.468 Sum_probs=222.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LV 512 (720)
+.|++.+.||+|.||.||+|+. +|+.+|+|.+.+..... .....+.+|++||+++. |||||+++++|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 6799999999999999999987 68999999998776533 24567899999999997 99999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC----CCcEEEEecccccccc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKH 588 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~----~g~IKL~DFGlAk~~~ 588 (720)
||+|.||.|++.+.+. .+++..+..++.|++.++.|||..| |+||||||+|+|+.. ++.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999998765 3999999999999999999999998 999999999999963 3579999999999876
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLV 666 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l 666 (720)
. .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+.........+....... .....++..+
T Consensus 191 ~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 191 P-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA 269 (382)
T ss_pred C-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence 6 455667899999999999999999999999999999999999999999998887777776444333 3345779999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++||..||..||.+|+++.++++|
T Consensus 270 kd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 270 KDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHhcccCcccCCCHHHHhcC
Confidence 999999999999999999999995
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.14 Aligned_cols=245 Identities=31% Similarity=0.548 Sum_probs=208.0
Q ss_pred EeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 444 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
.||+|+||.||+|++ +++.||+|.+.... .......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 599999999999977 78899999876443 344556788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC--CCCCC
Q 004986 522 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAG 599 (720)
Q Consensus 522 ~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~--~s~~G 599 (720)
.+++.+....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......... ....+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999765556899999999999999999999998 9999999999999999999999999987544321111 11123
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 600 T~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
+..|+|||.+.+..++.++||||||+++|||++ |..||...........+.. ......+..++..+.+|+.+||+.+|
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 457999999999889999999999999999997 8999987776655544432 23445667788999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 004986 679 SLRPSFAQLTVALK 692 (720)
Q Consensus 679 ~kRPS~~ELL~~L~ 692 (720)
.+||++.++++.|+
T Consensus 238 ~~Rps~~~~~~~l~ 251 (252)
T cd05084 238 GQRPSFSTVHQELQ 251 (252)
T ss_pred hhCcCHHHHHHHHh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=339.73 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=216.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
++..+|.+.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.++..++||||+++++++.+.
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45677889999999999999999762 4679999987543 333456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 004986 507 PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~---------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd 571 (720)
...++++||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 9999999999999999998421 134788888999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 004986 572 KNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 648 (720)
Q Consensus 572 ~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~ 648 (720)
+++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999886543221 1223356789999999998889999999999999999998 8899988888777776
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
+.... ....+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 239 i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 65332 334567899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=334.18 Aligned_cols=257 Identities=25% Similarity=0.463 Sum_probs=216.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||++.+ +++.||||.+..... ......++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999986 788999998876433 3334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998853 2346899999999999999999999998 999999999999999999999999998866443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~--~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
........|+..|+|||.+.+..++.++||||||+++|+|++|..||.+... ......+.........+..++..+++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 3333345789999999999998899999999999999999999999976443 23333332222222233467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
||.+||+.+|.+|||+.+|++.++++.
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=331.47 Aligned_cols=252 Identities=30% Similarity=0.506 Sum_probs=210.2
Q ss_pred eEeEEeeecCcEEEEEEEEC--Cc--EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cce
Q 004986 440 VLGERIGLGSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PNL 509 (720)
Q Consensus 440 ~i~k~LGkG~fG~Vyka~~~--g~--~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------~~l 509 (720)
.+++.||+|+||.||+|.+. +. .||+|.+............+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 46788999999999999873 32 589998876655556677889999999999999999999976432 247
Q ss_pred EEEEeecCCCCHHHHHcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 510 SIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~-----~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcc
Confidence 899999999999988732 2235789999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 004986 585 RLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 585 k~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ 661 (720)
+....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCC
Confidence 86543221 1122346778999999999999999999999999999999 89999887777766665432 23345667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
++..++++|.+||+.+|.+||++.+|++.|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.19 Aligned_cols=249 Identities=35% Similarity=0.518 Sum_probs=208.4
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|++++.||+|+||+||++++ +++.||+|++..............+|+.++++++|+||+++++++.+...+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999998 5668999999887655555555567999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCC
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s 596 (720)
++++|.+++.+ ...+++..++.++.||+.||.+||+++ |+|+||||+|||+++++.++|+|||++............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999973 346899999999999999999999998 999999999999999999999999999754333334455
Q ss_pred CCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHhhhhcccccc--CCCCCCcHHHHHHH
Q 004986 597 TAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRL--EIPKELDPLVARII 670 (720)
Q Consensus 597 ~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~---i~~~i~~~~~~~--~ip~~ls~~l~dLI 670 (720)
..++..|+|||++. +..++.++||||||+++|+|++|..||....... ............ .........+.+||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 67899999999998 8889999999999999999999999999873322 222221111111 11122348999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||+.||++||++.+++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.35 Aligned_cols=258 Identities=33% Similarity=0.530 Sum_probs=218.6
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
++..+|.+.+.||+|+||.||+|++ .+..+++|.+.... ......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567899999999999999999974 23458888875433 23346788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd 571 (720)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 99999999999999999986421 34788999999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 004986 572 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 648 (720)
Q Consensus 572 ~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~ 648 (720)
.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999997554322 11233457889999999999999999999999999999998 9999988877776665
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+.. ......+..++..+.+|+.+||+.+|.+||++.++++.|+.+.+
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 532 23334556778999999999999999999999999999999966
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.75 Aligned_cols=246 Identities=34% Similarity=0.595 Sum_probs=216.0
Q ss_pred EEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 443 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
+.||+|+||.||+|... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 35999999999999874 7789999987654433 56788899999999999999999999999999999999999
Q ss_pred CCCHHHHHcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 518 RGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 518 ggsL~d~L~~~--------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999775 467999999999999999999999998 99999999999999999999999999987654
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 TF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 ~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 22334568889999999998889999999999999999998 6999999887777776653 33556677889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.+++.+||+.+|.+||++.|++++|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.07 Aligned_cols=254 Identities=34% Similarity=0.578 Sum_probs=216.2
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++..++|++.+.||+|+||.||+|.. .+..+|+|.+...... ...+.+|+.++++++|+||+++++++. ....++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 45678899999999999999999986 5678999998765543 346889999999999999999999875 456899
Q ss_pred EEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999998653 345899999999999999999999998 999999999999999999999999999865433
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~-~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.. ......+...+..+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPISLHE 234 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHH
Confidence 211 122345678999999998889999999999999999999 8999988877776666542 2344566778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
|+.+||.++|.+||++.++.+.|+.
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.32 Aligned_cols=260 Identities=27% Similarity=0.473 Sum_probs=217.6
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+..++|++.+.||+|+||+||+|++ ++. .||+|.+.... ......++.+|+.+++.++|+||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 3457899999999999999999986 443 48999886543 33445678899999999999999999999875 4
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..+++|||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 578999999999999999776567899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 588 HNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 588 ~~~~~~--~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQPPICTI 238 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCCccCCH
Confidence 432211 112235678999999999999999999999999999998 9999988776666555442 233445667899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
.+.++|.+||+.||.+||++.+++..|+++.+..
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 9999999999999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=328.38 Aligned_cols=256 Identities=32% Similarity=0.570 Sum_probs=218.8
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++..++|++.+.||+|+||.||++.. .+..||||.+...... ..++.+|+.++++++|+||+++++++......++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 46678999999999999999999986 4577999988765443 4568899999999999999999999999899999
Q ss_pred EEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999997643 46899999999999999999999998 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+.. ......+...+.++++
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 1 11122335678999999999889999999999999999998 9999988777766666542 2234456677899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
++.+||+.+|.+||+++++++.|+.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.90 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=203.0
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
.++|++.+.||+|+||.||++.+ ++..||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999976 6889999998766544455667889999999999999999999986543
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999975 56666543 4788899999999999999999998 999999999999999999999999999764
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc----------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF---------------- 651 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~---------------- 651 (720)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 332 223345789999999999999999999999999999999999999987654332211100
Q ss_pred ----ccccc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 652 ----QNRRL--------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 652 ----~~~~~--------------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
..... ......+.++++||.+||+.||.+||++.|++.|-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000 01123467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=339.24 Aligned_cols=263 Identities=31% Similarity=0.530 Sum_probs=222.1
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE---------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 500 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~---------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~ 500 (720)
.+++..++|.+.+.||+|+||.||+|++ .+..||+|++.... ......++.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3567778999999999999999999974 23468999876442 334466788999999999 899999999
Q ss_pred eeeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 501 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 501 g~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
+++......++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999986531 24677888999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999986543221 1222346778999999999889999999999999999998 8899988877
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.++...+.. ......+..++..+++||.+||+.+|.+||++.++++.|+++...
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 777766642 234455678899999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=327.69 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=219.9
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||.++. ++..+++|.+...........++.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488999999999999998876 688999999887766666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+++++|.+++.+. ...+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 446899999999999999999999998 9999999999999999999999999998664433233
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
....|+..|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.... ....+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHc
Confidence 44678999999999998888999999999999999999999998887777666654332 23344678899999999999
Q ss_pred hcCCCCCCCHHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~L 691 (720)
+.+|.+||++.++++++
T Consensus 238 ~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 238 QQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCcccCCCHHHHhhCc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.11 Aligned_cols=251 Identities=29% Similarity=0.453 Sum_probs=208.1
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||.||+|++ +++.||+|++...... ....+.+|+.++++++|+||+++++.+...+.+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46799999999999999999986 6788999988654322 2446778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999998654 36899999999999999999999998 999999999999999999999999999866443333
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---cCCCCCCcHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~---~~ip~~ls~~l~ 667 (720)
.....|+..|+|||.+. ...++.++|||||||++|||++|..||....+.+....+...... ......++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 34457899999999985 344788999999999999999999999766544332222111111 112235678999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
+||.+||+.+|++||++++++++|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.99 Aligned_cols=255 Identities=30% Similarity=0.508 Sum_probs=216.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--C---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~---g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
..+|++.+.||+|+||.||+|++ + +..+|+|.+.... .......+.+|+.++++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46789999999999999999976 2 3368999876543 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++.+....+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999776567899999999999999999999998 999999999999999999999999999865432
Q ss_pred cccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 591 FLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 591 ~~~~---~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.... ....++..|+|||.+.+..++.++|+||||+++||+++ |..||......+....+... .....+..++..+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAAL 238 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHH
Confidence 2111 11233568999999999889999999999999999886 99999887776666655432 2334456778999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+|+.+||+.+|.+||++.++++.|+++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.71 Aligned_cols=263 Identities=31% Similarity=0.547 Sum_probs=221.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE---------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 501 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~---------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g 501 (720)
+++..++|.+.+.||+|+||.||+|+. ....+|+|++.... ......++..|+.+++++ +||||+++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 456678999999999999999999975 23468999876543 334466788999999999 6999999999
Q ss_pred eeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC
Q 004986 502 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 566 (720)
Q Consensus 502 ~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPe 566 (720)
++.+.+.+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 163 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAAR 163 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccce
Confidence 9999999999999999999999986421 34788889999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 004986 567 NLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 643 (720)
Q Consensus 567 NILLd~~g~IKL~DFGlAk~~~~~~~~--~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~ 643 (720)
|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999865432211 112234568999999999889999999999999999999 89999888877
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 644 ~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
+....+.. ......+..++.++.+||.+||+.+|.+||++.++++.|.++....
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 ELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 77666543 2334566788899999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=333.51 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=214.0
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
++..++|.+.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345678999999999999999999873 4568888765433 33345678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NV 576 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~I 576 (720)
....++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 999999999999999999986532 25889999999999999999999998 99999999999998654 59
Q ss_pred EEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc
Q 004986 577 KVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 577 KL~DFGlAk~~~~~~~~--~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~ 653 (720)
||+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999999865322111 112234568999999999999999999999999999996 999999877776665543 23
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 654 ~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.....+..++..+.+|+.+||+.+|++||++.+|+++|.
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 345567788999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.56 Aligned_cols=243 Identities=22% Similarity=0.369 Sum_probs=204.5
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||+||+|+. +++.||+|++...... ......+.+|+.++.++ +|+||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 6788999999865432 23456678899999888 699999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999988654 36899999999999999999999998 99999999999999999999999999975433323334568
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------h-HHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN------P-MQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~------~-~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... . ......+ ......+|..++..+.+||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~ 235 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIRIPRFLSVKASHVLK 235 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999996421 1 1222222 23345677889999999999
Q ss_pred HhhhcCCCCCCC------HHHHHHH
Q 004986 672 ECWQTDPSLRPS------FAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS------~~ELL~~ 690 (720)
+||+.||.+|++ +.+++.|
T Consensus 236 ~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 236 GFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999997 4577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.20 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=214.5
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..++|++.+.||+|+||+||+|.+ +++ .+++|.+... .......++..|+.++++++||||+++++++. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 347899999999999999999987 444 4677776432 22334567888999999999999999999875 456
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.++++||+++|+|.+++......+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 78999999999999999776667899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 589 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.......+.+. .......+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCHH
Confidence 3211 1223457789999999998899999999999999999998 999998887766555443 22344455667889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+.+++.+||..+|.+||++.|+++.|..+.+
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.23 Aligned_cols=259 Identities=32% Similarity=0.588 Sum_probs=215.4
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcE--EEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~--VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
+.+++|++.+.||+|+||.||+|.+ ++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 5678999999999999999999986 4443 577765432 2334456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 004986 509 LSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 573 (720)
+++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~ 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence 999999999999999996432 24788999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc
Q 004986 574 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 652 (720)
Q Consensus 574 g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~ 652 (720)
+.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~- 238 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ- 238 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-
Confidence 99999999998643221 11122334678999999998889999999999999999998 9999988777766655532
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 653 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 653 ~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
......+..++..+.+||.+||+.+|.+||++.+++..|+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 223345567889999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=328.48 Aligned_cols=257 Identities=30% Similarity=0.499 Sum_probs=216.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g---~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
|..++|+..+.||+|+||.||+|+. ++ ..+|+|++.... ......++..|+.++++++|+||+++++++.+.+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 4456889999999999999999976 23 368999876543 33345678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.++||||+++++|.+++.+....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999999765567899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCcccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 589 NTFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 589 ~~~~~~---~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
...... .....+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... .....+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~ 237 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPS 237 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCH
Confidence 322111 11223457999999998889999999999999999997 99999887777766666432 23344556789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+.+|+.+||+.+|.+||++.++++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=356.62 Aligned_cols=263 Identities=32% Similarity=0.478 Sum_probs=219.3
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEee
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMG 501 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g 501 (720)
..+++..++|.+.+.||+|+||.||+|++. ++.||||++..... ......+.+|+.+|.++. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 346778889999999999999999999863 35799999875432 233456889999999997 999999999
Q ss_pred eeecCCceEEEEeecCCCCHHHHHcCCC----------------------------------------------------
Q 004986 502 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 529 (720)
Q Consensus 502 ~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------------------------------------------- 529 (720)
++.....+++||||+++|+|.+++++..
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999996432
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 004986 530 ---------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 564 (720)
Q Consensus 530 ---------------------------------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLK 564 (720)
..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk 266 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA 266 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence 13566778889999999999999988 9999999
Q ss_pred CCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 004986 565 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 641 (720)
Q Consensus 565 PeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~ 641 (720)
|+|||+++++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999998643221 12223467889999999999889999999999999999998 899997765
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 642 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 642 ~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
..+..........++..+..++.++.+|+.+||+.+|.+||++++|+..|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 544433333333455667788999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=329.89 Aligned_cols=255 Identities=33% Similarity=0.568 Sum_probs=214.4
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++..++|++.++||+|+||.||+|++ ....||+|++...... ...+.+|+++++.++|+||+++++.+. ....++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 35567899999999999999999987 3457999988764433 346789999999999999999999875 456899
Q ss_pred EEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999753 345788999999999999999999998 999999999999999999999999999765433
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~-~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+... .....+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCCccccCHHHHH
Confidence 221 122346778999999998889999999999999999999 88899887776666555322 233445678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
||.+||+.+|.+||++.++++.|+.+
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.42 Aligned_cols=249 Identities=27% Similarity=0.360 Sum_probs=199.6
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeeec-----CC
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTR-----PP 507 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L---~HpNIVkL~g~~~~-----~~ 507 (720)
+|++.+.||+|+||+||+|++ +++.||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488999999999999999987 688999998876433322233455677777665 79999999998764 24
Q ss_pred ceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
.+++||||+.+ +|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999975 888888653 335899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------c--c--
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------R--R-- 655 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------~--~-- 655 (720)
.... .......||..|+|||++.+..++.++|||||||++|+|++|.+||......+....+.... . .
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 5432 22234578999999999999999999999999999999999999998776554433321100 0 0
Q ss_pred --------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 --------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 --------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......++..+++||.+||+.||.+||++.|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01123567889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.17 Aligned_cols=254 Identities=32% Similarity=0.556 Sum_probs=213.4
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+..++|++.+.||+|+||.||+|.+. +..+|+|.+...... ...+.+|+.++++++|+||+++++++. .+..++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 45578999999999999999999874 457999987654332 346788999999999999999999875 4668999
Q ss_pred EeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999653 345788999999999999999999998 9999999999999999999999999998654322
Q ss_pred c-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 592 L-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 592 ~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.. ......+..++..+++|
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHH
Confidence 1 1122346778999999999889999999999999999999 8999998877766665542 22344566788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 670 IWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+.+||.++|.+||+++++++.|+.+
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=325.67 Aligned_cols=250 Identities=28% Similarity=0.466 Sum_probs=216.2
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCceEEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIIT 513 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--~~~l~LVm 513 (720)
+|++.+.||.|+||.||++.+ +++.||+|.+............+..|+.+++.++|+||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999976 67889999988776666667788899999999999999999998754 44589999
Q ss_pred eecCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 514 EFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLH-----TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~---~~~lse~~~~~Ia~qIa~AL~yLH-----s~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
||+++++|.+++... ...+++..++.++.||+.||.||| ..+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998642 457899999999999999999999 776 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.............|+..|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+... ....++..++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-KFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-CCCCCccccCHH
Confidence 7654433234457899999999999988999999999999999999999999988766666555422 233566788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+.+|+.+||+.+|.+||++.+|+++
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=334.55 Aligned_cols=259 Identities=31% Similarity=0.509 Sum_probs=215.1
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
++..++|++.+.||+|+||.||+|... +..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999999642 4479999876443 22334567889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 576 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~---------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~I 576 (720)
....++||||+++|+|.+++.+.. ..+....+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcE
Confidence 999999999999999999996421 23456778889999999999999998 9999999999999999999
Q ss_pred EEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc
Q 004986 577 KVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 577 KL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~ 653 (720)
||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.. .
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~ 237 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD-G 237 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Confidence 9999999985433221 1122345778999999999889999999999999999998 7899988877776665542 2
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 654 ~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.....+..++..+++++.+||+.+|.+||++.++++.|++..
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 334456677899999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.44 Aligned_cols=256 Identities=32% Similarity=0.516 Sum_probs=213.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECC------------------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNG------------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g------------------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN 495 (720)
+.+.+|++.+.||+|+||.||+|+... ..||+|.+..... ......+.+|++++++++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCC
Confidence 345789999999999999999987622 4589998775532 345677889999999999999
Q ss_pred eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 496 IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~----------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
|+++++++..+...++||||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp 158 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLAT 158 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccch
Confidence 9999999999999999999999999999986533 25899999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 641 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt--G~~PF~~~~ 641 (720)
+|||++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ +..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999997643322 11223456789999999998889999999999999999997 778998776
Q ss_pred hHHHHhhhhcc------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 642 PMQVVGAVGFQ------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 642 ~~~i~~~i~~~------~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
..+....+... ......+..++.++.+||.+||+.||.+||++.||++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 66655444311 1112234567789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=338.50 Aligned_cols=260 Identities=30% Similarity=0.467 Sum_probs=217.1
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 503 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~ 503 (720)
.++.+++|.+.+.||+|+||.||+++. .+..||||++..... ......+.+|+.+++++ +|+||+++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 456678999999999999999999974 234799998765432 33456788999999999 799999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
...+.+++||||+.+++|.+++.... ..+++.++..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999999996533 34899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCC
Q 004986 583 LSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 583 lAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip 659 (720)
+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....................+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 9986543211 1122346788999999999999999999999999999998 999998766554433332223333455
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
...+.++.+|+.+||+.+|++||++.|+++.|++.
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 67789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=345.15 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=222.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.++||+|.|+.||++.+ +|+.+|+|++....+.....+++++|+.|.+.|+|||||+|.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 36788889999999999999966 7999999998877776667788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~IKL~DFGlAk~~~~~ 590 (720)
|++.|++|..-+-++ ...++..+-.+++||+.||.|+|.++ |||||+||+|+|+- ..--+||+|||+|..+. .
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 999999997655332 45788889999999999999999999 99999999999995 33469999999999887 4
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~d 668 (720)
......++||+.|||||+++..+|+..+|||+.|++||-|+.|++||.+.+...+++.|....... ..+.+++++.++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 455677899999999999999999999999999999999999999999999999999887443333 355789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
|+.+||..||.+|.|+.|.+.|
T Consensus 246 LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHhccChhhhccHHHHhCC
Confidence 9999999999999999987654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=351.58 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=205.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----ceE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 510 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~-----~l~ 510 (720)
+|++.+.||+|+||.||++.+ +++.||||++............+.+|+.+++.++|+||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 6899999998654434444567889999999999999999999998876 789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 5788877553 36899999999999999999999998 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------
Q 004986 591 F-LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------- 652 (720)
Q Consensus 591 ~-~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~---------------- 652 (720)
. .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 2 122334689999999999874 4789999999999999999999999887765544332110
Q ss_pred --------ccc------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 --------NRR------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 --------~~~------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
... ..+....++++.+||.+||+.||.+||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 01234567899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=334.18 Aligned_cols=255 Identities=31% Similarity=0.532 Sum_probs=214.7
Q ss_pred CeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 438 DLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+|++.+.||+|+||.||+|... ...+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999762 2468888776543 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 004986 511 IITEFLPRGSLFRILHRP-----------------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 567 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~-----------------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeN 567 (720)
+||||+.+++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999998532 124788899999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 004986 568 LLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 644 (720)
Q Consensus 568 ILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~ 644 (720)
||+++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999975432211 1223356778999999998889999999999999999998 999998888777
Q ss_pred HHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 645 i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+...+... .....+..++..+.+|+.+||+.+|.+||++.++++.|+++..
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHhCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 76655422 2344567788999999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=347.70 Aligned_cols=248 Identities=24% Similarity=0.298 Sum_probs=203.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------C
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------~ 507 (720)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999986 688899999876544444566788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+|+||||+++ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 47999999965 67777753 4788899999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 654 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------- 654 (720)
.... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 4332 23346799999999999999999999999999999999999999988765444332211000
Q ss_pred -------cc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 -------RL--------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 -------~~--------------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+ ......+..+++||.+||+.||.+|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=327.36 Aligned_cols=251 Identities=32% Similarity=0.527 Sum_probs=213.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||.|+||.||+|.. +++.+|+|.+...... ....+.+|+.++++++||||+++++.+.+.+.++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 47899999999999999999986 5788999998765432 4577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++......+++.+++.++.|++.||.|||+++ |+|+||||+||++++++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999776457999999999999999999999998 999999999999999999999999999866543333
Q ss_pred CCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---cCCCCCCcHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~---~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~---~~ip~~ls~~l~ 667 (720)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+...... ...+...+.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3446789999999999877 7889999999999999999999999887655544333222111 122344577899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+|+.+||..+|.+||++.+++.+
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=376.78 Aligned_cols=258 Identities=25% Similarity=0.429 Sum_probs=215.6
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-C-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeee-eec-
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGA-VTR- 505 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~-~~~- 505 (720)
.++|...+++|.+.|.+|||+.||+|.. . +..||+|++... ++..+..+.+||.+|+.|+ |+|||.+++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 3556677899999999999999999987 3 389999998766 5667888999999999995 9999999993 221
Q ss_pred -----CCceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE
Q 004986 506 -----PPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 579 (720)
Q Consensus 506 -----~~~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~ 579 (720)
.-+++|.||||.||.|-|++.+ ....|++.++++|+.|+++|+.+||.+.++|||||||-|||||+.+|++|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 1247899999999999999864 3345999999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCcccC---------CCCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHh
Q 004986 580 DFGLSRLKHNTFLSS---------KSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 647 (720)
Q Consensus 580 DFGlAk~~~~~~~~~---------~s~~GT~~Y~APEvi---~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~ 647 (720)
|||.|.......... -....|+.|+|||+| .+...++|+|||+|||+||-|++...||+......+
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-- 266 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-- 266 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--
Confidence 999987533222111 112368999999997 477789999999999999999999999987644333
Q ss_pred hhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 648 AVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 648 ~i~~~~~~~~ip--~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
......+| +.++..+++||..||+.||.+||++.|++.++.++..
T Consensus 267 ----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 267 ----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 23344444 4788999999999999999999999999999998844
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.35 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=214.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--cCCceEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSI 511 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~--~~~~l~L 511 (720)
.++|+.++.|++|+||.||+|++ +++.||+|+++-+.........-.+||.+|.+++|||||.+-++.. +-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 37899999999999999999987 6889999999866544334455679999999999999999988764 4456999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|||||+. +|..++....+++...++..++.|++.||+|||.+. |+|||||++|+|++..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999965 899999887788999999999999999999999998 9999999999999999999999999999998887
Q ss_pred ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---------------
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------------- 655 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--------------- 655 (720)
...+..+-|.+|+|||.+.|.+ |++.+|+||+||++.||+.+.+-|.+....+.++.|-.....
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 7777788999999999998755 899999999999999999999999987765555443210000
Q ss_pred --c------------CCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 --L------------EIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 --~------------~ip~~-ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. .++.. ++....+|+..+|..||.+|.|+.|.++|
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 01111 55788999999999999999999999876
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=326.30 Aligned_cols=250 Identities=24% Similarity=0.443 Sum_probs=218.6
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||+++. +++.||+|.+...........++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999976 688999999877655555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+.+++|.+++... ...+++.+++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999998653 335789999999999999999999998 9999999999999999999999999998665433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+... .....+..++.+++++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-SYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHHHHHh
Confidence 3456889999999999988999999999999999999999999888777766655432 334456788999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
+.+|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 238 KRNPRDRPSVNSILEK 253 (256)
T ss_pred hCChhhCcCHHHHhhC
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=329.01 Aligned_cols=255 Identities=32% Similarity=0.552 Sum_probs=216.1
Q ss_pred CCCeeEeEEeeecCcEEEEEEEEC--C---cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~~--g---~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
..+|++.+.||+|+||.||+|.+. + ..||||++... .......++..|+.+++.++||||+++++++.++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 467899999999999999999762 3 35999987654 24445678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++......+++.+++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999999766567899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccc---CCCC--CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 591 FLS---SKST--AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 591 ~~~---~~s~--~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
... .... ..+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCH
Confidence 211 0111 12457999999999999999999999999999886 999998887777666663 2234445567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+.+++.+||..+|.+||++.+++..|+.+
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.61 Aligned_cols=255 Identities=32% Similarity=0.532 Sum_probs=215.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+++.+|.+.++||+|+||.||+++. ++..+|+|.+... .......+.+|+++++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 5678899999999999999999963 3557888876543 334466789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 572 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~--------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~ 572 (720)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 99999999999999999986532 24788999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 004986 573 NWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 649 (720)
Q Consensus 573 ~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i 649 (720)
++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999975432211 1122345788999999999999999999999999999998 99999887776666555
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 650 ~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
... .....+..+++.+.+||.+||+.||.+||++.+|++.|++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 TQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 422 3345567789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=333.73 Aligned_cols=256 Identities=31% Similarity=0.500 Sum_probs=215.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+..++|++.+.||+|+||.||+|.+ ++..||+|++.... ......++.+|+.++++++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4567899999999999999999976 35789999886543 334456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH---------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~---------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
..+++||||+++++|.+++.... ..+++.+++.++.||+.||.|||..+ ++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 99999999999999999986321 24678888999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+|||++.++.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875432211 1122345678999999999999999999999999999997 8899988887
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
.+....+.... ....+..++.++.+||.+||+.+|.+||++.|+++.|++
T Consensus 239 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 77766654322 334466788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=364.31 Aligned_cols=270 Identities=31% Similarity=0.556 Sum_probs=238.5
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEE--C-C---cEEEEEEEec-CCCCHHHHHHHHHHHHHHHHcCCCceeEEee
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADW--N-G---TEVAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~-g---~~VAVK~i~~-~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g 501 (720)
...+++..++..+.++||+|+||.||+|+. . + ..||||..+. .......+.+|.+|.++|++++|||||+|||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345667778888899999999999999976 2 2 2389998875 3466778899999999999999999999999
Q ss_pred eeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 502 ~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
+......+++|||+|.||+|.++|.+.+..++..+++.++.+.+.||+|||+++ +|||||-.+|||++.++.+||+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999999988777999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCC
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 660 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~ 660 (720)
|+++.............-...|+|||.+....|+.++|||||||++||+++ |..||.+....++..++.....+...+.
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 999765321111111124579999999999999999999999999999998 8889999999999999977777888888
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
..+.++..++.+||..+|++||+|.++.+.|+.+.....+
T Consensus 387 ~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 387 KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999999999999877665
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=326.60 Aligned_cols=247 Identities=30% Similarity=0.513 Sum_probs=209.6
Q ss_pred EEeeecCcEEEEEEEE--C---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 443 ERIGLGSYGEVYHADW--N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~---g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
++||+|+||.||+|.+ . +..+|+|.+...... ....++.+|+.+++.+.|+|||++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 3699999999999976 2 267999988766543 44567889999999999999999999876 456899999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC---
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--- 594 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~--- 594 (720)
+++|.+++.+.. .+++..++.++.|++.||+|||..+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999997654 6899999999999999999999998 9999999999999999999999999998654332211
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.. ......+..++..+++||.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHH
Confidence 11223568999999999999999999999999999997 9999988887776666643 334456778899999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHhhh
Q 004986 674 WQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~L~~i~ 695 (720)
|..+|.+||++.++++.|+++.
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=334.33 Aligned_cols=251 Identities=30% Similarity=0.465 Sum_probs=212.1
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.+.|++++.||+|+||.||+|++ +++.||+|++... .......+.+|+.+++.++|+||+++++.+..+..+++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 36799999999999999999987 5788999998654 3344677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|..++.+....+++..+..++.||+.+|.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999999999988665567899999999999999999999998 999999999999999999999999998764433333
Q ss_pred CCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~ 667 (720)
.....++..|+|||++. ...++.++|||||||++|+|++|..||...+..+....+..... ....+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 34456889999999985 34467899999999999999999999988776554444322211 2234567788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||..+|++||++.+++++
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.94 Aligned_cols=245 Identities=26% Similarity=0.472 Sum_probs=207.7
Q ss_pred eeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCC
Q 004986 445 IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 520 (720)
Q Consensus 445 LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggs 520 (720)
||+|+||.||+|.+ .+..||+|++.... .......+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 89999999999975 24569999876543 34445678999999999999999999998764 57899999999999
Q ss_pred HHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc---CCCC
Q 004986 521 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKST 597 (720)
Q Consensus 521 L~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~---~~s~ 597 (720)
|.+++......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 99999765567899999999999999999999998 999999999999999999999999999855432211 1112
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 004986 598 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676 (720)
Q Consensus 598 ~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~ 676 (720)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..++.++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 34578999999998889999999999999999996 999999888777665554 2334567778899999999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 004986 677 DPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 677 DP~kRPS~~ELL~~L~~i 694 (720)
+|.+||++.+|++.|+.+
T Consensus 238 ~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 238 KWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ChhhCcCHHHHHHHHhhh
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=357.69 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=198.2
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 506 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------ 506 (720)
...+|++++.||+|+||.||+|.+ +++.||||++.... ....+|+.+|+.++|+|||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 456899999999999999999987 67899999885432 1234799999999999999998876432
Q ss_pred --CceEEEEeecCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEe
Q 004986 507 --PNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSD 580 (720)
Q Consensus 507 --~~l~LVmEy~~ggsL~d~L~---~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~D 580 (720)
..+++||||+++ +|.+++. .....+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 246799999975 6766653 23457899999999999999999999998 99999999999999665 799999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc------
Q 004986 581 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------ 653 (720)
Q Consensus 581 FGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~------ 653 (720)
||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+.+..+....
T Consensus 215 FGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9999865433 223446789999999998764 68999999999999999999999998876544333221100
Q ss_pred ---------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 ---------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ---------------------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....+|...+.++++||.+||++||.+||++.|++.|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0011344577899999999999999999999999966
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=377.12 Aligned_cols=265 Identities=32% Similarity=0.564 Sum_probs=231.2
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEee
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 501 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g 501 (720)
....+++..+.+..+.||+|.||+||+|+. ....||||.++... ..+...+|++|+.+|..|+|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 344567888999999999999999999975 34569999886554 4456889999999999999999999999
Q ss_pred eeecCCceEEEEeecCCCCHHHHHcCC---------C----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcE
Q 004986 502 AVTRPPNLSIITEFLPRGSLFRILHRP---------H----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 568 (720)
Q Consensus 502 ~~~~~~~l~LVmEy~~ggsL~d~L~~~---------~----~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNI 568 (720)
+|..++.+|||+|||..|+|.+||... + .+++..+.+.||.|||.||.||-++. +|||||-.+|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC 634 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence 999999999999999999999999531 1 23888999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeccccccccCCcc-cCC-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 004986 569 LVDKNWNVKVSDFGLSRLKHNTFL-SSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQV 645 (720)
Q Consensus 569 LLd~~g~IKL~DFGlAk~~~~~~~-~~~-s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i 645 (720)
||.++..|||+|||+++......+ ... ...-..+|||||.|..+++++++||||+||+|||+++ |..||++....++
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 999999999999999996543322 111 2234579999999999999999999999999999986 8899999999999
Q ss_pred HhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 646 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 646 ~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
++.+..... +..|.+++.+++.|+..||+..|.+||+|+||-..|......
T Consensus 715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 999975554 788999999999999999999999999999999999876543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=331.55 Aligned_cols=250 Identities=27% Similarity=0.319 Sum_probs=204.2
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||.|+||.||+|++ ++..||||++............+.+|+.++++++||||+++++++.++..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 688999999876544433456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 516 LPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 516 ~~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
+. ++|.+++.... ..+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 58888886422 46899999999999999999999998 999999999999999999999999999765433332
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc--------------------
Q 004986 594 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------- 652 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-------------------- 652 (720)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3344678999999998754 4788999999999999999999999876543222111000
Q ss_pred -------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 -------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 -------~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.........+++++++||.+||+.||.+||++.+|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001123578899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.43 Aligned_cols=260 Identities=31% Similarity=0.533 Sum_probs=218.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
++..++|.+.+.||+|+||.||+|.+. ...||||...... .......+.+|+.++++++|+||+++++++.+ .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 345678999999999999999999762 2368888775443 24455678899999999999999999998875 5
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..++||||+++++|.+++.+....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 578999999999999999776557899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 588 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 588 ~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+.. ......+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPT 236 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHH
Confidence 43321 1222345568999999998889999999999999999885 9999988777666655543 2344567788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+.+||.+||..+|.+||++.+++..|+.+...
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=349.82 Aligned_cols=241 Identities=24% Similarity=0.397 Sum_probs=202.2
Q ss_pred eeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHc---CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 445 LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L---~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
||+|+||+||+|++ +++.||||++...... ......+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 5889999998754322 22344555677777665 699999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999998764 46899999999999999999999998 99999999999999999999999999976443333344568
Q ss_pred CCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC-CCCcHHHHHHHHHhhhc
Q 004986 599 GTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KELDPLVARIIWECWQT 676 (720)
Q Consensus 599 GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip-~~ls~~l~dLI~~cL~~ 676 (720)
||..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.... ..++ ..++.++++||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCC
Confidence 99999999999765 47899999999999999999999999988877776664332 2333 35789999999999999
Q ss_pred CCCCCC----CHHHHHHH
Q 004986 677 DPSLRP----SFAQLTVA 690 (720)
Q Consensus 677 DP~kRP----S~~ELL~~ 690 (720)
||.+|| ++.++++|
T Consensus 236 ~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 236 NPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CHHHCCCCCCCHHHHhcC
Confidence 999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=346.30 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=203.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999976 6889999998765545555667889999999999999999999886543
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999965 67666643 4788999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 652 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~--------------- 652 (720)
... .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 170 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 433 2234467999999999999999999999999999999999999999876643322111000
Q ss_pred -----cc--------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 -----NR--------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 -----~~--------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ....+...+.++++||.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 000112245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.28 Aligned_cols=250 Identities=33% Similarity=0.558 Sum_probs=214.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
..+|++.+.||+|+||.||++.+ .+..+|+|.+...... ...+.+|++++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 46899999999999999999987 4788999988755443 3467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc-
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS- 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~- 593 (720)
|+.+++|.+++......+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999999999765556889999999999999999999998 999999999999999999999999998765432211
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+... .....+...+..+.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHH
Confidence 122345678999999998889999999999999999998 99999888777766665422 2334456678999999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~L 691 (720)
||+.+|.+||++.++++.|
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HcccChhhCCCHHHHHHhh
Confidence 9999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=329.46 Aligned_cols=249 Identities=28% Similarity=0.434 Sum_probs=207.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC------C
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP------P 507 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~------~ 507 (720)
..|++.+.||+|+||.||+|.+ .++.||+|++...... ..++..|+.+++++ +|+||+++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5688889999999999999977 6788999998654322 35678899999998 799999999998753 4
Q ss_pred ceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
.+++||||+.+++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 589999999999999998763 346899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ 661 (720)
............|+..|+|||++. +..++.++|||||||++|||++|..||...........+.........+..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 654433445567999999999986 345788999999999999999999999876655444333222222233456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++..+++||.+||..+|.+||++.+++.+
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 78899999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=334.81 Aligned_cols=257 Identities=31% Similarity=0.500 Sum_probs=211.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECC----------------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCcee
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNG----------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g----------------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIV 497 (720)
++.++|++.+.||+|+||.||+|++.+ ..||+|.+... ........+.+|++++++++|+||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456789999999999999999996532 24899988654 3344556789999999999999999
Q ss_pred EEeeeeecCCceEEEEeecCCCCHHHHHcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC
Q 004986 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 566 (720)
Q Consensus 498 kL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~-----------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPe 566 (720)
++++++......++||||+++++|.+++.... ..+.+..++.++.|++.||.|||+++ ++||||||+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR 158 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence 99999999999999999999999999985421 13678888999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCh
Q 004986 567 NLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMNP 642 (720)
Q Consensus 567 NILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt--G~~PF~~~~~ 642 (720)
|||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999976433211 1122345778999999999889999999999999999988 6788887766
Q ss_pred HHHHhhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 643 MQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 643 ~~i~~~i~~------~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
.+....+.. .......+..++..+.+||.+||..+|.+||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 655543321 111123455678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.53 Aligned_cols=264 Identities=31% Similarity=0.522 Sum_probs=221.0
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 500 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~ 500 (720)
++++...+|++++.||+|+||.||+|++. ...||+|.+... .......++.+|+++++++ +|+||++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 45666678999999999999999999751 236899977643 3344567888999999999 899999999
Q ss_pred eeeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 501 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 501 g~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
+++...+.++++|||+++++|.+++.+.. ..+.+.+++.++.||+.||.|||+++ |+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 162 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence 99999999999999999999999986421 24778888999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~~--~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||...+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999865432211 122334578999999999999999999999999999998 8899988887
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
.+....+.. ......+..++.++.+||.+||+.+|.+||++.+++..|+++....
T Consensus 243 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 777665542 2344556678899999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=344.60 Aligned_cols=262 Identities=31% Similarity=0.495 Sum_probs=212.4
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 503 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~ 503 (720)
+.+..++|++.+.||+|+||+||+|.+ .++.||||++..... ......+.+|+.+|.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 345678999999999999999999963 467899999865432 33456788999999999 789999999987
Q ss_pred ecC-CceEEEEeecCCCCHHHHHcCCC-----------------------------------------------------
Q 004986 504 TRP-PNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 529 (720)
Q Consensus 504 ~~~-~~l~LVmEy~~ggsL~d~L~~~~----------------------------------------------------- 529 (720)
... ..+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 56889999999999999985421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc--cC
Q 004986 530 -------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SS 594 (720)
Q Consensus 530 -------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~--~~ 594 (720)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 13577888899999999999999998 99999999999999999999999999976432211 11
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....++..|+|||++.+..++.++||||||+++|+|++ |..||.....................+...++.+.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999999999999999999999999996 99999775443322222223334455667888999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHhhhH
Q 004986 674 WQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
|+.+|.+||++.+|+++|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=325.21 Aligned_cols=248 Identities=30% Similarity=0.503 Sum_probs=213.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||.|+||.||+|.+ ++..||+|.+..... ..++.+|+.++++++|+||+++++.+.+...+|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 6799999999999999999987 478899998865421 5678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+.+++|.+++......+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++..........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 99999999999766667899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+.. .......+..++..+.+||.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 445688999999999999999999999999999999999999987666544433321 1112234456788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|+.+|.+||++.|++.+
T Consensus 237 l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 237 LVKDPEERPSAIQLLQH 253 (256)
T ss_pred HhcChhhCcCHHHHhcC
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=335.75 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=207.0
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.+++|++.+.||+|+||.||+|++ +++.||+|.+....... ....+.+|+.++++++|+||+++++++...+.+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 357899999999999999999977 57889999986543221 234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||++ ++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99997 5899988766567899999999999999999999998 99999999999999999999999999976543333
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-----------------cc
Q 004986 593 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-----------------NR 654 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-----------------~~ 654 (720)
......++..|+|||++.+. .++.++||||||+++|+|++|++||...+..+....+... ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 33345678999999998764 4788999999999999999999999887654433221100 00
Q ss_pred ccC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 RLE-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ~~~-----------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
... ....+++.+++||.+||+.||.+|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 113568899999999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=346.05 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=208.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-----CCce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-----~~~l 509 (720)
..|...+.||+|+||.|..+.+ +++.||||++...-......++..+|+++|+.++|+||+.+++.+.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4455679999999999999976 78999999997555455567788999999999999999999999865 3459
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|+|+|+| +.+|..+++.+. .+++..+..++.||+.||.|+|+.+ |+||||||.|+|++.+..+||||||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 679999997643 5999999999999999999999999 99999999999999999999999999998753
Q ss_pred C--cccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc--------------
Q 004986 590 T--FLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------- 652 (720)
Q Consensus 590 ~--~~~~~s~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-------------- 652 (720)
. ....+..+.|.+|.|||++. ...|+.++||||+||+|.||++|++-|.+.+....+..|...
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 22335678899999999874 577999999999999999999999999887654333222100
Q ss_pred ----------ccccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 ----------NRRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 ----------~~~~~-----ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+. +-++.++++.+|+.+||..||.+|+|++|.++|
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00111 114778999999999999999999999999986
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=331.46 Aligned_cols=249 Identities=29% Similarity=0.447 Sum_probs=210.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
.|++.+.||+|+||.||++.+ ++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 367889999999999999987 56778888875432 34466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|..++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999999988665557899999999999999999999998 99999999999999999999999999976544333334
Q ss_pred CCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHH
Q 004986 596 STAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARI 669 (720)
Q Consensus 596 s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~ip~~ls~~l~dL 669 (720)
...|+..|+|||++. +..++.++|||||||++|+|++|..||...+..+....+.... .....+..++.++++|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 457899999999984 4457889999999999999999999998877655544442221 1223456788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||+.+|.+||++.+++++
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.64 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=203.1
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||+|++ +++.||+|.+............+.+|+.++++++|+||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999987 688999999876543333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+. ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 97 4788877654557899999999999999999999998 99999999999999999999999999986544333333
Q ss_pred CCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhc------------------cccc
Q 004986 596 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGF------------------QNRR 655 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~------------------~~~~ 655 (720)
...++..|+|||++.+.. ++.++|||||||++|+|++|..||.. .+..+.+..+.. ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987754 78999999999999999999988644 333222221100 0000
Q ss_pred ---------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ---------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ---------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......++.++++||.+||+.||.+|||+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 01123567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.48 Aligned_cols=255 Identities=31% Similarity=0.565 Sum_probs=215.9
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++..++|++.+.||+|+||.||++.+ .+..+|+|.+.... .....+.+|+.++++++|+||+++++.+.+ ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 56678999999999999999999986 56679999876432 235678899999999999999999999887 77899
Q ss_pred EEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+|||+++++|.+++.+ ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999965 3346788899999999999999999998 999999999999999999999999999765432
Q ss_pred cc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 FL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.. ......++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+....+.. ......+...+.++.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYN 234 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCcccCCHHHHH
Confidence 21 1122345678999999998889999999999999999998 9999998877666655542 2233455678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
++.+||+.+|.+||++.++++.|+.+
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.16 Aligned_cols=245 Identities=32% Similarity=0.569 Sum_probs=209.0
Q ss_pred EeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCHH
Q 004986 444 RIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~ 522 (720)
.||+|+||.||+|.. +++.+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 599999999999976 57789999876543 3344556889999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC-CCCCCCC
Q 004986 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS-KSTAGTP 601 (720)
Q Consensus 523 d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~-~s~~GT~ 601 (720)
+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......... ....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 998765556899999999999999999999998 9999999999999999999999999997544332211 1223467
Q ss_pred CccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 004986 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 680 (720)
Q Consensus 602 ~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~k 680 (720)
.|+|||++.+..++.++||||||+++|+|++ |..||...........+.. ......+..++..+.+|+.+||..+|++
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 8999999998889999999999999999998 9999988777666555542 2344556778999999999999999999
Q ss_pred CCCHHHHHHHHH
Q 004986 681 RPSFAQLTVALK 692 (720)
Q Consensus 681 RPS~~ELL~~L~ 692 (720)
||++.++++.|.
T Consensus 238 Rp~~~~l~~~l~ 249 (250)
T cd05085 238 RPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHhc
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.24 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=219.2
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~- 505 (720)
.+..++|++.+.||+|+||.||+|.+. +..|++|.+... ........+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 356689999999999999999999873 477888887543 344556778899999999999999999998765
Q ss_pred CCceEEEEeecCCCCHHHHHcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~-------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL 578 (720)
....++++||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+|||+++++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence 567899999999999999986532 35889999999999999999999998 999999999999999999999
Q ss_pred EeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccc
Q 004986 579 SDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR 655 (720)
Q Consensus 579 ~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~ 655 (720)
+|||+++.+..... ......++..|+|||++.+..++.++||||||+++||+++ |..||...+..++...+.. ...
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCC
Confidence 99999986532211 1122346778999999999889999999999999999998 9999988877776655543 223
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 656 ~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
...+..++..+.+++.+||..+|++||++.++++.|+.+.+.
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 344556789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=333.81 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=207.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.|++.+.||+|+||.||++.+ +++.||||.+....... .....+.+|+.++++++|+||+.+++.+.+.+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999987 68899999987654332 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 515 FLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 515 y~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 9999999998854 2345899999999999999999999998 9999999999999999999999999987653322 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... +....+. ......++..+++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 23457999999999999999999999999999999999999999864432 1111111 1112345667899999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 004986 671 WECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
.+||+.||.+||+ ++|++.|
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999 8899883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.47 Aligned_cols=251 Identities=30% Similarity=0.472 Sum_probs=214.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||.|+||.||++.+ ++..+|+|.+... .......+.+|+.++++++|+||+++++.+.....+++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 36799999999999999999987 5788999988654 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999776567999999999999999999999998 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~ 667 (720)
.....|+..|+|||++. +..++.++||||||+++|+|++|..||...+..+....+..... ....+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34457899999999985 34467899999999999999999999988877665544432221 2234567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||+.+|.+||++.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcC
Confidence 99999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.97 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=209.6
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
|++.+.||+|+||+||++.+ +++.||+|++........ ....+.+|+.+|+.++|+||+.+++++..++.+++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 77889999999999999987 688999999876544322 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCC-Ccc
Confidence 9999999888643 346899999999999999999999998 999999999999999999999999998754322 122
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--cccccCCCCCCcHHHHHHHHH
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~--~~~~~~ip~~ls~~l~dLI~~ 672 (720)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.. ......++..++..+.+|+.+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 345799999999999999999999999999999999999999987665433322211 222234556788999999999
Q ss_pred hhhcCCCCCCC-----HHHHHHH
Q 004986 673 CWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS-----~~ELL~~ 690 (720)
||+.||.+||+ +.+++.+
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcC
Confidence 99999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=332.97 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=198.2
Q ss_pred eeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 445 LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
||+|+||.||+++. +++.||+|++........ ....+..|++++++++||||+++++++.+...+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999976 689999999875433221 233456799999999999999999999999999999999999999
Q ss_pred HHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 004986 522 FRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 600 (720)
Q Consensus 522 ~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT 600 (720)
.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 988754 3345888999999999999999999998 9999999999999999999999999987654332 22345789
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 004986 601 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676 (720)
Q Consensus 601 ~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~ 676 (720)
..|+|||++.+..++.++|||||||++|||++|..||...... ++........ .......++.++++||.+||++
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-VKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-cccccccCCHHHHHHHHHHhcc
Confidence 9999999999988999999999999999999999999764332 2222221111 1112246889999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 004986 677 DPSLRPSFAQLTVAL 691 (720)
Q Consensus 677 DP~kRPS~~ELL~~L 691 (720)
||.+||+++|+++.+
T Consensus 237 ~P~~R~~~~~~~~~~ 251 (277)
T cd05607 237 KPEDRLGSREKNDDP 251 (277)
T ss_pred CHhhCCCCccchhhh
Confidence 999999997665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.19 Aligned_cols=257 Identities=30% Similarity=0.506 Sum_probs=210.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC------------------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~------------------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN 495 (720)
+..++|++.+.||+|+||.||++++. ...||+|++.... ......++.+|+.+++.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998542 3358999876543 3344567889999999999999
Q ss_pred eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 496 IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~----------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
|+++++++...+..++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLAT 158 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCh
Confidence 9999999999999999999999999999986532 23667789999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 641 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt--G~~PF~~~~ 641 (720)
+|||++.++.++|+|||+++....... ......++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999986533211 1122344678999999988889999999999999999998 779998776
Q ss_pred hHHHHhhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 642 PMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 642 ~~~i~~~i~~------~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
..+....... .......+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6655433211 111123345678999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.85 Aligned_cols=250 Identities=30% Similarity=0.460 Sum_probs=207.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||.||+|++ +++.||+|.+..... .....+.+|+.+++.++||||+++++.+...+.+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 36788999999999999999987 688999998875532 23456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++...+ .+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999986543 6899999999999999999999998 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-cC--CCCCCcHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LE--IPKELDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~-~~--ip~~ls~~l~ 667 (720)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||....+............. .. ....++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34567999999999974 455788999999999999999999999776544333222111111 11 1124678899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||..+|++||++.+|+++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=326.14 Aligned_cols=258 Identities=28% Similarity=0.496 Sum_probs=219.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+...+|++.+.||+|+||.||+|.+ ++. .+|+|.+..... .....++.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 3457899999999999999999976 232 589998765533 4455678899999999999999999999887 7
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 899999999999999999876667999999999999999999999988 999999999999999999999999999865
Q ss_pred cCCcccC--CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 588 HNTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 588 ~~~~~~~--~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
....... ....++..|+|||.+....++.++|+||||+++||+++ |..||......++...+.. ......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTI 238 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCH
Confidence 4322111 11223568999999988889999999999999999998 9999999887777666643 334455677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
.+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.41 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=214.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||.|+||.||+|.+ +++.||+|.+.... .......+.+|+.+++.++|+||+++++.+.++..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4688889999999999999987 67899999987553 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999764 6899999999999999999999998 9999999999999999999999999998765543334
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC-CcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~-ls~~l~dLI~~c 673 (720)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+... ....++.. ++.++.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHH
Confidence 4567899999999999988999999999999999999999999877766555444322 23334444 889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|..+|.+||++++++.+
T Consensus 235 l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 235 LNKDPKERPSAKELLKH 251 (274)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.80 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=204.6
Q ss_pred eeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceE
Q 004986 439 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 510 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~ 510 (720)
|++.+.||+|+||+||++.. ++..||+|.+..... ......+.+|+.+|++++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48899999999999988753 567899998865432 23456788999999999999999999987654 3589
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999999763 5899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHH------------hhhhccc
Q 004986 591 FLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVV------------GAVGFQN 653 (720)
Q Consensus 591 ~~~---~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~--~i~------------~~i~~~~ 653 (720)
... .....++..|+|||.+.+..++.++||||||+++|||++|..||...... +.. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 12234566799999999888999999999999999999999998653211 000 0000111
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 654 ~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.....+..++..+.+|+.+||+.+|++||++++++..|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 223345678899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.65 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=206.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|++ +++.||+|++............+.+|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4689999999999999999987 58899999887554333334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|++++.|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99998888877553 36899999999999999999999998 9999999999999999999999999998765443233
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------------
Q 004986 595 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------- 653 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------------------- 653 (720)
....++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34568899999999876 457889999999999999999999998766543332211000
Q ss_pred --ccc-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 --RRL-------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 --~~~-------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
... .....++..+.+||.+||+.+|++||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 0012457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.28 Aligned_cols=256 Identities=30% Similarity=0.528 Sum_probs=216.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+..++|++.+.||+|+||.||+|+. ..+.||+|.+.... ......++.+|+.++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 3457899999999999999999985 24568998775433 233467789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 004986 507 PNLSIITEFLPRGSLFRILHRPH--------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~--------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL 578 (720)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 99999999999999999986533 15899999999999999999999998 999999999999999999999
Q ss_pred EeccccccccCC-cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccccc
Q 004986 579 SDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 656 (720)
Q Consensus 579 ~DFGlAk~~~~~-~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~ 656 (720)
+|||+++..... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 999998754322 112233456778999999998888999999999999999998 889998877777666665444344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
..+..++..+.+++.+||..+|.+||++.+++..|.
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 456678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.31 Aligned_cols=243 Identities=28% Similarity=0.403 Sum_probs=203.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.++||+|+||.||+|.+ +++.||+|++.... ......++.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999986 68889999886543 33345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999997653 4688888999999999999999998 999999999999999999999999999865433 23
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHhhhhccccccCC-CCCCcHHH
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQNRRLEI-PKELDPLV 666 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-------~i~~~i~~~~~~~~i-p~~ls~~l 666 (720)
....|+..|+|||++.+..++.++||||||+++|+|++|..||...... .....+. ....... ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHH
Confidence 3467999999999999999999999999999999999999999653221 2222221 1112222 23578899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++||.+||+.+|.+||++++++++
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=323.91 Aligned_cols=249 Identities=30% Similarity=0.504 Sum_probs=210.6
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-------HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-------~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
+|.+.+.||+|+||.||+|.+ +++.||+|.+....... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999976 67899999886543321 223567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||+|+|||++.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999764 46888999999999999999999998 9999999999999999999999999998664
Q ss_pred CCc------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 589 NTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 589 ~~~------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. .....++..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCccc
Confidence 211 111234688999999999998899999999999999999999999987665544433322 2344567788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+..+++||.+||+.||.+||++.|++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 9999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.78 Aligned_cols=250 Identities=30% Similarity=0.467 Sum_probs=210.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCC----HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~----~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+|++.+.||+|+||.||+|.. +++.+|||.+...... ......+.+|+.++++++|+||+++++++.+.+.+++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 7888999988654321 22345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC--
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 590 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~-- 590 (720)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999664 36789999999999999999999998 999999999999999999999999998754211
Q ss_pred ----cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHH
Q 004986 591 ----FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPL 665 (720)
Q Consensus 591 ----~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-~~~~~ip~~ls~~ 665 (720)
........|+..|+|||++.+..++.++||||||+++|+|++|..||...+.......+... .....++..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11122356899999999999988999999999999999999999999876654433333222 2234566788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+.+||.+||+.+|.+||++.+++.+
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.57 Aligned_cols=248 Identities=30% Similarity=0.520 Sum_probs=204.1
Q ss_pred EeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee-cCCceEEEEeecC
Q 004986 444 RIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLSIITEFLP 517 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~-~~~~l~LVmEy~~ 517 (720)
.||+|+||.||+|.+ ....||+|.+.... .......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 589999999999975 23569999875432 2334567888999999999999999999765 4556899999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc----cc
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----LS 593 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~----~~ 593 (720)
+++|.+++.+......+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 99999999765556778888899999999999999998 9999999999999999999999999997543321 11
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG-~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
.....++..|+|||.+.+..++.++|||||||++|||++| .+||...+..+....+. .......+..++..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHHH
Confidence 1233567789999999988899999999999999999995 66777776666555443 223344556778999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHhhh
Q 004986 673 CWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
||..+|++||++.+++..|+.+.
T Consensus 238 cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 238 CWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HcCCChhhCCCHHHHHHHHHHHh
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.47 Aligned_cols=249 Identities=26% Similarity=0.466 Sum_probs=215.8
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||++.. ++..+|||.+............+.+|+.++++++|+||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 488999999999999999976 688899999987666656677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEeccccccccCCccc
Q 004986 516 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 516 ~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~DFGlAk~~~~~~~~ 593 (720)
+++++|.+++.+. ...+++..+..++.|++.+|+|||+++ |+|+||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 9999999999764 345899999999999999999999998 9999999999999865 468999999998765432 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. .....++..++..+++|+.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHH
Confidence 2335689999999999998899999999999999999999999988777666555532 223346677899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|..+|.+||++.|++++
T Consensus 237 l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 237 LNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCChhhCCCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.96 Aligned_cols=246 Identities=26% Similarity=0.451 Sum_probs=215.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||++.+ +++.||+|++...... ......+.+|++++++++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999987 6789999998765432 234566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+|+||+|.||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999765 46899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+. .....++..++..++++|.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHH
Confidence 334578999999999998888999999999999999999999998877666555553 334567778899999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 004986 674 WQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRP-----S~~ELL~~ 690 (720)
|..+|.+|+ ++++++.+
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcC
Confidence 999999998 77787754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.05 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=211.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.+|++.+.||+|+||.||+|.+ +++.||+|.+....... ...+.+|+.+++.++|+||+++++.|......++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 6899999999999999999976 68899999887654432 4567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++++|.+++.+. .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred ccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 99999999998653 4789999999999999999999998 9999999999999999999999999987654332223
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-ccccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~-~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++......+. ........+..++..+.+||.+|
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence 34578999999999999889999999999999999999999998776644332222 11122234567889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|..+|.+||++.+++.+
T Consensus 254 l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 254 LDMDVEKRGSAKELLQH 270 (296)
T ss_pred CcCCcccCcCHHHHhhC
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=319.72 Aligned_cols=246 Identities=32% Similarity=0.571 Sum_probs=210.0
Q ss_pred EEeeecCcEEEEEEEEC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 443 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
++||+|+||.||++.+. ++.||+|++...... .....+.+|++++++++|+||+++++++.+....++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36999999999999874 899999988765443 3456788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC--CCCCC
Q 004986 522 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAG 599 (720)
Q Consensus 522 ~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~--~s~~G 599 (720)
.+++.+....+++..++.++.+++.||.|||+++ |+||||||+|||++.++.+||+|||++.......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999765557889999999999999999999998 9999999999999999999999999998654221111 11234
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 600 T~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+... .....+..++.++.+|+.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998889999999999999999998 88999887766655555322 2344567788999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 004986 679 SLRPSFAQLTVALK 692 (720)
Q Consensus 679 ~kRPS~~ELL~~L~ 692 (720)
.+||++.|+++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.58 Aligned_cols=246 Identities=32% Similarity=0.560 Sum_probs=210.9
Q ss_pred EEeeecCcEEEEEEEEC---C--cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 443 ERIGLGSYGEVYHADWN---G--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~---g--~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
+.||+|+||.||+|.+. + ..||||.+...... .....+.+|+.++++++|+||+++++.+.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 35899999999999762 2 36899998776554 556788999999999999999999999988 88999999999
Q ss_pred CCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc---c
Q 004986 518 RGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---S 593 (720)
Q Consensus 518 ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~---~ 593 (720)
+++|.+++.+.. ..+++..++.++.|++.||.|||.++ ++||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997654 56899999999999999999999998 99999999999999999999999999987643211 1
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.........+..++..+.+++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 123457789999999999999999999999999999998 9999988877776665543333445566788999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~L~ 692 (720)
||+.+|.+||++.++++.|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.97 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=198.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
.+...+|++.+.||+|+||.||+|.+ +++.||||... ...+.+|+++|++++|||||+++++|......+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 35557899999999999999999987 68899999642 234678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+|||++. ++|..++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9999995 6888888654 36889999999999999999999998 999999999999999999999999999754322
Q ss_pred -cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHhhhh------------
Q 004986 591 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVG------------ 650 (720)
Q Consensus 591 -~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~-------~~i~~~i~------------ 650 (720)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1223346799999999999999999999999999999999999988754221 00010000
Q ss_pred ---------------cccccc-CCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 651 ---------------FQNRRL-EIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 651 ---------------~~~~~~-~ip-----~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.....+ ..+ ..++.++.+||.+||+.||.+|||++|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 000 1346689999999999999999999999964
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.09 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=207.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||++.+ ++..+|+|.+... .......++.+|++++++++||||+++++.|.+++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4789999999999999999987 5778899887644 234455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999764 468899999999999999999997 46 9999999999999999999999999987654322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------------
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------------- 652 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~--------------------- 652 (720)
.....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 23467899999999998888999999999999999999999999765543332222100
Q ss_pred --------------ccccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 653 --------------NRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 653 --------------~~~~~ip-~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
...+..| ..++.++++||.+||..+|++||++.+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0011112 13678899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.05 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=209.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--Cce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~---~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l 509 (720)
.+|++.+.||+|+||.||++.+ +++.||||.+..... .......+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999986 678999998864321 223456788999999999999999999998764 458
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999998654 35788899999999999999999998 99999999999999999999999999875432
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 ~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+.........|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 11 112334689999999999988899999999999999999999999987765555444443333455677788899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.++|.+||. +|.+||++++++++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhcC
Confidence 999999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.46 Aligned_cols=248 Identities=34% Similarity=0.587 Sum_probs=211.7
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
..++|++.+.||+|+||.||++..+++.||+|.+.... ....+.+|+.++++++|+||+++++++... ..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 44789999999999999999999999999999885432 235678899999999999999999998764 5799999
Q ss_pred ecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 515 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 99999999999653 335789999999999999999999998 9999999999999999999999999987643321
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+... .....+..++..+.+|+.+
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHH
Confidence 22344678999999998889999999999999999997 99999888777666555432 2334456788999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHh
Q 004986 673 CWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~L~~ 693 (720)
||+.+|.+||++.+++..|++
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=326.17 Aligned_cols=254 Identities=29% Similarity=0.438 Sum_probs=207.2
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeee-----
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT----- 504 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~----- 504 (720)
....++|++.+.||+|+||.||+|.+ +++.+|+|++..... ...++.+|+.+++++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34568999999999999999999977 678899998754321 234677899999999 7999999999873
Q ss_pred cCCceEEEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 505 RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 505 ~~~~l~LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
.++.+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 44568999999999999998752 2346888999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cc
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RR 655 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~g-----~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~ 655 (720)
|+++.............|+..|+|||++.. ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 999866443333344579999999999853 447889999999999999999999998776544433322111 12
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 656 ~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
...+..++..+.+||.+||+.||.+||++.|+++++
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 223455688999999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.52 Aligned_cols=259 Identities=29% Similarity=0.520 Sum_probs=215.1
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..++|++.+.||+|+||.||+|.+ ++. .||+|.+.... ......++.+|+.+++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 447889999999999999999976 443 47888775443 233445788999999999999999999998754 5
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.++++||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccccc
Confidence 67999999999999999876667899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 589 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.. ......+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHH
Confidence 3221 1222345778999999999999999999999999999997 9999988766555544432 2334455677889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
+.+++.+||..+|++||++.++++.|+.+.+..
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 999999999999999999999999999885443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.00 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=210.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||++.+ .++.||+|.+... ........+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688999999999999999987 5899999988654 234445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~--~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+++++|..++... ...+++..+..++.||+.||.|||. ++ |+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998763 2368999999999999999999996 47 999999999999999999999999999765432
Q ss_pred ccCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh--ccccccCCCCCCc
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELD 663 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~------~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~--~~~~~~~ip~~ls 663 (720)
......|+..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+. .......++..++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 223456888999999986543 4789999999999999999999997765544333221 1223445667799
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.++.+||.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=342.04 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=202.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------~~ 508 (720)
++|++.+.||+|+||+||+|.+ +++.||||++............+.+|+.+|++++|+||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 7899999999999999999976 678899999876543333455677899999999999999999987543 34
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 78999998 7799988864 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 653 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------------- 653 (720)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 170 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 32 234679999999999977 568899999999999999999999998765543332221000
Q ss_pred -------cccC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -------RRLE--------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -------~~~~--------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.... .....++.+.+||.+||+.||.+||++.|++.|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 112356778999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=329.88 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=213.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+..|++.+.||.|+||.||++.+ +++.||+|.+...... ....+.+|+.+++.++|+||+++++++...+.+++||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 46799999999999999999975 7889999988754432 2456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+. .+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999999998653 5899999999999999999999998 999999999999999999999999998865443322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-~~~~~~ip~~ls~~l~dLI~~ 672 (720)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. .......+..++..+.+||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 3345789999999999998899999999999999999999999988776544433321 122334566788999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||..||.+||++.+++.+
T Consensus 252 ~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 252 CLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HhhcChhhCCCHHHHhhC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=325.32 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=205.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--~~~ 508 (720)
.+|++.+.||+|+||.||++.. ++..||+|++.... ......+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5789999999999999999974 47789999876543 3445678899999999999999999998654 346
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999765556899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----------------HHhhh
Q 004986 589 NTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----------------VVGAV 649 (720)
Q Consensus 589 ~~~~~---~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~----------------i~~~i 649 (720)
..... .....++..|+|||++.+..++.++||||||+++|||++|..++....... +...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 32211 111234456999999999889999999999999999999877654322110 00111
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 650 ~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
........+..++.++.+||.+||..+|++|||+.+|++.|+.+
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 -KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11223334567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.73 Aligned_cols=250 Identities=29% Similarity=0.488 Sum_probs=208.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--Cce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~---~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l 509 (720)
.+|++.+.||+|+||.||++.+ +++.||+|++...... ......+.+|+.++++++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999986 6889999988654322 23445688999999999999999999988763 568
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+++|||+++++|.+++.... .+++..++.++.||+.||+|||.++ |+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999987643 5889999999999999999999998 99999999999999999999999999875432
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 ~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+......+.++..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 111234688999999999998899999999999999999999999987765555444443444556677889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++|| +||..+|.+||+++||+.|
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcC
Confidence 9999 6788999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=330.57 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=212.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|.. +++.||+|.+....... .....+..|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4789999999999999999987 57999999998765443 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc-
Q 004986 514 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~- 591 (720)
||+.+++|.+++.+. ...+++..+..++.||+.||.|||..+ |+|+||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998753 356899999999999999999999998 9999999999999999999999999987542211
Q ss_pred ----------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 004986 592 ----------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 643 (720)
Q Consensus 592 ----------------------------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~ 643 (720)
.......||..|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112346889999999999988999999999999999999999999888776
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 004986 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS----FAQLTVA 690 (720)
Q Consensus 644 ~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS----~~ELL~~ 690 (720)
.....+............++..+++||.+||..+|.+||+ +.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 6655543222222222236899999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=385.04 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=230.2
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
.....+..+||+|+++||+|+||.|.++++ +++.||+|++.+-. .......-|..|..||..-+.+=||+++.+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 345567789999999999999999999987 68889999987633 223445668889999998889999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
+.++||||||++||+|-.++.+.. .+++..+..|+.+|+.||.-||+.| +|||||||+|||||..|+|||+|||.+-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999998876 8999999999999999999999999 9999999999999999999999999876
Q ss_pred ccc-CCcccCCCCCCCCCccCccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC
Q 004986 586 LKH-NTFLSSKSTAGTPEWMAPEVLR----N-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 586 ~~~-~~~~~~~s~~GT~~Y~APEvi~----g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip 659 (720)
.+. ++.......+|||.|++||++. + +.|+..+|||||||++|||++|..||+.....+.+..|......+.+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 555 4555566779999999999985 3 568999999999999999999999999999999999998776677788
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHh
Q 004986 660 --KELDPLVARIIWECWQTDPSLRPS---FAQLTVALKP 693 (720)
Q Consensus 660 --~~ls~~l~dLI~~cL~~DP~kRPS---~~ELL~~L~~ 693 (720)
..++.++++||++++. +|+.|.. ++++..|--.
T Consensus 304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence 5689999999999995 8999987 9999887543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=320.08 Aligned_cols=250 Identities=32% Similarity=0.473 Sum_probs=211.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||.|+||+||+|.. ++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999986 67889999887654433 56778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 515 FLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 515 y~~ggsL~d~L~~~--~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999999653 246899999999999999999999998 99999999999999999999999999886554322
Q ss_pred c----CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC-----CCC
Q 004986 593 S----SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-----KEL 662 (720)
Q Consensus 593 ~----~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip-----~~l 662 (720)
. .....|+..|+|||++... .++.++|+||||+++|+|++|..||...+..+........ ....++ ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccc
Confidence 1 2334689999999998876 7889999999999999999999999887765544443222 111111 256
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+..+.+|+.+||.+||.+||++.+|+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.37 Aligned_cols=249 Identities=34% Similarity=0.532 Sum_probs=213.4
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~---~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+|+..+.||+|+||.||+|.. +++.|++|.+..... .......+.+|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999999987 688999998865432 234556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999997643 5889999999999999999999998 9999999999999999999999999988654432
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
......|+..|+|||.+.... ++.++|+||||+++|+|++|..||......+....+........++..++..+.+|+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 234467899999999998776 8999999999999999999999998776555444444333445667788999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
+||+.+|.+||++.+++.+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhhcCcccCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=324.60 Aligned_cols=250 Identities=26% Similarity=0.330 Sum_probs=208.9
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||.|+||.||+|++ +++.||+|++............+.+|+.++++++|+||+++++++.+...+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999987 688999999887665455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-cC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-~~ 594 (720)
+ +++|.+++......+++.+++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999998765567999999999999999999999998 99999999999999999999999999986644321 12
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------------
Q 004986 595 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 654 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------------- 654 (720)
....|+..|+|||++.+. .++.++||||||+++|+|++|.+||...........+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345789999999998754 468999999999999999999888877655443322210000
Q ss_pred -----c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 -----R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 -----~----~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. .......+..+.+||.+||+.+|.+||++++++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 01113457899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=323.41 Aligned_cols=247 Identities=32% Similarity=0.585 Sum_probs=205.1
Q ss_pred EeeecCcEEEEEEEE--CCc--EEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 444 RIGLGSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~--~g~--~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
.||+|+||.||+|++ ++. .+|+|.+... ........+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 589999999999987 333 4677876533 2334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccc
Q 004986 519 GSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583 (720)
Q Consensus 519 gsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGl 583 (720)
++|.+++.... ..+++.+++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence 99999986432 24788999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 584 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 584 Ak~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
+...... ........+..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+... .....+..+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNC 236 (270)
T ss_pred ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCCCcC
Confidence 8643221 11122234667999999998889999999999999999996 99999887776666655422 233456678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
+.++.+|+.+||..+|.+||++.+++..|+++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.75 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=206.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+..+.+.....||+|+||.||+|++ ++..||+|.+.... ......+.+|+.++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3344455556899999999999986 56789999876543 2345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecccccccc
Q 004986 512 ITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKH 588 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~l--se~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~~~ 588 (720)
||||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999997643344 78888899999999999999998 999999999999986 6799999999987654
Q ss_pred CCcccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~--~s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..........|+..|+|||.+.+.. ++.++||||||+++|+|++|..||....... .............++..++++
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 3333333456899999999987643 7889999999999999999999997644322 221222223344567788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+++|+.+||+.+|.+||++.|++.+
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=317.31 Aligned_cols=249 Identities=38% Similarity=0.654 Sum_probs=212.2
Q ss_pred eeEeEEeeecCcEEEEEEEECC------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 439 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+++.+.||.|+||.||++.+.. ..||+|.+..... ......+..|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999998743 7899999865432 22466788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~-lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|||+++++|.+++...... +++.+++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999764433 899999999999999999999998 9999999999999999999999999998654431
Q ss_pred ccCC-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 592 LSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~-s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
.... ...++..|+|||.+.+..++.++|||+||+++|+|++ |..||...+..+....+... .....+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-YRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHH
Confidence 1111 2236789999999988889999999999999999998 88999887777776666433 3445566789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L 691 (720)
+.+||..+|.+||++.|+++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.10 Aligned_cols=252 Identities=27% Similarity=0.329 Sum_probs=210.7
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCC-----
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPP----- 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN-IVkL~g~~~~~~----- 507 (720)
+..|+.+++||+|+||+||+|+. +|+.||+|+++.....+.......+|+.+|++|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677788899999999999976 7899999999876543334456789999999999999 999999998877
Q ss_pred -ceEEEEeecCCCCHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccc
Q 004986 508 -NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583 (720)
Q Consensus 508 -~l~LVmEy~~ggsL~d~L~~~~---~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGl 583 (720)
.+++||||++ -+|.+++.... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 7999999995 59999997644 45777889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------
Q 004986 584 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------- 654 (720)
Q Consensus 584 Ak~~~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-------- 654 (720)
|+...-+....+..++|.+|+|||++.|. .|+..+||||+||+++||++++..|.+....+.+..|-..-.
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99766555555667899999999999987 689999999999999999999999999777655543321000
Q ss_pred --------ccCCC------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 --------RLEIP------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 --------~~~ip------------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...++ +..++...+++.+||+.+|.+|.+++.++.|
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00011 1233589999999999999999999999887
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=327.11 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=206.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~---~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+|++.+.||+|+||.||+|.+ +++.||||++...... ......+..|+.++++++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999987 5789999999766543 22344567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+ +++|.+++......+++..++.++.||+.||.|||.++ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 89999999765457899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------------c----
Q 004986 593 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------R---- 654 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------------~---- 654 (720)
......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334467889999999865 457889999999999999999988887766544332221000 0
Q ss_pred ----cc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 ----RL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ----~~-----~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ......+..+.+||.+||+++|.+||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 0113457789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=342.60 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=199.5
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
...+|++++.||+|+||.||+|.. .++.||+|.+.... .+.+|+.+|++++|||||++++++.....+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 346799999999999999999975 34678999775432 3458999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+|||++. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 163 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999995 688888843 357899999999999999999999998 999999999999999999999999999765433
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHhhhhc--cc----------
Q 004986 591 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGF--QN---------- 653 (720)
Q Consensus 591 ~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~---i~~~i~~--~~---------- 653 (720)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+..+.. +.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 21 2234579999999999999999999999999999999999999997654211 1110000 00
Q ss_pred -------------cc--cCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -------------RR--LEIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -------------~~--~~ip-----~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+ ...+ ..++.++.+||.+||..||.+||++.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0111 2346789999999999999999999999987
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=321.61 Aligned_cols=251 Identities=31% Similarity=0.469 Sum_probs=207.5
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC----
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP---- 507 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~---- 507 (720)
..++|++.+.||+|+||.||+|.+ +++.+++|++..... ....+.+|+.+++++ .|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 457899999999999999999987 567899998875532 345788999999999 7999999999997654
Q ss_pred --ceEEEEeecCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 508 --NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 508 --~l~LVmEy~~ggsL~d~L~~~---~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
.+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988642 357899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-cc
Q 004986 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RL 656 (720)
Q Consensus 583 lAk~~~~~~~~~~s~~GT~~Y~APEvi~g-----~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~ 656 (720)
++..............|+..|+|||++.. ..++.++||||||+++|+|++|..||...........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765443333345678999999999854 3467889999999999999999999987665544444332211 11
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+..++.++++||.+||..||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2233467899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=330.30 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=211.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.+|++.+.||+|+||.||++.. +++.||+|.+...... ....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 6899999999999999999986 6899999998765433 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++++|.+++.+. .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 97 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred ccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 99999999998653 5788999999999999999999998 9999999999999999999999999987654333333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-~~~~~~ip~~ls~~l~dLI~~c 673 (720)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.. .......+..++..+++|+.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 345789999999999998899999999999999999999999987665433322221 1122234567888999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|+.+|.+||++.+++++
T Consensus 253 l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 253 LEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=373.27 Aligned_cols=267 Identities=31% Similarity=0.533 Sum_probs=231.3
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE---CCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW---NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~---~g~----~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
+++++..+..+.||+|.||.||.|.. .+. .||||.+.+. .+.+...+|.+|..+|+.++|||||+++|++.+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 36678899999999999999999976 333 4888887543 356678899999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 579 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~ 579 (720)
....+|++|||.+|+|..||++. ...++....+.++.|||+|++||+++. +|||||-.+||||+....+||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence 99999999999999999999876 567899999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCcccCCCCC--CCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccccc
Q 004986 580 DFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 656 (720)
Q Consensus 580 DFGlAk~~~~~~~~~~s~~--GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~ 656 (720)
|||+|+.+.+......... -...|||||.+..+.++.|+|||||||+|||+++ |..||.+.+..+++.....+. ++
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 9999994433222222122 2358999999999999999999999999999998 889999999888887555444 88
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
..|..++..+.+++..||+.+|++||+|..|+..+..+..-..+..=
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 89999999999999999999999999999999999888665555443
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.86 Aligned_cols=249 Identities=32% Similarity=0.526 Sum_probs=210.6
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||++.. +++.||+|.+............+.+|+.++++++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488899999999999999976 678999999887765555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC-
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS- 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~- 594 (720)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999764 35788999999999999999999998 9999999999999999999999999988654332211
Q ss_pred ---CCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccCCCCCC--cHH
Q 004986 595 ---KSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKEL--DPL 665 (720)
Q Consensus 595 ---~s~~GT~~Y~APEvi~g~~---~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~~~~ip~~l--s~~ 665 (720)
....++..|+|||++.+.. ++.++|||+||+++|+|++|+.||...... .....+.. .....+|... +..
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHH
Confidence 1246889999999998776 789999999999999999999999765332 22222222 3333445444 899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+.+||.+||+.+|.+||++.+++.+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC
Confidence 9999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=362.25 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=221.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEEC--CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|+|+..||-|+||+||++... +-..|.|+|... .++.+.++.-||.||..++||+||+|++.|..++.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 55889999999999999999763 444677777544 35568889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
||.||-++.++-.-+..+.+.++..+++|++.||.|||+++ |||||||..|||+.-+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999998877788999999999999999999999998 9999999999999999999999999987655555556
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-CCCCCCcHHHHH
Q 004986 595 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLVAR 668 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~-~ip~~ls~~l~d 668 (720)
.++.||++|||||++. ..+|++++|||||||+|.||..+.+|....++..++-.|.....+. -.|...+..+.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 7899999999999875 4679999999999999999999999999999999887776443322 356677889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
|+.+||.+||..||++.||++|
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhC
Confidence 9999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=323.42 Aligned_cols=254 Identities=32% Similarity=0.521 Sum_probs=210.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEEC------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--~~~ 508 (720)
.+|++.+.||+|+||.||++++. +..||||++...... .....+.+|+.+++.+.|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 56888899999999999999863 678999998765433 346788999999999999999999999877 557
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999999876557999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------------HHhhhh
Q 004986 589 NTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------------VVGAVG 650 (720)
Q Consensus 589 ~~~~~---~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~---------------i~~~i~ 650 (720)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..||....... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 32111 112245667999999998889999999999999999999999986532211 112221
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 651 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 651 ~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.......+..++..+.+|+.+||+.+|.+||++.||++.|+.+
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 -EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2223334556788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.65 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=211.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
.|++.+.||+|+||.||+|.+ ++..||+|.+..... ......+.+|+.++++++|+||+++++.+......++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 466778899999999999976 578899998865433 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+|+||+|+||++++++.+||+|||++...........
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 999999999865 35889999999999999999999998 99999999999999999999999999986654333333
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~ 675 (720)
...|+..|+|||.+.+..++.++|+||||+++|||++|..||...........+. ......++..++..+.+||.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4568999999999999889999999999999999999999998766555444332 222334556678899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 004986 676 TDPSLRPSFAQLTVA 690 (720)
Q Consensus 676 ~DP~kRPS~~ELL~~ 690 (720)
.+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~il~~ 253 (277)
T cd06642 239 KDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCcCHHHHHHh
Confidence 999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=325.78 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=206.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec------
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR------ 505 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~------ 505 (720)
....|++.+.||+|+||.||+|.+ .++.+|+|++.... ....++..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346789999999999999999987 67889999875542 2345678899999998 79999999999853
Q ss_pred CCceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
...++++|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45689999999999999998653 345788889999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip 659 (720)
..............|+..|+|||++. +..++.++|||||||++|||++|..||....+......+..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 76543333334567999999999986 3457889999999999999999999998766544433332222222233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++.++.+||.+||..||.+||++.||+.+
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 4678999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.47 Aligned_cols=253 Identities=31% Similarity=0.513 Sum_probs=207.2
Q ss_pred CeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--Cce
Q 004986 438 DLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l 509 (720)
-|++.+.||+|+||.||++++ .+..||+|.+.... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478899999999999999974 46789999886543 334456789999999999999999999998775 568
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++.+....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999999765556899999999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHhhhhc
Q 004986 590 TFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------------PMQVVGAVGF 651 (720)
Q Consensus 590 ~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~---------------~~~i~~~i~~ 651 (720)
... ......++..|+|||++.+..++.++||||||+++|||++++.|+.... .......+ .
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL-E 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-H
Confidence 221 1123457778999999998889999999999999999999876643210 01111111 1
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 652 ~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.......+..++..+.+||.+||+.+|.+||++.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2223345667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=324.55 Aligned_cols=248 Identities=30% Similarity=0.491 Sum_probs=213.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
..|++.+.||.|+||.||+|.+ ++..||+|.+..... ......+.+|+.+++++.|+||+++++.+.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577788999999999999986 578999998875533 3446678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++++|.+++... .+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99999999998753 5889999999999999999999998 9999999999999999999999999997665433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
....++..|+|||.+.+..++.++|+||||+++|||++|..||...++......+. ......++..++..+.+||.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 34568899999999999889999999999999999999999998877665554432 22344555678889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
+.+|.+||++.+++.+
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 238 NKDPSFRPTAKELLKH 253 (277)
T ss_pred ccCcccCcCHHHHHhC
Confidence 9999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.48 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=213.6
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 507 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~ 507 (720)
..+.++-..|++++.||.||.+.||++.. +.+.||+|++.....+...+.-|.+|+..|.+| .|.+||+|++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 34567778999999999999999999987 567789998887777888888999999999999 6999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+||||||- ..+|..+|.+....+....+..|..||++|+.++|++| |||.||||.|+|+- .|.+||+|||+|..+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999999987 55999999887666665578889999999999999999 99999999999994 579999999999976
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccc
Q 004986 588 HNTF--LSSKSTAGTPEWMAPEVLRNEP-----------SNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQN 653 (720)
Q Consensus 588 ~~~~--~~~~s~~GT~~Y~APEvi~g~~-----------~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~ 653 (720)
.... ....+.+||+.||+||.+.... .+.++|||||||+||+|+.|++||.... ....+..|..-+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 5432 2234568999999999986443 3568999999999999999999997643 223333443333
Q ss_pred cccCCCCCCcHH-HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 RRLEIPKELDPL-VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ~~~~ip~~ls~~-l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...++|..-+.. +.++++.||.+||.+||++.+||+|
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 334555544444 9999999999999999999999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=334.68 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=199.4
Q ss_pred EeEEeeec--CcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 441 LGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 441 i~k~LGkG--~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
++++||+| +|++||++.+ +++.||||++............+.+|+.+++.++|||||+++++|..++.+++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999976 6899999998776555555667788999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc---
Q 004986 517 PRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 592 (720)
Q Consensus 517 ~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~--- 592 (720)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999998653 335899999999999999999999998 99999999999999999999999986543321110
Q ss_pred ----cCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-----------
Q 004986 593 ----SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 655 (720)
Q Consensus 593 ----~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~----------- 655 (720)
......++..|+|||++.+ ..++.++|||||||++|||++|..||......+..........+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122356788999999976 45889999999999999999999999865443322111100000
Q ss_pred ---------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ---------------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ---------------------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......+++.+.+||.+||+.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00112356789999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=325.69 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=206.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4689999999999999999987 57899999886654443345667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|++++.|.++.... ..+++.+++.++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99999998877553 35899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------------
Q 004986 595 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 654 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------------- 654 (720)
....++..|+|||++.+ ..++.++||||||+++|||++|..||......+....+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 44568899999999876 4478899999999999999999999976554332211110000
Q ss_pred -cc---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 -RL---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 -~~---------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. .....++..+.+|+.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 1123567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.45 Aligned_cols=249 Identities=31% Similarity=0.485 Sum_probs=215.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|++|.||+|++ +++.||||++...... .....+.+|+.++.+++|+||+++++.+.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4688999999999999999987 5889999998765433 446778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+++++|.+++... ..+++..++.++.||+.||.|||+ .+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999764 468999999999999999999999 88 999999999999999999999999999876544333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhhccccccCCCCC-CcHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKE-LDPLVARI 669 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~---~~~i~~~i~~~~~~~~ip~~-ls~~l~dL 669 (720)
.....++..|+|||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+. ......++.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 334568899999999999989999999999999999999999998763 344444443 2333445555 88999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||..+|++||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.90 Aligned_cols=244 Identities=27% Similarity=0.327 Sum_probs=205.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-C-----CceeEEeeeeecCCce
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-----PNVVLFMGAVTRPPNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-H-----pNIVkL~g~~~~~~~l 509 (720)
+|+|++.||+|+||.|.+|.+ +++.||||+++... ....+...|+.||..|+ | -|||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 789999999999999999976 78999999987653 33456678999999996 4 4899999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEecccccc
Q 004986 510 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 586 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~IKL~DFGlAk~ 586 (720)
|||+|.+ ..+|+++++.++ ..++...++.|+.||+.||.+||+.+ |||+|||||||||.+ ...|||+|||.++.
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999999 569999997643 46899999999999999999999998 999999999999974 34799999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc---------------
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 651 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~--------------- 651 (720)
..+... +++.++.|+|||+|.|.+|+.+.|||||||+++||++|.+.|.+.+..+.+..|..
T Consensus 341 ~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 341 ESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred cCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 766543 67889999999999999999999999999999999999999998877655432210
Q ss_pred -----cc------------------------------cccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 004986 652 -----QN------------------------------RRLEIP-----------KELDPLVARIIWECWQTDPSLRPSFA 685 (720)
Q Consensus 652 -----~~------------------------------~~~~ip-----------~~ls~~l~dLI~~cL~~DP~kRPS~~ 685 (720)
.. .....| ..-...+.+||.+||.+||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 00 000011 12234689999999999999999999
Q ss_pred HHHHH
Q 004986 686 QLTVA 690 (720)
Q Consensus 686 ELL~~ 690 (720)
|.++|
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 99987
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=317.43 Aligned_cols=250 Identities=28% Similarity=0.490 Sum_probs=213.3
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||++.. ++..+|+|.+............+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478899999999999999987 578899999876554444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccCCccc
Q 004986 516 LPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 516 ~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~~~~~ 593 (720)
+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++ .+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999986533 35789999999999999999999998 99999999999999886 4699999999866543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+. ......++..++..++++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 334468999999999998889999999999999999999999998877666554443 2223345567788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|..+|++||++.+++++
T Consensus 238 l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 238 FKVSPRDRPSITSILKR 254 (257)
T ss_pred hccChhhCcCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.94 Aligned_cols=267 Identities=26% Similarity=0.358 Sum_probs=210.2
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----ceE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 510 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~-----~l~ 510 (720)
.|.-.+++|.|+||.||+|.. ++..||||++..+..- -.+|++||+.++|||||+|..+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 477789999999999999976 6789999988654321 137999999999999999999885432 356
Q ss_pred EEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecccccc
Q 004986 511 IITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRL 586 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~DFGlAk~ 586 (720)
|||||++. +|.++++. .+..++...+.-+..||+.||.|||..| |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999975 88888863 3457888888889999999999999988 9999999999999965 9999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc------------cc
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------QN 653 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~------------~~ 653 (720)
+... ....++.-|+.|+|||.+.|. .|+.+.||||.||++.||+.|++-|.+.+..+.+..|.. .+
T Consensus 176 L~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7655 334667789999999999875 589999999999999999999999999776554432210 00
Q ss_pred cc------c---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCCCCCCCCCCCC
Q 004986 654 RR------L---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEIS 715 (720)
Q Consensus 654 ~~------~---------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~~~~~~~~~~~ 715 (720)
.. + .+....++++.+|+.++|..+|.+|.++.|++.|= -+..+..|...-+--.++|..+.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~-fFdelr~~~~~l~~g~~lp~lf~ 330 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP-FFDELRDPNTKLPNGRPLPPLFN 330 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch-hhHHhhCcCccCcCCCcCCCccC
Confidence 00 0 13346789999999999999999999999998762 22333344444444446665554
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=329.73 Aligned_cols=253 Identities=26% Similarity=0.320 Sum_probs=207.1
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 510 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~ 510 (720)
..++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999987 688999999876543333334566899999999999999999998765 4689
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+.+ +|.+++......+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999965 888888765567899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---------------
Q 004986 591 FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 654 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~--------------- 654 (720)
........++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222233456888999999876 4578999999999999999999999998777665543321000
Q ss_pred --ccCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 --RLEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 --~~~i-----------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+ ...+++.+.+||.+||+.||++||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 02357889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.37 Aligned_cols=250 Identities=29% Similarity=0.492 Sum_probs=220.6
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|.+.+.||.|+||.||++.+ ++..||+|++............+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588899999999999999987 488999999987766556677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 516 LPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 516 ~~ggsL~d~L~~~---~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
+++++|.+++.+. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999764 367899999999999999999999998 99999999999999999999999999987655432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
......|++.|+|||.+.+..++.++|+|+||+++++|++|..||...+..+....... .....++..++..+.+++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 33445789999999999998899999999999999999999999988877766665542 23445667889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||..+|++||++.+++.+
T Consensus 238 ~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 238 LLQKDPEERPSIAQILQS 255 (258)
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=344.55 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=221.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
-|.++++||+|+||.||++.+ .|..+|||.+..+ ..++++..|+.||++++.+++|++||.|.....+|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 377889999999999999966 7999999987543 3478899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
|..|++.++++.+...+.+.++..+++..++||+|||... -||||||..|||++.+|+.||+|||.|..+.+......
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999999999887789999999999999999999999986 79999999999999999999999999999888877788
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHHhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~dLI~~cL 674 (720)
+..||+.|||||++..-.|+.++|||||||+..||..|++||.+..+...+.-|..... .+..|...+.++-||++.||
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999888765544432211 11234566789999999999
Q ss_pred hcCCCCCCCHHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~L 691 (720)
-+.|++|.++.++++|-
T Consensus 268 iK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHT 284 (502)
T ss_pred cCCHHHHHHHHHHhhhh
Confidence 99999999999998873
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.85 Aligned_cols=245 Identities=26% Similarity=0.407 Sum_probs=196.5
Q ss_pred EeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 444 RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
.||+|+||.||+|.. ++..+|+|.+..... ......+.+|+.++++++||||+++++++.+...+++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 599999999999975 345689998765543 233457888999999999999999999999999999999999999
Q ss_pred CHHHHHcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc--c
Q 004986 520 SLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--S 593 (720)
Q Consensus 520 sL~d~L~~~~----~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~--~ 593 (720)
+|.+++.... ...++..+..++.|++.||+|||+.+ |+||||||+||+++.++++||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999986422 24566777889999999999999998 99999999999999999999999999975433221 1
Q ss_pred CCCCCCCCCccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc-cc---ccCCCCC
Q 004986 594 SKSTAGTPEWMAPEVLRNE-------PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ-NR---RLEIPKE 661 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~-------~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~-~~---~~~ip~~ 661 (720)
.....|+..|+|||++.+. .++.++||||||+++|||++ |..||......+........ .. .+.+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 2234678899999998643 35789999999999999996 99999877665544332211 11 1222335
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
++..+.+++.+|| .+|++||++++|++.|.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 6788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.46 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=207.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|++++++++|+||+++++.+...+.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999987 57899999887654444445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-c
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-~ 593 (720)
|++++.+..++.+. ..+++.+++.++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 99987777666543 45899999999999999999999998 99999999999999999999999999987654432 2
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------------c
Q 004986 594 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------N 653 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-------------------~ 653 (720)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+... .
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345788999999999888 7899999999999999999999999875543322111100 0
Q ss_pred -c----------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -R----------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -~----------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ....+..++.++++||.+||..+|++||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 001233458899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=368.99 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=209.5
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--C
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--P 507 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~ 507 (720)
.++..++|++++.||+|+||+||+|++ .+..||+|++............+..|+.+|+.|+|||||+++++|.+. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 345668999999999999999999987 577899999887766666677889999999999999999999988553 4
Q ss_pred ceEEEEeecCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCEEeeCCCCCcEEEcC-------
Q 004986 508 NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTST-----PTIVHRDLKSPNLLVDK------- 572 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~---~~~lse~~~~~Ia~qIa~AL~yLHs~g-----~~IIHrDLKPeNILLd~------- 572 (720)
.+||||||+++++|.++|... ...+++..++.|+.||+.||.|||..+ .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 589999999999999998642 246899999999999999999999853 24999999999999964
Q ss_pred ----------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004986 573 ----------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGM 640 (720)
Q Consensus 573 ----------~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~ 640 (720)
.+.+||+|||++....... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3459999999998654332 2234579999999999864 45889999999999999999999999765
Q ss_pred ChHH-HHhhhhccccccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 641 NPMQ-VVGAVGFQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 641 ~~~~-i~~~i~~~~~~~~ip-~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+... ++..+. . .+.++ ...+.++.+||..||..+|.+||++.|++.+
T Consensus 247 ~~~~qli~~lk-~--~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFSQLISELK-R--GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHHHHHHHHh-c--CCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 5433 333222 1 12222 4578999999999999999999999999954
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.11 Aligned_cols=248 Identities=28% Similarity=0.472 Sum_probs=199.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHH-HHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~i-L~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||++.+ +++.||||++........ ..++..|+.+ ++.++|+||+++++++..+...++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999987 689999999876543332 3445556655 56669999999999999999999999
Q ss_pred eecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 514 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 514 Ey~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
||++ ++|.+++.. ....+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 578777643 334689999999999999999999986 7 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCC-CCCc
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIP-KELD 663 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g----~~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip-~~ls 663 (720)
.. ......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||.... ..+....+. ......++ ..++
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 22 1233568899999999865 446889999999999999999999997532 222222222 22222333 3578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.++.+||.+||..+|.+||++.+++.+
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=321.04 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=210.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||.|+||.||++.+ +++.+|+|.+..... .....++.+|++++++++||||+++++.+...+.+++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 3678889999999999999987 488899998876543 3456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|+++++|.+++......+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999997654678999999999999999999999 87 99999999999999999999999999876543222
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHhhhhccccccCCCCC-CcHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIPKE-LDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~-----~~~i~~~i~~~~~~~~ip~~-ls~~l~ 667 (720)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+. ....+.++.. ++.+++
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 12678999999999999999999999999999999999999997642 222333332 2223344444 889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||..+|.+||++.+++.+
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhC
Confidence 99999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.42 Aligned_cols=245 Identities=27% Similarity=0.444 Sum_probs=196.3
Q ss_pred EeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 444 RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
.||+|+||.||+|+. ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.+...+++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 599999999999965 23467888765433 3444567889999999999999999999999999999999999999
Q ss_pred CHHHHHcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--cc
Q 004986 520 SLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LS 593 (720)
Q Consensus 520 sL~d~L~~~~----~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~~ 593 (720)
+|.+++.... ...++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999986532 23467788899999999999999998 9999999999999999999999999987532221 11
Q ss_pred CCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccc----ccCCCCC
Q 004986 594 SKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR----RLEIPKE 661 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-------~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~----~~~ip~~ 661 (720)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+..... ...++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 223456778999999753 346789999999999999998 7889988766655444322211 1234456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
++..+.+++..|| .||.+||++++|++.|.
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 7889999999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=325.55 Aligned_cols=254 Identities=29% Similarity=0.403 Sum_probs=211.5
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+..++|++.+.||+|+||+||++.+ +++.||+|++.... .......+.+|+++++.++||||+++++.+.....+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4557899999999999999999987 48899999876543 23346678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.+. ..+++..+..++.+++.||.|||+ ++ |+||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999999998764 368999999999999999999997 46 999999999999999999999999998754322
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHhhhhccccccCCC
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGFQNRRLEIP 659 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-----------~i~~~i~~~~~~~~ip 659 (720)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... +....+. ......++
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLP 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCC
Confidence 123457899999999998888999999999999999999999999865442 1122221 11122233
Q ss_pred C-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 660 K-ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 660 ~-~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
. .++.++.+||.+||+.||.+||++.|++++.--+
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 3 3788999999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=309.66 Aligned_cols=250 Identities=34% Similarity=0.549 Sum_probs=216.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceEEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIIT 513 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~LVm 513 (720)
+|.+.+.||+|++|.||+|.. +++.|++|++............+.+|+.++++++|+||+++++.+.+. ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 477889999999999999987 488999999877665555677889999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+++++|.+++.+.. .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999997654 7899999999999999999999988 99999999999999999999999999987655432
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 593 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 593 -~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
......++..|+|||.+.+...+.++|||+||+++|+|++|..||.... .......+........++..++..+++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334578999999999998889999999999999999999999998765 22333333222344567778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||..+|.+||++.+++.+
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.77 Aligned_cols=253 Identities=29% Similarity=0.509 Sum_probs=210.5
Q ss_pred eeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 439 LVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
|.+.+.||+|+||.||+|.+ ++..||||++...........++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56778999999999999975 3678999998776656666778889999999999999999999876532
Q ss_pred ceEEEEeecCCCCHHHHHcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 508 NLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~-----~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
..++++||+.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 24788999999999988642 1224788899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCC
Q 004986 583 LSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 583 lAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip 659 (720)
+++...... .......++..|++||.+.+..++.++||||||+++|+|++ |..||...+..+....+... .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCCCC
Confidence 998654321 11223345678999999999989999999999999999998 89999888776666555422 233445
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=325.57 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=207.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~LV 512 (720)
++|++.+.||.|+||.||+|++ +++.+|+|.+............+.+|+.++++++||||+++++++... ..+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788999999999999999987 578899999876554433344667899999999999999999998877 889999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++ +|.+++......+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 999975 999988765557899999999999999999999998 99999999999999999999999999987655433
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------------
Q 004986 593 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------- 652 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~------------------- 652 (720)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 333456789999999987654 688999999999999999999999877655443322100
Q ss_pred ----------ccccCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 ----------NRRLEIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 ----------~~~~~ip~~-ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.....++.. +++.+.+||.+||+.+|++||++.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000112222 58889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=320.77 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=212.1
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+|++.+.||.|+||.||+|.+ +++.||+|.+....... .....+.+|++++++++||||+++++.+.....+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 488999999999999999987 58999999987654332 456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+.+++|.+++... ..+++..+..++.||+.||.|||.++ |+|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999765 47899999999999999999999998 9999999999999999999999999987654432 22
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~---~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ........ .....++..++..+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--cccccCcccCcHHHHHHHH
Confidence 345688999999999988899999999999999999999999987663 33332221 1345677788999999999
Q ss_pred HhhhcCCCCCCCH--HHHHH
Q 004986 672 ECWQTDPSLRPSF--AQLTV 689 (720)
Q Consensus 672 ~cL~~DP~kRPS~--~ELL~ 689 (720)
+||+.||.+||++ +|++.
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHccCChhHcCCccHHHHhc
Confidence 9999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.49 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=204.6
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||.|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999987 688999998876544333445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+. ++|..++.. ....+++..++.++.||+.||+|||..+ ++||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 96 588888854 3356899999999999999999999998 9999999999999999999999999998654433333
Q ss_pred CCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------------
Q 004986 595 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 654 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------------- 654 (720)
....++..|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3446788999999987654 58899999999999999999999987655432221110000
Q ss_pred --------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 --------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 --------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+...++.++++||.+||+.||.+||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 001123567889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.73 Aligned_cols=245 Identities=31% Similarity=0.529 Sum_probs=205.7
Q ss_pred EeeecCcEEEEEEEECC--------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 444 RIGLGSYGEVYHADWNG--------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~~g--------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
.||+|+||.||+|++.. ..+|||.+.... ......++.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 59999999999997632 578999875432 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-----cEEEEecccc
Q 004986 516 LPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLS 584 (720)
Q Consensus 516 ~~ggsL~d~L~~~------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-----~IKL~DFGlA 584 (720)
+++++|.+++.+. ...+++.+++.++.||+.||.|||+.+ ++|+||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999998642 234788999999999999999999998 99999999999999877 8999999999
Q ss_pred ccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 004986 585 RLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 585 k~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ 661 (720)
+....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 75533211 1122345788999999999999999999999999999998 999998877766665553 2234456677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
++..+.+||.+||..+|.+||++.++++.|.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8999999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.25 Aligned_cols=250 Identities=30% Similarity=0.490 Sum_probs=205.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC--------HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~--------~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+|.+.+.||.|+||.||+|.. +++.||+|.+...... ......+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999976 6889999987642211 112346788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999765 46899999999999999999999998 999999999999999999999999999765
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC----C
Q 004986 588 HNTF--LSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI----P 659 (720)
Q Consensus 588 ~~~~--~~~~s~~GT~~Y~APEvi~g~~--~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~i----p 659 (720)
.... .......|+..|+|||.+.... ++.++|+||||+++|+|++|..||...+.......+........+ .
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 1123346889999999988754 788999999999999999999999766554433322212222222 2
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++..+++||.+||+.+|.+||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3568899999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.38 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=210.8
Q ss_pred CeeEeEEeeecCcEEEEEEEEC---CcEEEEEEEecCC--------CCHHHHHHHHHHHHHHHH-cCCCceeEEeeeeec
Q 004986 438 DLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQD--------FSGAALLEFKREVKIMRR-LRHPNVVLFMGAVTR 505 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~---g~~VAVK~i~~~~--------~~~~~~~e~~~Ei~iL~~-L~HpNIVkL~g~~~~ 505 (720)
.|++.+.||+|+||.||+|.+. ++.+|+|.+.... .......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999873 5789999876432 223345567789988875 699999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 506 PPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~---~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
.+..++||||+++++|.+++. .....+++..++.++.|++.+|.|||. .+ |+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998874 234568999999999999999999996 56 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ 661 (720)
|++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......+.....
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9998655432 334457899999999999988999999999999999999999999887766655555433222222236
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
++..+.+||.+||+.||.+||++.|+..+|+
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7899999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=308.10 Aligned_cols=247 Identities=31% Similarity=0.528 Sum_probs=211.6
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|++|.||++.+ +++.+++|++..... .....+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 578899999999999999987 488899999876543 3466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|.+++......+++..+..++.|++.||.+||..+ ++||||+|+||++++++.++|+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999776457899999999999999999999988 99999999999999999999999999986654322 33
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWEC 673 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~~ls~~l~dLI~~c 673 (720)
...|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......... ......+ ..++..+.+||.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 45789999999999988899999999999999999999999988755544433322 1122222 23488999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|+.||.+||++.+++++
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.05 Aligned_cols=250 Identities=28% Similarity=0.506 Sum_probs=208.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC----HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~----~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+|++.+.||+|+||.||+++. +++.||+|.+...... ......+.+|+.++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999976 7889999998754321 2235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999754 36889999999999999999999998 99999999999998776 5999999998765432
Q ss_pred cc----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccccccCCCCCCc
Q 004986 591 FL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 591 ~~----~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---~i~~~i~~~~~~~~ip~~ls 663 (720)
.. ......|+..|+|||++.+..++.++|||+||+++|+|++|..||...... .....+........++..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 112346889999999999888999999999999999999999999754432 22222222233455667789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+++.+++.+||..+|.+||++.+++.+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=341.51 Aligned_cols=245 Identities=23% Similarity=0.372 Sum_probs=216.4
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC--CcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
.+...+|..+.+||+|+||+|.++.++ .+.||||++++...- ....+-...|-++|.-. +-|++|+++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 456688999999999999999999884 566999998876542 22222234566777665 67999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||+.||+|-.++++-+ ++.+..+..+|.+|+.||-+||++| ||+||||.+|||+|.+|+|||+|||+++.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999999997754 6888888899999999999999999 9999999999999999999999999998655
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
-....+.++|||+.|+|||++..++|+..+||||+|++||||+.|++||.+.+..++++.|. +....+|+.++.++.+
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAVA 579 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHHH
Confidence 55566788999999999999999999999999999999999999999999999999999984 4467789999999999
Q ss_pred HHHHhhhcCCCCCC
Q 004986 669 IIWECWQTDPSLRP 682 (720)
Q Consensus 669 LI~~cL~~DP~kRP 682 (720)
+++.+|.+.|.+|.
T Consensus 580 ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHhhcCCcccc
Confidence 99999999999995
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.48 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=214.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC---C---HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---S---GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 507 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~---~---~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~ 507 (720)
+.|+-.+.||+|..++|.++.+ ++..+|+|++..... . ....+...+|+.||+++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566667899999999999965 788999998864321 1 12234457899999998 8999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++|+|.|+.|.|+|+|... -.+++....+|++|++.+++|||..+ ||||||||+|||++++.+|||+|||+++.+
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999999764 46899999999999999999999999 999999999999999999999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCC
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIP 659 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g------~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip 659 (720)
... ......|||++|+|||.+.. ..|+..+|+|++|++||.|+.|.+||......-++..|..+...+ +.+
T Consensus 174 ~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 655 44566899999999999864 347889999999999999999999998877666666664333322 334
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
.+++...++||.+||+.||++|.|++|.++|=
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 67889999999999999999999999999874
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=318.94 Aligned_cols=247 Identities=27% Similarity=0.484 Sum_probs=213.1
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
-|++.+.||.|+||.||+|.+ ++..||||.+..... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 467788999999999999976 678999998765433 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 9999999998653 5889999999999999999999998 99999999999999999999999999876544333333
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~ 675 (720)
...|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4578899999999998888999999999999999999999998877665555443 223444566788999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 004986 676 TDPSLRPSFAQLTVA 690 (720)
Q Consensus 676 ~DP~kRPS~~ELL~~ 690 (720)
.+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 239 KEPSFRPTAKELLKH 253 (277)
T ss_pred CChhhCcCHHHHHhC
Confidence 999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.59 Aligned_cols=242 Identities=23% Similarity=0.346 Sum_probs=187.1
Q ss_pred eEEeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCceEEEEee
Q 004986 442 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIITEF 515 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--~~~l~LVmEy 515 (720)
+++||+|+||+||+|++ +++.||+|.+...... ..+.+|+.+|++++||||+++++++.. ...+++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 45799999999999985 4578999988655432 346789999999999999999999854 4558899999
Q ss_pred cCCCCHHHHHcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEeccc
Q 004986 516 LPRGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 583 (720)
Q Consensus 516 ~~ggsL~d~L~~~--------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~IKL~DFGl 583 (720)
+. ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 95 4888877421 225888999999999999999999998 9999999999999 4668999999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHhhhh
Q 004986 584 SRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QVVGAVG 650 (720)
Q Consensus 584 Ak~~~~~~---~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~---------~i~~~i~ 650 (720)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98754322 122345789999999999874 5899999999999999999999999653321 0011000
Q ss_pred c-c--------------cc-----------cc----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 651 F-Q--------------NR-----------RL----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 651 ~-~--------------~~-----------~~----------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. . .. .. ......+..+.+||.+||+.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0 00 00 0001235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.80 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=201.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||.||+|+. +++.||||.+....... ....+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 68899999987543221 2234668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+.+ +|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99975 899998776567899999999999999999999998 999999999999999999999999998754322222
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhc-------------------c
Q 004986 594 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGF-------------------Q 652 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~-------------------~ 652 (720)
.....++..|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+.. .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 223457889999999876 457899999999999999999999997654 2221111100 0
Q ss_pred cccc---------CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 NRRL---------EIPKELD--PLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 ~~~~---------~ip~~ls--~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.... .....++ ..+.+||.+||+.+|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0001233 788999999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.71 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=206.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC-----C
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP-----P 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~-----~ 507 (720)
.++|++.+.||+|+||.||++.. +++.+|+|.+..... ....+.+|+.+++++ +||||+++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 47899999999999999999987 688999998865322 235677899999999 899999999998653 3
Q ss_pred ceEEEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 508 NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
.+++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecccc
Confidence 58999999999999998853 3346899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCC
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEI 658 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~-----~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~i 658 (720)
..............|+..|+|||++.... ++.++|||||||++|+|++|+.||...+..+....+.... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence 86554333333457899999999986432 6789999999999999999999998877655444432211 11223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+...+..+.+||.+||+++|.+||++.+++++
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 44567889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.43 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=209.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||++.+ .++.||+|.+...... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4689999999999999999987 5788999988765432 233457789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-- 591 (720)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999664 36899999999999999999999998 9999999999999999999999999986421100
Q ss_pred -------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccC
Q 004986 592 -------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLE 657 (720)
Q Consensus 592 -------------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ 657 (720)
.......|+..|+|||.+.+..++.++|+||||+++|||++|..||.+....+....+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011124578899999999988899999999999999999999999998877776665543221 122
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
....++.++++||.+||+.+|.+||++.++++.|+
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 23367899999999999999999999655544444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.32 Aligned_cols=238 Identities=22% Similarity=0.368 Sum_probs=194.7
Q ss_pred EeeecCcEEEEEEEEC--------------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 444 RIGLGSYGEVYHADWN--------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~~--------------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.||+|+||.||+|++. ...||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 5999999999999752 2247888765432 23345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-------EEEEecc
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VKVSDFG 582 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-------IKL~DFG 582 (720)
++||||+++++|..++.+....+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999999998766567899999999999999999999998 999999999999987664 8999999
Q ss_pred ccccccCCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHhhhhccccccCCCC
Q 004986 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPK 660 (720)
Q Consensus 583 lAk~~~~~~~~~~s~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELl-tG~~PF~~~~~~~i~~~i~~~~~~~~ip~ 660 (720)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..||......+..... ........
T Consensus 158 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~~ 230 (262)
T cd05077 158 IPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLVT 230 (262)
T ss_pred CCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCCC
Confidence 98754322 2346888999999987 566899999999999999997 588888776544432211 11222333
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
..+.++.+||.+||+.||.+||++.+|+++|+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 45678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=309.73 Aligned_cols=249 Identities=31% Similarity=0.561 Sum_probs=217.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|++|.||++++ .++.||+|.+............+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478899999999999999977 578899999987766556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999765 47899999999999999999999998 99999999999999999999999999987655433334
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~ 675 (720)
...++..|+|||.+.+..++.++|||+||+++|+|++|..||............. ......++..++..+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999988888999999999999999999999998766544443332 233445677889999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 004986 676 TDPSLRPSFAQLTVA 690 (720)
Q Consensus 676 ~DP~kRPS~~ELL~~ 690 (720)
.+|++||++.+++.+
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=315.98 Aligned_cols=241 Identities=26% Similarity=0.393 Sum_probs=209.4
Q ss_pred eeecCcEEEEEEEEC--CcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 445 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 445 LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
||.|+||.||+|+.. ++.||+|++...... ......+.+|+.+++.++|+||+++++.+.++..+++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999884 889999998765433 23456788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCC
Q 004986 522 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 601 (720)
Q Consensus 522 ~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~ 601 (720)
.+++.+.. .+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++....... ......|+.
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 99997643 5899999999999999999999998 9999999999999999999999999998765432 223457899
Q ss_pred CccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 004986 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 679 (720)
Q Consensus 602 ~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~--~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~ 679 (720)
.|++||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+........+|...+.++++||.+||+.+|.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999998889999999999999999999999998776 55555555433456667777899999999999999999
Q ss_pred CCCC-----HHHHHH
Q 004986 680 LRPS-----FAQLTV 689 (720)
Q Consensus 680 kRPS-----~~ELL~ 689 (720)
+||+ ++|+++
T Consensus 237 ~R~~~~~~~~~~l~~ 251 (262)
T cd05572 237 ERLGNLKGGIKDIKK 251 (262)
T ss_pred hCcCCcccCHHHHhc
Confidence 9999 788876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.27 Aligned_cols=238 Identities=22% Similarity=0.369 Sum_probs=197.4
Q ss_pred EeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 444 RIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.||+|+||.||+|.+. ...+|+|.+.... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5999999999999762 2347888764332 2334577889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--------EEEEecccccc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRL 586 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--------IKL~DFGlAk~ 586 (720)
|+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++|+|||++..
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999876667899999999999999999999998 999999999999987765 69999999865
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~-~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||...+........ .....++...+.
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAPKWT 230 (258)
T ss_pred cCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCCCcH
Confidence 432 223568899999999986 45789999999999999999984 666665554433222 224456667788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
++.+||.+||+.+|.+||+++++++.|+
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 9999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.49 Aligned_cols=237 Identities=24% Similarity=0.405 Sum_probs=194.6
Q ss_pred EEeeecCcEEEEEEEECCc------------EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 443 ERIGLGSYGEVYHADWNGT------------EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~g~------------~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+.||+|+||.||+|.+... .+++|.+..... ....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3599999999999987432 377776544322 15678899999999999999999999988 7789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-------cEEEEeccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGL 583 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-------~IKL~DFGl 583 (720)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999775557899999999999999999999998 99999999999999887 899999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCC
Q 004986 584 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 660 (720)
Q Consensus 584 Ak~~~~~~~~~~s~~GT~~Y~APEvi~g~--~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~ 660 (720)
+..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+......... .....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCCC
Confidence 986543 2234577889999999877 78999999999999999999 588887765443333222 1222223
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.....+.+||.+||..+|.+||++.++++.|+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 33488999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=312.38 Aligned_cols=248 Identities=29% Similarity=0.485 Sum_probs=216.3
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||+|+||.||++++ ++..+|+|.+...........++.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 488999999999999999976 678899999887665555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 516 LPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 516 ~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
+++++|.+++.+ ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999998855 2346899999999999999999999998 999999999999999999999999999876554
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.. .....++..++.++++++.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCchhhCHHHHHHHHH
Confidence 22335688999999999999899999999999999999999999998887666555432 22334556788999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 236 MLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HcCCCcccCCCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.19 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=194.9
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
....|++.+.||+|+||.||+|++ +++.||+|+.... ....|+.++++++|+|||++++++.+....++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 345799999999999999999988 5678999974332 224689999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+. ++|.+++......+++..++.|+.||+.||.|||.++ ||||||||+|||++.++.+||+|||+++..... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence 99995 5888888766667999999999999999999999998 999999999999999999999999999754322 2
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHhhhhc-cccccCCC-
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGF-QNRRLEIP- 659 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-----------~i~~~i~~-~~~~~~ip- 659 (720)
......||..|+|||++.+..++.++|||||||++|||+++..++....+. .+...+.. ...+..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 223467999999999999999999999999999999999865554332111 01110000 00000011
Q ss_pred -----------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 -----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 -----------------------------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++.++.+||.+||+.||.+|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1346677889999999999999999999876
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.04 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=212.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC---CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--Cce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~---~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l 509 (720)
.+|++.+.||+|+||.||++++ ++..||+|.+.... ........+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999986 68899999875432 2234456788999999999999999999998764 458
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999987543 5789999999999999999999998 99999999999999999999999999986532
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 ~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.. .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.....+..+|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 112235689999999999998899999999999999999999999988766655555544445566788899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+++|.+||. +|.+||++.+++.|
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhcC
Confidence 999999998 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=320.08 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=202.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|++|+||+|++ +++.||+|++............+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999986 57889999886654433344567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEeccccccccCCcc
Q 004986 515 FLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 515 y~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~~~~~~~ 592 (720)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 996 478777754 3334678888899999999999999998 999999999999985 56799999999976543322
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-cc----------------
Q 004986 593 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NR---------------- 654 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-~~---------------- 654 (720)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 23345678999999998764 5789999999999999999999999876654333221100 00
Q ss_pred ------cc----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 ------RL----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ------~~----~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. .....++..+.+|+.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0123567889999999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=354.07 Aligned_cols=246 Identities=30% Similarity=0.437 Sum_probs=215.4
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.|.-++.||.|+||.||.+++ +...||||++.... ...+...++..|+..|++++|||+|.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366678899999999999987 78889999997754 344567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|| -|+-.|++.-.+.++.+.++..|+.+.+.||.|||+++ .||||||..|||+.+.|.|||+|||.|.... ..
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----PA 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMA----PA 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcC----ch
Confidence 99 55777877655567999999999999999999999999 9999999999999999999999999997653 34
Q ss_pred CCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 595 KSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
.+++||+.|||||+|. .+.|+-++|||||||+..||...++|+..++....+..|.....+.-.....+..|+.|+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 5699999999999985 4568999999999999999999999999999988887776443333333567889999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
.||++-|.+|||.+++++|
T Consensus 260 ~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHhhCcccCCcHHHHhhc
Confidence 9999999999999988765
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.62 Aligned_cols=251 Identities=24% Similarity=0.275 Sum_probs=201.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc-----
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN----- 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~----- 508 (720)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999987 688999998765543333345678899999999 56999999999887666
Q ss_pred eEEEEeecCCCCHHHHHcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEeccc
Q 004986 509 LSIITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGL 583 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~----~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGl 583 (720)
.|+||||+++ +|.+++... ...+++..++.++.||+.||.|||.++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 788887542 245899999999999999999999998 999999999999998 89999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--------
Q 004986 584 SRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------- 654 (720)
Q Consensus 584 Ak~~~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-------- 654 (720)
++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9865433232333467889999998865 4578999999999999999999999987665443322110000
Q ss_pred --------------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 --------------R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 --------------~----~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ......++..+.+||.+||..||.+||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00113578889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.73 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=208.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCceEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~---HpNIVkL~g~~~~~~~l~LV 512 (720)
.|++.+.||+|+||.||+|.+ +++.||+|.+.... ......++.+|+.++++++ ||||+++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999987 68899999886543 2334567889999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999998653 6899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC-CCcHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARII 670 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~-~ls~~l~dLI 670 (720)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+... ....++. .++.++.+|+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3444579999999999875 44688999999999999999999999887665544333211 2233333 3788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||+.||.+||++.+++.+
T Consensus 236 ~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 236 AACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.41 Aligned_cols=276 Identities=23% Similarity=0.298 Sum_probs=225.7
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHH-HHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAA-LLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~-~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+..+.|...++||+|+||.||-++. +|+.||+|++.+..+.... ..-..+|.+||+++..++||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 345668899999999999999998854 8999999988766554322 2345789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+||||..|.||+|..+|...+ ..+++..++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+++|.|+|||..+
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999999987633 46999999999999999999999998 999999999999999999999999999877
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCc
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----~i~~~i~~~~~~~~ip~~ls 663 (720)
.... .....+||.+|||||++.++.|+...|||+|||+||||+.|+-||...... ++-..+ .....+++..++
T Consensus 338 ~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS 414 (591)
T KOG0986|consen 338 PEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFS 414 (591)
T ss_pred CCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccC
Confidence 6543 334559999999999999999999999999999999999999999864432 222233 334556788999
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHHH--HH-----hh-hHhcCCCCCCCCCCCCCC
Q 004986 664 PLVARIIWECWQTDPSLRPS-----FAQLTVA--LK-----PL-QRLVIPSHPDQPSSALPQ 712 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS-----~~ELL~~--L~-----~i-~~~~~p~~p~~~~~~~~~ 712 (720)
+++++|.+.+|++||.+|.. +.++.+| ++ ++ ..++.|.+--.|..++-+
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyak 476 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAK 476 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchh
Confidence 99999999999999999974 4455554 11 22 344555555444454443
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.03 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=209.4
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
.|.....||+|+||.||++.. +++.||+|.+...... ....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 344556799999999999976 6889999998654332 245678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999998865 35899999999999999999999998 99999999999999999999999999976544333334
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHHHhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~ip~~ls~~l~dLI~~cL 674 (720)
...|+..|+|||++.+..++.++||||||+++|||++|..||......+....+.... .....+..++..+.+||.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 4679999999999999889999999999999999999999998877655554443211 112234567889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
+.+|.+||++.+++++
T Consensus 256 ~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 256 TREPQERATAQELLDH 271 (297)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.67 Aligned_cols=248 Identities=29% Similarity=0.417 Sum_probs=208.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|.....||+|+||.||++.. ++..||||++.... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3455567799999999999976 68899999886533 2335568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||++..........
T Consensus 100 ~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999999998653 5889999999999999999999998 9999999999999999999999999987654433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~ip~~ls~~l~dLI~~c 673 (720)
....|+..|+|||.+.+..++.++||||||+++|||++|..||...+..+....+.... ........++..+.+|+.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 44578999999999998889999999999999999999999998877665544432111 11122335788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|..||.+||++++++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.84 Aligned_cols=242 Identities=31% Similarity=0.508 Sum_probs=212.5
Q ss_pred EeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 444 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
+||+|.||+||-|++ +...+|||.+...+. ...+-+..||.+.++|+|.|||+++|.+.+++.+-|.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 699999999999987 556679998765442 2345678999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccccccCCcccCCCCC
Q 004986 522 FRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 522 ~d~L~~~~~~l--se~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
.++|+..=+++ ++..+-.+.+||++||.|||++. |||||||-+||||+ -.|.+||.|||.++.+..-...+.++.
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 99998755556 88889999999999999999998 99999999999998 689999999999998776666778899
Q ss_pred CCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 004986 599 GTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675 (720)
Q Consensus 599 GT~~Y~APEvi~g~--~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~ 675 (720)
||..|||||+|..+ .|+.++|||||||++.||.||++||.... +....-++......+.+|..++.+++.||.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 99999999999765 48999999999999999999999998753 3444445555566778999999999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 004986 676 TDPSLRPSFAQLTV 689 (720)
Q Consensus 676 ~DP~kRPS~~ELL~ 689 (720)
.||..||++.+++.
T Consensus 818 pd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcccCccHHHhcc
Confidence 99999999999986
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.76 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=198.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|.. ++..||+|.+...... .....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999976 6889999998654322 223356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+. ++|.+++......+.+..+..++.||+.||.|||.++ |+|+||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 996 6777766554456788888899999999999999998 9999999999999999999999999997654333233
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhc--c-----------------c
Q 004986 595 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGF--Q-----------------N 653 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~--~-----------------~ 653 (720)
....++..|+|||++.+. .++.++||||||+++|+|++|..||...... +.+..+.. . .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 345678999999998764 5788999999999999999999999765432 11111100 0 0
Q ss_pred c--ccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 R--RLEIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ~--~~~ip---------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ....+ ...+..+.+|+.+||..||.+|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 00000 0125689999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=321.69 Aligned_cols=248 Identities=29% Similarity=0.428 Sum_probs=207.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
..|.+.+.||+|+||+||+|+. +++.||+|++..... ......++.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688899999999999999987 688999999865433 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+. |+|.+++......+++..+..++.||+.||.|||..+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9997 5777776554456899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
....|+..|+|||++. ...++.++||||||+++|||++|..||...+.......+.........+..++..+++||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 2457889999999984 355788999999999999999999999887766655444322222222345678999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L 691 (720)
.+||..+|.+||++.+++.+.
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHhcCChhhCcCHHHHhcCh
Confidence 999999999999999998863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=319.77 Aligned_cols=252 Identities=24% Similarity=0.305 Sum_probs=200.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
.++|++.+.||+|+||.||+|.. +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 36799999999999999999987 6889999988765433333345668999999999999999999886654
Q ss_pred --ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 508 --NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 508 --~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
..++||||+.+ +|.+++......+++.+++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 35999999964 888888765557899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcc----cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc------
Q 004986 586 LKHNTFL----SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------ 654 (720)
Q Consensus 586 ~~~~~~~----~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------ 654 (720)
....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 6543221 112346788999999987654 68899999999999999999999987765443322211000
Q ss_pred -----------ccCC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 -----------RLEI-------------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 -----------~~~i-------------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+ +...+..+++||.+||+.||.+||+++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 11235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=348.48 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=224.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
..|.+.+.||+|.|++|.++++ ++..||||.+.+..........+.+|+++|+.|+|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 5689999999999999999987 79999999999988877777779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+.+|.+++++.+.+ ...+..+..++.|++.|++|||.++ |||||||++||||+.+.++||+|||++..+.. ....
T Consensus 136 ya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~l 211 (596)
T KOG0586|consen 136 YASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLML 211 (596)
T ss_pred eccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecc-cccc
Confidence 999999999998765 5666888889999999999999999 99999999999999999999999999998763 3456
Q ss_pred CCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.++||++.|.|||++.+..| +..+|+|+||++||-|++|..||.+.+..+........ +..+|..++.++.+||+++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--eecccceeechhHHHHHHh
Confidence 77999999999999999887 67899999999999999999999998887776665433 4567778999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|-++|.+|++++++..+
T Consensus 290 lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hccCccccCCHHHhhhh
Confidence 99999999999998764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.96 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=203.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|++.+.||.|++|.||+|++ +++.||||++...... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 488999999999999999987 6889999998765432 2244567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 516 LPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 516 ~~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8888875432 46899999999999999999999998 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc----------------ccc
Q 004986 594 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RRL 656 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~----------------~~~ 656 (720)
.....++..|++||++.+. .++.++|||+||+++|+|++|..||.+.+..+....+.... ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3345678999999998664 57889999999999999999999998776554433221000 000
Q ss_pred C-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 E-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ~-----------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. +...++..++++|.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 112457789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=361.56 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=210.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.++||+|+||.||+|.+ +++.||||++...... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999987 5889999998764332 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccc
Q 004986 514 EFLPRGSLFRILHRP----------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~----------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGl 583 (720)
||++|++|.+++... ....+...++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999988531 123456677889999999999999998 99999999999999999999999999
Q ss_pred cccccCC------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 004986 584 SRLKHNT------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 645 (720)
Q Consensus 584 Ak~~~~~------------------~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i 645 (720)
++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865210 0111234799999999999999999999999999999999999999987655443
Q ss_pred HhhhhccccccC--CCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhH
Q 004986 646 VGAVGFQNRRLE--IPKELDPLVARIIWECWQTDPSLRP-SFAQLTVALKPLQR 696 (720)
Q Consensus 646 ~~~i~~~~~~~~--ip~~ls~~l~dLI~~cL~~DP~kRP-S~~ELL~~L~~i~~ 696 (720)
....... .+.. ....+++.+.+++.+||..||.+|+ +++++++.|+.+..
T Consensus 240 ~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3221111 1111 1236788999999999999999995 67888888887644
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=323.00 Aligned_cols=242 Identities=25% Similarity=0.370 Sum_probs=186.3
Q ss_pred eEEeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCceEEEEee
Q 004986 442 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIITEF 515 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--~~~l~LVmEy 515 (720)
+.+||+|+||+||+|++ ++..||+|.+...... ..+.+|+.+|++++||||+++++++.. ...+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 46799999999999986 3468999988654332 356789999999999999999998854 5568999999
Q ss_pred cCCCCHHHHHcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEeccc
Q 004986 516 LPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 583 (720)
Q Consensus 516 ~~ggsL~d~L~~--------~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~IKL~DFGl 583 (720)
+.+ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 965 77777642 1235788999999999999999999998 9999999999999 5678999999999
Q ss_pred cccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH----------HHHhhh
Q 004986 584 SRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM----------QVVGAV 649 (720)
Q Consensus 584 Ak~~~~~~~---~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~----------~i~~~i 649 (720)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... +....+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 986643321 22345789999999999774 5789999999999999999999999753321 000000
Q ss_pred hc--------------cc---------cc------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 650 GF--------------QN---------RR------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 650 ~~--------------~~---------~~------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. .. .. .......+..+.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 00 00 00011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.14 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=215.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LV 512 (720)
++|++.+.||+|+||.||+++. ++..||+|++..... .......+.+|+.+++++. |+||+++++++.+.+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999987 689999999876433 3334567889999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc-
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~- 591 (720)
|||+++++|.+++.+.. .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999997653 6999999999999999999999998 9999999999999999999999999988654322
Q ss_pred -------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc
Q 004986 592 -------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 652 (720)
Q Consensus 592 -------------------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~ 652 (720)
.......|+..|+|||++.+..++.++|+|+||++++++++|+.||...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 12233467899999999998889999999999999999999999999877655555443
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 004986 653 NRRLEIPKELDPLVARIIWECWQTDPSLRPSF----AQLTVA 690 (720)
Q Consensus 653 ~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~----~ELL~~ 690 (720)
.....++..+++.+.+||.+||+.+|.+||++ ++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 33445677889999999999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.33 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=203.6
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|++.+.||.|++|.||+|.+ +++.||+|++............+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999986 6899999998765444333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 517 PRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 517 ~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+ ++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68999886543 46899999999999999999999998 99999999999999999999999999976543322223
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------------
Q 004986 596 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------------- 652 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~---------------------- 652 (720)
...++..|+|||++.+. .++.++||||||+++|+|++|..||...+.......+...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34678899999988764 4688999999999999999999999876553322111000
Q ss_pred -----ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 -----NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 -----~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.........++..+.+||.+||+.+|.+||+++|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00001234567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=314.27 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=199.1
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC--CceEEEE
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNLSIIT 513 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~--~~l~LVm 513 (720)
|++.+.||+|+||.||+|.. +++.||+|++........ .....+|+.++.++ +|+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999986 688999998876432222 23445788899998 499999999999987 8899999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||++ ++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||+++. +.+||+|||+++.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9997 4788877665557899999999999999999999998 999999999999999 9999999999986643322
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc----------------cccc
Q 004986 594 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------------NRRL 656 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~----------------~~~~ 656 (720)
.....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+..+....+... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 233568899999997654 55788999999999999999999999887665443322100 0000
Q ss_pred CC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 EI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ~i-----------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+ ...++..+.+||.+||+.+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11 13567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=318.65 Aligned_cols=247 Identities=30% Similarity=0.430 Sum_probs=209.1
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|...+.||+|++|.||++.+ +++.+++|++..... .....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567899999999999976 678899998764332 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999976 35899999999999999999999998 99999999999999999999999998876544333333
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHHhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~dLI~~cL 674 (720)
...|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..... ....+..++..+.+||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 45789999999999998899999999999999999999999988777666555542211 11223347889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
+.+|.+||++.+++++
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.39 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=210.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||.||++.. ++..||+|.+..... .....+.+|+.+++.++||||+++++.+...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47899999999999999999975 678899998854432 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999999999753 4788899999999999999999998 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-~~~~~~ip~~ls~~l~dLI~~ 672 (720)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. .......+..++..+++||.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 3345789999999999888899999999999999999999999987665443322211 111222344578899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||..+|.+||++.+++.+
T Consensus 252 ~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 252 CLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.55 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=207.4
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|++.+.||.|++|.||+|.. +++.+|+|.+............+.+|+.++++++|+||+++++++.+...+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999987 6888999998766555445667888999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCC
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s 596 (720)
++ +|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 75 888888765567899999999999999999999998 999999999999999999999999999876544322233
Q ss_pred CCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--------------------
Q 004986 597 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-------------------- 655 (720)
Q Consensus 597 ~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~-------------------- 655 (720)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5688899999999876 7899999999999999999999999876654433222110000
Q ss_pred --------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 --------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 --------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......++.++++||.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 01123467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=345.04 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=197.7
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
...|.+.+.||+|+||.||++.+ .++.||||... ...+.+|+++|++++|+|||++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999988 57889999532 123568999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
|++. ++|.+++......+++.+++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9995 6888888765557999999999999999999999998 99999999999999999999999999986543211
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHhhhhccccc-cCCC---
Q 004986 593 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------PMQVVGAVGFQNRR-LEIP--- 659 (720)
Q Consensus 593 -~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~--------~~~i~~~i~~~~~~-~~ip--- 659 (720)
.....+||..|+|||++.+..++.++|||||||+||||++|..|+.... ..++...+...... ..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234579999999999999999999999999999999999886654321 11222221110000 0000
Q ss_pred ----------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 ----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 ----------------------------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++..+.+||.+||+.||.+||++.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1345689999999999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=317.18 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=213.0
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.+.|++.+.||+|+||.||+|.+ .+..||+|++..... ....+.+|+.+++.++|+||+++++.+......++|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 46688889999999999999988 488999999876543 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++......+++..++.++.|++.||.|||+.| |+|+||+|+||+++.++.++|+|||++.........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999875447899999999999999999999988 999999999999999999999999998755433222
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~dLI~~ 672 (720)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..... ....+..++..+++||.+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 2344688899999999988899999999999999999999999988776655444432211 112233478899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.+|.+||++.+++.+
T Consensus 253 ~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 253 CLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HhccChhhCcCHHHHhhC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.31 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=202.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------C
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------~ 507 (720)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++|+||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 37899999999999999999986 788999999876544444556778899999999999999999988644 3
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..|+||||+. ++|.+.+... +++..+..++.||+.||+|||.++ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 4799999996 4888887642 888999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 652 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~--------------- 652 (720)
.... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 4432 233456899999999999999999999999999999999999999876543322111000
Q ss_pred -----cccc---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 -----NRRL---------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 -----~~~~---------------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.... ..+...+..+++||.+||+.||.+||++.|++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0011345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=317.40 Aligned_cols=238 Identities=22% Similarity=0.367 Sum_probs=194.9
Q ss_pred EeeecCcEEEEEEEEC--------------------------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCcee
Q 004986 444 RIGLGSYGEVYHADWN--------------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~~--------------------------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIV 497 (720)
.||+|+||.||+|.+. ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999998641 1347888775432 22345678899999999999999
Q ss_pred EEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---
Q 004986 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 574 (720)
Q Consensus 498 kL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g--- 574 (720)
++++++.+....++||||+++++|..++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999765567899999999999999999999998 99999999999997643
Q ss_pred ----cEEEEeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHhh
Q 004986 575 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGA 648 (720)
Q Consensus 575 ----~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELl-tG~~PF~~~~~~~i~~~ 648 (720)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||......+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999988643221 22457889999998875 56899999999999999984 79999987765544332
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.. ....++....+.+.+||.+||+.+|.+||++.++++.|+
T Consensus 234 ~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 21 123344556788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=319.04 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=200.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|+..+.||+|+||.||++.+ +++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 35677888999999999999987 6789999998765433 44567889999999995 99999999999999999999
Q ss_pred EeecCCCCHHHHH---c-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 513 TEFLPRGSLFRIL---H-RPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 513 mEy~~ggsL~d~L---~-~~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
|||+.. +|.++. . .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999864 554432 2 2235689999999999999999999974 7 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccccc----CCC
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL----EIP 659 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~---~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~~~----~ip 659 (720)
..... .....|+..|+|||++.+. .++.++|||||||++|+|++|..||...... +....+. ....+ ..+
T Consensus 159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (288)
T cd06616 159 VDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE 236 (288)
T ss_pred ccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence 43322 2334689999999999876 6889999999999999999999999765421 1111111 11111 122
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++.++.+||.+||+++|.+||++++|+.+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3578899999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.44 Aligned_cols=252 Identities=28% Similarity=0.423 Sum_probs=211.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
..|...+.||+|+||.||++++ ++..||+|++..... .......+.+|++++++++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4478889999999999999986 678999999875433 3334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+.+ +|.+++......+++.++..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 99975 788877655567899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.....|+..|+|||.+. ...++.++|||||||++|+|++|..||...+.......+............++..+++||
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 23357899999999974 456788999999999999999999999887766555554433333333456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 671 WECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.+||+.+|.+||++.++++++-.+.
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhc
Confidence 9999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=347.01 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=231.4
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEECCcE--EEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~--VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
++.+.+++++..||-|+||.|-+++.++.. +|+|++++.... ......+..|.+||..++.|+||++|..|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 466788999999999999999999886655 899998876543 33456688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
||+||-|-||.|+.+|++++ .+++..+..++..+++|++|||.++ ||+|||||+|+|++.+|.+||.|||+|+.+..
T Consensus 496 YmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999999998765 6888888888889999999999999 99999999999999999999999999998876
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
. ..+.++|||++|.|||++..+..+.++|.|+|||++|||++|.+||.+.++...+..|........+|..+.....+|
T Consensus 573 g-~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 G-RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred C-CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 6 456679999999999999999999999999999999999999999999999999999998888899999999999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHHH
Q 004986 670 IWECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
|+++...+|.+|.. +.+|.+|
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhh
Confidence 99999999999975 6677665
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.89 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=205.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP---- 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~---- 507 (720)
...++|++.+.||+|+||.||+|.+ +++.||||.+............+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999987 5789999998765433333456778999999999999999999987655
Q ss_pred ------ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 508 ------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 508 ------~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
.+++|+||+++ +|..++......+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 777777665557899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCcc-cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc----
Q 004986 582 GLSRLKHNTFL-SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---- 655 (720)
Q Consensus 582 GlAk~~~~~~~-~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~---- 655 (720)
|++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99986543321 11223567889999988653 4788999999999999999999999876654433222110000
Q ss_pred ------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ------------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......++..+.+||.+||+.+|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00122468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.58 Aligned_cols=241 Identities=27% Similarity=0.359 Sum_probs=201.2
Q ss_pred eeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 445 LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
||+|+||+||+|.+ +++.||+|.+....... .....+..|+.+|++++||||+++++.+...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999976 68899999987643322 2234567899999999999999999999999999999999999999
Q ss_pred HHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 004986 522 FRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 600 (720)
Q Consensus 522 ~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT 600 (720)
.+++.+.. ..+++..++.++.|++.||.|||+++ |+||||+|+|||++.++.+||+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99986533 36899999999999999999999998 999999999999999999999999998765432 222345688
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 004986 601 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676 (720)
Q Consensus 601 ~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~ 676 (720)
..|+|||++.+..++.++||||||+++|+|++|+.||...... ++...+ .......+..+++.+.+||.+||+.
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--LEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--ccccccCCccCCHHHHHHHHHHccC
Confidence 8999999999888999999999999999999999999775432 222222 2234456677899999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 004986 677 DPSLRP-----SFAQLTVA 690 (720)
Q Consensus 677 DP~kRP-----S~~ELL~~ 690 (720)
+|.+|| ++.+++.+
T Consensus 236 ~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 236 DPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ChhHccCCCcccHHHHHhC
Confidence 999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.74 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=211.9
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
....++++++..||.|+.|+|++++. ++...|||.+.+.... +..+.++..+.++... .+|+||+++|+|..+..+
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34456778889999999999999987 5689999999887654 3456666777766655 589999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++.||.| ...+..++.+-+.+++|..+-++...++.||.||.++. +|||||+||+|||+|+.|+|||||||++-.+.+
T Consensus 167 ~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999998 55677788776778999999999999999999998763 499999999999999999999999999987766
Q ss_pred CcccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCC--CCc
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPK--ELD 663 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~---~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip~--~ls 663 (720)
.. ..+..+|.+.|||||.+.-. .|+.++|||||||+++||.||++||.+.+ +.+++..+.. +.++.++. .++
T Consensus 245 Sk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 245 SK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFS 322 (391)
T ss_pred cc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcC
Confidence 53 34456899999999999643 58999999999999999999999999843 4455555543 44454543 489
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+++.+|+..||++|+.+||.+.++++|
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999998875
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.95 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=203.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~LV 512 (720)
++|++.+.||.|++|.||+|.+ +++.+|+|.+..... ......+.+|++++++++|+||++++++|.+. ..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4688999999999999999987 678899998875533 24456788999999999999999999988654 468999
Q ss_pred EeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 513 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 513 mEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988642 3346889999999999999999999998 99999999999999999999999999875543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHhhhhccccccCCC-----
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIP----- 659 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~-----~~~i~~~i~~~~~~~~ip----- 659 (720)
.. .....++..|+|||.+.+..++.++|||+||+++|+|++|..||.... ..+....+... ....++
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPGN 234 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCCC
Confidence 22 123567889999999999999999999999999999999999997652 22333333211 111111
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 -~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...++.+.+||.+||..+|.+||++.|++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2346789999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.79 Aligned_cols=245 Identities=22% Similarity=0.388 Sum_probs=194.4
Q ss_pred EeeecCcEEEEEEEE-CC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 444 RIGLGSYGEVYHADW-NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~-~g---~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
.||+|+||.||+++. ++ ..+++|.+.... .......+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999975 32 345566654433 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC--cccC
Q 004986 520 SLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSS 594 (720)
Q Consensus 520 sL~d~L~~~~---~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~--~~~~ 594 (720)
+|.+++.+.. ....+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999997532 24566777889999999999999998 999999999999999999999999998643221 1122
Q ss_pred CCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc----cccCCCCCC
Q 004986 595 KSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN----RRLEIPKEL 662 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g-------~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~----~~~~ip~~l 662 (720)
...+|+..|+|||++.. ..++.++||||||+++|||++ |..||...+..+....+.... .++.++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34578899999999853 235779999999999999996 577887777665554432221 123344567
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
++.+.+++..|| .+|.+||++++|++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 889999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.54 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=195.0
Q ss_pred EeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH-HHHHHHHHHHHHH---HcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 444 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMR---RLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~e~~~Ei~iL~---~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
.||+|+||.||++.+ +++.+|+|.+........ ....+.+|..+++ ..+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999987 578999998876543222 1222334444333 3479999999999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCC
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 597 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~ 597 (720)
+++|.+++... ..+++..+..++.||+.||.|||.++ |+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 99999998754 36899999999999999999999998 999999999999999999999999998755332 22335
Q ss_pred CCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 598 AGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 598 ~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~--i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
.|+..|+|||.+. +..++.++|||||||++|+|++|..||....... ..... .......++..++.++++||.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHh
Confidence 7999999999986 4568899999999999999999999997643221 11111 122344567788999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 004986 675 QTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRP-----S~~ELL~~ 690 (720)
+.||.+|| +++++++|
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhC
Confidence 99999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.84 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=212.1
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN- 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~- 508 (720)
.-|+-++|.|.+.||+|||+-||+++. ++..||+|++.... .+......+|+...++++||||++++++...+..
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 446778999999999999999999985 78899999997765 3457788899999999999999999998755444
Q ss_pred ----eEEEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 509 ----LSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 509 ----l~LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
.||++.|...|+|.+.+.. .+..+++.++++|+.+|+.||++||...++++||||||.|||+.+++.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 9999999999999998864 445799999999999999999999999888999999999999999999999999
Q ss_pred cccccccCCc---------ccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhh
Q 004986 582 GLSRLKHNTF---------LSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 649 (720)
Q Consensus 582 GlAk~~~~~~---------~~~~s~~GT~~Y~APEvi~g~---~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i 649 (720)
|.+....-.. .......-|..|.|||.+.-+ ..++++|||||||+||+|++|.-||...-..----..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 9987532111 011123468899999998754 4588999999999999999999999653221000011
Q ss_pred hccccccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 650 GFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 650 ~~~~~~~~ip--~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
...+....+| ..++..+.+||+.||+.||.+||++.+++..+..+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1122222233 34889999999999999999999999999998765
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.20 Aligned_cols=243 Identities=27% Similarity=0.436 Sum_probs=205.9
Q ss_pred eeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 445 LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
||.|+||.||++++ +++.+|+|.+...... ......+.+|+.++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999988 4899999998765432 23456788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc--------c
Q 004986 522 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--------S 593 (720)
Q Consensus 522 ~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~--------~ 593 (720)
.+++.+.. .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99997644 6899999999999999999999998 99999999999999999999999999875433211 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC--CcHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARIIW 671 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~--ls~~l~dLI~ 671 (720)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+... ....+.. ++..+.+|+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcCCCccccCCHHHHHHHH
Confidence 23346888999999999888999999999999999999999999988877776666432 2333334 3899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L~ 692 (720)
+||+.+|.+||++.++.+.|+
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhc
Confidence 999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=348.79 Aligned_cols=247 Identities=34% Similarity=0.502 Sum_probs=214.8
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc--eEEE
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--LSII 512 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~--~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~--l~LV 512 (720)
.+...+||+|+|-+||+|.+ +|..||.-.++..+ .....+..|..|+.+|+.|+|+|||+||+.|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 35567899999999999976 57677764433332 234456889999999999999999999999988766 8899
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~~~~~ 591 (720)
+|.+..|+|+.|+.+. +..+...+..|++||++||.|||.+.|+|||||||.+||+|+ ..|.|||+|+|||.+.....
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999999764 478999999999999999999999999999999999999998 56999999999999876654
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
. ....|||.|||||+.. ..|+..+||||||++|+||+|+.+||.. .++.+++.++..+..+..+..--++++++||
T Consensus 201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 3 3478999999999998 6799999999999999999999999976 7888999888766666666667789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||.. ...|+++.|+|.+
T Consensus 278 ekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhcC-chhccCHHHHhhC
Confidence 999998 9999999999875
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.18 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=197.1
Q ss_pred CeeEeEEeeecCcEEEEEEEE----CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceE
Q 004986 438 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 510 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~ 510 (720)
.|++.+.||+|+||.||+|.+ .++.||+|.+..... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478899999999999999987 468999999876431 112234567899999999999999999999988 7899
Q ss_pred EEEeecCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC----CCcEEEEecc
Q 004986 511 IITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFG 582 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~----~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~----~g~IKL~DFG 582 (720)
+||||+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 67666532 1236889999999999999999999998 999999999999999 9999999999
Q ss_pred ccccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------HHhhh
Q 004986 583 LSRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------VVGAV 649 (720)
Q Consensus 583 lAk~~~~~~~---~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~---------i~~~i 649 (720)
+++....... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543322 22345688999999988764 57899999999999999999999997654322 00000
Q ss_pred h-------------------c-----cccccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 650 G-------------------F-----QNRRLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 650 ~-------------------~-----~~~~~~ip-----------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. + ......++ ...+..+.++|.+||+.||.+||++.|++.+
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0 00000111 1566789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.81 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=205.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----Cce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~-----~~l 509 (720)
++|.+.+.||+|+||+||++++ +++.||||.+............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999986 688999999876433333455677899999999999999999988654 348
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999995 6899888664 46899999999999999999999998 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-----------------
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF----------------- 651 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~----------------- 651 (720)
.........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3222334578999999998865 4688999999999999999999999977653322211100
Q ss_pred ---------cccc---cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 004986 652 ---------QNRR---LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 694 (720)
Q Consensus 652 ---------~~~~---~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~i 694 (720)
.... ......+++++.+||.+||+.+|.+||++++++++ ++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 01224678899999999999999999999999998 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.18 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=203.9
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--CceEEEEe
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIITE 514 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l~LVmE 514 (720)
|++.+.||.|+||.||+|+. +++.+|+|++............+.+|+.++++++|+||+++++++.+. ..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999987 568999999987643333456678899999999999999999999988 78999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-c
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-~ 593 (720)
|+++ +|.+++......+++..++.++.||+.||+|||..+ ++|+||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 899888765457899999999999999999999998 99999999999999999999999999986644321 1
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-----------------
Q 004986 594 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------------- 655 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~----------------- 655 (720)
.....++..|+|||.+.+ ..++.++|||+||+++|||++|..||...+.......+......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223457889999998775 45789999999999999999999999887765443332110000
Q ss_pred ------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+...++..+.++|.+||+.+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111237889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=306.90 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=198.2
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHH-HcCCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~-~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.||+|+||.||+|.. +++.||||.+...... ......+..|..++. ..+|+||+++++++...+.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999987 6789999998765432 222334455555544 45899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.+||+|||+++.... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999999764 36899999999999999999999998 99999999999999999999999999875433 23456
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccCCCCCCcHHHHHHHHHhhhc
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARIIWECWQT 676 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~--~~~ip~~ls~~l~dLI~~cL~~ 676 (720)
|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .......++.++.++|.+||+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88999999999988889999999999999999999999988877766655432211 2233446789999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 004986 677 DPSLRPSFAQLTVA 690 (720)
Q Consensus 677 DP~kRPS~~ELL~~ 690 (720)
+|++||++.++.+.
T Consensus 235 ~p~~R~~~~~~~~~ 248 (260)
T cd05611 235 DPAKRLGANGYQEI 248 (260)
T ss_pred CHHHccCCCcHHHH
Confidence 99999966544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.21 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=200.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------- 506 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------- 506 (720)
.++|++.+.||+|+||.||+|.+ +++.+|||++............+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 48899999999999999999987 578899998876543333334567899999999999999999987543
Q ss_pred -CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 507 -PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 507 -~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
..+++||||+.+ +|...+......+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999965 677777665567999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccc-----------CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc
Q 004986 586 LKHNTFLS-----------SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 586 ~~~~~~~~-----------~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~ 653 (720)
........ .....|++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 64332111 1223578889999988754 57899999999999999999999998876654433221100
Q ss_pred c---------------------ccCC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 R---------------------RLEI-------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ~---------------------~~~i-------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. .... ...+...+.+||.+||+.+|.+||++.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 0000 02345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=313.40 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=205.5
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEEC--CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++.+.||+|+||.||+|.+. ++.||||.+....... ...++..|+.++.++ .|+||+++++++.+...
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4567789999999999999999999884 8999999987654332 345566777777776 59999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+++||||+. ++|.+++......+++..+..++.||+.||.|||+ ++ |+||||+|+||++++++.+||+|||++...
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999985 47887776544578999999999999999999997 47 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhcccc-ccCCCCC
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNR-RLEIPKE 661 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~----~s~ksDVWSLGilLyELltG~~PF~~~~~-~~i~~~i~~~~~-~~~ip~~ 661 (720)
..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||..... .+.+..+..... .......
T Consensus 166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 43322 22345788999999997654 78899999999999999999999976433 233333322211 1122234
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
++.++.+||.+||+.||.+||++.+++.+-
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 788999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=337.69 Aligned_cols=263 Identities=28% Similarity=0.507 Sum_probs=228.5
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEEC----Cc--EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeee
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADWN----GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~----g~--~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~ 502 (720)
...+++..+..+..+.||.|-||.||+|.++ |. .||||.-+.+. ..+..+.|..|..+|+.++|||||+|+|+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 3456677777888899999999999999762 32 48888765543 34457889999999999999999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
|.+ ...|||||+++.|.|..||+.++..++......++.||+.||.|||+.. +|||||-..|||+....-|||+|||
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence 976 7789999999999999999998888999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHhhhhccccccCCCC
Q 004986 583 LSRLKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPK 660 (720)
Q Consensus 583 lAk~~~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELl-tG~~PF~~~~~~~i~~~i~~~~~~~~ip~ 660 (720)
+++.+.+... ......-...|||||-+.-.+++.++|||.||+++||++ .|..||.+....+++..+. ...++..|+
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~ 615 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPP 615 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCC
Confidence 9998765533 223333456899999999999999999999999999975 5899999988777776665 455778999
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
++++.+..|+.+||..+|.+||.+.||...|..+..
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998865
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=307.98 Aligned_cols=248 Identities=26% Similarity=0.320 Sum_probs=201.1
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeeecCCc-----
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPN----- 508 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L---~HpNIVkL~g~~~~~~~----- 508 (720)
|++.+.||+|+||.||+|++ +++.||+|++............+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999987 478999999875543333344566788777766 59999999999988777
Q ss_pred eEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
++++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999975 7988886533 36899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 654 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------- 654 (720)
.... ......++..|+|||++.+..++.++|||||||++|+|++|.+||......+....+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 4332 22234578899999999999999999999999999999999999988776554433321000
Q ss_pred --------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 --------R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 --------~----~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ......++..+.+||.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00112346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=310.48 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=195.9
Q ss_pred EeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHH-HHHHHHHH---HHHHHcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 444 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAA-LLEFKREV---KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~-~~e~~~Ei---~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
.||+|+||.||++.+ +++.||+|++......... ...+..|. .+++...||||+++++++...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 6789999998765433211 11223333 34455689999999999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCC
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 597 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~ 597 (720)
|++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 99999988654 46899999999999999999999998 999999999999999999999999998755332 22345
Q ss_pred CCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 598 AGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 598 ~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~---~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.|+..|+|||++.+. .++.++||||||+++|+|++|+.||.... .......+ ......++..++..+.++|.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHH
Confidence 799999999999754 68899999999999999999999998753 22222222 2234556777899999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 004986 674 WQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRP-----S~~ELL~~ 690 (720)
|..+|.+|| ++.+++++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhC
Confidence 999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.07 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=207.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----ceE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 510 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~-----~l~ 510 (720)
+|++.+.||.|+||.||+|+. ++..||||++............+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 488999999999999999987 5789999998765433444567889999999999999999999998875 789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||++ ++|.+++.+.. .+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 48999887644 7999999999999999999999998 999999999999999999999999999876543
Q ss_pred c---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-----------
Q 004986 591 F---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 655 (720)
Q Consensus 591 ~---~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~----------- 655 (720)
. .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 123345688999999999888 7899999999999999999999999887765443332210000
Q ss_pred ------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......++..+.+||.+||+++|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01123467889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.05 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=203.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~----~~~l~ 510 (720)
++|++.+.||+|+||.||+|.. +++.||+|++............+.+|+.+|++++|+||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999976 68999999987654333345667789999999999999999998763 34689
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 58999886543 5899999999999999999999998 999999999999999999999999999765432
Q ss_pred ccc----CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------
Q 004986 591 FLS----SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 651 (720)
Q Consensus 591 ~~~----~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-------------- 651 (720)
... .....|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 123478999999999866 4588999999999999999999999987654332211110
Q ss_pred ----------cccccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 652 ----------QNRRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 652 ----------~~~~~~-----ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
...... +....+..+.+||.+||+.+|.+||++.+++.+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000001 1245688999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.52 Aligned_cols=240 Identities=19% Similarity=0.341 Sum_probs=195.1
Q ss_pred CCeeEeEEe--eecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEE
Q 004986 437 EDLVLGERI--GLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 437 ~~y~i~k~L--GkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~L 511 (720)
++|++.+.+ |.|+||.||++.. ++..+|+|.+........ |+.....+ +|+||+++++.|...+.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 345555555 9999999999976 678899998866543221 22222222 79999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~~ 590 (720)
||||+++++|.+++.... .+++.++..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999997654 7899999999999999999999998 99999999999999988 9999999998765432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HhhhhccccccCCCCCCcHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i--~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
....|+..|+|||++.+..++.++||||||+++|+|++|..||........ .............+..++..+++
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 235689999999999998999999999999999999999999986543321 11111122334455678999999
Q ss_pred HHHHhhhcCCCCCCC-HHHHHHH
Q 004986 669 IIWECWQTDPSLRPS-FAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS-~~ELL~~ 690 (720)
||.+||+.+|.+||+ ++|+++|
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcC
Confidence 999999999999995 6998854
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.03 Aligned_cols=245 Identities=29% Similarity=0.439 Sum_probs=205.8
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
|...+.||+|+||+||+|++ +++.||+|++..... .......+.+|+.+++.++|+||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999986 688999999876433 333456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+. ++|.+++......+++.+++.++.||+.||.|||.++ |+|+||||+||+++.++.+||+|||++.... ...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~~ 175 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PAN 175 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC----CCC
Confidence 96 5788877665567899999999999999999999998 9999999999999999999999999986432 123
Q ss_pred CCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 596 STAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 596 s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
...|+..|+|||++. ...++.++||||||+++|+|++|..||...+.......+............++..+++|+.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 457899999999984 45578899999999999999999999988776655554433332333334567889999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.+|.+||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.45 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=202.5
Q ss_pred eeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCC
Q 004986 439 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.+++.+|.|+++.|++++.+++.||||++............+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 44566677778888888877899999999987655566677899999999999999999999999999999999999999
Q ss_pred CCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-----
Q 004986 519 GSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL----- 592 (720)
Q Consensus 519 gsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~----- 592 (720)
++|.+++.+. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999999753 346889999999999999999999998 99999999999999999999999998875432111
Q ss_pred --cCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-hhhhcc---------------
Q 004986 593 --SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQ--------------- 652 (720)
Q Consensus 593 --~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~-~~i~~~--------------- 652 (720)
......++..|+|||++.+ ..++.++|||||||++|||++|..||......... +.+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 1223457789999999876 35788999999999999999999999876543322 111000
Q ss_pred ----------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 653 ----------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 653 ----------------~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
.........++.++.+|+.+||+.||++||++.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000011223456899999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=329.54 Aligned_cols=262 Identities=31% Similarity=0.492 Sum_probs=221.7
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEECC-cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
...++..+.+.+.++||+|-||.|.+|+..+ ..||||+++..... ....+|.+|+++|.+|+|||||+++++|..++.
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3446777889999999999999999998865 99999998766533 346889999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~-lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+++|+||+++|+|.+|+.+..-+ +.......|+.||+.||+||.+.+ +|||||.+.|||++.++++||+|||+++-+
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999999775322 355666789999999999999999 999999999999999999999999999954
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHH--HhCCCCCCCCChHHHHhhhhccc------cccC
Q 004986 588 HNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL--ATLKLPWIGMNPMQVVGAVGFQN------RRLE 657 (720)
Q Consensus 588 ~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyEL--ltG~~PF~~~~~~~i~~~i~~~~------~~~~ 657 (720)
.... ......+-..+|||+|.+.-+++++++|+|+||+++||+ +|...||.....+++.+...... .-+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 3322 222233456899999999999999999999999999996 46789999988888776543111 1224
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.|.-++..+.+|+.+||+.+-.+||+++++..+|...
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 6678999999999999999999999999999988654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.88 Aligned_cols=254 Identities=18% Similarity=0.207 Sum_probs=189.1
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHH-H--------HHHHHHHHHHHHcCCCceeE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAA-L--------LEFKREVKIMRRLRHPNVVL 498 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~-~--------~e~~~Ei~iL~~L~HpNIVk 498 (720)
++..++|++.+.||+|+||+||+|.+. +..+|+|+.......... . .....+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 355578999999999999999999873 345666654322211100 0 01123334455668999999
Q ss_pred EeeeeecCC----ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 004986 499 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 574 (720)
Q Consensus 499 L~g~~~~~~----~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 574 (720)
+++++.... ..++++|++. .++.+++... ...++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 999765543 2467888774 4677766543 23578888999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccccCCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 004986 575 NVKVSDFGLSRLKHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVV 646 (720)
Q Consensus 575 ~IKL~DFGlAk~~~~~~-------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~-~~i~ 646 (720)
.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999998653211 112234799999999999999999999999999999999999999987632 2211
Q ss_pred hh-----hhc-cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 647 GA-----VGF-QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 647 ~~-----i~~-~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
.. +.. .... .....+++.+.+++..||..+|.+||++.+|++.|
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 110 1111 12345688999999999999999999999999876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=305.65 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=206.8
Q ss_pred CeeEeEEeeecCcEEEEEEEEC--CcEEEEEEEec---CCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~--g~~VAVK~i~~---~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+|.+.+.||+|+||.||++++. +..+++|.++. .........++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4888999999999999999873 44566665543 222333345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 513 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 513 mEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|||+++++|.+++.+ ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998853 3346899999999999999999999998 999999999999975 5799999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333344568999999999988888999999999999999999999998766655554443 223344566788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||+.+|++||++.+++++
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=301.04 Aligned_cols=240 Identities=28% Similarity=0.435 Sum_probs=208.8
Q ss_pred eeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCH
Q 004986 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 521 (720)
Q Consensus 445 LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL 521 (720)
||+|+||.||++.+ +++.||+|.+...... ......+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999987 4889999998766443 23466788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCC
Q 004986 522 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 601 (720)
Q Consensus 522 ~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~ 601 (720)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99997653 5899999999999999999999988 99999999999999999999999999987654323334567899
Q ss_pred CccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 004986 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 681 (720)
Q Consensus 602 ~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kR 681 (720)
.|+|||.+.+...+.++|+|+||+++|+|++|..||...+..+....+.. ....++..++..+.+||.+||..||.+|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999988899999999999999999999999988776666665543 4556777889999999999999999999
Q ss_pred CCH---HHHHH
Q 004986 682 PSF---AQLTV 689 (720)
Q Consensus 682 PS~---~ELL~ 689 (720)
|++ ++++.
T Consensus 236 ~~~~~~~~l~~ 246 (250)
T cd05123 236 LGSGGAEEIKA 246 (250)
T ss_pred CCcccHHHHHh
Confidence 999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=315.28 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=207.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+.|...+.||+|+||.||+|+. ++..+|+|.+..... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577788999999999999987 678899998875422 3334567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+. ++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 9996 5788777554456899999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.....|+..|+|||.+. ...++.++|||||||++|+|++|..||...+.......+............++..+++||
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 23356889999999975 345788999999999999999999999877655444433322222223456888999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.+||..+|.+||++.+++.+..
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcc
Confidence 9999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=309.90 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=204.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 438 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
.|++.+.||+|+||.||+|+. +++.||+|++...... ......+.+|+++++++ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 6788999998754321 12345678899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999998764 36888999999999999999999998 99999999999999999999999999986543
Q ss_pred Cc-ccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCC
Q 004986 590 TF-LSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 590 ~~-~~~~s~~GT~~Y~APEvi~g~--~~s~ksDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~~~~~ip~~l 662 (720)
.. .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+...+ ......++..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccC
Confidence 22 222345689999999998753 467899999999999999999999964322 2222222 11233456778
Q ss_pred cHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 004986 663 DPLVARIIWECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
+..+.+|+.+||+.+|.+|| ++++++.+
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999999997 77888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=318.86 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=200.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----ce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~-----~l 509 (720)
++|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.++++++|+||+++++++.... .+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6899999999999999999976 688999998864322 223456778999999999999999999865543 47
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++|+||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999964 88888754 35899999999999999999999998 99999999999999999999999999976543
Q ss_pred Ccc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------
Q 004986 590 TFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 651 (720)
Q Consensus 590 ~~~---~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-------------- 651 (720)
... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 211 1123568999999998765 5688999999999999999999999977554322211100
Q ss_pred --------c--cccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 004986 652 --------Q--NRRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 694 (720)
Q Consensus 652 --------~--~~~~-----~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~i 694 (720)
. .... ......+.++.+||.+||+.+|.+||++.|++.+ ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 0000 0113457889999999999999999999999998 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=342.53 Aligned_cols=252 Identities=17% Similarity=0.219 Sum_probs=188.7
Q ss_pred CCCeeEeEEeeecCcEEEEEEEEC---CcEEEEEEE--------------ec-CCCCHHHHHHHHHHHHHHHHcCCCcee
Q 004986 436 WEDLVLGERIGLGSYGEVYHADWN---GTEVAVKKF--------------LD-QDFSGAALLEFKREVKIMRRLRHPNVV 497 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~~---g~~VAVK~i--------------~~-~~~~~~~~~e~~~Ei~iL~~L~HpNIV 497 (720)
.++|++++.||+|+||+||+|... +..+++|.+ .+ ..........+.+|+.+|++++|+|||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 478999999999999999998652 222222211 11 011122345678999999999999999
Q ss_pred EEeeeeecCCceEEEEeecCCCCHHHHHcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 004986 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573 (720)
Q Consensus 498 kL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~----~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 573 (720)
++++++.+.+..|+|+|++. ++|.+++.... .......+..|+.||+.||.|||+++ ||||||||+||||+.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 99999999999999999995 57777764321 22345677789999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCC--h-HHHHhh
Q 004986 574 WNVKVSDFGLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW-IGMN--P-MQVVGA 648 (720)
Q Consensus 574 g~IKL~DFGlAk~~~~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF-~~~~--~-~~i~~~ 648 (720)
+.+||+|||+++.+.... ......+||..|+|||++.+..++.++|||||||++|||++|..++ .... + .++...
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998765432 2233467999999999999999999999999999999999988644 3221 1 111111
Q ss_pred hhccc------------------------cccCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 649 VGFQN------------------------RRLEI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 649 i~~~~------------------------~~~~i-----p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+.... ....+ ...++.++.++|.+||+.||.+||++.|++.+
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11000 00000 11345678889999999999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.69 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=202.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
.++|++.+.||+|+||.||++.. ++..||||++............+.+|+.+|++++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 36799999999999999999976 6889999998655434444556889999999999999999999987654
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999999 7799988864 35899999999999999999999998 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 653 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~------------- 653 (720)
... .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 233567899999999876 457889999999999999999999998765433322111000
Q ss_pred -------------c---ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -------------R---RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -------------~---~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ...+...+++++.++|.+||+.||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 001224677889999999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=344.59 Aligned_cols=267 Identities=32% Similarity=0.519 Sum_probs=237.8
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+|.-....|.++||.|.||.|++|+. +...||||.++.. ..+....+|+.|..||-++.||||++|.|+.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 56667889999999999999999976 2456999987654 45667889999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.++||+|||++|.|+.||+++..+++..+..-+++.|+.||+||-+++ +|||||-..||||+.+..-|+.|||+++.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999999998889999999999999999999999999 999999999999999999999999999988
Q ss_pred cCCcccCCCCCC---CCCccCcccccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 004986 588 HNTFLSSKSTAG---TPEWMAPEVLRNEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 588 ~~~~~~~~s~~G---T~~Y~APEvi~g~~~s~ksDVWSLGilLyELl-tG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls 663 (720)
.+......+..| ..+|.|||.|...+++.++||||+||+|||.+ +|..||=++...+++..|. +..++.-|.+++
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP 860 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCP 860 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCc
Confidence 665433333332 46999999999999999999999999999965 6999999999999988886 444666788999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
..+.+|+..||++|=.+||.|.||+..|+++.+...+-..
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~ 900 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT 900 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence 9999999999999999999999999999999887665544
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.87 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=203.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------c
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------~ 508 (720)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6799999999999999999986 6889999998765433334456789999999999999999999986543 4
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++|+||+.. +|..++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6899999964 7877763 25889999999999999999999998 9999999999999999999999999997643
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 653 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------------- 653 (720)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 AE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 22 233567899999999876 458899999999999999999999998876544332221100
Q ss_pred -------ccc--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhhH
Q 004986 654 -------RRL--------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQR 696 (720)
Q Consensus 654 -------~~~--------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~i~~ 696 (720)
... ......+..+.+||.+||+.||.+||++.+++.| ++.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 0112467789999999999999999999999976 776654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=319.31 Aligned_cols=249 Identities=20% Similarity=0.314 Sum_probs=201.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC--CceEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNLSI 511 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~--~~l~L 511 (720)
++|++.+.||+|+||.||+|.+ +++.+|||++............+.+|+.+++++ +|+||++++++|... ..+++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 6789999999999999999987 578999998865433333455677899999999 999999999988654 35899
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||++ ++|..++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999997 5999988664 6788999999999999999999998 9999999999999999999999999998654322
Q ss_pred c-----cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc------------
Q 004986 592 L-----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------ 653 (720)
Q Consensus 592 ~-----~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~------------ 653 (720)
. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 2233568999999998765 457889999999999999999999997755443322211000
Q ss_pred -----------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -----------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -----------------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......+.++.++.+||.+||+.+|.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0001223468899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.66 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=208.9
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 506 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------ 506 (720)
..++|++.+.||+|+||.||++.+ +++.||+|++............+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 347899999999999999999975 688999999876543333455678899999999999999999987543
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
...+++++++ +++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478888887 78999888653 5899999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-----------
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------- 654 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~----------- 654 (720)
.... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 170 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5332 234578999999999876 5688899999999999999999999987655443322110000
Q ss_pred -------------cc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCCCCCCCC
Q 004986 655 -------------RL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALP 711 (720)
Q Consensus 655 -------------~~-----~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~~~~~~~ 711 (720)
.+ ......++++.+||.+||+.||.+||++.+++.+= .-..+....+++.+..++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~--~f~~~~~~~~~~~~~~~~ 319 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA--YFAQYHDPDDEPVADPYD 319 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh--hhhhcCCCCccccCCCcc
Confidence 00 01123578899999999999999999999999874 222233344444444433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.79 Aligned_cols=243 Identities=29% Similarity=0.429 Sum_probs=205.3
Q ss_pred eEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 442 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
...||+|+||.||++.. ++..||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 46799999999999977 68899999875432 234566889999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 599 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~G 599 (720)
+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..............|
T Consensus 103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 999988653 5789999999999999999999998 999999999999999999999999998765433222334578
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHHHhhhcCC
Q 004986 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 600 T~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
+..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+.... ........++..+.+++.+||+.+|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 999999999988889999999999999999999999998876665544442111 1112234578899999999999999
Q ss_pred CCCCCHHHHHHH
Q 004986 679 SLRPSFAQLTVA 690 (720)
Q Consensus 679 ~kRPS~~ELL~~ 690 (720)
.+||++.+++.+
T Consensus 259 ~~R~~~~~ll~~ 270 (292)
T cd06657 259 AQRATAAELLKH 270 (292)
T ss_pred ccCcCHHHHhcC
Confidence 999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.01 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=205.1
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|++.+.||+|+||.||+|+. +++.||+|++............+..|+.++++++|+||+++++++.+...+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56678899999999999987 5889999998776433334566778999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCC
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s 596 (720)
+ ++|.+++.+....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 7 5899999775457999999999999999999999998 999999999999999999999999999866543323333
Q ss_pred CCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc------------------cccc-
Q 004986 597 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------NRRL- 656 (720)
Q Consensus 597 ~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~------------------~~~~- 656 (720)
..++..|+|||.+.+. .++.++|||+||+++|||++|..||...+..+....+... ....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999998776 7889999999999999999999999876654433222100 0000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 --------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 --------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..-+.++..+.++|.+||..+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0112347789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.84 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=206.3
Q ss_pred CeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 438 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
+|++.+.||+|+||.||+++. +++.||||.+...... ......+.+|+.++.++ +|+||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999974 4678999998754322 22345678899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+.+++|.+++.+. ..+++..+..++.|++.+|.|||..+ ++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999998654 36889999999999999999999988 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCC
Q 004986 590 TFL-SSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 590 ~~~-~~~s~~GT~~Y~APEvi~g~~--~s~ksDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~~~~~ip~~l 662 (720)
... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||..... .++...+ .......+..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 321 122346899999999987765 68899999999999999999999964322 2222222 12234566778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+..+++||.+||+.+|++||++.++.+.|+..
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 99999999999999999999988777766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.43 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=198.7
Q ss_pred EEeeec--CcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCC
Q 004986 443 ERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 443 k~LGkG--~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
..||+| +||+||++++ +++.||||++..........+.+.+|+.+++.++||||++++++|..++.+++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999987 789999999877655555667888999999999999999999999999999999999999
Q ss_pred CCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc----
Q 004986 519 GSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---- 593 (720)
Q Consensus 519 gsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~---- 593 (720)
++|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999998753 235889999999999999999999998 999999999999999999999999865432211110
Q ss_pred ---CCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc---------------
Q 004986 594 ---SKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 653 (720)
Q Consensus 594 ---~~s~~GT~~Y~APEvi~g~--~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~--------------- 653 (720)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||......+.........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0112356679999999764 47889999999999999999999998765433321111000
Q ss_pred ------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhhH
Q 004986 654 ------------------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQR 696 (720)
Q Consensus 654 ------------------------------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~i~~ 696 (720)
.....+..++..+++||.+||+.||.+|||+.|++++ ++.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0011123456789999999999999999999999854 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.79 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=200.2
Q ss_pred CCee-EeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHH------------HHHHHHHHHHHHHcCCCceeEEee
Q 004986 437 EDLV-LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAA------------LLEFKREVKIMRRLRHPNVVLFMG 501 (720)
Q Consensus 437 ~~y~-i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~------------~~e~~~Ei~iL~~L~HpNIVkL~g 501 (720)
++|. +.+.||.|+||+||+|.+ .++.||||++......... ...+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 567899999999999976 6889999998654322100 124678999999999999999999
Q ss_pred eeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 502 ~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
++...+..++||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 5899988653 36899999999999999999999998 999999999999999999999999
Q ss_pred cccccccC--------------CcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 004986 582 GLSRLKHN--------------TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 646 (720)
Q Consensus 582 GlAk~~~~--------------~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~ 646 (720)
|++..... .........++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99976541 11111233568899999998764 4688999999999999999999999887765544
Q ss_pred hhhhccccc-------------------c-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 647 GAVGFQNRR-------------------L-------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 647 ~~i~~~~~~-------------------~-------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+...... . ......+..+.+||.+||+.+|.+||+++|++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 333110000 0 0113457889999999999999999999999973
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.44 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=204.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc-----
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 508 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~----- 508 (720)
.++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999987 57889999887654334445667789999999999999999998876654
Q ss_pred -eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 -LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 -l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799999875 35899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-----------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 655 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~----------- 655 (720)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..+......
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 234578899999999865 36788999999999999999999999876655443332110000
Q ss_pred ------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......++..+.+||.+||+.+|.+||++.+|+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 01112458899999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=366.93 Aligned_cols=249 Identities=31% Similarity=0.451 Sum_probs=213.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|.-...||.|.||.||.|.. +|...|+|-++-..........+.+|..+|..|+|||+|++||+-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 345567899999999999976 788999998876665555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc----
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF---- 591 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~---- 591 (720)
|++|+|.+++... +..++.....+..|++.|+.|||++| ||||||||+|||++.+|.||++|||.|..+....
T Consensus 1316 C~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999999753 35677777778889999999999999 9999999999999999999999999998765442
Q ss_pred ccCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccCCCCCCcHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~---~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
.......||+-|||||++.+.. ...++|||||||++.||++|+.||...+.+ ++...+. ....+++|..++.+-+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEGR 1471 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhHH
Confidence 1123458999999999998643 567899999999999999999999876543 4444443 4557889999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||..||++|+++.||+++
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999998876
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=301.67 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=199.1
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEEee
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
|++.+.||+|+||+||+|.. +++.||||++...... .......+|+..+++++ |+||+++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 5788999988654332 22234457899999998 99999999999999999999999
Q ss_pred cCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+ +++|.+++.... ..+++.++..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence 9 789998886643 46899999999999999999999998 9999999999999999999999999998654322 22
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------------cc-
Q 004986 595 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------RR- 655 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-----------------~~- 655 (720)
....++..|+|||++.+ ..++.++|+||||+++++|++|+.||......+....+.... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 34568899999998854 457899999999999999999999997765443322111000 00
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ----------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.......+..+.+||.+||+.+|.+||+++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00111236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=312.77 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=198.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-------- 506 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~-------- 506 (720)
.+|++.+.||.|+||.||+|.. +++.||+|++..... .....+.+|+.++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6899999999999999999987 688999999876543 2356678899999999999999999876554
Q ss_pred ------CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEE
Q 004986 507 ------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVS 579 (720)
Q Consensus 507 ------~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~ 579 (720)
..+++||||++ ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898888643 5889999999999999999999998 99999999999998 45679999
Q ss_pred eccccccccCCcc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---
Q 004986 580 DFGLSRLKHNTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--- 652 (720)
Q Consensus 580 DFGlAk~~~~~~~---~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~--- 652 (720)
|||+++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...++.+....+...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999976532211 1122357889999998754 56788999999999999999999999876654433222100
Q ss_pred --------------------cccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 --------------------NRRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 --------------------~~~~-----~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.... .+...++.++++||.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 1123577899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.47 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=200.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-~~~l~LV 512 (720)
.++|++.+.||+|+||.||++.+ +++.||||++............+..|+.+++.++||||++++++|.. ...+++|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 36799999999999999999976 68899999887654433445667889999999999999999999866 5678999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||++......
T Consensus 89 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 89 TELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred eehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 9999 56899888653 4788888899999999999999998 999999999999999999999999998754322
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--------------------
Q 004986 593 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------- 651 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-------------------- 651 (720)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 233567889999999866 5689999999999999999999999987654322111100
Q ss_pred ----ccccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 652 ----QNRRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 652 ----~~~~~-----~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..... .....++..++++|.+||+.+|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 1113567899999999999999999999999766
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=316.23 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=212.0
Q ss_pred CCeeE-eEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec----CCc
Q 004986 437 EDLVL-GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 508 (720)
Q Consensus 437 ~~y~i-~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~----~~~ 508 (720)
++|.| -++||-|-.|.|..|.+ +++.+|+|++... ....+|+++.-.. .|||||+++++|.. ..+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45555 36799999999999966 7899999987543 2345677665544 79999999998754 456
Q ss_pred eEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecccc
Q 004986 509 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 584 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlA 584 (720)
+.+|||.|+||+|+..++. ....+++.++..|++||..|+.|||+.+ |.||||||+|+|... +-.+||+|||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence 8899999999999998865 4457999999999999999999999999 999999999999974 557999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHhhhhcccccc--CC
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRL--EI 658 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----~i~~~i~~~~~~~--~i 658 (720)
+..... ....+.|-|+.|.|||++..++|+..+|+||||+++|-|+||.+||+..... .+..+|......+ +-
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 865432 3456678999999999999999999999999999999999999999876543 2334443332222 22
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCCCCCCCC
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALP 711 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~~~~~~~ 711 (720)
+..++...+++|+.+|..+|++|.++.+++.+==--.....|+.|=.....+.
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~ 343 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLK 343 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcc
Confidence 34689999999999999999999999999887544455566666654444443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=339.23 Aligned_cols=147 Identities=29% Similarity=0.454 Sum_probs=133.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+++|.+.++||+|+||+||+|.+ .++.||||++..... .......+..|+.++..++|+||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999988 489999999876543 344456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
|||+.+++|.+++... ..+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999754 36889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.50 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=210.6
Q ss_pred eEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 442 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
.++||.|-||+||-|++ +|+.||||+|.+..+.......+.+|++||++++||.||.|..+|+..+.++.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36799999999999976 7999999999988887666788899999999999999999999999999999999999887
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEeccccccccCCcccCCC
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTFLSSKS 596 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~IKL~DFGlAk~~~~~~~~~~s 596 (720)
-|.-+|.....++++.....++.||+.||.|||-++ |+|+||||+|||+... -++||||||+|+.+.... ...+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhh
Confidence 788888887788999999999999999999999999 9999999999999743 479999999999887653 3456
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhh
Q 004986 597 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675 (720)
Q Consensus 597 ~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~ 675 (720)
.+||+.|+|||+++.+.|+..-|+||.|+++|--+.|.+||.... ..+.++...+. .++.-+..+++++.|||..+|+
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cCCCchhhcCHHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999996533 22222222221 2333446799999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 004986 676 TDPSLRPSFAQLTV 689 (720)
Q Consensus 676 ~DP~kRPS~~ELL~ 689 (720)
..-.+|.+.++-+.
T Consensus 805 Vkm~kRysvdk~ls 818 (888)
T KOG4236|consen 805 VKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHhcchHhhcc
Confidence 99999999875543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.74 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=196.9
Q ss_pred CeeEeEEeeecCcEEEEEEEEC----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec----CCc
Q 004986 438 DLVLGERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 508 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~----~~~ 508 (720)
+|++.+.||+|+||.||++.+. +..||||++............+.+|+.+++++ +|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999873 66899998865433333355677899999999 59999999987532 245
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++++||+. ++|.+++... ..+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788999985 6899888653 46899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc----cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-----------
Q 004986 589 NTFL----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------- 652 (720)
Q Consensus 589 ~~~~----~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~----------- 652 (720)
.... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1233578999999998765 56899999999999999999999999876543322211100
Q ss_pred --------------c-ccc---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 --------------N-RRL---EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 --------------~-~~~---~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ... ......+..+++|+.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000 1123457899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.32 Aligned_cols=259 Identities=35% Similarity=0.614 Sum_probs=225.4
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEEC--CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
.+++....+.....+||-|-||.||.|.|+ ...||||.++.+. ..+.+|+.|..+|+.++|||+|+|+|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 445666677888999999999999999884 5679999875443 34789999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
.+|||+|||..|+|.+||++.. ..++....++++.||..||+||..++ +|||||-..|||+.++..||++||||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999998744 35677788899999999999999999 99999999999999999999999999998
Q ss_pred ccCCcccC-CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 587 KHNTFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 587 ~~~~~~~~-~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
+....+.. ....-.+.|.|||-+....++.|+|||+||++|||+.+ |--||.+.+..+++..+. ...+..-|..|++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPP 493 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCH
Confidence 76543321 11223568999999999999999999999999999976 778999999988887765 3446677899999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+.+|+..||++.|.+||+|.|+-+.++.+
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 999999999999999999999999999865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=314.32 Aligned_cols=269 Identities=24% Similarity=0.362 Sum_probs=213.5
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 506 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~ 506 (720)
...++..++++-+..||.|+||+|++..+ .|+..|||+|+.... +..+.++..|.....+- ++||||++||+...+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34456667788888999999999999987 689999999988765 44567777787766555 799999999999999
Q ss_pred CceEEEEeecCCCCHHHHHc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 507 PNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~----~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
+.+|+.||+| ..+|+.+.. ..+..++|..+-+|...++.||.||...- .||||||||+||||+..|.|||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeeccc
Confidence 9999999999 456665442 23457899999999999999999998752 59999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccccc-CC
Q 004986 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL-EI 658 (720)
Q Consensus 583 lAk~~~~~~~~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~~~-~i 658 (720)
++-.+.+... .+..+|...|||||.+.. ..|+.++|||||||+|||+.+|++||.+++.. +.+..+.....+. ..
T Consensus 214 IcGqLv~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 214 ICGQLVDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred chHhHHHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 9988766543 345689999999999963 45899999999999999999999999997652 2222232222111 12
Q ss_pred C---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCC
Q 004986 659 P---KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 704 (720)
Q Consensus 659 p---~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~ 704 (720)
+ .+++..+..||.-||.+|-..||.+.+++.+ .+.+++....|+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~--~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF--PFYRMYAVEGPD 339 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC--chhhhhhhcCCc
Confidence 2 2478899999999999999999999998764 234444444443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.52 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=205.4
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
....-|..++.||-|+||.|.++.. +...||+|.+++.+ +.......++.|..||...+.+-||+||..|++.+++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3445689999999999999999975 56779999887754 34556678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc--
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH-- 588 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~-- 588 (720)
+||||++||++-.+|-+.+ .|.|..+..++.++..|+++.|..| +|||||||+|||||.+|+|||+||||+.-+.
T Consensus 706 FVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999886654 5778888888889999999999999 9999999999999999999999999985311
Q ss_pred -C------C---------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHH
Q 004986 589 -N------T---------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 628 (720)
Q Consensus 589 -~------~---------------------------------~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLy 628 (720)
+ . .......+||+.|+|||++....|+..+|||+.|++||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 0 00011347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHhhhhccccccCC--CCCCcHHHHHHHHHhhhcCCCCCC
Q 004986 629 ELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARIIWECWQTDPSLRP 682 (720)
Q Consensus 629 ELltG~~PF~~~~~~~i~~~i~~~~~~~~i--p~~ls~~l~dLI~~cL~~DP~kRP 682 (720)
||+.|++||....+.+....+..+...+.+ ..++++++.+||.+++. +++.|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999998887776665433333333 35789999999998774 778875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.29 Aligned_cols=245 Identities=22% Similarity=0.370 Sum_probs=212.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
.+.+++|.++++||+|+|.+|.++++ +.+.||+|+++++...+. .+.=++.|-.+..+. +||++|-+..+|+.+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 35568999999999999999999977 678899999988765443 344456788888777 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++|.||++||+|..+++++ ++++++.+..+..+|..||.|||+.| ||+||||.+|||||.+|++||+|+|+++.-.
T Consensus 326 lffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999999888765 47999999999999999999999999 9999999999999999999999999998755
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CChHH-HHhhhhccccccCCCC
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-------MNPMQ-VVGAVGFQNRRLEIPK 660 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~-------~~~~~-i~~~i~~~~~~~~ip~ 660 (720)
.+...+.++|||+.|+|||+++|..|+..+|||+||++++||+.|+-||.- .+.++ +++-| .+....+|.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--lekqiripr 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--LEKQIRIPR 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--hhhcccccc
Confidence 555667889999999999999999999999999999999999999999952 22222 23333 445667889
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC
Q 004986 661 ELDPLVARIIWECWQTDPSLRP 682 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRP 682 (720)
.++-.+..+++..|++||.+|.
T Consensus 481 slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhc
Confidence 9999999999999999999995
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.43 Aligned_cols=257 Identities=32% Similarity=0.566 Sum_probs=224.6
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEEC---Cc--EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 504 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~---g~--~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~ 504 (720)
..+-|..++..+.++||+|.||.|++|.|+ |+ .||||+++...... .+.+|.+|+.+|.+|+|+|+++|||+..
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 345577788889999999999999999983 33 58999998776543 6889999999999999999999999998
Q ss_pred cCCceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccc
Q 004986 505 RPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583 (720)
Q Consensus 505 ~~~~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGl 583 (720)
+ ..+.||||++++|+|.+.|++ ....|.......|+.||+.||.||..++ +|||||-..||||-....|||+||||
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccc
Confidence 8 788999999999999999987 4456777888889999999999999998 99999999999999999999999999
Q ss_pred cccccCCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCC
Q 004986 584 SRLKHNTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 584 Ak~~~~~~~~---~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip 659 (720)
.+.+...... .....-...|+|||.++..+++.++|||++||+||||++ |..||.+....++++.|. ...++.-|
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRP 337 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRP 337 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCC
Confidence 9977543221 111123458999999999999999999999999999997 689999999999999998 66677889
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
+.++.++.++++.||..+|.+||+|..|.+.+
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 99999999999999999999999999997544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=344.30 Aligned_cols=247 Identities=30% Similarity=0.425 Sum_probs=198.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee----------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT---------- 504 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~---------- 504 (720)
.+|+.++.||+||||.||+++. +|+.||||+|.... .......+.+|+.+|.+|+|||||+++..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 6788999999999999999976 89999999998776 5666778899999999999999999985431
Q ss_pred --------------------------------------------------------------------c-----------
Q 004986 505 --------------------------------------------------------------------R----------- 505 (720)
Q Consensus 505 --------------------------------------------------------------------~----------- 505 (720)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ----------------------C--------CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 004986 506 ----------------------P--------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555 (720)
Q Consensus 506 ----------------------~--------~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g 555 (720)
+ ..+||-||||+..+|.+++.++...-.....|+++++|+.||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1267899999999999999886643357888999999999999999999
Q ss_pred CCEEeeCCCCCcEEEcCCCcEEEEecccccccc------------------CCcccCCCCCCCCCccCcccccCCC---C
Q 004986 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH------------------NTFLSSKSTAGTPEWMAPEVLRNEP---S 614 (720)
Q Consensus 556 ~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~------------------~~~~~~~s~~GT~~Y~APEvi~g~~---~ 614 (720)
||||||||.||++++++.|||+|||+|+... ......++.+||.-|+|||++.+.. |
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999999999999999998621 0111345678999999999997654 9
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 004986 615 NEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLE--IPKELDPLVARIIWECWQTDPSLRPSFAQLTV 689 (720)
Q Consensus 615 s~ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~~~~~~~--ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~ 689 (720)
+.|+|||||||+|+||+. ||.. +....++..++...-+.. +...--+.-..+|++||+.||.+|||+.|+|.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999985 5643 444455555542221211 11122245688999999999999999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.45 Aligned_cols=241 Identities=27% Similarity=0.406 Sum_probs=202.4
Q ss_pred eEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCC
Q 004986 442 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
.+.||+|+|+.|--+.. ++..||||++.+. .......+.+|++++.++ .|+||++|+++|+++..+|||||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 35699999999999865 8999999999776 344567888999999999 699999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEEEEeccccccccCC-----
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLKHNT----- 590 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~IKL~DFGlAk~~~~~----- 590 (720)
|.|..++.+.. .+++.++..+.++|+.||.+||.+| |.||||||+|||-.... -||||||.|.......
T Consensus 161 GplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 161 GPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred chHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99999997754 6899999999999999999999999 99999999999997543 4899999987643321
Q ss_pred --cccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHhh
Q 004986 591 --FLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNP---------------MQVVGA 648 (720)
Q Consensus 591 --~~~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~---------------~~i~~~ 648 (720)
.....+.+|+.+|||||+.. ...|++++|.||||+++|-|++|++||.+.-. ..+++.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 11234568999999999863 34589999999999999999999999976322 233444
Q ss_pred hhccccccCCCC----CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 004986 649 VGFQNRRLEIPK----ELDPLVARIIWECWQTDPSLRPSFAQLTV 689 (720)
Q Consensus 649 i~~~~~~~~ip~----~ls~~l~dLI~~cL~~DP~kRPS~~ELL~ 689 (720)
| ++...++|. .++.+.++||..+|..|+.+|.++.+++.
T Consensus 318 I--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 I--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred H--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 4 455566664 68999999999999999999999998887
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=327.37 Aligned_cols=239 Identities=23% Similarity=0.327 Sum_probs=203.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|++...+|.|+|+.|..+.+ +++.+++|++.+... +..+|+.++... .||||+++.+.+.+....|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 36778888899999999999977 788899999876622 223567666665 799999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE-cCCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-DKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL-d~~g~IKL~DFGlAk~~~~~~ 591 (720)
||++.|+.|.+-+...+ ....++..|+.+|+.|+.|||.+| ||||||||+|||+ +..|+++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999998888776543 233777789999999999999998 9999999999999 69999999999999876554
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
..+.+-|..|.|||++....|+.++||||||++||+|++|+.||...... ++...+. ...+...+|..+++||
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKFSECVSDEAKDLL 543 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCccccccCHHHHHHH
Confidence 34567899999999999999999999999999999999999999876554 4444442 3444478999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L 691 (720)
.+||+.||.+|+++.++..+=
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred HHhccCChhhCcChhhhccCc
Confidence 999999999999999998763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=328.03 Aligned_cols=250 Identities=29% Similarity=0.461 Sum_probs=216.8
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec-----C
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR-----P 506 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~-----~ 506 (720)
..+-|+|.++||+|.+|.||+++. +++.+|+|++.... ...++++.|.+||+.+ .|||++.++++|.. +
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 346799999999999999999965 78999999875543 2345777899999988 79999999999854 4
Q ss_pred CceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
+.+|||||||.||+.-|+++. .+..+.|..+.+|++.++.||.|||.+. +||||||-.|||++.++.|||+|||++.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeee
Confidence 679999999999999999864 3567999999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCcccCCCCCCCCCccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CC
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EI 658 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~-----~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~i 658 (720)
.+..+.....+.+||+.|||||++... .|+.++|+|||||+..||--|.+|+.++.+...+-.|.... ++ .-
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLkr 250 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLKR 250 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Cccccc
Confidence 988887788889999999999999754 36779999999999999999999999999988776664221 22 22
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
|..-+.++-+||..||.+|-.+||++.++++|
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 45667899999999999999999999998865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=284.96 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=210.3
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|.-.++||+|.||+||+++. +++.||+|.++..+.++.......+|+.+|+.++|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455567899999999999976 678899999987766665566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
|. -+|..+.....+.++.+.+..++.|++.+|.++|+++ ++||||||.|+||+.+|++||+|||+++.+.-+...-.
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 95 4899888777778999999999999999999999999 99999999999999999999999999998876655545
Q ss_pred CCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccc------c---CC------
Q 004986 596 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR------L---EI------ 658 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~------~---~i------ 658 (720)
..+-|.+|.+|.++.|.+ |++..|+||.||++.|+.. |++.|.+.+..+.+..|-+.-.. + .+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 557899999999999876 7899999999999999976 67778887766655444221111 1 01
Q ss_pred ---C---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 ---P---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 ---p---------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
| +.++..-++|++++|.-+|.+|.++++.+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1 2234457899999999999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=289.88 Aligned_cols=218 Identities=21% Similarity=0.262 Sum_probs=182.6
Q ss_pred cCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCHHHHH
Q 004986 448 GSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 525 (720)
Q Consensus 448 G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~L 525 (720)
|.||.||++.+ +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 78899999986643 2234555555667999999999999999999999999999999998
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccC
Q 004986 526 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605 (720)
Q Consensus 526 ~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~A 605 (720)
.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SKFL-NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HHhc-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 6543 5899999999999999999999998 999999999999999999999999988655432 223456778999
Q ss_pred cccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 004986 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 684 (720)
Q Consensus 606 PEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~ 684 (720)
||.+.+..++.++||||||+++|||++|..||...... .. ......++..+++.+++||.+||+.||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN-----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc-----cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99998888999999999999999999999887543211 10 112334667889999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=325.74 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=202.0
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------ceE
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------NLS 510 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------~l~ 510 (720)
|...+.||+|+||.||++++ +|+.||||.+..... ....+..-+|+++|++++|+|||++++.-.+.. .-.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45567799999999999986 799999999876542 223455678999999999999999999865544 467
Q ss_pred EEEeecCCCCHHHHHcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCC--cEEEEecccc
Q 004986 511 IITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNW--NVKVSDFGLS 584 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~--~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g--~IKL~DFGlA 584 (720)
+|||||.||+|+.+|.+ +...+++.+.+.++.++..||.|||++| ||||||||.||++- .+| ..||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999986 4457999999999999999999999999 99999999999995 334 4799999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHhhhh---------
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVG--------- 650 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~----i~~~i~--------- 650 (720)
+.+.+.. ...+++||..|++||+.. .+.|+..+|.|||||++|+++||..||....... +.-.+.
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 9887654 567889999999999998 5889999999999999999999999997633221 221111
Q ss_pred ----cccc------ccCCCCCCcH----HHHHHHHHhhhcCCCCCC--CHHHHHHHHHhhhH
Q 004986 651 ----FQNR------RLEIPKELDP----LVARIIWECWQTDPSLRP--SFAQLTVALKPLQR 696 (720)
Q Consensus 651 ----~~~~------~~~ip~~ls~----~l~dLI~~cL~~DP~kRP--S~~ELL~~L~~i~~ 696 (720)
..+. .+++|..++. .+-..+..+|..+|.+|. .+.+....+..|.+
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 0111 1122333443 466778889999999999 77777777776644
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=325.39 Aligned_cols=260 Identities=33% Similarity=0.580 Sum_probs=224.0
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 500 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~ 500 (720)
.+++..+++.+.+.||.|.||.|++|... ...||||.++..... .....+..|+++|+.+ +|+|||.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 67788888888899999999999999641 456999988766544 6678899999999999 699999999
Q ss_pred eeeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 501 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 501 g~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
+++...+.+++|+||+..|+|..++++.+ ..++....+.++.||+.|++||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998765 34888999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCc-ccCCCCCC--CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTF-LSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 641 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~-~~~~s~~G--T~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~ 641 (720)
+||||.++..+||+|||+|+...... .......| ...|||||.+....|+.++||||+||+||||++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999644322 22122233 345999999999999999999999999999987 789998865
Q ss_pred -hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 642 -PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 642 -~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
..++.+.+. ...+...|..++.++.++++.||+.+|++||++.++.+.|+..
T Consensus 527 ~~~~l~~~l~-~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEELLEFLK-EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 555555443 5567788999999999999999999999999999999999984
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.77 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=199.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEE----C--CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW----N--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~----~--g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-~~~l 509 (720)
..|++.+.||+|.||.||+|.. . .+.+|||+++.+.-....-...-+|+.+++.++||||+.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5789999999999999999954 1 3379999998763222223456789999999999999999999977 7789
Q ss_pred EEEEeecCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC----CcEEEEec
Q 004986 510 SIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSDF 581 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~----~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~----g~IKL~DF 581 (720)
+|++||.+. +|..+++- ....++...+..|+.||+.|+.|||++= |+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999976 88888742 2346899999999999999999999998 9999999999999876 99999999
Q ss_pred cccccccCCccc---CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHhh
Q 004986 582 GLSRLKHNTFLS---SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPM---------QVVGA 648 (720)
Q Consensus 582 GlAk~~~~~~~~---~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~---------~i~~~ 648 (720)
|+++++.+.... ....+-|.+|.|||.+.|.+ |+.++|||++||++.||++-.+.|.+.... +.++.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999988765433 23456799999999999865 899999999999999999988877653221 01111
Q ss_pred hhc------ccccc---CC--------------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 649 VGF------QNRRL---EI--------------------------PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 649 i~~------~~~~~---~i--------------------------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
|.. ...++ .+ ...-++...+|+.+||+.||.+|.|++|.+++.=.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 100 00000 00 01234458999999999999999999999887643
Q ss_pred h
Q 004986 694 L 694 (720)
Q Consensus 694 i 694 (720)
.
T Consensus 341 ~ 341 (438)
T KOG0666|consen 341 T 341 (438)
T ss_pred c
Confidence 3
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=272.17 Aligned_cols=236 Identities=31% Similarity=0.500 Sum_probs=199.5
Q ss_pred CcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCHHHHHc
Q 004986 449 SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 526 (720)
Q Consensus 449 ~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~ 526 (720)
+||.||+|.+ +++.+|+|++........ ...+.+|++++++++|+||+++++.+......+++|||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 5899999988 468999999876544322 5688899999999999999999999999999999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCc
Q 004986 527 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606 (720)
Q Consensus 527 ~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~AP 606 (720)
... .+++..++.++.+++.+|.+||+.+ |+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 643 3889999999999999999999998 9999999999999999999999999998765432 23445789999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCC-CCcHHHHHHHHHhhhcCCCCCCCH
Q 004986 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPK-ELDPLVARIIWECWQTDPSLRPSF 684 (720)
Q Consensus 607 Evi~g~~~s~ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~~~~~~~ip~-~ls~~l~dLI~~cL~~DP~kRPS~ 684 (720)
|.+.+..++.++|||+||+++++|++|..||.. .+.......+........... .++..+.+++.+||..+|.+||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988889999999999999999999999987 555555554432222211111 188899999999999999999999
Q ss_pred HHHHH
Q 004986 685 AQLTV 689 (720)
Q Consensus 685 ~ELL~ 689 (720)
.++++
T Consensus 236 ~~~~~ 240 (244)
T smart00220 236 EEALQ 240 (244)
T ss_pred HHHhh
Confidence 99986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=337.10 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=192.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
.|...+.||+|+||.||+|++ ++..||||++...... ...|++++++++|||||++++++.+....++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456677899999999999986 6889999988643321 12468889999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
+++|+|.++++. +++..+..++.||+.||+|||.. .++|+||||||+|||++.++..++. ||....... .
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~ 835 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----D 835 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----C
Confidence 999999999953 78999999999999999999943 2249999999999999998888875 666543321 1
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhhhcc--cc------ccC------C
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQ--NR------RLE------I 658 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~--~~i~~~i~~~--~~------~~~------i 658 (720)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+..+.... .. .+. .
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 234689999999999999999999999999999999999999854211 1111111100 00 011 1
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+.....++.+++.+||+.||++||++.|+++.|+++.+
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 11223367899999999999999999999999988765
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=304.33 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=204.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHH----HHHHHHHHHHHHHcCCCceeEEeeeeec-CCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAA----LLEFKREVKIMRRLRHPNVVLFMGAVTR-PPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~----~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-~~~ 508 (720)
++|-++.+||+|+|+.||++.+ ..+.||||+-.... +.++. .+..-+|..|.+.|+||.||++|++|.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5788889999999999999976 67889999654332 22222 2345689999999999999999999965 456
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEeccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSR 585 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~IKL~DFGlAk 585 (720)
+|-|+|||+|.+|+.||... ..+++.++..|+.||+.||.||.+..++|||-||||.|||+- ..|.|||+||||++
T Consensus 543 FCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 89999999999999999764 478999999999999999999999999999999999999995 56899999999999
Q ss_pred cccCCccc-------CCCCCCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhc-c
Q 004986 586 LKHNTFLS-------SKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGF-Q 652 (720)
Q Consensus 586 ~~~~~~~~-------~~s~~GT~~Y~APEvi~g~----~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~-~ 652 (720)
.+.+.... +...+||++|++||.+.-. +.+.|+||||+||++|.++.|+.||.... ..++++.... .
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 87654322 3345899999999987532 36889999999999999999999997643 3334332221 1
Q ss_pred ccccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 NRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 ~~~~~ip--~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.....+| +.++.++++||.+||..--+.|.+..++..+
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1122333 5689999999999999999999999988754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.30 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=203.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--------C
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------P 506 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--------~ 506 (720)
..|+-..+||+|.||.||+|+. +++.||+|++.-++..+.......+|+.+|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4577778899999999999976 67889998776544333334567799999999999999999998753 2
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
..+|+||++|+. +|+-+|.....+++..++.+++.+++.||.|+|... |+|||+|++|+||+.+|.+||+|||+++.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999965 899999887788999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcc----cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--cccccC--
Q 004986 587 KHNTFL----SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLE-- 657 (720)
Q Consensus 587 ~~~~~~----~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~--~~~~~~-- 657 (720)
+..... .-+..+-|.+|++||.+.|.+ |+++.|||+.||++.||+++.+-|.+....+.+..|.. +....+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 543211 112335699999999998754 89999999999999999999999988777665544421 000000
Q ss_pred ----------------CC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 658 ----------------IP-------------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 658 ----------------ip-------------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
++ ..-+++..+|+.++|..||.+|+++.+++.|-
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11 12345789999999999999999999998774
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.03 Aligned_cols=257 Identities=32% Similarity=0.476 Sum_probs=207.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc--CCCceeEEeeeeecCC----ceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRPP----NLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L--~HpNIVkL~g~~~~~~----~l~ 510 (720)
...++.++||+|.||.||+|..+++.||||++. .+..+.|.+|.+|.+.. +|+||++|+++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 445667889999999999999999999999974 34467788899888764 8999999999876665 799
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCEEeeCCCCCcEEEcCCCcEEEEeccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-------TPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~-------g~~IIHrDLKPeNILLd~~g~IKL~DFGl 583 (720)
||+||.+.|+|.+||..+ .++|....+++..|+.||+|||+. +++|+|||||..||||..++...|+||||
T Consensus 285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999874 589999999999999999999975 34699999999999999999999999999
Q ss_pred cccccCCc--ccCCCCCCCCCccCcccccCCCC------CchhhHHHHHHHHHHHHhCCC------------CCCC----
Q 004986 584 SRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATLKL------------PWIG---- 639 (720)
Q Consensus 584 Ak~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~------s~ksDVWSLGilLyELltG~~------------PF~~---- 639 (720)
|..+.... ...-..+||.+|||||++.+.-. -.+.||||+|.+||||++... ||..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98765332 22233589999999999987532 236899999999999998542 3321
Q ss_pred -CChHHHHhhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 640 -MNPMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 640 -~~~~~i~~~i~~~~~~~~ip~~-----ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
...+++...+.....++.+|.. --..+++.+..||+.|++.|.|+.=+.+.+..+...+.-
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1223444555555556666542 234689999999999999999999888888887766643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=312.40 Aligned_cols=253 Identities=29% Similarity=0.512 Sum_probs=221.2
Q ss_pred eeEeEEeeecCcEEEEEEEE--C----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 439 LVLGERIGLGSYGEVYHADW--N----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+...++||.|+||+||+|.| + +.+||||++.... ......++..|.-+|.+++|||+++|++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 45568899999999999987 3 3468999876543 3344678899999999999999999999998766 8899
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
++|++.|.|.+|++..+..+-....+.|..||++||.|||.+. ++||||-.+||||..-.++|++|||+++++.....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999888888999999999999999999999988 99999999999999999999999999998764432
Q ss_pred cCC--CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 593 SSK--STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 593 ~~~--s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
.-. ...-.+.|||-|.+....|+.++|||||||++||++| |..||.+....++.+.+...+ ++..|+.++.++.-+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCCCCccHHHHHH
Confidence 222 2233568999999999999999999999999999876 899999999988888877655 488899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 670 IWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+.+||..|+..||+|+++...+.+..+
T Consensus 933 mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHhccCcccCccHHHHHHHHHHHhc
Confidence 999999999999999999999987743
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=286.72 Aligned_cols=253 Identities=36% Similarity=0.649 Sum_probs=203.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeecCC----ceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~--L~HpNIVkL~g~~~~~~----~l~ 510 (720)
.+..+.+.||+|.||.||+|.|.|..||||+|...+ ...+.+|.+|.+. |+|+||+.|++.-..++ ++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 567889999999999999999999999999986554 3456788888876 49999999998765543 489
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~------g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
||++|.+.|+|+|||.+ ..++-...++++..++.||+|||.. +|.|.|||||..||||.++|.-.|+|+|||
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999987 3689999999999999999999975 346999999999999999999999999999
Q ss_pred ccccCC----cccCCCCCCCCCccCcccccCCCC------CchhhHHHHHHHHHHHHhC----------CCCCCCCCh--
Q 004986 585 RLKHNT----FLSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATL----------KLPWIGMNP-- 642 (720)
Q Consensus 585 k~~~~~----~~~~~s~~GT~~Y~APEvi~g~~~------s~ksDVWSLGilLyELltG----------~~PF~~~~~-- 642 (720)
...... .......+||.+|||||++...-. -..+||||||.++||+... ++||++.-+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 754332 223455689999999999865421 3469999999999999852 478876433
Q ss_pred ---HHHHhhhhccccccCCCCCC--c---HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 643 ---MQVVGAVGFQNRRLEIPKEL--D---PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 643 ---~~i~~~i~~~~~~~~ip~~l--s---~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+++.+-+..+..++.+|... . ..+.+|++.||..+|.-|.++-.+.+.|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 33444444455555555322 1 357889999999999999999999988887753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=304.21 Aligned_cols=249 Identities=19% Similarity=0.224 Sum_probs=170.8
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--C----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeee----
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--N----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA---- 502 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~---- 502 (720)
.+..++|++.+.||+|+||.||+|++ + +..||||++......+ ....| .++...+.+++.++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 45668999999999999999999987 4 6789999875432211 11111 1122222233322222
Q ss_pred --eecCCceEEEEeecCCCCHHHHHcCCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 004986 503 --VTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------------VDEKRRIKMALDVARGMNCLHTSTPTIVHR 561 (720)
Q Consensus 503 --~~~~~~l~LVmEy~~ggsL~d~L~~~~~~-------------------lse~~~~~Ia~qIa~AL~yLHs~g~~IIHr 561 (720)
......+++||||+.+++|.+++...... ..+..+..++.||+.||+|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 24566799999999999999998653211 123345678999999999999998 9999
Q ss_pred CCCCCcEEEcC-CCcEEEEeccccccccCC-cccCCCCCCCCCccCcccccCC----------------------CCCch
Q 004986 562 DLKSPNLLVDK-NWNVKVSDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNE----------------------PSNEK 617 (720)
Q Consensus 562 DLKPeNILLd~-~g~IKL~DFGlAk~~~~~-~~~~~s~~GT~~Y~APEvi~g~----------------------~~s~k 617 (720)
||||+|||++. ++.+||+|||+++.+... .......+||+.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 689999999999865332 2233456899999999976422 23456
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-----------ccc--------cCCCCCCcHHHHHHHHHhhhcCC
Q 004986 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-----------NRR--------LEIPKELDPLVARIIWECWQTDP 678 (720)
Q Consensus 618 sDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-----------~~~--------~~ip~~ls~~l~dLI~~cL~~DP 678 (720)
+|||||||+||||+++..++.... ......+... ... ..+.........+||.+||++||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 799999999999999877654311 1111111000 000 00111123345699999999999
Q ss_pred CCCCCHHHHHHH
Q 004986 679 SLRPSFAQLTVA 690 (720)
Q Consensus 679 ~kRPS~~ELL~~ 690 (720)
.+|||+.|+++|
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=289.01 Aligned_cols=248 Identities=22% Similarity=0.280 Sum_probs=198.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-C-C----ceeEEeeeeec
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-P----NVVLFMGAVTR 505 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-H-p----NIVkL~g~~~~ 505 (720)
+...+|+|.+.+|+|.||.|..+.+ ++..||||+++.-. .-.+...-|+++|+++. + | -+|++.+||..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3357899999999999999999966 57889999875421 12334556899999993 2 3 38899999999
Q ss_pred CCceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-------------
Q 004986 506 PPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD------------- 571 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd------------- 571 (720)
.++.|||+|.+ |-+++++|.. ...+++..++..++.|++.++++||+.+ ++|.||||+|||+-
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999998 7799999977 4457899999999999999999999998 99999999999993
Q ss_pred -------CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 004986 572 -------KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 644 (720)
Q Consensus 572 -------~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~ 644 (720)
++..|||+|||.|....... .+.+.|..|.|||++.+.+|+..+||||+||+|+|+.+|...|+..+..+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 13459999999998655432 45788999999999999999999999999999999999999998766444
Q ss_pred ---HHhhhhc----------------cccccCC---------------CC----------CCcHHHHHHHHHhhhcCCCC
Q 004986 645 ---VVGAVGF----------------QNRRLEI---------------PK----------ELDPLVARIIWECWQTDPSL 680 (720)
Q Consensus 645 ---i~~~i~~----------------~~~~~~i---------------p~----------~ls~~l~dLI~~cL~~DP~k 680 (720)
+.+.|.- ...++.. +. ....++.|||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 2222210 0000000 00 01125899999999999999
Q ss_pred CCCHHHHHHH
Q 004986 681 RPSFAQLTVA 690 (720)
Q Consensus 681 RPS~~ELL~~ 690 (720)
|+|+.|++.|
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=293.83 Aligned_cols=256 Identities=18% Similarity=0.195 Sum_probs=184.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE------------------CCcEEEEEEEecCCCCH--H----------HHHHHH
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW------------------NGTEVAVKKFLDQDFSG--A----------ALLEFK 482 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~------------------~g~~VAVK~i~~~~~~~--~----------~~~e~~ 482 (720)
.+..++|++.++||+|+||+||+|.+ .++.||||++....... . ......
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 45678999999999999999999853 34679999986432110 0 011234
Q ss_pred HHHHHHHHcCCCce-----eEEeeeeec--------CCceEEEEeecCCCCHHHHHcCCC--------------------
Q 004986 483 REVKIMRRLRHPNV-----VLFMGAVTR--------PPNLSIITEFLPRGSLFRILHRPH-------------------- 529 (720)
Q Consensus 483 ~Ei~iL~~L~HpNI-----VkL~g~~~~--------~~~l~LVmEy~~ggsL~d~L~~~~-------------------- 529 (720)
.|+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777788876654 667777643 356899999999999999986421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-cCCCCCCCCCccC
Q 004986 530 ---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SSKSTAGTPEWMA 605 (720)
Q Consensus 530 ---~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-~~~s~~GT~~Y~A 605 (720)
..+++..+..++.|++.+|.|||..+ |+||||||+|||++.++.+||+|||++........ ......+|+.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12356678889999999999999998 99999999999999999999999999975433221 1112245889999
Q ss_pred cccccCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCChH---------HHHhhhhccc
Q 004986 606 PEVLRNEP--------------------S--NEKCDVYSFGVILWELATLKL-PWIGMNPM---------QVVGAVGFQN 653 (720)
Q Consensus 606 PEvi~g~~--------------------~--s~ksDVWSLGilLyELltG~~-PF~~~~~~---------~i~~~i~~~~ 653 (720)
||++.... | ..+.||||+||++|+|++|.. ||...... ....+.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99986432 1 124799999999999999985 77542111 0111111111
Q ss_pred c--ccCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 004986 654 R--RLEIPKELDPLVARIIWECWQTDP---SLRPSFAQLTVA 690 (720)
Q Consensus 654 ~--~~~ip~~ls~~l~dLI~~cL~~DP---~kRPS~~ELL~~ 690 (720)
. ........+...++|+.+||.++| .+|+|+.|+++|
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1 222335678899999999999876 689999999976
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=266.83 Aligned_cols=215 Identities=30% Similarity=0.460 Sum_probs=181.6
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
.++.-+++.-+..||+|+||.|-+.++ +|+..|+|.+..... .+.+++..+|+.+..+. .+|++|+|||.+.+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 567778888889999999999988876 899999999987654 44567788899888776 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 509 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~---~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
.++.||.| ..+|..+-. +.+..++|..+-+|+..++.||.|||++- .|||||+||.||||+.+|++|+||||++-
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999 457776643 35567999999999999999999999873 49999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhh
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVG 650 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g----~~~s~ksDVWSLGilLyELltG~~PF~~~-~~~~i~~~i~ 650 (720)
.+.+... .+...|...|||||.+.. ..|+.++||||||++++||.++++||..+ .+.+.+..+.
T Consensus 198 ~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 198 YLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred eehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 8766543 233678899999999864 36899999999999999999999999875 4555555553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=244.32 Aligned_cols=211 Identities=38% Similarity=0.636 Sum_probs=186.5
Q ss_pred eeecCcEEEEEEEEC--CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCHH
Q 004986 445 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522 (720)
Q Consensus 445 LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~ 522 (720)
||+|.+|.||++... ++.+++|++....... ....+.+|+++++.+.|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999985 8999999987654432 3467889999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEeccccccccCCcccCCCCCCCC
Q 004986 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 601 (720)
Q Consensus 523 d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~~~~~~~~~~s~~GT~ 601 (720)
+++......++...++.++.+++.+|.+||..+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999765346899999999999999999999998 999999999999999 89999999999986654322233456888
Q ss_pred CccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 004986 602 EWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 680 (720)
Q Consensus 602 ~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~k 680 (720)
.|++||.+... .++.+.|+|+||+++++| ..+.+++.+||..+|.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence 99999999887 788999999999999999 67899999999999999
Q ss_pred CCCHHHHHHHH
Q 004986 681 RPSFAQLTVAL 691 (720)
Q Consensus 681 RPS~~ELL~~L 691 (720)
||++.+++++|
T Consensus 205 R~~~~~l~~~~ 215 (215)
T cd00180 205 RPSAKEILEHL 215 (215)
T ss_pred CcCHHHHhhCC
Confidence 99999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=270.66 Aligned_cols=83 Identities=60% Similarity=1.102 Sum_probs=81.6
Q ss_pred hhhhhHHHHHhhccceeeeeeeccccchhhHHHHHHHhhhcCCCceeeecccccCC-CCCceeEEeecCcceeehccccC
Q 004986 2 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGV-EDDAVNIIKLEEEREFLVDLMAA 80 (720)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~ 80 (720)
|++++.+||+ .++|+|||+|++|+|||||||||||||+||||||||||+||||+ +|+|||+|++.+++|||||||++
T Consensus 121 w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~ 198 (204)
T PF14381_consen 121 WELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGA 198 (204)
T ss_pred HHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCC
Confidence 9999999999 99999999999999999999999999999999999999999999 99999999999999999999999
Q ss_pred CCcccc
Q 004986 81 PGTLIP 86 (720)
Q Consensus 81 pg~l~~ 86 (720)
||+|||
T Consensus 199 PG~L~P 204 (204)
T PF14381_consen 199 PGQLIP 204 (204)
T ss_pred CCCcCC
Confidence 999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=291.38 Aligned_cols=251 Identities=20% Similarity=0.239 Sum_probs=203.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC------CceeEEeeee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAV 503 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H------pNIVkL~g~~ 503 (720)
.++.-.+|.+....|+|-|++|..|.+ .+..||||+|...... .+.=+.|++||++|.. -++++|+..|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 345557899999999999999999977 5789999999876432 3445689999999953 4799999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEe
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSD 580 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~D 580 (720)
.+.+++|||||-+ ..+|.++|.+.+ ..+....+..|+.|++.||.+|..+| |+|.||||+|||+++. ..+||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 9999999999988 558999997643 35778899999999999999999999 9999999999999965 5689999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC---
Q 004986 581 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--- 657 (720)
Q Consensus 581 FGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~--- 657 (720)
||.|....... .+.+.-+..|.|||+|.|.+|++..|+||+||+||||.+|+..|.+....+++........++.
T Consensus 581 fGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 581 FGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred Ccccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 99997665432 2335567899999999999999999999999999999999999998776665522210000000
Q ss_pred -------------------------------------CC-----------CCC-------cHHHHHHHHHhhhcCCCCCC
Q 004986 658 -------------------------------------IP-----------KEL-------DPLVARIIWECWQTDPSLRP 682 (720)
Q Consensus 658 -------------------------------------ip-----------~~l-------s~~l~dLI~~cL~~DP~kRP 682 (720)
.| +.+ -..+++|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 00 011 12589999999999999999
Q ss_pred CHHHHHHH
Q 004986 683 SFAQLTVA 690 (720)
Q Consensus 683 S~~ELL~~ 690 (720)
+..|.|+|
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=288.98 Aligned_cols=200 Identities=27% Similarity=0.404 Sum_probs=174.6
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHH------HHHHHHHHHHHHHcC---CCceeEEeeee
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAA------LLEFKREVKIMRRLR---HPNVVLFMGAV 503 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~------~~e~~~Ei~iL~~L~---HpNIVkL~g~~ 503 (720)
++.+|..++.||.|+||.|++|.+ +...|+||.|.++..-... +-.+-.||+||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 346799999999999999999987 5677999988776543221 223567999999997 99999999999
Q ss_pred ecCCceEEEEeec-CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 504 TRPPNLSIITEFL-PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 504 ~~~~~l~LVmEy~-~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
++++.+||+||-. ++.+|++++.... .++|.++..|++|++.|+++||+.| |||||||-+||.++.+|-+||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeecc
Confidence 9999999999974 5779999997643 6999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 004986 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIG 639 (720)
Q Consensus 583 lAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~ 639 (720)
.+....... ...++||..|.|||++.|.+| +..-|||+|||+||.++....||+.
T Consensus 716 saa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 998765542 346899999999999999987 6778999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=295.70 Aligned_cols=251 Identities=31% Similarity=0.496 Sum_probs=217.0
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
..++|+.+.++|.|+||.||++++ +++..|+|+++...-. ...-+..|+-+++..+|+|||.+++.+...+.+|++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 348899999999999999999976 7899999998765432 245567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
||||.||+|.++-+-. ..+++.++.+.+++.+.+|+|||++| =+|||||-.|||+++.|.+||+|||.+..+.....
T Consensus 91 MEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999999987654 47999999999999999999999998 89999999999999999999999999998888778
Q ss_pred cCCCCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc---cccccCCCCCCcHHH
Q 004986 593 SSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF---QNRRLEIPKELDPLV 666 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi---~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~---~~~~~~ip~~ls~~l 666 (720)
+...+.||+.|||||+. +.+.|...+|||++|++..|+-.-++|..+..+.+.+..... +.-...-+..-++.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 88899999999999986 356689999999999999999999999888777766544332 222223334567789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+|++.||.++|.+||+++.+++|
T Consensus 248 h~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheec
Confidence 999999999999999999987763
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=259.44 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=195.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCc--eE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN--LS 510 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~--l~ 510 (720)
.++|++.+++|+|-|+.||.|.. ++..++||+++. ...+.+.+|+.||+.|. ||||++|++...+... ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 37899999999999999999975 788899998743 34678899999999995 9999999999988654 77
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~~~~ 589 (720)
||+||+.+.+...+.. .++...+..++.|++.||.|||++| |+|||+||.|++||. ...++|+|+|+|...+.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999999988877654 4788888999999999999999999 999999999999995 45799999999988765
Q ss_pred CcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-C-ChHHHH------------hhhhcc--
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIG-M-NPMQVV------------GAVGFQ-- 652 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~-~-~~~~i~------------~~i~~~-- 652 (720)
... -...+.+..|.-||.+... .|++.-|+|||||+|..|++.+-||.. . +..++. ..+...
T Consensus 186 ~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred Cce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 432 2335678899999998764 589999999999999999999999864 2 222222 001000
Q ss_pred -------------ccc-c--CCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 -------------NRR-L--EIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 -------------~~~-~--~ip----~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+. + .++ .-.++++.||+.++|..|-.+|+|++|...|
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 0 011 1246899999999999999999999998875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=273.14 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=199.3
Q ss_pred eEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-----ceEEEEe
Q 004986 442 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLSIITE 514 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~-----~l~LVmE 514 (720)
.+.||.|+||.||.+++ +++.||+|++..-...-...+.+.+|+++|..++|.|++..++..+-.. ++|.|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 35699999999999987 7999999998654333344567889999999999999999988765543 4788999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc-
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS- 593 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~- 593 (720)
.|. .+|..++-.. +.++...+.-+++||+.||+|||+.+ |+||||||.|+|++.+..+||||||+++........
T Consensus 138 LmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 984 4888888654 47888889899999999999999999 999999999999999999999999999976544322
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc------------------
Q 004986 594 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------ 654 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------------ 654 (720)
.+..+-|..|.|||++.|.+ |+.++||||.||++.||+..+..|...++-+.++.|.....
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 23335688999999999865 89999999999999999999999998887665544321110
Q ss_pred ------ccCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 655 ------RLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 655 ------~~~i--------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.+.+ +.....+..+++..+|..||++|.+..+.+.++.
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111 1233457889999999999999999999988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=296.69 Aligned_cols=239 Identities=29% Similarity=0.450 Sum_probs=188.9
Q ss_pred eEEeeecCcEE-EEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEeecCCC
Q 004986 442 GERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 442 ~k~LGkG~fG~-Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
.+.+|.|+-|+ ||+|...++.||||++..+. ..-+.+|+..|+.- +|||||++|+.-++...+||+.|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 45689999975 79999999999999875432 33567999999988 799999999999999999999999955
Q ss_pred CHHHHHcCC--CCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---C--CcEEEEeccccccccCC-
Q 004986 520 SLFRILHRP--HCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---N--WNVKVSDFGLSRLKHNT- 590 (720)
Q Consensus 520 sL~d~L~~~--~~~-lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~--g~IKL~DFGlAk~~~~~- 590 (720)
+|.+++... ... ......+.++.|++.||+|||+.+ ||||||||.||||.. + ..++|.|||+++.+...
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999999763 111 111445678899999999999998 999999999999975 3 46899999999976543
Q ss_pred --cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhcccccc-CCCCCCcHHH
Q 004986 591 --FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLV 666 (720)
Q Consensus 591 --~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG-~~PF~~~~~~~i~~~i~~~~~~~-~ip~~ls~~l 666 (720)
.....+..||.+|+|||++....-..++|||||||++|+.++| ..||.+.-..+. .|...+... .+....+.++
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 2234456799999999999999888999999999999998886 899976543322 222222221 1222222389
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||.+|++.+|..||++.+|+.|
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=263.91 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=198.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------c
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------~ 508 (720)
.+|.-++.+|.|.- .|..+.+ .++.||+|++..............+|..++..+.|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999998 6666654 7999999988766444445667889999999999999999999986443 4
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
.|+|||||. .+|...+. ..++...+.++..|++.|++|||+.| |+||||||+||++..++.+||.|||+|+...
T Consensus 96 ~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccC
Confidence 899999994 58888776 35788899999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-----------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF----------------- 651 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~----------------- 651 (720)
.. ...+..+.|..|.|||++.+..|...+||||+||++.||+.|..-|.+.+.-+...++..
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 44 345667899999999999999899999999999999999999999987654332211110
Q ss_pred ----cccc----cC----CC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 652 ----QNRR----LE----IP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 652 ----~~~~----~~----ip-----------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+ .. +| +.-...+++|+.+||-.+|++|-+++++|+|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 00 11 1112368999999999999999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-28 Score=237.12 Aligned_cols=209 Identities=34% Similarity=0.548 Sum_probs=178.2
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|.+.+.||.|++|.||++.. +++.+|+|.+...... .....+.+|+..+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 56778999999999999988 3689999998765443 24667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc-ccCC
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSSK 595 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-~~~~ 595 (720)
++++|.+++......+++..++.++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999764433889999999999999999999998 9999999999999999999999999998765432 1223
Q ss_pred CCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChH-HHHhhhh
Q 004986 596 STAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPM-QVVGAVG 650 (720)
Q Consensus 596 s~~GT~~Y~APEvi-~g~~~s~ksDVWSLGilLyELltG~~PF~~-~~~~-~i~~~i~ 650 (720)
...++..|++||++ ....++.++|||+||+++++|++|+.||.. .+.. .+.+.+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 45788899999998 666778899999999999999999999977 4443 5555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=263.13 Aligned_cols=267 Identities=26% Similarity=0.400 Sum_probs=222.0
Q ss_pred CCccccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEE
Q 004986 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499 (720)
Q Consensus 427 ~~~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL 499 (720)
....+..+..++++...++-+|.||.||.|.|. .+.|.+|.++.. .++-....+..|--++..+.|||+...
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 344556677788999999999999999999652 334666655433 344456677889999999999999999
Q ss_pred eeeeec-CCceEEEEeecCCCCHHHHHc-----C--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 004986 500 MGAVTR-PPNLSIITEFLPRGSLFRILH-----R--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571 (720)
Q Consensus 500 ~g~~~~-~~~l~LVmEy~~ggsL~d~L~-----~--~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd 571 (720)
.++..+ ....+.++.++.-|+|..+|. + ..+.++..+...++.|++.|++|||+++ |||.||-.+|++||
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID 430 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh
Confidence 998755 456788899999999999997 2 2245677788889999999999999999 99999999999999
Q ss_pred CCCcEEEEeccccccccCCcccCCC--CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 004986 572 KNWNVKVSDFGLSRLKHNTFLSSKS--TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 648 (720)
Q Consensus 572 ~~g~IKL~DFGlAk~~~~~~~~~~s--~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~ 648 (720)
+.-++||+|=.+++.+-.....+-. .-....||+||.+....|+.++|+||||++||||++ |+.||...++.++...
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 9999999999999865433322211 123458999999999999999999999999999987 8999999999999888
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
++ ...++..|.++++++..++..||...|++||+++|+...|.++...
T Consensus 511 lk-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 511 LK-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred Hh-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 76 4557788999999999999999999999999999999999988654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=259.38 Aligned_cols=130 Identities=21% Similarity=0.308 Sum_probs=107.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-----C---CceeEEeeeeec
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----H---PNVVLFMGAVTR 505 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-----H---pNIVkL~g~~~~ 505 (720)
..+|.+.++||.|.|++||+|.+ ..+.||+|+.+... .-.+....||.+|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 37899999999999999999977 67889999876432 22345678999999983 2 469999999976
Q ss_pred C----CceEEEEeecCCCCHHHHHc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE
Q 004986 506 P----PNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 570 (720)
Q Consensus 506 ~----~~l~LVmEy~~ggsL~d~L~-~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL 570 (720)
. .++|||+|++ |.+|..+|. ...+.++...+..|++||+.||.|||..- +|||.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 4 4699999999 556666664 45667999999999999999999999762 49999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=244.12 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=192.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee-eecCCceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA-VTRPPNLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~-~~~~~~l~LV 512 (720)
+.|.|.+.||+|.||.+.++++ .++.+++|.+..... .+.+|.+|..---.| .|.||+.-|+. |+..+.+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 6799999999999999999998 567899998876543 367888887655555 58999987764 7778888999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEeccccccccCC
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~IKL~DFGlAk~~~~~ 590 (720)
+||++.|+|..-+... .+.+....+++.|++.||.|+|+++ +||||||.+||||- +.-+|||||||+.+..+..
T Consensus 101 qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999988664 4888999999999999999999999 99999999999995 3348999999998765443
Q ss_pred cccCCCCCCCCCccCcccccCC---C--CCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHhhhhcccc-ccCCCC--
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNE---P--SNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNR-RLEIPK-- 660 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~---~--~s~ksDVWSLGilLyELltG~~PF~~~~~~--~i~~~i~~~~~-~~~ip~-- 660 (720)
... .--+..|.+||+.... + ..+.+|+|.|||++|.+++|.+||...... ....+..+..+ ....|.
T Consensus 177 V~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 177 VKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred ehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 322 2245579999986533 2 366899999999999999999999853222 12223332222 223443
Q ss_pred -CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 661 -ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 661 -~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
-+++.+..+.++-|..++.+|-...+..+..+..
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 4678899999999999999997777666655533
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-25 Score=220.30 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=205.3
Q ss_pred eeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHHcCCC-ceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHP-NVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~-~~~e~~~Ei~iL~~L~Hp-NIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 678899999999999999888 8889998877655443 567889999999999888 7999999997777789999999
Q ss_pred CCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccCCcc-
Q 004986 517 PRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 517 ~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~~~~- 592 (720)
.+++|.+++.... ..+.......++.|++.++.|+|..+ ++|||+||+|||++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999998876643 26889999999999999999999998 99999999999999988 799999999985544321
Q ss_pred -----cCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccc-c--C
Q 004986 593 -----SSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRR-L--E 657 (720)
Q Consensus 593 -----~~~s~~GT~~Y~APEvi~g---~~~s~ksDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~~~-~--~ 657 (720)
......||..|+|||.+.+ ..+....|+|++|+++++++.|..||..... .+....+...... . .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999988 5788899999999999999999999877653 3444444322222 1 1
Q ss_pred CCCCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 658 IPKEL----DPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 658 ip~~l----s~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..... ...+.+++..|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2579999999999999999998887776
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=281.25 Aligned_cols=195 Identities=21% Similarity=0.202 Sum_probs=144.4
Q ss_pred HcCC-CceeEEeeee-------ecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 004986 490 RLRH-PNVVLFMGAV-------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561 (720)
Q Consensus 490 ~L~H-pNIVkL~g~~-------~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHr 561 (720)
.++| .||++++++| .+...++++|||+ +++|.++|......+++.+++.++.||+.||+|||++| ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 3445 5888888887 3345678889988 66999999876667999999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCC-------------------cEEEEeccccccccCCc----------------ccCCCCCCCCCccCc
Q 004986 562 DLKSPNLLVDKNW-------------------NVKVSDFGLSRLKHNTF----------------LSSKSTAGTPEWMAP 606 (720)
Q Consensus 562 DLKPeNILLd~~g-------------------~IKL~DFGlAk~~~~~~----------------~~~~s~~GT~~Y~AP 606 (720)
||||+||||+..| .+||+|||+++...... ......+||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 45556666654321100 001124689999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 004986 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 686 (720)
Q Consensus 607 Evi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~E 686 (720)
|++.+..|+.++|||||||+||||++|.+||..... ....+.....+... ....+...+++.+||+++|.+||++.|
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 999999999999999999999999999888754221 11112111111111 112456779999999999999999999
Q ss_pred HHHH
Q 004986 687 LTVA 690 (720)
Q Consensus 687 LL~~ 690 (720)
++++
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=220.62 Aligned_cols=164 Identities=23% Similarity=0.279 Sum_probs=132.0
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 598 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~ 598 (720)
|+|.+++...+..+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++..... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876667999999999999999999999875 999999999999999 9999865432 236
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccccc-----CCCCCCcH--HHHHHH
Q 004986 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL-----EIPKELDP--LVARII 670 (720)
Q Consensus 599 GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~~~-----~ip~~ls~--~l~dLI 670 (720)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... ..+..++. .+++||
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221111111 11223333 699999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 671 WECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.+||..+|.+||++.|+++++..+...
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=233.84 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=202.0
Q ss_pred CeeEeEEeeecCcEEEEEEEECC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC----CCceeEEeeee-ecCCce
Q 004986 438 DLVLGERIGLGSYGEVYHADWNG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR----HPNVVLFMGAV-TRPPNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~g---~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~----HpNIVkL~g~~-~~~~~l 509 (720)
+|.+.+.||+|+||.||+|.... ..+|+|.......... ..+..|+.++..+. ..++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998743 4688887665432211 15667888888886 26899999999 577789
Q ss_pred EEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-----CcEEEEeccc
Q 004986 510 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-----WNVKVSDFGL 583 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-----g~IKL~DFGl 583 (720)
++||+.+ |.+|.++..... ..++...++.++.|++.+|++||+.| +|||||||.|+++... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999988 889999886544 68999999999999999999999999 9999999999999865 4699999999
Q ss_pred cc--cccCCc-------cc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc
Q 004986 584 SR--LKHNTF-------LS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 584 Ak--~~~~~~-------~~-~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~ 653 (720)
++ .+.... .. ...+.||..|+++.+..+...+.+.|+|||+.++.+++.|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321111 11 224569999999999999999999999999999999999999998765432222221111
Q ss_pred cccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 654 RRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 654 ~~~~---ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
.... .....+.++.++...+-..+...+|.+..+...|+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111 33445678888888888899999999999999988876554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=248.79 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=193.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
.+.|.++++||.|.|++||++++ ..+.||+|.+..... ...+.+|+++|..+ .+.||+++.+++...+..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 46788999999999999999964 467899998866543 34578999999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~~ 588 (720)
.+||||++.....++... ++...+..+++.++.||.++|.+| ||||||||.|+|.+ ..+...|+|||+|....
T Consensus 111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999998864 678889999999999999999999 99999999999998 56889999999987210
Q ss_pred C---------------C--------------------c---------ccCCCCCCCCCccCcccccC-CCCCchhhHHHH
Q 004986 589 N---------------T--------------------F---------LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSF 623 (720)
Q Consensus 589 ~---------------~--------------------~---------~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSL 623 (720)
. . . ......+||++|.|||++.. ...+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 0 0 0 00012369999999999875 446889999999
Q ss_pred HHHHHHHHhCCCCCCCCChH-----HHH---------------hhh-hcc---------------cc-------------
Q 004986 624 GVILWELATLKLPWIGMNPM-----QVV---------------GAV-GFQ---------------NR------------- 654 (720)
Q Consensus 624 GilLyELltG~~PF~~~~~~-----~i~---------------~~i-~~~---------------~~------------- 654 (720)
|+++..++++++||...... ++. ..+ .++ ..
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999999753221 110 000 000 00
Q ss_pred cc-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 RL-EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ~~-~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. .....++..+.+|+.+||..||.+|.++++.|+|
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 0012345589999999999999999999999876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=226.00 Aligned_cols=254 Identities=17% Similarity=0.236 Sum_probs=213.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVm 513 (720)
-.|.++++||.|.||.++.|+. +++.||||.-..... .-++..|.+..+.| ..++|.+.|.+..++-.-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 4689999999999999999986 899999996543322 33566788888888 6799999999999988899999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-----CCcEEEEecccccccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKH 588 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-----~g~IKL~DFGlAk~~~ 588 (720)
|++ |-+|.|++.-+++.++...+..+|.||+.-++|+|.+. +|+|||||+|+||.. ...|.++|||+|+.+.
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 998 78999999888889999999999999999999999999 999999999999974 3459999999999876
Q ss_pred CCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhhcccccc--
Q 004986 589 NTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRL-- 656 (720)
Q Consensus 589 ~~~-------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~---~~~i~~~i~~~~~~~-- 656 (720)
++. ...++..||.+||+-....|...+.+.|+-|||-++++++-|..||.+.. ..+.+++|....+..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 542 23456679999999999999999999999999999999999999998843 345556664322222
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 657 -EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 657 -~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.+...++.++..-+...-..+-.+-|+++-+...+..+.+.
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 24467889999999999999999999999888887766443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=209.91 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=206.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~ 510 (720)
+-...|.++++||.|+||.+|+|.. .|..||||+-...... -++..|..+.+.|+ ...|..+..++.+.+.-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 3347899999999999999999976 8999999975543322 35667888999885 478888888888989999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEeccccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLK 587 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlAk~~ 587 (720)
||||.+ |-+|.+++.-+.+.++...++.++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+|+.+
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhh
Confidence 999998 78999998777778999999999999999999999999 999999999999973 456999999999965
Q ss_pred cCC-------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHhhhhcccc---
Q 004986 588 HNT-------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNR--- 654 (720)
Q Consensus 588 ~~~-------~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~---i~~~i~~~~~--- 654 (720)
.+. ........||.+|.+-....+...+.+.|+-|+|.+|.++--|..||.+..... ..+.|.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 432 223345679999999988888888999999999999999999999999865543 3344431111
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 655 ~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
...+...++.++.-.+..|-...-.+-|+..-+.+.++-+
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 1134578899999999999999999999987766665543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=224.67 Aligned_cols=166 Identities=18% Similarity=0.171 Sum_probs=129.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCceeE-EeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVL-FMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~---~~~~~~e~~~Ei~iL~~L~HpNIVk-L~g~~~~~ 506 (720)
...++|.+.+.||+|+||+||+|.+ +++.||||++..... .......+.+|+++|++++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 3457899999999999999999976 467789998753311 2334556899999999999999985 5442
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC-CCCcEEEcCCCcEEEEeccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDL-KPeNILLd~~g~IKL~DFGlAk 585 (720)
+..||||||++|++|... .. .. ...++.|++.+|.|||++| |+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 457999999999999732 11 11 1457889999999999998 999999 9999999999999999999999
Q ss_pred cccCCcc--------cCCCCCCCCCccCcccccCCC
Q 004986 586 LKHNTFL--------SSKSTAGTPEWMAPEVLRNEP 613 (720)
Q Consensus 586 ~~~~~~~--------~~~s~~GT~~Y~APEvi~g~~ 613 (720)
.+..... .-....++..|+|||.+....
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 6543221 113456888999999986543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-25 Score=246.08 Aligned_cols=226 Identities=28% Similarity=0.395 Sum_probs=190.1
Q ss_pred EeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEEeecC
Q 004986 444 RIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
++|+|+||.|++++. .+.-||+|+..+.............|..++..++ ||++|++..+|+.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998843 5677999987765443322235567888999986 9999999999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCC
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 597 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~ 597 (720)
||+|+..+.+.. .+++.....+..+++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++....... .
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----A 153 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----c
Confidence 999999887654 4566666667779999999999998 99999999999999999999999999987654432 2
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcC
Q 004986 598 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 677 (720)
Q Consensus 598 ~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~D 677 (720)
|||..|||||+++ .....+||||||++++||++|..||.. ++...|. ...+.+|..++..+++++..++..+
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il--~~~~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL--KAELEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh--hhccCCchhhhHHHHHHHHHHHhhC
Confidence 9999999999999 457889999999999999999999988 4444442 3356788999999999999999999
Q ss_pred CCCCCCH
Q 004986 678 PSLRPSF 684 (720)
Q Consensus 678 P~kRPS~ 684 (720)
|.+|.-.
T Consensus 226 p~nrLg~ 232 (612)
T KOG0603|consen 226 PENRLGA 232 (612)
T ss_pred HHHHhcc
Confidence 9999644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-24 Score=248.57 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=191.8
Q ss_pred eEeEEeeecCcEEEEEEEE--CCcEEEEEEEe----cCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 440 VLGERIGLGSYGEVYHADW--NGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 440 ~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~----~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.-...+|.|++|.|+.+.. ....++.|.++ ...........+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998888765 34445555443 22111111222667888888899999999888888877777779
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
|||++ +|+.++... .++....+-.++.|++.|++|+|.+| |.|||||++|+|+...|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999999764 36888889999999999999999999 99999999999999999999999999986544332
Q ss_pred ---cCCCCCCCCCccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChHHHH-hhh------hccccccCCCCC
Q 004986 593 ---SSKSTAGTPEWMAPEVLRNEPSNE-KCDVYSFGVILWELATLKLPWIGMNPMQVV-GAV------GFQNRRLEIPKE 661 (720)
Q Consensus 593 ---~~~s~~GT~~Y~APEvi~g~~~s~-ksDVWSLGilLyELltG~~PF~~~~~~~i~-~~i------~~~~~~~~ip~~ 661 (720)
.....+|+..|+|||++.+..|+. ..||||.|++++.|++|++||......+.. ... ........+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 345678999999999999999876 689999999999999999999764433221 111 111112223346
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTV 689 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~ 689 (720)
++...+.+|.+||+.+|.+|.++++|++
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhh
Confidence 7788999999999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=213.40 Aligned_cols=255 Identities=30% Similarity=0.623 Sum_probs=216.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
|...++.++-+|.+...|..|+|+|.|..+++|++.........-.+|..|.-.|+-+.||||+.+++.|....++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 55566777888999999999999999999999998877766666678889999999899999999999999999999999
Q ss_pred eecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE--eccccccccCC
Q 004986 514 EFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS--DFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~--DFGlAk~~~~~ 590 (720)
.||+.|+|+.+|+... -..+..++.+++.+|+.|++|||+..+-|----|....|+||++...+|. |--++
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs------ 340 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS------ 340 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee------
Confidence 9999999999998643 34677899999999999999999987434444689999999998877663 22221
Q ss_pred cccCCCCCCCCCccCcccccCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s---~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
.......-.+.||+||.+..++.+ .++|+|||++++|||.+...||.+..+.+.--++.....+..+|+.++..+.
T Consensus 341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 111223457899999999877643 4799999999999999999999999999888888878889999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
+|+.-|++.||.+||.++.|+-.|++.+
T Consensus 420 klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=228.95 Aligned_cols=204 Identities=30% Similarity=0.436 Sum_probs=156.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|..++.|-.|+||.||++++ +.+++|+| +.++.+. .+ .|+.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lR--nilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LR--NILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hh--ccccccCCccee-----------------
Confidence 6899999999999999999987 47889995 3332211 01 134444555555
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC-----
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN----- 589 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~----- 589 (720)
|+-...+...+ .++. +++.+++|||..+ |+|||+||+|+||..-|++||+|||+.+...-
T Consensus 136 ----gDc~tllk~~g-~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG-PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccCC-CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 44444443322 2332 3388999999998 99999999999999999999999999874210
Q ss_pred ----------CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-ccccccCC
Q 004986 590 ----------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEI 658 (720)
Q Consensus 590 ----------~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~-~~~~~~~i 658 (720)
.....+..|||+.|+|||++..+.|++.+|||++|+++||++.|..||.+..+++++..+. .....++-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 0112344689999999999999999999999999999999999999999999999886654 22223344
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC
Q 004986 659 PKELDPLVARIIWECWQTDPSLRP 682 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRP 682 (720)
...+.++++++|.++|+.+|..|-
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhc
Confidence 566889999999999999999994
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-21 Score=195.64 Aligned_cols=174 Identities=13% Similarity=0.104 Sum_probs=136.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHH-HHH------HHHHHHHHHHcCCCceeEEeeeeecC-
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA-LLE------FKREVKIMRRLRHPNVVLFMGAVTRP- 506 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~-~~e------~~~Ei~iL~~L~HpNIVkL~g~~~~~- 506 (720)
-..+|.+.++||.|+||.||++..++..+|||.+.......+. ... +.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 3478999999999999999998777889999998765433322 222 57899999999999999998886543
Q ss_pred -------CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE
Q 004986 507 -------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 579 (720)
Q Consensus 507 -------~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~ 579 (720)
...+|||||++|.+|.++.. +++. ...+++.+|..||..| |+|||+||.||+++.+| ++|+
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEEE
Confidence 35889999999999988742 2332 3559999999999999 99999999999999998 9999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 004986 580 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 632 (720)
Q Consensus 580 DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt 632 (720)
|||........... ...+....|+.++|+|+||+++..+..
T Consensus 177 Dfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 177 DLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99988654221100 113444557789999999999876653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-21 Score=190.53 Aligned_cols=140 Identities=21% Similarity=0.231 Sum_probs=107.8
Q ss_pred eEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHH------------------------HHHHHHHHHHHHHcCCCce
Q 004986 442 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA------------------------LLEFKREVKIMRRLRHPNV 496 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~------------------------~~e~~~Ei~iL~~L~HpNI 496 (720)
.+.||+|+||.||+|.+ +|+.||||+++........ ......|+++|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 6899999998764321110 1123459999999987776
Q ss_pred eEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeeCCCCCcEEEcCCCc
Q 004986 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWN 575 (720)
Q Consensus 497 VkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yL-Hs~g~~IIHrDLKPeNILLd~~g~ 575 (720)
........ ...+|||||++|++|...+.+. ..+++..+..++.|++.+|.+| |..| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 44332222 2338999999988776553222 3688999999999999999999 6888 99999999999998 578
Q ss_pred EEEEeccccccc
Q 004986 576 VKVSDFGLSRLK 587 (720)
Q Consensus 576 IKL~DFGlAk~~ 587 (720)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=196.41 Aligned_cols=232 Identities=22% Similarity=0.281 Sum_probs=152.1
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCC----------CceeEEeeeee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRH----------PNVVLFMGAVT 504 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~H----------pNIVkL~g~~~ 504 (720)
.+...+.||.|+++.||.+++ +++.+|||++.... ......+++++|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 457789999999999999998 67999999886554 223356677777655544322 12222222211
Q ss_pred ---------cC---C-----ceEEEEeecCCCCHHHHHc---CCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 004986 505 ---------RP---P-----NLSIITEFLPRGSLFRILH---RPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561 (720)
Q Consensus 505 ---------~~---~-----~l~LVmEy~~ggsL~d~L~---~~~---~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHr 561 (720)
.. . +.+++|+-+ -++|.+++. ... ..+....++.+..|+++.+++||..| |+|+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 11 1 236778877 458887753 111 12334455566689999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC--------CCCchhhHHHHHHHHHHHHhC
Q 004986 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE--------PSNEKCDVYSFGVILWELATL 633 (720)
Q Consensus 562 DLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~--------~~s~ksDVWSLGilLyELltG 633 (720)
||||+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|+|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999877655443221 2345789999987542 468899999999999999999
Q ss_pred CCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 004986 634 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 681 (720)
Q Consensus 634 ~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kR 681 (720)
+.||..........+ .+....+++..++.||..+|+.+|.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999987654333221 233334788999999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=217.99 Aligned_cols=246 Identities=22% Similarity=0.262 Sum_probs=187.2
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeec
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTR 505 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~---HpNIVkL~g~~~~ 505 (720)
.++++..+.|.|.+.||+|+||+||+|+. +++.||+|+-+....-+ |.--.+++.+|+ -+-|..+..++..
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 45667778999999999999999999976 78999999866554322 111123444444 2445556666677
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-------CCCcEEE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-------KNWNVKV 578 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-------~~g~IKL 578 (720)
.+..+||+||.+.|+|.+++... ..+++..+..++.||+..+++||.++ |||+||||+|+||. ..--++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence 78889999999999999999843 47899999999999999999999999 99999999999995 2345999
Q ss_pred Eecccccccc--CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc
Q 004986 579 SDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 656 (720)
Q Consensus 579 ~DFGlAk~~~--~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~ 656 (720)
+|||.+..+. .........++|-.+-.+|+..|..|++.+|.|.|+.+++.|++|++- + .+.....
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q-----~~~g~~~ 910 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E-----VKNGSSW 910 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H-----hcCCcce
Confidence 9999886322 122234456889999999999999999999999999999999999752 1 1111111
Q ss_pred C----CCCCCc-HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 657 E----IPKELD-PLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 657 ~----ip~~ls-~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
. ++.... ..+-+|+..+|+.|-..=|...+|...|+.+-
T Consensus 911 ~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 911 MVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred eccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 1 222222 34778899999966666688888888888764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=199.84 Aligned_cols=193 Identities=23% Similarity=0.369 Sum_probs=144.3
Q ss_pred CCCceeEEeeeeecC---------------------------CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHH
Q 004986 492 RHPNVVLFMGAVTRP---------------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544 (720)
Q Consensus 492 ~HpNIVkL~g~~~~~---------------------------~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qI 544 (720)
+|||||+++++|.+. ..+|+||...+. +|..++-.+. .+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999999887532 347899998854 8999986643 5556666688899
Q ss_pred HHHHHHHHhCCCCEEeeCCCCCcEEEc--CC--CcEEEEeccccccccCC-----ccc-CCCCCCCCCccCcccccCCC-
Q 004986 545 ARGMNCLHTSTPTIVHRDLKSPNLLVD--KN--WNVKVSDFGLSRLKHNT-----FLS-SKSTAGTPEWMAPEVLRNEP- 613 (720)
Q Consensus 545 a~AL~yLHs~g~~IIHrDLKPeNILLd--~~--g~IKL~DFGlAk~~~~~-----~~~-~~s~~GT~~Y~APEvi~g~~- 613 (720)
++|+.|||++| |.|||+|.+||||. ++ -.+.|+|||++-..... ... .....|.-.-||||+.+..+
T Consensus 351 LEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 351 LEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 99999999999994 33 35889999987432221 111 12235778899999987543
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 004986 614 -----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 688 (720)
Q Consensus 614 -----~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL 688 (720)
...|+|.|+.|.+.||++....||++.....+-...-.+...+.+|..+++.+++|+..+|+.||.+|++..=..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 235899999999999999999999984433221111113334568889999999999999999999998765433
Q ss_pred H
Q 004986 689 V 689 (720)
Q Consensus 689 ~ 689 (720)
.
T Consensus 509 N 509 (598)
T KOG4158|consen 509 N 509 (598)
T ss_pred h
Confidence 3
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-20 Score=186.13 Aligned_cols=186 Identities=16% Similarity=0.179 Sum_probs=141.6
Q ss_pred EeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCH--HHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEEeecC
Q 004986 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~--~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
+...|++|+||+||++...+..++.+.+.....-. .....+.+|+++|++|. |++|++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45789999999999998888888877765543311 11224789999999994 5889999886 45799999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC-CCCcEEEcCCCcEEEEeccccccccCCcc----
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 592 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDL-KPeNILLd~~g~IKL~DFGlAk~~~~~~~---- 592 (720)
|.+|...+.. . ...++.|++.+|.++|.+| |+|||| ||+|||++.+|.++|+|||++........
T Consensus 82 G~~L~~~~~~-----~---~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-----G---DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-----h---hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999765421 1 1346789999999999999 999999 79999999999999999999985432211
Q ss_pred -c--------CCCCCCCCCccCcccccCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 004986 593 -S--------SKSTAGTPEWMAPEVLRNE-PSN-EKCDVYSFGVILWELATLKLPWIGM 640 (720)
Q Consensus 593 -~--------~~s~~GT~~Y~APEvi~g~-~~s-~ksDVWSLGilLyELltG~~PF~~~ 640 (720)
. ..-...++.|+.|+...-. ..+ .+.+|++.|+-+|.++|++.++...
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0011367888888865433 222 5789999999999999999886543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=182.59 Aligned_cols=140 Identities=21% Similarity=0.245 Sum_probs=110.1
Q ss_pred eEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCH----------------------H--HHHHHHHHHHHHHHcCCCce
Q 004986 442 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------------A--ALLEFKREVKIMRRLRHPNV 496 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~----------------------~--~~~e~~~Ei~iL~~L~HpNI 496 (720)
.+.||+|+||.||+|++ +|+.||||++....... . ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 69999999987652110 0 01224578999999999887
Q ss_pred eEEeeeeecCCceEEEEeecCCCCHHH-HHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC
Q 004986 497 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 574 (720)
Q Consensus 497 VkL~g~~~~~~~l~LVmEy~~ggsL~d-~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g 574 (720)
.....+... ..+|||||++|+++.. .+.. ..++......++.|++.+|.+||. .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 554443333 2489999999885543 3433 357788889999999999999999 88 99999999999999 89
Q ss_pred cEEEEecccccccc
Q 004986 575 NVKVSDFGLSRLKH 588 (720)
Q Consensus 575 ~IKL~DFGlAk~~~ 588 (720)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-20 Score=214.78 Aligned_cols=245 Identities=19% Similarity=0.194 Sum_probs=179.7
Q ss_pred CeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~--~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+|...+.||.+.|=+|.+|++..-.|+||++-+.. ..-....+...|++ ...++|||.+.+..+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 67788999999999999999866669999987654 22222333444555 5556999999999988888888999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc--CCccc
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLS 593 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~--~~~~~ 593 (720)
+. .+|+|.+..+. .+...+...|+.||+.||..+|..| |+|||||.+||||..=.=+.|+||---+... .+...
T Consensus 103 vk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 95 48999887654 6888889999999999999999999 9999999999999988889999997655321 11111
Q ss_pred CC-----CCCCCCCccCcccccCCC-----------CCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcccccc
Q 004986 594 SK-----STAGTPEWMAPEVLRNEP-----------SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 656 (720)
Q Consensus 594 ~~-----s~~GT~~Y~APEvi~g~~-----------~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~ 656 (720)
.. +......|+|||.+.... .+++-||||+||+++||++ |++||.- .+++....-.....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRSGNADDP 255 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhccCccCH
Confidence 00 112234799999985422 3567899999999999977 6888742 11111110000000
Q ss_pred --CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 --EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 --~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
-+...-+..+++||..|++.||.+|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0111224579999999999999999999999887
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=172.75 Aligned_cols=136 Identities=23% Similarity=0.410 Sum_probs=115.7
Q ss_pred EEeeecCcEEEEEEEECCcEEEEEEEecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 443 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~------~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
+.||+|++|.||+|.+.+..+++|+......... ....+.+|+.++..+.|++|+....++.+....++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5699999999999999999999998664433211 1245778999999999999887777777778899999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+|++|.+++.... . .+..++.+++.+|.+||..+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986532 2 77889999999999999998 99999999999999 78999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=168.69 Aligned_cols=132 Identities=22% Similarity=0.367 Sum_probs=109.0
Q ss_pred EeeecCcEEEEEEEECCcEEEEEEEecCCCCH------HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 444 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~------~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
.||+|+||.||++.+.+..+++|......... ....++.+|++++..+.|+++.....++.+....++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999865443211 123567789999999988876555555556677899999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
|++|.+++..... .++.+++.+|.+||..+ ++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998854321 67889999999999998 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=172.28 Aligned_cols=134 Identities=19% Similarity=0.245 Sum_probs=103.6
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-----CCCceeEEeeeeecCC---c-eEEE
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-----RHPNVVLFMGAVTRPP---N-LSII 512 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-----~HpNIVkL~g~~~~~~---~-l~LV 512 (720)
.+.||+|+||.||.-..++.. +||++...... ....+.+|+.+++.+ .||||+++++++.++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 467999999999963224444 68887654322 345789999999999 5799999999998874 3 3378
Q ss_pred Eee--cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCEEeeCCCCCcEEEcC----CCcEEEEecccc
Q 004986 513 TEF--LPRGSLFRILHRPHCQVDEKRRIKMALDVARGM-NCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLS 584 (720)
Q Consensus 513 mEy--~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL-~yLHs~g~~IIHrDLKPeNILLd~----~g~IKL~DFGlA 584 (720)
||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. ++.++|+||+-+
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999663 35555 34567888777 9999999 999999999999974 347999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.9e-18 Score=189.90 Aligned_cols=210 Identities=32% Similarity=0.511 Sum_probs=167.9
Q ss_pred HHHcCCCceeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 004986 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 567 (720)
Q Consensus 488 L~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeN 567 (720)
|+.+.|.|+.+|+|.+.++...+.|.+||..|+|.|++......+++.....+.++|+.||.|||.-- ...|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecccc
Confidence 35678999999999999999999999999999999999887788999999999999999999999875 23999999999
Q ss_pred EEEcCCCcEEEEeccccccccCC--cccCCCCCCCCCccCcccccCCC-------CCchhhHHHHHHHHHHHHhCCCCCC
Q 004986 568 LLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEP-------SNEKCDVYSFGVILWELATLKLPWI 638 (720)
Q Consensus 568 ILLd~~g~IKL~DFGlAk~~~~~--~~~~~s~~GT~~Y~APEvi~g~~-------~s~ksDVWSLGilLyELltG~~PF~ 638 (720)
+++|....+||+|||+....... ........-..-|.|||.+++.. .+.+.|+||+|++++|+++..-||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998766421 01111112345799999998742 3567999999999999999999997
Q ss_pred C----CChHHHHhhhhccccccC---CC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 639 G----MNPMQVVGAVGFQNRRLE---IP--KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 639 ~----~~~~~i~~~i~~~~~~~~---ip--~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
. ..+.++...+......+. +. ..+.+++..++..||..+|.+||+++++...++.+.+..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 6 233345555443122211 11 145567999999999999999999999999998886654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=171.85 Aligned_cols=144 Identities=24% Similarity=0.251 Sum_probs=111.2
Q ss_pred CeeEeEEeeecCcEEEEEEE-E--CCcEEEEEEEecCCCCH----------------------HHHHHHHHHHHHHHHcC
Q 004986 438 DLVLGERIGLGSYGEVYHAD-W--NGTEVAVKKFLDQDFSG----------------------AALLEFKREVKIMRRLR 492 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~-~--~g~~VAVK~i~~~~~~~----------------------~~~~e~~~Ei~iL~~L~ 492 (720)
.|.+.+.||+|+||.||+|. + +++.||||++....... .....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 3 78999999987543210 01123568999999996
Q ss_pred CCc--eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE
Q 004986 493 HPN--VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 570 (720)
Q Consensus 493 HpN--IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL 570 (720)
+.. +.+++++ ...+|||||++|.+|..+.... ..+...+...++.||+.+|.+||.+| .|+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 533 3444443 2358999999998887665332 24566667889999999999999986 59999999999999
Q ss_pred cCCCcEEEEecccccccc
Q 004986 571 DKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 571 d~~g~IKL~DFGlAk~~~ 588 (720)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=187.44 Aligned_cols=136 Identities=20% Similarity=0.337 Sum_probs=113.8
Q ss_pred eeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCH------HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 439 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~------~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
|...+.||+|+||+||++.+.+..+++|+........ .....+.+|+++++.++|++|+....++.+....++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4567889999999999999877777776543322111 1234678999999999999999888887777888999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
|||++|++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999885 34678899999999999998 9999999999999 678999999999965
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=161.63 Aligned_cols=137 Identities=21% Similarity=0.224 Sum_probs=107.4
Q ss_pred eeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCH--------------------HHHHHHHHHHHHHHHcCCC--c
Q 004986 439 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG--------------------AALLEFKREVKIMRRLRHP--N 495 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~--------------------~~~~e~~~Ei~iL~~L~Hp--N 495 (720)
|.+.+.||+|+||.||++.+ +++.||||++....... .....+..|+.++..+.|. .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778899999999999987 68999999876532110 0112356789999999777 4
Q ss_pred eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 004986 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 575 (720)
Q Consensus 496 IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 575 (720)
++..++ ....++||||++|++|..+... .....++.+++.++.++|..+ |+||||||+||+|++++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCc
Confidence 444444 2456899999999998876431 234567889999999999988 999999999999999999
Q ss_pred EEEEecccccccc
Q 004986 576 VKVSDFGLSRLKH 588 (720)
Q Consensus 576 IKL~DFGlAk~~~ 588 (720)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-17 Score=182.26 Aligned_cols=172 Identities=23% Similarity=0.315 Sum_probs=130.6
Q ss_pred CceEEEEeecCCCCHHHHHcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 507 PNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~--~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
..+||.|++|...+|.++|.+ .....+......++.|++.|++| ++ .+|||+||.||++..+..+||+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 358899999999999999954 34457778888999999999999 56 999999999999999999999999998
Q ss_pred ccccCCc------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccC
Q 004986 585 RLKHNTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 657 (720)
Q Consensus 585 k~~~~~~------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ 657 (720)
....... ...+..+||..||+||.+.+..|+.++|||+||++|+|++. -+..|+... ....+.....++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChH
Confidence 7554332 23345689999999999999999999999999999999997 333332211 1122211111111
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQL 687 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~EL 687 (720)
+. .-.++-..|+.++|.+.|.+||++.+.
T Consensus 481 ~~-~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 481 FL-QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred Hh-hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 11 123456799999999999999954443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.9e-16 Score=141.92 Aligned_cols=134 Identities=19% Similarity=0.186 Sum_probs=112.8
Q ss_pred EeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecCCceEEEEeecCC
Q 004986 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H--pNIVkL~g~~~~~~~l~LVmEy~~g 518 (720)
+.+.||.|.++.||+++..+..+++|.+..... ...+.+|+.+++.++| .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357899999999999999888999998765432 4567889999999976 5899999998888889999999988
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g-~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+..+ +......++.+++.+|.+||... .+++|+|++|+|||+++.+.++|+|||+++.
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 776643 44555677889999999999852 2499999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=151.70 Aligned_cols=137 Identities=23% Similarity=0.223 Sum_probs=97.9
Q ss_pred eEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHH----------------------HHHHHHHHHHcCCCc--e
Q 004986 442 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLE----------------------FKREVKIMRRLRHPN--V 496 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e----------------------~~~Ei~iL~~L~HpN--I 496 (720)
.+.||+|+||+||+|.+ +++.||||++............ ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999987 4899999988754322111111 135666666664432 4
Q ss_pred eEEeeeeecCCceEEEEeecCCCCHHH-HHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC
Q 004986 497 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 574 (720)
Q Consensus 497 VkL~g~~~~~~~l~LVmEy~~ggsL~d-~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g 574 (720)
.++++. ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+ |+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 444443 24589999999854321 111111 11 5667889999999999999 88 99999999999999 89
Q ss_pred cEEEEecccccccc
Q 004986 575 NVKVSDFGLSRLKH 588 (720)
Q Consensus 575 ~IKL~DFGlAk~~~ 588 (720)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.9e-18 Score=194.81 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=195.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LV 512 (720)
..|.+.+.||+|+|+.|-.... ....+|+|.+............+..|..+-..+. |.|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4577778899999999998865 3445666665544333334455566887777775 99999999999999999999
Q ss_pred EeecCCCCHHHHH-cCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccC
Q 004986 513 TEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 589 (720)
Q Consensus 513 mEy~~ggsL~d~L-~~~~~~lse~~~~~Ia~qIa~AL~yLH-s~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~ 589 (720)
++|..|+++++.+ .......+...+..++.|+..++.|+| ..+ +.||||||+|.+++..+ .+++.|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999988 443225666677778999999999999 877 99999999999999999 999999999987654
Q ss_pred -C--cccCCCCCC-CCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--Hhhhhcccc-ccCCCCC
Q 004986 590 -T--FLSSKSTAG-TPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNR-RLEIPKE 661 (720)
Q Consensus 590 -~--~~~~~s~~G-T~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i--~~~i~~~~~-~~~ip~~ 661 (720)
. .......+| ++.|+|||...+. ......|+||+|+++.-+++|..||........ ..+...... .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2 222344578 9999999999985 457789999999999999999999976443321 122211111 2334467
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTV 689 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~ 689 (720)
++....+++.+++..+|..|.+.+++..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred CChhhhhcccccccCCchhccccccccc
Confidence 8889999999999999999999887654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.5e-15 Score=153.98 Aligned_cols=136 Identities=16% Similarity=0.263 Sum_probs=106.6
Q ss_pred EEee-ecCcEEEEEEEECCcEEEEEEEecCCC-----------CHHHHHHHHHHHHHHHHcCCCce--eEEeeeeecCCc
Q 004986 443 ERIG-LGSYGEVYHADWNGTEVAVKKFLDQDF-----------SGAALLEFKREVKIMRRLRHPNV--VLFMGAVTRPPN 508 (720)
Q Consensus 443 k~LG-kG~fG~Vyka~~~g~~VAVK~i~~~~~-----------~~~~~~e~~~Ei~iL~~L~HpNI--VkL~g~~~~~~~ 508 (720)
..|| .|+.|+||.++..+..++||.+..... .......+.+|+.++..|.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4587 899999999998899999998854321 11223567889999999988775 667766433222
Q ss_pred ----eEEEEeecCC-CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccc
Q 004986 509 ----LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583 (720)
Q Consensus 509 ----l~LVmEy~~g-gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGl 583 (720)
.++||||++| .+|.+++... .+++.. +.+|+.+|.+||..| |+||||||+|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2599999997 6999988653 344443 568999999999999 99999999999999999999999998
Q ss_pred ccc
Q 004986 584 SRL 586 (720)
Q Consensus 584 Ak~ 586 (720)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.2e-14 Score=165.24 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=195.0
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
+....+.+.+.+.+-.|.++.++.++- .+-..++|+..... +..........+-.++...++|.++....-+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 456778999999999999999998865 34345555433221 111123334455555555577889988887778889
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++|+++|+.+++|...|+... ..+.+....+...+.+++++||... ++|||++|.|+|+..+|+.++.|||+.....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999998755 3555555666678999999999987 8999999999999999999999998443211
Q ss_pred CC-------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004986 589 NT-------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637 (720)
Q Consensus 589 ~~-------------------------------~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF 637 (720)
.. ........||+.|++||...+......+|||++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 01123346899999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhhcccccc-CCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 004986 638 IGMNPMQVVGAVGFQNRRL-EIPKELDPLVARIIWECWQTDPSLRPSFA 685 (720)
Q Consensus 638 ~~~~~~~i~~~i~~~~~~~-~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ 685 (720)
....+.++++.+......+ .-+...+.+.++++..+|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999998876433333 45567899999999999999999997765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-13 Score=154.55 Aligned_cols=247 Identities=23% Similarity=0.189 Sum_probs=183.6
Q ss_pred CeeEeEEeee--cCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceE
Q 004986 438 DLVLGERIGL--GSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 438 ~y~i~k~LGk--G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~ 510 (720)
.|.+.+.+|. |.+|.||.+.. .+..+|+|+=+...........=.+|+.-.+.+ .|+|.|+.+..+...+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556677999 99999999865 567789886332221111111223455555556 5999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEeccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR 585 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~----AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~DFGlAk 585 (720)
+-+|+| +.+|..+.+.....+++..++.+..+... ||.++|..+ ++|-|+||+||++..+ ...+++|||+..
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence 999999 57888888876667888999999999999 999999998 9999999999999999 889999999998
Q ss_pred cccCCcccCC-----CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC
Q 004986 586 LKHNTFLSSK-----STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 660 (720)
Q Consensus 586 ~~~~~~~~~~-----s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~ 660 (720)
.+........ ...|...|++||.+.+. ++...|+|+||.++.+..++..++......... .+.....+.++..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-QLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcc-ccccccCchhhhc
Confidence 7765432222 22688899999998876 678999999999999998886654332111110 0110112233444
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 004986 661 ELDPLVARIIWECWQTDPSLRPSFAQLTV 689 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRPS~~ELL~ 689 (720)
..+..+...+..+++.+|..|++...+..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 55667777999999999999998776554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-12 Score=145.58 Aligned_cols=141 Identities=24% Similarity=0.260 Sum_probs=97.6
Q ss_pred EEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCH----------------------------HHH----------HHHHH
Q 004986 443 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------------------AAL----------LEFKR 483 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~----------------------------~~~----------~e~~~ 483 (720)
+.||.|++|.||+|+. +|+.||||+.+...... ... .++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 79999999875432100 000 12445
Q ss_pred HHHHHHHcC-----CCceeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCC
Q 004986 484 EVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR-GMNCLHTSTPT 557 (720)
Q Consensus 484 Ei~iL~~L~-----HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~-AL~yLHs~g~~ 557 (720)
|...+.+++ +++|.-..-+.......+|||||++|++|.++........+ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--
Confidence 666665552 34433222222234457899999999999887643211222 3345666665 468889988
Q ss_pred EEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 558 IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=125.29 Aligned_cols=129 Identities=17% Similarity=0.142 Sum_probs=96.3
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCcee-EEeeeeecCCceEEEEeecCCCC
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLPRGS 520 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIV-kL~g~~~~~~~l~LVmEy~~ggs 520 (720)
.+.|+.|.++.||+++..+..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 46789999999999999999999998654321 123457888999988654544 444443 234589999999987
Q ss_pred HHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 521 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP---TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 521 L~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~---~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
+.... . ....++.+++.+|..||..+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 78 l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76430 1 112356789999999999861 259999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.9e-11 Score=138.26 Aligned_cols=164 Identities=19% Similarity=0.256 Sum_probs=124.9
Q ss_pred CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHH
Q 004986 459 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 538 (720)
Q Consensus 459 ~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~ 538 (720)
++.+|.|+.+....- .....+.+-++.|+.++||||+++++.+..+..+|||+|-+. -|..++.+ +......
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 677888887765543 334456778889999999999999999999999999999984 46666654 3366666
Q ss_pred HHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchh
Q 004986 539 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618 (720)
Q Consensus 539 ~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ks 618 (720)
..+.||+.||.|||..+ .++|++|.-..|+|+..|++||++|-++..............---.|..|+.+.... -..
T Consensus 108 ~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 78899999999998543 499999999999999999999999988764433221111111222466676654443 347
Q ss_pred hHHHHHHHHHHHHhC
Q 004986 619 DVYSFGVILWELATL 633 (720)
Q Consensus 619 DVWSLGilLyELltG 633 (720)
|.|.|||+++|++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.2e-12 Score=145.69 Aligned_cols=250 Identities=20% Similarity=0.188 Sum_probs=186.5
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
....+|..+..||.|.|+.|+.+.. ++..|++|.+.+..........-..|+.+...+ -|.+++.++..|...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3457888999999999999999854 578899997766544433333334566666666 699999999988888889
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~DFGlAk~~~ 588 (720)
|+-.|||.++++...+ .....+++..++.+..|++.++.++|++. ++|+|+||+||++..+ +.-++.|||+...+.
T Consensus 342 ~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccc
Confidence 9999999999887665 22345788888899999999999999998 9999999999999876 788999999986422
Q ss_pred CCcccCCCCCC-CCCc-cCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 589 NTFLSSKSTAG-TPEW-MAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~~~s~~G-T~~Y-~APEvi~g~~~s~ksDVWSLGilLyELltG~~P-F~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
. . .....+ +..| .+++......+..++|+++||..+.+.+++..- +.+.. +................+
T Consensus 419 ~--~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 F--S-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------SLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred e--e-cccccccccccccchhhccccccccccccccccccccccccCcccCccccc------ceeeecccccCCCchHHh
Confidence 1 1 112233 3344 356666677788899999999999999998643 22211 111122233333444588
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
+..+.+.++..++..||.+.++..+.+.+.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 999999999999999999999888776554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.2e-12 Score=143.28 Aligned_cols=142 Identities=15% Similarity=0.165 Sum_probs=90.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE-C-CcEEEEEEEecCCC---------------------------CH-----HHHH---
Q 004986 437 EDLVLGERIGLGSYGEVYHADW-N-GTEVAVKKFLDQDF---------------------------SG-----AALL--- 479 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~-~-g~~VAVK~i~~~~~---------------------------~~-----~~~~--- 479 (720)
.+|+. +.||.|++|.||+|+. + |+.||||+.+.... .. +...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 7899999999999987 4 89999999875421 00 0011
Q ss_pred ---HHHHHHHHHHHcC----CCceeEEeeeeec-CCceEEEEeecCCCCHHHHH--cCCCC---CCCHHHHHHHHHHHHH
Q 004986 480 ---EFKREVKIMRRLR----HPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRIL--HRPHC---QVDEKRRIKMALDVAR 546 (720)
Q Consensus 480 ---e~~~Ei~iL~~L~----HpNIVkL~g~~~~-~~~l~LVmEy~~ggsL~d~L--~~~~~---~lse~~~~~Ia~qIa~ 546 (720)
++.+|...+.+++ +...|.+-.++.+ ....+|||||++|+.+.++. ...+. .+.+..+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 1334444444442 3333333333222 34567999999999998753 22211 1222223333333
Q ss_pred HHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecccccccc
Q 004986 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKH 588 (720)
Q Consensus 547 AL~yLHs~g~~IIHrDLKPeNILLd~~g----~IKL~DFGlAk~~~ 588 (720)
++..| ++|+|+||.||+++.+| .++++|||++..+.
T Consensus 276 ----if~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34567 99999999999999888 99999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.4e-12 Score=133.31 Aligned_cols=199 Identities=23% Similarity=0.337 Sum_probs=141.5
Q ss_pred HHHcCCCceeEEeeeeecCC-----ceEEEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 004986 488 MRRLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559 (720)
Q Consensus 488 L~~L~HpNIVkL~g~~~~~~-----~l~LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~II 559 (720)
|-.+-|.|||+++.+|.+.. ...++.||+.-|+|..+|++ ++..+....-.+|+.||+.||.|||.+.++|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44557999999999986543 48899999999999999965 44467778888999999999999999999999
Q ss_pred eeCCCCCcEEEcCCCcEEEEeccccccccCCcc-----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004986 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 634 (720)
Q Consensus 560 HrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-----~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~ 634 (720)
|+++..+-|++..+|-||++----. ....... ......+-++|.+||.=.....+.++|||++|....||..+.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999998887422111 1111110 111224677899999876666677899999999999998876
Q ss_pred CCCC-CCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 635 LPWI-GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 635 ~PF~-~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.--. ..........+. .... ..-+..=+++|.+||+-.|..||+++.++.|.-
T Consensus 280 iq~tnseS~~~~ee~ia--~~i~---~len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIA--NVII---GLENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred eccCCCcceeehhhhhh--hhee---eccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 4311 111111111110 0000 111223478899999999999999999987653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=117.66 Aligned_cols=137 Identities=20% Similarity=0.185 Sum_probs=97.7
Q ss_pred EEeeecCcEEEEEEEEC--------CcEEEEEEEecCC--CC------------------HHHHHH----HHHHHHHHHH
Q 004986 443 ERIGLGSYGEVYHADWN--------GTEVAVKKFLDQD--FS------------------GAALLE----FKREVKIMRR 490 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~--------g~~VAVK~i~~~~--~~------------------~~~~~e----~~~Ei~iL~~ 490 (720)
..||.|--+.||.|... +..+|||+.+... +. ...... .++|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999653 3789999764211 00 001112 3489999999
Q ss_pred cCC--CceeEEeeeeecCCceEEEEeecCCCCHHH-HHcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeeCCCCC
Q 004986 491 LRH--PNVVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSP 566 (720)
Q Consensus 491 L~H--pNIVkL~g~~~~~~~l~LVmEy~~ggsL~d-~L~~~~~~lse~~~~~Ia~qIa~AL~yL-Hs~g~~IIHrDLKPe 566 (720)
+.. -++.+++++ ...+|||||+.+..+.. .+.. ..+++.+...+..+++.+|..| |..| |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 843 455566654 46789999997654432 2322 1345556667788999999988 8888 999999999
Q ss_pred cEEEcCCCcEEEEecccccccc
Q 004986 567 NLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 567 NILLd~~g~IKL~DFGlAk~~~ 588 (720)
|||++ ++.+.|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4789999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.4e-10 Score=114.01 Aligned_cols=141 Identities=21% Similarity=0.261 Sum_probs=107.0
Q ss_pred EEeeecCcEEEEEEEECC-cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecC---CceEEEEeec
Q 004986 443 ERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRP---PNLSIITEFL 516 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H--pNIVkL~g~~~~~---~~l~LVmEy~ 516 (720)
+.|+.|.++.||+++..+ +.+++|+....... .....+..|..+++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998765 88999986543321 124467889999999965 3456677766553 3678999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------------------------------------------ 554 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~------------------------------------------ 554 (720)
+|.++.+.+.. ..+++.+...++.+++.+|..||+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775532 2467777777888888888888842
Q ss_pred ------------CCCEEeeCCCCCcEEEcC--CCcEEEEecccccc
Q 004986 555 ------------TPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 586 (720)
Q Consensus 555 ------------g~~IIHrDLKPeNILLd~--~g~IKL~DFGlAk~ 586 (720)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 124799999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.1e-10 Score=111.65 Aligned_cols=132 Identities=25% Similarity=0.367 Sum_probs=103.1
Q ss_pred EeeecCcEEEEEEEECCcEEEEEEEecCCCCHHH------HHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecC
Q 004986 444 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA------LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~------~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
.+++|+-+.+|.+.+-+..+.+|.=......... .....+|..+|.+++--.|...+=++.+.....|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5889999999999888877777643332222211 2345689999999876666666666777888899999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
|..|.+++... ...++..+-..+.-||..| |||+||.++||++...+ +.++||||+..
T Consensus 83 G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998764 1446677778888899999 99999999999997764 99999999963
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.8e-09 Score=107.56 Aligned_cols=144 Identities=18% Similarity=0.250 Sum_probs=108.3
Q ss_pred EeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~------~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.+..|-+|+-+.|+++.+.|+...||.=....+... .....++|.++|.+++--.|.-..-+|.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 467799999999999999999988884332222211 23456789999999876566655556677777889999
Q ss_pred ecCC-CCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEEEEecccccc
Q 004986 515 FLPR-GSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 586 (720)
Q Consensus 515 y~~g-gsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~IKL~DFGlAk~ 586 (720)
|++| .++.+++...- ..........++.+|-..+.-||..+ |||+||..+||+|..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 47777775422 22333333678899999999999999 99999999999997654 358999999854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-08 Score=111.46 Aligned_cols=249 Identities=18% Similarity=0.241 Sum_probs=162.3
Q ss_pred EeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee------eecCC-ceEEE
Q 004986 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTRPP-NLSII 512 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~------~~~~~-~l~LV 512 (720)
.++.||+|+-+.+|-...-+..|| |++....... .. ..+..|... .||-+-.-+.| .-+.. ...++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~--~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAA--QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhchhh-eeecCCCchH--HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 356799999999997754444444 6665543221 11 112233333 45543321211 12222 26788
Q ss_pred EeecCCCC-HHHHHcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 513 TEFLPRGS-LFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 513 mEy~~ggs-L~d~L~~-----~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
|..+.+.. +.+++.- ..-...|...++.++.|+.+.+.||..| .+-+|+.++|+|+.+++.|.|+|=..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence 88887653 3333321 1123688999999999999999999999 89999999999999999999998653332
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------hHH--HHhhh-h
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATL-KLPWIGMN-------PMQ--VVGAV-G 650 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG-~~PF~~~~-------~~~--i~~~i-~ 650 (720)
..+ .......+|...|.+||..+ +..-+...|.|.||+++++++.| +.||.+.. +.+ +.... .
T Consensus 167 ~~n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 NAN-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred ccC-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 222 12223457999999999865 44456789999999999999887 89997621 111 11000 0
Q ss_pred --ccccc------cCCC-CCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHhhhHhc
Q 004986 651 --FQNRR------LEIP-KELDPLVARIIWECWQT--DPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 651 --~~~~~------~~ip-~~ls~~l~dLI~~cL~~--DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
....+ ...| ..+++.+..|..+|+.. .+.-||+++..+..|..+....
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00111 1122 24678999999999974 3568999999998888776554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.5e-08 Score=107.45 Aligned_cols=135 Identities=20% Similarity=0.151 Sum_probs=96.3
Q ss_pred CcEEEEEEEECCcEEEEEEEecCCCCH---------HHHHHHHHHHHHHHHcCCCce--eEEeeeeec-----CCceEEE
Q 004986 449 SYGEVYHADWNGTEVAVKKFLDQDFSG---------AALLEFKREVKIMRRLRHPNV--VLFMGAVTR-----PPNLSII 512 (720)
Q Consensus 449 ~fG~Vyka~~~g~~VAVK~i~~~~~~~---------~~~~e~~~Ei~iL~~L~HpNI--VkL~g~~~~-----~~~l~LV 512 (720)
....|++++..|+.|.||......... .....+.+|...+.+|...+| +.++.++.. ....+||
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334466788889999999764333111 001136788888888743332 233334332 2347899
Q ss_pred EeecCCC-CHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-------CCcEEEEeccc
Q 004986 513 TEFLPRG-SLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKVSDFGL 583 (720)
Q Consensus 513 mEy~~gg-sL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-------~g~IKL~DFGl 583 (720)
||++++. +|.+++... ....+......++.+++..+..||..| |+|+|+++.||||+. ++.+.|+||+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 9999886 899988531 234566777789999999999999999 999999999999975 46899999998
Q ss_pred cc
Q 004986 584 SR 585 (720)
Q Consensus 584 Ak 585 (720)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 75
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.9e-08 Score=108.27 Aligned_cols=211 Identities=16% Similarity=0.197 Sum_probs=152.3
Q ss_pred cEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCceEEEEeecCC-CCHH
Q 004986 450 YGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLPR-GSLF 522 (720)
Q Consensus 450 fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~----~~~l~LVmEy~~g-gsL~ 522 (720)
-.+.|++.. +|..|.+|++.-..... ....-.-+++++++.|.|||+|.++|.. +..++|||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 367899965 79999999984322111 1111234678999999999999999873 4458999999885 4777
Q ss_pred HHHcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 523 RILHR--------------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 523 d~L~~--------------~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++-.. .+...++..+|.|+.|+..||.++|+.| +..+-|.|.+||++.+.+|+|...|+..++.
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 75422 1235778999999999999999999999 8889999999999998899998777776554
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHH-HhhhhccccccCCCCCCcHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMNPMQV-VGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~P-F~~~~~~~i-~~~i~~~~~~~~ip~~ls~~l 666 (720)
.... |.+.+ -.+-|.=.||.+++.|.+|..- +......+. .. .+...++.++
T Consensus 445 ~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~---------~I~~~yS~D~ 498 (655)
T KOG3741|consen 445 EDPT--------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT---------RITTTYSTDL 498 (655)
T ss_pred CCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---------HhhhhhhHHH
Confidence 3220 11222 2467999999999999999532 222222222 11 2335688899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
+++|..+....+++ -++.+++.++
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHHH
Confidence 99999999998886 5777776654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.5e-08 Score=98.62 Aligned_cols=126 Identities=28% Similarity=0.321 Sum_probs=81.0
Q ss_pred EEEEEEE-CCcEEEEEEEecC--CCCH----------------------HHHHHHHHHHHHHHHcCCC--ceeEEeeeee
Q 004986 452 EVYHADW-NGTEVAVKKFLDQ--DFSG----------------------AALLEFKREVKIMRRLRHP--NVVLFMGAVT 504 (720)
Q Consensus 452 ~Vyka~~-~g~~VAVK~i~~~--~~~~----------------------~~~~e~~~Ei~iL~~L~Hp--NIVkL~g~~~ 504 (720)
.||.|.. ++..+|||+.+.. .+.. .......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899976 7889999976432 1110 1123467899999999765 455666543
Q ss_pred cCCceEEEEeecC--CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 505 RPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC-LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 505 ~~~~l~LVmEy~~--ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~y-LHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 65555544331 1133445566778775555 57888 9999999999999887 9999999
Q ss_pred cccccc
Q 004986 582 GLSRLK 587 (720)
Q Consensus 582 GlAk~~ 587 (720)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.9e-08 Score=97.59 Aligned_cols=105 Identities=29% Similarity=0.317 Sum_probs=80.4
Q ss_pred HHHHHHHHHHHHcCCCc--eeEEeeeeecC----CceEEEEeecCCC-CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 004986 479 LEFKREVKIMRRLRHPN--VVLFMGAVTRP----PNLSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551 (720)
Q Consensus 479 ~e~~~Ei~iL~~L~HpN--IVkL~g~~~~~----~~l~LVmEy~~gg-sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yL 551 (720)
..+.+|...+..|...+ ..+.+++.... ...+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35677888777774322 33444444332 2358999999884 79999875332 66677788999999999999
Q ss_pred HhCCCCEEeeCCCCCcEEEcCCC---cEEEEecccccc
Q 004986 552 HTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 586 (720)
Q Consensus 552 Hs~g~~IIHrDLKPeNILLd~~g---~IKL~DFGlAk~ 586 (720)
|..| |+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.6e-08 Score=114.76 Aligned_cols=146 Identities=18% Similarity=0.263 Sum_probs=107.2
Q ss_pred HHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-cC--C------CCCCCCCccCcccccCCC
Q 004986 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SS--K------STAGTPEWMAPEVLRNEP 613 (720)
Q Consensus 543 qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-~~--~------s~~GT~~Y~APEvi~g~~ 613 (720)
+.+.||.|+|..- ++||+.|.|++|.++..|.+||+.|+++........ .. . ...-...|.|||.+.+..
T Consensus 107 ~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 5669999999874 699999999999999999999999998764332110 00 0 012356899999999988
Q ss_pred CCchhhHHHHHHHHHHHHhCCC-CCCCCChHHH--HhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 004986 614 SNEKCDVYSFGVILWELATLKL-PWIGMNPMQV--VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 689 (720)
Q Consensus 614 ~s~ksDVWSLGilLyELltG~~-PF~~~~~~~i--~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~ 689 (720)
.+.++|+||||+++|.+..|.. -+........ ................++.++++-+.++|..++..||++.++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 8999999999999999995444 4443322221 11121222233455788999999999999999999998776653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.4e-07 Score=97.51 Aligned_cols=136 Identities=25% Similarity=0.294 Sum_probs=97.5
Q ss_pred eeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecC--CC----------------C--HHHHHHHHHHHHHHHHcCCC--c
Q 004986 439 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQ--DF----------------S--GAALLEFKREVKIMRRLRHP--N 495 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~--~~----------------~--~~~~~e~~~Ei~iL~~L~Hp--N 495 (720)
..++..||-|--+.||.|.. .+.++|||.=+.- .+ + .......++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35678899999999999988 6999999942110 00 0 11233467899999998654 6
Q ss_pred eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 004986 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 575 (720)
Q Consensus 496 IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 575 (720)
+.+.+++ +...+||||++|..|...-- +....-.++..|+.-+..+-..| |||+|+.+-|||++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 6676665 56799999999987776431 22333344455555555455667 999999999999999999
Q ss_pred EEEEecccccc
Q 004986 576 VKVSDFGLSRL 586 (720)
Q Consensus 576 IKL~DFGlAk~ 586 (720)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.5e-06 Score=87.52 Aligned_cols=140 Identities=17% Similarity=0.113 Sum_probs=101.7
Q ss_pred eeecCcEEEEEEEECCcEEEEEEEecCCC---C-HHHHHHHHHHHHHHHHcCCC--ceeEEeeee--ecC--CceEEEEe
Q 004986 445 IGLGSYGEVYHADWNGTEVAVKKFLDQDF---S-GAALLEFKREVKIMRRLRHP--NVVLFMGAV--TRP--PNLSIITE 514 (720)
Q Consensus 445 LGkG~fG~Vyka~~~g~~VAVK~i~~~~~---~-~~~~~e~~~Ei~iL~~L~Hp--NIVkL~g~~--~~~--~~l~LVmE 514 (720)
-|+||-+.|+.....|..+-+|.-..... . ..-...|.+|+..|.+|... .+.+..... ... -..+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 46799999999998888888886431110 0 11245788999999988432 244444221 111 12679999
Q ss_pred ecCC-CCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--EEEEecccccc
Q 004986 515 FLPR-GSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 586 (720)
Q Consensus 515 y~~g-gsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--IKL~DFGlAk~ 586 (720)
-+.| .+|.+++.+. -.+.+..+...++.+++.+|.-||..| +.|+|+-+.|||++.+|. ++++||--++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7753 5898888552 235677878889999999999999999 999999999999987777 99999976653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.9e-06 Score=82.46 Aligned_cols=140 Identities=18% Similarity=0.213 Sum_probs=83.3
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCC--ceeEEeeee---ecCCceEEEEeec
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV---TRPPNLSIITEFL 516 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~Hp--NIVkL~g~~---~~~~~l~LVmEy~ 516 (720)
++.|+.|..+.||+++..+..+++|..... .....+.+|..+++.+... -+.+++... ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999997789999986443 3456677888888888432 245555533 2223478999999
Q ss_pred CCCCHHH----------------HHc---CC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 004986 517 PRGSLFR----------------ILH---RP---HCQVDEKR---------RIKM------------ALDVAR-GMNCLH 552 (720)
Q Consensus 517 ~ggsL~d----------------~L~---~~---~~~lse~~---------~~~I------------a~qIa~-AL~yLH 552 (720)
+|..+.. ++. .. ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 111 11 01111100 0000 011222 233333
Q ss_pred h-----CCCCEEeeCCCCCcEEEc-CCCcEEEEeccccc
Q 004986 553 T-----STPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 585 (720)
Q Consensus 553 s-----~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk 585 (720)
. ....++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 223599999999999999 67778899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.4e-06 Score=86.24 Aligned_cols=140 Identities=16% Similarity=0.178 Sum_probs=95.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHH-HHH------HHHHHHHHHHcC---CCceeEEeee-
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA-LLE------FKREVKIMRRLR---HPNVVLFMGA- 502 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~-~~e------~~~Ei~iL~~L~---HpNIVkL~g~- 502 (720)
+...+|.+.+++-......|.+...+++.+.+|..+......+. ... ..+++..+.+++ ...++.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 33467888899988888889999999999999987654432221 111 234444444442 2222232222
Q ss_pred ----eecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 004986 503 ----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578 (720)
Q Consensus 503 ----~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL 578 (720)
+......+|||||++|..|.++.. +++ .++..|.++|.-||..| +.|+|..|.|+++.+++ +++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEE
Confidence 222345678999999988877642 222 24456778899999999 99999999999998654 999
Q ss_pred Eeccccc
Q 004986 579 SDFGLSR 585 (720)
Q Consensus 579 ~DFGlAk 585 (720)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.3e-06 Score=85.18 Aligned_cols=136 Identities=20% Similarity=0.193 Sum_probs=83.8
Q ss_pred EEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeeeeecCCceEEEEeecCCCC
Q 004986 443 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIITEFLPRGS 520 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN--IVkL~g~~~~~~~l~LVmEy~~ggs 520 (720)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++..+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999985 35567788765432 1345678999999885433 4567777777777889999999863
Q ss_pred -HHHHH---------------------cCCC-CCCCHHH-HHHHHH----------HHHH-HHHHHH--hCCCCEEeeCC
Q 004986 521 -LFRIL---------------------HRPH-CQVDEKR-RIKMAL----------DVAR-GMNCLH--TSTPTIVHRDL 563 (720)
Q Consensus 521 -L~d~L---------------------~~~~-~~lse~~-~~~Ia~----------qIa~-AL~yLH--s~g~~IIHrDL 563 (720)
+...+ +... ....... ...+.. .+.. ...+|. .....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11111 1100 0011000 000100 0111 112222 22335899999
Q ss_pred CCCcEEEcCCCcEEEEeccccc
Q 004986 564 KSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 564 KPeNILLd~~g~IKL~DFGlAk 585 (720)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.1e-06 Score=98.60 Aligned_cols=142 Identities=21% Similarity=0.210 Sum_probs=92.8
Q ss_pred EEeeecCcEEEEEEEE-CCcEEEEEEEecCCCC---------------------------H-HHHH----------HHHH
Q 004986 443 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS---------------------------G-AALL----------EFKR 483 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~---------------------------~-~~~~----------e~~~ 483 (720)
..|+.++-|.||+|+. +|+.||||+.+..-.. . .... ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999998 5999999986432111 0 0001 2344
Q ss_pred HHHHHHHcC-----CCceeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 004986 484 EVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558 (720)
Q Consensus 484 Ei~iL~~L~-----HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~I 558 (720)
|..-+.+++ .++|.-..=+++....-.|+|||++|..+.++..-.....+...+.....++. +..+-..| +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg--f 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG--F 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC--c
Confidence 555555542 34443333334445667899999999999888532223455444333222222 22233346 9
Q ss_pred EeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 559 IHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|.|.+|.||+++.+|.+-+.|||+...+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCC
Confidence 999999999999999999999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.3e-05 Score=82.66 Aligned_cols=136 Identities=21% Similarity=0.224 Sum_probs=83.4
Q ss_pred eeecCc-EEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEEeecCCCCHH
Q 004986 445 IGLGSY-GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522 (720)
Q Consensus 445 LGkG~f-G~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~ 522 (720)
|-.|.. ..||++...+..+.||+..... ..++.+|+.+++.+. +--+.+++++....+..++|||+++|..|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 445555 7899998777778888754332 234667888888873 444567777777666789999999988766
Q ss_pred HHH-------------------cCC---CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh-----
Q 004986 523 RIL-------------------HRP---HCQVDEK--RRIKMAL--------------------DVARGMNCLHT----- 553 (720)
Q Consensus 523 d~L-------------------~~~---~~~lse~--~~~~Ia~--------------------qIa~AL~yLHs----- 553 (720)
... +.. ...+... ....... .+...+..|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 110 0011100 0000000 01111222211
Q ss_pred CCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 554 ~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
..+.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12359999999999999998888999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.9e-05 Score=82.59 Aligned_cols=138 Identities=21% Similarity=0.175 Sum_probs=92.3
Q ss_pred eEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHH--------------------HHH--HHHHHHHHHHcC--CCce
Q 004986 442 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA--------------------LLE--FKREVKIMRRLR--HPNV 496 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~--------------------~~e--~~~Ei~iL~~L~--HpNI 496 (720)
...|..|--+.||+|.. ++..+|||+++........ +.. ..+|..-|+++. +=.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 44677888889999975 6899999988643221111 111 245777777773 3344
Q ss_pred eEEeeeeecCCceEEEEeecCCCC-HHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCC
Q 004986 497 VLFMGAVTRPPNLSIITEFLPRGS-LFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 574 (720)
Q Consensus 497 VkL~g~~~~~~~l~LVmEy~~ggs-L~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g 574 (720)
.+.+.+.. -.|||||+.... -.-.|... .+...+...+..++++.+.-|-. .+ +||+||..-|||+. ++
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 44555433 379999996431 11112221 23333566677888888887776 56 99999999999999 88
Q ss_pred cEEEEecccccccc
Q 004986 575 NVKVSDFGLSRLKH 588 (720)
Q Consensus 575 ~IKL~DFGlAk~~~ 588 (720)
.+.++|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999886554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.6e-07 Score=103.21 Aligned_cols=183 Identities=21% Similarity=0.217 Sum_probs=134.8
Q ss_pred eEeEEeeecCcEEEEEEEECCcE-EEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCceEEEEeecC
Q 004986 440 VLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 440 ~i~k~LGkG~fG~Vyka~~~g~~-VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN-IVkL~g~~~~~~~l~LVmEy~~ 517 (720)
....-+++|++++++|.+-..+. ...+.+... ....-++++|.+++||| .+..++-++-+...+++++++.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 33455899999999998654332 223433222 34456788999999999 7777777888888999999998
Q ss_pred CC-CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCC
Q 004986 518 RG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596 (720)
Q Consensus 518 gg-sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s 596 (720)
++ +-...+......+.+.+...+.+.-.++|++||+.- =+||| |||..+ +..|+.||+....+.... ...+
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t 389 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRT 389 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-cccc
Confidence 77 332222222233455555666777788899999863 38998 777655 789999999998776554 4566
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004986 597 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637 (720)
Q Consensus 597 ~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF 637 (720)
..+|+.++|||++....+..+.|+|++|.--.+|.-|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 78999999999999999999999999998777777776654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.7e-05 Score=76.64 Aligned_cols=127 Identities=28% Similarity=0.416 Sum_probs=92.6
Q ss_pred CCeeEeEEeeecCc-EEEEEEEECCcEEEEEEEec---CC-------CCH---------HHHHHHHHHHHHHHHcC---C
Q 004986 437 EDLVLGERIGLGSY-GEVYHADWNGTEVAVKKFLD---QD-------FSG---------AALLEFKREVKIMRRLR---H 493 (720)
Q Consensus 437 ~~y~i~k~LGkG~f-G~Vyka~~~g~~VAVK~i~~---~~-------~~~---------~~~~e~~~Ei~iL~~L~---H 493 (720)
.+++.++.||.|.- |.||+++..|..||+|++.. .. ... ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68899999999999 99999999999999999432 11 110 11234778888888874 4
Q ss_pred Cce--eEEeeeeecC------------------CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 004986 494 PNV--VLFMGAVTRP------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553 (720)
Q Consensus 494 pNI--VkL~g~~~~~------------------~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs 553 (720)
.++ |+++||..-. ....||.||++... .+... -+.+|..-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 566 9999987222 11457889886533 12222 24578888888999
Q ss_pred CCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 554 ~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
.| |+-+|+++.|.. .-||+|||.+
T Consensus 183 ~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CC--eeeccCcccccc-----CCEEEecccC
Confidence 98 999999999986 4589999854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0002 Score=72.28 Aligned_cols=100 Identities=21% Similarity=0.271 Sum_probs=79.9
Q ss_pred HHHHHHHHcCC-CceeEEeeeeecCCceEEEEeecCCCCHHHH---HcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-C
Q 004986 483 REVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNCLHTSTP-T 557 (720)
Q Consensus 483 ~Ei~iL~~L~H-pNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~---L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~-~ 557 (720)
.|..+|+.+.+ +++.+++|+|-+ ++|.||...+.+... +.. -...+|..+.+||.+++..+++|+..-. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57888888865 699999999854 789999987755421 111 1246899999999999999999987411 3
Q ss_pred EEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 558 IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+.-.|++++|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=6.1e-05 Score=75.36 Aligned_cols=130 Identities=22% Similarity=0.229 Sum_probs=92.3
Q ss_pred eeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCcee-EEeeeeecCCceEEEEeecC
Q 004986 439 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIV-kL~g~~~~~~~l~LVmEy~~ 517 (720)
..+.+.|++|++|.||+|.+.+..+|+|+=+.+.. ...++.|.++|..+.-.++. ++|.+..+ .+.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 34567899999999999999999999997544432 45677899999988766654 45554433 45599999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC-CCcEEEcCCCcEEEEecccccc
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLK-PeNILLd~~g~IKL~DFGlAk~ 586 (720)
|-.|.+.-.. .+..+++ .++++-.-|-..| |-|+.|. |...+|-.++.+.|+||.-|..
T Consensus 96 G~~L~~~~~~----~~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIG----GDRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhc----ccHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9888876542 1233333 4445544456667 9999987 6655565666999999998863
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00016 Score=88.15 Aligned_cols=144 Identities=19% Similarity=0.262 Sum_probs=89.7
Q ss_pred eEEeeecCcEEEEEEEECC----cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCce--eEEeeeeecC---CceEE
Q 004986 442 GERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV--VLFMGAVTRP---PNLSI 511 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g----~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNI--VkL~g~~~~~---~~l~L 511 (720)
.+.|+.|.+..+|+.+..+ ..+++|+....... .....+.+|..+|+.+. |.+| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 5678999999999997743 46777765433211 12346789999999995 6665 7777777664 45789
Q ss_pred EEeecCCCCHHH--------------------HH---cCCC----------CCCC--HHHHHHHHH--------------
Q 004986 512 ITEFLPRGSLFR--------------------IL---HRPH----------CQVD--EKRRIKMAL-------------- 542 (720)
Q Consensus 512 VmEy~~ggsL~d--------------------~L---~~~~----------~~ls--e~~~~~Ia~-------------- 542 (720)
||||++|..+.+ .| +... .+.. ..++..|..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998764211 11 1100 0000 112211111
Q ss_pred -HHHHHHHHHHhCC---------CCEEeeCCCCCcEEEcC-CCc-EEEEecccccc
Q 004986 543 -DVARGMNCLHTST---------PTIVHRDLKSPNLLVDK-NWN-VKVSDFGLSRL 586 (720)
Q Consensus 543 -qIa~AL~yLHs~g---------~~IIHrDLKPeNILLd~-~g~-IKL~DFGlAk~ 586 (720)
.+...+.+|..+- +.+||+|+++.|||++. ++. +-|.||.++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 1233456664431 23999999999999985 333 57999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00011 Score=75.80 Aligned_cols=72 Identities=14% Similarity=0.124 Sum_probs=44.5
Q ss_pred EEeeecCcE-EEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCC---ceeEEeeeeecCC---ceEEEEee
Q 004986 443 ERIGLGSYG-EVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVTRPP---NLSIITEF 515 (720)
Q Consensus 443 k~LGkG~fG-~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~Hp---NIVkL~g~~~~~~---~l~LVmEy 515 (720)
+.|+.|+.. .||+. +..+.+|...... ....+.+|..+|..+... -+.+.++.....+ ..+++||+
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457877776 48876 3456777543321 234678899999887431 2344444433322 34789999
Q ss_pred cCCCCH
Q 004986 516 LPRGSL 521 (720)
Q Consensus 516 ~~ggsL 521 (720)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 988665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00019 Score=73.32 Aligned_cols=73 Identities=18% Similarity=0.270 Sum_probs=47.9
Q ss_pred eEEeeecCcEEEEEEEEC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCceEEEEeecC
Q 004986 442 GERIGLGSYGEVYHADWN---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~---g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN-IVkL~g~~~~~~~l~LVmEy~~ 517 (720)
++.|..|-...+|++... +..|++|+...... ......+|+.+++.+...+ ..++++.+. + .+||||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence 466888889999999765 57888887643211 1223457888888884333 344444332 1 47999998
Q ss_pred CCCH
Q 004986 518 RGSL 521 (720)
Q Consensus 518 ggsL 521 (720)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.4e-06 Score=102.86 Aligned_cols=202 Identities=15% Similarity=0.096 Sum_probs=140.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CC
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PP 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~---~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--~~ 507 (720)
++++++.=-+|.|.++ ++++ .-..+-+|+.+.-++ .+...+....|+.-++...|++++..+.-... ..
T Consensus 1228 ~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 3555665555555554 4544 233455565544332 22223334456666667789998887665533 34
Q ss_pred ceEEEEeecCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 508 NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~---~~~lse~~~~~Ia~qIa~AL~yLHs~---g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
..+.+++|+.+|.++.++-+. ...+++..+.....+.+.+..-+|.. |-..+|+++|+-|.+|..+.++|++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 578999999999999988542 22344444444444446666666654 224799999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 640 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~ 640 (720)
|+.+............++++.|++|++...-.++.++|+|.+|+.+|+...|..+|...
T Consensus 1385 gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~f 1443 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFF 1443 (2724)
T ss_pred ccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHH
Confidence 99995444434445567888999999999989999999999999999999998887543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0002 Score=87.49 Aligned_cols=233 Identities=15% Similarity=0.141 Sum_probs=156.0
Q ss_pred eeecCcEEEEEEEECC------cEEEEEEEec-CCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc----eEEEE
Q 004986 445 IGLGSYGEVYHADWNG------TEVAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIIT 513 (720)
Q Consensus 445 LGkG~fG~Vyka~~~g------~~VAVK~i~~-~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~----l~LVm 513 (720)
|..-.+|++++.++.- .++-++.-.. ...........+.|+..+..+.|+|++.++.|...... +.+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 5566777888876621 1222211000 01122334455678888889999999999998755433 33556
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC---cEEEcCCCcEEEE--ecccccccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP---NLLVDKNWNVKVS--DFGLSRLKH 588 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPe---NILLd~~g~IKL~--DFGlAk~~~ 588 (720)
|+|...++...+..-. ..+....+.+..++.++|.|+|... ..|.-|... +..++.++.+.+. ||+..+...
T Consensus 266 ~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred hhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCC
Confidence 7888888988886643 6778888888999999999999985 555544444 4445566777777 998887665
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCc--hhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCCCcHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNE--KCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~--ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
+... .....-...+.++|......+.. ..|+|.+|.++..+..|..+-.. .... ..++......
T Consensus 343 d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~------------~~l~~~~~~~ 409 (1351)
T KOG1035|consen 343 DNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV------------SLLDVLSTSE 409 (1351)
T ss_pred Cccc-chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh------------hhhccccchh
Confidence 4322 22234456778888877666554 47999999999999887654211 1111 1112222237
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKP 693 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~ 693 (720)
..++..+|+.-+.++|++..+++.+.-.
T Consensus 410 ~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 410 LLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred hhhhhhhhcchhhhhccchhhhhhchhc
Confidence 8899999999999999999999987643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0006 Score=73.36 Aligned_cols=77 Identities=14% Similarity=-0.022 Sum_probs=55.2
Q ss_pred EeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC---CceeEEeeeeec---CCceEEEEe
Q 004986 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVLFMGAVTR---PPNLSIITE 514 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H---pNIVkL~g~~~~---~~~l~LVmE 514 (720)
-.+.||.|..+.||.....+..+.+|..+. ... ...+..|...|+.|.- -.+.+.++++.+ .+..+||||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 456799999999999987555677776432 111 2467789999988842 357777777654 366899999
Q ss_pred ecCCCCH
Q 004986 515 FLPRGSL 521 (720)
Q Consensus 515 y~~ggsL 521 (720)
+++|.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00023 Score=82.11 Aligned_cols=141 Identities=18% Similarity=0.172 Sum_probs=86.5
Q ss_pred EEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCH-----------------------------HHH------HHHHHHHH
Q 004986 443 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG-----------------------------AAL------LEFKREVK 486 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~-----------------------------~~~------~e~~~Ei~ 486 (720)
+.||.-+.|.||+|+. +|+.||||+=+..-... +.. .+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999987 78999999743221100 000 02344444
Q ss_pred HHHHc----CCCc------eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 004986 487 IMRRL----RHPN------VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556 (720)
Q Consensus 487 iL~~L----~HpN------IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~ 556 (720)
-..++ +|-+ |.++|- .....-.|+||||+|.-+.|.-.-....++...+..-+.+...-+ +=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcC-
Confidence 33333 3444 222222 223456899999999877654321122456555444333333222 22336
Q ss_pred CEEeeCCCCCcEEEcC----CCcEEEEeccccccccC
Q 004986 557 TIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 557 ~IIHrDLKPeNILLd~----~g~IKL~DFGlAk~~~~ 589 (720)
++|+|-+|.||++.. ++.+.|.|||+...+..
T Consensus 322 -ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 -FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999876543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00028 Score=73.48 Aligned_cols=135 Identities=16% Similarity=0.146 Sum_probs=77.7
Q ss_pred eeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCceEEEEeecCCCCHHH
Q 004986 445 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRGSLFR 523 (720)
Q Consensus 445 LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNI-VkL~g~~~~~~~l~LVmEy~~ggsL~d 523 (720)
+..|-...+|+.+..+..+++|........ ......+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 566788899999888888888864432111 00235678888888854333 33443332 368999999865431
Q ss_pred --------------HH---cCC---CCCCCHH-HHHHHHHHH---------HHHHHHHHhC------CCCEEeeCCCCCc
Q 004986 524 --------------IL---HRP---HCQVDEK-RRIKMALDV---------ARGMNCLHTS------TPTIVHRDLKSPN 567 (720)
Q Consensus 524 --------------~L---~~~---~~~lse~-~~~~Ia~qI---------a~AL~yLHs~------g~~IIHrDLKPeN 567 (720)
.+ +.. ...++.. .+..+..++ ...+..+-.. ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 111 1111211 111221111 1112222111 2248999999999
Q ss_pred EEEcCCCcEEEEecccccc
Q 004986 568 LLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 568 ILLd~~g~IKL~DFGlAk~ 586 (720)
||+++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00096 Score=68.05 Aligned_cols=130 Identities=18% Similarity=0.235 Sum_probs=88.2
Q ss_pred EEeeecCcEEEEEEEECCcEEEEEEEecCC--------------CCHHHHHHHHHHHHHHHHcC------CCceeEEeee
Q 004986 443 ERIGLGSYGEVYHADWNGTEVAVKKFLDQD--------------FSGAALLEFKREVKIMRRLR------HPNVVLFMGA 502 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~--------------~~~~~~~e~~~Ei~iL~~L~------HpNIVkL~g~ 502 (720)
..||+|+.=.||.--. +....||+..... .......+..+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 4599999988886543 3345667766554 01112345556666655554 7899999999
Q ss_pred eecCCceEEEEeecCC------CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC--C
Q 004986 503 VTRPPNLSIITEFLPR------GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN--W 574 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~g------gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~--g 574 (720)
.+++..+.+|+|.+.+ -+|.+++.+. .++. .....+ -.-..||-.+. |+.+||+|.||++... +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L---~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQAL---DEFKRYLLDHH--IVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHH---HHHHHHHHHcC--CeecCCCcccEEEEecCCC
Confidence 9999999999998742 2688888653 3555 333333 33445666777 9999999999999632 2
Q ss_pred --cEEEEec
Q 004986 575 --NVKVSDF 581 (720)
Q Consensus 575 --~IKL~DF 581 (720)
.+.|+|-
T Consensus 158 ~~~lvlIDG 166 (199)
T PF10707_consen 158 EFRLVLIDG 166 (199)
T ss_pred ceEEEEEeC
Confidence 4777773
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00099 Score=70.95 Aligned_cols=73 Identities=23% Similarity=0.351 Sum_probs=47.0
Q ss_pred eEEeeecCcEEEEEEEEC--------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCceEEE
Q 004986 442 GERIGLGSYGEVYHADWN--------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSII 512 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~--------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNI-VkL~g~~~~~~~l~LV 512 (720)
++.|..|-...||+++.. ++.+++|+...... ......+|..++..+...++ .++++.+.. .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 356777777899999764 47888888654321 13455688888888843333 345554432 358
Q ss_pred EeecCCCCH
Q 004986 513 TEFLPRGSL 521 (720)
Q Consensus 513 mEy~~ggsL 521 (720)
+||++|..+
T Consensus 76 ~e~i~G~~l 84 (302)
T cd05156 76 EEFIPSRTL 84 (302)
T ss_pred hheeCCCcC
Confidence 999887655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.004 Score=66.84 Aligned_cols=139 Identities=16% Similarity=0.108 Sum_probs=75.9
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-----CCceeEEe-e--eeecCCceEEEE
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFM-G--AVTRPPNLSIIT 513 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-----HpNIVkL~-g--~~~~~~~l~LVm 513 (720)
.+.|+.|....+|+++.++..+++|++. .... ..+..|+.++..|. .|.++.-. + +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4567788888999998766688999875 2222 23334555555552 23333211 0 112345678999
Q ss_pred eecCCCCH-----------HHHHc---C--CC--------CCCCH-HHHHH------------HHHH-HHHHHHHHHh--
Q 004986 514 EFLPRGSL-----------FRILH---R--PH--------CQVDE-KRRIK------------MALD-VARGMNCLHT-- 553 (720)
Q Consensus 514 Ey~~ggsL-----------~d~L~---~--~~--------~~lse-~~~~~------------Ia~q-Ia~AL~yLHs-- 553 (720)
||++|..+ .+.+. . .. ..+.+ ...+. .+.+ +...++.+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 99988742 11111 1 00 00101 11110 1111 1112233321
Q ss_pred ---CCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 554 ---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 554 ---~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
.-.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12259999999999999976556899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0028 Score=67.12 Aligned_cols=139 Identities=19% Similarity=0.147 Sum_probs=83.8
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeee------eecCCceEEEE
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGA------VTRPPNLSIIT 513 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN--IVkL~g~------~~~~~~l~LVm 513 (720)
.+.|..|....+|++...+..+++|+.... . ...+..|+.++..+.+.+ +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 567888888999999877778999986541 1 234567777887774322 4444432 12345678999
Q ss_pred eecCCCCHHH-----------HH---cC--CC--------CCCCHHHHH----------HHHHHHHHHHHHHHh-----C
Q 004986 514 EFLPRGSLFR-----------IL---HR--PH--------CQVDEKRRI----------KMALDVARGMNCLHT-----S 554 (720)
Q Consensus 514 Ey~~ggsL~d-----------~L---~~--~~--------~~lse~~~~----------~Ia~qIa~AL~yLHs-----~ 554 (720)
+|++|..+.. .+ +. .. ....+.... .....+..++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998865421 11 10 00 000111000 011112334444443 1
Q ss_pred CCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 555 g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
..+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 1249999999999999998778999998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0041 Score=66.75 Aligned_cols=143 Identities=18% Similarity=0.146 Sum_probs=82.8
Q ss_pred eeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeeee------ecCCceE
Q 004986 439 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAV------TRPPNLS 510 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN--IVkL~g~~------~~~~~l~ 510 (720)
....+.++.|....+|+++.++..+.+|+..... . ..++..|++++..|.... +.+++... ...+..+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 4446778888888999998766678888765422 1 223445667777763222 34444321 2245578
Q ss_pred EEEeecCCCCHH-----------HHH---cC--CC--CC------C-CHHHHH------------HHHHHHHHHHHHHHh
Q 004986 511 IITEFLPRGSLF-----------RIL---HR--PH--CQ------V-DEKRRI------------KMALDVARGMNCLHT 553 (720)
Q Consensus 511 LVmEy~~ggsL~-----------d~L---~~--~~--~~------l-se~~~~------------~Ia~qIa~AL~yLHs 553 (720)
++|||++|..+. ..+ +. .. .. . .+.... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885421 111 11 00 00 0 000000 001122334555532
Q ss_pred -----CCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 554 -----STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 554 -----~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...+++|+|+.+.||+++.++...|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 12359999999999999998877999999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.02 Score=64.38 Aligned_cols=76 Identities=17% Similarity=0.051 Sum_probs=51.2
Q ss_pred eEEeeecCcEEEEEEEECC--cEEEEEEEecCCC---C--HHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCceEE
Q 004986 442 GERIGLGSYGEVYHADWNG--TEVAVKKFLDQDF---S--GAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g--~~VAVK~i~~~~~---~--~~~~~e~~~Ei~iL~~L~---HpNIVkL~g~~~~~~~l~L 511 (720)
.+.||-|.+..||++...+ +.+.||.-..... . .........|...|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999998843 4899997431110 0 112445667778887762 2456667665 4466789
Q ss_pred EEeecCCC
Q 004986 512 ITEFLPRG 519 (720)
Q Consensus 512 VmEy~~gg 519 (720)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0011 Score=72.11 Aligned_cols=134 Identities=20% Similarity=0.234 Sum_probs=91.7
Q ss_pred eeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCC--C----------------C--HHHHHHHHHHHHHHHHcC-CCc-
Q 004986 439 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQD--F----------------S--GAALLEFKREVKIMRRLR-HPN- 495 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~--~----------------~--~~~~~e~~~Ei~iL~~L~-HpN- 495 (720)
+.+++.||-|--+.||.+-+ .|++.++|.=+.-. + . .-......+|...|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 46788899999999999987 58998888321100 0 0 001123457888888883 332
Q ss_pred eeEEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc
Q 004986 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 575 (720)
Q Consensus 496 IVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 575 (720)
+.+.++ .+..++|||++.|-.|...-+- .+... +...+..-+--|-.+| +||+|..--||+|++++.
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEecCCC
Confidence 333343 4567999999998777665421 22222 3344555556677788 999999999999999999
Q ss_pred EEEEeccccc
Q 004986 576 VKVSDFGLSR 585 (720)
Q Consensus 576 IKL~DFGlAk 585 (720)
++++||--..
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997554
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0039 Score=68.86 Aligned_cols=141 Identities=22% Similarity=0.293 Sum_probs=93.5
Q ss_pred eEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCC----------------------CHHHHHH--HHHHHHHHHHcCCC
Q 004986 440 VLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF----------------------SGAALLE--FKREVKIMRRLRHP 494 (720)
Q Consensus 440 ~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~----------------------~~~~~~e--~~~Ei~iL~~L~Hp 494 (720)
.|-..|..|--..||.++. +|..+|||+++..-+ .+..+.. .+.|++-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788999999999976 788999997643211 0111222 35688888888655
Q ss_pred ceeEEeeeeecCCceEEEEeecCCCCH-HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcC
Q 004986 495 NVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDK 572 (720)
Q Consensus 495 NIVkL~g~~~~~~~l~LVmEy~~ggsL-~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~ 572 (720)
.|...--... ....|||+|+.+..- .-.|.. -.++...+..+-.+++.-|.-|.+ ++ +||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-
Confidence 5433222111 245799999953211 112222 246666677777788888877755 45 99999999999985
Q ss_pred CCcEEEEeccccccc
Q 004986 573 NWNVKVSDFGLSRLK 587 (720)
Q Consensus 573 ~g~IKL~DFGlAk~~ 587 (720)
+|.+.++|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 579999999877543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0057 Score=67.49 Aligned_cols=103 Identities=18% Similarity=0.222 Sum_probs=67.9
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
...|++|++. |+.|..+- .....++..|+.+.+..++-+..+ .++-|||+...||||+ +|+|-|+||-++++
T Consensus 299 ~y~yl~~kdh-gt~is~ik-----~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIK-----ADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeeee-----cccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeeeec
Confidence 3467777775 55544321 245677888888888877776664 4689999999999999 99999999999985
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 623 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSL 623 (720)
-...... -.-..--|-.+.|. -+..-+||-+
T Consensus 371 ~~~q~~i-----sy~rldhp~lF~G~-dd~QFeIYrl 401 (488)
T COG5072 371 SYSQGII-----SYNRLDHPDLFNGV-DDYQFEIYRL 401 (488)
T ss_pred ccCCcee-----eccccCchhhhcCc-cceeeeHHHH
Confidence 4332211 11122234444433 3556677664
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.013 Score=64.56 Aligned_cols=137 Identities=15% Similarity=0.247 Sum_probs=78.2
Q ss_pred eEEeeecCcEEEEEEEEC------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCceEEEEe
Q 004986 442 GERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNI-VkL~g~~~~~~~l~LVmE 514 (720)
.+.|-.|-.-.+|++... ++.|++|+..... .......+|..+++.+...++ .++++.+... .|+|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 345555888899999752 3578888765432 112234678888888854333 3455555332 5899
Q ss_pred ecCCCCHHHH-----------------HcCCC---C--CCCHHHHHHHHHHH-----------------HHHHHHH----
Q 004986 515 FLPRGSLFRI-----------------LHRPH---C--QVDEKRRIKMALDV-----------------ARGMNCL---- 551 (720)
Q Consensus 515 y~~ggsL~d~-----------------L~~~~---~--~lse~~~~~Ia~qI-----------------a~AL~yL---- 551 (720)
|+++.+|... +++.. . ...+..+.++..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987665311 11111 0 11122222332111 1111122
Q ss_pred Hh--CCCCEEeeCCCCCcEEEcC-CCcEEEEeccccc
Q 004986 552 HT--STPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSR 585 (720)
Q Consensus 552 Hs--~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk 585 (720)
.. ....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 21 1225999999999999986 4789999998875
|
|
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0019 Score=53.37 Aligned_cols=53 Identities=30% Similarity=0.267 Sum_probs=42.3
Q ss_pred eccccchhhHHHHHHHhhhcCCCceeeeccccc---------CCCCCceeEEeecCcceeehc
Q 004986 23 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYT---------GVEDDAVNIIKLEEEREFLVD 76 (720)
Q Consensus 23 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~---------~~~~~~~~~~~~~~~~~~~~d 76 (720)
-+.|.|.+.|.||..|+..+|||||+|.|...- ....-+|++|.+. ++=+.+|
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~~W~~~D 65 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-GGWVPVD 65 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-CCeEEEe
Confidence 468999999999999999999999999996432 1344579999975 5556666
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.017 Score=63.03 Aligned_cols=141 Identities=18% Similarity=0.244 Sum_probs=78.7
Q ss_pred CeeEeEEeeecCcEEEEEEEECC-----cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCceEE
Q 004986 438 DLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSI 511 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~g-----~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNI-VkL~g~~~~~~~l~L 511 (720)
++++ +.|..|-...+|++...+ ..|.+|+..... . ......+|..+++.+..-++ .++++++.. + +
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~ 87 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D--YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---M 87 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C--eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---E
Confidence 4444 445557788899987543 378888765432 1 12344678888888854444 355555532 2 5
Q ss_pred EEeecCCCCHHH--------------HH---cCCCCC----C-CHHHHHHHHHHH-------------------------
Q 004986 512 ITEFLPRGSLFR--------------IL---HRPHCQ----V-DEKRRIKMALDV------------------------- 544 (720)
Q Consensus 512 VmEy~~ggsL~d--------------~L---~~~~~~----l-se~~~~~Ia~qI------------------------- 544 (720)
|.+|+++..|.. .+ +..... . -+..+.++..++
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 889987765421 11 111100 1 122222222111
Q ss_pred HHHHHHHH-hC--CCCEEeeCCCCCcEEEcC-CCcEEEEecccccc
Q 004986 545 ARGMNCLH-TS--TPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 586 (720)
Q Consensus 545 a~AL~yLH-s~--g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~ 586 (720)
+..+..+. .. ...++|+|+.+.|||+++ ++.++|+||..|..
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111111 11 124899999999999975 57899999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.016 Score=61.84 Aligned_cols=30 Identities=23% Similarity=0.491 Sum_probs=25.3
Q ss_pred CEEeeCCCCCcEEEcCCCc-EEEEecccccc
Q 004986 557 TIVHRDLKSPNLLVDKNWN-VKVSDFGLSRL 586 (720)
Q Consensus 557 ~IIHrDLKPeNILLd~~g~-IKL~DFGlAk~ 586 (720)
.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.032 Score=60.06 Aligned_cols=30 Identities=20% Similarity=0.307 Sum_probs=27.3
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 557 ~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.035 Score=59.04 Aligned_cols=28 Identities=29% Similarity=0.406 Sum_probs=24.9
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 557 ~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 5999999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0031 Score=56.98 Aligned_cols=54 Identities=22% Similarity=0.203 Sum_probs=40.4
Q ss_pred eccccchhhHHHHHHHhhhcCCCceeeecccccC----------CCCCceeEEeecCcceeehc
Q 004986 23 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG----------VEDDAVNIIKLEEEREFLVD 76 (720)
Q Consensus 23 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~----------~~~~~~~~~~~~~~~~~~~d 76 (720)
-++|.|..-|.||..|+..+|||||+|.|..... ...-+|++|.+.++.=+.+|
T Consensus 49 ~~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 49 SGRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp CEEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred cCCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 3569999999999999999999999999976421 12237999999666655555
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.087 Score=57.68 Aligned_cols=147 Identities=18% Similarity=0.224 Sum_probs=84.6
Q ss_pred eeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecCC--ceEEEEe
Q 004986 439 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPP--NLSIITE 514 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H--pNIVkL~g~~~~~~--~l~LVmE 514 (720)
..+.+.+-.|..-.+|....+++.+++. ...............+|..+|+.+.- --+...++.|.++. ..++||+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred CceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3445555445445556665567788887 33222222335566788888888743 22334455555544 5799999
Q ss_pred ecCCC------------------CHHHHHcC------CC-------CCCCHHHHHHHHHH--------------HHHHHH
Q 004986 515 FLPRG------------------SLFRILHR------PH-------CQVDEKRRIKMALD--------------VARGMN 549 (720)
Q Consensus 515 y~~gg------------------sL~d~L~~------~~-------~~lse~~~~~Ia~q--------------Ia~AL~ 549 (720)
|++|. .|.++|.. .+ ......+...+..+ +..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 99873 22222211 00 00011111111111 222345
Q ss_pred HHHhCCC------CEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 550 CLHTSTP------TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 550 yLHs~g~------~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+|+.+-+ .++|+|+.+.||+|+..+-+=+.||+++.+
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 5554432 599999999999999988899999999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.022 Score=57.62 Aligned_cols=30 Identities=33% Similarity=0.572 Sum_probs=21.4
Q ss_pred CEEeeCCCCCcEEE-cCCCcEEEEecccccc
Q 004986 557 TIVHRDLKSPNLLV-DKNWNVKVSDFGLSRL 586 (720)
Q Consensus 557 ~IIHrDLKPeNILL-d~~g~IKL~DFGlAk~ 586 (720)
.++|+|+.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 49999999999999 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.047 Score=57.01 Aligned_cols=117 Identities=11% Similarity=0.042 Sum_probs=73.3
Q ss_pred CcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeecCCCCHHHHHcCC
Q 004986 449 SYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 528 (720)
Q Consensus 449 ~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~ 528 (720)
+-.+...++.+=-+..+|++..-...- ...-+..+..++.+++ .|+++..- ..-.+.+++|+|....
T Consensus 74 gNsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------- 140 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------- 140 (308)
T ss_pred CceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--------
Confidence 444444443332344556665433321 1234567888888764 57887732 3445779999984310
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 529 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 529 ~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
... ..++..=+.+|.-+|+..+..+|+|..|+||+-|+.|.+||.|=+..
T Consensus 141 --i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 --INF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred --cch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111 11222225677888976567999999999999999999999998754
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.067 Score=57.67 Aligned_cols=75 Identities=21% Similarity=0.178 Sum_probs=48.6
Q ss_pred eEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCceEEEEeec
Q 004986 440 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 440 ~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~---HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
+-.+.|+-|....+|+.+.+++.+.||+-.... ...|..|..-|+.|. --.+.+.+.+....+..+|||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 346779999999999999889999999865322 235667787787773 455778888887777789999999
Q ss_pred CCC
Q 004986 517 PRG 519 (720)
Q Consensus 517 ~gg 519 (720)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.038 Score=63.48 Aligned_cols=152 Identities=17% Similarity=0.222 Sum_probs=91.4
Q ss_pred HHHHHHHHHHHHcCCCceeEEeeeeec-CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 004986 479 LEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557 (720)
Q Consensus 479 ~e~~~Ei~iL~~L~HpNIVkL~g~~~~-~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~ 557 (720)
.++....++++.+.|+|+.+++++-.. .....+|||++ +.+|.+++.... +- . . ++. -++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~---~---~-s~~-------~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LK---D---E-SLL-------AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cc---h---h-hhc-------ccc--
Confidence 345566788999999999999887643 23488899999 668999886532 11 0 0 111 112
Q ss_pred EEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004986 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 637 (720)
Q Consensus 558 IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF 637 (720)
+.|-. .++.+| ...... .+..| .|+|||++|.++.++.-|..-|
T Consensus 88 ~~~~~------------~~~~td-----~~~t~~---~~~~~----------------pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 88 VLHLN------------IIYITD-----HFLTKY---PSPIG----------------PKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred cceeh------------hhhccc-----cccccC---CCCCC----------------cchhhhhHHHHHHHHHHhhHHH
Confidence 33322 233343 000000 01111 3999999999999999998777
Q ss_pred CCCChHHHHhhhhc-ccccc---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 004986 638 IGMNPMQVVGAVGF-QNRRL---------EIPKELDPLVARIIWECWQTDPSLRPSFA 685 (720)
Q Consensus 638 ~~~~~~~i~~~i~~-~~~~~---------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ 685 (720)
......+....+.. ...+. .+-..++..+.++...|+...|..||...
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 65444333332221 00000 11234677788999999999999887443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.19 Score=56.44 Aligned_cols=79 Identities=14% Similarity=0.194 Sum_probs=45.2
Q ss_pred CeeEeEEeeecCcEEEEEEEECC---cEEEEEEEec--CCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCceEE
Q 004986 438 DLVLGERIGLGSYGEVYHADWNG---TEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSI 511 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~g---~~VAVK~i~~--~~~~~~~~~e~~~Ei~iL~~L~HpN-IVkL~g~~~~~~~l~L 511 (720)
++++ +.|..|-...+|++...+ ..+.+|.+.. -........+-.+|+++++.+...+ -.++++.+.. ++
T Consensus 52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 3444 456568889999997532 2222221111 0111111233457899999985444 4556666643 69
Q ss_pred EEeecCCCCH
Q 004986 512 ITEFLPRGSL 521 (720)
Q Consensus 512 VmEy~~ggsL 521 (720)
|+||++|..|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999988765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.29 Score=55.47 Aligned_cols=75 Identities=15% Similarity=-0.003 Sum_probs=50.0
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCC--CH---HHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCceEEEE
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SG---AALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~--~~---~~~~e~~~Ei~iL~~L~---HpNIVkL~g~~~~~~~l~LVm 513 (720)
.+.||-|....||++...+..++||.-..... .. ........|...|+.+. ...+.+++.++. +..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 57799999999999988777788986542111 00 12333344566666553 246777887776 4567899
Q ss_pred eecCC
Q 004986 514 EFLPR 518 (720)
Q Consensus 514 Ey~~g 518 (720)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.15 Score=56.85 Aligned_cols=73 Identities=19% Similarity=0.102 Sum_probs=44.8
Q ss_pred EeeecCcEEEEEEEECC--cEEEEEEEecCC-----CCHHHHHHHHHHHHHHHHcC--CCc-eeEEeeeeecCCceEEEE
Q 004986 444 RIGLGSYGEVYHADWNG--TEVAVKKFLDQD-----FSGAALLEFKREVKIMRRLR--HPN-VVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 444 ~LGkG~fG~Vyka~~~g--~~VAVK~i~~~~-----~~~~~~~e~~~Ei~iL~~L~--HpN-IVkL~g~~~~~~~l~LVm 513 (720)
.||-|....||++...+ +.|.||.-.... .-.-.......|...|+... .|. +.++|. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 47999999999998743 578888532110 00112334456777776652 343 444443 3456667999
Q ss_pred eecCC
Q 004986 514 EFLPR 518 (720)
Q Consensus 514 Ey~~g 518 (720)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.032 Score=63.34 Aligned_cols=56 Identities=27% Similarity=0.453 Sum_probs=45.9
Q ss_pred ccccchhhHHHHHHHhhhcCCCceeeecccccC-------CCCCceeEEeecCcceeehccccC
Q 004986 24 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG-------VEDDAVNIIKLEEEREFLVDLMAA 80 (720)
Q Consensus 24 ~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~-------~~~~~~~~~~~~~~~~~~~d~~~~ 80 (720)
-.++|--=|.|||.||-.+||+|-+|+|.--.+ ..+-|||.|++.| +-|+||.-..
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~-~yy~VDtTwg 270 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDN-EYYLVDTTWG 270 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECC-eEEEEeeecC
Confidence 457787789999999999999999999982222 2455999999988 8899998653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.42 Score=54.66 Aligned_cols=76 Identities=12% Similarity=0.181 Sum_probs=46.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEEC----------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCcee-EEeeeeec
Q 004986 437 EDLVLGERIGLGSYGEVYHADWN----------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV-LFMGAVTR 505 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~----------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIV-kL~g~~~~ 505 (720)
++. -++.|..|-.-.+|+++.. ++.|.+++..... ........|..+++.+...+|- ++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~- 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSKYRIAPQLLNTFS- 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHHCCCCCceEEEeC-
Confidence 455 5677777888899998753 4578888754321 1122345677777777543333 4555442
Q ss_pred CCceEEEEeecCCCC
Q 004986 506 PPNLSIITEFLPRGS 520 (720)
Q Consensus 506 ~~~l~LVmEy~~ggs 520 (720)
-+.|.||++|..
T Consensus 181 ---gg~I~efi~g~~ 192 (442)
T PTZ00296 181 ---GGRIEEWLYGDP 192 (442)
T ss_pred ---CCEEEEeeCCcc
Confidence 256789998763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.79 Score=57.67 Aligned_cols=30 Identities=30% Similarity=0.495 Sum_probs=25.7
Q ss_pred CEEeeCCCCCcEEEcCCC--cEE-EEecccccc
Q 004986 557 TIVHRDLKSPNLLVDKNW--NVK-VSDFGLSRL 586 (720)
Q Consensus 557 ~IIHrDLKPeNILLd~~g--~IK-L~DFGlAk~ 586 (720)
.+||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999999775 565 999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 720 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-100 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-99 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-41 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-41 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-40 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-40 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-38 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-38 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-38 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-38 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-38 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-38 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-38 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-38 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-38 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-38 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-38 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-37 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-37 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-37 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-37 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-37 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-37 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-37 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-37 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-37 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-37 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-36 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-36 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-36 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-36 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-36 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-36 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-34 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-33 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-32 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-32 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-32 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-32 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-32 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-32 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-32 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-32 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-32 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-32 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-32 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-31 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-31 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-31 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-31 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-31 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-31 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-31 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-31 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-31 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-31 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-31 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-31 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-31 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-31 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-31 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-31 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-31 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-31 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-31 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-31 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-31 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-30 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-30 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-30 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-30 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-30 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-30 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-30 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-30 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-30 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-30 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-30 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-30 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-30 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-30 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-30 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-30 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-29 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-29 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-29 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-29 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-29 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-29 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-29 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-29 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-29 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-29 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-29 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-29 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-29 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-29 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-29 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-29 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-29 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-29 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-29 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-29 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-29 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-29 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-28 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-28 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-28 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-28 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-28 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-28 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-28 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-28 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-28 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-28 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-28 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-28 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-28 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-28 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-28 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-28 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-28 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-28 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-28 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-28 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-28 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-28 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-27 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-27 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-27 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-27 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-27 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-27 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-27 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-27 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-27 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-27 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-27 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-27 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-27 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-27 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-27 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-27 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-27 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-27 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-26 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-26 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-26 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-26 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-26 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-26 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-26 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-26 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-26 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-26 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-26 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-26 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-26 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-26 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-25 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-25 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-25 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-25 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-25 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-25 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-25 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-25 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-25 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-25 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-25 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-25 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-25 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-25 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-25 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-25 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-25 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-25 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-25 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-25 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-25 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-25 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-24 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-24 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-24 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-24 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-24 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-24 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-24 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-24 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-24 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-24 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-23 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-23 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-23 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-23 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-23 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-22 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-21 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-21 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-21 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-21 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-21 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-21 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-21 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-21 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-21 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-21 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-21 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-21 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-21 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-21 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-21 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-21 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-20 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-20 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-20 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-20 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-20 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-20 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-20 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-19 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-19 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-19 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-19 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-19 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-18 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-18 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-18 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 480 bits (1238), Expect = e-167
Identities = 181/302 (59%), Positives = 224/302 (74%), Gaps = 3/302 (0%)
Query: 402 LKLRDLESPSSSVDSSTSKVDQIFD-DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG 460
+K P S D T++ D + +IPW DL + E+IG GS+G V+ A+W+G
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 461 TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 520
++VAVK ++QDF + EF REV IM+RLRHPN+VLFMGAVT+PPNLSI+TE+L RGS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 521 LFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578
L+R+LH+ Q+DE+RR+ MA DVA+GMN LH P IVHR+LKSPNLLVDK + VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 579 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 638
DFGLSRLK +TFLSSKS AGTPEWMAPEVLR+EPSNEK DVYSFGVILWELATL+ PW
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 639 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698
+NP QVV AVGF+ +RLEIP+ L+P VA II CW +P RPSFA + L+PL +
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 699 IP 700
+P
Sbjct: 301 VP 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 430 bits (1108), Expect = e-148
Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 11/270 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
I ++ L ++ GE++ W G ++ VK +D+S +F E +R
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 493 HPNVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMN 549
HPNV+ +GA PP + ++IT ++P GSL+ +LH VD+ + +K ALD+ARGM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 609
LHT P I L S ++++D++ ++S + S P W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEAL 180
Query: 610 RNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
+ +P + D++SF V+LWEL T ++P+ ++ M++ V + R IP + P V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
++++ C DP+ RP F + L+ +Q
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 425 bits (1096), Expect = e-146
Identities = 98/273 (35%), Positives = 147/273 (53%), Gaps = 15/273 (5%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRR 490
EI + +L L E IG+G +G+VY A W G EVAVK + + ++E K+
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
L+HPN++ G + PNL ++ EF G L R+L ++ + A+ +ARGMN
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 551 LHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 601
LH I+HRDLKS N+L+ + N +K++DFGL+R H T + S AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
WMAPEV+R ++ DV+S+GV+LWEL T ++P+ G++ + V V L IP
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
A+++ +CW DP RPSF + L +
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 423 bits (1090), Expect = e-144
Identities = 93/314 (29%), Positives = 150/314 (47%), Gaps = 22/314 (7%)
Query: 405 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 464
+L S+ + IF E +IP+E L +GE IG G +G+VYH W+G EVA
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQ---EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVA 59
Query: 465 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 524
++ + + L FKREV R+ RH NVVLFMGA PP+L+IIT +L+ +
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 525 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584
+ +D + ++A ++ +GM LH I+H+DLKS N+ D N V ++DFGL
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 585 RLKHNTFLSSKST-----AGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWEL 630
+ + G +APE++R P ++ DV++ G I +EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 631 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690
+ P+ ++ +G + + ++ I+ CW + RP+F +L
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 691 LKPLQRLVI-PSHP 703
L+ L + SHP
Sbjct: 297 LEKLPKRNRRLSHP 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 422 bits (1086), Expect = e-144
Identities = 100/279 (35%), Positives = 156/279 (55%), Gaps = 13/279 (4%)
Query: 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 486
D + EIP + +G+RIG GS+G VY W+G +VAVK + L FK EV
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 546
++R+ RH N++LFMG T P L+I+T++ SL+ LH + + K+ I +A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 604
GM+ LH +I+HRDLKS N+ + ++ VK+ DFGL+ K S + G+ WM
Sbjct: 132 GMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 605 APEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR---LE 657
APEV+R + SN + DVY+FG++L+EL T +LP+ +N Q++ VG + +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ + R++ EC + RPSF ++ ++ L R
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 409 bits (1053), Expect = e-139
Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 21/278 (7%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALL-----EFKREV 485
+ ++ ++IG G +G V+ + + VA+K + D G + EF+REV
Sbjct: 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
IM L HPN+V G + PP ++ EF+P G L+ L + ++++ LD+A
Sbjct: 75 FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKHNTFLSSKSTAGT 600
G+ + P IVHRDL+SPN+ + KV+DFGLS+ ++ G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGN 189
Query: 601 PEWMAPEVL--RNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRL 656
+WMAPE + E EK D YSF +IL+ + T + P+ + ++ + + + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
IP++ P + +I CW DP RP F+ + L L
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-138
Identities = 90/292 (30%), Positives = 128/292 (43%), Gaps = 17/292 (5%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
DL+ GE +G G +G+ T + F F +EVK+MR
Sbjct: 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
L HPNV+ F+G + + L+ ITE++ G+L I+ Q +R+ A D+A GM
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--------------KHNTFLSSKS 596
LH+ I+HRDL S N LV +N NV V+DFGL+RL K +
Sbjct: 124 LHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 597 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRR 655
G P WMAPE++ +EK DV+SFG++L E+ P + +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPS 707
P P I C DP RPSF +L L+ L+ + P P
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-134
Identities = 82/281 (29%), Positives = 135/281 (48%), Gaps = 14/281 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
I ++++ + E +G G++G V A W +VA+K+ + F E++ + R+
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERK----AFIVELRQLSRVN 59
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNC 550
HPN+V GA P + ++ E+ GSL+ +LH P + L ++G+
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 551 LHTSTPT-IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
LH+ P ++HRDLK PNLL+ V K+ DFG + ++K G+ WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVA 667
+EKCDV+S+G+ILWE+ T + P+ + P + R + K L +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 668 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 708
++ CW DPS RPS ++ + L R +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-120
Identities = 91/341 (26%), Positives = 146/341 (42%), Gaps = 58/341 (17%)
Query: 398 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 457
G +L+ +S SS S + Q + + + ++IG G YGEV+
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQ---------RTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 458 WNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTRP----PNLSI 511
W G +VAVK F + + + RE +I +RH N++ F+ A + L +
Sbjct: 58 WRGEKVAVKVFFTTEEA-----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112
Query: 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLKS 565
IT++ GSL+ L +D K +K+A G+ LHT P I HRDLKS
Sbjct: 113 ITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 566 PNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVL------RNEPSN 615
N+LV KN ++D GL+ + + + GT +M PEVL + S
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 616 EKCDVYSFGVILWELAT----------LKLPWIGMNPMQ-----VVGAVGFQNRRLEIPK 660
D+YSFG+ILWE+A +LP+ + P + V + R P
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 661 -----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
E + +++ ECW +P+ R + ++ L +
Sbjct: 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-119
Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHP 494
D+ L E +G G YGEV+ W G VAVK F +D + RE ++ LRH
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-----SWFRETELYNTVMLRHE 62
Query: 495 NVVLFMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
N++ F+ + L +IT + GSL+ L +D +++ L +A G+
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAH 120
Query: 551 LHT------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----LSSKSTAGT 600
LH P I HRDLKS N+LV KN ++D GL+ + + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 601 PEWMAPEVLRNEP------SNEKCDVYSFGVILWELAT----------LKLPWIGMNP-- 642
+MAPEVL S ++ D+++FG++LWE+A K P+ + P
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 643 ---MQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ V +R IP +A+++ ECW +PS R + ++ L +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 346 bits (889), Expect = e-114
Identities = 97/340 (28%), Positives = 151/340 (44%), Gaps = 58/340 (17%)
Query: 399 GTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADW 458
GT LK + +S S + Q +VL E IG G +GEV+ W
Sbjct: 13 GTTLKDLIYDMTTSGSGSGLPLLVQ---------RTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 459 NGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTR----PPNLSII 512
G EVAVK F ++ + RE +I LRH N++ F+ A + L ++
Sbjct: 64 RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118
Query: 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLKSP 566
+++ GSLF L+R V + IK+AL A G+ LH P I HRDLKS
Sbjct: 119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 567 NLLVDKNWNVKVSDFGLSRLKHNT----FLSSKSTAGTPEWMAPEVLRNE------PSNE 616
N+LV KN ++D GL+ + ++ GT +MAPEVL + S +
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 617 KCDVYSFGVILWELATL----------KLPWIGMNPM-----QVVGAVGFQNRRLEIPK- 660
+ D+Y+ G++ WE+A +LP+ + P ++ V Q R IP
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296
Query: 661 ----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
E ++A+I+ ECW + + R + ++ L L +
Sbjct: 297 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-111
Identities = 85/330 (25%), Positives = 126/330 (38%), Gaps = 56/330 (16%)
Query: 408 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 467
SS VD T L L E G +G V+ A VAVK
Sbjct: 6 HHHSSGVDLGTE-----------NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKI 54
Query: 468 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIITEFLPRGSLFR 523
F QD + + EV + ++H N++ F+GA R + L +IT F +GSL
Sbjct: 55 FPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111
Query: 524 ILHRPHCQVDEKRRIKMALDVARGMNCLHT--------STPTIVHRDLKSPNLLVDKNWN 575
L V +A +ARG+ LH P I HRD+KS N+L+ N
Sbjct: 112 FLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 576 VKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILW 628
++DFGL+ + + GT +MAPEVL + + D+Y+ G++LW
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 629 ELATLKLPWIGMNP----------------MQVVGAVGFQNRRLEIPKELDP-----LVA 667
ELA+ G + V + +R + ++
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289
Query: 668 RIIWECWQTDPSLRPSFAQLTVALKPLQRL 697
I ECW D R S + + +QRL
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = e-104
Identities = 84/331 (25%), Positives = 126/331 (38%), Gaps = 60/331 (18%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR- 489
E + ++L L E IG G YG VY + VAVK F + F E I R
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-----NFINEKNIYRV 61
Query: 490 -RLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
+ H N+ F+ R ++ E+ P GSL + L D ++A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHS 119
Query: 544 VARGMNCLHTST-------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 592
V RG+ LHT P I HRDL S N+LV + +SDFGLS L
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 593 ----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELA---TLKLPWI 638
++ S GT +MAPEVL E + ++ D+Y+ G+I WE+ T P
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 639 GMNPMQV---------------VGAVGFQNRRLEIPKELDP------LVARIIWECWQTD 677
+ Q+ V + +R + P+ + I +CW D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 678 PSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 708
R + + L + + P++
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-73
Identities = 78/255 (30%), Positives = 122/255 (47%), Gaps = 12/255 (4%)
Query: 441 LGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
IG GS+ VY D EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 499 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 555 TPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
TP I+HRDLK N+ + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK- 205
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQNRRLEIPKELDPLVARIIWE 672
+E DVY+FG+ + E+AT + P+ + V + K P V II
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 673 CWQTDPSLRPSFAQL 687
C + + R S L
Sbjct: 266 CIRQNKDERYSIKDL 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-70
Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 9/271 (3%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 488
+ + EDLVLGE+IG G++GEV+ T VAVK + +F +E +I+
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARIL 166
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
++ HPN+V +G T+ + I+ E + G L ++ K ++M D A GM
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAP 606
L + +HRDL + N LV + +K+SDFG+SR + + ++ P +W AP
Sbjct: 227 EYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
E L + + DV+SFG++LWE +L P+ ++ Q V + RL P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
V R++ +CW +P RPSF+ + L+ +++
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-68
Identities = 90/285 (31%), Positives = 145/285 (50%), Gaps = 18/285 (6%)
Query: 416 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG 475
S + D+ + + ++L L + IG G +G+V D+ G +VAVK +
Sbjct: 3 GSVAAQDEFYRS---GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----D 55
Query: 476 AALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILH-RPHCQVD 533
A F E +M +LRH N+V +G + L I+TE++ +GSL L R +
Sbjct: 56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 534 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593
+K +LDV M L VHRDL + N+LV ++ KVSDFGL++ +T +
Sbjct: 116 GDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 594 SKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 651
K P +W APE LR + + K DV+SFG++LWE+ + ++P+ + VV V
Sbjct: 174 GK----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE- 228
Query: 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ +++ P P V ++ CW D ++RPSF QL L+ ++
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-68
Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 25/312 (8%)
Query: 411 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAV 465
+ + + + + I L+LG+ +G G +G V + +VAV
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 466 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNLSIITEFLPRGS 520
K + S + EF E M+ HPNV+ +G P +I F+ G
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 521 LFRIL--HRPHCQVDE---KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 575
L L R + +K +D+A GM L S +HRDL + N ++ +
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMT 185
Query: 576 VKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL 633
V V+DFGLS+ ++ + P +W+A E L + K DV++FGV +WE+AT
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 634 -KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
P+ G+ ++ + RL+ P++ + I++ CW+TDP RP+F+ L + L+
Sbjct: 246 GMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 693 PLQRLVIPSHPD 704
L + S PD
Sbjct: 305 KL----LESLPD 312
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-68
Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 22/294 (7%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 485
+ IP + LG +G G +G V A +VAVK + + + EF RE
Sbjct: 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 486 KIMRRLRHPNVVLFMGAVTR------PPNLSIITEFLPRGSLFRIL--HRPH---CQVDE 534
M+ HP+V +G R P +I F+ G L L R +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 535 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594
+ ++ +D+A GM L S+ +HRDL + N ++ ++ V V+DFGLSR ++
Sbjct: 137 QTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 595 KSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 651
+ A P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ +
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253
Query: 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 705
RL+ P E V ++++CW DP RPSF L + L+ + + Q
Sbjct: 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-68
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 9/267 (3%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
I +L + IG G +G V+ W +VA+K + + +F E ++M +L
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEE--DFIEEAEVMMKL 60
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
HP +V G + ++TEF+ G L L + + M LDV GM L
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 610
++HRDL + N LV +N +KVSDFG++R + +S + P +W +PEV
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQI 237
Query: 670 IWECWQTDPSLRPSFAQLTVALKPLQR 696
+ CW+ P RP+F++L L +
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-68
Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 9/267 (3%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
E+ E++ L + +G G +G V W G +VAVK + + EF +E + M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSMSED--EFFQEAQTMMKL 60
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
HP +V F G ++ + I+TE++ G L L ++ + ++M DV GM L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 610
+ +HRDL + N LVD++ VKVSDFG++R + S P +W APEV
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ K DV++FG+++WE+ +L K+P+ +VV V Q RL P + +I
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI 237
Query: 670 IWECWQTDPSLRPSFAQLTVALKPLQR 696
++ CW P RP+F QL +++PL+
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-67
Identities = 82/273 (30%), Positives = 125/273 (45%), Gaps = 12/273 (4%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 485
+ I ED+VL +G G +GEVY + VAVK +D + +F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKFMSEA 64
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
IM+ L HP++V +G + P II E P G L L R + + +L +
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 604
+ M L + VHRD+ N+LV VK+ DFGLSR + S P +WM
Sbjct: 124 KAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
+PE + DV+ F V +WE+ + K P+ + V+G + + RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240
Query: 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
P++ ++ CW DPS RP F +L +L + +
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-67
Identities = 81/267 (30%), Positives = 125/267 (46%), Gaps = 9/267 (3%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EI +DL + +G G +G V + W G +VA+K + + EF E K+M L
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSED--EFIEEAKVMMNL 76
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
H +V G T+ + IITE++ G L L + ++ ++M DV M L
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 610
+ +HRDL + N LV+ VKVSDFGLSR + +S + P W PEVL
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTI 253
Query: 670 IWECWQTDPSLRPSFAQLTVALKPLQR 696
++ CW RP+F L + +
Sbjct: 254 MYSCWHEKADERPTFKILLSNILDVMD 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-67
Identities = 90/304 (29%), Positives = 150/304 (49%), Gaps = 27/304 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 79
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQVDEKRR------ 537
+M+ +VV +G V++ +I E + RG L + RP +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 538 -IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596
I+MA ++A GM L + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 140 MIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 597 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
G P WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 256
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ----RLVIPSHPDQPSSA 709
L+ P ++ ++ CWQ +P +RPSF ++ ++K R V + ++
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLP 316
Query: 710 LPQE 713
P+E
Sbjct: 317 EPEE 320
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-67
Identities = 90/287 (31%), Positives = 146/287 (50%), Gaps = 14/287 (4%)
Query: 424 IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFK 482
++D E E+P E L L ER+G G +GEV+ +NG T+VAVK L Q F
Sbjct: 3 WWED---EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPD--AFL 56
Query: 483 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMA 541
E +M++L+H +V VT+ P IITE++ GSL L ++ + + MA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 601
+A GM + +HRDL++ N+LV + K++DFGL+RL + +++ A P
Sbjct: 116 AQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 602 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 659
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRP 232
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 706
+ +++ CW+ P RP+F L L+ + QP
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-67
Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 14/274 (5%)
Query: 432 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 485
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+M + +P+V +G + +IT+ +P G L + + + + + +A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 603
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
V I+ +CW D RP F +L + + R
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-67
Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 18/293 (6%)
Query: 428 DVCECEIP--WEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLE 480
+V + IP IG G +G VYH ++ + A+K L + +
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEA 68
Query: 481 FKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 539
F RE +MR L HPNV+ +G + P ++ ++ G L + + P K I
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS 128
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKST 597
L VARGM L + VHRDL + N ++D+++ VKV+DFGL+R + + +
Sbjct: 129 FGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 598 AGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 654
P +W A E L+ K DV+SFGV+LWEL T P+ ++P + + Q R
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGR 245
Query: 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH-PDQP 706
RL P+ + +++ +CW+ DP++RP+F L ++ + ++ H P
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 7e-67
Identities = 86/295 (29%), Positives = 138/295 (46%), Gaps = 30/295 (10%)
Query: 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALL 479
+ I D+VL +G G++G+V+ A+ VAVK +D + AA
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARK 62
Query: 480 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR 537
+F+RE +++ L+H ++V F G L ++ E++ G L + L H P + +
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 538 -------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584
+ +A +A GM L ++ VHRDL + N LV N VK+ DFG+S
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 585 RLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMN 641
R ++T P WM PE + + DV+SFGVILWE+ T K PW ++
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 642 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+V+ + Q R LE P+ V ++ CWQ +P R + ++ L L +
Sbjct: 241 NTEVIECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-66
Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 28/300 (9%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 84
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 539
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 596
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 145 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 597 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 713
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP E
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPIE 316
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 7e-66
Identities = 87/271 (32%), Positives = 125/271 (46%), Gaps = 13/271 (4%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALL-EFKRE 484
C I +DL L E++G GS+G V +W+ VAVK S + +F RE
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 485 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544
V M L H N++ G V PP + ++TE P GSL L + + A+ V
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 601
A GM L + +HRDL + NLL+ VK+ DFGL R P
Sbjct: 131 AEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 660
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691
+ + ++ +CW P RP+F L L
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-65
Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 15/300 (5%)
Query: 414 VDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKF 468
+D S + + + E IG G +G VYH AVK
Sbjct: 2 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS- 60
Query: 469 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHR 527
L++ + +F E IM+ HPNV+ +G R + ++ ++ G L +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 528 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DFGL+R
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 588 HNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNP 642
++ + T P +WMA E L+ + K DV+SFGV+LWEL T P+ +N
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702
+ + Q RRL P+ + ++ +CW +RPSF++L + + I H
Sbjct: 239 FDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-65
Identities = 97/324 (29%), Positives = 150/324 (46%), Gaps = 30/324 (9%)
Query: 397 FMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA 456
MG+ L E S + + Q F D C I D+VL +G G++G+V+ A
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA-CVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 457 DWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509
+ + VAVK ++ S +A +F+RE +++ L+H ++V F G T L
Sbjct: 61 ECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 510 SIITEFLPRGSLFRIL--HRPHCQVDEKRR------------IKMALDVARGMNCLHTST 555
++ E++ G L R L H P ++ + +A VA GM L +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AG 176
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEP 613
VHRDL + N LV + VK+ DFG+SR ++T P WM PE +
Sbjct: 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 614 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
+ DV+SFGV+LWE+ T K PW ++ + + + Q R LE P+ P V I+
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRG 295
Query: 673 CWQTDPSLRPSFAQLTVALKPLQR 696
CWQ +P R S + L+ L +
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQ 319
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-65
Identities = 96/270 (35%), Positives = 144/270 (53%), Gaps = 13/270 (4%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 488
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 63
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 546
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 122
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 605
M L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W A
Sbjct: 123 AMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239
Query: 665 LVARIIWECWQTDPSLRPSFAQLTVALKPL 694
V ++ CWQ +PS RPSFA++ A + +
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-65
Identities = 84/288 (29%), Positives = 123/288 (42%), Gaps = 29/288 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
EI + E +G +G+VY G VA+K L G EF+ E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHEA 63
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 537
+ RL+HPNVV +G VT+ LS+I + G L L PH V
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 538 -------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590
+ + +A GM L S+ +VH+DL + N+LV NVK+SD GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 591 FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVG 647
P WMAPE + + D++S+GV+LWE+ + P+ G + VV
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 648 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695
+ + L P + V ++ ECW PS RP F + L+
Sbjct: 242 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-65
Identities = 82/273 (30%), Positives = 124/273 (45%), Gaps = 12/273 (4%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 485
+ EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 67
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
MR+ HP++V +G +T P II E G L L +D I A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 604
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WM
Sbjct: 127 TALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
APE + DV+ FGV +WE+ P+ G+ V+G + RL +P
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243
Query: 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
P + ++ +CW DPS RP F +L L +
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 6e-65
Identities = 85/302 (28%), Positives = 135/302 (44%), Gaps = 28/302 (9%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 125
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 539
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 596
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 186 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 597 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 713
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP E
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPIE 357
Query: 714 IS 715
Sbjct: 358 YG 359
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-65
Identities = 69/295 (23%), Positives = 127/295 (43%), Gaps = 19/295 (6%)
Query: 432 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 485
+L + +G G +G V+ W V +K ++ + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+ L H ++V +G L ++T++LP GSL + + + + + + +A
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EW 603
+GM L +VHR+L + N+L+ V+V+DFG++ L + TP +W
Sbjct: 126 KGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
MA E + + DV+S+GV +WEL T P+ G+ +V + + RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242
Query: 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQ 712
V ++ +CW D ++RP+F +L + R LVI + P+
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPE 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-64
Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 15/305 (4%)
Query: 409 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEV 463
+ + +D S + + + E IG G +G VYH
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 464 AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLF 522
AVK L++ + +F E IM+ HPNV+ +G R + ++ ++ G L
Sbjct: 121 AVKS-LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
+ K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DFG
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 583 LSRLKHNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPW 637
L+R ++ T P +WMA E L+ + K DV+SFGV+LWEL T P+
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
Query: 638 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697
+N + + Q RRL P+ + ++ +CW +RPSF++L + +
Sbjct: 298 PDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
Query: 698 VIPSH 702
I H
Sbjct: 357 FIGEH 361
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-64
Identities = 84/294 (28%), Positives = 141/294 (47%), Gaps = 19/294 (6%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 486
EI + + IG G +GEVY VA+K L ++ ++F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 98
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 546
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EW 603
GM L + VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+G P W
Sbjct: 159 GMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
APE + DV+SFG+++WE+ T + P+ ++ +V+ A+ RL P +
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 275
Query: 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALP 711
+ +++ +CWQ + + RP FA + L L R + + S LP
Sbjct: 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLP 329
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-64
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 37/310 (11%)
Query: 420 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQD 472
++ + + + E P ++ IG G++G V+ A G T VAVK L ++
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEE 88
Query: 473 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC 530
S +F+RE +M +PN+V +G + ++ E++ G L L PH
Sbjct: 89 ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 531 QVDEKRR---------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 569
+ +A VA GM L S VHRDL + N L
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCL 206
Query: 570 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVIL 627
V +N VK++DFGLSR ++ P WM PE + + DV+++GV+L
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 628 WELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 686
WE+ + P+ GM +V+ V L P+ + ++ CW P+ RPSF
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 687 LTVALKPLQR 696
+ L+ +
Sbjct: 326 IHRILQRMCE 335
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-64
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 18/295 (6%)
Query: 432 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 485
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+M + +P+V +G + +IT+ +P G L + + + + + +A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 603
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPL----QRLVIPSHPDQPSSALPQE 713
V I+ +CW D RP F +L + + QR ++ ++ P +
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 3e-64
Identities = 88/272 (32%), Positives = 140/272 (51%), Gaps = 19/272 (6%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK--KFLDQDFSGAALLEFKREVKIM 488
+ ++L L + IG G +G+V D+ G +VAVK K + A F E +M
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------NDATAQAFLAEASVM 240
Query: 489 RRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVAR 546
+LRH N+V +G + L I+TE++ +GSL L R + +K +LDV
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 605
M L VHRDL + N+LV ++ KVSDFGL++ +T + K P +W A
Sbjct: 301 AMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTA 354
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
PE LR + + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413
Query: 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
V ++ CW D + RP+F QL L+ ++
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 3e-64
Identities = 84/280 (30%), Positives = 141/280 (50%), Gaps = 11/280 (3%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 489
EIP E L L +++G G +GEV+ A +N T+VAVK ++ F E +M+
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMK 238
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGM 548
L+H +V VT+ P IITEF+ +GSL L + + I + +A GM
Sbjct: 239 TLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPE 607
+ +HRDL++ N+LV + K++DFGL+R+ + +++ A P +W APE
Sbjct: 298 AFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 608 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
+ K DV+SFG++L E+ T ++P+ GM+ +V+ A+ + R+ P+ +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 414
Query: 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 706
I+ CW+ P RP+F + L + + P
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-64
Identities = 95/316 (30%), Positives = 160/316 (50%), Gaps = 35/316 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 483
E+P + LVLG+ +G G++G+V A+ G T+VAVK L D + L +
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 123
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 527
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + H
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 528 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
P Q+ K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 588 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
H+ K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 704
+ + + R++ P + ++ +CW PS RP+F QL ++ L R+V +
Sbjct: 302 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIVALTSNQ 357
Query: 705 QPSSALPQEISVNSTP 720
+ P
Sbjct: 358 EMGYYHHHHHHDYDIP 373
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-64
Identities = 89/290 (30%), Positives = 148/290 (51%), Gaps = 32/290 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 483
E P + L LG+ +G G++G+V A+ G VAVK L D + L +
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVS 89
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC---------- 530
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L RP
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 531 ---QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
Q+ K + +ARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 588 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
+N K+T G P +WMAPE L + + DV+SFGV++WE+ TL P+ G+ +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ + + R++ P + ++ +CW PS RP+F QL L +
Sbjct: 268 LFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 9e-64
Identities = 92/285 (32%), Positives = 143/285 (50%), Gaps = 15/285 (5%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 489
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 234
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARG 547
+LRH +V V+ P I+TE++ +GSL L + + + MA +A G
Sbjct: 235 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 292
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 606
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 293 MAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 710
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 452
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-63
Identities = 88/295 (29%), Positives = 143/295 (48%), Gaps = 37/295 (12%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E P ++LVLG+ +G G +G+V A T VAVK L ++ S + L + E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSEF 77
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 537
+++++ HP+V+ GA ++ L +I E+ GSL L R
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 538 ---------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
I A +++GM L + +VHRDL + N+LV + +K+SDFG
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 583 LSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 639
LSR + K + G P +WMA E L + + DV+SFGV+LWE+ TL P+ G
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 640 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ P ++ + R+E P + R++ +CW+ +P RP FA ++ L+ +
Sbjct: 256 IPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-63
Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 431 ECEIPWEDLVLGER-IGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 485
E + + L L ++ +G G++G V + VAVK ++ A E E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+M++L +P +V +G + ++ E G L + L + + V +K I++ V+
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVS 127
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 602
GM L VHRDL + N+L+ K+SDFGLS+ K+ P +
Sbjct: 128 MGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
W APE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
+ ++ CW D RP FA + + L+
Sbjct: 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-63
Identities = 88/273 (32%), Positives = 130/273 (47%), Gaps = 13/273 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 487
EI + + + IG G GEV + VA+K L ++ +F E I
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEASI 103
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
M + HPN++ G VTR I+TE++ GSL L Q + + M V G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 604
M L S VHRDL + N+LVD N KVSDFGLSR+ + ++ +T G P W
Sbjct: 164 MRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
APE + + DV+SFGV++WE+ + P+ M V+ +V + RL P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCP 280
Query: 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ +++ +CW D + RP F+Q+ L L R
Sbjct: 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-63
Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 32/293 (10%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 484
+ L +++G G++G V ++ VAVKK L + L +F+RE
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDFERE 61
Query: 485 VKIMRRLRHPNVVLFMGAVTRPPNLS--IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
++I++ L+H N+V + G + +I E+LP GSL L + ++D + ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 600
+ +GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 601 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPM 643
P W APE L + DV+SFGV+L+EL T M
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
++ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 240 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 95/330 (28%), Positives = 159/330 (48%), Gaps = 40/330 (12%)
Query: 398 MGTNLKLRDLESPSSSVDS-----STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGE 452
M +N L + + SS S+ + D E P + L LG+ +G G +G+
Sbjct: 40 MNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW---EFPRDKLTLGKPLGEGCFGQ 96
Query: 453 VYHADWNG---------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502
V A+ G VAVK L D + L + E+++M+ + +H N++ +GA
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155
Query: 503 VTRPPNLSIITEFLPRGSL--FRILHRPHC-------------QVDEKRRIKMALDVARG 547
T+ L +I E+ +G+L + RP Q+ K + +ARG
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMA 605
M L ++ +HRDL + N+LV +N +K++DFGL+R +N K+T G P +WMA
Sbjct: 216 MEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
PE L + + DV+SFGV++WE+ TL P+ G+ ++ + + R++ P
Sbjct: 274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTN 332
Query: 665 LVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ ++ +CW PS RP+F QL L +
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 8e-63
Identities = 89/302 (29%), Positives = 148/302 (49%), Gaps = 18/302 (5%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 487
E+ ++ + + +G G +GEV VA+K L ++ +F E I
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEASI 99
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
M + HPN++ G VT+ + I+TE++ GSL L + Q + + M +A G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 604
M L S VHRDL + N+L++ N KVSDFGL R+ + ++ +T G P W
Sbjct: 160 MKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
+PE + DV+S+G++LWE+ + + P+ M+ V+ AV + RL P +
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276
Query: 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQEISVNS 718
+ +++ +CWQ D + RP F Q+ L L R +I S +PS+ L + +V+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDI 336
Query: 719 TP 720
T
Sbjct: 337 TT 338
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-62
Identities = 89/285 (31%), Positives = 138/285 (48%), Gaps = 30/285 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIM 488
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 79
Query: 489 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR-------- 537
+L HPN++ +GA L + E+ P G+L L R
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 538 -----IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592
+ A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR +
Sbjct: 140 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-- 195
Query: 593 SSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 649
K T G P WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 255 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-62
Identities = 93/272 (34%), Positives = 144/272 (52%), Gaps = 13/272 (4%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 488
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 270
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 546
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 329
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 605
M L +HR+L + N LV +N VKV+DFGLSR + +T+ + +W A
Sbjct: 330 AMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446
Query: 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
V ++ CWQ +PS RPSFA++ A + + +
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-62
Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 30/290 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVK 486
L +G G +G+V + G +VAVK L + G + + K+E++
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIE 75
Query: 487 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544
I+R L H N+V + G T + +I EFLP GSL L + +++ K+++K A+ +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 601
+GM+ L + VHRDL + N+LV+ VK+ DFGL++ P
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQVV 646
W APE L DV+SFGV L EL T M ++V
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 647 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ + +RL P V +++ +CW+ PS R SF L + L +
Sbjct: 254 NTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-62
Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 32/291 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 486
+ L +++G G++G V ++ VAVKK Q + L +F+RE++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 94
Query: 487 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544
I++ L+H N+V + G L +I E+LP GSL L + ++D + ++ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-TP- 601
+GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +P
Sbjct: 155 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 602 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPMQV 645
W APE L + DV+SFGV+L+EL T M +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 646 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 273 IELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-62
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 14/269 (5%)
Query: 433 EIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKI 487
+ ++L++ + +G G++G V + +VA+K L Q A E RE +I
Sbjct: 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQI 63
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
M +L +P +V +G + ++ E G L + L ++ ++ V+ G
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 604
M L VHRDL + N+L+ K+SDFGLS+ + + P +W
Sbjct: 123 MKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 239
Query: 664 PLVARIIWECWQTDPSLRPSFAQLTVALK 692
P + ++ +CW RP F + ++
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-62
Identities = 89/325 (27%), Positives = 140/325 (43%), Gaps = 37/325 (11%)
Query: 403 KLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-- 460
+L+ ++ SS + + ++ D+ + E P E+L G+ +G G++G+V +A G
Sbjct: 12 QLQMVQVTGSSDNEYFYVDFREYEYDL-KWEFPRENLEFGKVLGSGAFGKVMNATAYGIS 70
Query: 461 -----TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 514
+VAVK L + + E+K+M +L H N+V +GA T + +I E
Sbjct: 71 KTGVSIQVAVKM-LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129
Query: 515 FLPRGSLFRIL--HRPHCQVDEKRR--------------------IKMALDVARGMNCLH 552
+ G L L R DE + A VA+GM L
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL- 188
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLR 610
+ VHRDL + N+LV VK+ DFGL+R + P +WMAPE L
Sbjct: 189 -EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
K DV+S+G++LWE+ +L P+ G+ + +++ P + I
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 307
Query: 670 IWECWQTDPSLRPSFAQLTVALKPL 694
+ CW D RPSF LT L
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-62
Identities = 86/290 (29%), Positives = 139/290 (47%), Gaps = 32/290 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E P + L LG+ +G G++G+V AD G VAVK L + + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSEL 81
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRIL--HRPHC----------- 530
KI+ + H NVV +GA T+P L +I EF G+L L R
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 531 --QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588
+ + I + VA+GM L ++ +HRDL + N+L+ + VK+ DFGL+R +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 589 NTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM-NPMQ 644
+ P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 260 FCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 9e-62
Identities = 80/290 (27%), Positives = 123/290 (42%), Gaps = 31/290 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E P L G+ +G G++G+V A G VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPH------------- 529
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 530 --CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
+D + + + VA+GM L ++ +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 588 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
N P +WMAPE + N + DV+S+G+ LWEL +L P+ GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ + R+ P+ + I+ CW DP RP+F Q+ ++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 2e-61
Identities = 82/271 (30%), Positives = 123/271 (45%), Gaps = 12/271 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 487
EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALT 444
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
MR+ HP++V +G +T P II E G L L +D I A ++
Sbjct: 445 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 606
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WMAP
Sbjct: 504 LAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 620
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ ++ +CW DPS RP F +L L +
Sbjct: 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-61
Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 483
+I EDL+ E +G G++ +++ TEV +K LD+ F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-LDKA-HRNYSESFFE 61
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
+M +L H ++VL G ++ EF+ GSL L + ++ ++++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRLKHNTFLSSK 595
+A M+ L T++H ++ + N+L+ + + +K+SD G+S + K
Sbjct: 122 LAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLPK 174
Query: 596 STAGTP-EWMAPEVLRNEPS-NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 652
W+ PE + N + N D +SFG LWE+ + P ++ + +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-D 233
Query: 653 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695
+L PK +A +I C +P RPSF + L L
Sbjct: 234 RHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-61
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 32/292 (10%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 484
L +G G +G+V ++ VAVK L D +K+E
Sbjct: 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQE 83
Query: 485 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
+ I+R L H +++ + G +L ++ E++P GSL L R + + + A
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQ 141
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 600
+ GM LH +HRDL + N+L+D + VK+ DFGL++ + G +
Sbjct: 142 QICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 601 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQ 644
P W APE L+ DV+SFGV L+EL T + M ++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ + + RL P + V ++ CW+T+ S RP+F L LK +
Sbjct: 260 LTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-61
Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 29/287 (10%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 485
E P +L G+ +G G++G+V A G +VAVK L E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSEL 100
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR----- 537
KIM L +H N+V +GA T + +ITE+ G L L + D
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 538 ------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591
+ + VA+GM L ++ +HRD+ + N+L+ K+ DFGL+R N
Sbjct: 161 ASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 592 LSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG-MNPMQVVG 647
P +WMAPE + + + DV+S+G++LWE+ +L P+ G + +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 648 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
V ++ P + I+ CW +P+ RP+F Q+ L+
Sbjct: 279 LVK-DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-61
Identities = 92/285 (32%), Positives = 143/285 (50%), Gaps = 15/285 (5%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 489
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 317
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARG 547
+LRH +V V+ P I+TE++ +GSL L + + + MA +A G
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 375
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 606
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 376 MAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 710
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 535
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-59
Identities = 78/313 (24%), Positives = 132/313 (42%), Gaps = 36/313 (11%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 484
L ++G G++G V ++ VAVK+ Q +F+RE
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQRE 74
Query: 485 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
++I++ L +V + G P +L ++ E+LP G L L R ++D R + +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGT 600
+ +GM L + VHRDL + N+LV+ +VK++DFGL++L + + +
Sbjct: 135 QICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 601 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF------- 651
P W APE L + + + DV+SFGV+L+EL T +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 652 ------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL-------KPLQRLV 698
+ +RL P V ++ CW P RPSF+ L L + +
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
Query: 699 IPSHPDQPSSALP 711
+HP+ +L
Sbjct: 313 FTAHPEGKHHSLS 325
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-54
Identities = 67/271 (24%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 431 ECEIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 485
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 387
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+IM +L +P +V +G + ++ E G L + L ++ ++ V+
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 602
GM L VHR+L + N+L+ K+SDFGLS+ + + P +
Sbjct: 447 MGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
P + ++ +CW RP F + ++
Sbjct: 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-54
Identities = 61/254 (24%), Positives = 128/254 (50%), Gaps = 6/254 (2%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
E V ++IG GS+G+ +G + +K+ S E +REV ++ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLHT 553
N+V + + +L I+ ++ G LF+ + + E + + + + + +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
I+HRD+KS N+ + K+ V++ DFG++R+ ++T +++ GTP +++PE+ N+P
Sbjct: 144 RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
N K D+++ G +L+EL TLK + + +V + + + ++ +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQL 260
Query: 674 WQTDPSLRPSFAQL 687
++ +P RPS +
Sbjct: 261 FKRNPRDRPSVNSI 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-54
Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 11/261 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 495 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMN 549
N+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 550 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 244
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
II RPS ++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEI 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 7e-54
Identities = 71/292 (24%), Positives = 118/292 (40%), Gaps = 19/292 (6%)
Query: 405 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTE 462
+ + D+ + + E + R+G GS+GEV+ D G +
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 463 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522
AVKK + F E+ L P +V GAV P ++I E L GSL
Sbjct: 86 CAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDF 581
+++ + + E R + G+ LHT I+H D+K+ N+L+ + + DF
Sbjct: 139 QLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDF 195
Query: 582 GLSR-----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 636
G + + L+ GT MAPEV+ +P + K D++S ++ + P
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
Query: 637 WIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
W + + + EIP PL A+ I E + +P R S +L
Sbjct: 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-53
Identities = 66/260 (25%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 493
+ + ++IG G + EVY A +G VA+KK + A + +E+ ++++L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMNC 550
PNV+ + + L+I+ E G L R++ + + E+ K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
+H+ ++HRD+K N+ + VK+ D GL R + ++ S GTP +M+PE +
Sbjct: 152 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-LDPLVA 667
N K D++S G +L+E+A L+ P+ G MN + + Q +P + +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSDHYSEELR 268
Query: 668 RIIWECWQTDPSLRPSFAQL 687
+++ C DP RP +
Sbjct: 269 QLVNMCINPDPEKRPDVTYV 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 6e-53
Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 14/281 (4%)
Query: 416 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDF 473
S S + + D+ E + +++ +G G+YG VY D N +A+K+ ++D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 474 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH--CQ 531
+ L E+ + + L+H N+V ++G+ + + I E +P GSL +L +
Sbjct: 61 RYSQPLH--EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 532 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNT 590
+E+ + G+ LH + IVHRD+K N+L++ + +K+SDFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 591 FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFG-VILWELATLKLPWIGM-NPMQVV 646
+++ GT ++MAPE++ P + D++S G I+ E+AT K P+ + P +
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAM 235
Query: 647 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
VG EIP+ + I +C++ DP R L
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-50
Identities = 55/264 (20%), Positives = 109/264 (41%), Gaps = 22/264 (8%)
Query: 441 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 497
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ ++ E L L + +D R ++ ++ +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 128
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 614
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 615 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 663
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 664 PLVARIIWECWQTDPSLRPSFAQL 687
+ ++ C + DP R S +L
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-50
Identities = 55/264 (20%), Positives = 109/264 (41%), Gaps = 22/264 (8%)
Query: 441 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 497
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ ++ E L L + +D R ++ ++ +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 147
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 614
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 615 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 663
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 664 PLVARIIWECWQTDPSLRPSFAQL 687
+ ++ C + DP R S +L
Sbjct: 267 KDLQDVLKCCLKRDPKQRISIPEL 290
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-50
Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 43/285 (15%)
Query: 437 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
D +G G++G+V A + A+KK + L EV ++ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 495 NVVLFMGAVTRPPNLS-------------IITEFLPRGSLFRILHRPHCQVDEKRRIKMA 541
VV + A N I E+ G+L+ ++H + ++
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--- 598
+ ++ +H+ I+HRDLK N+ +D++ NVK+ DFGL++ H + K +
Sbjct: 123 RQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 599 -----------GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVV 646
GT ++A EVL NEK D+YS G+I +E+ + GM + ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNIL 238
Query: 647 GAVGFQNRRLEIPKELD----PLVARIIWECWQTDPSLRPSFAQL 687
+ ++ +E P + D + +II DP+ RP L
Sbjct: 239 KKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-49
Identities = 60/272 (22%), Positives = 120/272 (44%), Gaps = 38/272 (13%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 493
D E IG G +G+V+ A +G +K+ + + + +REVK + +L H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLDH 63
Query: 494 PNVVLFMGA----------------VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR 536
N+V + G ++ L I EF +G+L + + R ++D+
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 537 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSK 595
+++ + +G++ +H+ +++RDLK N+ + VK+ DFGL LK++
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 655
+ GT +M+PE + ++ ++ D+Y+ G+IL EL + + R
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF-TDLRD 233
Query: 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
I D ++ + P RP+ +++
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-49
Identities = 54/264 (20%), Positives = 108/264 (40%), Gaps = 22/264 (8%)
Query: 441 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 497
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ ++ E L L + +D R ++ ++ +H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 175
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
IVH DLK N L+ +K+ DFG++ T + S G +M PE +++ S+
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 616 -----------EKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 663
K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 664 PLVARIIWECWQTDPSLRPSFAQL 687
+ ++ C + DP R S +L
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 73/288 (25%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 437 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
++G G +G+VY +G +VA+K+ + S + EF+ E++ + RHP+
Sbjct: 43 HKFLIGH----GVFGKVYKGVLRDGAKVALKR-RTPE-SSQGIEEFETEIETLSFCRHPH 96
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH 552
+V +G + +I +++ G+L R L+ P + ++R+++ + ARG++ LH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 610
T I+HRD+KS N+L+D+N+ K++DFG+S+ + ST GT ++ PE
Sbjct: 157 T--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------RRLEIPKE 661
EK DVYSFGV+L+E+ + + N ++ +
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLC------ARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 662 LDPL------------VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697
+DP +C RPS + L+ RL
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-47
Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 44/281 (15%)
Query: 445 IGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 503
+G G +G+VY +GT VAVK+ L ++ + L+F+ EV+++ H N++ G
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 504 TRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIV 559
P ++ ++ GS+ L +D +R ++AL ARG+ LH P I+
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 617
HRD+K+ N+L+D+ + V DFGL++L +T +++ GT +APE L S+EK
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 215
Query: 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------------FQNRRLEIPKEL-D 663
DV+ +GV+L EL T G + + ++LE L D
Sbjct: 216 TDVFGYGVMLLELIT------GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---ALVD 266
Query: 664 PL---------VARIIW---ECWQTDPSLRPSFAQLTVALK 692
V ++I C Q+ P RP +++ L+
Sbjct: 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 69/324 (21%), Positives = 110/324 (33%), Gaps = 29/324 (8%)
Query: 370 NSKDENPKNVE--DHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD 427
+ + V+ + + + R L+SP S Q F
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQ- 60
Query: 428 DVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREV 485
R+G GSYGEV+ +G AVK+ + EV
Sbjct: 61 -------------RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544
++ +HP V A L + TE SL + + E + D
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 604
+ LH+ +VH D+K N+ + K+ DFGL + T + + G P +M
Sbjct: 167 LLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYM 223
Query: 605 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELD 663
APE+L DV+S G+ + E+A G Q + Q E L
Sbjct: 224 APELL-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLS 278
Query: 664 PLVARIIWECWQTDPSLRPSFAQL 687
+ ++ + DP LR + L
Sbjct: 279 SELRSVLVMMLEPDPKLRATAEAL 302
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-46
Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 23/287 (8%)
Query: 416 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFS 474
SS S D++ + + +G G+ G + + ++ +VAVK+ L + FS
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS 62
Query: 475 GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVD 533
A REV+++R HPNV+ + I E +L + +
Sbjct: 63 FA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 534 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRL-- 586
I + G+ LH+ IVHRDLK N+L+ +SDFGL +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 587 -KHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATL-KLPWIGMN 641
++F GT W+APE+L + D++S G + + + + P+
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 642 PMQVVGAVG-FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
Q +G L K D + +I + DP RPS +
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-46
Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 32/294 (10%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
+ + +++G G + V +G A+K+ L + E +RE + R HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHP 86
Query: 495 NVVLFMGAVTRPPN----LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARG 547
N++ + R ++ F RG+L+ + + E + + + L + RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--------- 598
+ +H HRDLK N+L+ + D G S+
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 599 GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLP--WIGMNPMQVVGAVGFQN 653
T + APE+ + +E+ DV+S G +L+ + + P + V AV
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---Q 261
Query: 654 RRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 705
+L IP+ + +++ DP RP L L+ LQ H Q
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKR 483
D+ + P E + E++G GSYG VY A G VA+K+ ++ D E +
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIK 73
Query: 484 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 543
E+ IM++ P+VV + G+ + +L I+ E+ GS+ I+ + + E +
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 544 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKST 597
+G+ LH +HRD+K+ N+L++ + K++DFG++ K NT +
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----- 186
Query: 598 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RL 656
GTP WMAPEV++ N D++S G+ E+A K P+ ++PM+ + +
Sbjct: 187 -GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF 245
Query: 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
P+ + +C P R + QL
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 171 bits (433), Expect = 4e-45
Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 22/280 (7%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+ ER+G G +G V G +VA+K+ Q+ S + E++IM++L HPNVV
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 498 -LF-----MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMN 549
+ + + E+ G L + L++ C + E + D++ +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 605
LH + I+HRDLK N+++ K+ D G ++ L GT +++A
Sbjct: 136 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLA 191
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
PE+L + D +SFG + +E T P++ + + E D L
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDL 250
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 705
+ + P+ L+ + ++ H Q
Sbjct: 251 TGAVKFSSVLPTPNHLSGILA--GKLERWLQCMLMWHQRQ 288
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 57/273 (20%), Positives = 98/273 (35%), Gaps = 38/273 (13%)
Query: 442 GERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 497
E+IG G +G V+ +G A+K+ REV L +H +VV
Sbjct: 16 LEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+ A ++ I E+ GSL + +R E + L V RG+ +H+
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 555 TPTIVHRDLKSPNLLVDKN-------------------WNVKVSDFGLSRLKHNTFLSSK 595
+ +VH D+K N+ + + K+ D G + +
Sbjct: 135 S--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----Q 188
Query: 596 STAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 654
G ++A EVL+ N K D+++ + + A + + + Q R
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----RQGR 244
Query: 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
IP+ L ++ DP RPS L
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 77/269 (28%), Positives = 135/269 (50%), Gaps = 36/269 (13%)
Query: 435 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
P E E+IG GS+GEV+ + VA+K +D + + + + ++E+ ++ +
Sbjct: 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCD 78
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
P V + G+ + L II E+L GS +L +DE + + ++ +G++ LH
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH 136
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAP 606
+ +HRD+K+ N+L+ ++ VK++DFG++ ++K NTF GTP WMAP
Sbjct: 137 SEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAP 188
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP-L 665
EV++ + K D++S G+ ELA + P ++PM+V+ IPK P L
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTL 239
Query: 666 VARI-------IWECWQTDPSLRPSFAQL 687
+ C +PS RP+ +L
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPTAKEL 268
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-45
Identities = 67/296 (22%), Positives = 119/296 (40%), Gaps = 55/296 (18%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 498 -LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCL 551
LF A+ T + +I EF P GSL+ +L P + E + + DV GMN L
Sbjct: 71 KLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 552 HTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 606
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P
Sbjct: 129 REN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHP 184
Query: 607 EVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-------------- 644
++ + D++S GV + AT LP+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 645 ---VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 26/275 (9%)
Query: 440 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVV 497
+GE G +G VY N T VAVKK + +F +E+K+M + +H N+V
Sbjct: 38 KMGE----GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTST 555
+G + +L ++ ++P GSL L R K+A A G+N LH
Sbjct: 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-- 151
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLRNEP 613
+HRD+KS N+L+D+ + K+SDFGL+R + ++ GT +MAPE LR E
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE- 210
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVGFQNRRLEIPKELDPL------ 665
K D+YSFGV+L E+ T Q + ++ I +D
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270
Query: 666 -----VARIIWECWQTDPSLRPSFAQLTVALKPLQ 695
+ + +C + RP ++ L+ +
Sbjct: 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 68/327 (20%), Positives = 130/327 (39%), Gaps = 50/327 (15%)
Query: 405 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTE 462
+ LE + +++ E+ +D +G G+ G V+ +G
Sbjct: 2 KKLEELELD-EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 463 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 522
+A K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 61 MARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 523 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
++L + ++ E+ K+++ V +G+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 120 QVLKKAG-RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 642
+S ++ + S GT +M+PE L+ + + D++S G+ L E+A + P +
Sbjct: 178 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 643 MQVVGAVGFQNRRLE---------------------------------IPKELDPLVARI 669
++ G Q I E P +
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
Query: 670 IW---------ECWQTDPSLRPSFAQL 687
++ +C +P+ R QL
Sbjct: 296 VFSLEFQDFVNKCLIKNPAERADLKQL 322
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 27/272 (9%)
Query: 428 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF---LDQDFSGAALLEFK 482
V + P L +IG GS G V A +G +VAVK Q
Sbjct: 36 MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-----LLF 90
Query: 483 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
EV IMR +H NVV + L ++ EFL G+L I+ +++E++ +
Sbjct: 91 NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCE 148
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKS 596
V + + LH ++HRD+KS ++L+ + VK+SDFG K +
Sbjct: 149 AVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----- 201
Query: 597 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-R 655
GTP WMAPEV+ + D++S G+++ E+ + P+ +P+Q + + +
Sbjct: 202 -VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK 260
Query: 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
L+ ++ P++ + DP R + +L
Sbjct: 261 LKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 37/309 (11%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVV 497
+ + G + VY A +G E A+K+ L + +EV M++L HPN+V
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPNIV 89
Query: 498 LFMGAVTRPPNLS-------IITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGM 548
F A + S ++ L +G L L + +K+ R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---------- 598
+H P I+HRDLK NLL+ +K+ DFG + + S S
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 599 --GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 653
TP + PE++ N P EK D+++ G IL+ L + P+ +++V N
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------N 263
Query: 654 RRLEIPKELD--PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALP 711
+ IP + +I Q +P R S A++ L+ + + + L
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLE 323
Query: 712 QEISVNSTP 720
Q S
Sbjct: 324 QNGGYGSAT 332
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 70/270 (25%), Positives = 130/270 (48%), Gaps = 23/270 (8%)
Query: 428 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKRE 484
+ P + E+IG G+ G VY A G EVA+++ L Q E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINE 67
Query: 485 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544
+ +MR ++PN+V ++ + L ++ E+L GSL ++ +DE + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCREC 125
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTA 598
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + K +T
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------V 177
Query: 599 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLE 657
GTP WMAPEV+ + K D++S G++ E+ + P++ NP++ + + L+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 658 IPKELDPLVARIIWECWQTDPSLRPSFAQL 687
P++L + + C + D R S +L
Sbjct: 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 65/253 (25%), Positives = 115/253 (45%), Gaps = 10/253 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 493
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
PN++ G + +I E+ P G+++R L + + DE+R ++A ++ H+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHS 127
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
++HRD+K NLL+ +K++DFG S H GT +++ PE++
Sbjct: 128 KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 241
Query: 674 WQTDPSLRPSFAQ 686
+ +PS RP +
Sbjct: 242 LKHNPSQRPMLRE 254
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 41/296 (13%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 63
Query: 495 NVVLFMGA------------VTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKM 540
+V + A + L I + + +L ++ + + + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 541 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-- 598
L +A + LH+ ++HRDLK N+ + VKV DFGL
Sbjct: 124 FLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 599 ----------GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 648
GT +M+PE + + K D++S G+IL+EL M ++ +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239
Query: 649 VGFQNRRLEIPKELD---PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701
V R L+ P P ++ + P RP + + + L P
Sbjct: 240 V----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI-IENAVFEDLDFPG 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-43
Identities = 67/307 (21%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV- 497
L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 498 LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLH 552
LF A+ T + +I EF P GSL+ +L P + E + + DV GMN L
Sbjct: 72 LF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 553 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 607
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P+
Sbjct: 130 EN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPD 185
Query: 608 VLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------- 644
+ + D++S GV + AT LP+ +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 645 --VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 693 PLQRLVI 699
+ ++
Sbjct: 306 DILHRMV 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 55/298 (18%), Positives = 121/298 (40%), Gaps = 43/298 (14%)
Query: 441 LGERIGLGSYGEVYHADWNGTEVAVK---------------KFLDQDFSGAALLEFKREV 485
+ + G + ++ + + A+K D+ + +FK E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+I+ +++ + G +T + II E++ S+ + +D+ + + V
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVI 153
Query: 546 R--------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 597
+ + +H + I HRD+K N+L+DKN VK+SDFG S + + K +
Sbjct: 154 KCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGS 210
Query: 598 AGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQNR 654
GT E+M PE NE + K D++S G+ L+ + +P + ++ +++ + + +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI--RTK 268
Query: 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIP---SHP 703
+E P + + + + + + + L P +R+ H
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK--NPAERITSEDALKHE 324
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 24/275 (8%)
Query: 427 DDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKRE 484
+ V P E + +G G++G+VY A G A K ++ S L ++ E
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVE 66
Query: 485 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 544
++I+ HP +V +GA L I+ EF P G++ I+ + E + + +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTA 598
+N LH+ I+HRDLK+ N+L+ +++++DFG+S K ++F+
Sbjct: 127 LEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------ 178
Query: 599 GTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 653
GTP WMAPEV+ E + K D++S G+ L E+A ++ P +NPM+V+ + +
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238
Query: 654 R-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
L P + + +P RPS AQL
Sbjct: 239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 46/287 (16%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
I +D L E IG G+ V A +VA+K+ ++ + ++ E +E++ M +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQC 70
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMAL-DV 544
HPN+V + + L ++ + L GS+ I+ + + K I L +V
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-----------RLKHNTFLS 593
G+ LH + +HRD+K+ N+L+ ++ +V+++DFG+S TF
Sbjct: 131 LEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-- 186
Query: 594 SKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF- 651
GTP WMAPEV+ + + K D++SFG+ ELAT P+ PM+V+
Sbjct: 187 ----VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL----ML 238
Query: 652 --QNR--RLEIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 687
QN LE + ++ + +I C Q DP RP+ A+L
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 62/253 (24%), Positives = 115/253 (45%), Gaps = 10/253 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 493
+D +G +G G +G VY A N +A+K + +RE++I LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
PN++ + ++ EF PRG L++ L + H + DE+R ++A ++ H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHE 132
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
++HRD+K NLL+ +K++DFG S + ++ GT +++ PE++ +
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLPPEMIEGKT 188
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
+EK D++ GV+ +E P+ + + + N L+ P L +I +
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLISKL 246
Query: 674 WQTDPSLRPSFAQ 686
+ P R
Sbjct: 247 LRYHPPQRLPLKG 259
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-42
Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 35/297 (11%)
Query: 408 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAV 465
+ ++ + P + IG GS+G VY A N VA+
Sbjct: 25 AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAI 84
Query: 466 KKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 524
KK S + +EV+ +++LRHPN + + G R ++ E+ GS +
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDL 143
Query: 525 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584
L + E + +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG +
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA 201
Query: 585 --RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIG 639
N+F GTP WMAPEV+ + K DV+S G+ ELA K P
Sbjct: 202 SIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
Query: 640 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 687
MN M + I + P + W C Q P RP+ L
Sbjct: 256 MNAMSAL---------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 50/302 (16%)
Query: 416 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDF 473
+S S + + D+ P L E +G G+YG+VY G A+K D
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV---MDV 59
Query: 474 SGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTRPPNLSIITEFLPRGSLFRILH 526
+G E K+E+ ++++ H N+ + GA L ++ EF GS+ ++
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 527 RPHCQVDEKRRIKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS- 584
++ I ++ RG++ LH ++HRD+K N+L+ +N VK+ DFG+S
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 585 -----RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLK 634
+ NTF GTP WMAPEV+ + + + K D++S G+ E+A
Sbjct: 178 QLDRTVGRRNTF------IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 635 LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPSFA 685
P M+PM+ + F IP+ P + W C + S RP+
Sbjct: 232 PPLCDMHPMRAL----FL-----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATE 282
Query: 686 QL 687
QL
Sbjct: 283 QL 284
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 45/284 (15%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEF----------- 481
L + IG GSYG V A + + T A+K K + Q
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 482 --------KREVKIMRRLRHPNVV-LF--MGAVTRPPNLSIITEFLPRGSLFRILHRPHC 530
+E+ I+++L HPNVV L + +L ++ E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPL 134
Query: 531 QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KH 588
D+ R D+ +G+ LH I+HRD+K NLLV ++ ++K++DFG+S
Sbjct: 135 SEDQARFY--FQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 589 NTFLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQV 645
+ L +T GTP +MAPE L + DV++ GV L+ + P++ M +
Sbjct: 191 DALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 646 VGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQL 687
+ +++ LE P ++ + +I +P R ++
Sbjct: 249 HSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 43/280 (15%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 489
E+ +DL +G G+YG V +G +AVK+ + + ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVAR 546
+ P V F GA+ R ++ I E + SL + + + + E K+A+ + +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTP 601
+ LH S +++HRD+K N+L++ VK+ DFG+S + + AG
Sbjct: 121 ALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCK 173
Query: 602 EWMAPEVLRNEPS----NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRL 656
+MAPE + E + + K D++S G+ + ELA L+ P+ P Q +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ-------- 225
Query: 657 EIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 687
+ +E P + + +C + + RP++ +L
Sbjct: 226 -VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 26/259 (10%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 496
G +G G + + + A K + + E+ I R L H +V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 548
V F G + ++ E R SL + KRR + AR G
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGC 128
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEV
Sbjct: 129 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
L + + + DV+S G I++ L K P+ + + + IPK ++P+ A
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAAS 244
Query: 669 IIWECWQTDPSLRPSFAQL 687
+I + QTDP+ RP+ +L
Sbjct: 245 LIQKMLQTDPTARPTINEL 263
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 61/309 (19%), Positives = 111/309 (35%), Gaps = 26/309 (8%)
Query: 422 DQIFDDDVCECEIPWEDLVLGERIGLG--SYGEVYHA--DWNGTEVAVKKFLDQDFSGAA 477
+ ++ + L IG G V A G V V++ + S
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 478 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 537
+ + E+ + + HPN+V + L ++T F+ GS ++ +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 538 IKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNT 590
I L V + ++ +H VHR +K+ ++L+ + V +S + +
Sbjct: 130 IAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 591 -FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 647
K + W++PEVL+ + K D+YS G+ ELA +P+ M Q++
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML- 246
Query: 648 AVGFQNRRLEIPKELDP-LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 706
LE P L+ + S S A ++ PS+ D P
Sbjct: 247 --------LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 707 SSALPQEIS 715
S + S
Sbjct: 299 SHPYHRTFS 307
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 71/252 (28%), Positives = 117/252 (46%), Gaps = 13/252 (5%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
L + IG G++ +V A G EVA+K + +L + REV+IM+ L HPN+V
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ L +I E+ G +F ++ + E R + + H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--FRQIVSAVQYCHQKR-- 134
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN- 615
IVHRDLK+ NLL+D + N+K++DFG S L + G P + APE+ + + +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYDG 192
Query: 616 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 675
+ DV+S GVIL+ L + LP+ G N ++ V + IP + ++
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFLV 250
Query: 676 TDPSLRPSFAQL 687
+P R + Q+
Sbjct: 251 LNPIKRGTLEQI 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 4e-39
Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 7/250 (2%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 497
+G +G GS+ VY A G EVA+K + A +++ + EVKI +L+HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ ++ E G + R L E + GM LH+
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 617
I+HRDL NLL+ +N N+K++DFGL+ + GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 618 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 677
DV+S G + + L + P+ + V E+P L +I + + +
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIHQLLRRN 250
Query: 678 PSLRPSFAQL 687
P+ R S + +
Sbjct: 251 PADRLSLSSV 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 81/341 (23%), Positives = 134/341 (39%), Gaps = 74/341 (21%)
Query: 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEF 481
D + E P + L LG+ +G G++G+V AD G K L + + +
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 72
Query: 482 KREVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRP----------- 528
E+KI+ + H NVV +GA T+P L +I EF G+L L
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 529 -----------HCQVDEKRRIKM-----------ALDVARGMNCLHTSTPTIVHRDLKSP 566
VD KRR+ ++ + P +++D +
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192
Query: 567 NLLVDKNWNV------------------------------KVSDFGLSR-LKHNTFLSSK 595
L+ ++ V K+ DFGL+R + + K
Sbjct: 193 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 596 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 26/259 (10%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 496
G +G G + + + A K + + E+ I R L H +V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 548
V F G + ++ E R SL + KRR + AR G
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGC 154
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEV
Sbjct: 155 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
L + + + DV+S G I++ L K P+ + + + IPK ++P+ A
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAAS 270
Query: 669 IIWECWQTDPSLRPSFAQL 687
+I + QTDP+ RP+ +L
Sbjct: 271 LIQKMLQTDPTARPTINEL 289
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-39
Identities = 76/274 (27%), Positives = 114/274 (41%), Gaps = 43/274 (15%)
Query: 435 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR----- 546
H NVV F G + E+ G LF RI I M A+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQ 113
Query: 547 ---GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAG 599
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L G
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCG 169
Query: 600 TPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQN 653
T ++APE+L+ E DV+S G++L + +LPW + Q + N
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+I L+ +I+ +PS R + +
Sbjct: 230 PWKKIDSAPLALLHKIL----VENPSARITIPDI 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 35/278 (12%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 489
+ EDL IG G+YG V +G +AVK+ + + ++ + MR
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMR 76
Query: 490 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----VDEKRRIKMALDVA 545
P +V F GA+ R + I E + S + + + E+ K+ L
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605
+ +N L I+HRD+K N+L+D++ N+K+ DFG+S ++ ++ AG +MA
Sbjct: 136 KALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMA 193
Query: 606 PEVLRNEPSNE----KCDVYSFGVILWELATLKLPWIGMNPM-----QVVGAVGFQNRRL 656
PE + S + + DV+S G+ L+ELAT + P+ N + QVV +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV--------KG 245
Query: 657 EIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 687
+ P+ + + C D S RP + +L
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 73/257 (28%), Positives = 127/257 (49%), Gaps = 22/257 (8%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 497
LG+ +G+G++G+V G +VAVK Q ++ KRE++ ++ RHP+++
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCLH 552
++ P + ++ E++ G LF I + E RR I A+D H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD------YCH 128
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRN 611
+VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 129 RHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISG 184
Query: 612 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670
+ + D++S GVIL+ L LP+ + + + + IP+ L+ VA ++
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVATLL 242
Query: 671 WECWQTDPSLRPSFAQL 687
Q DP R + +
Sbjct: 243 MHMLQVDPLKRATIKDI 259
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 57/285 (20%), Positives = 113/285 (39%), Gaps = 15/285 (5%)
Query: 413 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLD 470
S SS + + + DL +G G+ G+V+ G +AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQ-RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MR 59
Query: 471 QDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 529
+ + ++ + ++ P +V G ++ I E + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 530 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589
+ E+ KM + + + + L ++HRD+K N+L+D+ +K+ DFG+S +
Sbjct: 120 P-IPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 590 TFLSSKSTAGTPEWMAPEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNP-M 643
+ +AG +MAPE + + + DV+S G+ L ELAT + P+
Sbjct: 178 D-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236
Query: 644 QVVGA-VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+V+ + + L + +C D RP + +L
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
++ ++ + + G LF I+ R E + + H++
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN--G 125
Query: 558 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 183
Query: 614 SNEKCDVYSFGVIL 627
++ D+++ GVIL
Sbjct: 184 YSKPVDIWACGVIL 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 14/193 (7%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
E +G G++ EV+ T A+K + LE E+ ++++++H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVT 70
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ ++ + + G LF RIL R EK + V + LH +
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG-- 126
Query: 558 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
IVHRDLK NLL ++N + ++DFGLS+++ N + + GTP ++APEVL +P
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKPY 184
Query: 615 NEKCDVYSFGVIL 627
++ D +S GVI
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 60/273 (21%), Positives = 115/273 (42%), Gaps = 44/273 (16%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHP 494
++G+ +G GSYG+V AVK L + K+E++++RRLRH
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 495 NVV-LF--MGAVTRPPNLSIITEFLPRGS--LF-RILHRPHCQVDEKRRIKMALDVAR-- 546
NV+ L + + ++ E+ G + + + + + A
Sbjct: 67 NVIQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPVCQAHGY 114
Query: 547 ------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKS 596
G+ LH+ IVH+D+K NLL+ +K+S G++ + ++
Sbjct: 115 FCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RT 170
Query: 597 TAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 654
+ G+P + PE+ S K D++S GV L+ + T P+ G N ++ +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKG 228
Query: 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
IP + P ++ ++ + +P+ R S Q+
Sbjct: 229 SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 494
+GE +G G + V G E A K + G + E +REV I+R++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
NV+ ++ +I E + G LF + + + E+ + G+N LHT
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 554 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 608
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 609 LRNEPSNEKCDVYSFGVIL 627
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 76/274 (27%), Positives = 114/274 (41%), Gaps = 43/274 (15%)
Query: 435 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR----- 546
H NVV F G + E+ G LF RI I M A+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQ 113
Query: 547 ---GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAG 599
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L G
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCG 169
Query: 600 TPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQN 653
T ++APE+L+ E DV+S G++L + +LPW + Q + N
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+I L+ +I+ +PS R + +
Sbjct: 230 PWKKIDSAPLALLHKIL----VENPSARITIPDI 259
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ +G GS+GEV T E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH--N 141
Query: 558 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 614 SNEKCDVYSFGVIL 627
+EKCDV+S GVIL
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 494
+GE +G G + V G E A K + L G + E +REV I+R +RHP
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
N++ ++ +I E + G LF + + + E + + G++ LH+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHS 126
Query: 554 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 608
I H DLK N+++ N +K+ DFG++ ++ K+ GTPE++APE+
Sbjct: 127 KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 609 LRNEPSNEKCDVYSFGVIL 627
+ EP + D++S GVI
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 494
GE +G G + V G + A K + G + + +REV I++ ++HP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
NV+ ++ +I E + G LF + + + E+ + + G+ LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHS 132
Query: 554 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 608
I H DLK N+++ +K+ DFGL+ + K+ GTPE++APE+
Sbjct: 133 LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 609 LRNEPSNEKCDVYSFGVIL 627
+ EP + D++S GVI
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
++ ++ + + G LF I+ R E + + H++
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN--G 148
Query: 558 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 206
Query: 614 SNEKCDVYSFGVIL 627
++ D+++ GVIL
Sbjct: 207 YSKPVDIWACGVIL 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 44/283 (15%)
Query: 440 VLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 497
V + +G GS G V + G VAVK+ L A E+K++ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVI 72
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLF-RILHR-----PHCQVDEKRRIKMALDVARGMNCL 551
+ + T L I E +L + + E I + +A G+ L
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 552 HTSTPTIVHRDLKSPNLLVD-------------KNWNVKVSDFGLSRL----KHNTFLSS 594
H+ I+HRDLK N+LV +N + +SDFGL + + + +
Sbjct: 132 HSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 595 KSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ-- 644
+ +GT W APE+L D++S G + + + + K P+ +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 645 -VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 686
+ G + + L +I + DP RP+ +
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-37
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
L E +G G++ V E A + S + +RE +I R L+HPN+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+++ + +I + + G LF I+ R + E + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM--G 130
Query: 558 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
+VHR+LK NLL+ K VK++DFGL+ + AGTP +++PEVLR +P
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 615 NEKCDVYSFGVIL 627
+ D+++ GVIL
Sbjct: 191 GKPVDLWACGVIL 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 58/260 (22%), Positives = 103/260 (39%), Gaps = 26/260 (10%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFL-DQDFSGAALLEFKREVKIMRRL 491
+G G++G V+ A EV VK K L D L + E+ I+ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGS-LF-RILHRPHCQVDEKRRIKMALDVARGMN 549
H N++ + ++ E G LF I P I + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI--FRQLVSAVG 144
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 608
L I+HRD+K N+++ +++ +K+ DFG + + + GT E+ APEV
Sbjct: 145 YLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPEV 200
Query: 609 LRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667
L P + +++S GV L+ L + P+ + + V A + P + +
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYLVSKELM 252
Query: 668 RIIWECWQTDPSLRPSFAQL 687
++ Q P R + +L
Sbjct: 253 SLVSGLLQPVPERRTTLEKL 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 494
+GE +G G + V G E A K + G E +REV I+R++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
N++ ++ +I E + G LF + + + E+ + G+N LHT
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 554 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 608
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 609 LRNEPSNEKCDVYSFGVIL 627
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 386 YHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI 445
+H + NL + + S ++S T+ + + D + + + +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 446 GLGSYGEVYHADWNGT--EVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
G G+ VY GT A+K K +D+ + E+ ++ RL HPN++
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-------IVRTEIGVLLRLSHPNIIKLK 114
Query: 501 GAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
P +S++ E + G LF RI+ + + E+ + + LH + IV
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG--IV 170
Query: 560 HRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
HRDLK NLL + +K++DFGLS+ ++H + K+ GTP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYG 228
Query: 616 EKCDVYSFGVIL 627
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 60/285 (21%), Positives = 122/285 (42%), Gaps = 22/285 (7%)
Query: 441 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 496
+ +++G G VY A D +VA+K + L F+REV +L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
V + ++ E++ +L + H + I + G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
IVHRD+K N+L+D N +K+ DFG+++ L + + GT ++ +PE + E ++
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 616 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-------ELDPLVAR 668
E D+YS G++L+E+ + P+ G + + ++ + +P ++ ++
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----IKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 713
+I + D + R Q L ++ + ++ L +
Sbjct: 247 VILRATEKDKANRYKTIQ--EMKDDLSSVLHENRANEDVYELDKM 289
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 495
L E IG G + V G + AVK G + + KRE I L+HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVD--EKRRIKMALDVARGMNCLH 552
+V + + L ++ EF+ L I+ R E + + H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 553 TSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 609
+ I+HRD+K +L+ + + VK+ FG++ + L + GTP +MAPEV+
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 610 RNEPSNEKCDVYSFGVIL 627
+ EP + DV+ GVIL
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 49/320 (15%), Positives = 101/320 (31%), Gaps = 51/320 (15%)
Query: 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRL 491
LV G +G A G V + A+ + K EV +R L
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 492 R----------------------HPNVVLFMGAVTRPPNLSIITEFLPR-------GSLF 522
R P + ++ +++ F +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 523 RILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 579
+L H + R+++ L V R + LH +VH L+ ++++D+ V ++
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLT 253
Query: 580 DFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEK-----CDVYSFGVILWELATL 633
F + +S PE A +L + D ++ G+ ++ +
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 634 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL--TVAL 691
LP + + F++ + IP+ + L+ + + R Q T
Sbjct: 314 DLPNTDDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQAMETPEY 367
Query: 692 KPLQRLVIPSHPDQPSSALP 711
+ L+ + + P + P
Sbjct: 368 EQLRTELSAALPLYQTDGEP 387
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 12/196 (6%)
Query: 440 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNV 496
+ + +G G + V G E A K + E E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+ + +I E+ G +F L V E I++ + G+ LH +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 556 PTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 611
IVH DLK N+L+ ++K+ DFG+SR + H L + GTPE++APE+L
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNY 207
Query: 612 EPSNEKCDVYSFGVIL 627
+P D+++ G+I
Sbjct: 208 DPITTATDMWNIGIIA 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 31/261 (11%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 493
+ E +G GS+G+V A +VA+K D +RE+ ++ LRH
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM----RVEREISYLKLLRH 68
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGM 548
P+++ +T P ++ ++ E+ G LF I+ + DE RR I A++
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIE----- 122
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPE 607
H IVHRDLK NLL+D N NVK++DFGLS + FL K++ G+P + APE
Sbjct: 123 -YCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPE 177
Query: 608 VLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
V+ + + + DV+S G++L+ + +LP+ + V + +P L P
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGA 235
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
+I DP R + ++
Sbjct: 236 QSLIRRMIVADPMQRITIQEI 256
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK-------KFLDQDFSGAALLEFKREVKIMRRL 491
E +G G V E AVK + +EV I+R++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 492 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 549
HPN++ ++ + + +G LF + + + EK K+ + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVIC 138
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 608
LH IVHRDLK N+L+D + N+K++DFG S L L + GTP ++APE+
Sbjct: 139 ALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEI 194
Query: 609 LRNEPS------NEKCDVYSFGVIL 627
+ + ++ D++S GVI+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 49/301 (16%)
Query: 409 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 466
+P + S + +++ +++G G+YGEV T E A+K
Sbjct: 23 TPGMFITSKKGHLSEMYQ--------------RVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 467 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RIL 525
S ++ + EV +++ L HPN++ N ++ E G LF I+
Sbjct: 69 IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 526 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFG 582
HR +E + V G+ LH IVHRDLK NLL+ +K+ +K+ DFG
Sbjct: 129 HRMK--FNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 583 LSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 641
LS + ++ + + GT ++APEVLR + +EKCDV+S GVIL+ L P+ G
Sbjct: 185 LSAVFENQKKMKER--LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
Query: 642 PMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPSLRPSFAQLTVAL 691
+++ V + + + L+ +++ Q D R S Q AL
Sbjct: 242 DQEILRKV----EKGKYTFDSPEWKNVSEGAKDLIKQML----QFDSQRRISAQQ---AL 290
Query: 692 K 692
+
Sbjct: 291 E 291
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 61/288 (21%), Positives = 109/288 (37%), Gaps = 32/288 (11%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 493
+G +G G +G VY + VA+K + EV +++++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 494 --PNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 549
V+ + RP + +I E P LF I R Q + R V +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVR 163
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
H ++HRD+K N+L+D N +K+ DFG L +T GT + PE
Sbjct: 164 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEW 219
Query: 609 LRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667
+R V+S G++L+++ +P+ +++ ++ + +
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQRVSSECQ 271
Query: 668 RIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIPSHPDQPSSA 709
+I C PS RP+F + + L P + I H P +
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 16/194 (8%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
L IG GS+GEV A A KK K+E++IM+ L HPN++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF--KQEIEIMKSLDHPNIIR 70
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
++ ++ E G LF R++H+ E ++ DV + H
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL--N 126
Query: 558 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+ HRDLK N L + +K+ DFGL+ K + ++ GTP +++P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEG-L 183
Query: 614 SNEKCDVYSFGVIL 627
+CD +S GV++
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-35
Identities = 76/288 (26%), Positives = 139/288 (48%), Gaps = 27/288 (9%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNV 496
LG+ +G+G++G+V + G +VAVK L++ S + + +RE++ ++ RHP++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCL 551
+ ++ P ++ ++ E++ G LF I E RR I +D
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD------YC 132
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLR 610
H +VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 133 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 188
Query: 611 NEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ + D++S GVIL+ L LP+ + + + + P+ L+P V +
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVISL 246
Query: 670 IWECWQTDPSLRPSFAQLTV---ALKPLQRLVIPSHPDQPSSALPQEI 714
+ Q DP R + + + L + + P P S+ + E
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-35
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 493
+ E +G G++G V+ T K LD+ K E+ IM +L H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-------TVKNEISIMNQLHH 107
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 552
P ++ A + +I EFL G LF RI + ++ E I G+ +H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH 166
Query: 553 TSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 609
+ IVH D+K N++ K +VK+ DFGL+ L + + K T T E+ APE++
Sbjct: 167 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIV 222
Query: 610 RNEPSNEKCDVYSFGVIL 627
EP D+++ GV+
Sbjct: 223 DREPVGFYTDMWAIGVLG 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 492
+ + +G G+ GEV A +VA+K + F+ + E + E++I+++L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 551
HP ++ + I+ E + G LF +++ + + + + L
Sbjct: 74 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--FYQMLLAVQYL 130
Query: 552 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 607
H + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APE
Sbjct: 131 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPE 186
Query: 608 VLRNEPS---NEKCDVYSFGVIL 627
VL + + N D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 45/197 (22%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 441 LGERIGLGSYGEVYHADWNGT--EVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 494
+ E +G G +G V+ + K K DQ K+E+ I+ RH
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-------LVKKEISILNIARHR 61
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
N++ + L +I EF+ +F RI +++E+ + V + LH+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 554 STPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 610
I H D++ N++ ++ +K+ +FG +R LK + PE+ APEV +
Sbjct: 121 HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQ 176
Query: 611 NEPSNEKCDVYSFGVIL 627
++ + D++S G ++
Sbjct: 177 HDVVSTATDMWSLGTLV 193
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 440 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 496
+ + +GLG G+V G + A+K D + ++EV + P++
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHI 84
Query: 497 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 551
V + L II E + G LF RI R E+ ++ D+ + L
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 552 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
H+ I HRD+K NLL +K+ +K++DFG ++ L ++ TP ++APEV
Sbjct: 145 HSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPEV 200
Query: 609 LRNEPSNEKCDVYSFGVIL 627
L E ++ CD++S GVI+
Sbjct: 201 LGPEKYDKSCDMWSLGVIM 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 495
L IG GSYG V A A+K K + + + K EV++M++L HPN
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+ + ++ E G L ++ + + + C +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 555 TPT------------------------------------IVHRDLKSPNLLV--DKNWNV 576
I HRD+K N L +K++ +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 577 KVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWEL 630
K+ DFGLS+ + + + AGTP ++APEVL NE KCD +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 631 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV---AR-IIWECWQTDPSLRPSFAQ 686
+P+ G+N + V N++L ++ AR ++ + R +
Sbjct: 270 LMGAVPFPGVNDADTISQV--LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 492
+ + +G G+ GEV A +VA++ + F+ + E + E++I+++L
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 551
HP ++ + I+ E + G LF +++ + E + + L
Sbjct: 199 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYL 255
Query: 552 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 607
H + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APE
Sbjct: 256 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPE 311
Query: 608 VLRNEPS---NEKCDVYSFGVIL 627
VL + + N D +S GVIL
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 2e-34
Identities = 43/321 (13%), Positives = 84/321 (26%), Gaps = 60/321 (18%)
Query: 438 DLVLGERIGLGSYGEVYHA-DWN-GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 494
L L E + +G V+ D + A+K F + + S + L RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 495 NVVLFMG--------AVTRPPNLSIITEFLPRGSLFRILHR----PHCQVD--------- 533
+ + + P + + + P VD
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 534 ----------EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583
+ + R L + +VH NL + + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 584 SRLKHNTFLSSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGM 640
+ P AP + + G+ ++ + L LP+ +
Sbjct: 241 LWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 641 NP-------MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK- 692
P + G + L V +I D R + A++
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE---AMET 353
Query: 693 -PLQRLVIPSHPDQPSSALPQ 712
+L ++ SS+L
Sbjct: 354 PEFLQL-----QNEISSSLST 369
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 65/301 (21%), Positives = 111/301 (36%), Gaps = 42/301 (13%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLR- 492
LG +G G +G V+ + +VA+K + + + EV ++ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 493 ---HPNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVARG 547
HP V+ + ++ E LP LF I + R V
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF--FGQVVAA 151
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
+ H+ +VHRD+K N+L+D + K+ DFG L H+ GT + P
Sbjct: 152 IQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPP 207
Query: 607 EVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------LEIP 659
E + V+S G++L+++ V G + F+ + L P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDM--------------VCGDIPFERDQEILEAELHFP 253
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 719
+ P +I C PS RPS + + L P + P PS P ++ +
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEE--ILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
Query: 720 P 720
P
Sbjct: 312 P 312
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 28/263 (10%)
Query: 440 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+ ++G G++G+V+ + +G E +K +++D S + + + E+++++ L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHTS 554
N+ I+ E G L RI+ E ++ + + H+
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 555 TPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 610
+VH+DLK N+L + +K+ DFGL+ K + + AGT +MAPEV +
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFK 199
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP------ 664
KCD++S GV+++ L T LP+ G + +V + E P
Sbjct: 200 -RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRPLTPQAV 256
Query: 665 -LVARIIWECWQTDPSLRPSFAQ 686
L+ +++ DP RPS AQ
Sbjct: 257 DLLKQML----TKDPERRPSAAQ 275
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 438 DLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRR 490
+ E +G G +G+V+ + T ++A K D++ E K E+ +M +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMNQ 142
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 549
L H N++ A ++ ++ E++ G LF RI+ + + E I + G+
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIR 201
Query: 550 CLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 606
+H I+H DLK N+L +K+ DFGL+R K L K GTPE++AP
Sbjct: 202 HMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAP 257
Query: 607 EVLRNEPSNEKCDVYSFGVIL 627
EV+ + + D++S GVI
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR 492
+ IG G V G E AVK + L + +RE I+R++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 493 -HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 550
HP+++ + + + ++ + + +G LF + + + EK + + ++
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSF 215
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 609
LH + IVHRDLK N+L+D N +++SDFG S L+ L + GTP ++APE+L
Sbjct: 216 LHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEIL 271
Query: 610 RNEPS------NEKCDVYSFGVIL 627
+ ++ D+++ GVIL
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-34
Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 27/265 (10%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ +G GS+GEV E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 499 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH--N 141
Query: 558 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEP 613
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-----GAVGFQNRR-LEIPKELDPLVA 667
+EKCDV+S GVIL+ L + P+ G N ++ G F + I + L+
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 668 RIIWECWQTDPSLRPSFAQLTVALK 692
+++ PSLR + Q L+
Sbjct: 259 KML----TFHPSLRITATQ---CLE 276
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 40/267 (14%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 496
+ IG G++G VAVK ++++ A ++ +RE+ R LRHPN+
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVK-YIERG----AAIDENVQREIINHRSLRHPNI 78
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCL 551
V F + P +L+II E+ G L+ RI + DE R + + M
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ-- 136
Query: 552 HTSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 608
I HRDLK N L+D + +K+ DFG S+ ++ KST GTP ++APEV
Sbjct: 137 ------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEV 188
Query: 609 LRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQN-RRLEIP 659
L + + + DV+S GV L+ + P+ Q + +V + + I
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248
Query: 660 KELDPLVARIIWECWQTDPSLRPSFAQ 686
E L++RI DP+ R S +
Sbjct: 249 PECCHLISRIF----VADPATRISIPE 271
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 42/308 (13%)
Query: 441 LGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 496
LGE +G G EV+ A +VAVK L D + + L F+RE + L HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 497 VLFMGAV--------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
V AV P I+ E++ +L I+H + KR I++ D + +
Sbjct: 75 V----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMA 605
N H + I+HRD+K N+++ VKV DFG++R ++ S TA GT ++++
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--------VGAVGFQNRRLE 657
PE R + + + DVYS G +L+E+ T + P+ G +P+ V ++
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--G 245
Query: 658 IPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPLQRLVIPSHPDQPSSALPQ 712
+ +LD +V + +P R A L D ++L
Sbjct: 246 LSADLDAVVLK----ALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLS 301
Query: 713 EISVNSTP 720
+ N +
Sbjct: 302 SAAGNLSG 309
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-34
Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 42/298 (14%)
Query: 409 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK 466
+P V ST+ + +G GS+GEV G E AVK
Sbjct: 12 TPGMFVQHSTAIFSDRYK--------------GQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 467 KFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RI 524
+ E REV+++++L HPN++ ++ E G LF I
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 525 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDF 581
+ R E ++ V G+ +H + IVHRDLK NLL+ K+ N+++ DF
Sbjct: 118 ISRKR--FSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 582 GLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 640
GLS + + + K GT ++APEVL +EKCDV+S GVIL+ L + P+ G
Sbjct: 174 GLSTHFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA 230
Query: 641 NPMQVV-----GAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
N ++ G F+ + ++ + L+ +++ PS+R S AL
Sbjct: 231 NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML----TYVPSMRISARD---ALD 281
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 75/312 (24%), Positives = 125/312 (40%), Gaps = 60/312 (19%)
Query: 409 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 466
+P V K+ + + ++G G+YGEV E A+K
Sbjct: 22 NPGMYVRKKEGKIGESYF--------------KVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 467 -----------KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515
D E E+ +++ L HPN++ ++TEF
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 516 LPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---D 571
G LF +I++R DE + + G+ LH IVHRD+K N+L+ +
Sbjct: 128 YEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKN 183
Query: 572 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 630
N+K+ DFGLS + L + GT ++APEVL+ + NEKCDV+S GVI++ L
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDR--LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240
Query: 631 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPSL 680
P+ G N ++ V + + + + L+ ++ D +
Sbjct: 241 LCGYPPFGGQNDQDIIKKV----EKGKYYFDFNDWKNISDEAKELIKLML----TYDYNK 292
Query: 681 RPSFAQLTVALK 692
R + + AL
Sbjct: 293 RCTAEE---ALN 301
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 41/240 (17%), Positives = 85/240 (35%), Gaps = 38/240 (15%)
Query: 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKR 483
E ++ + + + +G G++ +VY A N + +K A EF
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-----KPANPWEFYI 113
Query: 484 EVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKR 536
++M RL+ + F A ++ E G+L ++ P + +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 537 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----------DKNWNVKVSDFGLSR 585
I A+ + + +H I+H D+K N ++ D + + + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 586 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 641
T ++K T + E+L N+P N + D + ++ + +
Sbjct: 232 DMKLFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 47/251 (18%), Positives = 91/251 (36%), Gaps = 25/251 (9%)
Query: 454 YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513
+ + + + + S + + +++ M N V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 514 EFLPRGSLF-RILHRPHCQVDEKRRI-KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571
+ + +L + R + E + + +A + LH+ ++HRDLK N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 572 KNWNVKVSDFGLSRLKHNTFLSSKSTA------------GTPEWMAPEVLRNEPSNEKCD 619
+ VKV DFGL GT +M+PE + + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 620 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD---PLVARIIWECWQT 676
++S G+IL+EL M ++++ V R L+ P P ++ +
Sbjct: 259 IFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSP 312
Query: 677 DPSLRPSFAQL 687
P+ RP +
Sbjct: 313 SPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 64
Query: 495 NVV 497
+V
Sbjct: 65 GIV 67
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 48/327 (14%), Positives = 96/327 (29%), Gaps = 76/327 (23%)
Query: 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-- 492
LV G +G A G V + A+ + K EV +R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 493 -----------------------HPNVVLFMGAVTRPPNLSI-ITEFLPRGSLFRILH-- 526
++ LS + +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 527 ----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
H + R+++ L V R + LH +VH L+ ++++D+ V ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 583 LSRLKHNTFLSSKSTAGTPEWMAPEVL-----------RNEPSNEKCDVYSFGVILWELA 631
+ ++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 632 TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691
LP + + F++ + IP+ + L+ + + R Q
Sbjct: 308 CADLPITKDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQ----- 356
Query: 692 KPLQRLVIPSHP------DQPSSALPQ 712
P + S+ALP
Sbjct: 357 -------AMETPEYEQLRTELSAALPL 376
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 16/195 (8%)
Query: 440 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV 496
+ + +G GS+ + AVK + + ++E+ ++ HPN+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEITALKLCEGHPNI 68
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
V + ++ E L G LF RI + H E + + ++ +H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVG 126
Query: 556 PTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
+VHRDLK NLL + N +K+ DFG +RLK K+ T + APE+L
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 613 PSNEKCDVYSFGVIL 627
+E CD++S GVIL
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-33
Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 37/279 (13%)
Query: 360 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 419
P L + + + + E G R K T + + V+
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 420 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQD 472
V +D + E +G G++G V+ T A K D++
Sbjct: 154 HVLDHYD--------------IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 473 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQ 531
++E++ M LRHP +V A + +I EF+ G LF ++ H +
Sbjct: 200 -------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNK 251
Query: 532 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-LKH 588
+ E ++ V +G+ +H + VH DLK N++ K N +K+ DFGL+ L
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 627
+ K T GT E+ APEV +P D++S GV+
Sbjct: 310 KQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 440 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 496
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 117
Query: 497 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 551
V + L I+ E L G LF RI R E+ ++ + + L
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 552 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 607
H+ I HRD+K NLL N +K++DFG ++ + L + TP ++APE
Sbjct: 178 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPE 233
Query: 608 VLRNEPSNEKCDVYSFGVIL 627
VL E ++ CD++S GVI+
Sbjct: 234 VLGPEKYDKSCDMWSLGVIM 253
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 38/291 (13%)
Query: 441 LGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRH 493
L +G G G+VY A + VA+K + + S +RE + RL+
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRER---IVALK-LMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 494 PNVVLFMGAV----TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 549
P+VV + L + + L +L R + R + + + ++
Sbjct: 94 PHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALD 148
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPEV 608
H + HRD+K N+LV + + DFG++ + L+ GT +MAPE
Sbjct: 149 AAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------NRRLEIPKEL 662
+ + D+Y+ +L+E T P+ G + + V+GA Q R IP
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAF 265
Query: 663 DPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVIPSHPDQPSSALPQ 712
D ++AR +P R + L+ A + + D+ + L +
Sbjct: 266 DAVIAR----GMAKNPEDRYVTCGDLSAA---AHAALATADQDRATDILRR 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 22/197 (11%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 497
+ E IG+GSY E AVK + + E++I+ R +HPN++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNII 79
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+ ++TE + G L +IL + E+ + + + + LH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQG- 136
Query: 557 TIVHRDLKSPNLLV----DKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLR 610
+VHRDLK N+L ++++ DFG ++ N L + T ++APEVL
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLE 193
Query: 611 NEPSNEKCDVYSFGVIL 627
+ + CD++S GV+L
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-32
Identities = 60/283 (21%), Positives = 105/283 (37%), Gaps = 35/283 (12%)
Query: 441 LGERIGLGSYGEVYHA-DW--NGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 494
+ I G G +Y A D NG V +K + D + E + + + HP
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----AMAERQFLAEVVHP 139
Query: 495 NVVL-----FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 549
++V P I+ E++ SL R + + I L++ ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALS 196
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 609
LH+ +V+ DLK N+++ + +K+ D G S GTP + APE++
Sbjct: 197 YLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQAPEIV 249
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
R P+ D+Y+ G L L G + V + + L+ L+ R
Sbjct: 250 RTGPT-VATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTYDSYGRLLRR- 303
Query: 670 IWECWQTDPSLRP-SFAQLTVALKPLQRLVIPSHPDQPSSALP 711
DP R + +++ L + R V+ P L
Sbjct: 304 ---AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLS 343
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 38/234 (16%)
Query: 413 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLD 470
S DS + + + ++ + + +G G++ V E AVK
Sbjct: 2 STDSFSGRFEDVYQ-------------LQEDVLGEGAHARVQTCINLITSQEYAVKIIEK 48
Query: 471 QDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRP 528
Q + REV+++ + + H NV+ + ++ E + GS+ I R
Sbjct: 49 QPGHIRS--RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR 106
Query: 529 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR 585
H +E + DVA ++ LH I HRDLK N+L ++ VK+ DF L
Sbjct: 107 H--FNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162
Query: 586 -LKHNTFLSSKST------AGTPEWMAPEVLRNEPS-----NEKCDVYSFGVIL 627
+K N S ST G+ E+MAPEV+ +++CD++S GVIL
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 53/259 (20%), Positives = 110/259 (42%), Gaps = 28/259 (10%)
Query: 437 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFK------REVKI 487
ED G+ +G GS+ V E A+K +++ RE +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA-TSREYAIKIL-----EKRHIIKENKVPYVTRERDV 83
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
M RL HP V L + G L + + + + R A ++
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSA 142
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMA 605
+ LH I+HRDLK N+L++++ +++++DFG +++ +++ + GT ++++
Sbjct: 143 LEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKEL 662
PE+L + + + D+++ G I+++L P+ N + FQ + P++
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKF 255
Query: 663 DPLVARIIWECWQTDPSLR 681
P ++ + D + R
Sbjct: 256 FPKARDLVEKLLVLDATKR 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 42/199 (21%)
Query: 440 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 496
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 73
Query: 497 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 551
V + L I+ E L G LF RI R E+ ++ + + L
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 552 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
H+ I HRD+K NLL N +K++DFG A E
Sbjct: 134 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKET 170
Query: 609 LRNEPSNEKCDVYSFGVIL 627
E ++ CD++S GVI+
Sbjct: 171 TG-EKYDKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 51/241 (21%), Positives = 107/241 (44%), Gaps = 33/241 (13%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 496
IG G++GEV + A+K + +L+ F+ E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMNC 550
A NL ++ ++ G L +L + ++ E+ + +A+D
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------S 190
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVL 609
+H VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L
Sbjct: 191 VHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 610 RNEPSNEK-----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
+ + CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 665 L 665
+
Sbjct: 309 V 309
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 61/300 (20%), Positives = 126/300 (42%), Gaps = 49/300 (16%)
Query: 409 SPSSSVDSSTSKVDQIFDDDVCECEIPW----------EDLVLGERIGLGSYGEVYHADW 458
+ ++ S V + + W + + +G GS+G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 459 NGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMRRLRHPNVVLFMGAVTRPPNLS 510
+ A+K +++ K+ E +I++ + P +V + NL
Sbjct: 63 KESGNHYAMKIL-----DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 511 IITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALDVARGMNCLHTSTPTIVHRDLKS 565
++ E++ G +F L R + R I + + LH+ +++RDLK
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------YLHSLD--LIYRDLKP 169
Query: 566 PNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG 624
NLL+D+ ++V+DFG + R+K T+ + GTPE +APE++ ++ N+ D ++ G
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 625 VILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWECWQTDPSLR 681
V+++E+A P+ P+Q+ ++ ++ P + ++ Q D + R
Sbjct: 226 VLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 496
+IG GSYG V+ G VA+KKF +D AL RE++++++L+HPN+
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQLKHPNL 64
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 553
V + R L ++ E+ ++ L R V E K L + +N H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHK 120
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 608
+HRD+K N+L+ K+ +K+ DFG +RL L+ S E W +PE+
Sbjct: 121 HN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPEL 173
Query: 609 LRNEPS-NEKCDVYSFGVILWELATLK 634
L + DV++ G + EL +
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 48/238 (20%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 496
IG G++ EV T A+K + +L+ F+ E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTST 555
A L ++ E+ G L +L + ++ + R +A ++ ++ +H
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG 182
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
VHRD+K N+L+D+ +++++DFG +L+ + + S GTP++++PE+L+
Sbjct: 183 --YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 615 NEK-------CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
CD ++ GV +E+ + P+ + + G + L +P + +
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 496
E+IG G+YG V+ A VA+K+ LD D G AL RE+ +++ L+H N+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 63
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 553
V + L+++ EF + L + + +D K + L +G+ H+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHS 119
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 608
++HRDLK NLL+++N +K+++FGL+R + E W P+V
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPDV 172
Query: 609 LRNEPS-NEKCDVYSFGVILWELATLKLP 636
L + D++S G I ELA P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 443 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 497
E++G G+YG VY A D G VA+K+ LD + G A+ RE+ +++ L HPN+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELHHPNIV 82
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 554
+ + L+++ EF+ + L ++L + + K + L RG+ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH 138
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 609
I+HRDLK NLL++ + +K++DFGL+R + T E W AP+VL
Sbjct: 139 R--ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVTLWYRAPDVL 191
Query: 610 RNEPS-NEKCDVYSFGVILWELATLK 634
+ D++S G I E+ T K
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 443 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 497
E+IG G+YG VY A + G A+KK L+++ G + RE+ I++ L+H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----REISILKELKHSNIV 63
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 554
+ L ++ E L + L ++L ++ K + L G+ H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 609
++HRDLK NLL+++ +K++DFGL+R T E W AP+VL
Sbjct: 120 R--VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPDVL 172
Query: 610 RNEPS-NEKCDVYSFGVILWELATLK 634
+ D++S G I E+
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 501
IG G++GEV T A+K + + F E IM P VV
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMNCLHTST 555
A L ++ E++P G L ++ V EK + +ALD +H+
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALD------AIHSMG 188
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
+HRD+K N+L+DK+ ++K++DFG ++ + + GTP++++PEVL+++
Sbjct: 189 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 615 NEK----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663
+ CD +S GV L+E+ P+ + + + L P + D
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 496
+G GSYG V G VA+KKF D A+ RE+K++++LRH N+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQLRHENL 86
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 553
V + + ++ EF+ ++ L +D ++ + + G+ H+
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHS 142
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 608
I+HRD+K N+LV ++ VK+ DFG +R L++ E W APE+
Sbjct: 143 HN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVATRWYRAPEL 195
Query: 609 LRNEPS-NEKCDVYSFGVILWELATLK 634
L + + DV++ G ++ E+ +
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 42/289 (14%), Positives = 84/289 (29%), Gaps = 54/289 (18%)
Query: 441 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAA--LLEFKREVKIMRRLRHPNV 496
L G + + A D +VA+ F+D L E + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 556
+ V ++ E++ GSL + I+ +A + H +
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 616
+ + V + +V ++ +N
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANP 181
Query: 617 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------NRRLEIPKELDPLVA 667
+ D+ G L+ L + P + + +IP ++ + A
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 668 RIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPSHPDQPSSALPQ 712
R Q D +R + L + + + V+ + P SA P+
Sbjct: 242 R----SVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 443 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFK---------REVKIMRRLR 492
I GSYG V D G VA+K+ + G + RE++++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 493 HPNVVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 546
HPN++ + ++TE + L +++H + + +
Sbjct: 88 HPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
G++ LH + +VHRDL N+L+ N ++ + DF L+R + + AP
Sbjct: 146 GLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRWYRAP 202
Query: 607 EVLRNEPS-NEKCDVYSFGVILWELATLK 634
E++ + D++S G ++ E+ K
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 5e-23
Identities = 61/265 (23%), Positives = 119/265 (44%), Gaps = 45/265 (16%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTE--VAVK---KFLDQDFSGAALLEFKR------EV 485
+D + +G GS+G V+ A+K K ++ K+ E
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--------EIVVRLKQVEHTNDER 57
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKM 540
++ + HP ++ G + +I +++ G LF +L + + + + +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 541 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAG 599
AL+ LH+ I++RDLK N+L+DKN ++K++DFG + + T+ + G
Sbjct: 118 ALE------YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCG 165
Query: 600 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRL 656
TP+++APEV+ +P N+ D +SFG++++E+ P+ N M+ ++ L
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAEL 220
Query: 657 EIPKELDPLVARIIWECWQTDPSLR 681
P + V ++ D S R
Sbjct: 221 RFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 443 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 497
+++G G+Y VY T+ VA+K+ L+ + A+ REV +++ L+H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKHANIV 63
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 554
+ +L+++ E+L + L + L ++ K + L RG+ H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR- 118
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 609
++HRDLK NLL+++ +K++DFGL+R K S + E W P++L
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVTLWYRPPDIL 172
Query: 610 RNEPS-NEKCDVYSFGVILWELATLK 634
+ + D++ G I +E+AT +
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 497
E++G G+Y VY G VA+K+ LD + A+ RE+ +M+ L+H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIV 66
Query: 498 LFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
+ L+++ EF+ R K L +G+
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-A 605
H + I+HRDLK NLL++K +K+ DFGL+R + E W A
Sbjct: 124 CHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEVVTLWYRA 176
Query: 606 PEVLRNEPS-NEKCDVYSFGVILWELATLK 634
P+VL + + D++S G IL E+ T K
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 60/249 (24%), Positives = 101/249 (40%), Gaps = 21/249 (8%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G G +GEV T A KK + AL E K+ I+ ++ VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQ---ILEKVNSRFVV 247
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTP 556
A L ++ + G L ++ E R + A ++ G+ LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER- 306
Query: 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSN 615
IV+RDLK N+L+D + ++++SD GL+ H + GT +MAPEV++NE
Sbjct: 307 -IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 616 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 672
D ++ G +L+E+ + P+ V + E + P + +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVPEEYSERFSPQARSLCSQ 422
Query: 673 CWQTDPSLR 681
DP+ R
Sbjct: 423 LLCKDPAER 431
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGA---ALLEFKREVKIMRRLRH 493
+ +G G + VY A VA+KK + G AL RE+K+++ L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKLLQELSH 71
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNC 550
PN++ + A N+S++ +F+ L I+ + K + M L +G+
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEY 127
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-A 605
LH I+HRDLK NLL+D+N +K++DFGL++ S + A T + W A
Sbjct: 128 LHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVTRWYRA 180
Query: 606 PEVLRNEPS-NEKCDVYSFGVILWELATLK 634
PE+L D+++ G IL EL
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 60/246 (24%), Positives = 110/246 (44%), Gaps = 19/246 (7%)
Query: 445 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTA 212
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+ L + E+ G LF L R E R ++ ++ LH S +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLH-SEKNV 270
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE++APEVL +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330
Query: 619 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQ 675
D + GV+++E+ +LP+ + ++ F+ + P+ L P ++ +
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLGPEAKSLLSGLLK 385
Query: 676 TDPSLR 681
DP R
Sbjct: 386 KDPKQR 391
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 496
+IG G++GEV+ A G +VA+KK ++ + G AL RE+KI++ L+H NV
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLLKHENV 78
Query: 497 VLFMGAVT--------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
V + ++ ++ +F L +L + ++ + G+
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM 604
+H + I+HRD+K+ N+L+ ++ +K++DFGL+R + +S+ T W
Sbjct: 138 YYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA-FSLAKNSQPNRYTNRVVTLWY 194
Query: 605 -APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
PE+L E D++ G I+ E+ T
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 61/250 (24%), Positives = 103/250 (41%), Gaps = 20/250 (8%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G G +GEV+ T A KK + A++E K+ I+ ++ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE-KK---ILAKVHSRFIV 248
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---DEKRRIKMALDVARGMNCLHTS 554
A +L ++ + G + ++ E R I + G+ LH
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
I++RDLK N+L+D + NV++SD GL+ +K AGTP +MAPE+L E
Sbjct: 309 N--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIW 671
+ D ++ GV L+E+ + P+ + Q + + P + P
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSPASKDFCE 425
Query: 672 ECWQTDPSLR 681
Q DP R
Sbjct: 426 ALLQKDPEKR 435
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 86
Query: 497 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 546
+ + T +L I+ E + +L +++ + +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-------LLYQMLC 138
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + AP
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAP 195
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLK 634
EV+ E D++S G I+ E+
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G G+YG V A G VA+KK F F+ L RE+KI++ +H N++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENII 72
Query: 498 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVAR 546
+ RP + II E + L R++ H Q R
Sbjct: 73 TIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-------FIYQTLR 123
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 604
+ LH S ++HRDLK NLL++ N ++KV DFGL+R+ + + G M
Sbjct: 124 AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 605 --------APEVLRNEPS-NEKCDVYSFGVILWEL 630
APEV+ + DV+S G IL EL
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 44/215 (20%)
Query: 443 ERIGLGSYGEVYHADWNGT-EVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 500
+ IG GS+G V+ A + EVA+KK D+ F RE++IMR ++HPNVV
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKHPNVVDLK 98
Query: 501 GAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------VAR 546
+ L+++ E++P +++R K + M + + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQLLR 152
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPE--- 602
+ +H+ I HRD+K NLL+D +K+ DFG ++ +
Sbjct: 153 SLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNVSYICS 204
Query: 603 -WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
+ APE++ + D++S G ++ EL +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 55/251 (21%), Positives = 118/251 (47%), Gaps = 25/251 (9%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
IG GS+G+V N T+ A+K K ++++ + +E++IM+ L HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN----EVRNVFKELQIMQGLEHPFLV 78
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ ++ ++ + L G L L + +E ++ + ++ ++ L
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR-- 135
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-- 614
I+HRD+K N+L+D++ +V ++DF ++ L T +++ + GT +MAPE+ +
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGAG 193
Query: 615 -NEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRLEIPKELDPLVARII 670
+ D +S GV +EL + P+ + ++V F+ + P + ++
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTYPSAWSQEMVSLL 251
Query: 671 WECWQTDPSLR 681
+ + +P R
Sbjct: 252 KKLLEPNPDQR 262
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 34/211 (16%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 496
++G G+YGEVY A VA+K+ L+ + G A+ REV +++ L+H N+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKELQHRNI 95
Query: 497 VLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+ + L +I E+ L + + + K + + G+N H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---NGVNFCH-- 149
Query: 555 TPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 604
+ +HRDLK NLL+ + +K+ DFGL+R T E W
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFTHEIITLWYR 204
Query: 605 APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
PE+L + D++S I E+
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 440 VLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPN
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPN 79
Query: 496 VVLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA-------- 545
V+ + + + ++ L+ I+ K+ +++ +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWN----VKVSDFGLSRLKHNTFLSSKSTAGTP 601
G++ LH + ++HRDLK N+LV VK++D G +RL ++ P
Sbjct: 139 DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLDP 194
Query: 602 E----WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
W APE+L + D+++ G I EL T +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 59/246 (23%), Positives = 111/246 (45%), Gaps = 20/246 (8%)
Query: 445 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 69
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
A L + E+ G LF L R E+R ++ + LH+ +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRD--V 126
Query: 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 618
V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE++APEVL +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 619 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQ 675
D + GV+++E+ +LP+ + ++ F+ + P+ L P ++ +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 676 TDPSLR 681
DP R
Sbjct: 242 KDPKQR 247
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 67/250 (26%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 445 IGLGSYGEVY---HADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
+G GS+G+V+ + V K L + K E I+ + HP
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR----DRVRTKMERDILVEVNHPF 87
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTS 554
+V A L +I +FL G LF L + E+ + +A ++A ++ LH+
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYLA-ELALALDHLHSL 145
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
I++RDLK N+L+D+ ++K++DFGLS+ + + S GT E+MAPEV+
Sbjct: 146 G--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIW 671
+ D +SFGV+++E+ T LP+ G + + +L +P+ L P ++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAKLGMPQFLSPEAQSLLR 258
Query: 672 ECWQTDPSLR 681
++ +P+ R
Sbjct: 259 MLFKRNPANR 268
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLR---HPNV 496
G G++G V G VA+KK D F RE++IM+ L HPN+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNI 81
Query: 497 V----LFMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD------ 543
V F R L+++ E++P +L R + +R++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPPPILIKVFL 135
Query: 544 --VARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGT 600
+ R + CLH + + HRD+K N+LV++ + +K+ DFG ++ S S
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSPSEPNV 189
Query: 601 PEWM-----APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
APE++ D++S G I E+ +
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 443 ERIGLGSYGEVYHA-DWNGTE--VAVKKF-LDQDFSGA---ALLEFKREVKIMRRLR--- 492
IG G+YG+V+ A D VA+K+ + G + REV ++R L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRHLETFE 72
Query: 493 HPNVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDV 544
HPNVV + R L+++ E + + + + P + K + L
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL-- 130
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPE 602
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ T
Sbjct: 131 -RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TSV 179
Query: 603 ----WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 634
W APEVL D++S G I E+ K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-21
Identities = 61/248 (24%), Positives = 105/248 (42%), Gaps = 19/248 (7%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 497
IG G +GEVY T A+K + AL E + + ++ P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 255
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-RNEPSNE 616
+V+RDLK N+L+D++ +V++SD GL+ + ++ GT +MAPEVL + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 617 KCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
D +S G +L++L P+ ++ +E+P P + ++
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 428
Query: 674 WQTDPSLR 681
Q D + R
Sbjct: 429 LQRDVNRR 436
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 6e-21
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 123
Query: 497 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 546
+ + T L ++ E + +L +++ + +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-------LLYQMLC 175
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + AP
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAP 232
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLK 634
EV+ E D++S G I+ E+ K
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 44/214 (20%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+G G+YG V A +G +VA+KK F + F+ A RE+ +++ ++H NV
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENV 85
Query: 497 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 546
+ + T +L ++ F+ L +I+ Q + + +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-------LVYQMLK 137
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 604
G+ +H++ +VHRDLK NL V+++ +K+ DFGL+R T +
Sbjct: 138 GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTR 187
Query: 605 ---APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
APEV+ + N+ D++S G I+ E+ T K
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 41/214 (19%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
+ IG GS+G VY A +G VA+KK D+ F RE++IMR+L H N+V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRL 112
Query: 500 MGAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------VA 545
L+++ +++P +++R+ + + + + +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY-----SRAKQTLPVIYVKLYMYQLF 166
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR-LKHNTFLSSK-STAGTPE 602
R + +H+ I HRD+K NLL+D + +K+ DFG ++ L S +
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS----R 220
Query: 603 WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
+ APE++ DV+S G +L EL +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 66/213 (30%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK--REVKIMRRLR---HP 494
IG+G+YG VY A +G VA+K + G L REV ++RRL HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 495 NVV-----LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGM 548
NVV R ++++ E + + L L + IK + RG+
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPE---- 602
+ LH + IVHRDLK N+LV VK++DFGL+R+ TP
Sbjct: 134 DFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVVVTL 183
Query: 603 WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 634
W APEVL D++S G I E+ K
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 42/259 (16%)
Query: 445 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 492
+G G YG+V+ T A+K A ++ ++ I+ ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVL-----KKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCL 551
HP +V + A L +I E+L G LF L R E +A +++ + L
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLA-EISMALGHL 137
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMA 605
H I++RDLK N++++ +VK++DFGL + +TF GT E+MA
Sbjct: 138 HQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------GTIEYMA 189
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKEL 662
PE+L N D +S G +++++ T P+ G N + +L +P L
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKILKCKLNLPPYL 244
Query: 663 DPLVARIIWECWQTDPSLR 681
++ + + + + R
Sbjct: 245 TQEARDLLKKLLKRNAASR 263
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 35/254 (13%)
Query: 445 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIM--RR-----LR 492
+G GS+G+V+ A++ T A+KK +L M +R
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK--------DVVLMDDDVECTMVEKRVLSLAWE 76
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HP + NL + E+L G L + H D R A ++ G+ LH
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 135
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 610
+ IV+RDLK N+L+DK+ ++K++DFG+ K N +K+ GTP+++APE+L
Sbjct: 136 SKG--IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVA 667
+ N D +SFGV+L+E+ + P+ G + ++ F P+ L+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEAK 246
Query: 668 RIIWECWQTDPSLR 681
++ + + +P R
Sbjct: 247 DLLVKLFVREPEKR 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 56/229 (24%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
IG GSYG VY A VA+KK F D L RE+ I+ RL+ +
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILNRLKSDYI 87
Query: 497 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDV 544
+ + P +L I+ E L ++ P H + + ++
Sbjct: 88 IRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-------ILYNL 138
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR------------LKHNTFL 592
G N +H S I+HRDLK N L++++ +VKV DFGL+R
Sbjct: 139 LLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 593 SSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 630
+ + APE++ + + + D++S G I EL
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 25/249 (10%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
IG GS+G+V A EV AVK L + + E R V +++ ++HP +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE--RNV-LLKNVKHPFLV 102
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ L + +++ G LF L R C E R A ++A + LH+
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLN-- 159
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 615
IV+RDLK N+L+D ++ ++DFGL K N +S ++ GTPE++APEVL +P +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 616 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWE 672
D + G +L+E+ P+ N ++ + N + L++ + ++
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLKPNITNSARHLLEG 272
Query: 673 CWQTDPSLR 681
Q D + R
Sbjct: 273 LLQKDRTKR 281
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+G G+YG V A G VAVKK F + RE+++++ ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENV 90
Query: 497 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 549
+ + T +L ++T + L I+ CQ ++ + + RG+
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLIYQILRGLK 146
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW-MAPEV 608
+H++ I+HRDLK NL V+++ +K+ DFGL+R + +T W APE+
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT----RWYRAPEI 200
Query: 609 LRNEPS-NEKCDVYSFGVILWELATLK 634
+ N N+ D++S G I+ EL T +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 443 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+ +G G+YG V A G +VA+KK F + F+ A RE+++++ +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENV 86
Query: 497 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 549
+ + T L ++ F+ L +++ + + RI+ + + +G+
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLVYQMLKGLR 142
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 604
+H + I+HRDLK NL V+++ +K+ DFGL+R + T W
Sbjct: 143 YIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVVTRWYR 192
Query: 605 APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
APEV+ N + D++S G I+ E+ T K
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 445 IGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG G+YG V A + N VA+KK F Q + L RE+KI+ R RH N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 500 MGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLH 552
+ R P + I+ + + L+++L Q I L + RG+ +H
Sbjct: 91 N-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYIH 145
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-------- 604
++ ++HRDLK NLL++ ++K+ DFGL+R + ++
Sbjct: 146 SAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVATRW 196
Query: 605 --APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
APE++ N + D++S G IL E+ + +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 3e-19
Identities = 80/453 (17%), Positives = 166/453 (36%), Gaps = 33/453 (7%)
Query: 241 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 300
T + ++ + V R ++ + + ++ K + K
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 301 REPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ--L 358
+ + + I D SR+ GS S + +
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 359 NGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSST 418
+G + P E E R+K + + + + S +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 419 SKVDQIFDDDVCECEIPWEDL-VLGERIGLGSYGEVYHADWNGTE------VAVKKFLDQ 471
D++ D + L VLG+ GS+G+V ++ GT+ + K + Q
Sbjct: 333 GNRDRMKLTD-------FNFLMVLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQ 381
Query: 472 DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ 531
D + KR + + + P + L + E++ G L + + +
Sbjct: 382 DDDVECTMVEKRVLALPGK--PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-R 438
Query: 532 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591
E + A ++A G+ L + I++RDLK N+++D ++K++DFG+ +
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF 651
+++K+ GTP+++APE++ +P + D ++FGV+L+E+ + P+ G + ++ F
Sbjct: 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----F 551
Query: 652 Q---NRRLEIPKELDPLVARIIWECWQTDPSLR 681
Q + PK + I P R
Sbjct: 552 QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 47/217 (21%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 434 IPWE---DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM 488
+ W D L ++G G Y EV+ A N +V VK + KRE+KI+
Sbjct: 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKIL 84
Query: 489 RRLR-HPNVVLFMGAVTRPP---NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMA 541
LR PN++ + + P +++ E + ++ + +
Sbjct: 85 ENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR----FYMYEI 139
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGT 600
L + ++ H+ I+HRD+K N+++D ++ +++ D+GL+ H + A +
Sbjct: 140 L---KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-S 193
Query: 601 PEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLP 636
+ PE+L + + D++S G +L + K P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 61/234 (26%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 496
IG GSYG V A VA+KK F D L RE+ I+ RL H +V
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHV 114
Query: 497 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDV 544
V + + P ++ ++ E ++ P H + + ++
Sbjct: 115 VKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-------LLYNL 165
Query: 545 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------------LK 587
G+ +H++ I+HRDLK N LV+++ +VKV DFGL+R
Sbjct: 166 LVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 588 HNTFLSSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 630
++ T + APE++ + + E DV+S G I EL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 42/220 (19%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ +G G G V+ A + VA+KK D AL RE+KI+RRL H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDHDNIVK 72
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRI----------LHRP-HCQVDEKRRIKMAL-DVAR 546
+ P + + L + L + ++ + + R
Sbjct: 73 VF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 604
G+ +H++ ++HRDLK NL ++ ++ +K+ DFGL+R +
Sbjct: 132 GLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHYSHKGHLS 182
Query: 605 ---------APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
+P +L + + + D+++ G I E+ T K
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 52/229 (22%)
Query: 443 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLR-HPN 495
+++G G+YG V+ + G VAVKK F + + RE+ I+ L H N
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70
Query: 496 VVLFMGAVTRPPNLS---IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARG 547
+V + V R N ++ +++ L ++ H Q + + +
Sbjct: 71 IVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQY-------VVYQLIKV 121
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------LKHNTFLSSKS 596
+ LH+ ++HRD+K N+L++ +VKV+DFGLSR + + ++++
Sbjct: 122 IKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 597 TAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWELATLK 634
+ APE+L + D++S G IL E+ K
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 25/249 (10%)
Query: 445 IGLGSYGEVYHADWNGTE--VAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G GS+G+V A T AVK L D + E + + + HP +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRI-LSLARNHPFLT 87
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
P L + EF+ G L + + DE R A ++ + LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKG-- 144
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 615
I++RDLK N+L+D + K++DFG+ K + GTP+++APE+L+
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 616 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 672
D ++ GV+L+E+ P+ N + F+ N + P L I+
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGILKS 257
Query: 673 CWQTDPSLR 681
+P++R
Sbjct: 258 FMTKNPTMR 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 60/257 (23%), Positives = 108/257 (42%), Gaps = 32/257 (12%)
Query: 445 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
IG GSY +V T+ A+K D + E + V + HP +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 73
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
L + E++ G L + R + E+ + +++ +N LH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 130
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 611
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 184
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 664
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244
Query: 665 LVARIIWECWQTDPSLR 681
A ++ DP R
Sbjct: 245 KAASVLKSFLNKDPKER 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 56/253 (22%), Positives = 110/253 (43%), Gaps = 33/253 (13%)
Query: 445 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRR-LRHPNVV 497
+G GS+G+V ++ GT+ + K + QD E +++ + P +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFLT 84
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
L + E++ G L + + + E + A ++A G+ L +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG-- 141
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 611
I++RDLK N+++D ++K++DFG+ + TF GTP+++APE++
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAY 195
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVAR 668
+P + D ++FGV+L+E+ + P+ G + ++ FQ + PK +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVA 250
Query: 669 IIWECWQTDPSLR 681
I P R
Sbjct: 251 ICKGLMTKHPGKR 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 61/259 (23%), Positives = 113/259 (43%), Gaps = 34/259 (13%)
Query: 445 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 492
+G G+YG+V+ + T A+K A +++ + +++ +R
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVL-----KKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 493 H-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNC 550
P +V A L +I +++ G LF L + + E +I + ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVG-EIVLALEH 174
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMAPE 607
LH I++RD+K N+L+D N +V ++DFGLS K ++ GT E+MAP+
Sbjct: 175 LHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPD 230
Query: 608 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKEL 662
++R S ++ D +S GV+++EL T P+ + + P+E+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEM 289
Query: 663 DPLVARIIWECWQTDPSLR 681
L +I DP R
Sbjct: 290 SALAKDLIQRLLMKDPKKR 308
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 61/257 (23%), Positives = 108/257 (42%), Gaps = 32/257 (12%)
Query: 445 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
IG GSY +V T+ VKK D + E + V + HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 116
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
L + E++ G L + R + E+ + +++ +N LH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 173
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 611
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 227
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 664
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 287
Query: 665 LVARIIWECWQTDPSLR 681
A ++ DP R
Sbjct: 288 KAASVLKSFLNKDPKER 304
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 77/248 (31%)
Query: 443 ERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVV-- 497
+ +G GS+G V G A+KK L QD +K RE+ IM+ L H N++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVL-QDPR------YKNRELDIMKVLDHVNIIKL 65
Query: 498 ------------------------------LFMGAVTRPPN------LSIITEFLPRGSL 521
+ + N L++I E++P +L
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124
Query: 522 FRILHRPHCQVDEKRRIKMALD--------VARGMNCLHTSTPTIVHRDLKSPNLLVD-K 572
++L + + ++ + R + +H+ I HRD+K NLLV+ K
Sbjct: 125 HKVLKSFI-----RSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSK 177
Query: 573 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRNEPS-NEKCDVYSFGVI 626
+ +K+ DFG ++ S + APE++ D++S G +
Sbjct: 178 DNTLKLCDFGSAK------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 627 LWELATLK 634
EL K
Sbjct: 232 FGELILGK 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 4e-13
Identities = 35/197 (17%), Positives = 55/197 (27%), Gaps = 48/197 (24%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK------FLDQDFSGAALLEFKREVKI 487
+P E L E+IG G +GEV+ + T VA+K L E E+ I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 488 MRRL---------RHPNVVLFMGA------------------------------VTRPPN 508
+ L R + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 568
L I+ EF G + + + I + + S HRDL N+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSI--LHQLTASLAVAEAS-LRFEHRDLHWGNV 193
Query: 569 LVDKNWNVKVSDFGLSR 585
L+ K K+ +
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 43/220 (19%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 443 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR-- 492
++G G + V+ A D N T VA+K + + + E+K+++R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---------EDEIKLLQRVNDA 75
Query: 493 ---------HPNVVLFMGAVT-RPPNLS---IITEFLPRGSLFRILHRPHCQVDEKRRIK 539
+++ + + PN ++ E L +L ++ + + +K
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 540 -MALDVARGMNCLHTSTPTIVHRDLKSPNLLVD------KNWNVKVSDFGLSRLKHNTFL 592
++ + G++ +H I+H D+K N+L++ +K++D G + +
Sbjct: 135 QISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
+S T E+ +PEVL P D++S +++EL T
Sbjct: 194 NSIQT---REYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 60/233 (25%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 494
LG +IG GS+G++Y G EVA+K + + L E KI + ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQL--HIESKIYKMMQGGVGIP 68
Query: 495 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 541
+ V+ M G P+L LF R K +K
Sbjct: 69 TIRWCGAEGDYNVMVMELLG-----PSLE---------DLFNFCSR-------KFSLKTV 107
Query: 542 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 587
L +A M +H+ +HRD+K N L+ V + DFGL++ +
Sbjct: 108 LLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 640
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 443 ERIGLGSYGEVYHADW--NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRHP 494
IG GS+G+V A VA+K FL+Q A +E V+++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIE----VRLLELMNKH 110
Query: 495 ------NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARG 547
+V +L ++ E L +L+ +L + + + A +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 548 MNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTPE 602
+ L T +I+H DLK N+L+ K +K+ DFG S ++ S+
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 223
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
+ +PEVL P + D++S G IL E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 443 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH- 493
+ IG GS+G+V A D VA+K +F Q A E ++I+ LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-----AAEE----IRILEHLRKQ 153
Query: 494 -----PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARG 547
NV+ + T ++ + E L +L+ ++ + Q ++ A + +
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 548 MNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTPE 602
++ LH + I+H DLK N+L+ +KV DFG S +H T++ S+
Sbjct: 213 LDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------ 264
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
+ APEV+ D++S G IL EL T
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 46/236 (19%), Positives = 86/236 (36%), Gaps = 62/236 (26%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 494
+G++IG G++GE+ + VA+ K L E + ++L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAI-KLEPMKSRAPQL---HLEYRFYKQLGSGDGIP 68
Query: 495 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 541
V + + G P+L LF + R +K
Sbjct: 69 QVYYFGPCGKYNAMVLELLG-----PSLE---------DLFDLCDR-------TFSLKTV 107
Query: 542 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRL------ 586
L +A + +H+ +++RD+K N L+ + N + + DF L++
Sbjct: 108 LMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 587 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 641
KH + KS GT +M+ + + + D+ + G + LPW G+
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 1e-09
Identities = 67/434 (15%), Positives = 122/434 (28%), Gaps = 153/434 (35%)
Query: 357 QLNGPPLVEDLSSNSKDENPKNV----E-DHEIGYHDRRKCTHDRFMGTNLKLRDLESPS 411
+ V++ + PK++ E DH I D T R T L
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT-LRLFWT---LLS--KQE 76
Query: 412 SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI---------GLGSYGEVYHADWNGTE 462
V Q F ++V + L I Y E +N +
Sbjct: 77 EMV--------QKFVEEVLRINYKF----LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 463 VAVKKFLDQDFSGAALLEFKREVKIMR------RLR-HPNVVLF-MG---------AVTR 505
V K + R ++ LR NV++ + V
Sbjct: 125 VFAKYNV------------SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 506 PPNLSIITEFLPRGSL---FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 562
+ + + + + P ++ +++ +D H+S +
Sbjct: 173 --SYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 563 LKS-----------PN-LLV-DKNWNVKVSD-FGL-------SRLKHNT-FLSSKSTAGT 600
+++ N LLV N K + F L +R K T FLS+ +T
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT--- 286
Query: 601 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 660
+ + + E+ +L L ++ P ++P+
Sbjct: 287 ---------THISLDHHSMTLTPD----EVKSLLLKYLDCRPQ-------------DLPR 320
Query: 661 E---LDPLVARII----------WECWQT-----------------DPS-LRPSFAQLTV 689
E +P II W+ W+ +P+ R F +L+V
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 690 ----ALKPLQRLVI 699
A P L +
Sbjct: 381 FPPSAHIPTILLSL 394
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 8e-06
Identities = 91/652 (13%), Positives = 163/652 (25%), Gaps = 223/652 (34%)
Query: 57 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 116
V+D +I+ EE +D I+ +KD + L + +
Sbjct: 38 VQDMPKSILSKEE-----ID-----------HIIMSKDAVSGTL--RL--FWTLLSKQEE 77
Query: 117 GAVYSKPKPLHAEGSSQNSTVDGSLPLNGG--STSEKAESL-PSFPSPSYEPGAASSGIS 173
V+ L +N + K E PS + Y I
Sbjct: 78 MV---------------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--------IE 114
Query: 174 SR-VTPNQSDYLSS---------STIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQED 223
R N + + + +L + R NV+ G
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE-----------LRPAKNVLIDGV----- 158
Query: 224 SKSLFADLNPFQIKGAGKTSL------------------------HKNPTESKVEEFQS- 258
G+GKT + + N E+ +E Q
Sbjct: 159 -------------LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 259 -HRINPVSGRPPIPMMRKNQHPYNEVPRKKEY----SYMEGIL-------PKINREPNNN 306
++I+P ++ + Y +L K N +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 307 ---LSTSASTSSTSENFNPHSFKPS-NDANISSKDSESRSALSGSGPSLASSTSQLNGPP 362
L T+ T + S + +++ E +S L L+ P
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL----------KYLDCRP 315
Query: 363 LVEDLSSNSKDENP-------KNVEDHEIGYHDRRKCTHDRFMGTNL-KLRDLESPSSSV 414
+DL NP +++ D T D + N KL SS+
Sbjct: 316 --QDLPREVLTTNPRRLSIIAESIRDG--------LATWDNWKHVNCDKLT--TIIESSL 363
Query: 415 DSSTSKVDQ-------IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 467
+ + +F IP +L + W +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSA---HIPTI--LL----------SLI---WFDVIKSDVM 405
Query: 468 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 527
+ +L+E K+ + + SI E + LHR
Sbjct: 406 VVVNKLHKYSLVE-KQPKESTISI-P----------------SIYLELKVKLENEYALHR 447
Query: 528 -------PHCQVDEKRRIKMALD------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 574
D I LD + H R + +D +
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----HLKNIEHPERMTLFRMVFLDFRF 502
Query: 575 -NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSF 623
K+ + N S +T ++ P + N+P E+ + F
Sbjct: 503 LEQKIRHDSTAW---NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 62/236 (26%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 494
+G RIG GS+G ++ N +VA+K + S A L + E + + L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQL--RDEYRTYKLLAGCTGIP 69
Query: 495 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 541
NV VL + G P+L L + R K +K
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-----PSLE---------DLLDLCGR-------KFSVKTV 108
Query: 542 LDVARGM----NCLHTSTPTIVHRDLKSPNLLV----DKNWN-VKVSDFGLSRL------ 586
A+ M +H ++V+RD+K N L+ KN N + V DFG+ +
Sbjct: 109 AMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 587 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 641
+H + K+ +GT +M+ + + D+ + G + LPW G+
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/234 (25%), Positives = 90/234 (38%), Gaps = 60/234 (25%)
Query: 441 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 494
LG +IG GS+GE+Y EVA+K + + L E KI R L+ P
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQL--LYESKIYRILQGGTGIP 66
Query: 495 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 541
NV VL M G P+L LF R K +K
Sbjct: 67 NVRWFGVEGDYNVLVMDLLG-----PSLE---------DLFNFCSR-------KLSLKTV 105
Query: 542 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 587
L +A M +H+ + +HRD+K N L+ V + DFGL++ +
Sbjct: 106 LMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 641
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 47/235 (20%), Positives = 81/235 (34%), Gaps = 44/235 (18%)
Query: 441 LGERIGLGSYGEVYHAD-WNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+G IG G +G +Y AD + V + + S L E+K +R P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQI 96
Query: 498 LFMGAVTRPPNLSIIT-----EFLPRGSLFRIL-----------HRPHCQVDEKRR--IK 539
+ L + G +R + +R K
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN----AKRFSRK 152
Query: 540 MALDVARGM----NCLHTSTPTIVHRDLKSPNLLVD-KNWN-VKVSDFGLSRL------- 586
L ++ + +H VH D+K+ NLL++ KN + V + D+GL+
Sbjct: 153 TVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 587 KHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGM 640
K + GT E+ + + PS + D+ G + + T LPW
Sbjct: 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 47/236 (19%), Positives = 80/236 (33%), Gaps = 47/236 (19%)
Query: 440 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
VLG++IG G +G +Y A + A + ++ L E+K +R+ + +
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLF--SELKFYQRVAKKDCI 96
Query: 498 LFMGAVTRPPNLSIIT-----EFLPRGSLFRILHRPHCQV------------DEKRR--I 538
+ L I +G +R + V +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM------VMERLGIDLQKISGQNGTFKK 150
Query: 539 KMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL------ 586
L + M +H + VH D+K+ NLL+ +V +D+GLS
Sbjct: 151 STVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 587 -KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 640
K K GT E+ + + + S + DV G + KLPW
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 47/253 (18%), Positives = 89/253 (35%), Gaps = 74/253 (29%)
Query: 445 IGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-----HPN- 495
+G G + V+ + VA+K + ++ A E+++++ +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA----LDEIRLLKSVRNSDPNDPNR 100
Query: 496 --VVLFMGAVT-RPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGM 548
VV + N + ++ E L L + + + + Q +K + V +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 549 NCLHTSTPTIVHRDLKSPNLLV-------------------------------------- 570
+ LHT I+H D+K N+L+
Sbjct: 160 DYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 571 -----------DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 619
+ VK++D G + H F T ++ + EVL N D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT---RQYRSLEVLIGSGYNTPAD 275
Query: 620 VYSFGVILWELAT 632
++S + +ELAT
Sbjct: 276 IWSTACMAFELAT 288
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 53/235 (22%), Positives = 86/235 (36%), Gaps = 70/235 (29%)
Query: 443 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 493
+ +G G++G+V G VAVK ++ + A E ++++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA-----ARSE----IQVLEHLNT 70
Query: 494 P------NVVLFMGAVTRPPNLSIITEFLPRGSL--------FRILHRPHCQVDEKRRIK 539
V + ++ I+ E L S F H + K
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR-------K 122
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSD 580
MA + + +N LH++ + H DLK N L V N ++KV D
Sbjct: 123 MAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 581 FG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
FG H+T +S++ APEV+ ++ CDV+S G IL E
Sbjct: 181 FGSATYDDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 68/234 (29%)
Query: 443 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 493
+G G++G+V ++VA+K K+ + A LE + ++++++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA-----ARLE----INVLKKIKE 75
Query: 494 P------NVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKM 540
VL ++ I E L + + F+ PH + M
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR-------HM 128
Query: 541 ALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSDF 581
A + + LH + + H DLK N L V+ KN +++V+DF
Sbjct: 129 AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 582 G---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
G H T ++++ PEV+ + CDV+S G IL+E
Sbjct: 187 GSATFDHEHHTTIVATRHY------RPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 48/239 (20%), Positives = 89/239 (37%), Gaps = 74/239 (30%)
Query: 443 ERIGLGSYGEVYHADW---NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 493
++G G++G V N AVK K+ A +E I++++++
Sbjct: 41 RKMGDGTFGRVLLC-QHIDNKKYYAVKVVRNIKKYTRS-----AKIE----ADILKKIQN 90
Query: 494 -----PNVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMA 541
N+V + G ++ +I E L + + H +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK-------LYC 143
Query: 542 LDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------------KNWNV 576
+++ + +N L + + H DLK N LL D K+ +
Sbjct: 144 IEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 577 KVSDFG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 632
K+ DFG H + ++++ + APEV+ N + D++SFG +L EL T
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 43/236 (18%), Positives = 76/236 (32%), Gaps = 44/236 (18%)
Query: 440 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRHP 494
L + G +Y A T Q F + L+ K E +R P
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKF--SLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 495 NVVLFMGAVTRPPNLSI--ITEFLPRGSLFRIL-----------HRPHCQVDEKRR---I 538
V + P L+I F +R L +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP----KHVLSE 158
Query: 539 KMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL-----K 587
+ L VA + LH + VH ++ + N+ VD +V + +G + K
Sbjct: 159 RSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 588 HNTFLSSKSTA--GTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 640
H ++ + G E+++ ++ + PS + D+ S G + + LPW
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 29/162 (17%), Positives = 56/162 (34%), Gaps = 38/162 (23%)
Query: 441 LGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFKR 483
+G+ +G G V++ E VK D FS A+ +
Sbjct: 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 153
Query: 484 EVKIMRRLRH---PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 540
E + +++L+ P V + G ++ E I + +V + ++
Sbjct: 154 EFRALQKLQGLAVPKVYAWEGNA-------VLMEL--------IDAKELYRVRVENPDEV 198
Query: 541 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
+ + + IVH DL N+LV + + + DF
Sbjct: 199 LDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.01 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.85 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.58 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 94.92 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 93.29 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.57 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 91.67 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=484.47 Aligned_cols=253 Identities=24% Similarity=0.436 Sum_probs=223.9
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.+++|++++.||+|+||+||+|++ +++.||||++............+.+|+.+|++|+|||||+++++|.+++.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 358999999999999999999987 689999999998877777788899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+||+|.+++.. ....+++.+++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999964 3446799999999999999999999999 9999999999999999999999999999775543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
....+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..+.... .+.++..+++++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHHH
Confidence 33445689999999999999999999999999999999999999999999888887775433 34567789999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
+||++||.+|||+.|+++|
T Consensus 259 ~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-55 Score=464.57 Aligned_cols=263 Identities=34% Similarity=0.574 Sum_probs=224.0
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
.++|..++|++.++||+|+||+||+|++.+ .||||+++...........|.+|+.+|++++|||||++++++.+ +.++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 467888999999999999999999998765 59999998776677778889999999999999999999998765 6789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||||++|+|.++|......+++.+++.|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999999877678999999999999999999999998 999999999999999999999999999875432
Q ss_pred --cccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-ccccc---cCCCCC
Q 004986 591 --FLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRR---LEIPKE 661 (720)
Q Consensus 591 --~~~~~s~~GT~~Y~APEvi~g---~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~-~~~~~---~~ip~~ 661 (720)
.......+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+.......+. ..... ..++..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 223345689999999999974 358999999999999999999999998876554443332 22222 245678
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+++++.+||.+||+.||.+|||+.||+++|+.++..
T Consensus 266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 899999999999999999999999999999988653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=470.98 Aligned_cols=250 Identities=21% Similarity=0.351 Sum_probs=224.1
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|+++++||+|+||+||+|++ +++.||||++.+.... ......+.+|+++|++++|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999987 6899999999765322 22356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC--
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 590 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~-- 590 (720)
||||+||+|.+++.+. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999764 36999999999999999999999999 999999999999999999999999999976432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...+.. ....+|..+++++++||
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLV 265 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTCCHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCcccCHHHHHHH
Confidence 2334567999999999999999999999999999999999999999999998888888753 35677889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||++||.+|||++|++.+
T Consensus 266 ~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTCH
T ss_pred HHHccCCHhHCcChHHHcCC
Confidence 99999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=473.04 Aligned_cols=248 Identities=29% Similarity=0.414 Sum_probs=222.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|+++++||+|+||+||+|++ +++.||||++....... ...+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999988 68999999997654332 3457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
||+||+|.+++.+. .+++.++..|+.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 152 y~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 152 FLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred CCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 99999999999763 5999999999999999999999999 9999999999999999999999999999876655556
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~dLI~~c 673 (720)
.+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+..... ....+..+++++++||.+|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999999988888777753221 2234467899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|.+||.+|||+.|+++|
T Consensus 308 L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 308 LVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=462.39 Aligned_cols=260 Identities=33% Similarity=0.529 Sum_probs=224.0
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
.+..++|.+.++||+|+||+||+|++ +++.||||++... ......+|.+|+.+|++++|||||+++++|.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45668899999999999999999986 3678999998654 34556789999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 571 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~--------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd 571 (720)
.+.+|||||||++|+|.+++.+.. ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 999999999999999999996532 35899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhh
Q 004986 572 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 648 (720)
Q Consensus 572 ~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~ 648 (720)
+++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+..++...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998654332 22344679999999999999999999999999999999998 8999999998888877
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+.. ..++..|..+++++.+|+.+||++||++|||+.||+++|+.+.+.
T Consensus 273 i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 753 346678889999999999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-55 Score=461.49 Aligned_cols=260 Identities=30% Similarity=0.538 Sum_probs=228.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
+|..++|.+.+.||+|+||+||+|++ +++.||||++... ......+|.+|+++|++++|||||+++++|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 46678999999999999999999986 3678999998654 34556789999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 004986 506 PPNLSIITEFLPRGSLFRILHRP------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 573 (720)
++.+|||||||++|+|.++|.+. ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 99999999999999999999642 246999999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhh
Q 004986 574 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 650 (720)
Q Consensus 574 g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~ 650 (720)
+.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++ |+.||.+.+..++...+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543322 2233469999999999999999999999999999999998 899999999888887775
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 651 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 651 ~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
. ...+..|..+++++.+||.+||+.||.+|||+.||+..|+.+.+.
T Consensus 245 ~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 Q-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 3 345677889999999999999999999999999999999988653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=458.67 Aligned_cols=259 Identities=30% Similarity=0.511 Sum_probs=227.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
++..+++++.++||+|+||+||+|++ +++.||||++.... ......+|.+|+.+|++++|||||+++++|.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 46678899999999999999999986 45789999986543 23345789999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 570 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~---------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL 570 (720)
+..++||||||++|+|.++|... ...+++.+++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 99999999999999999999642 135899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHh
Q 004986 571 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 647 (720)
Q Consensus 571 d~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~ 647 (720)
++++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||+||||++ |..||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654332 23345689999999999999999999999999999999998 899999999988888
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 648 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 648 ~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.+.. ......|..++.++.+|+.+||+.||.+||++.||+++|+.+.
T Consensus 259 ~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 259 MIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 7764 3455678899999999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=464.30 Aligned_cols=253 Identities=27% Similarity=0.357 Sum_probs=221.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
..++|++.++||+|+||+||+|++ +++.||||++..+... .+|+.+|++++|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456799999999999999999987 6899999999876543 3699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~~~ 591 (720)
||||+||+|.+++.+. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+.+....
T Consensus 129 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999999764 36999999999999999999999998 99999999999999988 69999999998764322
Q ss_pred -----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-cCCCCCCcHH
Q 004986 592 -----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEIPKELDPL 665 (720)
Q Consensus 592 -----~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~-~~ip~~ls~~ 665 (720)
......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...+.....+ ..++..++++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1223468999999999999999999999999999999999999999988777766666543322 2577899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+++||.+||++||.+|||+.||+++|......
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999877544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=468.56 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=217.3
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
+..++|++++.||+|+||+||+|++ +++.||||++.+..........+.+|+.+|++++|||||+++++|.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3457899999999999999999976 46789999997654433334467889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|||||||+||+|.+++.+. ..+++.++..|+.||+.||+|||+++ ||||||||+|||++.+|++||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999999764 36999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...+.. ....+|..+++++++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 255 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQS 255 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCcCCHHHHH
Confidence 554555678999999999999999999999999999999999999999999999888887753 356678899999999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHHH
Q 004986 669 IIWECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
||.+||++||.+||+ ++|+++|
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 999999999999998 5777764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=475.67 Aligned_cols=248 Identities=29% Similarity=0.414 Sum_probs=223.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|+++++||+|+||+||+|++ +++.||||++....... ...+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 6799999999999999999988 68999999997654332 3467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
||+||+|.+++... .+++.++..|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 229 y~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 229 FLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 99999999999753 5999999999999999999999999 9999999999999999999999999999876655556
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~ip~~ls~~l~dLI~~c 673 (720)
.+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.... .....+..+++++++||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999888887775332 12345568899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|.+||.+|||+.|+++|
T Consensus 385 L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 385 LVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-54 Score=452.94 Aligned_cols=248 Identities=31% Similarity=0.469 Sum_probs=216.3
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCceEEE
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSII 512 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~----~~~l~LV 512 (720)
|++.++||+|+||+||+|.+ ++..||||++............|.+|+.+|++|+|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 47888999999999999988 58899999998877777777889999999999999999999999865 3458999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccccccCCc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+||+|.+++.+. ..+++..+..|+.||+.||+|||+++++||||||||+||||+ .+|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999999764 469999999999999999999999877799999999999998 4899999999999865432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
...+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.. ...+...+.....+..++..+++++++||
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 3456799999999999876 59999999999999999999999997754 44555555444444456677889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||.+||.+|||+.|+++|
T Consensus 264 ~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-54 Score=450.81 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=206.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999987 68999999998765433 23567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||| +|+|.+++.+. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+..... ..
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NF 167 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC-Cc
Confidence 999 67999998664 47999999999999999999999999 999999999999999999999999999876543 23
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
..+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKR 245 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 456799999999999999876 579999999999999999999999988888877774 33566788999999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||++||.+|||++|+++|
T Consensus 246 ~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HSCSSGGGSCCHHHHHHC
T ss_pred HccCChhHCcCHHHHHcC
Confidence 999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=459.38 Aligned_cols=268 Identities=31% Similarity=0.487 Sum_probs=229.5
Q ss_pred CccccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC-CceeEE
Q 004986 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLF 499 (720)
Q Consensus 428 ~~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H-pNIVkL 499 (720)
+..+++|+.++|++++.||+|+||+||+|++. ++.||||++.... .......|.+|+.+|.+++| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 34457888999999999999999999999873 2579999987554 34456789999999999965 899999
Q ss_pred eeeeecC-CceEEEEeecCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC
Q 004986 500 MGAVTRP-PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 563 (720)
Q Consensus 500 ~g~~~~~-~~l~LVmEy~~ggsL~d~L~~~---------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDL 563 (720)
+++|.+. +.++||||||++|+|.++|++. ...+++..++.|+.||+.||+|||+++ ||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9998664 5699999999999999999642 235899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004986 564 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 640 (720)
Q Consensus 564 KPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~ 640 (720)
||+||||++++.+||+|||+|+.+.... ......+||+.|||||++.+..|+.++|||||||+||||++ |..||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998664332 22345679999999999999999999999999999999998 99999987
Q ss_pred ChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 641 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 641 ~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
+..+.+........++..|..+++++.+||.+||+.||.+|||+.||+++|+.+.+..
T Consensus 292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 6544443333345567788899999999999999999999999999999999886543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=441.84 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=213.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------CCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~------~~~ 508 (720)
++|++++.||+|+||+||+|++ +|+.||||++............+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6799999999999999999987 68999999998776666667788999999999999999999998753 467
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|||||||+ |+|.+++.+. ..+++.++..|+.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 999999996 6799999764 47999999999999999999999999 9999999999999999999999999998654
Q ss_pred CC----cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-------
Q 004986 589 NT----FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------- 656 (720)
Q Consensus 589 ~~----~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~------- 656 (720)
.. .....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|......+
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 2234567999999999998875 56999999999999999999999999988877665553111110
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 ----------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ----------------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+...+++++++||.+||.+||.+|||+.|+++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0113578899999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=430.85 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=193.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 507 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------- 507 (720)
++|++++.||+|+||+||+|++ +++.||||++.... .+.....+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4799999999999999999987 68999999997654 3445667899999999999999999999987644
Q ss_pred -----ceEEEEeecCCCCHHHHHcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 004986 508 -----NLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 580 (720)
Q Consensus 508 -----~l~LVmEy~~ggsL~d~L~~~~~--~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~D 580 (720)
.+|||||||++|+|.+++..... ...+..++.|+.||+.||+|||+++ ||||||||+||||+.+|++||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976432 2456678899999999999999998 99999999999999999999999
Q ss_pred ccccccccCCcc------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHh
Q 004986 581 FGLSRLKHNTFL------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVG 647 (720)
Q Consensus 581 FGlAk~~~~~~~------------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~-~~i~~ 647 (720)
||+|+....... ...+.+||+.|||||++.+..|+.++|||||||++|||++ ||..... .....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999987643211 1234689999999999999999999999999999999996 7765322 12222
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 648 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 648 ~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+... ..+......++.+++||.+||++||.+|||+.|+++|
T Consensus 239 ~~~~~-~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHTT-CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhcC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22211 1111223445678999999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=429.60 Aligned_cols=256 Identities=33% Similarity=0.514 Sum_probs=203.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----ceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~----~l~LV 512 (720)
.+|.+.++||+|+||+||+|+++|+.||||++.... .....++.|+.++.+++|||||++++++.+++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468899999999999999999999999999986542 22223445777777899999999999998654 47999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~------g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
||||++|+|.+++++. .+++..++.++.|++.||+|||++ .++||||||||+||||+.++++||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999764 589999999999999999999986 22499999999999999999999999999987
Q ss_pred ccCCcc----cCCCCCCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------
Q 004986 587 KHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMN--------------- 641 (720)
Q Consensus 587 ~~~~~~----~~~s~~GT~~Y~APEvi~g~------~~s~ksDVWSLGilLyELltG~~PF~~~~--------------- 641 (720)
...... .....+||+.|||||++.+. .++.++|||||||+||||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 644321 22345899999999999765 35779999999999999999977653211
Q ss_pred hHHHHhhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 642 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 642 ~~~i~~~i~~~~~~~~ip~~-----ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
..++...+.....++.+|.. ....+.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 12233333333334455443 335789999999999999999999999999988653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=409.81 Aligned_cols=271 Identities=65% Similarity=1.103 Sum_probs=231.7
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
...++.+++|++.+.||+|+||+||+|+++++.||||++...........++.+|+.+|++++||||+++++++.+...+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 34567889999999999999999999999999999999988777777778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~--~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
++||||+++++|.+++.+... .+++..++.++.||+.||+|||+++.+|+||||||+||||+.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999976432 389999999999999999999998766999999999999999999999999999866
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+........++..+++++.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 55444445678999999999999999999999999999999999999999999988888777666667788899999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
+||.+||..||.+||++.++++.|+.+.+...|
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988776544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=451.93 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=222.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|++++.||+|+||+||+|++ +++.||||++.... ......+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999987 68999999987654 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC--CcEEEEeccccccccCCc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN--WNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~--g~IKL~DFGlAk~~~~~~ 591 (720)
|||+||+|++++.+....+++.++..|+.||+.||+|||+++ |+||||||+||||+.+ +++||+|||+|+.+...
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 999999999999776668999999999999999999999999 9999999999999854 89999999999976543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~dL 669 (720)
....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+....... ..+..+++++++|
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23345689999999999999999999999999999999999999999999988888775433222 2335789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||++||.+||++.|+++|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=452.82 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=214.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC----HHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~----~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
..+.+++|+++++||+|+||+||+|++ +++.||||++.+.... .........++.+++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 356779999999999999999999987 6899999999764321 1122223344666677799999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
.+.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999999764 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccCCCCC
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~---~~i~~~i~~~~~~~~ip~~ 661 (720)
..... ...+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.+. .++...+ ......+|..
T Consensus 341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~ 416 (689)
T 3v5w_A 341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDS 416 (689)
T ss_dssp ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTT
T ss_pred ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCcc
Confidence 76543 345679999999999996 46799999999999999999999999976432 3333333 2345677889
Q ss_pred CcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
+++++++||.+||++||.+|++ ++||++|
T Consensus 417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999999999999999999998 6888765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=420.46 Aligned_cols=244 Identities=22% Similarity=0.336 Sum_probs=200.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~ 510 (720)
++|++.++||+|+||+||+|++ +++.||||++..... ...+.+|+++|+.+ +|||||+++++|.+.+.+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 6799999999999999999975 367899999866532 34677899999998 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~DFGlAk~~~~ 589 (720)
||||||++|+|.+++. .+++.++..++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+....
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999994 4899999999999999999999999 9999999999999876 8999999999985433
Q ss_pred Cc----------------------------ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004986 590 TF----------------------------LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM 640 (720)
Q Consensus 590 ~~----------------------------~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~ 640 (720)
.. ....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 21 112345899999999999876 4899999999999999999999999654
Q ss_pred C-hHHHHhhhhc----------------------------------------------------cccccCCCCCCcHHHH
Q 004986 641 N-PMQVVGAVGF----------------------------------------------------QNRRLEIPKELDPLVA 667 (720)
Q Consensus 641 ~-~~~i~~~i~~----------------------------------------------------~~~~~~ip~~ls~~l~ 667 (720)
+ ..+.+..+.. ..........++++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 3 2222211100 0000112345789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
|||.+||++||.+|+|++|+++|
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHCcCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=398.55 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=225.8
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
..++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 347899999999999999999987 789999999988777777778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence 9999999999998654 36899999999999999999999998 999999999999999999999999999866443 2
Q ss_pred cCCCCCCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s-~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+.. ....+|..+++++.+||.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHH
Confidence 34557899999999999988875 799999999999999999999999988888777643 345677889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
+||..||.+|||++|+++|
T Consensus 247 ~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 247 RFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHCCSSTTTSCCHHHHTTC
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999886
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=402.15 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=223.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+..++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4568999999999999999999987 689999999976422 1123456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999999754 36899999999999999999999998 999999999999999999999999999865444
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++++||
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 4445567899999999999999999999999999999999999999999888887777643 34567788999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 004986 671 WECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
.+||++||.+|| ++.|+++|
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999 89999886
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=377.56 Aligned_cols=260 Identities=31% Similarity=0.603 Sum_probs=232.2
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--Cce
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 509 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~l 509 (720)
..+..++|++.+.||+|+||+||+|+++++.||||++............+.+|+.++++++||||+++++++.+. ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 356678999999999999999999999999999999988777777778899999999999999999999999887 778
Q ss_pred EEEEeecCCCCHHHHHcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~-~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++++|.+++.+... .+++..++.++.||+.||.|||+++.+|+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987543 5899999999999999999999987679999999999999999999999999876432
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~---ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
. ....||+.|+|||++.+..++. ++||||||+++|||++|+.||...+..+....+........++..++++
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 2357899999999998876544 8999999999999999999999988887776666566667788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+.+||.+||+.||.+||++.++++.|+.+.+
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999998854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=376.93 Aligned_cols=260 Identities=31% Similarity=0.526 Sum_probs=230.6
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+.+..++|++.+.||+|+||.||+|++ +++.||||++....... .++.+|+.++++++||||+++++++.+...++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 456678999999999999999999998 77889999998765443 46889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999999999876677999999999999999999999998 999999999999999999999999999865433
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+... .....+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQ 238 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHH
Confidence 2 22334567889999999999999999999999999999999 99999998888777766532 345566778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
||.+||+.||.+||++.+++++|+++.+.
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 99999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=396.65 Aligned_cols=263 Identities=31% Similarity=0.532 Sum_probs=228.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE---------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 501 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~---------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g 501 (720)
.++..++|++++.||+|+||+||+|++ ++..||||++... ........+.+|+.+|+++ +|||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345568999999999999999999986 2346999998655 3445567899999999999 8999999999
Q ss_pred eeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCC
Q 004986 502 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 566 (720)
Q Consensus 502 ~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPe 566 (720)
++.+.+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence 9999999999999999999999996532 34789999999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 004986 567 NLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 643 (720)
Q Consensus 567 NILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~ 643 (720)
||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654332 22233467889999999999999999999999999999999 99999998877
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 644 ~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
++...+.. ......+..++.++.+||.+||+.||.+||++.|++++|+++....
T Consensus 313 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 77665543 3355677889999999999999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.20 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=220.1
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||+||+|.+ +++.||||++....... ...+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 36799999999999999999986 78899999987654333 456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 999999999999764 5899999999999999999999998 999999999999999999999999999876655444
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc-cccccCCCCCCcHHHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~-~~~~~~ip~~ls~~l~dLI~~ 672 (720)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. .......+..++..+++||.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 5567899999999999999999999999999999999999999998887665544432 222344567889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.||.+||++.|++++
T Consensus 253 ~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HccCChhHCcCHHHHhhC
Confidence 999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=403.75 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=216.4
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
.+..++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+|+.+ +|||||+++++|.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999987 588999999976432 222345678899999998 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999999764 36999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..++.++++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLHEDATG 253 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHH
Confidence 444445667899999999999999999999999999999999999999999998888887743 355677889999999
Q ss_pred HHHHhhhcCCCCCCCH------HHHHHH
Q 004986 669 IIWECWQTDPSLRPSF------AQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~------~ELL~~ 690 (720)
||.+||++||.+||++ .|+++|
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999999999999998 777764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=387.91 Aligned_cols=266 Identities=33% Similarity=0.501 Sum_probs=224.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+..++|++.+.||+|+||+||+|++ +++.||+|++... .......+.+|+.++++++||||+++++++.++..+++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4457899999999999999999988 5889999988543 45567789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++++|.+++......+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999876667999999999999999999999998 9999999999999999999999999998654322
Q ss_pred cc--------------CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-hcccccc
Q 004986 592 LS--------------SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRL 656 (720)
Q Consensus 592 ~~--------------~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i-~~~~~~~ 656 (720)
.. ....+||+.|+|||++.+..++.++||||||+++|+|++|..||............ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 12467999999999999999999999999999999999999998764332211000 0011122
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
..+..+++.+.+||.+||+.||.+||++.++++.|+.++.......|
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~ 289 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCC
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCccc
Confidence 34678889999999999999999999999999999999877654444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=388.49 Aligned_cols=265 Identities=31% Similarity=0.466 Sum_probs=228.8
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
++..++|++.+.||+|+||+||+|++ .+..||||++.... .......+.+|+.+|++++||||+++++++.+.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45668999999999999999999987 24459999986543 4455678899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999999999876668999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 004986 588 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 588 ~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls 663 (720)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+... .....+..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcC
Confidence 44321 1223356788999999999999999999999999999999 99999998888877766533 3455677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCC
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~ 701 (720)
..+.+||.+||..||.+||++.+|++.|+.+.+.....
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 99999999999999999999999999999998765443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=373.70 Aligned_cols=258 Identities=38% Similarity=0.671 Sum_probs=215.8
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~--~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++..++|++.+.||+|+||.||+|.+.++.||||++...... ......+.+|+.+++.++||||+++++++.+...++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999998754322 223467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEeeCCCCCcEEEcC--------CCcEEEEec
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDF 581 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~-~IIHrDLKPeNILLd~--------~g~IKL~DF 581 (720)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++. +|+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999965 368999999999999999999999874 3889999999999986 788999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ 661 (720)
|+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.........+..
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 9998654432 23457999999999999999999999999999999999999999998887777666655556677888
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+++.+.+||.+||+.||.+||++.|++++|+.+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=373.55 Aligned_cols=260 Identities=33% Similarity=0.569 Sum_probs=226.8
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
.++..++|++.+.||+|+||.||+|++ ++..||||++...... ..++.+|+.++++++||||+++++++.+...++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 356678999999999999999999988 4567999999766544 356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999765556999999999999999999999998 999999999999999999999999999865443
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ......+..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-CCCCCCCCcChHHHHH
Confidence 2 22233457788999999999889999999999999999998 9999998888777666542 3344566778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
||.+||+.||.+||++.+++++|+.+.+.
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999999988643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=374.88 Aligned_cols=261 Identities=30% Similarity=0.499 Sum_probs=226.3
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.+++..++|++.+.||+|+||.||++++ ++..||||++....... .++.+|+.++++++||||+++++++.+...+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 3456778999999999999999999988 45689999998665443 5688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999999999875567999999999999999999999998 99999999999999999999999999986543
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 590 TF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 590 ~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.. ......+..+++.+.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 251 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVY 251 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHH
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-ccCCCCCCcCCHHHH
Confidence 22 22233457889999999999999999999999999999998 9999999888777766643 334456677899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+||.+||+.||.+||++.+++++|..+...
T Consensus 252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999999999999988653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=382.46 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=212.3
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+...++|++++.||+|+||+||+|++ +++.||||++............+.+|+.++++++|||||++++++.+...+++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34458899999999999999999988 78899999997665444456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999975 888888776667999999999999999999999998 9999999999999999999999999998765544
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---------------
Q 004986 592 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------------- 655 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--------------- 655 (720)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44455689999999999986 56899999999999999999999999886665544333210000
Q ss_pred -------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 -------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 -------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01123567899999999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=390.43 Aligned_cols=267 Identities=31% Similarity=0.502 Sum_probs=226.6
Q ss_pred CccccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 004986 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 499 (720)
Q Consensus 428 ~~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL 499 (720)
....+++..++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.+++++ +|||||++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3445677889999999999999999999984 34789999987543 344567789999999999 89999999
Q ss_pred eeeeecCCc-eEEEEeecCCCCHHHHHcCCCC------------------------------------------------
Q 004986 500 MGAVTRPPN-LSIITEFLPRGSLFRILHRPHC------------------------------------------------ 530 (720)
Q Consensus 500 ~g~~~~~~~-l~LVmEy~~ggsL~d~L~~~~~------------------------------------------------ 530 (720)
++++.+.+. +++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887655 9999999999999999976432
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--
Q 004986 531 -----------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 591 (720)
Q Consensus 531 -----------------~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-- 591 (720)
.+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 2889999999999999999999998 9999999999999999999999999998653321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+..............+..+++++.+||
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 329 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 22334568899999999999999999999999999999998 99999887655444444334445667788999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 671 WECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.+||+.||.+||++.|++++|+.+...
T Consensus 330 ~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999988654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=398.20 Aligned_cols=255 Identities=20% Similarity=0.335 Sum_probs=220.8
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecC
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 506 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~ 506 (720)
...+..++|++++.||+|+||+||+|++ +++.||||++.+... .......+..|..+|..+ +||||+++++++.+.
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 3456779999999999999999999998 467899999876432 112245677899999888 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++.
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999999999754 36899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..++.++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 248 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEA 248 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHH
Confidence 54433445667899999999999999999999999999999999999999999988888877753 3556788999999
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
++||.+||.+||.+||+ ++++++|
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999995 5787765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=390.85 Aligned_cols=270 Identities=31% Similarity=0.523 Sum_probs=234.0
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 499 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL 499 (720)
..+++..++|++.+.||+|+||+||+|++. +..||||++... ........+.+|+.+++++ +|||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 345677789999999999999999999862 257999998765 3455567889999999999 99999999
Q ss_pred eeeeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 004986 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 564 (720)
Q Consensus 500 ~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLK 564 (720)
++++.+.+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 999999999999999999999999996532 35899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 004986 565 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 641 (720)
Q Consensus 565 PeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~ 641 (720)
|+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998664332 22334467889999999999999999999999999999999 999999988
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 642 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 642 ~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
..++...+. .......+..++.++.+||.+||+.||.+||++.||+++|+.+......+..
T Consensus 299 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 299 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred HHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 887776664 3335566788999999999999999999999999999999999877655444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=390.72 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=218.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
+..++|++++.||+|+||.||+|++ +++.||||++.+... .......+.+|+.+++++ +|||||+++++|.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4568899999999999999999987 588999999987654 344566788999999998 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999999754 36899999999999999999999998 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHhhhhccccccCCCC
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---------NPMQVVGAVGFQNRRLEIPK 660 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~---------~~~~i~~~i~~~~~~~~ip~ 660 (720)
........+||+.|+|||++.+..++.++|||||||++|||++|..||... ....+...+. .....+|.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~ 240 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPR 240 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--HCCCCCCT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--cCCCCCCC
Confidence 434455678999999999999999999999999999999999999999752 2223333332 33556788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 004986 661 ELDPLVARIIWECWQTDPSLRPSF------AQLTVA 690 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRPS~------~ELL~~ 690 (720)
.++.++++||.+||+.||.+||++ .|+++|
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 899999999999999999999985 677655
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=385.01 Aligned_cols=264 Identities=29% Similarity=0.468 Sum_probs=227.4
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEECC-------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 504 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~g-------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~ 504 (720)
.++..++|++.+.||+|+||.||+|++.+ +.||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 45667899999999999999999998743 789999987543 3445678899999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 004986 505 RPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 561 (720)
Q Consensus 505 ~~~~l~LVmEy~~ggsL~d~L~~~~-----------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHr 561 (720)
+.+.+++||||+++++|.+++.... ..+++.+++.++.||+.||.|||+++ |+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence 9999999999999999999996531 46899999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 004986 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWI 638 (720)
Q Consensus 562 DLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~ 638 (720)
||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999998654322 22234568899999999999999999999999999999998 999999
Q ss_pred CCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcC
Q 004986 639 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 699 (720)
Q Consensus 639 ~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~ 699 (720)
+.+..+....+.. ......+..++.++.+||.+||+.||.+||++.+++++|+++...+.
T Consensus 279 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 9888877766643 23445678899999999999999999999999999999999866543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=380.00 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=212.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH------------------------HHHHHHHHHHHH
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG------------------------AALLEFKREVKI 487 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~------------------------~~~~e~~~Ei~i 487 (720)
+..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457899999999999999999987 68899999987654321 123568899999
Q ss_pred HHHcCCCceeEEeeeeec--CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 488 MRRLRHPNVVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 488 L~~L~HpNIVkL~g~~~~--~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
|++++||||+++++++.+ ...+++||||+++++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp 165 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKP 165 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence 999999999999999987 5679999999999999887643 36999999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~---~s~ksDVWSLGilLyELltG~~PF~~~~~ 642 (720)
+|||++.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999987655433344568999999999998765 37889999999999999999999998887
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......+............+++++.+||.+||+.||.+||++.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 776666544333333445789999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=398.18 Aligned_cols=252 Identities=24% Similarity=0.416 Sum_probs=220.2
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
.+..++|++.+.||+|+||+||+|++ +++.||||++.+... .......+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999987 588999999976432 112245677899999887 99999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999999753 36899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..++.++++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKD 247 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHH
Confidence 433445667899999999999999999999999999999999999999999988888877753 345677889999999
Q ss_pred HHHHhhhcCCCCCCCHH-HHHH
Q 004986 669 IIWECWQTDPSLRPSFA-QLTV 689 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~-ELL~ 689 (720)
||.+||..||.+||++. ++++
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHhcCCHhHcCCChHHHHc
Confidence 99999999999999997 6654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=386.33 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=211.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
.+..++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 35568999999999999999999986 6789999999765432 2234567889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
.+.+|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999999754 36899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. ....++..++.+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYLTQE 247 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHH
Confidence 654433334557899999999999999999999999999999999999999999888777766643 345677889999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
+++||.+||..||.+|| ++.|+++|
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 99999999999999999 78888875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=387.77 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=220.8
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+..++|++.+.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 4458899999999999999999987 68999999987643211 22456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999999764 36899999999999999999999998 999999999999999999999999999865432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
..+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. ....+|..++.++++||
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLL 234 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Confidence 3457899999999999999999999999999999999999999999888877776643 34567788999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 004986 671 WECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
.+||..||.+|| +++++++|
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999 89999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=377.88 Aligned_cols=252 Identities=24% Similarity=0.304 Sum_probs=210.0
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 36899999999999999999988 58899999997654433334667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9975 999999876667999999999999999999999998 9999999999999999999999999998765443334
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------------
Q 004986 595 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 654 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------------- 654 (720)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 456799999999999764 589999999999999999999999998776655443321000
Q ss_pred --------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 --------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 --------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+...+++++.+||.+||+.||.+||++.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001224578999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.88 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=212.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 36899999999999999999988 6889999999877666666678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++ +|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 99976 565555544457999999999999999999999998 999999999999999999999999999877655444
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHhhhhccc------------------
Q 004986 594 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAVGFQN------------------ 653 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF-~~~~~~~i~~~i~~~~------------------ 653 (720)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..+....+....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 55668999999999998766 799999999999999999888775 4444444443331100
Q ss_pred ---------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 ---------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ---------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
........++.++++||.+||+.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0011224578999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=380.91 Aligned_cols=278 Identities=30% Similarity=0.501 Sum_probs=230.6
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE---------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 499 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~---------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL 499 (720)
..+++..++|++.+.||+|+||.||+|++ ++..||||++.... .......+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 44567779999999999999999999986 35679999987543 445567889999999999 99999999
Q ss_pred eeeeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCC
Q 004986 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 564 (720)
Q Consensus 500 ~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLK 564 (720)
++++.+.+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 999999999999999999999999997643 24889999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 004986 565 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 641 (720)
Q Consensus 565 PeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~ 641 (720)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999998654432 12233467889999999999889999999999999999999 999999988
Q ss_pred hHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCCCCCCCC
Q 004986 642 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALP 711 (720)
Q Consensus 642 ~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~~~~~~~ 711 (720)
..++...+.. ......+..++.++.+||.+||..||.+||++.|++++|+++.........-..+.+++
T Consensus 265 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~~~~~l~ 333 (334)
T 2pvf_A 265 VEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLE 333 (334)
T ss_dssp HHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------------
T ss_pred HHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcccCCCCccc
Confidence 8777665543 23455677899999999999999999999999999999999988777665555555544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=367.03 Aligned_cols=259 Identities=32% Similarity=0.537 Sum_probs=228.5
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+.+..++|++.+.||+|+||.||+|++ +++.||+|++....... ..+.+|+.++++++||||+++++++.+.+.++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 456678999999999999999999988 67789999998765443 56889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999876667899999999999999999999998 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 591 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 591 ~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. .......|+..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+... .....+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcCCCCccCcHHHHH
Confidence 1 22234567889999999999999999999999999999999 89999998887777666432 244556778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
||.+||+.||.+||++.+++++|+.+.+
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=390.00 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=220.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++|||||++++++.+.+.+|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999987 58899999998877776677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~IKL~DFGlAk~~~~~~ 591 (720)
|+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 99999999999764 46899999999999999999999998 9999999999999865 45999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC--CCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~--ip~~ls~~l~dL 669 (720)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+........ ....+++++++|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 223456899999999999999999999999999999999999999999888877776653332222 224679999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||..||.+||++.|++++
T Consensus 265 i~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999998875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=392.33 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=218.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+|++++||||++++++|.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 6799999999999999999988 58899999998754322 12467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 586 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~IKL~DFGlAk~ 586 (720)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++.
T Consensus 92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999999764 47999999999999999999999998 99999999999998877 799999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 664 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~ 664 (720)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... ..+..++.
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 6543 23345689999999999999999999999999999999999999999988888777765332211 22357889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++++||.+||..||.+||++.|+++|
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=399.39 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=216.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
.+..++|+++++||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|.++ +|||||+++++|.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999987 57889999998764432 2345678899999887 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999999764 36999999999999999999999998 9999999999999999999999999998644
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHhhhhccccccCCC
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------PMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~---------~~~i~~~i~~~~~~~~ip 659 (720)
.......+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ......+|
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIP 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCC
Confidence 44445567899999999999999999999999999999999999999996432 12233333 23456778
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSF------AQLTVA 690 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~------~ELL~~ 690 (720)
..++.++++||.+||++||.+||++ .|+++|
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 8999999999999999999999985 566654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=396.09 Aligned_cols=263 Identities=31% Similarity=0.544 Sum_probs=229.4
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
.+.+..++|++.+.||+|+||.||+|++ +++.||||++... ........+.+|+.+|++++|||||++++++.+.+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4567778999999999999999999998 5889999988654 344455678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999765556899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccC--CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 589 NTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~~--~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
...... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..++..
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 332211 11235678999999999899999999999999999998 999999988877766554 33355677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=402.07 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=222.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||+||+|.+ +++.||+|++............+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 6799999999999999999987 78999999998877666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++......
T Consensus 91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999999988764 36999999999999999999999998 99999999999998 46889999999998766554
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC--CCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~--ip~~ls~~l~dL 669 (720)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ....+++++++|
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 444567899999999999999999999999999999999999999999988888777754433322 234789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||+.||.+||++.|+++|
T Consensus 248 i~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999885
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=375.45 Aligned_cols=264 Identities=31% Similarity=0.533 Sum_probs=228.8
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeee
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~ 502 (720)
...++..++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 34567778999999999999999999976 24789999987543 45556788999999999999999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIV 559 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~-----------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~II 559 (720)
+.+.+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 999999999999999999999996532 23889999999999999999999998 99
Q ss_pred eeCCCCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 004986 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 636 (720)
Q Consensus 560 HrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~P 636 (720)
||||||+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654322 12234467889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 637 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 637 F~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
|.+....+....+.. ......+..+++++.+||.+||+.||.+||++.+++++|+++...
T Consensus 253 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 999888777666543 334566788999999999999999999999999999999988653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=372.76 Aligned_cols=262 Identities=30% Similarity=0.508 Sum_probs=216.1
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
++++..++|++.+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 35667789999999999999999999872 4569999876543 3455677899999999999999999999985
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
++..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence 56789999999999999999866667999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 004986 586 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 586 ~~~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls 663 (720)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+... ....++..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 243 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-CCCCCCCCCC
Confidence 7644321 2233457789999999999999999999999999999996 99999988877777666432 3455778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+.+.+||.+||+.||.+||++.+++++|+.+...
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=380.99 Aligned_cols=264 Identities=30% Similarity=0.420 Sum_probs=222.5
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~ 502 (720)
.+++..++|++.+.||+|+||.||+|++ .+..||||++.... .......+.+|+.+|+++ +||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4667789999999999999999999986 34579999987543 233456788999999999 99999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPHC----------------------QVDEKRRIKMALDVARGMNCLHTSTPTIVH 560 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~~----------------------~lse~~~~~Ia~qIa~AL~yLHs~g~~IIH 560 (720)
+.+.+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+|
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 9999999999999999999999976432 3789999999999999999999998 999
Q ss_pred eCCCCCcEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 004986 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 637 (720)
Q Consensus 561 rDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF 637 (720)
|||||+||||+.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986543321 1233457889999999999999999999999999999998 99999
Q ss_pred CCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 638 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 638 ~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.+.........+.........+..+++++.+||.+||..||.+||++.+++++|+.+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 887655444444334445566778999999999999999999999999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=370.47 Aligned_cols=256 Identities=32% Similarity=0.588 Sum_probs=218.6
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHH-----HHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAAL-----LEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~-----~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+..++|++.+.||+|+||+||+|++ +++.||||++.......... ..+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4568999999999999999999988 68899999987654332211 6788999999999999999999998765
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-----EEEEec
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDF 581 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-----IKL~DF 581 (720)
. ++||||+++++|.+++.+....+++..++.++.||+.||+|||+++.+|+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 799999999999999877777899999999999999999999998766999999999999988776 999999
Q ss_pred cccccccCCcccCCCCCCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HhhhhccccccC
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRLE 657 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~--g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i--~~~i~~~~~~~~ 657 (720)
|+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||........ ...+........
T Consensus 174 g~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 174 GLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred Ccccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999854432 33467999999999994 45578999999999999999999999987654433 334444445567
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
++..+++++.+||.+||+.||.+||++.|+++.|+++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 7889999999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=380.31 Aligned_cols=268 Identities=28% Similarity=0.486 Sum_probs=212.8
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEEC--C---cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 504 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~--g---~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~ 504 (720)
....+..++|++.+.||+|+||+||+|++. + ..||||++............+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 345567789999999999999999999863 2 27999998876655566788999999999999999999999998
Q ss_pred cCCce------EEEEeecCCCCHHHHHcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 004986 505 RPPNL------SIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573 (720)
Q Consensus 505 ~~~~l------~LVmEy~~ggsL~d~L~~~-----~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 573 (720)
..... ++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence 87665 9999999999999998531 225899999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhh
Q 004986 574 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 650 (720)
Q Consensus 574 g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~ 650 (720)
+.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999999998654322 12223457889999999999999999999999999999999 999999988877776664
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 651 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 651 ~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
. ......+..++.++.+||.+||+.||.+||++.++++.|+++....+-
T Consensus 254 ~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 254 G-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp T-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred c-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 3 334566778999999999999999999999999999999999665443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.82 Aligned_cols=250 Identities=18% Similarity=0.292 Sum_probs=218.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||+||+|.+ +++.||+|.+.... .....+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 37899999999999999999988 58899999986442 34566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEeccccccccCCc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~IKL~DFGlAk~~~~~~ 591 (720)
||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999876667999999999999999999999998 999999999999987 7899999999998764432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~dL 669 (720)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .....++.++++|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 2234579999999999999989999999999999999999999999988887777664332221 1224689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L 691 (720)
|.+||..||.+||++.|+++|-
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHcCCChhHCcCHHHHhcCh
Confidence 9999999999999999999853
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=372.68 Aligned_cols=264 Identities=29% Similarity=0.438 Sum_probs=226.1
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~ 502 (720)
.+++..++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.+++++ +||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 4567778999999999999999999985 45789999987553 334467789999999999 99999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPHC-----------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~~-----------------~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
+.+.+..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 173 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence 9999999999999999999999965432 4899999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999986654322 1233457889999999999999999999999999999998 9999988765
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
................+..++..+.+||.+||+.||.+||++.|++++|+++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 4444333333334455678899999999999999999999999999999988664
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=372.00 Aligned_cols=262 Identities=36% Similarity=0.640 Sum_probs=212.5
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
..++..++|++.+.||+|+||+||+|++.+ .||||++............+.+|+.+|++++||||+++++++ ....++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 356778999999999999999999998755 599999987776777778899999999999999999999965 556789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999999999876778999999999999999999999998 999999999999999999999999999754421
Q ss_pred --cccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-hhhhcccc---ccCCCCC
Q 004986 591 --FLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQNR---RLEIPKE 661 (720)
Q Consensus 591 --~~~~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~-~~i~~~~~---~~~ip~~ 661 (720)
........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+.. ..+..... .......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 12223457999999999997 667889999999999999999999999886554333 33322111 1234457
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+++.+.+||.+||+.||.+||++.++++.|+++.+
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 88999999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=384.49 Aligned_cols=263 Identities=30% Similarity=0.398 Sum_probs=215.4
Q ss_pred CccccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 428 ~~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
...++.+..++|++.+.||+|+||+||+|++.++.||||++.... .....+.+|+.+|++++|||||++++++.+..
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 344556777899999999999999999999999999999986542 33445667999999999999999999998754
Q ss_pred c----eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCEEeeCCCCCcEEEcCC
Q 004986 508 N----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS----------TPTIVHRDLKSPNLLVDKN 573 (720)
Q Consensus 508 ~----l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~----------g~~IIHrDLKPeNILLd~~ 573 (720)
. +++||||+++|+|.+++... .+++..++.++.||+.||.|||+. + |+||||||+||||+.+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN 167 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence 3 79999999999999999764 489999999999999999999998 7 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----
Q 004986 574 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMNP---- 642 (720)
Q Consensus 574 g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~-----~~s~ksDVWSLGilLyELltG~~PF~~~~~---- 642 (720)
+.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999999986544322 23346799999999999874 456688999999999999999999976432
Q ss_pred ------------HHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 643 ------------MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 643 ------------~~i~~~i~~~~~~~~ip~-----~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
......+......+.++. ..+.++.+||.+||+.||.+|||+.|+++.|+++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222222222222222 2345699999999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=373.16 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=221.1
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
..++|++.+.||+|+||.||+|++ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 347899999999999999999987 688999999866533 44556788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999764 36899999999999999999999998 9999999999999999999999999998664332
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---cCCCCCCcHHHH
Q 004986 592 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLVA 667 (720)
Q Consensus 592 -~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~---~~ip~~ls~~l~ 667 (720)
......+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.............. ...+..++..+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 2233457999999999999999999999999999999999999999988776554333222111 234567899999
Q ss_pred HHHHHhhhcCCCCCC-CHHHHHHHHHhhhHhcCCCC
Q 004986 668 RIIWECWQTDPSLRP-SFAQLTVALKPLQRLVIPSH 702 (720)
Q Consensus 668 dLI~~cL~~DP~kRP-S~~ELL~~L~~i~~~~~p~~ 702 (720)
++|.+||.+||.+|| +++++.+.|..+........
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 999999999999998 89999999988765544333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=392.74 Aligned_cols=262 Identities=29% Similarity=0.504 Sum_probs=216.9
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
++..++|++.+.||+|+||.||+|++ ++..||||++.... .......+.+|+.+|++++|||||++++++.+..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 45567899999999999999999976 36679999986543 4455678999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+++++|.+++.+....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999887667999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 004986 588 HNTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 588 ~~~~~~---~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls 663 (720)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+... .....+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-EECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccc
Confidence 543211 122345788999999999999999999999999999997 99999998887777666432 2445567889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
..+.+||.+||+.||.+||++.+|++.|+.+.+..
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999996653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=373.52 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=216.3
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~- 505 (720)
++..++|++.+.||+|+||+||+|++ +++.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 35568899999999999999999984 6789999998654 34456788999999999999999999999854
Q ss_pred -CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 506 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 506 -~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
...+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999999876667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----------------HH
Q 004986 585 RLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------QV 645 (720)
Q Consensus 585 k~~~~~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----------------~i 645 (720)
+...... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 8754332 1222345778899999999999999999999999999999999998653221 11
Q ss_pred HhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 646 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 646 ~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
...+ ........+..+++++.+||.+||+.||.+||++.|+++.|+.+.+..
T Consensus 242 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111 223345567889999999999999999999999999999999987643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=395.36 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=211.2
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHH-HHHcCCCceeEEeeeeecCCc
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~i-L~~L~HpNIVkL~g~~~~~~~ 508 (720)
.+..++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|..+ ++.++|||||+++++|.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 34558899999999999999999988 5788999999876543 2334556677776 466899999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999999764 36899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....++..++..+++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ 268 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARH 268 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHH
Confidence 444455667999999999999999999999999999999999999999999988888877743 355677889999999
Q ss_pred HHHHhhhcCCCCCCCHH
Q 004986 669 IIWECWQTDPSLRPSFA 685 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ 685 (720)
||.+||++||.+||++.
T Consensus 269 li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHTCSSGGGSTTTT
T ss_pred HHHHHcccCHHhCCCCC
Confidence 99999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.19 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=221.5
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
...++|++++.||+|+||.||+|++ +++.||||++.+.... ......+.+|+.+|+.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 4558999999999999999999987 6889999998764321 123456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999999764 36899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++...+... ...+|..++.++++||
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 34568999999999999999999999999999999999999999999888887777533 4567788999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 004986 671 WECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
.+||+.||.+||+ +++|++|
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhhcCHHhccCCccCCHHHHHhC
Confidence 9999999999998 8888775
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=389.74 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=225.4
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
++..++|++++.||+|+||+||+|++ +++.||||++... ........+.+|+.++++++|||||++++++.+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 45668999999999999999999984 4568999998643 344556678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NV 576 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~I 576 (720)
....++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999996422 35899999999999999999999998 99999999999999555 59
Q ss_pred EEEeccccccccCC--cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc
Q 004986 577 KVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 577 KL~DFGlAk~~~~~--~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~ 653 (720)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+.. .
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~-~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-G 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-T
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Confidence 99999999854322 122334568999999999999999999999999999999998 9999999888887776653 3
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 654 ~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.....+..++..+.+||.+||+.||.+||++.+|+++|+.+...
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 34556778999999999999999999999999999999988654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=402.83 Aligned_cols=258 Identities=20% Similarity=0.332 Sum_probs=222.1
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
...+..++|+++++||+|+||+||+|++ +++.||||++.+..... .....+.+|+.++..++|||||+++++|.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3456778999999999999999999988 57889999987532111 11234788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+||||||+++|+|.+++.+....+++..++.++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 999999999999999999876667999999999999999999999998 999999999999999999999999999765
Q ss_pred cCCc-ccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCC-
Q 004986 588 HNTF-LSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK- 660 (720)
Q Consensus 588 ~~~~-~~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~- 660 (720)
.... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+..+....+........+|.
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc
Confidence 4332 2234568999999999997 55689999999999999999999999999998888877754333344443
Q ss_pred --CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 004986 661 --ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 690 (720)
Q Consensus 661 --~ls~~l~dLI~~cL~~DP~k--RPS~~ELL~~ 690 (720)
.+++++++||.+||..+|.+ |++++|+++|
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 58999999999999988888 9999999886
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.68 Aligned_cols=264 Identities=17% Similarity=0.240 Sum_probs=222.3
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~ 510 (720)
+..++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.+ +|+||+++++++.+....+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 3447899999999999999999986 7899999998755432 3567899999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-----EEEEeccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSR 585 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-----IKL~DFGlAk 585 (720)
+||||+ +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+++
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999999 99999999876667999999999999999999999998 999999999999987776 9999999998
Q ss_pred cccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHhhhhccc--
Q 004986 586 LKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQN-- 653 (720)
Q Consensus 586 ~~~~~~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~---~~~i~~~i~~~~-- 653 (720)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654321 2345679999999999999999999999999999999999999998743 333333322111
Q ss_pred -cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCC
Q 004986 654 -RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 704 (720)
Q Consensus 654 -~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~ 704 (720)
....+...+++++.+||.+||..||.+||++.+|++.|+.+.+.......+
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~ 291 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 291 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCS
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCC
Confidence 111234578999999999999999999999999999999998776554443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=401.76 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=213.0
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 4457899999999999999999987 688999999976432 2233456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|||||+++++|.+++.+. ..+++..+..++.||+.||+|||+ ++ ||||||||+||||+.++.+||+|||+++....
T Consensus 225 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999654 368999999999999999999998 88 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ....+|..+++++.+|
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 379 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 379 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHH
Confidence 44445567899999999999999999999999999999999999999999988888777643 3455778899999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHHH
Q 004986 670 IWECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
|.+||+.||.+|| +++|+++|
T Consensus 380 i~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 380 LSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999999999999 99999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.60 Aligned_cols=264 Identities=31% Similarity=0.545 Sum_probs=225.9
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
++++..++|++.+.||+|+||.||+|++. +..||||++...... ...+.+|+.++++++||||+++++++.+ +..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 35677789999999999999999999884 568999998765443 4578899999999999999999999864 568
Q ss_pred EEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999997532 25899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 589 NTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.. ......+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPEEL 239 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-ccCCCCcccccHHH
Confidence 4322 2233467889999999998889999999999999999999 9999999888777666543 23445667889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCC
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~ 701 (720)
.+||.+||..||.+||++.++++.|+.+......+
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 99999999999999999999999999987665443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=378.93 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=217.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999988 58899999997654321 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 586 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~IKL~DFGlAk~ 586 (720)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999999764 46999999999999999999999998 99999999999999887 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 664 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~ 664 (720)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..++.
T Consensus 168 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 64332 2345679999999999999999999999999999999999999999888777766554222111 12256789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+++||.+||..||.+||++.|+++|
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.20 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=221.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 37899999999999999999987 5889999999887777777788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---IKL~DFGlAk~~~~~ 590 (720)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999888654 36899999999999999999999998 999999999999986655 999999999866543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 668 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~d 668 (720)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....... .....+++++.+
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred -ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 22345679999999999999999999999999999999999999999988877776665333222 223578999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||.+||+.||.+||++.|++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHcccChhhCCCHHHHhcC
Confidence 9999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=395.84 Aligned_cols=257 Identities=32% Similarity=0.570 Sum_probs=225.1
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-ce
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-NL 509 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~-~l 509 (720)
.+++..++|++.+.||+|+||.||+|+++++.||||++.... ....+.+|+.+|++++|||||++++++.+.. .+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 456788999999999999999999999999999999987654 2457889999999999999999999987665 79
Q ss_pred EEEEeecCCCCHHHHHcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~-~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++|+|.+++.+... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999999976433 4799999999999999999999998 9999999999999999999999999998543
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.. ..+...|..+++.+.
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-TCCCCCCTTCCHHHH
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHH
Confidence 32 223467899999999999999999999999999999998 9999998887777766643 335667888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+||.+||+.||.+||++.++++.|+.+...
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999988654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=364.50 Aligned_cols=265 Identities=31% Similarity=0.546 Sum_probs=225.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce-EE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL-SI 511 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g---~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l-~L 511 (720)
.|.+.+.||+|+||+||+|++ ++ ..||+|++.... .......+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 467789999999999999986 22 369999886533 344567889999999999999999999999877665 99
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+.+++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999886678999999999999999999999998 9999999999999999999999999998654321
Q ss_pred ----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 592 ----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 592 ----~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG-~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+. .......+..++..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 223345688999999999999999999999999999999995 55566666666555554 333455677899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCCC
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 706 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~~ 706 (720)
.+||.+||+.||.+||++.++++.|+++.......+..+.
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~~l 297 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBCCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchhhC
Confidence 9999999999999999999999999999988877765544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.61 Aligned_cols=262 Identities=25% Similarity=0.443 Sum_probs=227.0
Q ss_pred cCCCCCCeeEeE-EeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 432 CEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 432 ~~i~~~~y~i~k-~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+.+..++|.+.+ .||+|+||.||+|.+ ++..||||++.... .......+.+|+.++++++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 445667888887 999999999999975 57789999987653 445577889999999999999999999999 45
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceee
Confidence 6799999999999999999776667999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 587 KHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 587 ~~~~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
..... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.. .....++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-CCcCCCCCCc
Confidence 64322 11233457899999999998889999999999999999998 9999999887777666643 3345677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
++++.+||.+||..||.+||++.+++++|+.+....
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999985544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=387.03 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=216.0
Q ss_pred CCCCCeeEeEEeeec--CcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 434 IPWEDLVLGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 434 i~~~~y~i~k~LGkG--~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
...++|++++.||+| +||+||+|++ +++.||||++............+.+|+.+++.++|||||+++++|.+.+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345789999999999 9999999998 589999999988777777778889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999998653 346999999999999999999999998 9999999999999999999999999986532
Q ss_pred CCc-------ccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-----
Q 004986 589 NTF-------LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----- 654 (720)
Q Consensus 589 ~~~-------~~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~----- 654 (720)
... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 11233479999999999988 6789999999999999999999999987665444322211000
Q ss_pred ---------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHh
Q 004986 655 ---------------------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKP 693 (720)
Q Consensus 655 ---------------------------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~ 693 (720)
....+..+++.+++||.+||+.||.+||++.|+++| ++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 012345678899999999999999999999999976 554
Q ss_pred hh
Q 004986 694 LQ 695 (720)
Q Consensus 694 i~ 695 (720)
+.
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=401.00 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=221.1
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
...+..++|+++++||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+++.++|||||+++++|.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3456778999999999999999999988 5789999998653211 111234778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+||||||++||+|.+++.+. .+++..+..++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 999999999999999999753 5899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--C
Q 004986 588 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 660 (720)
Q Consensus 588 ~~~~-~~~~s~~GT~~Y~APEvi~g~~----~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~ 660 (720)
.... ....+.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+........+| .
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 4432 2344678999999999998766 7889999999999999999999999999888887775433333344 4
Q ss_pred CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 004986 661 ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 690 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~k--RPS~~ELL~~ 690 (720)
.++.++++||.+||..+|.+ ||+++||++|
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 78999999999999999988 9999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=397.36 Aligned_cols=268 Identities=30% Similarity=0.528 Sum_probs=230.9
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+++..++|++.+.||+|+||+||+|++ .+..||||++...... ...+.+|+.+|++++|||||++++++. ...
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34577889999999999999999999998 4778999999765433 567889999999999999999999986 567
Q ss_pred eEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999999997532 35888999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 588 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 588 ~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.. ..+...+..++++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHH
Confidence 43321 2233457889999999999999999999999999999999 9999999888887766653 3345567889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCC
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 704 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~ 704 (720)
+.+||.+||+.||.+||++.+|++.|+.+.....++-.+
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~~~ 452 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEE 452 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSSBC
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccccc
Confidence 999999999999999999999999999886655544333
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=384.31 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=211.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~---~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++|++.+.||+|+||+||+|.+ +++.||||++..... .......+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999987 689999999864321 11124678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEeccccc
Q 004986 512 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSR 585 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---IKL~DFGlAk 585 (720)
||||+++++|.+++.+ ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999887753 2335899999999999999999999998 999999999999986655 9999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCc
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 663 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls 663 (720)
............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+....+....... .....++
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence 77654444455689999999999999999999999999999999999999998754 34444443221111 1124688
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.++++||.+||..||.+||++.|+++|
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=400.16 Aligned_cols=257 Identities=19% Similarity=0.308 Sum_probs=219.5
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+..+..++|++.+.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.++..++|||||+++++|.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3456778999999999999999999987 6899999998754321 112335788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+||||||+++|+|.+++.+.+..+++..++.++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheec
Confidence 999999999999999999765557999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC-
Q 004986 588 HNTFL-SSKSTAGTPEWMAPEVLR-------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI- 658 (720)
Q Consensus 588 ~~~~~-~~~s~~GT~~Y~APEvi~-------g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~i- 658 (720)
..... .....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+....+........+
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 44322 234568999999999997 356899999999999999999999999999888877776533222333
Q ss_pred --CCCCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 004986 659 --PKELDPLVARIIWECWQTDPSLR---PSFAQLTVA 690 (720)
Q Consensus 659 --p~~ls~~l~dLI~~cL~~DP~kR---PS~~ELL~~ 690 (720)
+..+++++++||.+||. +|.+| |+++|+++|
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 35799999999999998 99998 589999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=372.62 Aligned_cols=267 Identities=30% Similarity=0.490 Sum_probs=225.1
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEee
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 501 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g 501 (720)
..+++..++|++.+.||+|+||+||+|++ +++.||||++.... .......+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34567778999999999999999999974 45789999987553 344566789999999999 7999999999
Q ss_pred eeecCC-ceEEEEeecCCCCHHHHHcCCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 502 AVTRPP-NLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 502 ~~~~~~-~l~LVmEy~~ggsL~d~L~~~~~---------------~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
++...+ .+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 987755 49999999999999999976442 2789999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999999999998654322 12233467889999999999999999999999999999998 9999988664
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcC
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 699 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~ 699 (720)
................+..+++.+.+||.+||+.||.+||++.|++++|+.+.....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 443333322334456677899999999999999999999999999999999876544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=373.75 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=216.9
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
.|...+.||+|+||.||+|++ +++.||||++...... ....+.+|+.++++++||||+++++++...+.+++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 478888999999999999987 6899999998765433 245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+++++|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 9999999999753 5899999999999999999999998 99999999999999999999999999987655444445
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHHHHHhh
Q 004986 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~dLI~~cL 674 (720)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..... ....+..+++.+++||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 67899999999999999999999999999999999999999998887776665542221 12233468899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVA 690 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~ 690 (720)
+.||.+||++.|++++
T Consensus 280 ~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 280 VRDPQERATAQELLDH 295 (321)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999886
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.25 Aligned_cols=268 Identities=28% Similarity=0.477 Sum_probs=219.8
Q ss_pred CccccCCCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeee
Q 004986 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502 (720)
Q Consensus 428 ~~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~ 502 (720)
......+..++|.+.+.||+|+||.||+|++ ++..||||++............+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 3445567778999999999999999999976 23479999998776666677889999999999999999999999
Q ss_pred eecCCc-----eEEEEeecCCCCHHHHHc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC
Q 004986 503 VTRPPN-----LSIITEFLPRGSLFRILH-----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 572 (720)
Q Consensus 503 ~~~~~~-----l~LVmEy~~ggsL~d~L~-----~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~ 572 (720)
+.+... .++||||+++++|.+++. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~ 182 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRD 182 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECT
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcC
Confidence 987653 599999999999999983 23356999999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhh
Q 004986 573 NWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 649 (720)
Q Consensus 573 ~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i 649 (720)
++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999999999998654322 12233467889999999999999999999999999999999 89999988877776665
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 650 ~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
.. ......+..++..+.+||.+||..||.+||++.+++++|+.+....
T Consensus 263 ~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred Hc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 43 3345567789999999999999999999999999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.95 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=208.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 37899999999999999999988 5889999999877666666777889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999988754 36899999999999999999999998 999999999999999999999999999876544444
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------------c
Q 004986 594 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------N 653 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-------------------~ 653 (720)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 445689999999999986 56899999999999999999999999987766554332210 0
Q ss_pred cccCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 RRLEI----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ~~~~i----------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..... ...++..+.+||.+||+.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 13578889999999999999999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=378.07 Aligned_cols=258 Identities=25% Similarity=0.451 Sum_probs=217.6
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcE----EEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~----VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+..++|++.+.||+|+||+||+|++ +++. ||+|.+..... ......+.+|+.++++++||||+++++++. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 4558899999999999999999987 3444 77777654321 122345678999999999999999999886 46
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..++||||+.+++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 789999999999999999876567999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 588 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 588 ~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
..... ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. ......+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-GERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-TCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCCCcCcH
Confidence 43322 2234568889999999999999999999999999999999 9999998877776666543 335566778899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
++.+||.+||..||.+||++.+++++|+.+.+
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=377.70 Aligned_cols=258 Identities=28% Similarity=0.498 Sum_probs=215.3
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcE----EEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~----VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+..++|++.+.||+|+||+||+|++ +++. ||+|.+.... ......++.+|+.++++++|||||++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 3447899999999999999999987 3443 5777765432 223356788999999999999999999999875
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..++|+||+.+|+|.+++.+....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 478999999999999999876668999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 588 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 588 ~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+.. ......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-CCCCCCCccCCH
Confidence 43322 2233457889999999999999999999999999999999 9999998887776655543 334556778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
.+.+|+.+||+.||.+||++.|++++|+.+.+
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=390.88 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=216.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++|||||+++++|.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 356778999999999999999999987 578899999875432 11234678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999999999764 46999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHhhhhccccccCCCCCC
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g---~~~s~ksDVWSLGilLyELltG~~PF~~~~~---~~i~~~i~~~~~~~~ip~~l 662 (720)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||..... .+....+ ......+|..+
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~ 243 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAW 243 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTS
T ss_pred CC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcC
Confidence 43 33456789999999999974 4589999999999999999999999975433 3333333 23355677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 004986 663 DPLVARIIWECWQTDPSLRPS-FAQLTV 689 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS-~~ELL~ 689 (720)
+.++.+||.+||+.||.+||+ +.+++.
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999999998 777765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=368.78 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=194.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999987 78899999986543211 1245688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999999876667999999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. ......+..++.++.+||.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999998876555544442 22345677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.||.+||++.+++++
T Consensus 246 ~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HSCSSGGGSCCHHHHTTS
T ss_pred HcccCHhhCCCHHHHhcC
Confidence 999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=364.43 Aligned_cols=262 Identities=26% Similarity=0.375 Sum_probs=227.0
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
..++|++.+.||+|+||.||+|++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 347899999999999999999988 578899999876543 34456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999998653 36899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....++..++..+.+||.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHH
Confidence 44455679999999999999999999999999999999999999999888776665553 2345567889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhhhHhcCCCC
Q 004986 672 ECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~ 702 (720)
+||+.||.+||++.|++++-- +.....|..
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~-~~~~~~~~~ 277 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEF-FTSGYIPAR 277 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHH-HHTSCCCSC
T ss_pred HHcccChhhCcCHHHHhhChh-eecCCcCCC
Confidence 999999999999999998632 344444443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=367.12 Aligned_cols=261 Identities=35% Similarity=0.597 Sum_probs=227.9
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
.+++..++|++.+.||+|+||+||+|.+ ++..||||++.... .....+.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567778999999999999999999988 48899999987543 235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+++||||+++++|.+++.+ ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999965 3346899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 588 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 588 ~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.. ......+..+++.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPEGCPEK 240 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCCTTCCHH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-cCCCCCCCCCCHH
Confidence 53321 2233457889999999999999999999999999999999 9999998887777665542 3345667889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+.+||.+||..||.+||++.++++.|+.+...
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=374.04 Aligned_cols=254 Identities=18% Similarity=0.249 Sum_probs=214.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|++.+.||+|+||+||+|++ +++.||||++...... ..+.+|+.+++++ +||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 37899999999999999999986 7899999998765432 3577899999999 999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc-----EEEEeccccccc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRLK 587 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-----IKL~DFGlAk~~ 587 (720)
|||+ +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 99999999865567999999999999999999999998 999999999999998887 999999999875
Q ss_pred cCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhcccccc-
Q 004986 588 HNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRL- 656 (720)
Q Consensus 588 ~~~~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---~i~~~i~~~~~~~- 656 (720)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. +.+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43321 124568999999999999999999999999999999999999999885433 3333332111111
Q ss_pred --CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 657 --EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 657 --~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.....++ ++.+||.+||..||.+||++.+|++.|+.+.+.
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 1123355 999999999999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=377.48 Aligned_cols=257 Identities=27% Similarity=0.501 Sum_probs=214.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcE----EEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~----VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
+..++|++.+.||+|+||+||+|.+ +++. ||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4558899999999999999999987 4544 4667665432 2233567889999999999999999999998754
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.++|+||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999876667999999999999999999999998 999999999999999999999999999875
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 588 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 588 ~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 43221 2233457889999999999999999999999999999999 999999988777766554 3334556778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
++.+||.+||..||.+||++.|+++.|+.+.
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.77 Aligned_cols=251 Identities=33% Similarity=0.591 Sum_probs=204.6
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeec----CCc
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTR----PPN 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~--L~HpNIVkL~g~~~~----~~~ 508 (720)
..++|++.+.||+|+||+||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++.+ ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 34789999999999999999999999999999986532 3445567777776 799999999998654 345
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSD 580 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLH--------s~g~~IIHrDLKPeNILLd~~g~IKL~D 580 (720)
+++||||+++|+|.+++... .+++..++.++.||+.||+||| +++ |+||||||+||||+.++.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEee
Confidence 89999999999999999653 6899999999999999999999 777 99999999999999999999999
Q ss_pred ccccccccCCcc----cCCCCCCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 004986 581 FGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATL----------KLPWIGM 640 (720)
Q Consensus 581 FGlAk~~~~~~~----~~~s~~GT~~Y~APEvi~g~------~~s~ksDVWSLGilLyELltG----------~~PF~~~ 640 (720)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999976543322 12345899999999999887 445799999999999999999 8888653
Q ss_pred Ch-----HHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 641 NP-----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 641 ~~-----~~i~~~i~~~~~~~~ip~-----~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.. ......+........++. .++..+.+||.+||+.||.+||++.|+++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22 222222222222333332 3567899999999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=364.24 Aligned_cols=261 Identities=30% Similarity=0.481 Sum_probs=220.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee-ecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~-~~~~~l~ 510 (720)
.+|++.+.||+|+||+||+|++. ...+|+|.+.... .......+.+|+.++++++||||+++++++ ..++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 56999999999999999999862 2358888876533 445567889999999999999999999985 4566789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 999999999999999876677899999999999999999999998 999999999999999999999999999865432
Q ss_pred c----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 591 F----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 591 ~----~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
. .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+. .......+..++..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCHH
Confidence 2 12234467889999999999999999999999999999999 667777766666555543 23344556788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCC
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~ 701 (720)
+.+||.+||+.||.+||++.|+++.|+.+...+...
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 999999999999999999999999999998876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=366.28 Aligned_cols=252 Identities=25% Similarity=0.462 Sum_probs=217.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
++..++|++.+.||+|+||+||+|.+ +++.||||++....... .....+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678999999999999999999987 56789999986543221 1245688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999998654 36899999999999999999999998 99999999999999999999999999865433
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .....++..++..+.+|
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHH
Confidence 2 2234679999999999999999999999999999999999999999988877766663 23455678899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L 691 (720)
|.+||+.||.+||++.|+++|-
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHhccChhhCCCHHHHhhCc
Confidence 9999999999999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=373.39 Aligned_cols=262 Identities=29% Similarity=0.490 Sum_probs=221.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
++..++|++.+.||+|+||+||+|.+. +..||||++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 566789999999999999999999763 2359999987543 445566789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999999776667999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 587 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 587 ~~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......++...+... .....+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 275 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDC 275 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCcccC
Confidence 543321 1222356789999999999999999999999999999998 99999998887777666432 344566789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
+..+.+||.+||+.||.+||++.+++++|+++.+..
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999886543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.55 Aligned_cols=259 Identities=30% Similarity=0.478 Sum_probs=215.3
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP- 506 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~- 506 (720)
+...+|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 4456799999999999999999984 68899999987553 222356788999999999999999999999877
Q ss_pred -CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 507 -PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 507 -~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
..+++||||+++++|.+++.+....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence 6689999999999999999665567999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHhh
Q 004986 586 LKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------------PMQVVGA 648 (720)
Q Consensus 586 ~~~~~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~--------------~~~i~~~ 648 (720)
...... .......||..|+|||++.+..++.++||||||+++|+|++|..||.... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 765432 22334568889999999999999999999999999999999998864321 1111111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 649 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 649 i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
..........+..+++.+.+||.+||+.||.+||++.++++.|+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11233355677889999999999999999999999999999998874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.07 Aligned_cols=261 Identities=30% Similarity=0.499 Sum_probs=221.2
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
..+..++|++.+.||+|+||+||+|++. +..||||.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 3556689999999999999999999862 2359999887653 34456788999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+..++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4578999999999999999776567999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 587 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 587 ~~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.. ......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-GDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-TCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-CCCCCCCCCCCH
Confidence 543321 2233467889999999999999999999999999999998 9999988777666655542 234456778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.+.+||.+||..||.+||++.|++++|+.+...
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=366.11 Aligned_cols=264 Identities=24% Similarity=0.445 Sum_probs=211.1
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
..++|++.+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.++++++||||+++++++.+.+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 447899999999999999999987 68999999997643 344556778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 512 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999853 3456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHhhhhccccccCCCCCCcHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~--~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
..........|++.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+.........+..++.++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333445679999999999999999999999999999999999999997643 3334444432222223336789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
.+||.+||..||.+||++.++++.|+++....-+
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999776544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=369.82 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=214.1
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC--C-------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN--G-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 503 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~--g-------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~ 503 (720)
++..++|++.+.||+|+||+||+|++. + ..||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 355689999999999999999999763 3 569999986543 23356788999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--------
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------- 575 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-------- 575 (720)
.+.+..++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999876656999999999999999999999998 999999999999998887
Q ss_pred EEEEeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccc
Q 004986 576 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 576 IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG-~~PF~~~~~~~i~~~i~~~~ 653 (720)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++| .+||...+........ .
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 999999999755332 22457889999999987 6789999999999999999995 5555555554443332 2
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 654 ~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
....++...+.++.+||.+||+.||.+||++.+++++|+.+..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2445666778899999999999999999999999999987643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=371.74 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=224.6
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC--C-----cEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN--G-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~--g-----~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~ 502 (720)
.+++..++|++.+.||+|+||.||+|.+. + ..||+|.+.... .......+.+|+.+++++ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45677899999999999999999999873 2 479999986553 344567789999999999 89999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEE
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRP-------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 569 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~-------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNIL 569 (720)
+.+.+.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999998642 235799999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 004986 570 VDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 646 (720)
Q Consensus 570 Ld~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~ 646 (720)
|+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986543221 1233457889999999999999999999999999999998 99999887655444
Q ss_pred hhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 647 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 647 ~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
..+.........+..++..+.+||.+||+.||.+||++.|++++|+.+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 444333344556777899999999999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=365.64 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=221.2
Q ss_pred cCCCCCCeeEeE-EeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 432 CEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 432 ~~i~~~~y~i~k-~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
..+..++|++.+ .||+|+||+||+|.+ .++.||||++...........++.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 445667899998 999999999999964 367899999977655555577899999999999999999999999 56
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 7789999999999999999764 36899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 587 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 587 ~~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
...... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.. ......+..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 245 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGC 245 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCC
Confidence 543321 1223356789999999999889999999999999999999 9999999888777766643 3345677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=377.63 Aligned_cols=251 Identities=27% Similarity=0.343 Sum_probs=209.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||+||+|.+ +++.||||++...... .....+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 6889999998755432 22456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-- 591 (720)
||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999999764 36899999999999999999999998 9999999999999999999999999998654221
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .................++..+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22345689999999999988775 778999999999999999999998755432 2222211222222335689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||..||.+||++.|++++
T Consensus 242 i~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHccCChhhCcCHHHHhhC
Confidence 999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=376.91 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=197.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++++.||+|+||+||+|.+ +++.||||++..... ......+.+|+.++++++|||||++++++.+++.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 36899999999999999999987 588999999876542 222356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 514 EFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~-----~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
||++ ++|.+++... ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9998 5999988532 235899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 654 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~------------- 654 (720)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 44344455689999999999987 4689999999999999999999999998877665544321000
Q ss_pred -------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 -------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 -------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....+..++.++++||.+||+.||.+||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 001223578899999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.27 Aligned_cols=260 Identities=31% Similarity=0.527 Sum_probs=224.7
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 503 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~ 503 (720)
++++..++|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 45667789999999999999999999753 5789999987543 344556788999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 574 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~~~---------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 574 (720)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCC
Confidence 99999999999999999999986421 35789999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhc
Q 004986 575 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 651 (720)
Q Consensus 575 ~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~ 651 (720)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999998654322 12233467889999999999999999999999999999999 8999999888777766543
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 652 ~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
......+..++..+.+||.+||+.||.+||++.|++++|+.+
T Consensus 256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 233456778999999999999999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=365.08 Aligned_cols=257 Identities=33% Similarity=0.577 Sum_probs=217.0
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-CceE
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLS 510 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~-~~l~ 510 (720)
+.+..++|++.+.||+|+||+||+++++++.||||++.... ....+.+|+.++++++||||+++++++.+. +.++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 45677899999999999999999999999999999986543 345788999999999999999999987554 5799
Q ss_pred EEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999999996532 23789999999999999999999998 99999999999999999999999999976543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.. ......+..+++.+.+
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHH
T ss_pred c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCcccCCHHHHH
Confidence 2 223467899999999999999999999999999999998 9999998877776665542 2345667889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
||.+||+.||.+||++.|+++.|+.+....
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 999999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=367.12 Aligned_cols=254 Identities=31% Similarity=0.609 Sum_probs=211.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+..++|++.+.||+|+||+||++++.++.||||++... .....+.+|+.+|++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 45688999999999999999999999999999998543 235678899999999999999999999874 589999
Q ss_pred eecCCCCHHHHHcCCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCCEEeeCCCCCcEEEcCCCc-EEEEeccccccc
Q 004986 514 EFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHT---STPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLK 587 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~--~lse~~~~~Ia~qIa~AL~yLHs---~g~~IIHrDLKPeNILLd~~g~-IKL~DFGlAk~~ 587 (720)
||+++++|.+++..... .+++..++.++.||+.||.|||+ ++ |+||||||+||||+.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999976432 47889999999999999999999 66 999999999999998886 799999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHhhhhccccccCCCCCCcHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~--~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+ ........+..++..
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKP 232 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCHH
T ss_pred ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCHH
Confidence 432 22356999999999999999999999999999999999999999864332 222222 233345566788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcC
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 699 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~ 699 (720)
+.+||.+||+.||.+||++.+++++|+.+.+.+.
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999977654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=385.69 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=215.0
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|++.+.||+|+||+||+|.+ +++.||||++....... .....+.+|+.+++.++||||+++++++.+...+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999997 78899999987542211 1134678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+ +|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 9999 67898888653 36999999999999999999999998 9999999999999999999999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+ ......+|..+++++.+||.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHH
Confidence 3345689999999999998876 78999999999999999999999887665554444 23345577889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
+||..||.+|||+.|++++
T Consensus 241 ~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhC
Confidence 9999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=373.86 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=217.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--c
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--R 505 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~--~ 505 (720)
+..++|++.+.||+|+||.||+|++ +++.||||++.... ......+.+|+.++++++||||+++++++. +
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 4457899999999999999999984 57889999987543 444667899999999999999999999886 4
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 55689999999999999999765456999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------------HHHh
Q 004986 586 LKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---------------QVVG 647 (720)
Q Consensus 586 ~~~~~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---------------~i~~ 647 (720)
...... .......||..|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 654322 1233456888999999999999999999999999999999999998654332 1111
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcC
Q 004986 648 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 699 (720)
Q Consensus 648 ~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~ 699 (720)
.+ ........+..+++.+.+||.+||+.||.+||++.|++++|+.+.....
T Consensus 256 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 256 LL-EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred Hh-hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11 2333455678899999999999999999999999999999998855443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=372.33 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=222.0
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|++.+.||+|+||.||++++ +++.||+|++..... .......+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46899999999999999999988 578899999876543 344567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999999999998653 36899999999999999999999998 99999999999999999999999999987654434
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. ....++..++..+.+||.+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc--CCCCCCccCCHHHHHHHHH
Confidence 44556899999999999999999999999999999999999999998877766655532 3445678899999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.||.+||++.|++++
T Consensus 275 ~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 275 MLQTDPTARPTINELLND 292 (335)
T ss_dssp HTCSSGGGSCCGGGGGGS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.09 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=212.9
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H--pNIVkL~g~~~~~~~l 509 (720)
.+..++|++.+.||+|+||.||++.+ +++.||||++............+.+|+.+|++++| +||+++++++.+...+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45567899999999999999999987 67889999998877777777889999999999976 9999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++|||+ .+++|.+++.+. ..+++.+++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999994 588999999764 46899999999999999999999998 99999999999997 68899999999987643
Q ss_pred Ccc--cCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhccccc
Q 004986 590 TFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRR 655 (720)
Q Consensus 590 ~~~--~~~s~~GT~~Y~APEvi~g-----------~~~s~ksDVWSLGilLyELltG~~PF~~~~~-~~i~~~i~~~~~~ 655 (720)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 322 2335679999999999875 6789999999999999999999999987433 2333333333445
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 656 ~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
..++...+.++.+||.+||+.||.+||++.|+++|-
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 567778889999999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=364.47 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=219.1
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--cCCceEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSI 511 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~--~~~~l~L 511 (720)
.++|++.+.||+|+||.||+|++ +++.||+|++............+.+|+.++++++||||+++++++. ....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36899999999999999999988 6889999999887777777788999999999999999999999874 4567999
Q ss_pred EEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 512 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g---~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999864 2345899999999999999999999976 239999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..++...+... ....++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-ccccCCcccCHH
Confidence 6544322223357899999999999999999999999999999999999999998877776665432 234567789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
+.+||.+||+.||.+||++.||++++.
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 999999999999999999999998763
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.11 Aligned_cols=262 Identities=31% Similarity=0.581 Sum_probs=222.4
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEE--EEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCc
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEV--AVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~V--AVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~ 508 (720)
+.+++|++.+.||+|+||.||+|++ ++..+ |||.+.... .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 5668999999999999999999976 56644 899886532 233456788999999999 99999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC
Q 004986 509 LSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 573 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 573 (720)
+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999997643 46899999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhcc
Q 004986 574 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 652 (720)
Q Consensus 574 g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~ 652 (720)
+.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~- 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ- 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-
Confidence 99999999999754322 22233467889999999999989999999999999999998 9999999888877766643
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 653 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 653 ~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
......+..++..+.+||.+||..||.+||++.+++++|+.+......
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 234556778999999999999999999999999999999998776543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.40 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=213.0
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce---
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL--- 509 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l--- 509 (720)
.++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999986 688999999977543 344566788999999999999999999998776543
Q ss_pred -EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 -SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 -~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999999754 36899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCc
Q 004986 589 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 663 (720)
Q Consensus 589 ~~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls 663 (720)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....+............ .....++
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 322 22234579999999999999999999999999999999999999999888766654443221111 2235689
Q ss_pred HHHHHHHHHhhhcCCCCCCC-HHHHHHHHHhhhHhcCCCCC
Q 004986 664 PLVARIIWECWQTDPSLRPS-FAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS-~~ELL~~L~~i~~~~~p~~p 703 (720)
.++.+||.+||+.||.+||+ ++++...|.++.....|..|
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~ 288 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSC
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999996 55566667666555444443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=384.31 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=218.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||+||+|.+ +++.||+|++.... ......+.+|+.+|+.++|||||++++++.+...+++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 6799999999999999999987 68899999987653 2335578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEeccccccccCCcc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~IKL~DFGlAk~~~~~~~ 592 (720)
|+.+++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 99999999999876667999999999999999999999998 999999999999974 5789999999998764432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccCCCCCCcHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARII 670 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~--~~~ip~~ls~~l~dLI 670 (720)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... .......+++++++||
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 22345799999999999999999999999999999999999999999888777766643222 2233457899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||..||.+||++.|++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=374.99 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=217.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+...++|++.+.||+|+||+||+|++ +++.||||++...... ....+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ--GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS--HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34457899999999999999999987 5889999988665433 36678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 512 ITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~---~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999986533 35899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-------c--------
Q 004986 589 NTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------F-------- 651 (720)
Q Consensus 589 ~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~-------~-------- 651 (720)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+...... .
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 321 12234468999999999999999999999999999999999999997654432211110 0
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 652 ~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
......++..++..+.+|+.+||+.||.+||++.|++++|+.+.+.-
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 00011223345678999999999999999999999999999987653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.14 Aligned_cols=246 Identities=24% Similarity=0.262 Sum_probs=206.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.++||+|+||+||+|++ +++.||||++............+..|+..+.++ +|+|||+++++|.+...+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999988 589999999877655555556666777777666 9999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+ +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..... ..
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccC-CC
Confidence 999 67999988765667999999999999999999999998 999999999999999999999999999876443 22
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHh
Q 004986 594 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~c 673 (720)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||...... ..+........++..++.++.+||.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHHHHHHHHH
Confidence 344679999999999987 6899999999999999999997776553322 222222223344567899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|+.||.+||++.|++++
T Consensus 289 L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 289 LEPDPKLRATAEALLAL 305 (311)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred cCCChhhCcCHHHHHhC
Confidence 99999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=382.05 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=203.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCC--ceEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NLSI 511 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~--~l~L 511 (720)
++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|+.+. |||||++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 6899999999999999999987 6899999999776556666778889999999996 999999999997654 6899
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC-
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~- 590 (720)
||||++ ++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999997 589999875 36899999999999999999999998 999999999999999999999999999865321
Q ss_pred --------------------cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhh
Q 004986 591 --------------------FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 649 (720)
Q Consensus 591 --------------------~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i 649 (720)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112234589999999999987 67899999999999999999999999988776655444
Q ss_pred hcccccc---------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 004986 650 GFQNRRL---------------------------------------------EIPKELDPLVARIIWECWQTDPSLRPSF 684 (720)
Q Consensus 650 ~~~~~~~---------------------------------------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~ 684 (720)
......+ ..+..+++++.+||.+||..||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 2100000 0122678899999999999999999999
Q ss_pred HHHHHH--HHhh
Q 004986 685 AQLTVA--LKPL 694 (720)
Q Consensus 685 ~ELL~~--L~~i 694 (720)
.|+++| |..+
T Consensus 324 ~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 324 NDALKHPFVSIF 335 (388)
T ss_dssp HHHTTSTTTTTT
T ss_pred HHHhCCHHHHHh
Confidence 999987 5444
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=368.82 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=210.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC--ceEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSI 511 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~--~l~L 511 (720)
.++|++.+.||+|+||+||+|++ +++.||||++...... .....+.+|+.+|++++||||+++++++.... .+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 46899999999999999999988 4889999998754322 22456789999999999999999999988765 7899
Q ss_pred EEeecCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEeccccc
Q 004986 512 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR 585 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~IKL~DFGlAk 585 (720)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999997633 23899999999999999999999998 9999999999999 788899999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccc
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQN 653 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~--------g~~~s~ksDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~ 653 (720)
...... ......||+.|+|||++. +..++.++|||||||++|||++|..||..... .+....+....
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 765432 234567999999999986 57789999999999999999999999975432 22222221110
Q ss_pred c-----------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 654 R-----------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 654 ~-----------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
. ...++..++..+.+||.+||+.||.+||+++|++++....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0 0122334567899999999999999999999999999765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=396.45 Aligned_cols=260 Identities=35% Similarity=0.604 Sum_probs=228.1
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEEC--CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
..+++..++|++.+.||+|+||.||+|.+. +..||||++...... ..++.+|+.+|++++|||||++++++.+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 346677889999999999999999999884 789999998765433 567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 508 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
.++|||||+++|+|.+++.+ ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999999999999999975 3346899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 587 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 587 ~~~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...+...+..++.
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 64332 22233456789999999999999999999999999999998 999999988877766654 3335567788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=361.76 Aligned_cols=252 Identities=24% Similarity=0.435 Sum_probs=219.7
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 345668999999999999999999988 57889999986543211 123568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999998754 36899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....++..++..+++
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKD 241 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHH
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHH
Confidence 32 2345679999999999999999999999999999999999999999888777665553 2345677889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||.+||+.||.+||++.++++|
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHhhcCHhhCCCHHHHhhC
Confidence 9999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=414.52 Aligned_cols=254 Identities=20% Similarity=0.340 Sum_probs=222.4
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 507 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~ 507 (720)
..+..++|++++.||+|+||+||+|++ +++.||||++.+... .......+..|..+|..+ +||||++++++|.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 456678999999999999999999987 578899999875422 112245677899999887 7999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+||||||+++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999999764 36999999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 667 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~ 667 (720)
..........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..++...+.. ....+|..++++++
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAV 570 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHH
Confidence 4444455678999999999999999999999999999999999999999999999888888853 45677889999999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHHH
Q 004986 668 RIIWECWQTDPSLRPSF-----AQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~-----~ELL~~ 690 (720)
+||.+||++||.+||++ +||++|
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999999997 777764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.21 Aligned_cols=261 Identities=33% Similarity=0.541 Sum_probs=215.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE---CCc--EEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW---NGT--EVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~---~g~--~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
.+..++|++.+.||+|+||+||+|++ +++ .||||++..... .......+.+|+.++++++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 34557899999999999999999986 223 589998876543 234567889999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
. .++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 5 89999999999999999765556899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 587 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 587 ~~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
...... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.........+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 643321 1233467889999999999889999999999999999999 999999998888877776555556667789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
+.++.+||.+||..||.+||++.+++++|+++..
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 9999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.64 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=201.0
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
..++|++.+.||+|+||+||+|.+ +++.||||++............+.+|+.+|++++||||+++++++.+...+++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 347899999999999999999987 688999999977655555566778999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE-----cCCCcEEEEeccccccc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL-----d~~g~IKL~DFGlAk~~ 587 (720)
|||+++ +|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++..
T Consensus 112 ~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999975 9999987643 5899999999999999999999998 9999999999999 45566999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc----------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------- 656 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~---------- 656 (720)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+......+
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 5444444556789999999999875 48999999999999999999999999887766554432110000
Q ss_pred ------C------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 ------E------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ------~------------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ++..++.++++||.+||+.||.+||++.|+++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 111267899999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=377.63 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=210.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|.+ +++.||||++...... ..+|+.++.++ +|||||++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999988 5889999999765432 34688888888 7999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC----CcEEEEeccccccccC
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRLKHN 589 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~----g~IKL~DFGlAk~~~~ 589 (720)
||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||+..+ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999765 36999999999999999999999998 9999999999998533 3599999999987655
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CChHHHHhhhhcccccc--CCCCCCcH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRL--EIPKELDP 664 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~---~~~~~i~~~i~~~~~~~--~ip~~ls~ 664 (720)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.. ....++...+....... ..+..++.
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 44445567899999999999988899999999999999999999999986 34455555554322222 23467899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
++++||.+||..||.+||++.++++|-
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 999999999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=368.66 Aligned_cols=262 Identities=28% Similarity=0.433 Sum_probs=218.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC--Cc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~--~~ 508 (720)
..|++++.||+|+||+||++.+ +++.||||++.... .......+.+|+.+|++++||||+++++++.+. ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 4459999999999999999864 67889999987653 445567789999999999999999999999874 56
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||||+++++|.+++.+. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 89999999999999999764 4899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHhhhhc
Q 004986 589 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------VVGAVGF 651 (720)
Q Consensus 589 ~~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~--------------i~~~i~~ 651 (720)
... .......||..|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 12234568889999999999999999999999999999999999987532210 0111112
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 652 ~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
.......+..++.++.+||.+||+.||.+||++.|+++.|+.+...+.++.|
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 2334556788999999999999999999999999999999999888876655
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=377.89 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=201.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
...++|++.+.||+|+||+||++++ +++.||||++....... ..+.+|+.+++.++|||||++++++.+...+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3457899999999999999999988 68899999997654332 457799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--EEEEeccccccccC
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRLKHN 589 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--IKL~DFGlAk~~~~ 589 (720)
||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999998653 36999999999999999999999998 999999999999987765 99999999975432
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCCCCCCcH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEK-CDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~k-sDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
. ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+............+++
T Consensus 171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 2 22344679999999999998887665 8999999999999999999987544 2333333222222233346899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++++||.+||..||.+|||+.|+++|
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 99999999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=368.61 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=217.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5799999999999999999987 58899999997654322 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 586 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~IKL~DFGlAk~ 586 (720)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999764 46899999999999999999999998 99999999999999888 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 664 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--~~ip~~ls~ 664 (720)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+...... ..++..++.
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 65432 234467999999999999999999999999999999999999999998877776665432211 112356889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+.+||.+||..||.+||++.|+++|
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.20 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=198.1
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++..++|++.+.||+|+||+||+|++ +++.||||++............+.++...++.++||||+++++++.+.+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 56678999999999999999999988 7899999998766544444444555556677889999999999999999999
Q ss_pred EEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 511 IITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+||||+++ +|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+++.
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999975 88777643 345799999999999999999999998 8 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhhccccccCCCCC
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi----~g~~~s~ksDVWSLGilLyELltG~~PF~~~-~~~~i~~~i~~~~~~~~ip~~ 661 (720)
..... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||... ..................+..
T Consensus 160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 160 LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred ccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 65432 23345799999999996 5667899999999999999999999999863 333333333222223333457
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++.++.+||.+||+.||.+||++.|+++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 89999999999999999999999999884
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=360.13 Aligned_cols=252 Identities=31% Similarity=0.450 Sum_probs=215.6
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCc
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPN 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~----~~~ 508 (720)
....|++.+.||+|+||+||+|.+ ++..||+|++............+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345689999999999999999987 57889999998877777778889999999999999999999998865 355
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~ 587 (720)
+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+.+|+||||||+|||++ .++.+||+|||++...
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 89999999999999999753 368999999999999999999999866699999999999998 7899999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCCCCcHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+........++...++++
T Consensus 183 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 183 RAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred ccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 433 2234579999999998875 48999999999999999999999998744 3444444443333445566778999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||.+||+.||.+||++.|+++|
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=375.56 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=198.0
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
...++|++.+.||+|+||+||+|++ +++.||||++.... ....+.+|+.+|++++||||+++++++.+...+++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3447799999999999999999998 57889999987543 23467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecccccccc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKH 588 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlAk~~~ 588 (720)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+++...
T Consensus 126 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999999764 36899999999999999999999998 999999999999975 8999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccc--cCCCCCCcHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRR--LEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~~~~~~--~~ip~~ls~~ 665 (720)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||......+ ....+...... ......++.+
T Consensus 203 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 203 HQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred cc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 43 22345679999999999999999999999999999999999999998765544 44444322211 1233578999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+++||.+||..||.+||++.|++++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=389.23 Aligned_cols=263 Identities=33% Similarity=0.556 Sum_probs=222.5
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.+++..++|++.+.||+|+||.||+|++. +..||||++...... ..++.+|+.+|++++|||||++++++.+ +.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 45677889999999999999999999985 467999998765433 3578899999999999999999999876 778
Q ss_pred EEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999999642 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 589 NTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+.. ..+...+..++..+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l 410 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESL 410 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHH
Confidence 3321 2233457889999999999999999999999999999999 9999999888887776643 33456678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
.+||.+||+.||.+||++.+|++.|+.+.....|
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 9999999999999999999999999887654433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=370.73 Aligned_cols=269 Identities=28% Similarity=0.410 Sum_probs=204.7
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHH--HHHHHHHHcCCCceeEEeeeee-----
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFK--REVKIMRRLRHPNVVLFMGAVT----- 504 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~--~Ei~iL~~L~HpNIVkL~g~~~----- 504 (720)
..+..++|++.+.||+|+||.||+|+++++.||||++.... ...+. .|+..+..++|+||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 35677999999999999999999999999999999986543 22333 3444445589999999997542
Q ss_pred cCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCEEeeCCCCCcEEEcCCCc
Q 004986 505 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS---------TPTIVHRDLKSPNLLVDKNWN 575 (720)
Q Consensus 505 ~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~---------g~~IIHrDLKPeNILLd~~g~ 575 (720)
....+++||||+++|+|.+++... ..++..++.++.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 233578999999999999999764 358899999999999999999998 7 999999999999999999
Q ss_pred EEEEeccccccccCC--------cccCCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004986 576 VKVSDFGLSRLKHNT--------FLSSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATLKLPWIGM 640 (720)
Q Consensus 576 IKL~DFGlAk~~~~~--------~~~~~s~~GT~~Y~APEvi~g-------~~~s~ksDVWSLGilLyELltG~~PF~~~ 640 (720)
+||+|||+++..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999865432 112234579999999999987 34567899999999999999997776432
Q ss_pred ChH------------------HHHhhhhccccccCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 641 NPM------------------QVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 641 ~~~------------------~i~~~i~~~~~~~~ip~~------ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
... .....+.....+..++.. +++.+.+||.+||+.||.+|||+.|+++.|+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 210 111111112223333332 45689999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCC
Q 004986 697 LVIPSHPDQPSSA 709 (720)
Q Consensus 697 ~~~p~~p~~~~~~ 709 (720)
.|.-.....+.++
T Consensus 319 ~~~~~~~~~~~~~ 331 (336)
T 3g2f_A 319 IWERNKSVSPTAH 331 (336)
T ss_dssp CCCC---------
T ss_pred HHHhcccCCCccc
Confidence 8877766555443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=357.47 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=213.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|.+ ++..||+|++....... ...+.+|+.++++++||||+++++++.+....++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999988 56789999987654332 5678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 87 LCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999999988653 36899999999999999999999998 9999999999999 78899999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC----CCCcHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----KELDPLVA 667 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip----~~ls~~l~ 667 (720)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+... ....+ ..+++.+.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHH
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHH
Confidence 233456799999999998765 899999999999999999999999998887777666433 22223 26889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||+.||.+||++.+++++
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=395.11 Aligned_cols=252 Identities=26% Similarity=0.502 Sum_probs=221.9
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.+..++|.+++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 44568999999999999999999987 68999999987543211 2245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999999764 46999999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.. .....|..+++++++
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIFYTPQYLNPSVIS 245 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT--TCCCCCTTCCHHHHH
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCcCCCccCCHHHHH
Confidence 3 23345689999999999998876 6899999999999999999999999887777776643 344567789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||.+||+.||.+||++.|+++|
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHcCCCchhCcCHHHHHhC
Confidence 9999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=376.54 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=203.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|++++.||+|+||+||+|++ +++.||||++...... .....+.+|+.+|++++||||+++++++.+...+++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 36899999999999999999988 6889999998654321 11223457999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||++ ++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9997 5899988776667999999999999999999999998 999999999999999999999999999866544444
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc----------------
Q 004986 594 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------------- 656 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~---------------- 656 (720)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 445678999999999987 568999999999999999999999999988766554442110000
Q ss_pred ------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 ------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.....++.++.+||.+||+.||.+|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1123578899999999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=366.22 Aligned_cols=253 Identities=27% Similarity=0.357 Sum_probs=206.3
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHHc---CCCceeEEeeeeec
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRL---RHPNVVLFMGAVTR 505 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~---~~~~~e~~~Ei~iL~~L---~HpNIVkL~g~~~~ 505 (720)
+..++|++.+.||+|+||+||+|++ +++.||||++...... ......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457899999999999999999986 7889999998754321 11123455677777666 59999999999987
Q ss_pred CC-----ceEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEE
Q 004986 506 PP-----NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 579 (720)
Q Consensus 506 ~~-----~l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~ 579 (720)
.. .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 65 4899999997 59999987643 34899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc---
Q 004986 580 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 656 (720)
Q Consensus 580 DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--- 656 (720)
|||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999866433 23345689999999999999999999999999999999999999999988776655442110000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 ----------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ----------------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.....++..+.+||.+||+.||.+|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0123578899999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=375.20 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=215.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+.|++.+.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999986 6899999999765433 334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+. |+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 9997 5788887654557999999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 594 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
....+||+.|+|||++. +..++.++|||||||++|||++|..||...+.......+.....+...+..++..+++||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 23468999999999985 567899999999999999999999999988876666555444434444567899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L 691 (720)
.+||+.||.+||++.+++++.
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHcccChhhCcCHHHHhhCh
Confidence 999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=368.21 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=200.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC-------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 507 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------- 507 (720)
++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.+|++++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999988 68999999997654 2334677899999999999999999999986543
Q ss_pred --------------------------------------------------ceEEEEeecCCCCHHHHHcCCC--CCCCHH
Q 004986 508 --------------------------------------------------NLSIITEFLPRGSLFRILHRPH--CQVDEK 535 (720)
Q Consensus 508 --------------------------------------------------~l~LVmEy~~ggsL~d~L~~~~--~~lse~ 535 (720)
.+++||||+++++|.+++.+.. ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2899999999999999997643 235566
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc------------ccCCCCCCCCCc
Q 004986 536 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------LSSKSTAGTPEW 603 (720)
Q Consensus 536 ~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~------------~~~~s~~GT~~Y 603 (720)
.++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...... ......+||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78899999999999999998 9999999999999999999999999998765432 223445799999
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 004986 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 683 (720)
Q Consensus 604 ~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS 683 (720)
+|||++.+..++.++|||||||++|||++|..|+... ......+... .........++++.+||.+||+.||.+||+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhcc-CCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 9999999999999999999999999999987764221 1112222111 111122345678899999999999999999
Q ss_pred HHHHHHH
Q 004986 684 FAQLTVA 690 (720)
Q Consensus 684 ~~ELL~~ 690 (720)
+.|++++
T Consensus 320 ~~~~l~~ 326 (332)
T 3qd2_B 320 ATDIIEN 326 (332)
T ss_dssp HHHHHHS
T ss_pred HHHHhhc
Confidence 9999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.80 Aligned_cols=250 Identities=27% Similarity=0.470 Sum_probs=222.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5699999999999999999987 6889999998765433 235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 9999999999975 36899999999999999999999998 9999999999999999999999999998765544444
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 674 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL 674 (720)
....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. .....++..++..+.+||.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccCHHHHHHHHHHc
Confidence 566899999999999999999999999999999999999999998887766655542 3344567789999999999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 004986 675 QTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 675 ~~DP~kRPS~~ELL~~L~ 692 (720)
+.||.+||++.+++++.-
T Consensus 256 ~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CSSGGGSCCHHHHTTCHH
T ss_pred CCChhhCcCHHHHhhChh
Confidence 999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=371.34 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=209.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC---CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~---~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
++|++.+.||+|+||+||+|.+ +++.||||++.... ........+.+|+.++++++|||||++++++.+.+.+++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6799999999999999999987 67889999987542 233446788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 004986 512 ITEFLPRGSLFRILHRP---------------------------------------HCQVDEKRRIKMALDVARGMNCLH 552 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~---------------------------------------~~~lse~~~~~Ia~qIa~AL~yLH 552 (720)
||||+++++|.+++... ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998520 112357788889999999999999
Q ss_pred hCCCCEEeeCCCCCcEEEcCCC--cEEEEeccccccccCCc----ccCCCCCCCCCccCcccccC--CCCCchhhHHHHH
Q 004986 553 TSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTF----LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFG 624 (720)
Q Consensus 553 s~g~~IIHrDLKPeNILLd~~g--~IKL~DFGlAk~~~~~~----~~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLG 624 (720)
+++ |+||||||+||||+.++ .+||+|||+++...... .......||+.|+|||++.+ ..++.++||||||
T Consensus 186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 998 99999999999998776 89999999998653321 12345679999999999975 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 625 VILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 625 ilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
|++|||++|..||.+.+..+....+.........+ ..+++++.+||.+||+.||.+||++.|++++
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999988877766664333222222 3478999999999999999999999999885
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=377.83 Aligned_cols=267 Identities=18% Similarity=0.201 Sum_probs=211.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHH---------HHHHHHHHHHHHcCCCcee
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAAL---------LEFKREVKIMRRLRHPNVV 497 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~---------~e~~~Ei~iL~~L~HpNIV 497 (720)
+..++|++.+.||+|+||.||+|.+. ++.||||++.......... ..+..|+..+..++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45679999999999999999999873 4789999987653211100 1233456667778899999
Q ss_pred EEeeeeecC----CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--
Q 004986 498 LFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-- 571 (720)
Q Consensus 498 kL~g~~~~~----~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-- 571 (720)
++++++... ..++|||||+ +++|.+++......+++..++.|+.||+.||+|||+++ |+||||||+||||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence 999998765 4489999999 99999999876668999999999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-
Q 004986 572 KNWNVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM- 643 (720)
Q Consensus 572 ~~g~IKL~DFGlAk~~~~~~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~- 643 (720)
.++.+||+|||+++.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999986543211 123456999999999999999999999999999999999999999863222
Q ss_pred HHHhhhh--cccc------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 644 QVVGAVG--FQNR------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 644 ~i~~~i~--~~~~------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
....... .... .......++.++.+|+..||..||.+||++.+|++.|+.+.+..-....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 2111111 0000 0011256789999999999999999999999999999999776655443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=355.40 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=214.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee-ecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~-~~~~~l~LVm 513 (720)
++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+.++ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 6899999999999999999986 7899999998765433 2577899999999887766555544 6667789999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~IKL~DFGlAk~~~~~ 590 (720)
||+ +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999 89999999755567999999999999999999999998 9999999999999 48899999999999876543
Q ss_pred cc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhc---cccccC
Q 004986 591 FL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGF---QNRRLE 657 (720)
Q Consensus 591 ~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---~i~~~i~~---~~~~~~ 657 (720)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +....+.. ......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 22 124567999999999999999999999999999999999999999874322 22222211 111112
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCC
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p 703 (720)
++..+++++.+||.+||+.||.+||++.++++.|+.+.........
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 3367899999999999999999999999999999999777655443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=371.45 Aligned_cols=252 Identities=24% Similarity=0.253 Sum_probs=207.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH---HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~---~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
.++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++.+...++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 47899999999999999999987 58899999987543222 11246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99999976 899998876667999999999999999999999998 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-------------
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------------- 656 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~------------- 656 (720)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 4445567899999999999764 58999999999999999999999999887766554442110000
Q ss_pred -------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 -------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 -------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+...++.++++||.+||..||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0114567899999999999999999999999886
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=355.21 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=209.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|.+ +++.||||++...........++.+|+.++..+ +||||+++++++.+.+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 689999999987665556677888999999999 9999999999999999999999
Q ss_pred eecCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-----------------
Q 004986 514 EFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----------------- 573 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~---~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~----------------- 573 (720)
||+++++|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999652 246899999999999999999999998 9999999999999844
Q ss_pred --CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh
Q 004986 574 --WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 650 (720)
Q Consensus 574 --g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~ 650 (720)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++....... .+.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~ 241 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIR 241 (289)
T ss_dssp -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHH
T ss_pred CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHH
Confidence 47999999999866443 235699999999999876 56689999999999999999998775543322 221
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 651 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 651 ~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......++..++.++.+||.+||+.||.+||++.|++++
T Consensus 242 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 -QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 223446678899999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.94 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=212.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC--CCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~--HpNIVkL~g~~~~~~~l~ 510 (720)
+...+|++.+.||+|+||+||+|.+ .++.||||++............+.+|+.+|+++. |+|||++++++...+.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3446799999999999999999987 5888999999887767777788999999999996 599999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
|||| +.+++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 56889999997643 6899999999999999999999998 99999999999995 589999999999876433
Q ss_pred cc--cCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhcccccc
Q 004986 591 FL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRL 656 (720)
Q Consensus 591 ~~--~~~s~~GT~~Y~APEvi~g-----------~~~s~ksDVWSLGilLyELltG~~PF~~~~~-~~i~~~i~~~~~~~ 656 (720)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ...+..+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 21 2345689999999999975 3688999999999999999999999987533 33344443334455
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
.++...+.++.+||.+||+.||.+||++.|++++-
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 66777889999999999999999999999999763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=368.24 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=220.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 505 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~ 505 (720)
++..++|++.+.||+|+||.||+|++ +++.||||++.... ......++.+|+.++++++||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 35668999999999999999999973 46689999986443 44556678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcE
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNV 576 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~I 576 (720)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999997533 34889999999999999999999998 999999999999984 4469
Q ss_pred EEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccc
Q 004986 577 KVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 653 (720)
Q Consensus 577 KL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~ 653 (720)
||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. .
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-G 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-T
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc-C
Confidence 999999997543322 12233468899999999999999999999999999999998 9999998887777666543 2
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 654 ~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.....+..++..+.+||.+||+.||.+||++.+++++|..+...
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 34556778999999999999999999999999999999988553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=380.31 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=209.2
Q ss_pred eeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|...+.||+|+||.||+|++ +++.||||++..... .....+.+|+.+|++++|||||++++++.+.+.++|||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34467899999999999987 688999999876542 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE--cCCCcEEEEeccccccccCCcccC
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL--d~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 999999988765557999999999999999999999998 9999999999999 567899999999998765432 23
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHHHHH
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARIIWE 672 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~dLI~~ 672 (720)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+....... .....+++++++||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 44579999999999999999999999999999999999999999988877766664322221 2225689999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.||.+||++.|++++
T Consensus 326 ~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HcCCChhhCCCHHHHhcC
Confidence 999999999999999983
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=364.57 Aligned_cols=252 Identities=33% Similarity=0.582 Sum_probs=204.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeecC----CceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRP----PNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~--L~HpNIVkL~g~~~~~----~~l~ 510 (720)
++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++.+. ..++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 689999999999999999999999999999986442 2334445555554 4999999999999877 6799
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS--------TPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~--------g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
+||||+++++|.+++... .+++..++.++.|++.||.|||++ + |+||||||+||||+.++.+||+|||
T Consensus 112 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEEeCC
Confidence 999999999999999754 589999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCccc----CCCCCCCCCccCcccccCCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCCCh
Q 004986 583 LSRLKHNTFLS----SKSTAGTPEWMAPEVLRNEPSNEK------CDVYSFGVILWELATL----------KLPWIGMNP 642 (720)
Q Consensus 583 lAk~~~~~~~~----~~s~~GT~~Y~APEvi~g~~~s~k------sDVWSLGilLyELltG----------~~PF~~~~~ 642 (720)
+++........ ....+||+.|+|||++.+..+... +|||||||++|||++| ..||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 99765433221 234579999999999988776654 9999999999999999 777765322
Q ss_pred -----HHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 643 -----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 643 -----~~i~~~i~~~~~~~~ip~-----~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
......+........++. .++.++.+||.+||+.||.+||++.|++++|+.+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 222222222333333333 5667899999999999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=398.69 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=219.0
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.+..++|++.+.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|++++|||||+++++|.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35668999999999999999999987 68999999997643221 2245678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 510 SIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~---~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
|+||||++||+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|++||+|||+++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999998653 346999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhhccccccCCCCCC
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~----~~~i~~~i~~~~~~~~ip~~l 662 (720)
...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..++...+. .....+|..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCccc
Confidence 6554444455689999999999999999999999999999999999999998753 344444443 2345677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 004986 663 DPLVARIIWECWQTDPSLRPSF-----AQLTVA 690 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~-----~ELL~~ 690 (720)
+.++++||.+||++||.+||++ .+|++|
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 9999999999999999999965 667653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=384.53 Aligned_cols=250 Identities=25% Similarity=0.294 Sum_probs=191.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-----CCce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-----~~~l 509 (720)
++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|+.++|||||++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999976 68899999997766566667789999999999999999999999843 3569
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 56899998764 46999999999999999999999998 99999999999999999999999999987542
Q ss_pred Cc---------------------------ccCCCCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHh---------
Q 004986 590 TF---------------------------LSSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELAT--------- 632 (720)
Q Consensus 590 ~~---------------------------~~~~s~~GT~~Y~APEvi-~g~~~s~ksDVWSLGilLyELlt--------- 632 (720)
.. ......+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 123445789999999986 56679999999999999999998
Q ss_pred --CCCCCCCCCh--------------------HHHHhhhh------------------------cc-----ccccCCCCC
Q 004986 633 --LKLPWIGMNP--------------------MQVVGAVG------------------------FQ-----NRRLEIPKE 661 (720)
Q Consensus 633 --G~~PF~~~~~--------------------~~i~~~i~------------------------~~-----~~~~~ip~~ 661 (720)
|.++|.+... ...+..+. .. .........
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6677765431 00000000 00 000012245
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+++++.+||.+||..||.+|||++|+++|
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 68999999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=374.37 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=212.6
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
.+.++..++|++.+.||+|+||+||+|++ +++.||||++....... ....+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 44566778999999999999999999986 68899999987543221 12357899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 509 LSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~---~~lse~~~~~Ia~qIa~AL~yLHs~---g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCc
Confidence 999999999999999997633 3489999999999999999999998 8 9999999999999999999999999
Q ss_pred ccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHhhhhc-----
Q 004986 583 LSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGF----- 651 (720)
Q Consensus 583 lAk~~~~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~-----~~~~i~~~i~~----- 651 (720)
+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... .......++..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 998664332 2233456999999999999988999999999999999999999999521 11111111110
Q ss_pred -------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 652 -------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 652 -------~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.......+...+..+.+|+.+||+.||.+||++.||+++|++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 0001112233457899999999999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=387.91 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=203.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
.++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|+.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 6889999999876656666778899999999999999999999996654
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+||||||+++ +|.+.+.. .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46999999976 47776643 4899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 655 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~------------ 655 (720)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 543 2334578999999999999999999999999999999999999999988765554433211000
Q ss_pred --------cC---------CCCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 --------LE---------IPKE-----------LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 --------~~---------ip~~-----------ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ++.. .++++++||.+||..||.+|||++|+++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0110 15679999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=399.24 Aligned_cols=268 Identities=24% Similarity=0.424 Sum_probs=226.1
Q ss_pred CCCCCCeeEeE-EeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 433 EIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 433 ~i~~~~y~i~k-~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
.+..+++.+.+ .||+|+||.||+|.+ ++..||||++.... ......++.+|+.+|++++|||||++++++.. +
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 34556777776 899999999999976 35679999987653 22346788999999999999999999999976 5
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 699999999999999999876667999999999999999999999998 999999999999999999999999999875
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 004986 588 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 588 ~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls 663 (720)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.. ..+...+..++
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~ 565 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECP 565 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-TCCCCCCTTCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCC
Confidence 43221 1122346789999999999999999999999999999998 9999999888887777653 33566788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCC
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 705 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~ 705 (720)
+++.+||.+||+.||.+||++.+|++.|+.+........+++
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~ 607 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence 999999999999999999999999999999877765544433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=371.61 Aligned_cols=266 Identities=32% Similarity=0.552 Sum_probs=221.2
Q ss_pred ccccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 429 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 429 ~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
....++..++|++.+.||+|+||.||+|++.+ .||+|++............+.+|+.++++++||||+++++++.+...
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 34567888999999999999999999998866 49999987654433334567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999876667999999999999999999999998 99999999999998 6899999999987543
Q ss_pred CC-----cccCCCCCCCCCccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc
Q 004986 589 NT-----FLSSKSTAGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 654 (720)
Q Consensus 589 ~~-----~~~~~s~~GT~~Y~APEvi~g---------~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~ 654 (720)
.. ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 21 122233468999999999875 4578899999999999999999999999888777766654433
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 655 ~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
....+..++.++.+||.+||..||.+||++.++++.|+.+.+..
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 33344568889999999999999999999999999999986553
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.68 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=217.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++|++.+.||+|+||+||+|++ +++.||+|++....... .....+.+|+.++++++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5799999999999999999988 58899999987654322 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 586 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~IKL~DFGlAk~ 586 (720)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999999653 36899999999999999999999998 99999999999998877 899999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 664 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--~~ip~~ls~ 664 (720)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..++.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 64432 233457999999999999999999999999999999999999999998877766655422211 122356789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhhHhc
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA--LKPLQRLV 698 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~i~~~~ 698 (720)
.+.+||.+||..||.+||++.|++++ ++.+.+..
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 99999999999999999999999984 56655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=370.72 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=210.7
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
..++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 347899999999999999999988 488999999987766666677788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 103 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999999887654 36999999999999999999999998 99999999999999999999999999987654444
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc------------------
Q 004986 593 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------------ 653 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~------------------ 653 (720)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 44456799999999999875 68999999999999999999999999877655443321100
Q ss_pred -cc-c---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -RR-L---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -~~-~---------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. . .....++..+.+||.+||+.||.+||++.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 0113578999999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.29 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=209.2
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec---
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR--- 505 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~--- 505 (720)
.....++|++.+.||+|+||.||+|++ +++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344568899999999999999999998 7889999998765432 35678999999999 89999999999976
Q ss_pred ---CCceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 506 ---PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 506 ---~~~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeC
Confidence 46799999999999999999753 246899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 656 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~ 656 (720)
|++..............||+.|+|||++. +..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 99987654433344567999999999997 5668899999999999999999999999888766655554333333
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+..++..+.+||.+||..||.+||++.+++++
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 3456789999999999999999999999999884
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=369.20 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=210.5
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-----CCceeEEeee
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFMGA 502 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-----HpNIVkL~g~ 502 (720)
....+..++|++.++||+|+||+||+|++ +++.||||++... ......+..|+.+++.+. |||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33445568999999999999999999998 7889999998642 334556778999999996 9999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---------
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--------- 572 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~--------- 572 (720)
+...+.+++||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccc
Confidence 99999999999999 899999986533 45899999999999999999999998 999999999999975
Q ss_pred ----------------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004986 573 ----------------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 636 (720)
Q Consensus 573 ----------------~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~P 636 (720)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999865432 2356899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHhhhhcccccc------------------------CCC--------------------CCCcHHHHHHHHH
Q 004986 637 WIGMNPMQVVGAVGFQNRRL------------------------EIP--------------------KELDPLVARIIWE 672 (720)
Q Consensus 637 F~~~~~~~i~~~i~~~~~~~------------------------~ip--------------------~~ls~~l~dLI~~ 672 (720)
|...+..+....+....... ..+ ...++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 99877665544332110000 011 1123678899999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 004986 673 CWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRPS~~ELL~~ 690 (720)
||+.||.+|||+.|+++|
T Consensus 339 ~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred HhcCChhhCCCHHHHhcC
Confidence 999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=360.73 Aligned_cols=251 Identities=28% Similarity=0.452 Sum_probs=212.4
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
...++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.++++++||||+++++++.+.+.+++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3457899999999999999999988 488999999876542 3467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999754557999999999999999999999998 9999999999999999999999999998765544
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-cccCCCCCCcHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARII 670 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-~~~~ip~~ls~~l~dLI 670 (720)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... .....+..++..+.+||
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 44455689999999999999999999999999999999999999999877765544432221 12234556789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||..||.+||++.+++++
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTS
T ss_pred HHHccCChhhCcCHHHHHhC
Confidence 99999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=356.94 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=211.2
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.+..++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||+++++++.+...+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45568999999999999999999987 5899999998654321 12245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999999654 36899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
.. ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+.. ....++..++..+.+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--GVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--CcccCchhcCHHHHH
Confidence 32 2234579999999999998776 6899999999999999999999998887777666642 244567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||.+||+.||.+||++.+++++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=378.02 Aligned_cols=265 Identities=30% Similarity=0.497 Sum_probs=215.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--C-C--cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee-cCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--N-G--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~-g--~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~-~~~~l~ 510 (720)
..|++.+.||+|+||+||+|++ . + ..||||.+.... .......+.+|+.++++++|||||++++++. .++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4588899999999999999976 2 2 358999876533 3345678899999999999999999999865 456789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999877677899999999999999999999998 999999999999999999999999999865432
Q ss_pred cc----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 591 FL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 591 ~~----~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+. .......+..++..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 11 1233467889999999999999999999999999999999 788888776666555543 23345567789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCC
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 705 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~ 705 (720)
+.+||.+||+.||.+||++.|++++|+.+...+....-..
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~ 364 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 364 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceee
Confidence 9999999999999999999999999999988777655433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.70 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=209.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------- 506 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------- 506 (720)
.++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47899999999999999999987 688999999876655444455678999999999999999999998773
Q ss_pred -CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 507 -PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 507 -~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
+.+++||||+++ +|.+.+......+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999975 788877776667999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCC----cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccCC
Q 004986 586 LKHNT----FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEI 658 (720)
Q Consensus 586 ~~~~~----~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~--~~~i 658 (720)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 65421 122344578999999999986 4589999999999999999999999999877665544431111 1111
Q ss_pred CCC----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 PKE----------------------------LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 p~~----------------------------ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
... .++.+++||.+||+.||.+||++.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111 26789999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=390.31 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=215.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.+|++++|||||++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 6799999999999999999987 68899999987543333335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 99999999988654 36899999999999999999999998 99999999999995 5668999999999866443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCC--CCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~i--p~~ls~~l~dL 669 (720)
......+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.+..++...+......... +..+++++++|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 223456899999999999874 899999999999999999999999999888887777544333322 24689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||+.||.+|||+.|+++|
T Consensus 257 i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=370.43 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=213.7
Q ss_pred CCeeEe-EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEE
Q 004986 437 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 437 ~~y~i~-k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LV 512 (720)
++|.+. +.||+|+||+||+|.+ +++.||||++............+.+|+.+++.+ +||||+++++++.+...+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 467777 8999999999999987 589999999987655544567788999999999 569999999999999999999
Q ss_pred EeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecccccccc
Q 004986 513 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKH 588 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlAk~~~ 588 (720)
|||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||||+. ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999998543 357999999999999999999999998 999999999999997 7899999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--ccCCCCCCcHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~--~~~ip~~ls~~l 666 (720)
... .....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..... .......++..+
T Consensus 186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 186 HAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Ccc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 432 23446799999999999999999999999999999999999999999887776655542222 223445789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||.+||+.||.+||+++|++++
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHcCCChhhCcCHHHHhCC
Confidence 999999999999999999999876
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.27 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=208.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|.+.+.||+|+||+||+|++ ++..||+|++...... .....+.+|+.+|++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 6799999999999999999987 5889999998765432 235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEecccccccc
Q 004986 515 FLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 515 y~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~IKL~DFGlAk~~~ 588 (720)
|+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998853 2356999999999999999999999998 9999999999999 456889999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC-CCCCCcHHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE-IPKELDPLVA 667 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~-ip~~ls~~l~ 667 (720)
.. .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+........ ....+++++.
T Consensus 179 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Cc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 43 22345679999999999864 588999999999999999999999999888777666543332222 2234789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||+.||.+||++.|++++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=371.85 Aligned_cols=243 Identities=23% Similarity=0.383 Sum_probs=186.7
Q ss_pred CeeEe---EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEE
Q 004986 438 DLVLG---ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 438 ~y~i~---k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~L 511 (720)
+|++. +.||+|+||+||+|.+ +++.||||++... ....+.+|+.+++.+. |||||++++++.+....|+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 45554 7899999999999988 5889999998653 2456778999999996 9999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEEEEecccccccc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLKH 588 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~IKL~DFGlAk~~~ 588 (720)
||||+++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999999999764 46999999999999999999999998 99999999999998765 89999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHhhhhccccccCCC--
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGFQNRRLEIP-- 659 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~-------~~i~~~i~~~~~~~~ip-- 659 (720)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+. .+....+... ...++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~ 238 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSFEGE 238 (325)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--CCCCCSH
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--CCCCCcc
Confidence 544444567899999999999999999999999999999999999999986443 3344444322 22222
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 --KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 --~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+++++++||.+||+.||.+||++.|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 3578999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=356.19 Aligned_cols=259 Identities=21% Similarity=0.253 Sum_probs=210.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee-ecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~-~~~~~l~LVm 513 (720)
++|++.+.||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+.++ .+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6899999999999999999986 7889999987654332 2477899999999887766655554 6677789999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~IKL~DFGlAk~~~~~ 590 (720)
||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999 99999999865567999999999999999999999998 9999999999999 78999999999999865443
Q ss_pred cc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhcc---ccccC
Q 004986 591 FL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQ---NRRLE 657 (720)
Q Consensus 591 ~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---~i~~~i~~~---~~~~~ 657 (720)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +....+... .....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 21 223567999999999999999999999999999999999999999874432 222221111 11112
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCC
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~ 702 (720)
....+++++.+||.+||+.||.+||++.++++.|+.+....-...
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 235678999999999999999999999999999999977655433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=362.18 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=210.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++.+.||+|+||.||+|++ +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 36899999999999999999998 4889999998654322 3567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 999999999998765567999999999999999999999998 999999999999999999999999998654332223
Q ss_pred CCCCCCCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHH
Q 004986 594 SKSTAGTPEWMAPEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 667 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi-----~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~ 667 (720)
.....||+.|+|||++ .+..++.++||||||+++|+|++|..||...+.......+..... ....+..++..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 3446799999999998 466789999999999999999999999998887766555432222 2234567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||+.||.+||++.++++|
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.72 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=197.8
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeee----
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVT---- 504 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~---- 504 (720)
.++...+|++.+.||+|+||.||+|++ +++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 445567899999999999999999998 78899999986543 445667889999999995 999999999983
Q ss_pred ----cCCceEEEEeecCCCCHHHHHcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 004986 505 ----RPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578 (720)
Q Consensus 505 ----~~~~l~LVmEy~~ggsL~d~L~~--~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL 578 (720)
....+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+++++|+||||||+||||+.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 3345899999996 689888754 344699999999999999999999998666999999999999999999999
Q ss_pred EeccccccccCCcc------------cCCCCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 004986 579 SDFGLSRLKHNTFL------------SSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 643 (720)
Q Consensus 579 ~DFGlAk~~~~~~~------------~~~s~~GT~~Y~APEvi---~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~ 643 (720)
+|||+++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 99999986543211 11245699999999998 5667899999999999999999999999876554
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcC
Q 004986 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 699 (720)
Q Consensus 644 ~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~ 699 (720)
...... .....+...+..+.+||.+||+.||.+||++.|++++|+.+.....
T Consensus 260 ~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 RIVNGK----YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HhhcCc----ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 433222 2233345677889999999999999999999999999999976543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=389.12 Aligned_cols=253 Identities=30% Similarity=0.400 Sum_probs=213.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++++.||+|+||+||+|++ ++..||||++............+.+|+.+|+.++|||||+++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999988 68899999998765444445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlAk~~~~~~ 591 (720)
||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+++.....
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999999988654 36899999999999999999999998 999999999999975 455999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC--CCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~--ip~~ls~~l~dL 669 (720)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+........ ....+++.+++|
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 23345689999999999874 589999999999999999999999999998888777754333322 224689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH--HHhh
Q 004986 670 IWECWQTDPSLRPSFAQLTVA--LKPL 694 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~--L~~i 694 (720)
|.+||+.||.+|||+.|+++| |+..
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999976 5444
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=373.38 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=206.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------c
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------~ 508 (720)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+|+.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 6899999999999999999987 6899999998766555666778899999999999999999999997763 4
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 69999999 8899999976 35899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 653 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------------- 653 (720)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 32 345689999999999987 679999999999999999999999999877655443332100
Q ss_pred ---------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 ---------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ---------------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....+...+++++.+||.+||..||.+|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0012335678999999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.35 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=213.9
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.++..++|++.+.||+|+||+||+|++ +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 456668999999999999999999998 58899999987653 455567889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+. + |+||||||+||||+.++.+||+|||++....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999999997643 689999999999999999999985 7 9999999999999999999999999997653
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-------------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------- 649 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i------------------- 649 (720)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 32 233468999999999999999999999999999999999999999876654432211
Q ss_pred -----------------------hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 650 -----------------------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 650 -----------------------~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
............++.++.+||.+||+.||.+|||+.|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11111111223578899999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=394.81 Aligned_cols=263 Identities=32% Similarity=0.540 Sum_probs=227.5
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEEC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
..+++..++|++.+.||+|+||.||+|++. +..||||++...... ..+|.+|+.+|++++|+|||++++++.+ ..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 346677889999999999999999999985 467999999765543 3578899999999999999999999876 77
Q ss_pred eEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
++|||||+.+|+|.+++... ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999999642 245899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 588 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 588 ~~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+....++...+.. ..+...+..++..
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPES 492 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHH
Confidence 4322 12233457889999999999999999999999999999999 9999999888887776643 3345667889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcC
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 699 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~ 699 (720)
+.+||.+||+.||.+||++.+|++.|+.+.....
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 9999999999999999999999999988754433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=364.65 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=210.1
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee----cC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT----RP 506 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~----~~ 506 (720)
.+..++|++.+.||+|+||.||++++ +++.||||++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 45567899999999999999999986 7899999988654 3445677889999999999999999999986 34
Q ss_pred CceEEEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccc
Q 004986 507 PNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGl 583 (720)
..+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCc
Confidence 578999999999999998864 3457999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcc---------cCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHhhh
Q 004986 584 SRLKHNTFL---------SSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAV 649 (720)
Q Consensus 584 Ak~~~~~~~---------~~~s~~GT~~Y~APEvi~g~~---~s~ksDVWSLGilLyELltG~~PF~~~~~--~~i~~~i 649 (720)
+........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 875432111 011235799999999998664 68899999999999999999999954111 1111111
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 650 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 650 ~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
. .......+..++.++.+||.+||+.||.+||++.+++++|+.+.
T Consensus 261 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 Q-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp H-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred h-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 1 12233345678999999999999999999999999999998875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=377.25 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=198.2
Q ss_pred CCeeEe-EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHH-cCCCceeEEeeeeec----CCc
Q 004986 437 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR-LRHPNVVLFMGAVTR----PPN 508 (720)
Q Consensus 437 ~~y~i~-k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~-L~HpNIVkL~g~~~~----~~~ 508 (720)
++|.+. +.||+|+||+||+|.+ +++.||||++... ..+.+|+.++.+ .+||||++++++|.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 567776 7899999999999987 5889999998642 245678888755 489999999998865 567
Q ss_pred eEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecccc
Q 004986 509 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 584 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlA 584 (720)
+||||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++ |+||||||+||||+. ++.+||+|||++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999997643 46999999999999999999999998 999999999999997 789999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHhhhhcccccc--CC
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGFQNRRL--EI 658 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~----i~~~i~~~~~~~--~i 658 (720)
+..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... ....+....... ..
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 212 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 865433 22345689999999999999999999999999999999999999998755432 223332222111 12
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
...++.++++||.+||+.||.+||++.|+++|--
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 2568999999999999999999999999998743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.50 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=213.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||+||+|++ +++.||||++...... ....+.+|+.++++++||||+++++++.+...+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999987 6899999999765322 23567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~IKL~DFGlAk~~~~~~ 591 (720)
|+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999999998653 36899999999999999999999998 9999999999999 78899999999999764432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--~~ip~~ls~~l~dL 669 (720)
......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..++..+.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 123346999999999999999999999999999999999999999998887777666433222 23446789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||..||.+||++.|++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=357.22 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=210.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHHcCCCceeEEeeee--ecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~--~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~--~~~~~l~ 510 (720)
++|++.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.++++++||||+++++++ .+...++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 6899999999999999999987 6789999998754321 23356788999999999999999999998 4456799
Q ss_pred EEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+||||+.++ |.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 999999877 6666643 3457999999999999999999999998 99999999999999999999999999986542
Q ss_pred C--cccCCCCCCCCCccCcccccCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 590 T--FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 590 ~--~~~~~s~~GT~~Y~APEvi~g~~~--s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
. ........||+.|+|||++.+... +.++||||||+++|+|++|..||...+..+....+.. ....++..+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~ 239 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPGDCGPP 239 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCSSSCHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCCccCHH
Confidence 2 122234579999999999987543 7899999999999999999999999888777766643 345667889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+.+||.+||+.||.+||++.|++++
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=388.92 Aligned_cols=250 Identities=30% Similarity=0.432 Sum_probs=218.3
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|++++|||||++++++.+...+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999987 6889999999765432 23356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEeccccccccC
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~IKL~DFGlAk~~~~ 589 (720)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999998764 36999999999999999999999998 9999999999999 5678999999999986644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVA 667 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~~ls~~l~ 667 (720)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..++...+.........+ ..++++++
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred cc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 32 2234579999999999987 58999999999999999999999999999888887775443333322 46899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 004986 668 RIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 668 dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+||.+||+.||.+|||+.|+++|
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHCCCChhHCcCHHHHhhC
Confidence 99999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=376.10 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=201.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----Cce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~-----~~l 509 (720)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+|++++|||||++++++... ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 7899999999999999999987 678999999987655666677899999999999999999999999776 569
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999996 5999999764 46999999999999999999999998 99999999999999999999999999987543
Q ss_pred Ccc----------------------cCCCCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhCC-----------C
Q 004986 590 TFL----------------------SSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLK-----------L 635 (720)
Q Consensus 590 ~~~----------------------~~~s~~GT~~Y~APEvi-~g~~~s~ksDVWSLGilLyELltG~-----------~ 635 (720)
... .....+||+.|+|||++ .+..++.++|||||||++|||++|. +
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 211 13567899999999986 5667999999999999999999843 3
Q ss_pred CCCCCCh-----------------HHH------------------------HhhhhccccccC-----CCCCCcHHHHHH
Q 004986 636 PWIGMNP-----------------MQV------------------------VGAVGFQNRRLE-----IPKELDPLVARI 669 (720)
Q Consensus 636 PF~~~~~-----------------~~i------------------------~~~i~~~~~~~~-----ip~~ls~~l~dL 669 (720)
+|.+.+. ... ...+........ ....+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 4433221 000 001100000000 114578999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||+.||.+|||++|+++|
T Consensus 342 l~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=386.86 Aligned_cols=249 Identities=28% Similarity=0.424 Sum_probs=212.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-----------HHHHHHHHHHHHHHHcCCCceeEEeeee
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-----------AALLEFKREVKIMRRLRHPNVVLFMGAV 503 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-----------~~~~e~~~Ei~iL~~L~HpNIVkL~g~~ 503 (720)
++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+|++++|||||++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 6899999999999999999987 57899999997654332 2245788999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---cEEEEe
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSD 580 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~IKL~D 580 (720)
.+...+++|||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9999999999999999999988654 36999999999999999999999998 99999999999999776 699999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC--C
Q 004986 581 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--I 658 (720)
Q Consensus 581 FGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~--i 658 (720)
||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+........ .
T Consensus 193 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 193 FGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp CTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 9999876543 23345689999999999875 589999999999999999999999999998888877754332221 1
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+++++++||.+||..||.+|||+.|+++|
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 25789999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.95 Aligned_cols=254 Identities=30% Similarity=0.454 Sum_probs=210.4
Q ss_pred eeEeEEeeecCcEEEEEEEECCcEEEEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEeec
Q 004986 439 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 516 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~--~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy~ 516 (720)
|..++.||+|+||+||+|+++++.||||++.... ........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 3446889999999999999999999999987542 22344677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--c
Q 004986 517 PRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 592 (720)
Q Consensus 517 ~ggsL~d~L~~~--~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~ 592 (720)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999998642 346899999999999999999999998 9999999999999999999999999998654322 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhh----hcc---------ccccCCC
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV----GFQ---------NRRLEIP 659 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i----~~~---------~~~~~ip 659 (720)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+ ... ......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 22345799999999998764 789999999999999999999999875443222111 100 0111223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
...+..+.+||.+||+.||.+||++.+++++|+++.
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 445678999999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=372.09 Aligned_cols=257 Identities=21% Similarity=0.248 Sum_probs=204.3
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCCCHHH---------HHHHHHHHHHHHHcCCCceeEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAA---------LLEFKREVKIMRRLRHPNVVLF 499 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~---------~~e~~~Ei~iL~~L~HpNIVkL 499 (720)
+..++|++.+.||+|+||+||+|.+ .+..||||++......... ...+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 4457899999999999999999988 4578999998765421111 1235678889999999999999
Q ss_pred eeeeec----CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-
Q 004986 500 MGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW- 574 (720)
Q Consensus 500 ~g~~~~----~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g- 574 (720)
++++.+ ...+++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC
Confidence 999887 67899999999 999999997654 7999999999999999999999998 99999999999999877
Q ss_pred -cEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHH
Q 004986 575 -NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--NPMQ 644 (720)
Q Consensus 575 -~IKL~DFGlAk~~~~~~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~--~~~~ 644 (720)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999986543211 113457999999999999999999999999999999999999999652 2222
Q ss_pred HHhhhhccccccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 645 VVGAVGFQNRRLEIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 645 i~~~i~~~~~~~~ip---------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
..... ......++ ..++.++.+||.+||..||.+||++.+|++.|+.+..
T Consensus 270 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 22111 11111122 2788999999999999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=398.18 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=218.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.+..++|++.+.||+|+||.||+|++ +++.||||++.+.... ......+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 46668899999999999999999988 6899999998764321 11245678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
||||||++||+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999987643 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHhhhhccccccCCCCCCcH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~----~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.... ..++...+. .....++..+++
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSP 414 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCH
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCH
Confidence 432 2344689999999999999999999999999999999999999998753 233444442 334567788999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRP-----S~~ELL~~ 690 (720)
++++||.+||+.||.+|| ++.|+++|
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 999999999999999999 78999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=362.82 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=211.2
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 358899999999999999999987 688999999876543 33445778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999754 36899999999999999999999998 9999999999999999999999999998654332
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHHH
Q 004986 592 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARI 669 (720)
Q Consensus 592 -~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~dL 669 (720)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..... ....+..++.++.+|
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 222345799999999999999999999999999999999999999988776544444332211 224567789999999
Q ss_pred HHHhhhcCCCCCC-CHHHHHHHHHhhhHhc
Q 004986 670 IWECWQTDPSLRP-SFAQLTVALKPLQRLV 698 (720)
Q Consensus 670 I~~cL~~DP~kRP-S~~ELL~~L~~i~~~~ 698 (720)
|.+||+.||.+|| +++++++.|+......
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 9999999999999 9999999998775443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=362.00 Aligned_cols=253 Identities=35% Similarity=0.589 Sum_probs=210.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHH--cCCCceeEEeeeeecCC----ceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~--L~HpNIVkL~g~~~~~~----~l~ 510 (720)
++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|++++.. ++||||+++++++.... .++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 679999999999999999999999999999985432 3567788899988 69999999999998876 799
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLH--------s~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
+||||+++++|.+++.+. .+++..++.++.||+.||.||| +.+ |+||||||+||||+.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999763 5899999999999999999999 777 9999999999999999999999999
Q ss_pred ccccccCCcc----cCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCCC-
Q 004986 583 LSRLKHNTFL----SSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATL----------KLPWIGMN- 641 (720)
Q Consensus 583 lAk~~~~~~~----~~~s~~GT~~Y~APEvi~g~~------~s~ksDVWSLGilLyELltG----------~~PF~~~~- 641 (720)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++| ..||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9986544321 234457999999999998763 33689999999999999999 78987643
Q ss_pred ----hHHHHhhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 642 ----PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 642 ----~~~i~~~i~~~~~~~~ip~-----~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
...+...+.....+..++. .++..+.+||.+||+.||.+||++.+++++|+.+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 2333333332333333433 34568999999999999999999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=351.76 Aligned_cols=250 Identities=28% Similarity=0.348 Sum_probs=210.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999987 5889999998765432 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--c
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 592 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~ 592 (720)
|+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999998764 36899999999999999999999998 9999999999999999999999999998653221 2
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ....+............++..+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2344679999999999988765 779999999999999999999998755432 22222211112223356899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||..||.+||++.|++++
T Consensus 243 ~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHCCCCchhCCCHHHHhcC
Confidence 99999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.41 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=209.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
+..++|.....||+|+||.||+|++ +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 3445566667899999999999987 678999999876542 335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecccccccc
Q 004986 512 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKH 588 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~~~ 588 (720)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999997532 34678899999999999999999998 999999999999987 8999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~--~s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..........||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... .............++..++.+
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 254 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence 4333344568999999999997654 7899999999999999999999997644322 222222223345677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+.+||.+||+.||.+||++.+++++
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=367.64 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=200.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 37899999999999999999987 6889999999876656666778899999999999999999999997765
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+++ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999975 78888863 4899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 655 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~------------ 655 (720)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 178 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 433 2234468999999999999999999999999999999999999999988776554443211100
Q ss_pred --------cC--------------CCC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 --------LE--------------IPK------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 --------~~--------------ip~------~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ++. ..+.++++||.+||..||.+|||++|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 010 125689999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.05 Aligned_cols=242 Identities=22% Similarity=0.352 Sum_probs=209.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~------~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
++|++.+.||+|+||+||+|.+ +++.||||++........ ....+.+|+.+|++++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 6799999999999999999986 788999999987643221 23456789999999999999999999999999
Q ss_pred eEEEEeecCCC-CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~gg-sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+++||||+.+| +|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999766 9999997653 6999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... . .......+..+++++
T Consensus 181 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~------~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--T------VEAAIHPPYLVSKEL 251 (335)
T ss_dssp CTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--G------TTTCCCCSSCCCHHH
T ss_pred CCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--H------HhhccCCCcccCHHH
Confidence 5432 2344679999999999998876 7899999999999999999999976321 1 122334566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||.+||+.||.+||++.+++++
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=366.28 Aligned_cols=256 Identities=17% Similarity=0.180 Sum_probs=212.8
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEE-------ECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEe
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFM 500 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~-------~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~---HpNIVkL~ 500 (720)
..++..++|.+.+.||+|+||+||+|. ..++.||||++.... ..++..|+.+++.++ |+||++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 445667889999999999999999993 268899999986543 346778888888886 89999999
Q ss_pred eeeecCCceEEEEeecCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC----
Q 004986 501 GAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---- 572 (720)
Q Consensus 501 g~~~~~~~l~LVmEy~~ggsL~d~L~~----~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---- 572 (720)
+++...+..+|||||+++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTC
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccC
Confidence 999999999999999999999999963 3456999999999999999999999998 999999999999998
Q ss_pred -------CCcEEEEeccccccccC--CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 004986 573 -------NWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 643 (720)
Q Consensus 573 -------~g~IKL~DFGlAk~~~~--~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~ 643 (720)
++.+||+|||+++.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999975431 222334568999999999999999999999999999999999999999654321
Q ss_pred HHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHhhhHhcC
Q 004986 644 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVI 699 (720)
Q Consensus 644 ~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kR-PS~~ELL~~L~~i~~~~~ 699 (720)
... + .........+..+.+++..||+.+|.+| |++.++.+.|+.+.....
T Consensus 292 ~~~--~----~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 ECK--P----EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EEE--E----CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cee--e----chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 110 0 0111112347789999999999999999 689999999988765543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=352.52 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=215.2
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC---C----HHHHHHHHHHHHHHHHcC-CCceeEEeeeee
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---S----GAALLEFKREVKIMRRLR-HPNVVLFMGAVT 504 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~---~----~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~ 504 (720)
..++|++.+.||+|+||.||+|.+ +++.||||++..... . ......+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 347899999999999999999988 678999999976531 1 123456789999999995 999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 505 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 505 ~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
+...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999999753 36899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC-
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE- 657 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~------g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~- 657 (720)
...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||...+.......+........
T Consensus 172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 876433 2234567999999999985 45678999999999999999999999998887776665543322222
Q ss_pred -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 658 -IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 658 -ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....++..+.+||.+||+.||.+||++.|++++
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 224688999999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=361.65 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=218.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
.+..++|++.+.||+|+||.||+|++ +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34557899999999999999999984 57899999987643 34567889999999999999999999998765
Q ss_pred C--ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 507 P--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 507 ~--~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
+ .+++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 789999999999999999876667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----------------HH
Q 004986 585 RLKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------QV 645 (720)
Q Consensus 585 k~~~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----------------~i 645 (720)
+....... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87644321 123346788899999999988999999999999999999999988642110 11
Q ss_pred HhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 646 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 646 ~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
...+ ........+..++.++.+||.+||..||.+||++.||++.|+.+.+.+
T Consensus 273 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 273 IELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 122344567789999999999999999999999999999999997754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.23 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=201.8
Q ss_pred CCeeEe-EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEE
Q 004986 437 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 437 ~~y~i~-k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LV 512 (720)
+.|++. +.||+|+||+||+|++ +++.||||++...... ....+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 578885 7899999999999986 6899999999765432 245788999999995 799999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEeccccccccC
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHN 589 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---IKL~DFGlAk~~~~ 589 (720)
|||+++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999999764 36899999999999999999999998 999999999999998776 99999999976432
Q ss_pred Cc-------ccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 004986 590 TF-------LSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNP--------------- 642 (720)
Q Consensus 590 ~~-------~~~~s~~GT~~Y~APEvi~g-----~~~s~ksDVWSLGilLyELltG~~PF~~~~~--------------- 642 (720)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 11223569999999999975 4578899999999999999999999987542
Q ss_pred HHHHhhhhccccccCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 643 MQVVGAVGFQNRRLEIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip----~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+...+.. ....++ ..++..+++||.+||+.||.+||++.|+++|
T Consensus 247 ~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 223333321 122233 3578999999999999999999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=397.13 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=219.8
Q ss_pred CCCCeeEe-EEeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 435 PWEDLVLG-ERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 435 ~~~~y~i~-k~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
....+.+. +.||+|+||+||+|.+ .++.||||++...........++.+|+.+|++++|||||++++++.. +.+
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 444 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCE
Confidence 33445553 5899999999999965 45789999998765555556789999999999999999999999965 568
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+|||||+++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 9999999999999999754 46899999999999999999999998 99999999999999999999999999986643
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 590 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 590 ~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.. .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.. ......+..++.+
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPRE 600 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHH
Confidence 22 12233457889999999999999999999999999999998 9999999988887776653 3355677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
+.+||.+||+.||.+||++.+|++.|+.+...+
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999886554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=350.75 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=210.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec---------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 505 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--------- 505 (720)
.+|++.+.||+|+||.||+|++ +++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 5799999999999999999988 58999999987653 245689999999999999999998854
Q ss_pred -------CCceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEE
Q 004986 506 -------PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 577 (720)
Q Consensus 506 -------~~~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IK 577 (720)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999642 346899999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC
Q 004986 578 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 657 (720)
Q Consensus 578 L~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ 657 (720)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+. ...
T Consensus 163 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~----~~~ 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR----DGI 235 (284)
T ss_dssp ECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH----TTC
T ss_pred ECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh----ccc
Confidence 99999998765432 234467999999999999999999999999999999999999887432 12222221 223
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
++..++..+++||.+||+.||.+||++.|++++|..+.+..
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 55678999999999999999999999999999999886543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=358.81 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=207.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeee-----c
Q 004986 437 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 505 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L---~HpNIVkL~g~~~-----~ 505 (720)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 6899999999999999999987 478899999875443322223455677777666 8999999999987 5
Q ss_pred CCceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 584 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlA 584 (720)
...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCccc
Confidence 567999999997 5999998653 335899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 653 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~----------- 653 (720)
+..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+....
T Consensus 168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 865433 22345679999999999999999999999999999999999999999887765554432100
Q ss_pred --------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 --------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 --------------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....+...++..+++||.+||..||.+||++.|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0012345688999999999999999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.04 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=215.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCH---------------HHHHHHHHHHHHHHHcCCCcee
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG---------------AALLEFKREVKIMRRLRHPNVV 497 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~---------------~~~~e~~~Ei~iL~~L~HpNIV 497 (720)
.+..++|++.+.||+|+||.||+|+++++.||||++....... .....+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456899999999999999999999999999999987543221 1126788999999999999999
Q ss_pred EEeeeeecCCceEEEEeecCCCCHHHH------HcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEE
Q 004986 498 LFMGAVTRPPNLSIITEFLPRGSLFRI------LHRP-HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLL 569 (720)
Q Consensus 498 kL~g~~~~~~~l~LVmEy~~ggsL~d~------L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNIL 569 (720)
++++++.+.+.+++||||+++++|.++ +.+. ...+++..++.++.||+.||.|||+ +| |+||||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 6542 4579999999999999999999999 88 999999999999
Q ss_pred EcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 004986 570 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNE-KCDVYSFGVILWELATLKLPWIGMNP-MQVV 646 (720)
Q Consensus 570 Ld~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~-ksDVWSLGilLyELltG~~PF~~~~~-~~i~ 646 (720)
++.++.+||+|||++...... ......||..|+|||++.+. .++. ++||||||+++|+|++|..||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999875443 23456799999999999987 5666 99999999999999999999988766 5555
Q ss_pred hhhhccccccCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 647 GAVGFQNRRLEIP-------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 647 ~~i~~~~~~~~ip-------------------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+... ...++ ..++.++.+||.+||+.||.+||++.|++++
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 555322 22333 5688999999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=373.83 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=210.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR 505 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~--~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~ 505 (720)
+..++|++.+.||+|+||+||+|++ +++.||||++..... .......+.+|+.+|+.+ +||||+++++++.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 4457899999999999999999987 688999999865321 111234566799999999 79999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999754 36899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCC-cccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccccccCC
Q 004986 586 LKHNT-FLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEI 658 (720)
Q Consensus 586 ~~~~~-~~~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~~~~~i 658 (720)
..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ..+...+ ......+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCCC
Confidence 65432 222344679999999999986 3478999999999999999999999975432 2333333 2234557
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRP-----SFAQLTVAL 691 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRP-----S~~ELL~~L 691 (720)
+..++..+++||.+||..||.+|| +++|++++.
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 788999999999999999999999 999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.04 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=206.0
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------ 505 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~------ 505 (720)
...++|++++.||+|+||+||+|++ +++.||||++...... ..+|+.+|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4457899999999999999999987 7899999998755322 2379999999999999999999843
Q ss_pred --------------------------------CCceEEEEeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHH
Q 004986 506 --------------------------------PPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNC 550 (720)
Q Consensus 506 --------------------------------~~~l~LVmEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~y 550 (720)
...+++||||+++ +|.+++.. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3348899999984 77776642 34579999999999999999999
Q ss_pred HHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHH
Q 004986 551 LHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILW 628 (720)
Q Consensus 551 LHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLy 628 (720)
||++| |+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 157 LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99998 99999999999998 6899999999999866443 2334568899999999998754 899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHhhhhccc---------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 004986 629 ELATLKLPWIGMNPMQVVGAVGFQN---------------------------RRLEIPKELDPLVARIIWECWQTDPSLR 681 (720)
Q Consensus 629 ELltG~~PF~~~~~~~i~~~i~~~~---------------------------~~~~ip~~ls~~l~dLI~~cL~~DP~kR 681 (720)
||++|+.||.+.+..+.+..+.... ....++..++.++.+||.+||..||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999887766554432100 0111455688999999999999999999
Q ss_pred CCHHHHHHH--HHhhhH
Q 004986 682 PSFAQLTVA--LKPLQR 696 (720)
Q Consensus 682 PS~~ELL~~--L~~i~~ 696 (720)
||+.|+++| ++.+..
T Consensus 314 ~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 314 INPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCHHHHHTSGGGHHHHH
T ss_pred CCHHHHhcCHHHHHHHh
Confidence 999999964 555443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=364.55 Aligned_cols=260 Identities=17% Similarity=0.174 Sum_probs=212.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEEC----------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeE------
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADWN----------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL------ 498 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~~----------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVk------ 498 (720)
..++|++.+.||+|+||.||+|++. ++.||||++... ..+.+|+.++++++|||||+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3478999999999999999999873 678999998754 25678999999999999988
Q ss_pred ---------Eeeeeec-CCceEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCc
Q 004986 499 ---------FMGAVTR-PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 567 (720)
Q Consensus 499 ---------L~g~~~~-~~~l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeN 567 (720)
+++++.. ...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 5566655 67789999999 99999999764 357999999999999999999999998 9999999999
Q ss_pred EEEcCCC--cEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004986 568 LLVDKNW--NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 638 (720)
Q Consensus 568 ILLd~~g--~IKL~DFGlAk~~~~~~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~ 638 (720)
||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999986543221 1234579999999999999999999999999999999999999998
Q ss_pred CCC--hHHHHhhhh-ccccccCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCC
Q 004986 639 GMN--PMQVVGAVG-FQNRRLEIP------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 704 (720)
Q Consensus 639 ~~~--~~~i~~~i~-~~~~~~~ip------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~ 704 (720)
... ...+..... .......+. ..++.++.+||.+||..||.+||++.+|++.|+.+.........+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 344 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD 344 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence 753 333322221 111111111 256899999999999999999999999999999998776544433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=357.64 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=195.1
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
..+..++|++.+.||+|+||.||+|.+ +++.||||++..... .....++.+|+.++++++||||+++++++...+..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 456678999999999999999999976 688999998865432 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecc
Q 004986 510 SIITEFLPRGSLFRILHR-------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~-------~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFG 582 (720)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999999863 2346899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCc-----ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc--
Q 004986 583 LSRLKHNTF-----LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-- 654 (720)
Q Consensus 583 lAk~~~~~~-----~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-- 654 (720)
++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+..........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987654321 11234579999999999976 5689999999999999999999999988776554433321111
Q ss_pred ------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 ------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.......++.++.+||.+||+.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112335678999999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=376.81 Aligned_cols=248 Identities=16% Similarity=0.143 Sum_probs=198.9
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CCHHHHHHHHHHHH---HHHHcCCCceeEEe-------e
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVK---IMRRLRHPNVVLFM-------G 501 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~e~~~Ei~---iL~~L~HpNIVkL~-------g 501 (720)
..++|++.+.||+|+||+||+|++ +++.||||++.... ........+.+|+. +|++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 347899999999999999999986 68999999997543 23345677889994 55555899999998 5
Q ss_pred eeecCC-----------------ceEEEEeecCCCCHHHHHcCCCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 004986 502 AVTRPP-----------------NLSIITEFLPRGSLFRILHRPHC------QVDEKRRIKMALDVARGMNCLHTSTPTI 558 (720)
Q Consensus 502 ~~~~~~-----------------~l~LVmEy~~ggsL~d~L~~~~~------~lse~~~~~Ia~qIa~AL~yLHs~g~~I 558 (720)
++.+.+ ..||||||+ +|+|.+++.+... .+++..++.|+.||+.||+|||+++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 555543 288999999 6799999975321 1224888889999999999999998 9
Q ss_pred EeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-----------CCCchhhHHHHHHHH
Q 004986 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-----------PSNEKCDVYSFGVIL 627 (720)
Q Consensus 559 IHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~-----------~~s~ksDVWSLGilL 627 (720)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999986433 2334678 999999999987 899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHhhh
Q 004986 628 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTV--ALKPLQ 695 (720)
Q Consensus 628 yELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~--~L~~i~ 695 (720)
|||++|+.||.+.+.......+. ..+..+++++.+||.+||+.||.+||++.|+++ .++.+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 99999999998766544433331 233678999999999999999999999999997 444443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=364.04 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=213.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC--CH----HHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SG----AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 507 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~--~~----~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~ 507 (720)
++|++.+.||+|+||.||+|++ +|+.||||++..... .. .....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999987 589999999876532 22 2244678899999999 8999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+||||+.+|.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999999753 36899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccC--CC
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IP 659 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g------~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~--ip 659 (720)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+........ .+
T Consensus 251 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 543 23345689999999999864 3578899999999999999999999998887776665543322221 12
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++..+.+||.+||+.||.+||++.|++++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4678899999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=364.24 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=207.5
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce-----
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL----- 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l----- 509 (720)
++|.+.+.||+|+||+||+|.+ +++.||||++............+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 6899999999999999999987 689999999987766666678889999999999999999999999887765
Q ss_pred -EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 -SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 -~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+. ++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 589888753 4899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 655 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~------------ 655 (720)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 32 334679999999999987 67899999999999999999999999988766555443210000
Q ss_pred -----------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 -----------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 -----------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+..+++.+++||.+||+.||.+||++.|++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 01224578999999999999999999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=365.56 Aligned_cols=247 Identities=19% Similarity=0.214 Sum_probs=200.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC--------CCceeEEeeeee-
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--------HPNVVLFMGAVT- 504 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~--------HpNIVkL~g~~~- 504 (720)
.++|++.+.||+|+||+||+|++ +++.||||++... ......+.+|+.+|+.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999987 6889999998643 344567889999999985 788999999987
Q ss_pred ---cCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCC------
Q 004986 505 ---RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW------ 574 (720)
Q Consensus 505 ---~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g------ 574 (720)
....+++||||+.++.+..++......+++..++.++.||+.||.|||++ | |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhh
Confidence 56679999999955444444444445799999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------------cEEEEeccccccccCCcccCCCCCCCCCccCcccccC
Q 004986 575 -------------------------------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611 (720)
Q Consensus 575 -------------------------------------------~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g 611 (720)
.+||+|||+++..... ....+||+.|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence 7999999999876433 334679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHhhhhc--cc------------------------------
Q 004986 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPM------QVVGAVGF--QN------------------------------ 653 (720)
Q Consensus 612 ~~~s~ksDVWSLGilLyELltG~~PF~~~~~~------~i~~~i~~--~~------------------------------ 653 (720)
..++.++|||||||++|||++|+.||...+.. .....+.. ..
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999865421 11111100 00
Q ss_pred --------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 --------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 --------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.....+...+..+++||.+||+.||.+||++.|+++|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011233446789999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.16 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=207.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----Cce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~-----~~l 509 (720)
++|++++.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+|++++||||+++++++... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 6899999999999999999987 68889999987543 344557788999999999999999999998665 368
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
++||||+. ++|.+++... .+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999997 5899998753 5899999999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc----------
Q 004986 590 TFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------- 655 (720)
Q Consensus 590 ~~~---~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~---------- 655 (720)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 321 1244589999999998764 45899999999999999999999999987766555443210000
Q ss_pred -------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 -------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 -------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+...++.++.+||.+||+.||.+||++.|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01224678999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=371.32 Aligned_cols=248 Identities=14% Similarity=0.074 Sum_probs=188.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHc--CCCceeEEee-------eee
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL--RHPNVVLFMG-------AVT 504 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L--~HpNIVkL~g-------~~~ 504 (720)
.+|++.+.||+|+||+||+|++ +++.||||++...... ......+.+|+.+++.| +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4699999999999999999987 6889999999887653 34455677886555555 6999888653 333
Q ss_pred cC-----------------CceEEEEeecCCCCHHHHHcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCEEee
Q 004986 505 RP-----------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMALDVARGMNCLHTSTPTIVHR 561 (720)
Q Consensus 505 ~~-----------------~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~------~~Ia~qIa~AL~yLHs~g~~IIHr 561 (720)
.. ..+||||||++ ++|.+++......+.+..+ +.++.||+.||+|||+++ |+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence 22 33899999998 8999999764334555666 778899999999999998 9999
Q ss_pred CCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004986 562 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIG 639 (720)
Q Consensus 562 DLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~~ 639 (720)
||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998664322 13456799999999987 6799999999999999999999999987
Q ss_pred CChHHHHhh-----hhccccc--cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 640 MNPMQVVGA-----VGFQNRR--LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 640 ~~~~~i~~~-----i~~~~~~--~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......... ....... ...+..+++.+.+||.+||+.||.+||++.|+++|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 644321111 0011112 22335789999999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.20 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=214.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 6799999999999999999988 68899999997665444446778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~IKL~DFGlAk~~~~~~ 591 (720)
|+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999988653 36899999999999999999999998 9999999999999754 479999999998654332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC--CCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip--~~ls~~l~dL 669 (720)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+.........+ ..++.++.+|
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp -SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred -ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 22334688999999998875 8899999999999999999999999988877776664333222222 5689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||..||.+||++.|++++
T Consensus 257 i~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHcccChhhCcCHHHHhcC
Confidence 999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=352.66 Aligned_cols=242 Identities=20% Similarity=0.317 Sum_probs=201.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeec--CCceEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLSI 511 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~--~~~l~L 511 (720)
++|++.+.||+|+||+||+|.+ +++.||||++.... ...+.+|+.+|++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 7899999999999999999987 78899999986433 356889999999996 9999999999988 667899
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~~ 590 (720)
||||+.+++|.+++. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.....
T Consensus 111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999985 3889999999999999999999998 99999999999999776 8999999999866443
Q ss_pred cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhh-------------hccc--
Q 004986 591 FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAV-------------GFQN-- 653 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~-~~i~~~i-------------~~~~-- 653 (720)
. ......||..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+.+..+ ....
T Consensus 185 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 185 Q-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp C-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred C-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2 2345679999999999987 6789999999999999999999999965322 2111111 0000
Q ss_pred --------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 --------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 --------------------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.....+..+++++++||.+||+.||.+|||+.|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011123378999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=373.66 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=211.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC--ceEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSI 511 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~--~l~L 511 (720)
.++|++.+.||+|+||+||+|++ +++.||||++...... .....+.+|+.+|++++|||||++++++.+.. ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 46899999999999999999988 4889999998754322 22456779999999999999999999998765 6899
Q ss_pred EEeecCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEEEEeccccc
Q 004986 512 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR 585 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~IKL~DFGlAk 585 (720)
||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999997633 23899999999999999999999998 9999999999999 788889999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHhhhhccc
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRN--------EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQN 653 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g--------~~~s~ksDVWSLGilLyELltG~~PF~~~~~----~~i~~~i~~~~ 653 (720)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+....
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 765432 3345679999999999875 5578899999999999999999999975322 22222222111
Q ss_pred c-----------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 654 R-----------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 654 ~-----------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
. ...++..++..+.+||.+||..||.+||++.|+++.|+.+...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 0012234567899999999999999999999999999887543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.50 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=195.8
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
..+.+..++|++.+.||+|+||.||+|++ +++.||||++............+..+..+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 34556778999999999999999999988 5889999999876544444444555566778889999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
.+++||||+ ++.+..+.......+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 6677777655445799999999999999999999985 8 99999999999999999999999999976
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHhhhhccccccCCC-
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIP- 659 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~-~~~~i~~~i~~~~~~~~ip- 659 (720)
..... ......||+.|+|||++. +..++.++||||||+++|+|++|..||... ...+....+.. .....++
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCCCCc
Confidence 54432 233457999999999994 556889999999999999999999999874 33344433322 2222222
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 -~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++.++.+||.+||+.||.+||++.+++++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4689999999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=374.49 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=197.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC------HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~------~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.+|++++|||||++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 37899999999999999999987 6789999999765322 1122357899999999999999999999865 5
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC---CcEEEEecccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLS 584 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~IKL~DFGlA 584 (720)
.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 589999999999999988764 46999999999999999999999998 9999999999999754 45999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccc--ccCC
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNR--RLEI 658 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g---~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~--~~~i 658 (720)
+..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+..... ....
T Consensus 290 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 876543 22345689999999999864 56788999999999999999999999865433 22222221111 1122
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...++..+.+||.+||+.||.+||++.|+++|
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 24688999999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=369.90 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=192.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------~~ 508 (720)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999986 688999999877655556677888999999999999999999998654 56
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 7899998865 36999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 655 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~------------ 655 (720)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 334689999999999987 67899999999999999999999999988765554433210000
Q ss_pred ---------c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ---------L--------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ---------~--------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. .....+++++.+||.+||..||.+||++.|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0113567899999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=369.16 Aligned_cols=244 Identities=23% Similarity=0.301 Sum_probs=199.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------~~ 508 (720)
.+|++.+.||+|+||+||+|++ +++.||||++..... .+.+|+++|+.++|||||+++++|... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4699999999999999999998 689999999875432 124799999999999999999988432 23
Q ss_pred eEEEEeecCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-CcEEEEecccc
Q 004986 509 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLS 584 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~---~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~IKL~DFGlA 584 (720)
+++||||+++ +|.+++. +....+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7799999976 5665553 23457999999999999999999999998 9999999999999965 67899999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-----------
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------- 652 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~----------- 652 (720)
+..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 205 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876443 223456899999999999775 6899999999999999999999999987765444332210
Q ss_pred ----ccccC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 ----NRRLE------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 ----~~~~~------------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..... ++..+++++++||.+||..||.+||++.|+++|
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00011 234678999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=354.86 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=201.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC------HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~------~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
++|++.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999987 5789999998765321 122345789999999999999999999987654
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEeccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSR 585 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---IKL~DFGlAk 585 (720)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 89999999999999999764 47899999999999999999999998 999999999999987664 9999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccc--ccCCC
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNR--RLEIP 659 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~--~~~ip 659 (720)
...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .....+..... ....+
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 764332 122356999999999974 566889999999999999999999999765432 22222221111 11223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++..+.+||.+||..||.+||++.+++++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 5678999999999999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=351.99 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=211.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC--CCceeEEeeeeecCCc
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPN 508 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~--HpNIVkL~g~~~~~~~ 508 (720)
..+..++|++.+.||+|+||.||++.+ +++.||||++............+.+|+.++++++ |+||+++++++.+...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 455667899999999999999999987 6788999999877767777788999999999996 5999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||| +.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||+++ +.+||+|||+++...
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 5588999999764 36899999999999999999999998 999999999999964 899999999998654
Q ss_pred CCcc--cCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHhhhhcccc
Q 004986 589 NTFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNR 654 (720)
Q Consensus 589 ~~~~--~~~s~~GT~~Y~APEvi~g-----------~~~s~ksDVWSLGilLyELltG~~PF~~~~~-~~i~~~i~~~~~ 654 (720)
.... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 3221 1234579999999999876 4688899999999999999999999987533 233333333334
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 655 ~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
...++...+.++.+||.+||..||.+||++.|++++-
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 4566777899999999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.88 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=202.6
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCC---------CHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------SGAALLEFKREVKIMRRLRHPNVVLFMGAV 503 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~---------~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~ 503 (720)
...++|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.++++++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 3457899999999999999999976 688999999865332 223346789999999999999999999998
Q ss_pred ec-----CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEE
Q 004986 504 TR-----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 578 (720)
Q Consensus 504 ~~-----~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL 578 (720)
.. ...+++||||+. ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEEE
Confidence 43 345899999997 5888888776667999999999999999999999998 999999999999999999999
Q ss_pred EeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc---
Q 004986 579 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--- 654 (720)
Q Consensus 579 ~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~--- 654 (720)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999754433 22344679999999999987 6789999999999999999999999998776655543321000
Q ss_pred ---------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 ---------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ---------------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.......+++.+.+||.+||+.||.+||++.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 001224568899999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=354.89 Aligned_cols=249 Identities=26% Similarity=0.341 Sum_probs=205.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----Cc
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 508 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~-----~~ 508 (720)
.++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 37899999999999999999988 58899999986433 344566788999999999999999999987654 67
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999999997 589999875 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc----------cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--
Q 004986 589 NTFL----------SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-- 655 (720)
Q Consensus 589 ~~~~----------~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~-- 655 (720)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3211 1223578999999998765 67899999999999999999999999987765443322100000
Q ss_pred ----------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 ----------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 ----------------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
......+++++.+||.+||+.||.+||++.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 01124678999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=351.13 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=206.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCC------ceeEEeeeee
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP------NVVLFMGAVT 504 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~Hp------NIVkL~g~~~ 504 (720)
+..++|++.+.||+|+||+||+|.+ +++.||||++... ......+.+|+.+++.++|+ +|+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3347899999999999999999976 5789999998643 33456788999999988665 4999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-----------
Q 004986 505 RPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----------- 572 (720)
Q Consensus 505 ~~~~l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~----------- 572 (720)
+.+.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999999 889999886543 46899999999999999999999998 999999999999987
Q ss_pred --------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 004986 573 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 644 (720)
Q Consensus 573 --------~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~ 644 (720)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999865432 334689999999999999999999999999999999999999999877655
Q ss_pred HHhhhhcccc------------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 004986 645 VVGAVGFQNR------------------------------------------RLEIPKELDPLVARIIWECWQTDPSLRP 682 (720)
Q Consensus 645 i~~~i~~~~~------------------------------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRP 682 (720)
....+..... ....+...++++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 4432211000 0011223467899999999999999999
Q ss_pred CHHHHHHH
Q 004986 683 SFAQLTVA 690 (720)
Q Consensus 683 S~~ELL~~ 690 (720)
++.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=357.64 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=206.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN------ 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~------ 508 (720)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6899999999999999999987 68999999998766666667788999999999999999999999987764
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 588877743 4899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc---------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 652 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~--------------- 652 (720)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 32 234678999999999987 67899999999999999999999999987765544332110
Q ss_pred --------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 653 --------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 653 --------------~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.........+++++.+||.+||+.||.+||++.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00112335678999999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=368.42 Aligned_cols=246 Identities=24% Similarity=0.267 Sum_probs=206.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc------CCCceeEEeeeeecCC
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL------RHPNVVLFMGAVTRPP 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L------~HpNIVkL~g~~~~~~ 507 (720)
..+|++.+.||+|+||+||+|.+ +++.||||++... ......+.+|+.+++.+ .|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 46799999999999999999987 5789999998653 33455677889888887 5679999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc--EEEEecccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLS 584 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--IKL~DFGlA 584 (720)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999999996 58988886533 45899999999999999999999998 999999999999999887 999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc---------
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------- 655 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--------- 655 (720)
+..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 250 CYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp EETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred eecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 765432 34568999999999999999999999999999999999999999988776554332210000
Q ss_pred ------------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 004986 656 ------------------------------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687 (720)
Q Consensus 656 ------------------------------------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~EL 687 (720)
..++...++++.+||.+||++||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 00122347889999999999999999999999
Q ss_pred HHH
Q 004986 688 TVA 690 (720)
Q Consensus 688 L~~ 690 (720)
++|
T Consensus 407 L~H 409 (429)
T 3kvw_A 407 LRH 409 (429)
T ss_dssp HTS
T ss_pred hCC
Confidence 975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.48 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=198.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec---------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 505 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--------- 505 (720)
++|++.+.||+|+||.||+|++ +++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5799999999999999999987 6899999998643 3446778899999999999999999998755
Q ss_pred ----CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 506 ----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 506 ----~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
...+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeC
Confidence 35689999999999999999765556888999999999999999999998 999999999999999999999999
Q ss_pred cccccccCC--------------cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHH
Q 004986 582 GLSRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM-NPMQV 645 (720)
Q Consensus 582 GlAk~~~~~--------------~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~-~~~~i 645 (720)
|++...... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||... +..+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999865422 1122345799999999999865 68999999999999999998 55432 22333
Q ss_pred Hhhhhcc--ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 646 VGAVGFQ--NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 646 ~~~i~~~--~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
...+... ..+..++...+..+++||.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 3333211 11233455677889999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.54 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=200.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee----------
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT---------- 504 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~---------- 504 (720)
++|++.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 7899999999999999999988 48899999987543 445678889999999999999999998873
Q ss_pred ----cCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEE
Q 004986 505 ----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVS 579 (720)
Q Consensus 505 ----~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~ 579 (720)
+...+++||||++ ++|.+++.+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 599999975 36899999999999999999999998 99999999999997 56799999
Q ss_pred eccccccccCCc---ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-
Q 004986 580 DFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR- 654 (720)
Q Consensus 580 DFGlAk~~~~~~---~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~- 654 (720)
|||+++...... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..+....+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998654321 12233467999999999876 6789999999999999999999999998876655443321100
Q ss_pred ---------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 655 ---------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 655 ---------------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....+..++.++++||.+||+.||.+||++.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 001234688999999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=364.35 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=200.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN------ 508 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~------ 508 (720)
..+|++.+.||+|+||+||+|++ .+..||+|++...... ..+|+.+|+.++|||||+++++|.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35799999999999999999988 5566999988654321 1369999999999999999999854433
Q ss_pred eEEEEeecCCCCHHHHHc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccc
Q 004986 509 LSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 585 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~--~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk 585 (720)
+++||||++++.+..+.. .....+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 889999998754444332 23457999999999999999999999998 99999999999999 79999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-----------
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 653 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~----------- 653 (720)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 191 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 191 ILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp ECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 76443 233456899999999999775 58999999999999999999999999887655443332100
Q ss_pred ------cc----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 ------RR----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 ------~~----------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ..++..+++++.+||.+||..||.+||++.|+++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 01334578999999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=356.64 Aligned_cols=271 Identities=19% Similarity=0.239 Sum_probs=200.9
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc----
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN---- 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~---- 508 (720)
..++|++.+.||+|+||+||+|++ +++.||||++...... ...+.+|++.+..++||||++++++|.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 347899999999999999999987 5889999988664322 2244567888888999999999999865433
Q ss_pred ---eEEEEeecCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEeeCCCCCcEEEcC-CCcEEEE
Q 004986 509 ---LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH--TSTPTIVHRDLKSPNLLVDK-NWNVKVS 579 (720)
Q Consensus 509 ---l~LVmEy~~ggsL~d~L~---~~~~~lse~~~~~Ia~qIa~AL~yLH--s~g~~IIHrDLKPeNILLd~-~g~IKL~ 579 (720)
+++||||++++ |.+.+. .....+++..++.++.||+.||.||| +++ |+||||||+||||+. ++.+||+
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEEC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEe
Confidence 88999999874 444332 34457899999999999999999999 777 999999999999996 8999999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc----
Q 004986 580 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---- 654 (720)
Q Consensus 580 DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~---- 654 (720)
|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 175 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 175 DFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 99999876543 2334567999999999997654 89999999999999999999999998877665544321000
Q ss_pred --------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCCCCCCCC
Q 004986 655 --------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 708 (720)
Q Consensus 655 --------------------------~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~p~~~~~ 708 (720)
....+...+.++++||.+||+.||.+||++.|+++|- -+.....+...-+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp-~f~~~~~~~~~~~~~~ 332 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP-YFDELHDPATKLPNNK 332 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG-GGGGGGCTTCCCTTSC
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc-cccccCCccccCCCCC
Confidence 0112233678999999999999999999999999862 2233444444444445
Q ss_pred CCCCC
Q 004986 709 ALPQE 713 (720)
Q Consensus 709 ~~~~~ 713 (720)
.++.+
T Consensus 333 ~~~~~ 337 (360)
T 3e3p_A 333 DLPED 337 (360)
T ss_dssp CCCGG
T ss_pred CCCcH
Confidence 55543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=354.49 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=187.9
Q ss_pred cccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHH-HHHHcCCCceeEEeeeeecC
Q 004986 430 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 430 ~~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~-iL~~L~HpNIVkL~g~~~~~ 506 (720)
..+.+..++|++.+.||+|+||.||+|.+ +++.||||++..... .....++..|+. +++.++||||+++++++.+.
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 34567789999999999999999999988 589999999976543 334455566666 66677999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 507 PNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~----~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
+..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999975 78777642 245789999999999999999999998 8 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHhhhhcccccc
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL 656 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi----~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~-~i~~~i~~~~~~~ 656 (720)
|+++...... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||...... +....+. .....
T Consensus 171 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~ 248 (327)
T 3aln_A 171 GISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDPP 248 (327)
T ss_dssp SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCCC
T ss_pred CCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCCC
Confidence 9998764432 22334799999999999 4667899999999999999999999999875432 2222221 11122
Q ss_pred CC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 EI----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ~i----p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+ ...+++.+.+||.+||..||.+||++.+++++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 22 24688999999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=388.75 Aligned_cols=260 Identities=30% Similarity=0.514 Sum_probs=222.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
.++..++|++.+.||+|+||+||+|.+. +..||||++.... .......+.+|+.+|++++|||||++++++. +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 4456688999999999999999999872 3568999876533 4445678899999999999999999999985 4
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 6789999999999999999866667999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 587 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 587 ~~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.. .....++..+++
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~ 619 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPP 619 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCCCCCTTCCH
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCCCccccH
Confidence 644322 2223457889999999999999999999999999999997 9999999888877776653 234567788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
.+.+||.+||..||.+||++.++++.|+.+..
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999998854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=376.24 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=212.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC-CceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H-pNIVkL~g~~~~~~~l~LV 512 (720)
.++|+++++||+|+||.||+|++ +++.||||++....... ++.+|+.+++.+.| ++|+.+..++.+.+..+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 37899999999999999999987 58999999887654332 46789999999976 6666777777788889999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE---cCCCcEEEEeccccccccC
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~IKL~DFGlAk~~~~ 589 (720)
|||+ +++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+|||| +.++.+||+|||+++....
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 99999999865667999999999999999999999998 9999999999999 6889999999999987654
Q ss_pred Ccc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhcc---cccc
Q 004986 590 TFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQ---NRRL 656 (720)
Q Consensus 590 ~~~-------~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---~i~~~i~~~---~~~~ 656 (720)
... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... +.+..+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 321 123568999999999999999999999999999999999999999875442 222222111 1111
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
.++..++.++.+||.+||..+|.+||++.+|++.|+.+..
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2335788999999999999999999999999999998844
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.86 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=202.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CC-cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc------eeEEeeeeec
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLFMGAVTR 505 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g-~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN------IVkL~g~~~~ 505 (720)
..++|++.+.||+|+||+||+|.+ ++ +.||||++... ......+.+|+.+++.++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 347899999999999999999987 33 68999998643 334567788999999997655 9999999999
Q ss_pred CCceEEEEeecCCCCHHHHHc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE--------------
Q 004986 506 PPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-------------- 570 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~-~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL-------------- 570 (720)
...+++||||+ +++|.+++. .....+++..++.++.||+.||+|||+++ |+||||||+||||
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccc
Confidence 99999999999 556666554 33357999999999999999999999998 9999999999999
Q ss_pred -----cCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 004986 571 -----DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 645 (720)
Q Consensus 571 -----d~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i 645 (720)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56889999999999864432 2446899999999999999999999999999999999999999998776554
Q ss_pred Hhhhhccccc------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 004986 646 VGAVGFQNRR------------------------------------------LEIPKELDPLVARIIWECWQTDPSLRPS 683 (720)
Q Consensus 646 ~~~i~~~~~~------------------------------------------~~ip~~ls~~l~dLI~~cL~~DP~kRPS 683 (720)
...+...... .......+.++.+||.+||+.||.+||+
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 3322110000 0011223568999999999999999999
Q ss_pred HHHHHHH
Q 004986 684 FAQLTVA 690 (720)
Q Consensus 684 ~~ELL~~ 690 (720)
+.|+++|
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.56 Aligned_cols=251 Identities=24% Similarity=0.245 Sum_probs=204.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CC-----ceeEEeeeee
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HP-----NVVLFMGAVT 504 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-Hp-----NIVkL~g~~~ 504 (720)
+...++|++.+.||+|+||+||+|.+ +++.||||++... .....++..|+.+++.++ |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34458999999999999999999987 5889999998643 334567788999998884 55 4999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEec
Q 004986 505 RPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDF 581 (720)
Q Consensus 505 ~~~~l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~IKL~DF 581 (720)
..+.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||.+..+|+||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999996 49999886543 468999999999999999999995333499999999999995 5788999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc-----
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----- 656 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~----- 656 (720)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999876432 345689999999999999999999999999999999999999999887766554432110000
Q ss_pred -----------CCC------------------C----------------------------CCcHHHHHHHHHhhhcCCC
Q 004986 657 -----------EIP------------------K----------------------------ELDPLVARIIWECWQTDPS 679 (720)
Q Consensus 657 -----------~ip------------------~----------------------------~ls~~l~dLI~~cL~~DP~ 679 (720)
.++ . ...+++++||.+||+.||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 000 0 0114789999999999999
Q ss_pred CCCCHHHHHHH
Q 004986 680 LRPSFAQLTVA 690 (720)
Q Consensus 680 kRPS~~ELL~~ 690 (720)
+|||+.|+++|
T Consensus 363 ~Rpta~e~L~h 373 (382)
T 2vx3_A 363 TRIQPYYALQH 373 (382)
T ss_dssp TSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.67 Aligned_cols=248 Identities=19% Similarity=0.293 Sum_probs=200.7
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-----------CCceeEEe
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFM 500 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-----------HpNIVkL~ 500 (720)
+..++|++.+.||+|+||+||+|++ +++.||||++... ......+.+|+.+++++. |+||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3457899999999999999999987 6899999998643 234566788999999886 89999999
Q ss_pred eeeecCC----ceEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeeCCCCCcEEEc---
Q 004986 501 GAVTRPP----NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVD--- 571 (720)
Q Consensus 501 g~~~~~~----~l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~-g~~IIHrDLKPeNILLd--- 571 (720)
+++...+ .+++||||+ +++|.+++.+ ....+++..++.++.||+.||.|||++ + |+||||||+||||+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9988654 689999999 8899999865 334689999999999999999999998 8 99999999999994
Q ss_pred ---CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----
Q 004986 572 ---KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----- 643 (720)
Q Consensus 572 ---~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~----- 643 (720)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876433 23457999999999999999999999999999999999999999865421
Q ss_pred -HHHhhhhc----------------------------------------cccccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 004986 644 -QVVGAVGF----------------------------------------QNRRLEIPKELDPLVARIIWECWQTDPSLRP 682 (720)
Q Consensus 644 -~i~~~i~~----------------------------------------~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRP 682 (720)
.....+.. ......++..++.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111100 0001123445678899999999999999999
Q ss_pred CHHHHHHH
Q 004986 683 SFAQLTVA 690 (720)
Q Consensus 683 S~~ELL~~ 690 (720)
++.|+++|
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.74 Aligned_cols=245 Identities=23% Similarity=0.420 Sum_probs=199.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHc----CCCceeEEeee
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRL----RHPNVVLFMGA 502 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L----~HpNIVkL~g~ 502 (720)
+...++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999987 68899999987654332 1223456799999998 89999999999
Q ss_pred eecCCceEEEEee-cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEe
Q 004986 503 VTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSD 580 (720)
Q Consensus 503 ~~~~~~l~LVmEy-~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~D 580 (720)
+.+.+..++|||| +.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 7899999999763 36899999999999999999999998 99999999999999 899999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCC
Q 004986 581 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659 (720)
Q Consensus 581 FGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s-~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip 659 (720)
||+++...... .....||..|+|||++.+..+. .++||||||+++|+|++|+.||.... +.. .....++
T Consensus 184 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~------~~~~~~~ 253 (312)
T 2iwi_A 184 FGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EIL------EAELHFP 253 (312)
T ss_dssp CSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HTCCCCC
T ss_pred cchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HHh------hhccCCc
Confidence 99998765432 3446799999999999877664 58999999999999999999996532 111 1234567
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..++..+.+||.+||..||.+||++.|++++
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 7899999999999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=360.40 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=183.3
Q ss_pred CCeeE-eEEeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeee--cCCce
Q 004986 437 EDLVL-GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNL 509 (720)
Q Consensus 437 ~~y~i-~k~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~--~~~~l 509 (720)
+.|++ +++||+|+||+||+|++ +++.||||++...... ..+.+|+.+|++++|||||+++++|. ....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34665 45799999999999986 3678999998765543 35678999999999999999999994 46779
Q ss_pred EEEEeecCCCCHHHHHcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEE----cCCCcEE
Q 004986 510 SIITEFLPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVK 577 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~--------~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~IK 577 (720)
++||||+.+ +|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+|
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 999999965 78777642 1224899999999999999999999998 9999999999999 6789999
Q ss_pred EEeccccccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------H
Q 004986 578 VSDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------Q 644 (720)
Q Consensus 578 L~DFGlAk~~~~~~---~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~---------~ 644 (720)
|+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998764321 223446899999999999874 5899999999999999999999999765431 1
Q ss_pred HHhhhhcccccc------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 004986 645 VVGAVGFQNRRL------------------------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLT 688 (720)
Q Consensus 645 i~~~i~~~~~~~------------------------------------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL 688 (720)
.+..+......+ ......+..+.+||.+||..||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111110000000 00112267899999999999999999999999
Q ss_pred HH
Q 004986 689 VA 690 (720)
Q Consensus 689 ~~ 690 (720)
+|
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 86
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.67 Aligned_cols=245 Identities=22% Similarity=0.380 Sum_probs=207.4
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHcC--CCceeEEeeeee
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVT 504 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L~--HpNIVkL~g~~~ 504 (720)
+...++|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457899999999999999999987 68899999997654322 11234667999999996 599999999999
Q ss_pred cCCceEEEEeecCC-CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEecc
Q 004986 505 RPPNLSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFG 582 (720)
Q Consensus 505 ~~~~l~LVmEy~~g-gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFG 582 (720)
+.+.+++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 8999998753 36899999999999999999999998 99999999999999 78999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCC
Q 004986 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 583 lAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ 661 (720)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ... .....++..
T Consensus 196 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~------~~~~~~~~~ 265 (320)
T 3a99_A 196 SGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFFRQR 265 (320)
T ss_dssp TCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCCSSC
T ss_pred ccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hhh------ccccccccc
Confidence 998765432 334679999999999987765 678999999999999999999996532 111 113345678
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++.++.+||.+||..||.+||++.|++++
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999999885
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.94 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=179.1
Q ss_pred CCeeEeE-EeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCce
Q 004986 437 EDLVLGE-RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNL 509 (720)
Q Consensus 437 ~~y~i~k-~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~----~~~l 509 (720)
++|++.+ .||+|+||+||+|.+ +++.||||++.... .... .....++.++||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6788855 699999999999988 58999999986531 1112 22234566799999999999876 4458
Q ss_pred EEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEeccccc
Q 004986 510 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSR 585 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlAk 585 (720)
++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999997643 46999999999999999999999998 999999999999976 4569999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHh----hhhcccc--ccCCC
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG----AVGFQNR--RLEIP 659 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~----~i~~~~~--~~~ip 659 (720)
..... .....+||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .+..... .....
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred ecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 65432 2334678999999999999889999999999999999999999998765543321 1111111 11223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCC
Q 004986 660 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 700 (720)
Q Consensus 660 ~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p 700 (720)
..++.++++||.+||..||.+||++.|++++----.....|
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 57899999999999999999999999999864333333333
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=362.62 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=196.9
Q ss_pred cCCCCCCeeEeEEeeecCcEEE-EEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCce
Q 004986 432 CEIPWEDLVLGERIGLGSYGEV-YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~V-yka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l 509 (720)
..+...+|.+.+.||+|+||+| |++..+++.||||++...... .+.+|+.+|+.+ +|||||++++++.+...+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 3455567999999999999985 555668999999998654332 346899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-----CCcEEEEecccc
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLS 584 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-----~g~IKL~DFGlA 584 (720)
|+|||||. |+|.+++......+.+..++.++.||+.||.|||+++ |+||||||+||||+. ...+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999996 5999999876656666677889999999999999998 999999999999953 235889999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccc-c
Q 004986 585 RLKHNTF---LSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR-L 656 (720)
Q Consensus 585 k~~~~~~---~~~~s~~GT~~Y~APEvi~---g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~-~ 656 (720)
+...... ......+||+.|+|||++. +..++.++|||||||++|||++ |..||...........+...... .
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8764321 2234567999999999998 4567889999999999999999 89999765554433322211111 1
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+...+..+++||.+||+.||.+||++.|+++|
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1223456779999999999999999999999954
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=353.05 Aligned_cols=244 Identities=26% Similarity=0.354 Sum_probs=187.9
Q ss_pred CCeeEeEEeeecCcEEEEEE-EECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka-~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|.+.+.||+|+||+||.+ ..+++.||||++.... ...+.+|+.+|+++ +|||||++++++.+...+++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 45677899999999999755 4489999999986542 34567899999887 89999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCC-------------Cc
Q 004986 515 FLPRGSLFRILHRPHCQ------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-------------WN 575 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~------lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-------------g~ 575 (720)
||. |+|.+++...... ..+..++.++.||+.||+|||+++ |+||||||+||||+.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 996 5999999764321 123345679999999999999998 9999999999999754 48
Q ss_pred EEEEeccccccccCCcc----cCCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 004986 576 VKVSDFGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 643 (720)
Q Consensus 576 IKL~DFGlAk~~~~~~~----~~~s~~GT~~Y~APEvi~g-------~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~ 643 (720)
+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654321 1234579999999999976 668999999999999999999 99999765443
Q ss_pred HHHhhhhcccccc-C----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 644 QVVGAVGFQNRRL-E----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 644 ~i~~~i~~~~~~~-~----ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+.. +....... . .+..++.++++||.+||+.||.+||++.++++|
T Consensus 247 ~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 321 11111111 1 122456889999999999999999999999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.89 Aligned_cols=231 Identities=15% Similarity=0.102 Sum_probs=193.2
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
..++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.++.+++||||+++++++.+.+.+|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 347899999999999999999998 4899999999876443 4556788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||++|++|.+++.+. ....++..|+.||+.||+|||++| |+||||||+||||+.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999999642 466678889999999999999998 9999999999999999999998554
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhh-hccccc----cCCCCCCcHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRR----LEIPKELDPLV 666 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i-~~~~~~----~~ip~~ls~~l 666 (720)
|++ .++.++|||||||++|||++|+.||.+.+..+..... ...... ..+...+++++
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 233 2789999999999999999999999886654322100 000111 12346789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
.+||.+||++||.+| |+.|+++.|+.+....
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999999999 9999999999986543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=322.93 Aligned_cols=224 Identities=25% Similarity=0.398 Sum_probs=182.6
Q ss_pred CCeeEe-EEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHH-HHcCCCceeEEeeeeec----CCc
Q 004986 437 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIM-RRLRHPNVVLFMGAVTR----PPN 508 (720)
Q Consensus 437 ~~y~i~-k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL-~~L~HpNIVkL~g~~~~----~~~ 508 (720)
++|.+. +.||+|+||.||+|.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 567776 7899999999999987 6889999998642 2456788888 55599999999999876 677
Q ss_pred eEEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecccc
Q 004986 509 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 584 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlA 584 (720)
+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999997543 46999999999999999999999998 999999999999998 789999999998
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--cccccCCC---
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP--- 659 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~--~~~~~~ip--- 659 (720)
.... +..++.++|||||||++|+|++|..||.............. ......++
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 6432 23467899999999999999999999987665443322211 11112222
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 004986 660 -KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 691 (720)
Q Consensus 660 -~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L 691 (720)
..++.++.+||.+||+.||.+||++.|+++|-
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 46899999999999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=367.32 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=201.0
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc--
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-- 508 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~-- 508 (720)
+..++|++.+.||+|+||+||+|.+ +++.||||++.... .......+.+|+.+|++++|||||++++++.+.+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 3457899999999999999999987 47899999886543 34456678899999999999999999999987666
Q ss_pred ---eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 509 ---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 509 ---l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
+||||||++|++|.+++.. .+++.+++.|+.||+.||.|||++| ||||||||+||||+.+ .+||+|||+++
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999998765 6899999999999999999999998 9999999999999885 99999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....+. ........++.
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------~~~~~~~~~~~ 296 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------EDDPVLKTYDS 296 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------TTCHHHHHCHH
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc--------ccccccccCHH
Confidence 76443 3467999999999998764 88999999999999999999888652211000 00000124578
Q ss_pred HHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhHhc
Q 004986 666 VARIIWECWQTDPSLRP-SFAQLTVALKPLQRLV 698 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRP-S~~ELL~~L~~i~~~~ 698 (720)
+.+||.+||+.||.+|| +++++...|..+.+..
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 99999999999999999 5777888888775544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.25 Aligned_cols=243 Identities=17% Similarity=0.142 Sum_probs=188.6
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCC-Ccee-------------
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVV------------- 497 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~H-pNIV------------- 497 (720)
...+|.+.+.||+|+||+||+|++ +++.||||++..... .......+.+|+.+++.+.| .|+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 445689999999999999999997 599999999874332 22335678899999999976 2211
Q ss_pred --E------Eeeeeec-----CCceEEEEeecCCCCHHHHHc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 004986 498 --L------FMGAVTR-----PPNLSIITEFLPRGSLFRILH------RPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558 (720)
Q Consensus 498 --k------L~g~~~~-----~~~l~LVmEy~~ggsL~d~L~------~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~I 558 (720)
. ++.++.. ...++++|+++ +++|.+++. .....+++..++.++.||+.||+|||+++ |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 1 1111111 22466777766 679999884 33445778899999999999999999998 9
Q ss_pred EeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccc----------cCCCCCchhhHHHHHHHHH
Q 004986 559 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL----------RNEPSNEKCDVYSFGVILW 628 (720)
Q Consensus 559 IHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi----------~g~~~s~ksDVWSLGilLy 628 (720)
|||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999865443 344678 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 629 ELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 629 ELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||++|+.||...+..+....+ ......++.++.+||.+||+.||.+||++.+++++
T Consensus 309 elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999887655443333 12234678999999999999999999997776543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=347.12 Aligned_cols=242 Identities=18% Similarity=0.182 Sum_probs=189.0
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCC------CHHHHHHHHHHHHHHHHcC---------CCceeE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRLR---------HPNVVL 498 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~------~~~~~~e~~~Ei~iL~~L~---------HpNIVk 498 (720)
+..++|++.+.||+|+||+||+|+++++.||||++..... .......+.+|+.+|+.++ |||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999986542 2223467889999999886 555555
Q ss_pred E-----------------eeeeec-------------CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHH
Q 004986 499 F-----------------MGAVTR-------------PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548 (720)
Q Consensus 499 L-----------------~g~~~~-------------~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL 548 (720)
+ +++|.+ ...+||||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5 444443 7889999999999976666644 4689999999999999999
Q ss_pred HHHH-hCCCCEEeeCCCCCcEEEcCCC--------------------cEEEEeccccccccCCcccCCCCCCCCCccCcc
Q 004986 549 NCLH-TSTPTIVHRDLKSPNLLVDKNW--------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 607 (720)
Q Consensus 549 ~yLH-s~g~~IIHrDLKPeNILLd~~g--------------------~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APE 607 (720)
+||| +++ |+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 888 99999999999999887 9999999999876532 347999999999
Q ss_pred cccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHhhhh----cccc-ccCCCCCCcHHHHHHHHHhhhcCCCC
Q 004986 608 VLRNEPSNEKCDVYSFGVI-LWELATLKLPWIGMNP-MQVVGAVG----FQNR-RLEIPKELDPLVARIIWECWQTDPSL 680 (720)
Q Consensus 608 vi~g~~~s~ksDVWSLGil-LyELltG~~PF~~~~~-~~i~~~i~----~~~~-~~~ip~~ls~~l~dLI~~cL~~DP~k 680 (720)
++.+.. +.++|||||+++ .++++.|..||..... ......+. .... ....+..+++++++||.+||++|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 999877 899999998776 7788999999854211 11111211 1110 11122357889999999999977
Q ss_pred CCCHHHHH-HH
Q 004986 681 RPSFAQLT-VA 690 (720)
Q Consensus 681 RPS~~ELL-~~ 690 (720)
|+.|++ +|
T Consensus 324 --sa~e~l~~H 332 (336)
T 2vuw_A 324 --SATDLLCQH 332 (336)
T ss_dssp --SHHHHHHHC
T ss_pred --CHHHHHhcC
Confidence 899988 54
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=360.67 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=203.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------CC
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PP 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~------~~ 507 (720)
.++|++.+.||+|+||+||+|.+ +++.||||++... ........+.+|+.++++++|||||++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999986 6889999988654 345556778999999999999999999998765 67
Q ss_pred ceEEEEeecCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCc---EEEEecc
Q 004986 508 NLSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFG 582 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~--~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---IKL~DFG 582 (720)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999997633 36889999999999999999999998 999999999999997665 9999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHh---------hh----
Q 004986 583 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG---------AV---- 649 (720)
Q Consensus 583 lAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~---------~i---- 649 (720)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765432 3345689999999999999999999999999999999999999997643221110 00
Q ss_pred ------hccc---cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHhh
Q 004986 650 ------GFQN---RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPL 694 (720)
Q Consensus 650 ------~~~~---~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~E-----LL~~L~~i 694 (720)
.+.. .+..+...++..+.+||.+||..||.+||++.| +.+.++.+
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 0000 011133446789999999999999999999988 44555555
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=299.36 Aligned_cols=187 Identities=16% Similarity=0.097 Sum_probs=134.8
Q ss_pred EEeeecCcEEEEEEEE--CCcEEEEEEEecCCC--------CHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCCceEE
Q 004986 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--------SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~--------~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~~l~L 511 (720)
..++.|++|.+..+++ .|+.||||++.+... .+....+|.+|+++|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3577888888877754 799999999976532 123456799999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
||||++|++|.++|.+.+ .+++. .|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999998754 56654 47889999999999999 9999999999999999999999999999776554
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 636 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~P 636 (720)
....+.+||+.|||||++.+. +..++|+|++|+++++|.++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 555667899999999999875 56789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=273.11 Aligned_cols=186 Identities=15% Similarity=0.226 Sum_probs=148.8
Q ss_pred eEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 440 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 440 ~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~------~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
...+.||+|+||+||+|++.++.+++|++........ ....+.+|+.+|++++||||+++..++...+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3456899999999999988999999998765443321 2345789999999999999996666666777889999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+++++|.+++.+ ++.++.||+.||+|||+++ |+||||||+|||++. ++||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999975 4578999999999999998 999999999999999 9999999999976543211
Q ss_pred -------CCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004986 594 -------SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWI 638 (720)
Q Consensus 594 -------~~s~~GT~~Y~APEvi~g--~~~s~ksDVWSLGilLyELltG~~PF~ 638 (720)
....+||+.|||||++.+ ..|+...|+|+..+-..+.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135689999999999987 567888999999998888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=219.51 Aligned_cols=145 Identities=19% Similarity=0.170 Sum_probs=116.0
Q ss_pred CeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCH----------------HHHHHHHHHHHHHHHcCCCceeEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------AALLEFKREVKIMRRLRHPNVVLFM 500 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~----------------~~~~e~~~Ei~iL~~L~HpNIVkL~ 500 (720)
.|.+++.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+|++++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 345669999999999999998 68899999986432211 23567889999999999 4 6666
Q ss_pred eeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEe
Q 004986 501 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 580 (720)
Q Consensus 501 g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~D 580 (720)
+++.. +.+|+||||++|++|.+ +.. .....++.||+.||.|||++| |+||||||+||||+ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65543 56799999999999998 422 123468999999999999998 99999999999999 99999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCccccc
Q 004986 581 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610 (720)
Q Consensus 581 FGlAk~~~~~~~~~~s~~GT~~Y~APEvi~ 610 (720)
||+++. +..|+|||.+.
T Consensus 236 FG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE-------------TTSTTHHHHHH
T ss_pred CCCCeE-------------CCCCCHHHHHH
Confidence 999963 33478899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=186.62 Aligned_cols=138 Identities=20% Similarity=0.232 Sum_probs=107.8
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcE--EEEEEEecCCCC----------------------HHHHHHHHHHHHHHHHc
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFS----------------------GAALLEFKREVKIMRRL 491 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~--VAVK~i~~~~~~----------------------~~~~~e~~~Ei~iL~~L 491 (720)
-|++.+.||+|+||.||+|.+ +|+. ||||+++..... ......+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999987 8889 999987543211 01123578899999999
Q ss_pred CCCce--eEEeeeeecCCceEEEEeecCC-C----CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEeeCC
Q 004986 492 RHPNV--VLFMGAVTRPPNLSIITEFLPR-G----SLFRILHRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDL 563 (720)
Q Consensus 492 ~HpNI--VkL~g~~~~~~~l~LVmEy~~g-g----sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLH-s~g~~IIHrDL 563 (720)
.|++| ..+++. ...+|||||+.+ | .|.++... .++..+..++.||+.+|.||| .+| |+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 87754 334432 367899999942 3 78877542 234566788999999999999 888 999999
Q ss_pred CCCcEEEcCCCcEEEEeccccccc
Q 004986 564 KSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 564 KPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=7.6e-17 Score=176.98 Aligned_cols=137 Identities=15% Similarity=0.160 Sum_probs=98.6
Q ss_pred eeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCC---------------CHHH-----HHHHHHHHHHHHHcCCCcee
Q 004986 439 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------------SGAA-----LLEFKREVKIMRRLRHPNVV 497 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~---------------~~~~-----~~e~~~Ei~iL~~L~HpNIV 497 (720)
|.+++.||+|+||.||+|.. +|+.||||+++.... .... .....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999987 789999998753211 0000 01124567777777544432
Q ss_pred EEeeeeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC---
Q 004986 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 574 (720)
Q Consensus 498 kL~g~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g--- 574 (720)
...-+.. ...+|||||++|+.|.++... .....++.||+.+|.+||++| ||||||||.||||+++|
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcc
Confidence 2111111 234799999999888665321 123457789999999999998 99999999999998776
Q ss_pred -------cEEEEecccccc
Q 004986 575 -------NVKVSDFGLSRL 586 (720)
Q Consensus 575 -------~IKL~DFGlAk~ 586 (720)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.8e-12 Score=129.40 Aligned_cols=141 Identities=16% Similarity=0.036 Sum_probs=111.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEEee
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+.|++...++.|+.+.||++...++.+++|+........ ...+.+|+.+++.+. +..+.++++++.+.+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 468888899999999999998888999999876532111 235788999999984 67788899999888899999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST---------------------------------------- 555 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g---------------------------------------- 555 (720)
++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 92 i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999886421 1223367789999999999810
Q ss_pred -----------------CCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 556 -----------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 556 -----------------~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 249999999999999876566799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=7.9e-11 Score=117.97 Aligned_cols=135 Identities=19% Similarity=0.135 Sum_probs=99.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN--IVkL~g~~~~~~~l~LVm 513 (720)
..+.+....+.|..+.||++.. +++.+++|...... ...+.+|+.+++.+.+.+ +.++++++...+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 4455544444666699999976 46789999865431 235678999999885434 556888888888899999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-------------------------------------- 555 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g-------------------------------------- 555 (720)
||++|.+|. ... ... ..++.+++..|..||...
T Consensus 95 e~i~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998884 221 222 245678888888888743
Q ss_pred ------------------CCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 556 ------------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 556 ------------------~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.1e-10 Score=122.37 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=107.0
Q ss_pred EeEEeeecCcEEEEEEEECCcEEEEEEEe--cCCCCHHHHHHHHHHHHHHHHcC--CCceeEEeeeeecC---CceEEEE
Q 004986 441 LGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRP---PNLSIIT 513 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~g~~VAVK~i~--~~~~~~~~~~e~~~Ei~iL~~L~--HpNIVkL~g~~~~~---~~l~LVm 513 (720)
..+.|+.|.++.||+++..+..+++|+.. .... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46779999999999998888888988765 2221 112346788999999996 45578888888776 4489999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS--------------------------------------- 554 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~--------------------------------------- 554 (720)
||++|..+.+.. -..++..+...++.+++.+|..||..
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999997764321 12367888888999999999999973
Q ss_pred -----------------CCCEEeeCCCCCcEEEcCCCc--EEEEecccccc
Q 004986 555 -----------------TPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 586 (720)
Q Consensus 555 -----------------g~~IIHrDLKPeNILLd~~g~--IKL~DFGlAk~ 586 (720)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997753 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=9.8e-10 Score=114.69 Aligned_cols=184 Identities=19% Similarity=0.172 Sum_probs=121.5
Q ss_pred EEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCc--eeEEeeeeecCC---ceEEEEeec
Q 004986 443 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN--VVLFMGAVTRPP---NLSIITEFL 516 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpN--IVkL~g~~~~~~---~l~LVmEy~ 516 (720)
+.++.|.+..||++. ..+++|+.... .....+.+|..+|+.+ .+.. +.+.+....... ..|+|||++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 459999999999874 66888875322 3456788999999988 3332 334444443333 347899999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 004986 517 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST----------------------------------------- 555 (720)
Q Consensus 517 ~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g----------------------------------------- 555 (720)
+|..|.+... ..++..++..++.+++..|..||...
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865332 13677777888889999888888621
Q ss_pred ---------------CCEEeeCCCCCcEEEcC--CCcEEEEeccccccccCCcccCCCCCCCCCccCccccc----CCC-
Q 004986 556 ---------------PTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR----NEP- 613 (720)
Q Consensus 556 ---------------~~IIHrDLKPeNILLd~--~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~----g~~- 613 (720)
+.++|+|++|.|||++. .+.+.|+||+.+..-..... .........-..|+... ...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHHHHHcCC
Confidence 24899999999999998 45689999998865321110 00000000002333221 111
Q ss_pred C---------CchhhHHHHHHHHHHHHhCCCCC
Q 004986 614 S---------NEKCDVYSFGVILWELATLKLPW 637 (720)
Q Consensus 614 ~---------s~ksDVWSLGilLyELltG~~PF 637 (720)
. ....+.|+++.++|.+.+|+.+|
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 12368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.6e-06 Score=91.13 Aligned_cols=135 Identities=18% Similarity=0.150 Sum_probs=95.6
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCC---ceeEEeeeee-cCCceEEEEeecC
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVT-RPPNLSIITEFLP 517 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~Hp---NIVkL~g~~~-~~~~l~LVmEy~~ 517 (720)
.+.++.|....||+. +..+++|+-. .......+.+|..+|+.+.+. .+.+.+.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456899999999998 6788888742 223456788999999999642 2455666553 4456789999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 004986 518 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------------------------------------------ 555 (720)
Q Consensus 518 ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g------------------------------------------ 555 (720)
|..|.+..-. .++..+...++.++...|..||...
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9888763221 2355555556666666666666432
Q ss_pred ----------------CCEEeeCCCCCcEEEcC---CCcE-EEEecccccc
Q 004986 556 ----------------PTIVHRDLKSPNLLVDK---NWNV-KVSDFGLSRL 586 (720)
Q Consensus 556 ----------------~~IIHrDLKPeNILLd~---~g~I-KL~DFGlAk~ 586 (720)
+.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 14699999999999987 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.1e-06 Score=85.89 Aligned_cols=132 Identities=18% Similarity=0.225 Sum_probs=92.9
Q ss_pred EeeecCcE-EEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEEeecCCC
Q 004986 444 RIGLGSYG-EVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 444 ~LGkG~fG-~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
.+..|..| .||+... .+..+++|+-... ...++.+|..+|+.+. +--+.+++.++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 35556555 6898865 4567888875432 3456788999999884 333667888888888999999999998
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 004986 520 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-------------------------------------------- 555 (720)
Q Consensus 520 sL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g-------------------------------------------- 555 (720)
++.+..... ......++.+++..|..||...
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765321 1122234555566666665421
Q ss_pred ------------CCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 556 ------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 556 ------------~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127999999999999987777899999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.6e-06 Score=91.89 Aligned_cols=82 Identities=6% Similarity=-0.024 Sum_probs=54.1
Q ss_pred eEeEEe-eecCcEEEEEEEEC--------CcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcC-C--CceeEEeeeeecC
Q 004986 440 VLGERI-GLGSYGEVYHADWN--------GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTRP 506 (720)
Q Consensus 440 ~i~k~L-GkG~fG~Vyka~~~--------g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~-H--pNIVkL~g~~~~~ 506 (720)
...+.| +.|....+|++... +..+++|+...... .......+.+|+.+|+.+. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88999999998764 67788887543220 0000134567888888773 2 3466777776654
Q ss_pred ---CceEEEEeecCCCCH
Q 004986 507 ---PNLSIITEFLPRGSL 521 (720)
Q Consensus 507 ---~~l~LVmEy~~ggsL 521 (720)
+..++||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=4.4e-05 Score=79.42 Aligned_cols=138 Identities=15% Similarity=0.061 Sum_probs=78.8
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC--CCceeEEee------eeecCCceEEEE
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMG------AVTRPPNLSIIT 513 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~--HpNIVkL~g------~~~~~~~l~LVm 513 (720)
.+.|+.|..+.||++...+..+++|+.... . .++..|..+++.|. .-.+.+++. +....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456777788999999887777999987652 1 23334555555542 112333333 123456688999
Q ss_pred eecCCCCHH-----------HHH---c---C-C--CC-------CCCHHH------------------------------
Q 004986 514 EFLPRGSLF-----------RIL---H---R-P--HC-------QVDEKR------------------------------ 536 (720)
Q Consensus 514 Ey~~ggsL~-----------d~L---~---~-~--~~-------~lse~~------------------------------ 536 (720)
||++|..+. ..| + . . .. ...+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986431 111 1 1 0 00 011111
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 537 -RIKMALDVARGMNCLHT-----------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 537 -~~~Ia~qIa~AL~yLHs-----------~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...+..++..++.+|+. ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 00111223345666653 22359999999999999888899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.5e-05 Score=84.37 Aligned_cols=77 Identities=17% Similarity=0.131 Sum_probs=49.0
Q ss_pred EeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC--CH---HHHHHHHHHHHHHHHcC-C-Cc-eeEEeeeeecCCceE
Q 004986 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SG---AALLEFKREVKIMRRLR-H-PN-VVLFMGAVTRPPNLS 510 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~--~~---~~~~e~~~Ei~iL~~L~-H-pN-IVkL~g~~~~~~~l~ 510 (720)
..+.||.|.++.||+++. .++.++||....... .. .....+..|..+|+.+. + +. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999954 567899997643211 00 01234567888888773 2 33 3455543 345568
Q ss_pred EEEeecCCC
Q 004986 511 IITEFLPRG 519 (720)
Q Consensus 511 LVmEy~~gg 519 (720)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=9.2e-05 Score=78.61 Aligned_cols=76 Identities=20% Similarity=0.126 Sum_probs=60.7
Q ss_pred EeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeeeeecCCceEEEEeecC
Q 004986 441 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLP 517 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~---HpNIVkL~g~~~~~~~l~LVmEy~~ 517 (720)
-.+.|+.|.+..+|+....+..+++|+.... ....+..|...|+.|. ...+.+.+.+....+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3577999999999999888888999976543 2456788988888883 3567788888887788999999999
Q ss_pred CCCH
Q 004986 518 RGSL 521 (720)
Q Consensus 518 ggsL 521 (720)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00014 Score=79.51 Aligned_cols=75 Identities=15% Similarity=0.053 Sum_probs=46.2
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCC--CCH-----HHHHHHHHHHHHHHH-cCCCceeEEeeeeecCCceEEEE
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQD--FSG-----AALLEFKREVKIMRR-LRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~--~~~-----~~~~e~~~Ei~iL~~-L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.+.||.|..+.||++...+..++||...... ... .....++.|+..+.. .....+.+++.+. ....++||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 5779999999999998777889999432210 000 012233444433322 2334566666655 46779999
Q ss_pred eec-CC
Q 004986 514 EFL-PR 518 (720)
Q Consensus 514 Ey~-~g 518 (720)
||+ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00051 Score=69.71 Aligned_cols=139 Identities=18% Similarity=0.168 Sum_probs=95.6
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCCCC
Q 004986 519 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 597 (720)
Q Consensus 519 gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yL-Hs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~s~ 597 (720)
.+|.++|...+.+++++++|.++.|.+.+|.-+ +... -..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 379999988788999999999999999998765 2222 11233457999999999998863 2111
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhc-
Q 004986 598 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT- 676 (720)
Q Consensus 598 ~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~- 676 (720)
.....+.|||... ...+.+.=|||||+++|..+--..| ...+..+++.+..||..|...
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcc
Confidence 1223466888763 3456889999999999998853322 223457899999999999866
Q ss_pred ------------------------CCCCCCCHHHHHHHHH
Q 004986 677 ------------------------DPSLRPSFAQLTVALK 692 (720)
Q Consensus 677 ------------------------DP~kRPS~~ELL~~L~ 692 (720)
.+..|+++++|++.=.
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 2467889999886543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00036 Score=72.37 Aligned_cols=71 Identities=11% Similarity=0.085 Sum_probs=44.0
Q ss_pred eEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCceEEEEeec-CCC
Q 004986 442 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFL-PRG 519 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNI-VkL~g~~~~~~~l~LVmEy~-~gg 519 (720)
.+.|+.|....+|++ ..+++|+..... .......+|..+++.+...++ .++++++ .+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 578999999999999 668888765421 111223467777777632222 3555443 34457899999 654
Q ss_pred CH
Q 004986 520 SL 521 (720)
Q Consensus 520 sL 521 (720)
.|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 33
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00064 Score=70.65 Aligned_cols=144 Identities=13% Similarity=0.084 Sum_probs=79.9
Q ss_pred CeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeee------eecCCce
Q 004986 438 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGA------VTRPPNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN--IVkL~g~------~~~~~~l 509 (720)
+..-.+.|+.|....+|++...+..+++|+..... ....+..|+.+++.|...+ +.+++.. ....+..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34456778889999999998766678899876521 1224456777777663212 2333321 1223557
Q ss_pred EEEEeecCCCCHH-----------HH---Hc----CCCCC----CC---HHHHHH------------HHHHHHHHHHHHH
Q 004986 510 SIITEFLPRGSLF-----------RI---LH----RPHCQ----VD---EKRRIK------------MALDVARGMNCLH 552 (720)
Q Consensus 510 ~LVmEy~~ggsL~-----------d~---L~----~~~~~----ls---e~~~~~------------Ia~qIa~AL~yLH 552 (720)
+++|+|++|..+. .. ++ .-... .. +...+. +...+...+++++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999886421 11 11 10000 01 111000 0011334455554
Q ss_pred hC-----CCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 553 TS-----TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 553 s~-----g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
.. ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 32 1259999999999999887666899999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0016 Score=66.97 Aligned_cols=77 Identities=17% Similarity=0.145 Sum_probs=53.7
Q ss_pred CeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-C--CceeEEeeeeecCCceEEEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-H--pNIVkL~g~~~~~~~l~LVm 513 (720)
+..-.+.+|.|..+.||+++. +|+.|.+|+-....... ...|..|...|+.|. . --+.+.+.+. .-++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 455678899999999999987 68899999754432221 234678999998884 2 1244455442 347899
Q ss_pred eecCCCC
Q 004986 514 EFLPRGS 520 (720)
Q Consensus 514 Ey~~ggs 520 (720)
||++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00075 Score=70.81 Aligned_cols=30 Identities=40% Similarity=0.489 Sum_probs=26.7
Q ss_pred CEEeeCCCCCcEEEcCC----CcEEEEecccccc
Q 004986 557 TIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 586 (720)
Q Consensus 557 ~IIHrDLKPeNILLd~~----g~IKL~DFGlAk~ 586 (720)
.++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 59999999999999874 6899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0019 Score=71.23 Aligned_cols=71 Identities=14% Similarity=0.216 Sum_probs=47.8
Q ss_pred EeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCceE
Q 004986 441 LGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLS 510 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN-IVkL~g~~~~~~~l~ 510 (720)
-.+.|+.|....||++... +..+++|+..... . ...+.+|..+++.|...+ ..++++.+.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3567889999999999864 4678888874321 1 134447888888874323 3566666543 3
Q ss_pred EEEeecCCC
Q 004986 511 IITEFLPRG 519 (720)
Q Consensus 511 LVmEy~~gg 519 (720)
+||||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0053 Score=63.83 Aligned_cols=74 Identities=9% Similarity=0.042 Sum_probs=46.7
Q ss_pred EEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeee-----eecCCceEEEEe
Q 004986 443 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGA-----VTRPPNLSIITE 514 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN--IVkL~g~-----~~~~~~l~LVmE 514 (720)
..|+ |....||++.. +|+.+++|........ ...+..|..+++.+.... +++++.. ....+..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 88889999876 4667999987643332 234566777777773212 3444443 122345678999
Q ss_pred ecCCCC
Q 004986 515 FLPRGS 520 (720)
Q Consensus 515 y~~ggs 520 (720)
|++|..
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0024 Score=71.20 Aligned_cols=72 Identities=17% Similarity=0.096 Sum_probs=47.1
Q ss_pred eEEeeecCcEEEEEEEECC--cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeeeeecCCceEEEEeecCC
Q 004986 442 GERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPR 518 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g--~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNI-VkL~g~~~~~~~l~LVmEy~~g 518 (720)
.+.|+.|-...+|++...+ ..+++|+..... .. .....+|..+++.|...++ .++++.+. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 5678889999999998865 788888764321 10 1122578899998864444 46776663 2 359999987
Q ss_pred CC
Q 004986 519 GS 520 (720)
Q Consensus 519 gs 520 (720)
..
T Consensus 186 ~~ 187 (458)
T 2qg7_A 186 YA 187 (458)
T ss_dssp EE
T ss_pred cc
Confidence 43
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0007 Score=72.28 Aligned_cols=72 Identities=13% Similarity=0.156 Sum_probs=42.9
Q ss_pred eEEeeecCcEEEEEEEECC----------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCceE
Q 004986 442 GERIGLGSYGEVYHADWNG----------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLS 510 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~~g----------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN-IVkL~g~~~~~~~l~ 510 (720)
.+.|+.|....+|++...+ ..+++|+..... ........|..+++.+...+ +.++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4678888889999998754 678888754321 11112457788888774223 345665442 37
Q ss_pred EEEeecCCCC
Q 004986 511 IITEFLPRGS 520 (720)
Q Consensus 511 LVmEy~~ggs 520 (720)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0046 Score=65.68 Aligned_cols=30 Identities=23% Similarity=0.426 Sum_probs=27.2
Q ss_pred CEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 557 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 557 ~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 599999999999999888899999987764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0014 Score=71.30 Aligned_cols=137 Identities=13% Similarity=0.162 Sum_probs=79.7
Q ss_pred EEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEE
Q 004986 443 ERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 443 k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LV 512 (720)
+.|..|-...+|++... ++.|.+|+.... .. ....+.+|..+++.|. +.-..++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 56777888899999763 367888875321 11 2345568999998873 3223566666554 399
Q ss_pred EeecCCCCHH--------------HHH---cCCC----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 004986 513 TEFLPRGSLF--------------RIL---HRPH----CQVD--EKRRIKMALDVAR-------------------GMNC 550 (720)
Q Consensus 513 mEy~~ggsL~--------------d~L---~~~~----~~ls--e~~~~~Ia~qIa~-------------------AL~y 550 (720)
|||++|..|. +.| +... .... +.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999875432 111 1211 1122 3444445543321 1222
Q ss_pred ----HHhC--CCCEEeeCCCCCcEEEcCC----CcEEEEecccccc
Q 004986 551 ----LHTS--TPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 586 (720)
Q Consensus 551 ----LHs~--g~~IIHrDLKPeNILLd~~----g~IKL~DFGlAk~ 586 (720)
|... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 2259999999999999876 7899999998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.58 E-value=0.0086 Score=66.17 Aligned_cols=73 Identities=12% Similarity=0.116 Sum_probs=47.4
Q ss_pred EeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceE
Q 004986 441 LGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~ 510 (720)
-.+.|..|-...+|++... +..|++++..... .......+|..+++.+. +.-..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3466777888999999875 5788888754321 11223457888888773 322345555432 27
Q ss_pred EEEeecCCCC
Q 004986 511 IITEFLPRGS 520 (720)
Q Consensus 511 LVmEy~~ggs 520 (720)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999999865
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=94.92 E-value=0.015 Score=61.22 Aligned_cols=53 Identities=19% Similarity=0.186 Sum_probs=41.3
Q ss_pred eccccchhhHHHHHHHhhhcCCCceeeecccccC--CCCCceeEEeecCcceeehc
Q 004986 23 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG--VEDDAVNIIKLEEEREFLVD 76 (720)
Q Consensus 23 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~--~~~~~~~~~~~~~~~~~~~d 76 (720)
-+.|+|++-|.||..|+-.+|||||+|-|.-... .+.-||++|.+.+ .=+-+|
T Consensus 176 ~~~G~C~d~A~l~val~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g-gWv~~D 230 (293)
T 3isr_A 176 ERAGVCRDFAHLGIALCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG-NWIIFD 230 (293)
T ss_dssp HCEECHHHHHHHHHHHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT-EEEEEC
T ss_pred CCcEehHHHHHHHHHHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC-cEEEEE
Confidence 4689999999999999999999999999975421 1233899999865 334444
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=93.29 E-value=0.058 Score=56.78 Aligned_cols=51 Identities=16% Similarity=0.126 Sum_probs=41.8
Q ss_pred eeccccchhhHHHHHHHhhhcCCCceeeecccccCCCCCceeEEeecC-cceeehcc
Q 004986 22 SINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVDL 77 (720)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~~~~~~~~~~~~~-~~~~~~d~ 77 (720)
.-+.|+|++-|.||-+|+-.+|||||+|-|. ++-||.+|.+.. ..=+-||-
T Consensus 137 ~~r~G~C~d~A~lf~al~Ra~GIpAR~V~Gy-----~~HaW~Evy~~g~~gWv~~Dp 188 (295)
T 2f4m_A 137 ETRCGRCGEWANCFTLCCRALGFEARYVWDY-----TDHVWTEVYSPSQQRWLHCDA 188 (295)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEET-----TTEEEEEEEETTTTEEEEEET
T ss_pred HcCCEeeHHHHHHHHHHHHHCCCCEEEEcCC-----CCEEEEEEEECCCCeEEEEeC
Confidence 3479999999999999999999999999997 355999999876 33334443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.57 E-value=0.32 Score=52.68 Aligned_cols=30 Identities=23% Similarity=0.411 Sum_probs=25.4
Q ss_pred CEEeeCCCCCcEEE------cCCCcEEEEecccccc
Q 004986 557 TIVHRDLKSPNLLV------DKNWNVKVSDFGLSRL 586 (720)
Q Consensus 557 ~IIHrDLKPeNILL------d~~g~IKL~DFGlAk~ 586 (720)
.++|+|+.+.|||+ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567899999998863
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=91.67 E-value=0.13 Score=54.91 Aligned_cols=51 Identities=22% Similarity=0.164 Sum_probs=42.0
Q ss_pred eeccccchhhHHHHHHHhhhcCCCceeeecccccCCCCCceeEEeecCcceee-hcc
Q 004986 22 SINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREFL-VDL 77 (720)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~d~ 77 (720)
..+.|.|.|=|-||-+|+-.+||++|+|.|. .|-+|.+|.+.....+| ||-
T Consensus 178 ~tr~G~C~e~A~lF~~llRalGi~aR~V~~~-----~~H~W~EV~~~~~~rWv~vDp 229 (335)
T 1x3z_A 178 ETRKGRCGEWCNLFTLILKSFGLDVRYVWNR-----EDHVWCEYFSNFLNRWVHVDS 229 (335)
T ss_dssp HHCEECHHHHHHHHHHHHHTTTCCEEEEEET-----TTEEEEEEEETTTTEEEEEET
T ss_pred HhCCcChHHHHHHHHHHHHHCCCCeEEEecC-----CCcEEEEEEECCCCCEEEECC
Confidence 4568999999999999999999999999884 47799999987754332 443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 720 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-83 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-76 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-73 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-73 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-73 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-72 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-71 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-70 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-70 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-70 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-69 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-68 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-68 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-67 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-67 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-67 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-65 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-64 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-61 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-61 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-60 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-47 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (672), Expect = 3e-83
Identities = 93/273 (34%), Positives = 151/273 (55%), Gaps = 13/273 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
EIP + +G+RIG GS+G VY W+G VAVK + L FK EV ++R+ R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
H N++LFMG T P L+I+T++ SL+ LH + + + I +A A+GM+ LH
Sbjct: 63 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 610
+I+HRDLKS N+ + ++ VK+ DFGL+ +K S + +G+ WMAPEV+R
Sbjct: 122 A--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 611 NE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----EIPKELD 663
+ P + + DVY+FG++L+EL T +LP+ +N + + + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ R++ EC + RP F Q+ +++ L R
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 1e-76
Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 13/267 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
+ ++L L + IG G +G+V D+ G +VAVK + A F E +M +LR
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 493 HPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 550
H N+V +G + L I+TE++ +GSL L R + +K +LDV M
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
L VHRDL + N+LV ++ KVSDFGL++ +T + +W APE LR
Sbjct: 119 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 611 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669
+ + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P V +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEV 232
Query: 670 IWECWQTDPSLRPSFAQLTVALKPLQR 696
+ CW D ++RPSF QL L+ ++
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 7e-73
Identities = 80/257 (31%), Positives = 122/257 (47%), Gaps = 9/257 (3%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
I +DL + +G G +G V + W +VA+K + S EF E K+M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
H +V G T+ + IITE++ G L L + ++ ++M DV M L
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 611
+ +HRDL + N LV+ VKVSDFGLSR + + + SS + W PEVL
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 612 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 671 WECWQTDPSLRPSFAQL 687
+ CW RP+F L
Sbjct: 235 YSCWHEKADERPTFKIL 251
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 8e-73
Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 11/261 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 495 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMN 549
N+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 550 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 606
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 667 ARIIWECWQTDPSLRPSFAQL 687
II RPS ++
Sbjct: 243 NEIITRMLNLKDYHRPSVEEI 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 236 bits (602), Expect = 9e-73
Identities = 87/287 (30%), Positives = 135/287 (47%), Gaps = 20/287 (6%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 487
EI + + + IG G +GEV VA+K L ++ +F E I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASI 80
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
M + HPNV+ G VT+ + IITEF+ GSL L + Q + + M +A G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPE 602
M L VHRDL + N+LV+ N KVSDFGLSR T+ S+
Sbjct: 141 MKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
W APE ++ DV+S+G+++WE+ + + P+ M V+ A+ Q+ RL P +
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 708
+ +++ +CWQ D + RP F Q+ L + R +P+ +
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR-----NPNSLKA 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 1e-72
Identities = 81/265 (30%), Positives = 130/265 (49%), Gaps = 9/265 (3%)
Query: 434 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
I +L + IG G +G V+ W N +VA+K + S +F E ++M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HP +V G + ++ EF+ G L L + + M LDV GM L
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 611
++HRDL + N LV +N +KVSDFG++R + + + SS T +W +PEV
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 612 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 671 WECWQTDPSLRPSFAQLTVALKPLQ 695
CW+ P RP+F++L L +
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 9e-72
Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 11/266 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
E+P E L L ER+G G +GEV+ +N T+VAVK S F E +M++L
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQL 65
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNC 550
+H +V VT+ P + IITE++ GSL L P ++ + + MA +A GM
Sbjct: 66 QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 609
+ +HRDL++ N+LV + K++DFGL+R ++ N + + + +W APE +
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P + +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQ 241
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPL 694
++ CW+ P RP+F L L+
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 1e-71
Identities = 87/274 (31%), Positives = 129/274 (47%), Gaps = 13/274 (4%)
Query: 432 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLE-FKREV 485
C I +DL L E++G GS+G V +W+ VAVK S ++ F REV
Sbjct: 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
M L H N++ G V PP + ++TE P GSL L + + A+ VA
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 602
GM L + +HRDL + NLL+ VK+ DFGL R + ++ +
Sbjct: 122 EGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P++
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695
+ ++ +CW P RP+F L L Q
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 1e-70
Identities = 91/282 (32%), Positives = 142/282 (50%), Gaps = 13/282 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 491
EIP E L L ++G G +GEV+ WNGT VA+K S F +E ++M++L
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 69
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 550
RH +V V+ P + I+TE++ +GSL L + + + MA +A GM
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVL 609
+ VHRDL++ N+LV +N KV+DFGL+RL + N + + + +W APE
Sbjct: 129 VER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 245
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 710
++ +CW+ +P RP+F L L+ QP L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 1e-70
Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 14/271 (5%)
Query: 431 ECEIPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREV 485
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 60
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+IM +L +P +V +G V + L ++ E G L + L ++ ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 602
GM L VHRDL + N+L+ K+SDFGLS+ + + + + +
Sbjct: 120 MGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 603 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 661
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236
Query: 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
P + ++ +CW RP F + ++
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-70
Identities = 79/255 (30%), Positives = 121/255 (47%), Gaps = 12/255 (4%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
IG GS+ VY EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 499 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 555 TPTIVHRDLKSPN-LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
TP I+HRDLK N + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEKY 189
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
E DVY+FG+ + E+AT + P+ N Q+ V + K P V II
Sbjct: 190 D-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248
Query: 673 CWQTDPSLRPSFAQL 687
C + + R S L
Sbjct: 249 CIRQNKDERYSIKDL 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-70
Identities = 81/269 (30%), Positives = 126/269 (46%), Gaps = 12/269 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKI 487
EI E + LG IG G +G+V+ + E VA+K S + +F +E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALT 61
Query: 488 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 547
MR+ HP++V +G +T + II E G L L +D I A ++
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 548 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 606
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ +T+ + +WMAP
Sbjct: 121 LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 237
Query: 666 VARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ ++ +CW DPS RP F +L L +
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 2e-69
Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 14/269 (5%)
Query: 434 IPWEDLVLGER-IGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIM 488
+ + L L ++ +G G++G V + VAVK ++ A E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 489 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
++L +P +V +G + + ++ E G L + L + + V +K I++ V+ GM
Sbjct: 63 QQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMA 605
L S VHRDL + N+L+ K+SDFGLS+ N + + +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664
PE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237
Query: 665 LVARIIWECWQTDPSLRPSFAQLTVALKP 693
+ ++ CW D RP FA + + L+
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 226 bits (578), Expect = 2e-69
Identities = 89/268 (33%), Positives = 137/268 (51%), Gaps = 9/268 (3%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
E+ D+ + ++G G YGEVY W VAVK + EF +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 69
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMN 549
++HPN+V +G TR P IITEF+ G+L L +V + MA ++ M
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 608
L +HRDL + N LV +N VKV+DFGLSR + +T+ + +W APE
Sbjct: 130 YLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
L + K DV++FGV+LWE+AT + + V + ++ R+E P+ V
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPLQR 696
++ CWQ +PS RPSFA++ A + + +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 1e-68
Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGT----EVAVKKFLDQDFSGAALLEFKREVKIM 488
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64
Query: 489 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---------------V 532
+L HPN++ +GA L + E+ P G+L L + +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 533 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592
++ + A DVARGM+ L +HRDL + N+LV +N+ K++DFGLSR ++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 651
WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-68
Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGT-------EVAVKKFLDQDFSGAALLEFKREV 485
E P E+L G+ +G G++G+V +A G +VAVK L + + E+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSEL 91
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------------- 531
K+M +L H N+V +GA T + +I E+ G L L +
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 532 ---------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
+ + + A VA+GM L + VHRDL + N+LV VK+ DFG
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 583 LSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 639
L+R + ++ + +WMAPE L K DV+S+G++LWE+ +L P+ G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 640 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
+ + +++ P + I+ CW D RPSF LT L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 7e-68
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 19/279 (6%)
Query: 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 492
P + + +G G++G+VY A A K + ++ E+ I+
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCD 67
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HPN+V + A NL I+ EF G++ ++ + E + + +N LH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL--- 609
+ I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 128 DN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 610 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLV 666
++ P + K DV+S G+ L E+A ++ P +NPM+V+ + L P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 667 ARIIWECWQTDPSLRPSFAQL-------TVALKPLQRLV 698
+ +C + + R + +QL + KP++ L+
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (565), Expect = 1e-67
Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 19/286 (6%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVK 486
EI + + IG G +GEVY + VA+K L ++ ++F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 61
Query: 487 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 546
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 547 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEW 603
GM L VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+ W
Sbjct: 122 GMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 604 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKEL 662
APE + DV+SFG+++WE+ T ++ +V+ A+ RL P +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238
Query: 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 708
+ +++ +CWQ + + RP FA + L L R PD +
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-----APDSLKT 279
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-67
Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 10/254 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 493
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
PN++ G + +I E+ P G+++R L + DE+R ++A ++ H+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 124
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
++HRD+K NLL+ +K++DFG S ++ + GT +++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238
Query: 674 WQTDPSLRPSFAQL 687
+ +PS RP ++
Sbjct: 239 LKHNPSQRPMLREV 252
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 5e-67
Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 17/288 (5%)
Query: 428 DVCECEIPWEDLVL--GERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLE 480
V I L++ E IG G +G VYH D AVK L++ + +
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 74
Query: 481 FKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIK 539
F E IM+ HPNV+ +G R ++ ++ G L + K I
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 540 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----NTFLSSK 595
L VA+GM L + VHRDL + N ++D+ + VKV+DFGL+R + ++ +
Sbjct: 135 FGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 596 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 654
+WMA E L+ + K DV+SFGV+LWEL T P+ +N + + Q R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 251
Query: 655 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702
RL P+ + ++ +CW +RPSF++L + + I H
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (561), Expect = 9e-67
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 37/295 (12%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 485
E P ++ IG G++G V+ A T VAVK L ++ S +F+RE
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREA 67
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------- 531
+M +PN+V +G + ++ E++ G L L
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 532 ---------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 582
+ ++ +A VA GM L VHRDL + N LV +N VK++DFG
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 583 LSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIG 639
LSR + + + + + A WM PE + + DV+++GV+LWE+ + L P+ G
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 640 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
M +V+ V L P+ + ++ CW P+ RPSF + L+ +
Sbjct: 246 MAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-65
Identities = 83/279 (29%), Positives = 140/279 (50%), Gaps = 23/279 (8%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 485
E+ E + + +G GS+G VY D T VA+K +++ S +EF E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 74
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---------DEKR 536
+M+ +VV +G V++ +I E + RG L L + +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 537 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 596
I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 135 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 597 TA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 653
WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 251
Query: 654 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-65
Identities = 86/300 (28%), Positives = 132/300 (44%), Gaps = 45/300 (15%)
Query: 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 496
+VL E IG G +GEV+ W G EVAVK F ++ + E+ LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENI 59
Query: 497 VLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
+ F+ A + L +++++ GSLF L+R V + IK+AL A G+ LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 553 T------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPE 602
P I HRDLKS N+LV KN ++D GL+ ++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 603 WMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------------ 644
+MAPEVL + S ++ D+Y+ G++ WE+A Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 645 ---VVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696
+ V Q R IP E ++A+I+ ECW + + R + ++ L L +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 4e-65
Identities = 67/263 (25%), Positives = 124/263 (47%), Gaps = 9/263 (3%)
Query: 428 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREV 485
+ P + E+IG G+ G VY A G EVA+++ Q E+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE--LIINEI 68
Query: 486 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
+MR ++PN+V ++ + L ++ E+L GSL ++ DE + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECL 126
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDP 664
PEV+ + K D++S G++ E+ + P++ NP++ + + L+ P++L
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 665 LVARIIWECWQTDPSLRPSFAQL 687
+ + C D R S +L
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 2e-64
Identities = 68/251 (27%), Positives = 106/251 (42%), Gaps = 13/251 (5%)
Query: 443 ERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 499
IG GS+G VY A N VA+KK S + +EV+ +++LRHPN + +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 500 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 559
G R ++ E+ + + + E + +G+ LH+ ++
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHN--MI 137
Query: 560 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR---NEPSNE 616
HRD+K+ N+L+ + VK+ DFG + + S GTP WMAPEV+ +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 617 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 676
K DV+S G+ ELA K P MN M + + + C Q
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 677 DPSLRPSFAQL 687
P RP+ L
Sbjct: 254 IPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-64
Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 34/297 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 485
E P L G+ +G G++G+V A VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 486 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----------------- 527
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 528 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL- 586
+D + + + VA+GM L + +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 587 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQ 644
+ ++ + +WMAPE + N + DV+S+G+ LWEL +L GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701
+ + R+ P+ + I+ CW DP RP+F Q+ ++ +++ + S
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI---VQLIEKQISES 309
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 4e-64
Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 13/283 (4%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
E+ +D +G G+ G V+ +G +A K + + A + RE++++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHE 60
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
P +V F GA +SI E + GSL ++L + ++ E+ K+++ V +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 176
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670
+ + D++S G+ L E+A + P + ++ + F + E P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG 234
Query: 671 WECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 713
RP A + L +V P PS E
Sbjct: 235 RPLSSYGMDSRPPMA----IFELLDYIVNEPPPKLPSGVFSLE 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 6e-64
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 12/291 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRL 491
+ + +G G++G VY W G +V + K L + S A E E +M +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 492 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 551
+P+V +G + +IT+ +P G L + + + + + +A+GMN L
Sbjct: 69 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVL 609
+VHRDL + N+LV +VK++DFGL++L ++ +WMA E +
Sbjct: 128 ED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 610 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668
+ + DV+S+GV +WEL T P+ G+ ++ + + RL P V
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYM 244
Query: 669 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 719
I+ +CW D RP F +L + + R Q + +S
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-62
Identities = 89/294 (30%), Positives = 152/294 (51%), Gaps = 35/294 (11%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKR 483
E+P + LVLG+ +G G++G+V A+ T+VAVK L D + L +
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 67
Query: 484 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH---------------R 527
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 528 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 588 H--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 644
H + + + + +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 645 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698
+ + + R++ P + ++ +CW PS RP+F QL ++ L R+V
Sbjct: 246 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIV 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-61
Identities = 72/257 (28%), Positives = 114/257 (44%), Gaps = 10/257 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
ED L + +G G+YGEV A VAVK +D + K+E+ I + L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
NVV F G + E+ G LF + + E + + G+ LH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNE 612
I HRD+K NLL+D+ N+K+SDFGL+ + +N GT ++APE+L+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 613 P-SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 670
E DV+S G++L + +LPW + Q + L K++D ++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 671 WECWQTDPSLRPSFAQL 687
+ +PS R + +
Sbjct: 241 HKILVENPSARITIPDI 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-61
Identities = 55/272 (20%), Positives = 112/272 (41%), Gaps = 16/272 (5%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 493
ED G+ +G GS+ V A E A+K + RE +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
P V L + G L + + + DE ++ + LH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG 126
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRN 611
I+HRDLK N+L++++ +++++DFG +++ + + S GT ++++PE+L
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671
+ + + D+++ G I+++L P+ N + + + P++ P ++
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 242
Query: 672 ECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703
+ D + R ++ + +HP
Sbjct: 243 KLLVLDATKRLGCEEM------EGYGPLKAHP 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-60
Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 30/294 (10%)
Query: 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLE 480
D + E P + L LG+ +G G++G+V AD VAVK L + + +
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRA 62
Query: 481 FKREVKIMRR-LRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQ------- 531
E+KI+ H NVV +GA T+P L +I EF G+L L +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 532 --------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 583
+ + I + VA+GM L + +HRDL + N+L+ + VK+ DFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 584 SRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 640
+R K ++ +WMAPE + + + DV+SFGV+LWE+ +L P+ G+
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 641 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 201 bits (513), Expect = 3e-59
Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 17/283 (6%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
+ + E +G G++G V+ G A K + S ++E++ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRHP 83
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+V A + +I EF+ G LF + H ++ E ++ V +G+ +H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 555 TPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
VH DLK N++ ++ +K+ DFGL+ + S K T GT E+ APEV +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARII 670
P D++S GV+ + L + P+ G N + + V N + I
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 671 WECWQTDPSLRPSFAQL------TVALKPLQRLVIPSHPDQPS 707
+ DP+ R + Q T P + IPS
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-58
Identities = 47/258 (18%), Positives = 107/258 (41%), Gaps = 12/258 (4%)
Query: 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 493
+E ++ E +G G +G V+ + K G + K+E+ I+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
N++ + L +I EF+ +F ++ +++E+ + V + LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 554 STPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
+ I H D++ N++ ++ +K+ +FG +R + + PE+ APEV ++
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQH 177
Query: 612 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 669
+ + D++S G +++ L + P++ Q++ + E KE+
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 670 IWECWQTDPSLRPSFAQL 687
+ + R + ++
Sbjct: 238 VDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 196 bits (499), Expect = 3e-57
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 11/257 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
+ + E +G G++G V+ G K K E+ IM +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHP 86
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
++ A + +I EFL G LF + ++ E I G+ +H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 555 TPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
+IVH D+K N++ + K +VK+ DFGL+ + + +T T E+ APE++ E
Sbjct: 147 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDRE 203
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARII 670
P D+++ GV+ + L + P+ G + ++ + V + + + P I
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 671 WECWQTDPSLRPSFAQL 687
Q +P R +
Sbjct: 264 KNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 4e-57
Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ +G G++ EV A+ VA+K + + + E+ ++ +++HPN+V
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+L +I + + G LF + E+ ++ V + LH I
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD--LGI 128
Query: 559 VHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 615
VHRDLK NLL D++ + +SDFGLS+++ + S + GTP ++APEVL +P +
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKPYS 187
Query: 616 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWEC 673
+ D +S GVI + L P+ N ++ + + P ++ I
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 674 WQTDPSLRPSFAQL 687
+ DP R + Q
Sbjct: 248 MEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-57
Identities = 63/254 (24%), Positives = 121/254 (47%), Gaps = 9/254 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRR-LR 492
ED +L + +G GS+G+V+ A++ A+K +E E +++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
HP + NL + E+L G L + H + D R A ++ G+ LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
+ IV+RDLK N+L+DK+ ++K++DFG+ + + + GTP+++APE+L +
Sbjct: 121 S--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
N D +SFGV+L+E+ + P+ G + ++ ++ + P+ L+ ++ +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 673 CWQTDPSLRPSFAQ 686
+ +P R
Sbjct: 237 LFVREPEKRLGVRG 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 191 bits (487), Expect = 5e-56
Identities = 62/257 (24%), Positives = 114/257 (44%), Gaps = 11/257 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 493
+D + +G GS+G V+ NG A+K + +E E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
P ++ G + +I +++ G L R + A +V + LH+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
I++RDLK N+L+DKN ++K++DFG ++ + + GTP+++APEV+ +P
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
N+ D +SFG++++E+ P+ N M+ + N L P + V ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRL 235
Query: 674 WQTDPSLRPSFAQLTVA 690
D S R Q
Sbjct: 236 ITRDLSQRLGNLQNGTE 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (477), Expect = 5e-55
Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 22/270 (8%)
Query: 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-------FKREVK 486
+E+ E +G G V E AVK + E +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 487 IMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
I+R++ HPN++ ++ + + +G LF L + EK K+ +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALL 120
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605
+ LH IVHRDLK N+L+D + N+K++DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLA 177
Query: 606 PEVLRNEPS------NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 659
PE++ + ++ D++S GVI++ L P+ M ++ + N + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 660 --KELDPLVARIIWECWQTDPSLRPSFAQL 687
+ V ++ P R + +
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 59/257 (22%), Positives = 113/257 (43%), Gaps = 8/257 (3%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 493
D + +G G++G+V G A+K + + + E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
P + A L + E+ G LF L R E+R ++ + LH+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE++APEVL +
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
D + GV+++E+ +LP+ + ++ + + P+ L P ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGL 239
Query: 674 WQTDPSLRPSFAQLTVA 690
+ DP R
Sbjct: 240 LKKDPKQRLGGGPSDAK 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-53
Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 16/259 (6%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKF----LDQDFSGAALLEFKREVKIMRRLRHP 494
GE +G G + V G + A K G + + +REV I++ ++HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
NV+ ++ +I E + G LF L + E+ + + G+ LH+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS- 131
Query: 555 TPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 610
I H DLK N+++ +K+ DFGL+ K+ GTPE++APE++
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVN 189
Query: 611 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 668
EP + D++S GVI + L + P++G + + V N E L
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 669 IIWECWQTDPSLRPSFAQL 687
I DP R +
Sbjct: 250 FIRRLLVKDPKKRMTIQDS 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (466), Expect = 2e-53
Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 17/273 (6%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 493
+ LGE +G G EV+ A +VAVK D + L F+RE + L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 494 PNVVLFMGAVTRPPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 549
P +V I+ E++ +L I+H + KR I++ D + +N
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALN 125
Query: 550 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAP 606
H I+HRD+K N+++ VKV DFG++R N+ + + GT ++++P
Sbjct: 126 FSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 664
E R + + + DVYS G +L+E+ T + P+ G +P+ V ++ + L
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697
+ ++ + +P R A L R+
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAE--MRADLVRV 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-51
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 22/257 (8%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE----FKREVKIMRRLR-- 492
+G +G G +G VY + VA+K S L EV +++++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 493 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
V+ + RP + +I E + E+ V + H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 553 TSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 611
++HRD+K N+L+D N +K+ DFG L +T + GT + PE +R
Sbjct: 128 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWIRY 183
Query: 612 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670
V+S G++L+++ +P+ + ++ + + +I
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLI 235
Query: 671 WECWQTDPSLRPSFAQL 687
C PS RP+F ++
Sbjct: 236 RWCLALRPSDRPTFEEI 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (447), Expect = 7e-50
Identities = 60/262 (22%), Positives = 103/262 (39%), Gaps = 13/262 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRR 490
D + IG G +GEVY G A+K + L + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 491 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 550
P +V A P LS I + + G L L + H E A ++ G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEH 122
Query: 551 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 609
+H +V+RDLK N+L+D++ +V++SD GL+ ++ GT +MAPEVL
Sbjct: 123 MH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178
Query: 610 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVAR 668
+ + D +S G +L++L P+ + +E+P P +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 669 IIWECWQTDPSLRPSFAQLTVA 690
++ Q D + R
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-50
Identities = 62/265 (23%), Positives = 114/265 (43%), Gaps = 27/265 (10%)
Query: 440 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 496
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 67
Query: 497 V----LFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCL 551
V ++ L I+ E L G LF + R E+ ++ + + L
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 552 HTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 608
H+ I HRD+K NLL +K++DFG ++ + S + TP ++APEV
Sbjct: 128 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEV 184
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------PKEL 662
L E ++ CD++S GVI++ L P+ + + + + + R + E+
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 663 DPLVARIIWECWQTDPSLRPSFAQL 687
V +I +T+P+ R + +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 8e-49
Identities = 52/276 (18%), Positives = 100/276 (36%), Gaps = 25/276 (9%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
LG +IG GS+G++Y G EVA+K + + E KI + ++ +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIP 66
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+ + +++ L SL + + + K + +A + + +H+
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NF 124
Query: 559 VHRDLKSPNLLV---DKNWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAPEV 608
+HRD+K N L+ K V + DFGL++ +H + +K+ GT + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 609 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------GFQNRRLEIPKEL 662
+ + D+ S G +L LPW G+ + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 663 DPLVARIIWECWQTDPSLRPSFAQLTVALK-PLQRL 697
A + C +P ++ L + R
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 63/281 (22%), Positives = 110/281 (39%), Gaps = 32/281 (11%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
E+ E+IG G+YG VY A G VA+KK + RE+ +++ L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
N+V + + L ++ EFL + + + + +G+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP- 613
+ ++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV----------------GAVGFQNRRLE 657
+ D++S G I E+ T + + G + + + G + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 658 IPK-----------ELDPLVARIIWECWQTDPSLRPSFAQL 687
PK LD ++ + DP+ R S
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (424), Expect = 2e-47
Identities = 45/274 (16%), Positives = 95/274 (34%), Gaps = 26/274 (9%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+G RIG GS+G ++ N +VA+K + + + + E + + L +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIP 64
Query: 499 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 558
+ + +++ L SL +L + K A + + +H + +
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--L 122
Query: 559 VHRDLKSPNLLVDK-----NWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAP 606
V+RD+K N L+ + + V DFG+ + +H + K+ +GT +M+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 607 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPK 660
+ + D+ + G + LPW G+ +G E+
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 661 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694
+ + P + L +
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 3e-47
Identities = 58/257 (22%), Positives = 114/257 (44%), Gaps = 11/257 (4%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 493
+ + +G GS+G V +G A+K Q +E E +I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 494 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 553
P +V + NL ++ E++ G +F L R + E A + LH+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 554 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
+++RDLK NLL+D+ ++V+DFG ++ + GTPE +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKG 214
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 673
N+ D ++ GV+++E+A P+ P+Q+ + + ++ P + ++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNL 272
Query: 674 WQTDPSLRPSFAQLTVA 690
Q D + R + V
Sbjct: 273 LQVDLTKRFGNLKNGVN 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 166 bits (420), Expect = 5e-47
Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 32/280 (11%)
Query: 437 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 495
E E+IG G+YG VY A + G A+KK + RE+ I++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 496 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 555
+V + L ++ E L L ++L ++ L + G+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--D 118
Query: 556 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 614
++HRDLK NLL+++ +K++DFGL+R T + AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 615 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------------- 649
+ D++S G I E+ + G++ + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 650 --GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
K LD ++ + + DP+ R + Q
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 39/287 (13%)
Query: 437 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-- 491
+ IG G+YG+V+ G VA+K+ Q L REV ++R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 492 -RHPNVVLFMGAVTRPPN-----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
HPNVV T L+++ E + + + P V + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ ++ ++ S T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 606 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV---------------- 649
PEVL D++S G I E+ K + G + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 650 ---------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ ++D L ++ +C +P+ R S
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 5e-45
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 42/303 (13%)
Query: 443 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA---ALLEFKREVKIMRRLRHPNVV 497
+ +G G + VY A VA+KK S A RE+K+++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 498 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 557
+ A N+S++ +F+ L I+ + L +G+ LH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HW 120
Query: 558 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 616
I+HRDLK NLL+D+N +K++DFGL++ + + T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 617 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--------------------------G 650
D+++ G IL EL G + + + +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 651 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD-QPSSA 709
I + +I + +P R + Q L+ + P P
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRPGPTPGCQ 294
Query: 710 LPQ 712
LP+
Sbjct: 295 LPR 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 9e-45
Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 16/267 (5%)
Query: 437 EDLVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAA--LLEFKREVKIMR 489
E+ L + +G G+YG+V+ G A+K A + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 490 RLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 548
+R P +V A L +I +++ G LF L + + E ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 142
Query: 549 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPE 607
LH I++RD+K N+L+D N +V ++DFGLS + + GT E+MAP+
Sbjct: 143 EHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 608 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELD 663
++R S ++ D +S GV+++EL T P+ + P+E+
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 664 PLVARIIWECWQTDPSLRPSFAQLTVA 690
L +I DP R
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-44
Identities = 68/318 (21%), Positives = 122/318 (38%), Gaps = 51/318 (16%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
IG G+YG V A N VA+KK + RE+KI+ R RH N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 499 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+ P + L L+++L H + + RG+ +H++
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSA 128
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEVLRN 611
++HRDLK NLL++ ++K+ DFGL+R+ H+ T + APE++ N
Sbjct: 129 N--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 612 E-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--------------------- 649
+ D++S G IL E+ + + + G + + + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 650 --------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK-P-LQRLVI 699
+ + D ++ + +P R Q AL P L++
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ---ALAHPYLEQYYD 303
Query: 700 PSHPDQPSSALPQEISVN 717
PS D+P + P + +
Sbjct: 304 PS--DEPIAEAPFKFDME 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 60/304 (19%), Positives = 116/304 (38%), Gaps = 52/304 (17%)
Query: 433 EIPWEDLV----LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK 486
E P+ D V +IG G++GEV+ A G +VA+KK L ++ + RE+K
Sbjct: 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 487 IMRRLRHPNVVLFMGAVTRPP--------NLSIITEFLPRGSLFRILHRPHCQVDEKRRI 538
I++ L+H NVV + ++ ++ +F + + + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK- 120
Query: 539 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSS 594
++ + G+ +H I+HRD+K+ N+L+ ++ +K++DFGL+R K++
Sbjct: 121 RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 595 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV---- 649
+ T + PE+L E D++ G I+ E+ T G + +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 650 --------------------------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 683
+ + DP +I + DP+ R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 684 FAQL 687
Sbjct: 299 SDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 55/282 (19%), Positives = 105/282 (37%), Gaps = 34/282 (12%)
Query: 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 494
+ E+IG G+YG V+ A VA+K+ D RE+ +++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 495 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
N+V + L+++ EF + D + + +G+ H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCH-- 118
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 614
+ ++HRDLK NLL+++N +K+++FGL+R + T + P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 615 -NEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAV----------------------- 649
+ D++S G I ELA P G + + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 650 ----GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
+ + +L+ ++ + +P R S +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 42/283 (14%)
Query: 441 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ +G G+YG V A G +VA+KK S RE+++++ +RH NV+
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 499 FMGAVTRPPNLSIITEFL----PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 554
+ T L T+F G+ L + H ++ E R + + +G+ +H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 555 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EP 613
I+HRDLK NL V+++ +K+ DFGL+R + T + APEV+ N
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMR 195
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------------- 656
+ D++S G I+ E+ T K + G + + + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 657 ------------EIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
I PL ++ + D R + +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-37
Identities = 59/256 (23%), Positives = 106/256 (41%), Gaps = 21/256 (8%)
Query: 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 498
+ IG G+ G V A VA+KK + RE+ +M+ + H N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 499 FMGAVTRPP------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 552
+ T ++ ++ E + I D +R + + G+ LH
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH 136
Query: 553 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 612
+ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGM 193
Query: 613 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672
E D++S G I+ E+ K+ + G + + N+ +E P + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW------NKVIEQLGTPCPEFMKKLQP 247
Query: 673 CWQTDPSLRPSFAQLT 688
+ RP +A LT
Sbjct: 248 TVRNYVENRPKYAGLT 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 51/281 (18%), Positives = 89/281 (31%), Gaps = 46/281 (16%)
Query: 445 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 502
IG GS+G VY A +G VA+KK L RE++IMR+L H N+V
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYF 81
Query: 503 VTRP------PNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTS 554
L+++ +++P H R + + R + +H+
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 140
Query: 555 TPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 613
I HRD+K LL +K+ DFG ++ + +
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 614 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------------ 649
DV+S G +L EL + + G + + + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 650 ---GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 687
P + + P+ R + +
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 45/292 (15%)
Query: 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 490
E+P E +G G+YG V A G VAVKK S RE+++++
Sbjct: 15 EVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 73
Query: 491 LRHPNVVLFMGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 545
++H NV+ + T +L + L L I+ D + + +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI--YQIL 131
Query: 546 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 605
RG+ +H + I+HRDLK NL V+++ +K+ DFGL+R + T + A
Sbjct: 132 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRA 186
Query: 606 PEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV------------------ 646
PE+ L N+ D++S G I+ EL T + + G + + +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 647 ---GAVGFQNRRLEIPK--------ELDPLVARIIWECWQTDPSLRPSFAQL 687
A + ++PK +PL ++ + D R + AQ
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (329), Expect = 4e-34
Identities = 58/319 (18%), Positives = 121/319 (37%), Gaps = 60/319 (18%)
Query: 415 DSSTSKVDQIFDDDVCECEIPW---EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFL 469
D +T + + +D + + W +D L ++G G Y EV+ A N +V VK
Sbjct: 12 DVNTHRPREYWDYE--SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 470 DQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH 526
+ KRE+KI+ LR PN++ V P + +++ E + ++
Sbjct: 70 PVKKK-----KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 527 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 585
+ + ++ + ++ H+ I+HRD+K N+++D ++ +++ D+GL+
Sbjct: 125 T----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-- 642
H + + PE+L + + D++S G +L + K P+ +
Sbjct: 179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 643 ------MQVVGAVGFQNRRLEIPKELDPLVARI--------------------------- 669
+V+G + + ELDP I
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297
Query: 670 -IWECWQTDPSLRPSFAQL 687
+ + + D R + +
Sbjct: 298 FLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 3e-27
Identities = 49/287 (17%), Positives = 103/287 (35%), Gaps = 30/287 (10%)
Query: 440 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 497
+L ++G G + V+ A N T VA+K + E+K+++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 498 L---------------FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
F ++ ++ E L L I H + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLKHNTFLSSKS 596
+ G++ +H I+H D+K N+L++ +K++D G + + +
Sbjct: 133 QLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 188
Query: 597 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 656
+ T E+ +PEVL P D++S +++EL T + + +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 657 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 703
E+ EL + R S + PL+ ++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.6 bits (224), Expect = 2e-21
Identities = 31/193 (16%), Positives = 60/193 (31%), Gaps = 45/193 (23%)
Query: 440 VLGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFK 482
+G+ +G G V++ E VK D FS A+ +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 483 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 542
E + +++L+ V +++ E + + +V + ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELID--------AKELYRVRVENPDEVLD 110
Query: 543 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 602
+ + + IVH DL N+LV + + DF S E
Sbjct: 111 MILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVGE 154
Query: 603 WMAPEVLRNEPSN 615
E+L + N
Sbjct: 155 EGWREILERDVRN 167
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.1 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 90.68 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=444.94 Aligned_cols=250 Identities=25% Similarity=0.467 Sum_probs=223.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+.+++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|++++|||||++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 4568999999999999999999988 58899999987543222 22456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+|||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.....
T Consensus 83 ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999999754 36999999999999999999999998 999999999999999999999999999865443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+. .....+|..+++++++||
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 235 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 2345689999999999999999999999999999999999999999998888877764 335567888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||++||.+|||++|+++|
T Consensus 236 ~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTC
T ss_pred HHHccCCHhHCcCHHHHHcC
Confidence 99999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=444.91 Aligned_cols=253 Identities=27% Similarity=0.449 Sum_probs=212.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--CCceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--~~~l~LV 512 (720)
++|++++.||+|+||+||+|++ +++.||||++......+.....+.+|+++|++++|||||++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999987 68899999998887777777889999999999999999999999865 4568999
Q ss_pred EeecCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 513 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 513 mEy~~ggsL~d~L~~---~~~~lse~~~~~Ia~qIa~AL~yLHs~g---~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
||||++|+|.+++.+ ....+++..++.++.||+.||+|||+++ .+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999853 3357999999999999999999999864 2499999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...+... ....++..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHH
Confidence 765544455678999999999999999999999999999999999999999999888887776533 2345778899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++||.+||+.||.+|||+.|+++|
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=444.71 Aligned_cols=263 Identities=35% Similarity=0.599 Sum_probs=222.6
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
+++|+.++|++++.||+|+||+||+|++++ .||||++............|.+|+.+|++++|||||++++++.+ ..++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 357788999999999999999999998765 59999998776666678889999999999999999999998754 6789
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
||||||++|+|.+++...+..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999876678999999999999999999999998 999999999999999999999999999876432
Q ss_pred c--ccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-cccc---ccCCCCC
Q 004986 591 F--LSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNR---RLEIPKE 661 (720)
Q Consensus 591 ~--~~~~s~~GT~~Y~APEvi~g~---~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~-~~~~---~~~ip~~ 661 (720)
. .......||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+......... .... ...++..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2 233456899999999999753 47899999999999999999999999876554433222 2211 1245678
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+++++++||.+||+.||.+|||+.||+++|+.+.+-
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 899999999999999999999999999999998763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=434.64 Aligned_cols=257 Identities=32% Similarity=0.539 Sum_probs=218.1
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
|+.++|++++.||+|+||+||+|++ +++.||||++...... ..+|.+|++++++++|||||++++++.+++.+++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3457899999999999999999998 5778999998765544 35788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+++|+|.+++......+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999999999877778999999999999999999999998 99999999999999999999999999987654322
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 593 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 593 -~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..++...+.. ..+...|..+++++.+||
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHH
Confidence 2334579999999999999999999999999999999999 5677777777777776653 345567788999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 671 WECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
.+||+.||.+||+++||+++|+++.+
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=444.17 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=221.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++.+.||+|+||+||+|++ +++.||||++....... ...+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999986 68999999997654433 4568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
||+||+|.+++.+. .+++.+++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 98 y~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 99999999998753 5999999999999999999999998 9999999999999999999999999999776554555
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-ccccCCCCCCcHHHHHHHHHh
Q 004986 595 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWEC 673 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~-~~~~~ip~~ls~~l~dLI~~c 673 (720)
...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+... ......+..+++++++||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 6678999999999999999999999999999999999999999988877666554422 223456678999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 004986 674 WQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 674 L~~DP~kRPS~~ELL~~ 690 (720)
|++||.+|||+.|+++|
T Consensus 254 L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TCSSTTTSCCHHHHTTC
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=443.86 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=220.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|++++.||+|+||+||+|++ +++.||||++...... ....+.+|+++|++++|||||++++++.+++.++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5699999999999999999987 6889999999765432 35678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
||++|+|.+++.+....+++.++..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998765567999999999999999999999998 9999999999999999999999999998665443344
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc-ccCCCCCCcHHHHH
Q 004986 595 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVAR 668 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~-----g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~-~~~ip~~ls~~l~d 668 (720)
.+.+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+.+..+..... ....+..+++++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 45688999999999999999999999999888887776653322 23456788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~ 690 (720)
||.+||++||.+|||+.|+++|
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=445.54 Aligned_cols=250 Identities=21% Similarity=0.356 Sum_probs=219.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
.++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 37899999999999999999987 588999999975432 122356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc-
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 591 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~- 591 (720)
||||+||+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+++|.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999998754 36999999999999999999999999 9999999999999999999999999998764322
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 592 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 592 -~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++++||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--TCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc--CCCCCCccCCHHHHHHH
Confidence 233456899999999999999999999999999999999999999999998888877743 35567889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||++||.+|||++|++.+
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCH
T ss_pred HHHccCCHhHCcCHHHHcCC
Confidence 99999999999999997654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=449.33 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=227.2
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
|.+++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 5678999999999999999999987 6899999999765321 223567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
+|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999999997643 6899999999999999999999999 999999999999999999999999999976555
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 670 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI 670 (720)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++...+.. ....+|..+++++++||
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHH
Confidence 4555678999999999999999999999999999999999999999999999888877743 35678899999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 004986 671 WECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
.+||++||.+|++ ++|+++|
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhhccCCchhhcccccccHHHHHcC
Confidence 9999999999994 8888875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-52 Score=436.79 Aligned_cols=260 Identities=32% Similarity=0.534 Sum_probs=218.7
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEEC--C---cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~--g---~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
++..++|++.++||+|+||+||+|++. + ..||||++.... ......+|.+|+.+|++++|||||++++++.+.+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 355678999999999999999999872 2 258888775443 4455678999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++|||||++|+|.+++......+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999887778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCC
Q 004986 588 HNTFL-----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 661 (720)
Q Consensus 588 ~~~~~-----~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ 661 (720)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+.. ..++..+..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 43221 1122457899999999999999999999999999999997 8999999998888777753 345567788
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 662 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 662 ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
++.++.+||.+||+.||.+||++.||++.|+++.+
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-52 Score=438.09 Aligned_cols=259 Identities=35% Similarity=0.604 Sum_probs=225.6
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
+++++.++|++.+.||+|+||+||+|++ +++.||||++...... .++|.+|+.+|++++|||||+++++|.+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4678889999999999999999999988 5889999998765443 4578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 509 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
+++|||||++|+|.+++.+ ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999864 4457899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 588 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 588 ~~~~~-~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF-~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
..... ......||+.|+|||++.+..|+.++|||||||++|||++|..|| .+.+..++...+. ...++.++..++++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-cCCCCCCCccchHH
Confidence 54322 223345899999999999999999999999999999999976655 4556555555443 34466778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
+++||.+||+.||.+|||+.||++.|+.+.
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=436.33 Aligned_cols=251 Identities=27% Similarity=0.342 Sum_probs=210.9
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
.++|++++.||+|+||+||+|++ +++.||||++...... .....+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 37899999999999999999987 5889999999765432 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC--c
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~--~ 591 (720)
|||++|+|.+++.+. ..+++.+++.++.||+.||+|||++| ||||||||+||||+.++++||+|||+|+..... .
T Consensus 83 Ey~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999764 47999999999999999999999998 999999999999999999999999999876432 2
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhhccccccCCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
......+||+.|+|||++.+..+ +.++|||||||++|||++|++||....... ....+............+++++++|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23455789999999999998876 578999999999999999999997754432 2222222222223345789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||+.||.+|||++|+++|
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=443.44 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=212.5
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++..++|++++.||+|+||+||+|++ +++.||||++.... .......+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45668999999999999999999987 68899999987653 3344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
||||||+||+|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+||||||+||||+.+|++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999999764 369999999999999999999997 47 99999999999999999999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-------------------
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------------------- 650 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~------------------- 650 (720)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+......
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 2345799999999999999999999999999999999999999998755432210000
Q ss_pred ----------------------ccccccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 651 ----------------------FQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 651 ----------------------~~~~~~~ip-~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....++.++ ..++.++++||.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000111122 2468899999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=428.95 Aligned_cols=249 Identities=31% Similarity=0.461 Sum_probs=215.2
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec----CCceEE
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSI 511 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~----~~~l~L 511 (720)
.|++.++||+|+||+||+|++ +++.||+|++............+.+|+++|++++|||||+++++|.+ ...+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 357788999999999999988 57889999998877777777889999999999999999999999865 345899
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc-CCCcEEEEeccccccccCC
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~IKL~DFGlAk~~~~~ 590 (720)
|||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++++||||||||+||||+ +++.+||+|||+++.....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999764 368999999999999999999999877799999999999996 5799999999999865433
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 591 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 591 ~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~-~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
...+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.. ..++...+.....+..++..+++++++|
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 2345789999999999876 49999999999999999999999998754 4455555544444455667789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||++||++|||++|+++|
T Consensus 246 i~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 246 IEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCCHhHCcCHHHHhCC
Confidence 999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=439.97 Aligned_cols=259 Identities=30% Similarity=0.445 Sum_probs=221.5
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC--C-----cEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN--G-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~--g-----~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~ 502 (720)
.++++.++|+++++||+|+||+||+|++. + ..||||++.... .......+.+|+.+|.++ +|||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 35677899999999999999999999872 2 368999886543 233456788999999998 89999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPH----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~----------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIH 560 (720)
+.+.+.++||||||++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH 187 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 187 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 999999999999999999999997543 24788999999999999999999998 999
Q ss_pred eCCCCCcEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 004986 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 637 (720)
Q Consensus 561 rDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF 637 (720)
|||||+|||++.++++||+|||+|+....... ...+..||+.|||||++.+..|+.++|||||||++|||++ |..||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999986544322 2234568999999999999999999999999999999997 89999
Q ss_pred CCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 004986 638 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 692 (720)
Q Consensus 638 ~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~ 692 (720)
.+.+..+.+..+.....++..|..+++++++||.+||+.||++|||++||+++|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9877666555555455567788899999999999999999999999999999984
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=425.31 Aligned_cols=254 Identities=30% Similarity=0.511 Sum_probs=228.3
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+.++|+++++||+|+||+||+|++ +++.||||++....... .+|.+|+.++++++|||||++++++.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 457899999999999999999998 56689999998765543 57889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc-
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 592 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~- 592 (720)
||+++|+|.+++......+++..+++++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999999998776678999999999999999999999998 99999999999999999999999999986554322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.. ..+...|..+++++.+||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHH
Confidence 2334679999999999999999999999999999999998 8999999998888877753 4466788899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhh
Q 004986 672 ECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
+||+.||++|||+++|+++|..|
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999999653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=426.90 Aligned_cols=257 Identities=32% Similarity=0.573 Sum_probs=223.4
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
+++|+.++|++.+.||+|+||+||+|++ +++.||||++...... ..+|.+|+.+|++++|||||++++++.+ +.+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 4678889999999999999999999998 4678999999765543 3578999999999999999999998754 668
Q ss_pred EEEEeecCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~-~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999999886532 35899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 589 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG-~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
... .......||+.|+|||++.+..++.++|||||||++|||++| .+||...+..++...+. ...++..|..+++++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l 239 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEEL 239 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHH
Confidence 432 233456799999999999999999999999999999999995 55666677777766664 334566788999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
.+||.+||+.||++|||++||++.|+.+
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 9999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=428.25 Aligned_cols=258 Identities=25% Similarity=0.451 Sum_probs=226.2
Q ss_pred CCCCCeeEeEE-eeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 434 IPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 434 i~~~~y~i~k~-LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
+..++|.+.+. ||+|+||+||+|.+ ++..||||++.... ......+|.+|+.+|++++|||||++++++.+ +.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 45578888885 99999999999976 34579999986543 45567789999999999999999999999875 56
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhccc
Confidence 89999999999999998776668999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 589 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 589 ~~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.. ..++.+|..+++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~ 239 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPP 239 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTTCCH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCH
Confidence 322 22334578999999999999999999999999999999998 8999999888887777653 445678899999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
++.+||.+||+.||++||++.+|++.|+.+..
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999987754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-52 Score=436.79 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=203.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+.|++.+.||+|+||+||+|++ +++.||||++....... ....+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6699999999999999999987 58899999998765432 24567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEeccccccccCCc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~IKL~DFGlAk~~~~~~ 591 (720)
||+||+|.+++.+. ..+++.++..++.||+.||+|||+++ ||||||||+|||+. +++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 99999999999764 47999999999999999999999998 99999999999995 5789999999999876443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~dL 669 (720)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+....... ..+..+++++++|
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 23345789999999999999999999999999999999999999999988888877775443333 3446789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||++||.+|||+.|+++|
T Consensus 244 i~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999885
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-51 Score=442.03 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=221.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|++++.||+|+||+||+|++ +|+.||||++.... ......+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999987 68999999987653 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEeccccccccCCc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~IKL~DFGlAk~~~~~~ 591 (720)
|||+||+|.+++.+....+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+++.+...
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 999999999999776667999999999999999999999999 99999999999996 4689999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~dL 669 (720)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+....... .....+++++++|
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23345689999999999999999999999999999999999999999998888887775433222 2335689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||+.||.+|||++|+++|
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=424.30 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=220.3
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEECC------cEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~~g------~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
+|..++|++.++||+|+||+||+|.+.+ ..||||++.... ......+|.+|+.+|++++|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 5677899999999999999999998632 469999986543 445566789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+++||||+.+++|.+++......+++.+++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999988776668999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHhhhhccccccCCCCCC
Q 004986 587 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKEL 662 (720)
Q Consensus 587 ~~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~-~PF~~~~~~~i~~~i~~~~~~~~ip~~l 662 (720)
...... ......||+.|+|||++.+..++.++|||||||++|||++|. +||...+..++...+. ...++..+..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhh
Confidence 644321 223346899999999999999999999999999999999964 5556667767766654 33456678889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 663 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 663 s~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
+.++.+||.+||+.||++||++.||++.|+++.+.
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 99999999999999999999999999999988763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=423.76 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=218.2
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 506 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~ 506 (720)
++|..++|++++.||+|+||+||+|++. +..||||.+... ........+.+|+.+|++++|||||++++++. +
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 5678899999999999999999999873 345888877543 34455678999999999999999999999986 4
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+++||||+++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhee
Confidence 6789999999999999998766668999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcH
Q 004986 587 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 664 (720)
Q Consensus 587 ~~~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~ 664 (720)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+.. ..+..++..+++
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTCCH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCH
Confidence 54332 23344578999999999999999999999999999999998 8999999988888877753 345577889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
++.+||.+||..||.+|||+.||+++|+.+...
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999988543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=427.23 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=219.8
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~ 510 (720)
++|++++.||+|+||+||+|++ +|+.||||++.+..... ...+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999987 58899999997654322 23567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC----cEEEEecccccc
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 586 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~IKL~DFGlAk~ 586 (720)
||||||++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999997643 6999999999999999999999999 99999999999998776 599999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 664 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~ 664 (720)
.... ....+..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....... ..+..+++
T Consensus 167 ~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 6543 23445689999999999999999999999999999999999999999998888877765332222 23367899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 665 LVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
++++||.+||+.||.+|||++|+++|
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-51 Score=433.13 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=217.4
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
.|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999987 6889999999876554 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
||.+|+|..++... ..+++.+++.|+.||+.||.|||++| ||||||||+||||+.++++||+|||+|+.... .
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC----C
Confidence 99999998776543 46999999999999999999999998 99999999999999999999999999986543 2
Q ss_pred CCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 595 KSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g---~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+.....+...+..+++++++||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 35689999999999864 458899999999999999999999999988877776665444444455678999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 004986 672 ECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRPS~~ELL~~ 690 (720)
+||+.||.+|||+.|+++|
T Consensus 249 ~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHCcCChhHCcCHHHHHhC
Confidence 9999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=423.92 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=214.9
Q ss_pred eeEe-EEeeecCcEEEEEEEE----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 439 LVLG-ERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 439 y~i~-k~LGkG~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+.+. ++||+|+||+||+|.+ .++.||||++...........+|.+|+.+|++++|||||++++++.+ +.++|||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 3443 5799999999999976 24679999997665555566789999999999999999999999865 5678999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc--
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~-- 591 (720)
|||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 87 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp ECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999999999764 46999999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 592 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 592 -~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.. ..++.+|..+++++++|
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 242 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHH
Confidence 12234579999999999999999999999999999999997 8999999988887776653 44667888999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 670 IWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
|.+||+.||.+||++.+|++.|+.+-
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 99999999999999999999887753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.6e-51 Score=439.66 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=222.0
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
++|++++.||+|+||+||+|++ +++.||||++.... ......+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 6799999999999999999987 68999999987654 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc--CCCcEEEEeccccccccCCcc
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~IKL~DFGlAk~~~~~~~ 592 (720)
||+||+|.+++.+....+++.+++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+..... .
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-S
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC-C
Confidence 99999999998776668999999999999999999999998 99999999999998 6789999999999876543 2
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARII 670 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--~~ip~~ls~~l~dLI 670 (720)
...+..||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+...... ...+..+++++++||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 334568999999999999999999999999999999999999999999888887777543322 234467899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 004986 671 WECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 671 ~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+||++||.+|||+.|+++|
T Consensus 264 ~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999885
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-51 Score=432.77 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=221.9
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEE
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~L 511 (720)
.+++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 357899999999999999999987 5899999999754321 1235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|||||+||+|..++.... .+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999999987643 6888999999999999999999998 999999999999999999999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.. ....+|..+++++++||.
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999998888877743 345678889999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHH
Q 004986 672 ECWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 672 ~cL~~DP~kRP-----S~~ELL~~ 690 (720)
+||.+||.+|+ +++++++|
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccchhhHHHHHcC
Confidence 99999999996 89999886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.6e-50 Score=413.73 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=215.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc----e
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----L 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~----l 509 (720)
++|++.+.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|+.++|||||++++++...+. +
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999987 6899999999876543 4456679999999999999999999999876543 8
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
||||||++|++|.+++... ..+++.+++.|+.||+.||+|||++| ||||||||+||||+.++.++|+|||+++....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 9999999999999988664 36899999999999999999999998 99999999999999999999999999876533
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc--cCCCCCCcH
Q 004986 590 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 664 (720)
Q Consensus 590 ~~---~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~--~~ip~~ls~ 664 (720)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+...... ......+++
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 22 2334568999999999999999999999999999999999999999998887776555433222 234567899
Q ss_pred HHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhh
Q 004986 665 LVARIIWECWQTDPSLRP-SFAQLTVALKPLQ 695 (720)
Q Consensus 665 ~l~dLI~~cL~~DP~kRP-S~~ELL~~L~~i~ 695 (720)
++.+||.+||.+||.+|| +++++++.|.+++
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 999999999999999999 8999999998875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=418.04 Aligned_cols=255 Identities=33% Similarity=0.595 Sum_probs=219.3
Q ss_pred cCCCCCCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCceE
Q 004986 432 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLS 510 (720)
Q Consensus 432 ~~i~~~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-~~~l~ 510 (720)
+++..++|++++.||+|+||.||+|+++++.||||+++... ..+.+.+|+.+|++++|||||++++++.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 56788999999999999999999999999999999986543 24578899999999999999999998855 46789
Q ss_pred EEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+||||+++|+|.+++.+. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999999653 235899999999999999999999998 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHH
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 668 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~d 668 (720)
. .....+|..|+|||++.+..++.++|||||||++|||++ |++||...+..++...+. ...+++++..+++++++
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHH
Confidence 3 234578999999999999999999999999999999998 799999988888887775 34566788899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 669 IIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 669 LI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
||.+||+.||.+|||+.+|+++|++++.
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=420.26 Aligned_cols=266 Identities=31% Similarity=0.512 Sum_probs=215.3
Q ss_pred CccccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 004986 428 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 499 (720)
Q Consensus 428 ~~~~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL 499 (720)
+..+++++.++|+++++||+|+||+||+|++ +++.||||++.... .......+.+|..++.++ +|+|||.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3445678889999999999999999999986 23679999986543 334456777888888887 78999999
Q ss_pred eeeeecC-CceEEEEeecCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCC
Q 004986 500 MGAVTRP-PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 563 (720)
Q Consensus 500 ~g~~~~~-~~l~LVmEy~~ggsL~d~L~~~---------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDL 563 (720)
++++... ..+++|||||++|+|.+++... ...+++.+++.++.||+.||+|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9987664 4689999999999999998642 235889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 004986 564 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 640 (720)
Q Consensus 564 KPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG-~~PF~~~ 640 (720)
||+||||+.++++||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++| .+||.+.
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654332 223456799999999999999999999999999999999986 5678776
Q ss_pred ChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 641 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 641 ~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
...+.+........++.+|..+++++++||.+||+.||.+|||+.||+++|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 65444444433445667888999999999999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-50 Score=420.81 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=227.4
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 503 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~ 503 (720)
.++++.++|++.+.||+|+||+||+|++. ++.||||++.... ......+|.+|+.+|++++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 35677789999999999999999999863 3689999986543 445567899999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVH 560 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~~~-----------------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIH 560 (720)
.+.+.+++||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999985321 24788999999999999999999998 999
Q ss_pred eCCCCCcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 004986 561 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPW 637 (720)
Q Consensus 561 rDLKPeNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~-~PF 637 (720)
|||||+||||+.++.+||+|||+++...... ....+..||+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654332 2234567899999999999999999999999999999999985 689
Q ss_pred CCCChHHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 004986 638 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 695 (720)
Q Consensus 638 ~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~ 695 (720)
.+.+..++...+... ..+.+|..+++++.+||.+||+.||.+|||+.||++.|+++.
T Consensus 244 ~~~~~~e~~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 888888888777643 356678899999999999999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=430.39 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=220.4
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHH-HcCCCceeEEeeeeecCCceEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~-~L~HpNIVkL~g~~~~~~~l~L 511 (720)
.++|++++.||+|+||+||+|++ +++.||||++.+... .......+..|+.++. .++|||||++++++.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 37899999999999999999988 789999999975432 1122445667777665 6899999999999999999999
Q ss_pred EEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCc
Q 004986 512 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 512 VmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~ 591 (720)
|||||++|+|.+++... ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999999754 36899999999999999999999998 9999999999999999999999999998766555
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 671 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~ 671 (720)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.. ..+.+|..+++++++||.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDLLV 235 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHHH
Confidence 555667899999999999999999999999999999999999999999999888877753 356778899999999999
Q ss_pred HhhhcCCCCCCCHH-HHHH
Q 004986 672 ECWQTDPSLRPSFA-QLTV 689 (720)
Q Consensus 672 ~cL~~DP~kRPS~~-ELL~ 689 (720)
+||.+||.+||++. ++++
T Consensus 236 ~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGG
T ss_pred HhcccCCCCCcCHHHHHHh
Confidence 99999999999995 7765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-50 Score=433.73 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=221.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 512 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LV 512 (720)
+++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+|+.++|||||+++++|.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999987 6899999998754321 12345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 592 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~ 592 (720)
|||+.+|+|.+++.+.+ .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999987643 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHHHHHHHHH
Q 004986 593 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 672 (720)
Q Consensus 593 ~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~ 672 (720)
..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...+...+.. ....+|..+++++.+||.+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999988888877743 3456778899999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHH
Q 004986 673 CWQTDPSLRP-----SFAQLTVA 690 (720)
Q Consensus 673 cL~~DP~kRP-----S~~ELL~~ 690 (720)
||++||.+|+ +++++++|
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhhCHHhccccccccHHHHHcC
Confidence 9999999994 89999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=421.80 Aligned_cols=256 Identities=28% Similarity=0.503 Sum_probs=217.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
.++|+++++||+|+||+||+|++ +++ .||+|++.... .....++|.+|+.+|++++|||||++++++.+ ...
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCe
Confidence 36799999999999999999987 333 58888876432 22345678999999999999999999999986 467
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+++|||+.+++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 8889999999999988777778999999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 590 TFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 590 ~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
... ......||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.+..++...+. ...++..|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 322 2233468999999999999999999999999999999998 899999888777766554 334567788999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
.+||.+||+.||.+|||+.||+.+|+++.+
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998854
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=417.73 Aligned_cols=260 Identities=32% Similarity=0.554 Sum_probs=217.7
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCce
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 509 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l 509 (720)
+++|..++|++++.||+|+||+||+|++ +++.||||++...... ...|.+|+.+|++++|||||++++++.+ +.+
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 3567789999999999999999999988 4567999998765543 3578999999999999999999999854 668
Q ss_pred EEEEeecCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 510 SIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~-~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
++||||+++|+|..++.. ....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhcc
Confidence 999999999999998864 2346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhccccccCCCCCCcHHH
Q 004986 589 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~-~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG-~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~l 666 (720)
... .......||+.|+|||++.+..++.++|||||||++|||++| .+||......++...+.. ..+...+..+++++
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l 243 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESL 243 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHH
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHH
Confidence 332 223345799999999999999999999999999999999996 455566777777766653 34556788999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 667 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
++||.+||+.||++||++++|+..|+.+...
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999999999999988775543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=417.95 Aligned_cols=258 Identities=33% Similarity=0.530 Sum_probs=216.9
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 507 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~-~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~ 507 (720)
|..++|++.+.||+|+||.||+|++. ...||||++..... .....++|.+|+.+|++++|||||++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 45688999999999999999999862 23689998876543 33446789999999999999999999999976 5
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhc
Confidence 778999999999999988765567999999999999999999999998 999999999999999999999999999976
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHhhhhccccccCCCCCCc
Q 004986 588 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 663 (720)
Q Consensus 588 ~~~~~---~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls 663 (720)
..... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.....+++.+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 44322 2233468889999999999999999999999999999997 8999999999998888876666777888999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 664 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 664 ~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
..+++||.+||+.||++|||+.||++.|++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999999999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=424.25 Aligned_cols=249 Identities=18% Similarity=0.296 Sum_probs=219.2
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|++++.||+|+||+||+|.+ +++.||||++.... .....+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999987 68899999997653 23456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC--CCcEEEEeccccccccCCc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 591 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~IKL~DFGlAk~~~~~~ 591 (720)
|||+||+|.+++.+....+++.+++.|+.||+.||+|||++| |+||||||+|||++. .+.+||+|||+++......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999876667999999999999999999999998 999999999999985 4589999999998764432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CCCCCCcHHHHHH
Q 004986 592 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 669 (720)
Q Consensus 592 ~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ip~~ls~~l~dL 669 (720)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+++..+......+ ..+..+++++++|
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 2344679999999999999999999999999999999999999999999888887775332222 1224689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 004986 670 IWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~ 690 (720)
|.+||.+||.+|||+.|+++|
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=415.59 Aligned_cols=247 Identities=24% Similarity=0.254 Sum_probs=204.8
Q ss_pred EeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH---HHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEee
Q 004986 441 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA---ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~---~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
.+++||+|+||+||+|++ +++.||||++........ ....+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999987 688999999876543221 234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccCC
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 595 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~~ 595 (720)
+.++++..++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 988777666543 457899999999999999999999998 99999999999999999999999999987766555556
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc------------------
Q 004986 596 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------------------ 656 (720)
Q Consensus 596 s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~------------------ 656 (720)
..+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 67899999999998754 57999999999999999999999999888776654442110000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 --------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 --------~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.+...+++++++||.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0113568899999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=418.18 Aligned_cols=261 Identities=31% Similarity=0.585 Sum_probs=223.6
Q ss_pred CCCCCCeeEeEEeeecCcEEEEEEEE--CCc--EEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeecCC
Q 004986 433 EIPWEDLVLGERIGLGSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 507 (720)
Q Consensus 433 ~i~~~~y~i~k~LGkG~fG~Vyka~~--~g~--~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~~~ 507 (720)
.|++++|++.++||+|+||+||+|++ ++. .||||++..... ......+.+|+++|+++ +|||||++++++.+++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 36789999999999999999999987 444 477787754332 23456789999999999 7999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC
Q 004986 508 NLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 572 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~---------------~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~ 572 (720)
.+++||||+++|+|.+++.+. ...+++.+++.++.||+.||.|||+++ ||||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 999999999999999999653 356899999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHhhhhc
Q 004986 573 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGF 651 (720)
Q Consensus 573 ~g~IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~-~PF~~~~~~~i~~~i~~ 651 (720)
++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..++...+..
T Consensus 163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 9999999999998654432 233457999999999999999999999999999999999965 67888888888877653
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhc
Q 004986 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 698 (720)
Q Consensus 652 ~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~ 698 (720)
..++..+..+++++++||.+||+.||++||++.||+++|+++.+..
T Consensus 242 -~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 242 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 3466788899999999999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-49 Score=428.21 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=211.2
Q ss_pred CCCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeeeeecCCc
Q 004986 435 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 508 (720)
Q Consensus 435 ~~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~ 508 (720)
.+++|+++++||+|+||+||+|++ +++.||||++.+..... ........|+.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 468999999999999999999987 68999999987543221 112222345667777789999999999999999
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999999764 46899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh-ccccccCCCCCCcHHH
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEIPKELDPLV 666 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~-~~~~~~~ip~~ls~~l 666 (720)
.. .....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+......... .......++..+++++
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 234568999999999996 4568999999999999999999999998755433322211 2334556778899999
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHHH
Q 004986 667 ARIIWECWQTDPSLRPS-----FAQLTVA 690 (720)
Q Consensus 667 ~dLI~~cL~~DP~kRPS-----~~ELL~~ 690 (720)
++||.+||++||.+||+ ++|+++|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999 7888875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-49 Score=410.46 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=218.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCH-------HHHHHHHHHHHHHHHcC-CCceeEEeeeeec
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-------AALLEFKREVKIMRRLR-HPNVVLFMGAVTR 505 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~-------~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~ 505 (720)
.++|++.+.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999987 78999999998764321 12345789999999996 9999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
++.+|||||||++|+|.+++... ..+++.+++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999764 47999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--C
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--E 657 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g------~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~ 657 (720)
...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....... .
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 765532 3455789999999999863 346889999999999999999999999998887776665433222 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....+++++++||.+||+.||++||+++|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 334789999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=413.49 Aligned_cols=262 Identities=32% Similarity=0.549 Sum_probs=225.9
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 500 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~ 500 (720)
+++|+.++|++++.||+|+||.||+|+.. +..||||++.... ......++.+|...+.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 36788899999999999999999999752 2469999986544 445567888999999988 899999999
Q ss_pred eeeecCCceEEEEeecCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 501 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 501 g~~~~~~~l~LVmEy~~ggsL~d~L~~~~---------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
++|.+++.+++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 99999999999999999999999996542 35899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~~--~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+|||++.++.+||+|||+++....... ......||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999987654322 2344578999999999999999999999999999999997 7999999888
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
.++...+. ...++..|..+++++++||.+||+.||.+|||+.||++.|+++..
T Consensus 244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 88777665 345667888999999999999999999999999999999998864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=415.09 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=211.0
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|++++.||+|+||+||+|++ +++.||||++......+.....+.+|+++|++++|||||+++++|.+++.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 47899999999999999999987 5899999999765544444567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
||+.++.+..........+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999765555554555567999999999999999999999998 999999999999999999999999999877665555
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccc----------------cc
Q 004986 594 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------------RL 656 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~----------------~~ 656 (720)
.....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+..... ..
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 66678999999999987765 57899999999999999999999998876655433211000 00
Q ss_pred C-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 657 E-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 657 ~-----------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ....+++++++||.+||..||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 112567899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=411.11 Aligned_cols=264 Identities=29% Similarity=0.446 Sum_probs=227.5
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEE-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 502 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~ 502 (720)
.+++..++|+++++||+|+||.||+|++ .++.||||++.... ......++.+|+.+++++ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4567789999999999999999999975 34679999987654 344566789999999999 79999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCC
Q 004986 503 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 565 (720)
Q Consensus 503 ~~~~~~l~LVmEy~~ggsL~d~L~~~~-----------------~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKP 565 (720)
+.+...+++|||||++|+|.+++.+.. ..+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999986432 25889999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 004986 566 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 642 (720)
Q Consensus 566 eNILLd~~g~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELlt-G~~PF~~~~~ 642 (720)
+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++ |.+||...+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765432 22344679999999999999999999999999999999998 5666767666
Q ss_pred HHHHhhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 643 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 643 ~~i~~~i~~~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.+.+..+.....++..+..++..+.+||.+||+.||.+|||+.||++.|+++...
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 5555544445556677788999999999999999999999999999999876543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-48 Score=405.86 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=210.5
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEEe
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 514 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVmE 514 (720)
+++|+++++||+|+||+||+|++ +++.||||++......+.....+.+|+.+|++++|||||+++++|.+.+..+++||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 47899999999999999999987 68999999997765544445778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcccC
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 594 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~~ 594 (720)
|+.++.+..+... ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++..........
T Consensus 81 ~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9988777776654 457999999999999999999999998 9999999999999999999999999998776554555
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc--------------------
Q 004986 595 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------- 653 (720)
Q Consensus 595 ~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~-------------------- 653 (720)
....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 566799999999999764 56899999999999999999999999887665544321000
Q ss_pred -------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
........+++.+++||.+||++||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0012335678899999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=407.34 Aligned_cols=251 Identities=28% Similarity=0.375 Sum_probs=209.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--C-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEeeeeec-----
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTR----- 505 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L---~HpNIVkL~g~~~~----- 505 (720)
++|++++.||+|+||+||+|++ + ++.||||++............+.+|+.+|+.| +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999987 2 56799999876544333333455777777665 79999999999853
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...++++|||+.++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 34689999999988877766666667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc------------
Q 004986 586 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------ 653 (720)
Q Consensus 586 ~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~------------ 653 (720)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65443 33456789999999999999999999999999999999999999999988776654432100
Q ss_pred -------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -------------~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
....++..+++.+++||.+||++||.+|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0112345678999999999999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=409.54 Aligned_cols=260 Identities=32% Similarity=0.531 Sum_probs=228.2
Q ss_pred ccCCCCCCeeEeEEeeecCcEEEEEEEEC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeee
Q 004986 431 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 503 (720)
Q Consensus 431 ~~~i~~~~y~i~k~LGkG~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~ 503 (720)
+++|.+++|++.+.||+|+||+||+|.+. ++.||||++.... .......|.+|+.++++++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 46788899999999999999999999763 4689999987543 445566789999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC
Q 004986 504 TRPPNLSIITEFLPRGSLFRILHR---------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 574 (720)
Q Consensus 504 ~~~~~l~LVmEy~~ggsL~d~L~~---------~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 574 (720)
..+...++||||+++|+|.+++.. ....+++..+++++.|++.||.|||+++ |+||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 999999999999999999998853 1134788999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHhhhhc
Q 004986 575 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 651 (720)
Q Consensus 575 ~IKL~DFGlAk~~~~~~--~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG-~~PF~~~~~~~i~~~i~~ 651 (720)
++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+....+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999998664432 223345689999999999999999999999999999999998 588999988888877753
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 004986 652 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 694 (720)
Q Consensus 652 ~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i 694 (720)
...+..|..+++.+.+||.+||+.+|.+|||+.||+++|++.
T Consensus 251 -~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 345667889999999999999999999999999999998765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=414.59 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=203.1
Q ss_pred CCeeEeE-EeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeeeeec----CCc
Q 004986 437 EDLVLGE-RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 508 (720)
Q Consensus 437 ~~y~i~k-~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L-~HpNIVkL~g~~~~----~~~ 508 (720)
++|++.+ .||+|+||+||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|.+ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 6898875 699999999999987 6889999998643 3466899887655 89999999999875 456
Q ss_pred eEEEEeecCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC---CCcEEEEecccc
Q 004986 509 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 584 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~-~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~IKL~DFGlA 584 (720)
+|||||||+||+|.+++.+. ...+++.+++.|+.||+.||+|||++| |+||||||+|||++. .+.+||+|||+|
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccccee
Confidence 89999999999999999764 346999999999999999999999998 999999999999985 567999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--cccccCCC---
Q 004986 585 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP--- 659 (720)
Q Consensus 585 k~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~--~~~~~~ip--- 659 (720)
+..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.......+.. ......+|
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 162 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp EECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 876543 334557899999999999999999999999999999999999999987665444333221 11222233
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 660 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 660 -~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..+++++++||.+||++||.+|||+.|+++|
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2578999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=405.07 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=217.5
Q ss_pred EeEEeeecCcEEEEEEEEC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec-CCceEEEEe
Q 004986 441 LGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITE 514 (720)
Q Consensus 441 i~k~LGkG~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~-~~~l~LVmE 514 (720)
..++||+|+||+||+|++. ...||||++... .......+|.+|+++|++++|||||++++++.+ +..+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3688999999999999872 235899988643 345567889999999999999999999999765 567999999
Q ss_pred ecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCcc--
Q 004986 515 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 592 (720)
Q Consensus 515 y~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~-- 592 (720)
||++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999887777889999999999999999999998 99999999999999999999999999987543321
Q ss_pred --cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhccccccCCCCCCcHHHHHH
Q 004986 593 --SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLVARI 669 (720)
Q Consensus 593 --~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~~~~~~~ip~~ls~~l~dL 669 (720)
......||+.|+|||.+.+..++.++||||||+++|||++|..||.. .+..++...+. ...++..|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHHH
Confidence 22335689999999999999999999999999999999998777755 34444444443 344667788999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCC
Q 004986 670 IWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 701 (720)
Q Consensus 670 I~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~ 701 (720)
|.+||+.||++||++.||+++|+.+...+..+
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999998876654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=404.22 Aligned_cols=241 Identities=22% Similarity=0.383 Sum_probs=205.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHH----HHHHHHHHHHHHHHcC--CCceeEEeeeeecCCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA----ALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~----~~~e~~~Ei~iL~~L~--HpNIVkL~g~~~~~~~ 508 (720)
++|++.+.||+|+||+||+|++ +++.||||++.+...... ....+.+|+.+|++++ |||||+++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999987 689999999976543221 1234668999999996 8999999999999999
Q ss_pred eEEEEeecCC-CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-CCcEEEEecccccc
Q 004986 509 LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 586 (720)
Q Consensus 509 l~LVmEy~~g-gsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~IKL~DFGlAk~ 586 (720)
+++||||+.+ +++.+++.+. ..+++.+++.++.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 6888888653 36999999999999999999999998 999999999999985 57999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccccCCCCCCcHH
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 665 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g~~~-s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~~ip~~ls~~ 665 (720)
.... ...+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+ ++. .....++..++++
T Consensus 161 ~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~------~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFFRQRVSSE 230 (273)
T ss_dssp CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCCSSCCCHH
T ss_pred cccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHh------hcccCCCCCCCHH
Confidence 5443 2345789999999999987765 577999999999999999999997632 221 1234567789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 666 VARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 666 l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
+++||.+||.+||.+|||++|+++|
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=386.34 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=215.6
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCCceEEEE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~~l~LVm 513 (720)
+++|+++++||+|+||+||+|++ +++.||||+++...........+.+|+.+|+.++|||||+++++|.+...+++||
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 47899999999999999999987 6889999999877666666788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCCccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 593 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~~~~ 593 (720)
|++.+++|..++... ..+++..+..++.|++.||+|||+++ ||||||||+||||+.++.+||+|||+++........
T Consensus 81 ~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999998888654 47899999999999999999999998 999999999999999999999999999987665555
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHhhhhc--------------------
Q 004986 594 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGF-------------------- 651 (720)
Q Consensus 594 ~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~-~~~~~i~~~i~~-------------------- 651 (720)
.....+++.|+|||++.+.. ++.++|||||||++|||++|+.||.. .+..+....+..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 55567889999999988765 68999999999999999999998654 344433332210
Q ss_pred -------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 652 -------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 652 -------~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
..........+++.+.+||.+||+.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112335678899999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=397.39 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=207.7
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC------
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 507 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~------ 507 (720)
.++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 37899999999999999999987 5899999999877666667778999999999999999999999997665
Q ss_pred ceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccc
Q 004986 508 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 587 (720)
Q Consensus 508 ~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~ 587 (720)
.+|+||||+ +.+|..++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 479999999 6688888765 35999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc---------------
Q 004986 588 HNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 651 (720)
Q Consensus 588 ~~~~~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~--------------- 651 (720)
... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 543 3457899999999998764 568999999999999999999999988776544322210
Q ss_pred --------------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 004986 652 --------------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 694 (720)
Q Consensus 652 --------------~~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~i 694 (720)
..........+++++++||.+||..||.+|||+.|+++| |+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000112335678999999999999999999999999987 5443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=390.55 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=203.2
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec--------C
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------P 506 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~--------~ 506 (720)
++|+++++||+|+||+||+|++ +++.||||++......+.....+.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7899999999999999999987 68999999987665555456678899999999999999999998855 3
Q ss_pred CceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 507 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 507 ~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
+.+|+||||+.++.+..+. .....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceeee
Confidence 4689999999877665544 44457899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCc----ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcccccc--CC-
Q 004986 587 KHNTF----LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EI- 658 (720)
Q Consensus 587 ~~~~~----~~~~s~~GT~~Y~APEvi~g~-~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~~--~i- 658 (720)
..... ....+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+....... ..
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 54321 223445799999999999765 68999999999999999999999999887766554432111000 00
Q ss_pred ------------------C---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 659 ------------------P---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 659 ------------------p---------~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. ...++++++||.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0136678999999999999999999999965
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=392.02 Aligned_cols=256 Identities=33% Similarity=0.511 Sum_probs=202.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----ceEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 512 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~----~l~LV 512 (720)
.+|.+.+.||+|+||+||+|+++|+.||||++.... ......+.|+..+..++|||||++++++.+.+ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 468899999999999999999999999999986442 12222345666667789999999999997654 48999
Q ss_pred EeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeeCCCCCcEEEcCCCcEEEEecccccc
Q 004986 513 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 586 (720)
Q Consensus 513 mEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~------g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~ 586 (720)
||||++|+|.+++++. .+++..++.++.|++.||+|||.. ..+||||||||+||||+.++++||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999764 589999999999999999999974 12499999999999999999999999999987
Q ss_pred ccCCcc----cCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCC---------------
Q 004986 587 KHNTFL----SSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMN--------------- 641 (720)
Q Consensus 587 ~~~~~~----~~~s~~GT~~Y~APEvi~g~~------~s~ksDVWSLGilLyELltG~~PF~~~~--------------- 641 (720)
...... .....+||+.|+|||++.+.. ++.++|||||||+||||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 644321 223467999999999987653 5678999999999999999988774321
Q ss_pred hHHHHhhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHh
Q 004986 642 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 697 (720)
Q Consensus 642 ~~~i~~~i~~~~~~~~ip~~-----ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~ 697 (720)
.......+.....++.++.. ....+.+|+.+||+.||.+|||+.||+++|+++.++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 11222222222223333332 234699999999999999999999999999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=391.04 Aligned_cols=249 Identities=23% Similarity=0.274 Sum_probs=202.5
Q ss_pred CeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeec------CCce
Q 004986 438 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPNL 509 (720)
Q Consensus 438 ~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~------~~~l 509 (720)
+|+.+++||+|+||+||+|++ +++.||||++...... +.+|+.+|++++|||||+++++|.. ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 689999999999999999998 6899999999765422 2379999999999999999999853 2347
Q ss_pred EEEEeecCCCCHHHHHc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEecccccc
Q 004986 510 SIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRL 586 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~--~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~ 586 (720)
|||||||+++.+..+.. .....+++.++..|+.||+.||+|||++| |+||||||+||||+.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 89999998764444332 23457999999999999999999999998 99999999999999775 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhcc-------------
Q 004986 587 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 652 (720)
Q Consensus 587 ~~~~~~~~~s~~GT~~Y~APEvi~g-~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~------------- 652 (720)
.... ....+.+||..|+|||++.+ ..|+.++|||||||++|||++|++||...+..+.+..+...
T Consensus 173 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 6543 23445789999999999875 46899999999999999999999999887766554333110
Q ss_pred ----ccc----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhh
Q 004986 653 ----NRR----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 695 (720)
Q Consensus 653 ----~~~----------~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~--L~~i~ 695 (720)
... ......+++++.+||.+||++||.+|||+.|+++| |+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 01224578999999999999999999999999976 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=391.51 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=202.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecCC----ceE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLS 510 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~~----~l~ 510 (720)
++|++++.||+|+||+||+|++ +++.||||++.... .......+.+|+.+|++++|||||++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5699999999999999999987 69999999997644 3445667889999999999999999999986643 235
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccCC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~~ 590 (720)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 556667799999999753 5899999999999999999999998 999999999999999999999999999865432
Q ss_pred c---ccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc-------------
Q 004986 591 F---LSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 653 (720)
Q Consensus 591 ~---~~~~s~~GT~~Y~APEvi~-g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~------------- 653 (720)
. ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+.........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 1234567999999999985 5567899999999999999999999998876544332221000
Q ss_pred -------------cc---cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -------------RR---LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -------------~~---~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ......+++++++||.+||+.||.+|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01224678899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-45 Score=379.28 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=204.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpN-IVkL~g~~~~~~~l~LVm 513 (720)
++|++++.||+|+||+||+|++ +++.||||++...... .++..|+++++.++|+| |+.+.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999987 5889999988765432 24678999999997665 555666677788899999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEc---CCCcEEEEeccccccccCC
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 590 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~IKL~DFGlAk~~~~~ 590 (720)
||+ +++|.+.+......+++..++.++.|++.||+|||++| ||||||||+|||++ .+..+||+|||+|+.....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 55677766555567999999999999999999999999 99999999999986 3557999999999976532
Q ss_pred c-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhh------ccccccC
Q 004986 591 F-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------FQNRRLE 657 (720)
Q Consensus 591 ~-------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~------~~~~~~~ 657 (720)
. ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+. .......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 2 22345689999999999999999999999999999999999999998765543332211 0111122
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhH
Q 004986 658 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 696 (720)
Q Consensus 658 ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~ 696 (720)
++..+++++.+||.+||+.+|++||++.++.+.|+.+..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 446789999999999999999999999999999888743
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=395.61 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=213.8
Q ss_pred CCCCCeeEeEEeeecCcEEEEEEEE-----CCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHHcCC-CceeEEeeeeec
Q 004986 434 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTR 505 (720)
Q Consensus 434 i~~~~y~i~k~LGkG~fG~Vyka~~-----~g~~VAVK~i~~~~~--~~~~~~e~~~Ei~iL~~L~H-pNIVkL~g~~~~ 505 (720)
+.+++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 4568899999999999999999976 478999999865432 11224457789999999966 899999999999
Q ss_pred CCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 506 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 506 ~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...+++||||+.+|+|.+++.... .+.+..++.++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999999997643 5788999999999999999999998 9999999999999999999999999998
Q ss_pred cccCC-cccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhc--cccccCCCC
Q 004986 586 LKHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPK 660 (720)
Q Consensus 586 ~~~~~-~~~~~s~~GT~~Y~APEvi~g~--~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~--~~~~~~ip~ 660 (720)
.+... .....+..|++.|+|||.+.+. .++.++|||||||+||+|++|..||.+.+..+....+.. ....+.++.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 65432 2234456899999999999765 467899999999999999999999988655444333321 223456778
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH--HHhh
Q 004986 661 ELDPLVARIIWECWQTDPSLRP-----SFAQLTVA--LKPL 694 (720)
Q Consensus 661 ~ls~~l~dLI~~cL~~DP~kRP-----S~~ELL~~--L~~i 694 (720)
.+++++++||.+||.+||.+|| +++|+++| ++++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 8999999999999999999999 58899874 5444
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=390.06 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=206.3
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC-----Cce
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 509 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~-----~~l 509 (720)
++|+++++||+|+||+||+|++ +++.||||++............+.+|+.+|++++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 7899999999999999999987 689999999987766666677889999999999999999999998643 345
Q ss_pred EEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEeccccccccC
Q 004986 510 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 589 (720)
Q Consensus 510 ~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~~ 589 (720)
+++|||+.+|+|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCc
Confidence 6777888899999999653 6999999999999999999999998 99999999999999999999999999976543
Q ss_pred CcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccccc-------------
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 655 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~~~------------- 655 (720)
. ..+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+......
T Consensus 174 ~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp G---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred c---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 2 34568999999999977654 688999999999999999999999987766554433211000
Q ss_pred --------cC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 656 --------LE--------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 656 --------~~--------ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
.. ....+++++++||.+||+.||.+|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 113578899999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-44 Score=376.20 Aligned_cols=259 Identities=17% Similarity=0.244 Sum_probs=215.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC-CceeEEeeeeecCCceEEEE
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSIIT 513 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H-pNIVkL~g~~~~~~~l~LVm 513 (720)
++|+++++||+|+||+||+|++ +++.||||++...... ..+.+|+++++.+.| +||+.+++++.+....++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 6899999999999999999987 6889999988654322 246678899999965 89999999999999999999
Q ss_pred eecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcC-----CCcEEEEecccccccc
Q 004986 514 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKH 588 (720)
Q Consensus 514 Ey~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~-----~g~IKL~DFGlAk~~~ 588 (720)
||+ +++|.+++......+++..++.++.|++.||+|||++| ||||||||+||||+. ++.+||+|||+|+...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999 78999998776678999999999999999999999999 999999999999974 6789999999998754
Q ss_pred CCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHhhhhccc---cc
Q 004986 589 NTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQN---RR 655 (720)
Q Consensus 589 ~~~-------~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~---~i~~~i~~~~---~~ 655 (720)
... ......+||+.|||||++.+..++.++|||||||++|||++|..||.+.... .....+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 321 1234568999999999999999999999999999999999999999865432 2222222111 11
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhHhcCCCC
Q 004986 656 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 702 (720)
Q Consensus 656 ~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~L~~i~~~~~p~~ 702 (720)
..++..+++++.+|+..|+..+|++||+++.+.+.|+++.+...-..
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 23446789999999999999999999999999999998865554433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=382.82 Aligned_cols=243 Identities=20% Similarity=0.301 Sum_probs=199.8
Q ss_pred CCCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeec--CCceE
Q 004986 436 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLS 510 (720)
Q Consensus 436 ~~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~--~~~l~ 510 (720)
.++|+++++||+|+||+||+|++ +++.||||++.... ...+.+|+.+|+.+. ||||++++++|.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36899999999999999999987 68999999986543 456789999999995 9999999999874 45699
Q ss_pred EEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCC-cEEEEeccccccccC
Q 004986 511 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 589 (720)
Q Consensus 511 LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~IKL~DFGlAk~~~~ 589 (720)
+|||||.+++|..+. ..+++..+..++.||+.||+|||++| ||||||||+||||+.++ .+||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999987764 35899999999999999999999999 99999999999998655 699999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHhhhh----------------c
Q 004986 590 TFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVG----------------F 651 (720)
Q Consensus 590 ~~~~~~s~~GT~~Y~APEvi~g~~-~s~ksDVWSLGilLyELltG~~PF~~~~~~~-i~~~i~----------------~ 651 (720)
. ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||....... ....+. .
T Consensus 183 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 G-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp T-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 3 2345568999999999988754 7999999999999999999999997654321 110000 0
Q ss_pred c-------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 652 Q-------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 652 ~-------------------~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
. .........+++++++||.+||+.||.+|||++|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00001123478899999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=388.53 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=197.1
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeeeeecC------Cc
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNIVkL~g~~~~~------~~ 508 (720)
++|+++++||+|+||+||+|.+ +++.||||++............+.+|+.+|++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999987 589999999988777777777899999999999999999999999643 57
Q ss_pred eEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEecccccccc
Q 004986 509 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 588 (720)
Q Consensus 509 l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk~~~ 588 (720)
+|+|||||.++. .+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l-~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANL-CQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEH-HHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHH-HHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhccc
Confidence 899999997654 44443 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHhhhhccc---------------
Q 004986 589 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 653 (720)
Q Consensus 589 ~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~i~~~i~~~~--------------- 653 (720)
.. ......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 43 33445689999999999999999999999999999999999999998877654433221000
Q ss_pred -----ccc--------------CC------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 004986 654 -----RRL--------------EI------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 690 (720)
Q Consensus 654 -----~~~--------------~i------p~~ls~~l~dLI~~cL~~DP~kRPS~~ELL~~ 690 (720)
... .. +...++++.+||.+||..||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00 01246689999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-39 Score=343.33 Aligned_cols=246 Identities=19% Similarity=0.288 Sum_probs=188.7
Q ss_pred CCeeEeEEeeecCcEEEEEEEE--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-----------CCceeEEeeee
Q 004986 437 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFMGAV 503 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-----------HpNIVkL~g~~ 503 (720)
.+|+++++||+|+||+||+|++ +++.||||++.... .....+.+|+.+++.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 68999999987543 23456778898888875 57899999987
Q ss_pred ecC--CceEEEEeecCCCCH--HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeeCCCCCcEEEcCCCc---
Q 004986 504 TRP--PNLSIITEFLPRGSL--FRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWN--- 575 (720)
Q Consensus 504 ~~~--~~l~LVmEy~~ggsL--~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~--- 575 (720)
... ...+++|+++..+.. ..........+++..+..++.||+.||+|||+ +| |+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 653 456666776654432 22334455678999999999999999999997 67 999999999999986654
Q ss_pred ---EEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------H
Q 004986 576 ---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-------V 645 (720)
Q Consensus 576 ---IKL~DFGlAk~~~~~~~~~~s~~GT~~Y~APEvi~g~~~s~ksDVWSLGilLyELltG~~PF~~~~~~~-------i 645 (720)
+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||....... .
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 999999999865432 345689999999999999999999999999999999999999997543210 0
Q ss_pred Hhhhhc-------------------c--------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 004986 646 VGAVGF-------------------Q--------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 686 (720)
Q Consensus 646 ~~~i~~-------------------~--------------------~~~~~ip~~ls~~l~dLI~~cL~~DP~kRPS~~E 686 (720)
...+.. . ......+...++++++||.+||.+||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000000 0 0011122345678999999999999999999999
Q ss_pred HHHH
Q 004986 687 LTVA 690 (720)
Q Consensus 687 LL~~ 690 (720)
+++|
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9.5e-24 Score=205.41 Aligned_cols=165 Identities=18% Similarity=0.135 Sum_probs=120.8
Q ss_pred eeEeEEeeecCcEEEEEEEE-CCcEEEEEEEecCCCC----------------HHHHHHHHHHHHHHHHcCCCceeEEee
Q 004986 439 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----------------GAALLEFKREVKIMRRLRHPNVVLFMG 501 (720)
Q Consensus 439 y~i~k~LGkG~fG~Vyka~~-~g~~VAVK~i~~~~~~----------------~~~~~e~~~Ei~iL~~L~HpNIVkL~g 501 (720)
+.++++||+|+||+||+|++ +|+.||||+++..... ......+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999986 7899999987532110 111234567899999999999999887
Q ss_pred eeecCCceEEEEeecCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeeCCCCCcEEEcCCCcEEEEec
Q 004986 502 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 581 (720)
Q Consensus 502 ~~~~~~~l~LVmEy~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~IKL~DF 581 (720)
+.. .+++|||+++..+.+ +.......++.||+.+|+|||++| |+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 642 379999998865433 344445678999999999999998 9999999999999865 5999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcc-----cccCCCCCchhhHHHHHHH
Q 004986 582 GLSRLKHNTFLSSKSTAGTPEWMAPE-----VLRNEPSNEKCDVYSFGVI 626 (720)
Q Consensus 582 GlAk~~~~~~~~~~s~~GT~~Y~APE-----vi~g~~~s~ksDVWSLGil 626 (720)
|+|........ ..|.... .+..+.|+.++|+||+.--
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99976543211 1122111 0123557888999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=2.8e-07 Score=90.72 Aligned_cols=141 Identities=15% Similarity=0.021 Sum_probs=94.6
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecCCceEEEEee
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 515 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~~~l~LVmEy 515 (720)
+.|++.+..+-++.+.||++...+..+.||+........ ...+.+|..++..+. +--+.+++.++.+++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 456666655555557999998888888899875443211 234667888888773 33356677777888889999999
Q ss_pred cCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 004986 516 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS----------------------------------------- 554 (720)
Q Consensus 516 ~~ggsL~d~L~~~~~~lse~~~~~Ia~qIa~AL~yLHs~----------------------------------------- 554 (720)
++|..+.+..... .. ...++.+++..|..||+.
T Consensus 92 l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9998876654221 11 112333444444444431
Q ss_pred ----------------CCCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 555 ----------------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 555 ----------------g~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127999999999999977666799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=4.2e-05 Score=74.27 Aligned_cols=73 Identities=16% Similarity=0.156 Sum_probs=50.2
Q ss_pred EeeecCc-EEEEEEEEC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeeeeecCCceEEEEeecCCC
Q 004986 444 RIGLGSY-GEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 444 ~LGkG~f-G~Vyka~~~-g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H--pNIVkL~g~~~~~~~l~LVmEy~~gg 519 (720)
.+..|.. ..||+.+.. +..+.+|....... ..+..|...|+.+.. -.+.+++.+..+.+..++||||++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4556654 689999874 45577786544332 245677778877732 33567788888888899999999876
Q ss_pred CH
Q 004986 520 SL 521 (720)
Q Consensus 520 sL 521 (720)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00018 Score=75.72 Aligned_cols=77 Identities=16% Similarity=0.093 Sum_probs=47.1
Q ss_pred eEEeeecCcEEEEEEEE--CCcEEEEEEEecCC-CC----HHHHHHHHHHHHHHHHc-CC--CceeEEeeeeecCCceEE
Q 004986 442 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FS----GAALLEFKREVKIMRRL-RH--PNVVLFMGAVTRPPNLSI 511 (720)
Q Consensus 442 ~k~LGkG~fG~Vyka~~--~g~~VAVK~i~~~~-~~----~~~~~e~~~Ei~iL~~L-~H--pNIVkL~g~~~~~~~l~L 511 (720)
.+.||.|....||+++. .++.+.||.-.... .. .........|...|+.+ .+ ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999975 46678888543210 00 01122345677777766 33 335555544 4456689
Q ss_pred EEeecCCCC
Q 004986 512 ITEFLPRGS 520 (720)
Q Consensus 512 VmEy~~ggs 520 (720)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.59 E-value=0.0023 Score=64.03 Aligned_cols=145 Identities=13% Similarity=0.017 Sum_probs=76.9
Q ss_pred CCeeEeEEeeecCcEEEEEEEECCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCC-----CceeEEee---eeecCCc
Q 004986 437 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-----PNVVLFMG---AVTRPPN 508 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~H-----pNIVkL~g---~~~~~~~ 508 (720)
..+.-.+.|..|.--+.|+++.++..+++|++..... ..++..|+.++..|.. |..+...+ +......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 4455566677888899999988777899998754321 2345556667776632 22222111 1112334
Q ss_pred eEEEEeecCCCCHH-----------HHH---c----CC--C--CC------------------CCHHHHHHHHHHHHHHH
Q 004986 509 LSIITEFLPRGSLF-----------RIL---H----RP--H--CQ------------------VDEKRRIKMALDVARGM 548 (720)
Q Consensus 509 l~LVmEy~~ggsL~-----------d~L---~----~~--~--~~------------------lse~~~~~Ia~qIa~AL 548 (720)
...++.++.+.... ..+ + .. . .. .........+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 55566666543210 000 0 00 0 00 00111112223333334
Q ss_pred HHHHhCC--CCEEeeCCCCCcEEEcCCCcEEEEeccccc
Q 004986 549 NCLHTST--PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 585 (720)
Q Consensus 549 ~yLHs~g--~~IIHrDLKPeNILLd~~g~IKL~DFGlAk 585 (720)
...+..+ .++||+|+.++|||++.+...-|+||+.+.
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 4333321 159999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.39 E-value=0.0033 Score=65.44 Aligned_cols=75 Identities=16% Similarity=0.256 Sum_probs=49.4
Q ss_pred CCeeEeEEeeecCcEEEEEEEEC---------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeeeeecC
Q 004986 437 EDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP 506 (720)
Q Consensus 437 ~~y~i~k~LGkG~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~-HpNIVkL~g~~~~~ 506 (720)
+++++ +.|+-|-.-.+|+++.. .+.|.+++..... . .....+|..+++.+. +.-..++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34444 67888999999999763 2456666654221 1 234568888998884 4334477777653
Q ss_pred CceEEEEeecCCCC
Q 004986 507 PNLSIITEFLPRGS 520 (720)
Q Consensus 507 ~~l~LVmEy~~ggs 520 (720)
.+||||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 68999998643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.10 E-value=0.0078 Score=60.88 Aligned_cols=67 Identities=10% Similarity=0.047 Sum_probs=42.8
Q ss_pred cEEEEEEEE-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHHcCCCce--eEEee-----eeecCCceEEEEeecCCC
Q 004986 450 YGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV--VLFMG-----AVTRPPNLSIITEFLPRG 519 (720)
Q Consensus 450 fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~e~~~Ei~iL~~L~HpNI--VkL~g-----~~~~~~~l~LVmEy~~gg 519 (720)
--.||+++. +|+.|++|+.+..... ..++..|+..+..|...+| +..+. .+......+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999986 7888999987655443 3456678888877742222 11111 223455678899998754
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.68 E-value=0.088 Score=52.78 Aligned_cols=52 Identities=15% Similarity=0.177 Sum_probs=44.3
Q ss_pred eeeeccccchhhHHHHHHHhhhcCCCceeeecccccCCCCCceeEEeecCcceee-hc
Q 004986 20 IGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREFL-VD 76 (720)
Q Consensus 20 ~~~~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~d 76 (720)
+-.-+.|.|.|=|.||-.|+-.+|++||.|.|.. |-+|.+|.+.+..++| ||
T Consensus 135 ll~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~~~-----~H~W~Ev~~~~~~rWv~vD 187 (287)
T d2f4ma1 135 LLETRCGRCGEWANCFTLCCRALGFEARYVWDYT-----DHVWTEVYSPSQQRWLHCD 187 (287)
T ss_dssp HHHHCEESHHHHHHHHHHHHHHTTCCEEEEEETT-----TEEEEEEEETTTTEEEEEE
T ss_pred HHHhcCccHHHHHHHHHHHHHHcCCCeEEEecCC-----cceeEEEEecCCCcEEEec
Confidence 3456899999999999999999999999999864 7799999998776544 45
|